Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.8558191203490492,-1.9746695838156523,0.0,0.0,0.0,28/83,5.79%,CCL4;GNLY;TRGC2;ITK;NKG7;SPON2;JAML;SAMD3;MYO1G;CCL3;THEMIS;CD2;CCL5;PYHIN1;CD96;CXCR4;GRAP2;VNN2;GZMB;PRF1;CD69;SELL;SLAMF6;CD247;PSTPIP1;TXK;IL10RA;SNX20
prerank,PanglaoDB_Augmented_2021__T Cells,-0.8589225855702746,-1.967065832227412,0.0,0.0,0.0,30/85,5.79%,CCL4;GNLY;ITK;NKG7;JAML;SKAP1;MYO1G;CCL3;THEMIS;CD2;CCL5;PYHIN1;CD96;CXCR4;GRAP2;GZMB;JUNB;PRF1;CD69;IL7R;IFIT3;SELL;SLAMF6;CD247;RORA;PSTPIP1;LSP1;TXK;IL10RA;SNX20
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8466655594059563,-1.9497473224895612,0.0,0.0,0.0,59/84,11.24%,RPS13;RPS4X;RPL28;SRP14;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;RPS20;RPS23;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;RPL23;RPS26;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;RPL18A;RPL27;RPL27A;RPL15;RPL21;RPL18;RPS5
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.8665466542165725,-1.9207158058719918,0.0,0.0,0.0,19/58,3.29%,CCL4;GNLY;ITK;NKG7;JAML;MYO1G;THEMIS;CD2;CCL5;PYHIN1;CD96;CXCR4;GZMB;PRF1;CD69;SELL;SLAMF6;CD247;RORA
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8371837621802986,-1.9069072813685457,0.0,0.0,0.0,58/84,11.24%,RPS13;RPS4X;RPL28;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;RPS20;RPS23;RPL29;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;TMA7;RPL23;RPS26;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;RPL18A;RPL27;RPL27A;RPL15;RPL21;RPL18;RPS5
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8396316093128978,-1.9021583249218041,0.0,0.0,0.0,59/87,11.24%,RPS13;RPS4X;RPL28;SRP14;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;RPS20;RPS23;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;RPL23;RPS26;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;RPL18A;RPL27;RPL27A;RPL15;RPL21;RPL18;RPS5
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8282005440557195,-1.898866660566333,0.0,0.0011940410153556294,0.01,59/95,11.24%,RPS13;RPS4X;RPL28;SRP14;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;RPS20;RPS23;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;RPL23;RPS26;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;RPL18A;RPL27;RPL27A;RPL15;RPL21;RPL18;RPS5
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.8523269865189893,-1.8837635700548165,0.0,0.0010447858884361757,0.01,24/75,5.79%,GNLY;ITK;NKG7;JAML;SKAP1;MYO1G;THEMIS;CD2;ACAP1;PYHIN1;CD96;GRAP2;GZMB;PRF1;CD69;IL7R;SELL;SLAMF6;CD247;PSTPIP1;LSP1;ARHGEF1;IL10RA;SNX20
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.8594153539683054,1.8805835794604822,0.02702702702702703,1.0,0.49,4/22,1.65%,PRKAB2;AVIL;PDK4;ADIPOR2
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.8475063516847497,-1.8633268403902212,0.0,0.0027860957024964683,0.03,19/58,5.79%,GNLY;NKG7;JAML;MYO1G;CD2;CD37;PYHIN1;CD96;GRAP2;VNN2;GZMB;PRF1;SELL;SLAMF6;CD247;PSTPIP1;LSP1;IL10RA;SNX20
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.8350747431964083,-1.8623425973277765,0.0,0.0025074861322468213,0.03,61/102,11.66%,RPS13;RPS4X;RPL28;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;RPS20;RPS23;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;RPL23;RPS26;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;PNRC2;RPL18A;NCBP2;RPL27;RPL27A;RPL15;RPL21;RPL18;RPS5;EIF4A3
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.8375281361830907,-1.848530876149749,0.0,0.0022795328474971106,0.03,22/64,7.14%,CCL4;GNLY;ITK;JAML;CD2;CCL5;PYHIN1;CD96;GPR183;GZMB;PRF1;CD69;SELL;SLAMF6;CD247;PSTPIP1;LSP1;IL10RA;SNX20;PLEK;SP140;HLA-F
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.8206328110591087,-1.8461954121254838,0.0,0.002089571776872351,0.03,20/72,5.79%,CCL4;GNLY;NKG7;JAML;MYO1G;CD2;CD37;PYHIN1;GPR183;VNN2;GZMB;PRF1;SELL;SLAMF6;CD247;PSTPIP1;LSP1;IL10RA;NCF4;SNX20
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.7398728394672157,-1.8457154330407877,0.0,0.0019288354863437086,0.03,46/127,14.29%,CCL4;JAML;CD36;CCL3;ADGRE1;CXCR4;MNDA;VNN2;IFIT1;AIF1;MX1;IFIT3;SELL;RGS1;RGS2;TNFSF10;LSP1;IFITM3;CD14;IL10RA;FCER1G;NCF4;SNX20;PECAM1;TYMP;CD300LF;PLEK;IRF7;SIRPB2;CLEC12A;LY6E;C5AR1;OAS1;TNFRSF1B;CD44;PLSCR1;NCF2;S100A4;ITGB2;ITGAL;TYROBP;CSF3R;CSF2RB;HLA-DRA;PTPRC;MS4A6A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.9329380872896843,-1.8421772571987942,0.0,0.0017910615230334439,0.03,4/22,1.13%,CCL4;MYLK;CCL3;CCL5
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.8857533770834204,-1.8399572395444115,0.0,0.002228876561997175,0.04,4/32,1.13%,CCL4;MYLK;CCL3;CCL5
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.8273217022992474,-1.839865500794638,0.0,0.0020895717768723513,0.04,20/75,5.79%,CCL4;GNLY;NKG7;JAML;MYO1G;CD2;CD37;CXCR4;VNN2;GZMB;PRF1;CD69;SELL;SLAMF6;CD247;PSTPIP1;LSP1;IL10RA;NCF4;SNX20
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.7677502692214336,-1.826124715066098,0.0,0.0034416476324956374,0.07,23/91,9.93%,GNLY;NKG7;SPON2;JAML;CXCR4;MNDA;VNN2;AIF1;TSPAN32;PSTPIP1;FCER1G;NCF4;SNX20;PECAM1;F13A1;CD300LF;PLEK;LILRB3;FERMT3;CLEC12A;C5AR1;TNFRSF1B;TSPAN9
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7826870464706308,-1.8211199574007566,0.0,0.0037147942699952913,0.08,66/128,11.24%,RPS13;HARS2;RPS4X;RPL28;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;WARS1;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;RPS20;RPS23;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;ABCF1;RPL23;MRPS7;RPS26;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;MRPL51;RPL18A;RPL27;RPL27A;MRPS11;RPL15;MRPL52;MRPL32;RPL21;RPL18;RPS5
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.921826274979592,-1.8198359856857123,0.0,0.0035192787821008023,0.08,16/30,3.22%,GNLY;ITK;NKG7;JAML;THEMIS;CD2;PYHIN1;CD96;GRAP2;GZMB;ZNF831;PRF1;CD69;SELL;SLAMF6;CD247
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.7454273648258294,1.8021654511172358,0.0,1.0,0.82,24/44,18.93%,PLXNB1;LRP4;PLXNA2;CHODL;LRRC4C;PLXNB2;ROBO1;PLXNC1;PLXNA3;BRSK1;LINGO1;METRN;PTEN;RTN4;NTRK2;ROBO2;PLXNA1;GSK3B;KIF13B;TIAM2;MAP6;MARK2;SLIT2;TIAM1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.8513507756952621,1.8004260457985846,0.0,1.0,0.82,4/17,4.67%,B3GNT2;B4GALT4;GLB1;CHST1
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.9276059085346522,-1.7996536769196898,0.0,0.006268715330617053,0.15,17/29,3.29%,GNLY;ITK;JAML;BCL11B;THEMIS;CD2;PYHIN1;CD96;GZMB;ZNF831;PRF1;CD69;IL7R;SELL;SLAMF6;CD247;RORA
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7396979991964473,-1.7970155984640648,0.0,0.0059702050767781465,0.15,72/175,11.48%,RPS13;HARS2;RPS4X;RPL28;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;WARS1;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;RPS20;RPS23;RPL29;RPLP2;NARS1;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;ABCF1;TMA7;RPL23;MRPL57;MRPS7;RPS26;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;MRPL51;RPL18A;RPL27;RPL27A;MRPS11;RPL15;MRPL52;GTPBP2;MRPL32;RPL21;RPL18;RPS5;KARS1;LARS1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.929864031764369,1.7949152978933205,0.0,1.0,0.82,1/14,0.02%,CPA1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7513038050247501,-1.7865422670494513,0.0,0.0072185206837408495,0.17,64/153,11.66%,RPS13;RPS4X;ZFP36;RPL28;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;RPS20;RPS23;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;RPL23;RPS26;EXOSC10;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;PNRC2;RPL18A;NCBP2;POLR2G;RPL27;RPL27A;RPL15;RPL21;RPL18;RPS5;EIF4A3
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.941932869780181,-1.7802393468899391,0.0,0.009811902256617999,0.2,17/24,3.22%,CCL4;GNLY;TRGC2;NKG7;JAML;SKAP1;KLRC4-KLRK1;CD2;CCL5;PYHIN1;CD96;GRAP2;GZMB;PRF1;SELL;SLAMF6;CD247
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.7512452596725522,1.780025670552771,0.0,1.0,0.86,5/39,1.70%,SHROOM3;COL16A1;PLXNB1;PDPN;FKBP9
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.8536915000555239,1.7732731452752737,0.0,1.0,0.87,4/24,5.62%,TULP2;BBS9;TULP3;INVS
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6705081690528738,1.7700473672506483,0.0,0.9243231126788811,0.87,33/81,18.17%,PPARGC1A;ESRRG;PDZRN4;PCDH17;PLPPR1;NOL4;PBX1;SNAP91;MAGI1;PLPPR4;ASXL3;PTPRD;NFIB;GUCY1A2;SHC2;THSD7A;CNTN4;KALRN;GRIA2;NTRK2;NFASC;CSRNP3;SORBS2;PPFIA2;ABCC8;ERBB4;CNTN3;MAPK4;SYT4;MAP2;CNTN1;PCLO;MAP6
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.9174367028275364,-1.7615734354581762,0.0,0.013930478512482341,0.21,10/25,3.22%,GNLY;TRGC2;NKG7;SPON2;CD2;CCL5;CD96;GZMB;PRF1;CD247
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.7745909554821537,-1.7604046330974445,0.0,0.014376253824881776,0.22,8/56,7.20%,CCL4;CCL3;ZFP36;CCL5;PID1;CHI3L1;GBP3;RPS3
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6671813548974519,1.75922298717795,0.0,0.8949252622016682,0.88,22/77,14.55%,LEPR;PPARGC1A;BAIAP3;PCDH17;PLPPR1;NOL4;SNAP91;PLPPR4;GRIA3;UNC5B;ASXL3;PTPRD;LCORL;SHC2;CNTN4;KALRN;GRIA2;UNC5D;NFASC;CSRNP3;SORBS2;ABCC8
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7920985029720721,-1.7567704444607395,0.0,0.0147877387286351,0.24,25/70,5.79%,CCL4;GNLY;ITK;NKG7;JAML;MYO1G;THEMIS;CD2;PYHIN1;CD96;CXCR4;GRAP2;GZMB;ZNF831;PRF1;CD69;SELL;SLAMF6;CD247;RORA;PSTPIP1;LSP1;IL10RA;IL12RB2;SNX20
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.7195105977656829,-1.7565431928888466,0.0,0.014240044701648615,0.24,37/138,15.58%,ITK;BTN3A1;SKAP1;THEMIS;THEMIS2;GRAP2;PRKCQ;MNDA;NFKBID;PSMB3;VAV3;CD247;EIF2B1;BTK;BTN3A3;TXK;PSMA7;HLA-DRB5;BTN3A2;BTN2A1;PRKD2;PSMB9;PSMB6;BTN2A2;SPG21;FYN;NCKAP1L;PSMA5;PSMC4;PSMD8;HLA-DRA;PLEKHA1;PTPRC;PSMD12;PIK3CB;HLA-DPA1;PSME2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.903454773240963,-1.7531055951339403,0.0,0.015522533199623182,0.27,4/21,1.13%,CCL4;JAML;CCL3;CCL5
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.8192099369107565,-1.7502244921454904,0.0,0.01585192382454887,0.29,5/39,1.72%,CCL4;MYLK;CCL3;CCL5;PLN
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.7136012402788563,-1.7439420909565515,0.0,0.018109622066227044,0.37,25/111,7.33%,CCL4;NKG7;JAML;MYO1G;MCTP2;CD37;CXCR4;GPR183;MNDA;VNN2;GZMB;AIF1;SELL;SLAMF6;PSTPIP1;BTK;LSP1;IL10RA;FCER1G;NCF4;SNX20;CD300LF;IL3RA;PLEK;IRF7
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.7196871446336404,-1.7417339632359383,0.0,0.018064685038767424,0.38,29/92,13.96%,JAML;IL4I1;HLA-B;CD96;RSAD2;DHX58;CD200R1;B2M;SELL;SLAMF6;CD247;HLA-C;CD300LF;HLA-F;IRF7;KLRD1;IRF1;OSCAR;PLSCR1;CD226;ERAP1;KLRF1;ITGB2;ITGAL;ITGA4;APPL1;TYROBP;HLA-DRA;C3
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.7261316940907803,-1.73539290885077,0.0,0.020895717768723513,0.43,28/86,15.30%,NKG7;JAML;MYO1G;CCL5;MNDA;VNN2;AIF1;CD69;PSTPIP1;IL10RA;FCER1G;NCF4;SNX20;CD300LF;PLEK;CYTIP;CLEC12A;C5AR1;TNFRSF1B;ITGB2;NCKAP1L;ITGAL;TYROBP;CSF3R;CSF2RB;PTPRC;MYO1F;LY86
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.8461064901443887,1.726883285646332,0.0,1.0,0.99,6/13,7.10%,NRP1;PKD2;TGFBR2;FGF2;PKD1;SALL1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.7029221633583533,-1.7258981603845966,0.0,0.025834705604967253,0.51,89/233,15.55%,RPS13;HARS2;RPS4X;RPL28;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;WARS1;RPL12;RPL3;RPS14;GCNT1;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;PTMA;RPS20;RPS23;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;POLE3;RPL37;RPS18;RPL41;HUS1;ING5;TIPIN;ABCF1;RPL23;MRPS7;RPS26;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;MRPL51;RPL18A;POLR2G;RPL27;RPL27A;MRPS11;RPL15;MRPL52;GTPBP2;MRPL32;RPL21;RPL18;RPS5;ING4;CDC7;BRIP1;RPS28;EEF1B2;RPA3;RPLP0;RPS9;MCM7;KAT5;MRPS15;RPL9;BRCA1;TYMS;RAD9A
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.7407688830109163,1.7234498376520957,0.02631578947368421,1.0,0.99,3/20,7.37%,KLHL18;PPP1R10;MDM2
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.775703199491602,1.721284925796346,0.02702702702702703,0.97338168204466,0.99,2/23,0.36%,LEPR;ANXA1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.8812643115307061,-1.71939039509569,0.0,0.03048316474496136,0.58,6/23,5.94%,CCL4;JAML;CCL3;CCL5;FCER1G;PECAM1
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.7185285830269523,-1.7183479954821714,0.0,0.030328641790032983,0.58,27/73,15.30%,JAML;ADGRE1;MNDA;VNN2;AIF1;PSTPIP1;FCER1G;NCF4;SNX20;CD300LF;PLEK;SIRPB2;LILRB3;CYTIP;CLEC12A;C5AR1;TNFRSF1B;NCF2;S100A4;ITGB2;ITGAL;TYROBP;CSF3R;CSF2RB;PTPRC;MYO1F;LY86
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.7464390604938875,-1.7175393219031228,0.0,0.02971835415996233,0.58,21/65,15.58%,CD36;HLA-B;PSMB3;B2M;FCER1G;NCF4;HLA-C;PSMA7;HLA-F;MFSD6;PSMB9;PSMB6;TAP1;NCF2;PSMA5;PSMC4;PSMD8;CYBA;PSMD12;HLA-E;PSME2
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6490469253732473,1.7169066457757098,0.0,0.9252346739339886,0.99,45/89,21.47%,KCNQ2;CNTN2;NCAN;GFAP;CDH20;KCND3;SNAP91;OLFM3;NGB;CA10;SATB2;GRIA3;KCNC2;CTNNA2;PSD2;GRIA4;GRM5;GRIA1;CADM2;SORCS3;GRIN2B;RBFOX1;SNCB;CACNA1B;NXPH1;PTPN5;RTN4;GRIA2;GRIN2A;ADGRB3;DAB1;SYT4;MAP2;KCND2;KCNB1;GRM1;AGER;CACNG3;AMER2;KCNB2;GRM3;SYNPR;VSTM2B;RAB3C;OPCML
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.6454896524508921,1.7167189158567666,0.0,0.8570078199940286,0.99,35/100,15.21%,NPAS3;SLC39A12;CNTN2;GRIN3A;NCAN;GFAP;HEPACAM;SLC1A3;CDH20;KCND3;SLC1A2;LRRC4C;PLPPR4;CA10;GRIA3;CTNNA2;PSD2;GRIA4;GRM5;TNR;SLC4A4;GRIA1;CADM2;PTCH1;METRN;GRIN2B;RBFOX1;PTPN5;GRIA2;NTRK2;NFASC;GRIN2A;PPFIA2;LRRTM2;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.7602428009596279,-1.7139013091720998,0.0,0.031625951217527475,0.59,19/48,10.91%,OAS3;ZFP36;CCL5;RSAD2;IFIT1;TRIM5;MX1;OAS2;IFITM3;SHFL;SRPK1;ILF3;APOBEC3G;RNASEL;EIF2AK2;STAT1;OAS1;PLSCR1;TRIM13
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.9013407871153137,1.711121468662557,0.023255813953488372,0.8532213347805057,0.99,3/13,4.67%,B3GNT2;B4GALT4;CHST1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.6999349206834485,-1.7109913558110421,0.0,0.032553328734432424,0.62,39/119,15.49%,CCL4;ITK;FLNA;STAT4;TPD52;SRGN;CD2;CCL5;CD96;WARS1;GZMB;GCNT1;PRF1;RPL39;B2M;CD247;EIF5A;NCF4;ETS1;IRF7;NPM1;RPS3A;KLRD1;STAT1;GLMN;TAP1;GBP2;ITGB2;ITGAL;IFNGR2;HLA-DRA;HIF1A;CD47;RPS9;PTPRC;RPL9;BRCA1;LY86;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6915995871731696,1.708859453223073,0.02857142857142857,0.8150573035666768,0.99,12/48,12.18%,UBE2D1;ACVR2A;FGF2;SMAD1;SPRY2;SMAD7;PPARG;SPART;LEMD3;BMPR1B;BMPR1A;SORL1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.83960198312973,-1.7050370730896562,0.0,0.03771944951072142,0.65,3/27,1.13%,CCL4;CCL3;CCL5
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.7380337458035844,-1.7050044905790203,0.0,0.036776463272953384,0.65,19/62,15.58%,CD36;HLA-B;PSMB3;B2M;NCF4;HLA-C;PSMA7;HLA-F;PSMB9;PSMB6;TAP1;NCF2;PSMA5;PSMC4;PSMD8;CYBA;PSMD12;HLA-E;PSME2
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.7495372297234499,-1.7023182829541843,0.0,0.03771422231428146,0.67,35/78,14.00%,PROCR;CMPK2;RSAD2;WARS1;DHX58;HERC6;IFI44L;TRIM5;MX1;B2M;PARP14;IFIT3;SELL;IFITM3;SP110;OGFR;HLA-C;PARP9;SAMD9L;IRF7;PSMB9;LY6E;EIF2AK2;IRF1;OAS1;SAMD9;PLSCR1;TAP1;IFI44;IFIT2;GBP2;IFI35;EPSTI1;CD47;LAP3
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.712258701763978,-1.6968148648908197,0.0,0.04298547655280266,0.73,31/123,15.58%,ITK;BTN3A1;SKAP1;THEMIS;THEMIS2;GRAP2;PRKCQ;NFKBID;PSMB3;CD247;EIF2B1;BTN3A3;TXK;PSMA7;HLA-DRB5;BTN3A2;BTN2A1;PRKD2;PSMB9;PSMB6;BTN2A2;FYN;PSMA5;PSMC4;PSMD8;HLA-DRA;PTPRC;PSMD12;PIK3CB;HLA-DPA1;PSME2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.8381555638365853,1.6963250941678176,0.0,0.8582349216835962,0.99,5/19,6.33%,KLF4;ANXA1;FGF2;HDAC9;CIB1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.7011874375799544,-1.6942880626494772,0.0,0.044123980776746397,0.74,25/114,13.39%,CCL4;CCL3;ZFP36;CCL5;PID1;TNFRSF11B;CARD14;PSMB3;TNFRSF25;AIM2;EIF5A;PSMA7;TMSB4X;CHI3L1;GBP3;RPS3;PSMB9;PSMB6;STAT1;TNFRSF1B;GBP2;PSMA5;TNFSF13B;PSMC4;PSMD8
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.7855003195009068,1.686955302232172,0.0,0.8835709624505513,1.0,3/27,0.83%,CPA1;PLA2G4C;FAAH
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.7566308881469609,1.6848477915119466,0.0,0.8550444572907204,1.0,5/25,5.86%,AVIL;FER;AUTS2;AKIRIN1;WASF2
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.729989236188361,-1.6833140623097453,0.0,0.050909566927435465,0.83,26/83,13.28%,JAML;MYLK;CCL3;OAS3;MNDA;VNN2;AIF1;SELL;PSTPIP1;CD14;FCER1G;NCF4;SNX20;PECAM1;CD300LF;PLEK;SIRPB2;LILRB3;CLEC12A;C5AR1;NCF2;S100A4;ITGB2;TYROBP;CSF3R;CSF2RB
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6672284249802449,-1.6812983641616155,0.0,0.05070694178543573,0.84,88/275,14.77%,RPS13;USP6;HARS2;RPS4X;RPL28;RPS21;RPS27A;RPL31;RPL38;RPS8;YES1;RPL37A;WARS1;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;RPS20;RPS23;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;ABCF1;IGF1;RPL23;MRPS7;RPS26;RPL14;RPL4;ERO1A;LGALS1;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;CSF2RA;RPS2;RPS7;RPL36;RPL6;MRPL51;RPL18A;RPL27;RPL27A;MRPS11;RPL15;MRPL52;MRPL32;GPC3;RPL21;RPL18;RPS5;ADPRH;TMEM208;SPARCL1;CCDC59;RPS28;CSF2RB;SPG7;SEPHS1;C3;RPLP0;RPS9;PIGH;GGCX;MRPS15;RPL9
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.8429107520909224,1.6805541168618936,0.023809523809523808,0.8489993668621135,1.0,3/11,6.28%,SLC1A3;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.7580354311127783,1.6763890108145618,0.0,0.8378159495691909,1.0,4/18,5.86%,AVIL;AUTS2;AKIRIN1;WASF2
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.7322966847315546,1.6697529077549103,0.030303030303030304,0.8513982122702909,1.0,5/22,8.16%,SYNGR1;NETO1;GRIK2;SHISA9;PPFIA3
prerank,PanglaoDB_Augmented_2021__Basophils,-0.6947818042697932,-1.6695680954795915,0.0,0.06232374951888839,0.89,25/109,8.88%,CCL4;JAML;OSBPL5;PLEKHG5;H1-3;CCL3;GPR183;H2AC6;MNDA;AIF1;CD69;MS4A4A;SIGLEC1;CD14;FCER1G;NCF4;F13A1;CD300LF;IL3RA;PLEK;CD93;SIRPB2;LILRB3;CLEC12A;ENPP3
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6869937071827205,-1.6690724741306577,0.0,0.061531219982794344,0.9,50/137,11.17%,RPL28;RPL31;RPL38;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;UTP3;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPL7A;RPL35;NOB1;RPL37;RPL41;RPL23;EXOSC10;RPL14;RPL4;RPL34;RPS6;RPL30;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;RPL18A;RPL27;RPL27A;WDR46;RPL15;DDX27;EXOSC1;RPL21;RPL18
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.9106624554105469,1.6667617564065702,0.0,0.8359016709334655,1.0,4/11,5.56%,PRKAB2;PDK4;ADIPOR2;PPARG
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8977637302646846,-1.6632427516754273,0.0,0.06947826158100567,0.91,4/15,3.71%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.7906517215495786,-1.6622112338437456,0.0,0.06959553346644239,0.91,15/37,9.96%,OAS3;CCL5;RSAD2;IFIT1;MX1;OAS2;IFITM3;SHFL;SRPK1;ILF3;APOBEC3G;RNASEL;EIF2AK2;OAS1;PLSCR1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6755744732545923,-1.65911411133148,0.0,0.07288426357730761,0.91,61/162,14.05%,RBIS;RPL28;RPL31;RPL38;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;UTP3;RPL29;RPLP2;RPL11;RPL10A;METTL17;RPL13A;RPL7A;RPL35;NOB1;RPL37;RPL41;GLUL;RPL23;EXOSC10;RPL14;RPL4;NPM1;RPL34;RPS6;RPL30;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;RPL18A;RPL27;RPL27A;WDR46;RPL15;DDX27;EXOSC1;RPL21;RPL18;NOP53;WDR55;EIF2A;RPS28;SURF6;RPLP0;RPS9
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.8453004804859685,1.6566879303722424,0.0,0.8755744020796605,1.0,3/11,2.15%,KLF4;FGF2;SMAD1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.8433229953996134,-1.6538620546165355,0.0,0.08079677537239757,0.91,4/21,4.04%,ITK;MNDA;VAV3;BTK
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.6391659091621766,1.650908983136148,0.0,0.8853538690230408,1.0,36/82,20.04%,CACNA1A;CNTN2;KCNT1;AP3B2;FAM135B;SGSM1;OTUD7A;SV2B;ASPA;SCN3B;SLC1A2;KCNC2;CTNNA2;GRIA4;RUNDC3A;TNR;MOBP;ZNF493;ST8SIA5;CYP46A1;UNC80;CACNG2;GRIA2;CACNA1E;SLC24A2;P2RX7;CACNB4;NR3C1;KCNB1;CACNG3;SEZ6;DPP6;CABP1;AMER2;KCNJ6;SYNPR
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.9679034795171788,-1.650706964196938,0.0,0.08422581623700862,0.92,5/12,1.69%,CCL4;CCL3;CCL5;CH25H;GPR183
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.8545349686559375,1.650435225012224,0.0,0.85351303438214,1.0,4/14,6.28%,PDPN;SLC1A3;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.7236613463652919,1.6499330828795493,0.030303030303030304,0.8241214947136163,1.0,16/40,14.64%,UBE2D1;ACVR2A;SMAD1;SMAD7;UBE2O;PPARG;SMAD2;SPART;LEMD3;BMPR1B;BMPR1A;TWSG1;SORL1;PCSK6;SMURF1;XIAP
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.7238146036571683,1.6486466466211092,0.0,0.8044696883962444,1.0,5/27,9.65%,NRP1;SEMA5A;AUTS2;FLRT1;ALCAM
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.7621025370621843,1.6453294721488563,0.03571428571428571,0.799895001356724,1.0,10/31,12.18%,UBE2D1;ACVR2A;SMAD1;SMAD7;PPARG;SPART;LEMD3;BMPR1B;BMPR1A;SORL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.8982406938164003,-1.6432891051207206,0.0,0.09241426877337341,0.93,1/15,0.35%,DDX11
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.6733965472948743,1.6386581619727831,0.02702702702702703,0.81763901268459,1.0,3/39,1.65%,PPARGC1A;ACADS;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.7896250164278004,1.6380385139144578,0.0,0.795063726704655,1.0,3/20,1.65%,PRKAB2;PDK4;ADIPOR2
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.8224044957941032,-1.6354388703137588,0.0,0.10695511835694775,0.96,4/24,1.13%,CCL4;JAML;CCL3;CCL5
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.8046185456558969,1.63503758932783,0.024390243902439025,0.7949402248571887,1.0,10/15,17.46%,SERPINE1;FGF2;SERPINE2;CRK;PTEN;SLC12A2;TNF;CLASP1;PHLDB2;CLASP2
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.9204687597641669,1.6346204863038656,0.0,0.7732888072232774,1.0,1/6,1.24%,SERPINE1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.7216596766923251,-1.6324459305759154,0.0,0.11169710952735841,0.96,18/66,12.55%,TC2N;SIGIRR;ZFP36;JUNB;CTDSP1;CD55;NBEAL2;HLA-C;TYMP;HLA-F;IRF7;PRKD2;KIAA0040;IRF1;TAP1;IFI35;PIM3;LITAF
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.9370959346418835,-1.6322897763463289,0.0,0.10985177341271789,0.96,3/11,1.13%,CCL4;CCL3;CCL5
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.6701767461493903,-1.6316380817585303,0.0,0.10909764224512486,0.96,34/90,15.43%,CCL4;CD36;CCL3;MNDA;AIF1;MARCO;MS4A4A;PLET1;SIGLEC1;CD14;FCER1G;NCF4;TYMP;LILRB4;CD300LF;PLEK;SIRPB2;LILRB3;CLEC12A;C5AR1;OLR1;TNFAIP2;TNFRSF1B;NCF2;S100A4;ITGB2;TYROBP;CSF3R;CSF2RB;MS4A6A;KLHDC4;MYO1F;LY86;SLC11A1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7456588997103133,-1.6316034388630012,0.0,0.10750486521012236,0.96,22/75,9.89%,CCL4;MT2A;CCL3;OAS3;HLA-B;CCL5;GAPDH;AIF1;TRIM5;B2M;OAS2;RPL13A;HLA-C;HLA-DRB5;TRIM22;GBP3;HLA-F;IRF7;STAT1;IRF1;OAS1;CD44
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.649387421707794,-1.6266121955378559,0.0,0.11588269243942936,1.0,53/170,11.46%,RPL28;RPL31;RPL38;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPL5;RPS25;RPL19;RPL32;RPLP1;SSB;RPS15;RPS24;UTP3;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPL7A;RPL35;NOB1;RPL37;RPL41;RPL23;EXOSC10;RPL14;RPL4;RPL34;RPS6;RPL30;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;RPL18A;RPL27;RPL27A;WDR46;RPL15;DDX27;EXOSC1;RPL21;RPL18;ZCCHC8;KARS1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.7709211124467308,-1.6258494348497332,0.0,0.11520505729822896,1.0,7/26,12.57%,CD36;DHX58;TRIM5;CD55;IRF1;ERAP1;APPL1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6733477887178304,-1.622164788916679,0.0,0.11907133600669331,1.0,58/148,14.86%,RPL28;RPL31;RPL38;RPL37A;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPL5;RPS25;RPL19;RPL32;RPLP1;RPS15;RPS24;UTP3;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPL7A;RPL35;NOB1;RPL37;RPL41;RPL23;EXOSC10;RPL14;RPL4;RPL34;RPS6;RPL30;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;RPL18A;RPL27;RPL27A;WDR46;RPL15;DDX27;EXOSC1;RPL21;RPL18;NSA2;NOP53;WDR55;RPS28;RPLP0;RPS9;RPL9;DDX54
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.7104334499201462,1.6216038414227083,0.027777777777777776,0.8426693226759293,1.0,10/25,11.91%,ATRAID;ACVR2A;CTNNBIP1;TMEM119;HGF;NELL1;BMPR1B;FERMT2;BMPR1A;FBN2
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.6236917367252185,1.6215576344291467,0.0,0.8178849308325197,1.0,23/52,18.93%,PLXNB1;PLXNA2;FZD3;CHODL;NUMBL;PLXNB2;LIG4;ROBO1;PLXNC1;PLXNA3;NPTN;PTPRD;METRN;SHANK3;NTRK2;ROBO2;PLXNA1;CAPRIN2;TIAM2;IL1RAPL1;MAP6;SLIT2;TIAM1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.7981294166522023,-1.6205432357507443,0.015625,0.11957743007005002,1.0,5/23,4.63%,GNLY;ITK;MNDA;PRF1;LSP1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.7093484931526467,1.620230859793996,0.0,0.8043616515067502,1.0,7/23,12.92%,KLF4;PKD2;NACC2;SLFN11;PTEN;CDK6;GPNMB
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.8257748168229047,1.6153576618272882,0.022727272727272728,0.8146319083142933,1.0,3/10,5.22%,SCRIB;MSN;RAB10
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.8028463151748911,1.608999758478979,0.0,0.8457317504142179,1.0,2/12,3.38%,PANK3;PANK1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.8770255352240507,-1.6085815898516909,0.0,0.1424888944991051,1.0,1/11,1.12%,ZFP36
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.8185578617373744,-1.6068174035929033,0.047619047619047616,0.14287447024364702,1.0,1/17,0.16%,CALCR
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6227322827121008,1.6062138612756476,0.0,0.844297629862086,1.0,42/96,20.04%,NPAS3;KCNQ2;DPYSL5;CNTN2;NCAN;ZNF536;NOL4;SNAP91;SCN3B;OLFM3;LRRC4C;ROBO1;PURG;CTNNA2;GRIA4;FUT9;CADM2;SLC35F1;SOX5;RBFOX1;CACNA1B;NXPH1;PTPN5;NF1;GRIA2;CSRNP3;ROBO2;CAMKV;PPFIA2;SLC12A5;ATRNL1;ADGRB3;CELF5;MAPK4;SYT4;CLASP2;DCLK1;PCLO;AMER2;PHYHIPL;GRM3;SYNPR
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.6270924255382645,1.6057400212921116,0.06451612903225806,0.8259212438583154,1.0,8/52,7.98%,ACER2;RRAGD;DAPK2;DEPP1;LRRK2;DDIT3;SCARB2;BOK
prerank,PanglaoDB_Augmented_2021__Platelets,-0.6578835228713765,-1.6037941225114014,0.0,0.14864892148088849,1.0,42/143,16.15%,JAML;SLC2A3;CD36;SRGN;CCL5;CARD16;THEMIS2;CXCR4;GRAP2;MNDA;VNN2;OST4;AIF1;CD69;SELL;LSP1;FCER1G;NCF4;PECAM1;F13A1;CD300LF;ERO1A;PLEK;CD93;SIRPB2;FERMT3;CLEC12A;TNFRSF1B;CD226;NCF2;ITGB2;VEGFA;TYROBP;CSF3R;CSF2RB;MYO1F;LY86;DAB2;HLA-E;GPX1;NOD2;ALOX12
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.6659037341135088,-1.6036615483333119,0.0,0.14702986866356363,1.0,13/97,8.86%,NR4A3;ITK;GRAP2;FOS;PRKCQ;PSMB3;VAV3;BTK;FCER1G;PSMA7;CALM1;PSMB9;PSMB6
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8678650331536544,-1.6011696114426976,0.0,0.1495759140579074,1.0,10/17,9.96%,PYHIN1;MNDA;XAF1;AIM2;IFITM3;SHFL;STAT1;IRF1;OAS1;PLSCR1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.9017365083995422,-1.6008601652068128,0.0,0.14823668017106212,1.0,5/17,1.71%,CCL4;CCL3;RIPOR2;CCL5;DUSP1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6357131358576693,-1.6002114910629457,0.0,0.1474208030407914,1.0,37/152,10.92%,CCL4;NR4A3;JAML;MYO1G;CD36;CCL3;CCL5;ADGRE1;RUNX3;MNDA;AIF1;CD200R1;CHIT1;MS4A4A;PARP14;RGS1;LSP1;SIGLEC1;CD14;IL10RA;FCER1G;NCF4;SNX20;F13A1;LILRB4;CD300LF;PLEK;CYTIP;SELENOP;CLEC12A;RBPJ;C5AR1;EGLN3;TNFRSF1B;NCF2;S100A4;SAMSN1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5741914586993442,1.6001050456979227,0.0,0.8544063644121452,1.0,28/63,19.64%,KCNQ2;PKD2;SLC9C2;SLC1A3;KCNIP2;KCNJ2;KCND3;KCNJ5;HPN;KCNC2;SLC12A6;KCNN2;KCNK13;ABCB8;SLC9A1;KCNK6;KCNH5;SLC9A9;SLC24A2;ABCC8;SLC12A2;SLC12A5;SLC9A7;KCND2;KCNB1;KCNQ5;KCNB2;KCNJ6
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.7390703819753871,1.6000740965282516,0.03333333333333333,0.8335671847923368,1.0,8/21,18.46%,NRP1;SEMA5A;AUTS2;ALCAM;SLIT3;ULK1;PPP3CB;SLIT2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6055518628119855,1.5998908701745764,0.0,0.8152396158176982,1.0,28/56,19.64%,KCNQ2;PKD2;SLC9C2;SLC1A3;KCNIP2;KCNJ2;KCND3;KCNJ5;HPN;KCNC2;KCNMB4;KCNN2;KCNK13;ABCB8;SLC9A1;KCNK6;KCNH5;SLC9A9;SLC24A2;ABCC8;KCNMB3;SLC9A7;KCND2;KCNB1;CHP1;KCNQ5;KCNB2;KCNJ6
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7424387101296006,-1.599847541033449,0.0,0.14674764078720684,1.0,9/42,6.90%,CCL4;CCL3;CCL5;GAPDH;AIF1;RPL13A;IFITM3;SHFL;GBP3
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.5860505344150622,1.5986055977230733,0.045454545454545456,0.8060745387023939,1.0,51/104,23.65%,KCNQ2;CNTN2;GRID2;NCAN;PKP4;SNAP91;OLFM3;SLC22A15;CA10;GRIA3;CTNNA2;PSD2;GRIA4;SHANK2;GRM5;CADM2;MRPS35;CLSTN3;RBFOX1;SNCB;CACNG2;CACNA1B;NXPH1;PTPN5;NRXN2;GRIA2;SLC24A2;GAD1;SLC12A5;ADGRB3;CELF5;DLGAP1;SYT4;PPM1E;CERK;PRKG1;AMER2;GRM3;SYNPR;CNTNAP2;VSTM2B;RAB3C;OPCML;GRIK3;NRXN1;GRIN1;HIVEP2;SYP;ASIC2;ELAVL3;CADPS
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.8334973517094477,1.5970531971207078,0.06521739130434782,0.8010966048293656,1.0,5/13,11.14%,ACER2;ABCA2;PLPP1;SPTLC2;SPTLC3
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.976713341881167,1.596729530731186,0.0,0.7847124422299913,1.0,1/6,0.27%,KLF4
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.7136530587765024,-1.5958850336621075,0.0,0.15280361500734152,1.0,19/62,16.60%,UBC;RPS27A;PSMB3;ELOB;PSMA7;PSMB9;PSMB6;RBPJ;CITED2;EGLN3;RBX1;PSMA5;VEGFA;PSMC4;PSMD8;HIF1A;PSMD12;PSME2;UBA52
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.8226887462237652,1.5914525325214532,0.0,0.7734217432396474,1.0,2/10,3.38%,PANK3;PANK1
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.8226887462237652,1.5914525325214532,0.0,0.7734217432396474,1.0,2/10,3.38%,PANK3;PANK1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.8226887462237652,1.5914525325214532,0.0,0.7734217432396474,1.0,2/10,3.38%,PANK3;PANK1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.627232087629919,1.5909604150817194,0.0,0.7602420867595531,1.0,46/81,24.68%,CNTN2;NCAN;NOL4;SNAP91;SCN3B;OLFM3;SLC1A2;KCTD16;CA10;KCNC2;CTNNA2;PSD2;GRIA4;GRM5;TNR;FUT9;GRIA1;GRIN2B;RBFOX1;CACNA1B;NXPH1;PTPN5;GRIA2;CSRNP3;GRIN2A;PPFIA2;CELF5;GRM1;TMEM132B;CACNG3;AMER2;PHYHIPL;GRM3;SYNPR;GABRA2;OPCML;DLG2;GLS;NRXN1;GRIN1;ASIC2;ELAVL3;CADPS;LSAMP;SCN2A;MAGI2
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6703181075098636,-1.5909498928316865,0.0,0.16472790841010368,1.0,50/150,14.00%,MX2;MT2A;STAT4;OAS3;HLA-B;CCL5;CMPK2;RSAD2;WARS1;IFIT1;DHX58;HERC6;IFI44L;MX1;XAF1;CD69;B2M;PARP14;IFIT3;TNFSF10;OAS2;RNF213;NLRC5;IFITM3;IL10RA;SP110;OGFR;SAMD9L;IRF7;SRI;PSMB9;NAMPT;LY6E;EIF2AK2;STAT1;IRF1;TNFAIP2;PLSCR1;TAP1;BANK1;IFI44;IFIT2;TNFAIP3;IFI35;EPSTI1;APOL6;CSF2RB;BTG1;HIF1A;LAP3
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.899499271080095,1.589911865010423,0.0,0.7521838852644038,1.0,1/8,0.63%,PLA2G4C
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7034181530866791,1.5891802624177374,0.0,0.742439831659809,1.0,6/21,12.92%,KLF4;PKD2;SLFN11;PTEN;CDK6;GPNMB
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.717541456625311,-1.5865353452398194,0.0,0.17392107008597815,1.0,20/51,12.04%,CYCS;COX7C;UQCRB;NDUFC1;NDUFA2;NDUFA1;UQCRH;UQCR10;NDUFB4;NDUFA12;NDUFB9;COX5B;COX4I1;NDUFS5;NDUFS8;NDUFB1;NDUFB7;UQCRQ;COA6;COX6C
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.7435212546843581,1.5860310445577555,0.06060606060606061,0.7514770746912128,1.0,13/25,16.01%,ATRAID;ACVR2A;ZBTB16;WNT5A;TMEM119;NELL1;BMPR1B;BMPR1A;FBN2;ANO6;SLC8A1;P2RX7;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.8891937138408865,1.5846917156875677,0.0,0.7450035344571919,1.0,4/9,6.37%,SERPINE1;SERPINE2;LRRK2;SNX12
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6202638698555787,1.5825601101072229,0.030303030303030304,0.7446780223667937,1.0,22/71,15.59%,COL16A1;EPS8;RASSF8;FKBP9;COL5A2;MITF;BNC2;PHLDB1;RASAL2;PPARG;TIMP3;TANC1;SASH1;FAM114A1;MMP14;GPNMB;EPAS1;ENPP1;ITGAV;RAI14;ANTXR1;COL6A1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.9080298409688523,1.5819907842004775,0.06382978723404255,0.7346189285705349,1.0,2/6,4.31%,KCNIP2;KCND3
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.7498236863038078,1.5810004967254712,0.05263157894736842,0.7292490040859023,1.0,3/19,5.60%,PPARGC1A;RUVBL2;RPS6KA4
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.9071897406178517,-1.5795453999644593,0.016666666666666666,0.19099815538871057,1.0,3/13,1.13%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.9061429591001715,1.5793883732896863,0.0,0.7278736660518805,1.0,1/9,0.27%,KLF4
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.9119733275793951,1.5784328095832783,0.041666666666666664,0.7221451129254103,1.0,1/6,1.33%,RNF2
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.7985829853297601,1.5783231068626966,0.06382978723404255,0.7109868786022256,1.0,3/15,8.20%,PRKAB2;CPT1A;ACACB
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.8468991089865437,-1.5762643438443447,0.0,0.20037600292354601,1.0,2/16,0.74%,CCL4;CCL3
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.7280498581013318,1.5754853984153043,0.0625,0.7153021168827595,1.0,19/31,19.29%,PLXNB1;PLXNA2;CHODL;PLXNB2;ROBO1;PLXNC1;PLXNA3;METRN;NTRK2;ROBO2;PLXNA1;SHTN1;MAP3K13;SEMA4D;TIAM2;MAP6;SLIT2;TIAM1;ZFYVE27
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.7224782553810386,-1.5747194847224466,0.0,0.20125875535138962,1.0,6/37,6.27%,MX2;CD36;TFRC;MX1;FCER1G;LILRB4
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.9152817075930885,-1.5741815579397602,0.0,0.20038179221331745,1.0,4/5,8.50%,RPL5;RPL11;RPL23;RPS7
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.6790209665271429,-1.5721095306139707,0.0,0.20413508897137586,1.0,20/89,7.07%,NKG7;JAML;MYO1G;CD37;ACAP1;PYHIN1;MNDA;VNN2;IKZF3;CD69;SELL;SLAMF6;BTK;AIM2;LSP1;IL10RA;NCF4;SNX20;PLEK;SP140
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.817538849026267,-1.5712542451822653,0.03125,0.20461933247955078,1.0,2/22,1.12%,SYAP1;ZFP36
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.6913050615020934,1.571153881714626,0.0,0.7311916756131803,1.0,7/22,4.24%,PRKAB2;AVIL;PDK4;ADIPOR2;SIRT1;MITF;SIRPA
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.9350515941522767,1.5710778684977376,0.05405405405405406,0.7196040979028306,1.0,4/5,4.06%,FGF2;SPRY2;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.8895168591343479,-1.5709269523859855,0.016129032258064516,0.2034198124785234,1.0,1/11,1.41%,TFRC
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6753485710314663,1.5707668375037076,0.047619047619047616,0.7095997948091433,1.0,4/24,5.50%,SCRIB;MTCL1;MSN;LIN7A
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6135764252136592,1.570712847126769,0.04,0.6993099141134693,1.0,24/82,13.66%,COL16A1;BAG3;LGI4;RGS11;LRP4;CNTN2;GFAP;ARNT2;ASPA;CHST1;PHLDB1;SEMA3B;PLPPR4;NTM;HAPLN2;PSD2;CD82;OLIG1;RBFOX1;SHC2;GRIA2;NTRK2;NFASC;TMEM132C
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.923002719127328,1.5685551113193354,0.07317073170731707,0.7026875115140041,1.0,3/5,4.06%,SPRY2;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7138588506317598,-1.5684361856531572,0.0,0.2079252903900142,1.0,19/50,12.04%,CYCS;COX7C;UQCRB;NDUFC1;NDUFA2;NDUFA1;UQCRH;UQCR10;NDUFB4;NDUFA12;NDUFB9;COX5B;COX4I1;NDUFS5;NDUFS8;NDUFB1;NDUFB7;UQCRQ;COX6C
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.6450599484421236,1.5683898149609354,0.06666666666666667,0.6930075384282999,1.0,14/46,14.60%,HID1;SPON1;AMOT;NEO1;NDRG2;AHCYL2;PBX1;PARM1;ASXL3;SHC2;COBL;KALRN;TMEM132C;SLC12A2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6146950167056746,1.5665001538604573,0.02857142857142857,0.6950450489315747,1.0,27/64,19.91%,RASSF8;FGF2;PDE10A;PHLDB1;MAGI1;NTM;CDH11;GPR161;FLRT2;GUCY1A2;FERMT2;ENAH;RUNX1T1;BMPR1A;TJP1;SLIT3;TACC2;FBXL7;NFASC;PTPRG;ANTXR1;TYRO3;PPFIBP1;FARP1;SLIT2;ZNF462;NAV1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.8666071896121693,1.5664467199227516,0.018867924528301886,0.6850114725880442,1.0,3/8,8.20%,PRKAB2;CPT1A;ACACB
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.6299686859482638,1.5657442944893853,0.07692307692307693,0.6798925859832766,1.0,11/50,13.19%,MFNG;RFNG;MAML2;YJEFN3;TSPAN15;JAG1;MAML3;POGLUT1;FBXW7;MMP14;PRKCI
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.8908335154474222,-1.5653141151534415,0.017857142857142856,0.2156845795054583,1.0,2/8,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.9093083111466786,-1.5651913290002402,0.016666666666666666,0.21338807687674757,1.0,3/10,1.13%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.974022649417848,-1.5648193418640957,0.0,0.21184277680767788,1.0,2/7,0.74%,CCL4;CCL3
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.6462055763339798,1.5643511936042922,0.06896551724137931,0.679295447306018,1.0,26/65,18.46%,COL16A1;LRP4;ARNT2;GULP1;PBX1;PHLDB1;SEMA3B;MAGI1;NUAK1;NTM;CDH11;GPC6;FERMT2;ENAH;RUNX1T1;TJP1;FBXL7;NFASC;CSRNP3;ADCY6;PTPRG;ANTXR1;DCLK1;FARP1;RBFOX2;SLIT2
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.9009547534025848,1.5624112357195914,0.02,0.6815910410019785,1.0,1/8,0.45%,PCBP4
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6850823191001871,1.5620292398048832,0.0,0.6740742270059308,1.0,12/28,14.04%,CDK5R1;GRID2;GRIN3A;GNAQ;GRIK2;GRIA3;GRIA4;GRM5;GRIN2B;CPEB4;GRIA2;GRIN2A
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.7846125433527333,1.5615324595756908,0.0,0.6693856526203574,1.0,2/13,0.65%,COL16A1;NRP1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.7030891929052024,1.559702383402061,0.0,0.6724119279904233,1.0,9/27,10.55%,CDK5R1;SRCIN1;NLGN1;LRRK2;RELN;PDLIM5;TANC2;SHANK3;PTEN
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.941767254668111,1.5596791163203927,0.023255813953488372,0.6634464356172176,1.0,1/6,0.65%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.7310229284445636,1.5595001864262967,0.058823529411764705,0.6558923115038401,1.0,11/21,16.01%,ATRAID;ACVR2A;TMEM119;NELL1;BMPR1B;BMPR1A;FBN2;ANO6;SLC8A1;P2RX7;ADGRV1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.7946119664052387,1.5592986207528847,0.07692307692307693,0.6482029215863554,1.0,2/15,5.55%,RNF2;RYBP
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.8666807129262288,1.5586356642127532,0.0,0.643164898892044,1.0,6/11,8.07%,PLXNB1;NRP1;PLXNA2;PLXNB2;PLXNC1;PLXNA3
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.7178204849326979,-1.5577183454294148,0.014705882352941176,0.2317703848512062,1.0,16/51,19.37%,UBC;RPS27A;PSMB3;PSMA7;PSMB9;PSMB6;PSMA5;PSMC4;PSMD8;PSMD12;MCM7;PSME2;UBA52;MCM6;PSMA3;PSME1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.8097489158332826,-1.5573968194164576,0.0410958904109589,0.23033884238081268,1.0,2/18,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.8018358262671617,1.5570739406980394,0.0,0.6453622911158942,1.0,2/12,7.34%,BAG3;COPG1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.6652447467046108,1.5567906734596357,0.02857142857142857,0.639209541112671,1.0,9/52,5.56%,LEPR;PPARGC1A;PDK4;IGF1R;ADIPOR2;SIRT1;MCU;BACE2;PPARG
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.90444196614366,1.553006866531493,0.0,0.6506971823494887,1.0,2/8,2.45%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.9605857490147415,-1.5517527450040345,0.0,0.24844287885020233,1.0,2/5,0.74%,CALCR;CCL3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.809113477167789,1.550867101698781,0.024390243902439025,0.6556793408383336,1.0,4/15,10.91%,ETNPPL;CHKA;NAPEPLD;SELENOI
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.9073653707091279,1.550315008190736,0.02127659574468085,0.652238552027915,1.0,3/6,7.04%,CSGALNACT1;EXTL2;GFPT1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.6063566406061102,1.550171278657353,0.0,0.6455372954918748,1.0,35/80,18.46%,NPAS3;LRP4;CNTN2;NCAN;GFAP;ARNT2;NLGN1;SLC1A3;ZNF536;PCDH17;SNAP91;LRRC4C;PLPPR4;NTM;PURG;SLC35F1;ASXL3;PTPRD;GUCY1A2;RUNX1T1;PTPN5;GRIA2;MARK1;FBXL7;NTRK2;NFASC;CSRNP3;PPFIA2;CDH4;ADGRB3;MAPK4;MAP2;DCLK1;MAP6;SLIT2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.8626267950846008,1.5494617226766987,0.023809523809523808,0.6431976216037658,1.0,2/10,1.58%,SCRIB;MSN
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.684057991047093,-1.5494289964050851,0.0,0.2526482239309297,1.0,19/66,13.90%,NKG7;CD36;RSAD2;GRAP2;MNDA;VNN2;CD55;TSPAN32;BTK;NCF4;CD300LF;CLEC12A;CD44;KLRF1;UROS;ITGA4;CSF3R;CSF2RB;CD47
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.9262952907385708,-1.549337903824329,0.020833333333333332,0.25046687320982297,1.0,2/6,1.73%,CCL5;PRKCQ
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.6479787186879828,1.5486555685840693,0.04,0.641802720892462,1.0,19/51,19.01%,LRP4;FKBP9;WNT5A;MAGI1;NUAK1;TANC1;KITLG;GNA11;FERMT2;ENAH;TJP1;CD276;ADCY6;PTPRG;RAI14;ANTXR1;RBFOX2;SLIT2;SNX7
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.6249035465491406,1.5485165600953625,0.04,0.6347190541597096,1.0,29/71,20.26%,KCNQ2;DPYSL5;SRCIN1;CNTN2;NCAN;CHD5;NOL4;SNAP91;OLFM3;SMAD3;LINGO1;SNCB;CACNA1B;NXPH1;PTPN5;GRIA2;CSRNP3;CAMKV;ABCC8;ATRNL1;CELF5;MAPK4;SYT4;KCNB2;KCNJ6;PHYHIPL;ADCY1;CADPS2;BRSK2
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6718564252458941,-1.548101918022237,0.013157894736842105,0.2509343529381819,1.0,24/77,9.96%,FLNA;MX2;OAS3;RSAD2;IFIT1;IFI44L;PRF1;TRIM5;MX1;IFIT3;OAS2;DDIT4;NLRC5;IFITM3;SHFL;MLKL;IRF7;APOBEC3G;RNASEL;EIF2AK2;STAT1;IRF1;OAS1;PLSCR1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.6399467715573606,1.5468565773430012,0.0,0.6364976463787266,1.0,20/60,14.23%,KCNQ2;LRP4;DPYSL5;NCAN;ZNF536;GALNT13;NOL4;SNAP91;CSPG5;LRRC4C;PURG;CADM2;SLC35F1;LINGO1;SNCB;CACNA1B;GRIA2;UNC5D;CSRNP3;CAMKV
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.8177331687404338,-1.5463503944169292,0.0,0.2546062841973696,1.0,4/21,2.07%,SIGIRR;CARD16;NLRC3;DHX58
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.8987264895905827,-1.5460257507884683,0.015384615384615385,0.25292903594837507,1.0,1/12,0.15%,FLNA
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.8712693973812665,-1.545117110096495,0.016129032258064516,0.2529954645976632,1.0,4/13,3.79%,IL4I1;CD2;IKZF3;PRELID1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.6701750716426287,-1.5449724070248938,0.013513513513513514,0.2510153670685382,1.0,25/82,9.96%,FLNA;MX2;OAS3;RSAD2;IFIT1;IFI44L;PRF1;TRIM5;MX1;IFIT3;OAS2;DDIT4;NLRC5;IFITM3;SHFL;MLKL;PHB2;IRF7;APOBEC3G;RNASEL;EIF2AK2;STAT1;IRF1;OAS1;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7504737168388967,1.544481951023099,0.041666666666666664,0.6431115866089018,1.0,4/18,7.39%,PPARGC1A;RUVBL2;RPS6KA4;DIP2B
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.8580976201299784,1.5437172604172118,0.0,0.6397944595846983,1.0,4/10,9.93%,SYNGR1;NETO1;NPTN;SHANK3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.7684698483328276,-1.5437062987683783,0.014705882352941176,0.25233228867662755,1.0,7/29,11.76%,NR4A3;CCL5;AIF1;APOD;IGF1;STAT1;TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.7492108479099596,1.5430863432445596,0.05128205128205128,0.6362697560649497,1.0,2/13,7.49%,KLF4;HPN
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.9601270605747552,1.5429087699537836,0.0,0.6301860755145592,1.0,1/8,0.02%,CPA1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.7596946600919631,1.5419212361590353,0.025,0.6294477492525332,1.0,1/14,0.06%,SHROOM3
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.8287307801922558,-1.5395144322648713,0.034482758620689655,0.2643308297743524,1.0,4/14,6.94%,RPGRIP1L;CCL5;RGS2;PLEK
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.8504425700593641,1.5386110936871806,0.030303030303030304,0.6408081674201652,1.0,4/10,4.05%,NRP1;SCRIB;SEMA5A;TSC2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.9308129497887587,1.5379105482857829,0.0,0.6394362320037439,1.0,2/5,4.94%,LHFPL2;RNASE10
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6624743889057063,1.5375346180887688,0.030303030303030304,0.6346365421495491,1.0,5/24,7.65%,NUTF2;PKD1;XPO1;NUP42;RANBP3L
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.784886400894447,1.5372525101582535,0.03225806451612903,0.6300673805147345,1.0,4/20,4.22%,ANXA1;RUVBL2;NCOA3;NRIP1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.611975919680398,1.5369614136526186,0.03125,0.6253310210036612,1.0,11/31,17.09%,NRP1;FER;SRCIN1;TMEFF2;FERMT2;SRGAP2;ITGAV;ANTXR1;ATRNL1;NTN4;TYRO3
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.6068115299209607,1.5364362456789502,0.0,0.6209481608275893,1.0,21/70,12.34%,PLXNB1;HID1;FAAH;SRCIN1;KIAA1671;HIP1R;RAP1GAP;MTUS1;NEO1;NDRG2;BAIAP3;PLPPR1;TPPP;PIK3C2B;SHANK2;SLC12A6;PTCH1;SHC2;ZDHHC11B;COBL;KALRN
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.9068565060506584,1.5344983220051829,0.0,0.6263519696093814,1.0,2/8,2.57%,KLF4;SMAD7
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.8262782374368363,1.5342568408283435,0.06060606060606061,0.6215403702398483,1.0,5/10,12.01%,LARGE1;CHST7;EXTL2;CHST1;RENBP
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.8305490215275915,-1.532475012671576,0.03278688524590164,0.28995501151239017,1.0,1/14,0.09%,NR4A3
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.7377602119833636,-1.532460200223035,0.029411764705882353,0.28699628690512086,1.0,3/36,1.20%,OSBPL5;INSIG1;CH25H
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.6620287682038202,-1.5304750165029177,0.02666666666666667,0.29118921448213086,1.0,20/99,7.07%,NKG7;JAML;MYO1G;CD2;CD37;ACAP1;PYHIN1;MNDA;VNN2;IKZF3;STAG3;CD69;SELL;SLAMF6;PSTPIP1;IL10RA;NCF4;SNX20;PLEK;SP140
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.723944763158873,-1.5288029155056866,0.015384615384615385,0.29571619786297515,1.0,16/40,24.47%,PSMB3;PSMA7;ODC1;PSMB9;PSMB6;PSMA5;AZIN1;PSMC4;PSMD8;PSMD12;PSME2;PSMA3;PSME1;PSME3;PSMB5;PSMC3
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.7083033650591423,1.5271527842053882,0.05263157894736842,0.6611142687041508,1.0,5/12,14.28%,SIRT1;WNT5A;LAPTM5;IRAK3;CUEDC2
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7943412739323655,1.5262622506024444,0.02631578947368421,0.6590322371148155,1.0,6/14,10.10%,NCAN;CSGALNACT1;CHST7;UGDH;CSPG5;CHST15
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.8007217016707446,-1.5258434838328785,0.03508771929824561,0.3046223251749356,1.0,3/19,12.12%,OSBPL5;PLSCR1;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of B cell receptor signaling pathway (GO:0050859),0.9485949759844087,1.5257972014756154,0.06521739130434782,0.655885853073895,1.0,1/5,1.61%,CD22
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6844755763338806,1.525673818246487,0.06666666666666667,0.6501254871425819,1.0,8/28,6.31%,CACNA1A;GRID2;EIF4EBP2;NLGN1;GRIK2;GRID1;RELN;LRRC4C
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.665528132584385,1.5254561187306548,0.03225806451612903,0.6455573613056664,1.0,10/22,17.34%,LRP4;DIP2B;RNF6;LINGO1;DCC;PTEN;RTN4;KIAA0319;ULK1;MAP2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.7287536719408095,1.5252441097441811,0.08333333333333333,0.6415516997861327,1.0,2/13,7.45%,ANXA1;LIG4
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7798286859364131,-1.525184399072384,0.0136986301369863,0.3045858154758639,1.0,2/19,1.57%,UBC;RPS27A
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.609331353606345,1.5250097560635776,0.03571428571428571,0.6369112250963216,1.0,32/83,17.51%,CNTN2;PCDH15;NCAN;GFAP;ARNT2;ZNF536;SNAP91;CHST1;CSPG5;LRRC4C;PLPPR4;LHFPL3;NTM;HAPLN2;CA10;PSD2;TNR;SLC35F1;LINGO1;OLIG1;SNCB;NXPH1;PTPN5;NRXN2;GRIA2;NFASC;LRRC4B;ADGRB3;ETV5;MAPK4;MAP2;DCLK1
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.9891208132819606,-1.5240347607560165,0.0,0.30649757674745126,1.0,1/6,0.09%,NR4A3
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.7914099168330287,-1.5239896211235877,0.014925373134328358,0.30363085280860547,1.0,5/28,3.71%,H1-4;H1-3;H1-2;IL7R;H1-0
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.7332525862489495,1.5239103811915622,0.1111111111111111,0.6387953661479078,1.0,7/19,14.45%,GRIN3A;NLGN1;DLG5;TANC2;SHANK3;ARF6;PPFIA2
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.833057493941243,1.5238725845079237,0.07894736842105263,0.6331041524335769,1.0,4/10,6.33%,ANXA1;FGF2;HDAC9;CIB1
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.9418539960897316,-1.5235502740670672,0.0,0.3024903905567594,1.0,1/6,0.70%,CD36
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.736468440822588,1.5234167397116503,0.024390243902439025,0.6298149169071623,1.0,5/15,19.48%,PPT1;GCDH;ACACA;FASN;SCD5
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.7475531000247189,-1.5232156625413378,0.015384615384615385,0.30105603939994857,1.0,11/40,12.16%,H1-4;H1-3;H1-2;H1-0;POLE3;H2BC18;NPM1;H2BC5;H1-10;H2BC9;H2BC21
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.8391755801429759,-1.5219033935101032,0.0,0.3031636660202465,1.0,2/17,1.73%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.5587058176197116,1.5211266493298055,0.0,0.6361558109080613,1.0,12/48,17.09%,NRP1;FER;SRCIN1;RELN;TMEFF2;FERMT2;SRGAP2;ITGAV;ANTXR1;ATRNL1;NTN4;TYRO3
prerank,PanglaoDB_Augmented_2021__B Cells,-0.6506887251814348,-1.521065585903406,0.02631578947368421,0.30267834145732464,1.0,21/106,7.07%,NKG7;JAML;MYO1G;CD2;CD37;ACAP1;CXCR4;VNN2;CD55;CD69;IFIT3;SELL;SLAMF6;PSTPIP1;LSP1;CD14;IL10RA;NCF4;SNX20;PLEK;SP140
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.6023283652038651,-1.5189468893869724,0.0,0.30810639998066447,1.0,40/140,15.50%,CCL4;NR4A3;JAML;HLA-B;ADGRE1;CXCR4;MNDA;VNN2;AIF1;LSP1;KMO;CD14;IL10RA;FCER1G;NCF4;SNX20;HLA-C;LILRB4;CD300LF;HLA-DRB5;PLEK;CYTIP;CLEC12A;TNFRSF1B;NCF2;S100A4;FTL;ITGB2;ITGAL;TYROBP;CSF2RB;HLA-DRA;PPP1R14A;PTPRC;MS4A6A;MYO1F;LY86;DAB2;SLC11A1;HLA-DPA1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.6248911465767659,-1.5183572875878744,0.0,0.3081928409816093,1.0,39/133,12.55%,CCL4;NR4A3;SLC2A3;BCL2A1;FOSL2;SAT1;CEBPD;ZFP36;CCL5;GPR183;FOS;DUSP1;JUNB;BTG2;PPP1R15A;CD69;IL7R;BHLHE40;GADD45B;IER3;SPSB1;EIF1;PLEK;TNFAIP8;NAMPT;SGK1;PFKFB3;IER2;OLR1;IRF1;TNFAIP2;CD44;TAP1;CFLAR;IFIT2;TNFAIP3;ATF3;VEGFA;LITAF
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.7283120096117476,1.5176899541240043,0.03225806451612903,0.6509676729393359,1.0,11/22,16.01%,ATRAID;ACVR2A;TMEM119;NELL1;BMPR1B;BMPR1A;FBN2;ANO6;SLC8A1;P2RX7;ADGRV1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.9023340420556564,-1.5176115670442496,0.018518518518518517,0.30895542344170296,1.0,2/5,5.44%,CD36;CD14
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.9683710525634643,-1.5163984578174974,0.0,0.311719332571279,1.0,1/5,1.12%,ZFP36
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.855015684184479,1.516296550100064,0.038461538461538464,0.6516383589800057,1.0,5/11,10.93%,B3GNT2;CSGALNACT1;HS2ST1;FUT9;EXT1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.7708743516896646,-1.5160774193978184,0.014084507042253521,0.30992232726000535,1.0,1/20,0.09%,NR4A3
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.9022652815811577,-1.5155388386813529,0.018867924528301886,0.30984316944079143,1.0,3/6,6.09%,MYLK;TGFBR3;TTN
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.8293979397473111,-1.5155281825951414,0.038461538461538464,0.3071488810108715,1.0,4/11,12.48%,SLC7A5;ABCB1;ABCC3;ABCA8
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.8384259520961579,-1.5152881018073296,0.1111111111111111,0.3053656962201733,1.0,3/13,8.01%,CCL3;SRGN;TRPM4
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.590082986293555,1.5148781979897437,0.06666666666666667,0.6528522442882944,1.0,25/83,15.89%,SHROOM3;KLF4;LRP4;SMAD1;FRAS1;GULP1;SMAD3;MAGI1;SMAD2;KITLG;FERMT2;ARHGAP42;ENAH;FNBP1L;ANO6;PARD3;TJP1;DCBLD2;CD276;PTK2;PTPRG;RAI14;COL4A5;ANTXR1;WWC2
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.7298300816287084,-1.5140757987951206,0.0,0.30839936276095525,1.0,7/43,6.18%,SPON2;COL18A1;CD36;DEGS2;CD55;SLC51A;AQP11
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.9167730177828232,1.514026714262599,0.0784313725490196,0.6530550564176166,1.0,1/5,0.27%,KLF4
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.7662548994089945,1.5126221590948346,0.07692307692307693,0.6568538999623317,1.0,1/10,2.28%,SPRY2
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8662237936139965,-1.512561249936938,0.03389830508474576,0.31187744181589705,1.0,4/14,4.49%,APIP;GZMB;NAIP;AIM2
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.9056840868585279,-1.5117952724757464,0.0,0.3126982706096036,1.0,1/7,0.35%,DDX11
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.8055934542308619,1.5117778314031536,0.11904761904761904,0.6504257661442643,1.0,2/10,5.73%,UBIAD1;COQ9
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.8055934542308619,1.5117778314031536,0.11904761904761904,0.6504257661442643,1.0,2/10,5.73%,UBIAD1;COQ9
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7002083088576152,1.5117017305144576,0.075,0.645324597865683,1.0,9/22,17.34%,GRID2;CHD5;KNDC1;RYK;MDGA2;ZC4H2;NTRK2;SOX4;MAP2
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.9471387352123576,1.5116074714078707,0.022727272727272728,0.6404132163154378,1.0,1/5,0.05%,EGR1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.715002792787922,-1.5112507873989212,0.015384615384615385,0.3125302854275413,1.0,16/41,24.47%,PSMB3;PSMA7;ODC1;PSMB9;PSMB6;PSMA5;AZIN1;PSMC4;PSMD8;PSMD12;PSME2;PSMA3;PSME1;PSME3;PSMB5;PSMC3
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.8559743409043078,1.510993981327844,0.06060606060606061,0.6380928785751645,1.0,4/9,9.26%,SERPINE1;SERPINE2;HPN;RUNX1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.9086122915445229,1.5105265722705845,0.0,0.6351877402662044,1.0,3/5,7.10%,PKD2;FGF2;SALL1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.8663001880697295,-1.5104188885160412,0.05,0.3136775351661933,1.0,3/8,7.33%,OAS3;PHB2;IRF7
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.8217722731964396,-1.510062445807552,0.06153846153846154,0.31254512938005463,1.0,3/12,4.04%,IL4I1;IKZF3;BTK
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8820138218804076,-1.5100245165372042,0.0,0.31020797272917994,1.0,4/11,3.71%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.674494586858881,1.5098522742684857,0.0,0.6332557228827398,1.0,2/27,0.36%,PPARGC1A;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.9488660291983205,1.509827240899253,0.0,0.628393866820822,1.0,2/5,2.57%,ANXA1;SMAD7
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.9395541219716751,-1.5092916014710613,0.0,0.31067213934208604,1.0,1/8,0.09%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.8854583134141844,-1.5084421315393546,0.044444444444444446,0.3124662052263839,1.0,2/6,7.00%,FLNA;CD63
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7511016883461,1.5082379053264796,0.0,0.6311042422860079,1.0,6/18,10.10%,NCAN;CSGALNACT1;CHST7;UGDH;CSPG5;CHST15
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.7750192287486707,-1.5074065410849007,0.05714285714285714,0.3142981294863873,1.0,5/24,7.20%,H1-4;H1-3;H1-2;H1-0;RPS3
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.7535933006599992,1.5072207797704609,0.05555555555555555,0.6305563485132532,1.0,6/20,10.80%,SIRT1;LYPLAL1;PPT1;ABHD17B;HDAC1;SIRT6
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.5667496575009024,1.506299175469578,0.08695652173913043,0.630415823629807,1.0,46/104,21.73%,AVIL;VAMP1;CNTN2;NCAN;ZNF536;GDAP1;SNAP91;SCN3B;OLFM3;PARM1;KCTD16;PLPPR4;CA10;DHCR24;GRIA4;GRM5;CADM2;ASXL3;PTPRD;PRKX;RBFOX1;CACNA1B;PTPN5;GRIA2;NKAIN2;NFASC;CSRNP3;CCDC92;PPFIA2;ADGRB3;LRFN5;MAPK4;SYT4;MAP2;GCNT2;DCLK1;MAP6;AMER2;PHYHIPL;SYNPR;NOVA1;RAB3C;CRMP1;OPCML;DLG2;CPNE3
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6980926386515535,1.50594872732542,0.03333333333333333,0.6271117453159639,1.0,7/16,19.40%,GNPNAT1;UGDH;GFPT1;SLC35D1;RENBP;NANS;GNPDA1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5043279870773661,1.5052595874753343,0.0,0.6264108704904806,1.0,14/144,7.55%,CPA1;MMP17;CTSF;CTSK;DESI2;BACE2;CTSC;BMP1;ATG4C;CPM;MMP16;MDM2;HPN;FOLH1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.6436611325094983,1.5050089683721348,0.02857142857142857,0.6231878082817293,1.0,5/44,4.10%,RRAGD;PDK4;SIRT1;MAP1LC3A;LRRK2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.7356712194819913,-1.504508798830975,0.015873015873015872,0.32544669091759926,1.0,2/25,5.22%,NR4A3;RAB3A
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7124765677099859,-1.5037644662497016,0.028985507246376812,0.32610379542814133,1.0,16/36,15.03%,RPS14;RPS27;RPS25;RPS15;RPS24;METTL17;NOB1;MRPS7;NPM1;RPS6;RPS7;MRPS11;RPS5;RPS28;SURF6;LOC102724159
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.8440931702093699,1.5036096678119997,0.09090909090909091,0.6255243824820174,1.0,2/7,10.15%,GSN;LGALS9
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.8636747730381487,1.5027327725623247,0.08888888888888889,0.6264824667995863,1.0,2/5,2.03%,NRP1;TGFBR2
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.755082415897361,1.5027212832602406,0.06,0.6218072245100371,1.0,3/14,5.29%,SLC39A12;SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.8541881963794639,-1.5023228098631978,0.0,0.33089745936394105,1.0,4/13,9.37%,MX2;PYHIN1;IFITM3;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.8142214328299672,-1.5018170791939542,0.03125,0.33047381332688874,1.0,4/13,4.95%,PPP1R15A;DDRGK1;RACK1;DNAJB9
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7256474892899956,-1.5009657449152585,0.039473684210526314,0.3315879244093316,1.0,21/51,16.44%,MT2A;OAS3;HLA-B;TRIM5;B2M;OAS2;HLA-C;HLA-DRB5;TRIM22;HLA-F;IRF7;STAT1;IRF1;OAS1;CD44;GBP2;IFNGR2;HLA-DRA;HLA-E;HLA-DPA1;CIITA
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.9077905944191155,1.5008865437746943,0.02631578947368421,0.6281669893528841,1.0,1/5,0.36%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.9478439586187749,1.4999876058933883,0.0,0.6302105547810007,1.0,2/5,2.45%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7195593036727679,-1.4995625644289952,0.029850746268656716,0.3362944153626987,1.0,21/37,15.03%,RPL3;RPS14;RPS27;RPL23A;RPL5;RPS15;RPL11;MRPS7;NPM1;RPL10;RPL24;RPL6;MRPS11;RPS5;NOP53;EIF2A;RPS28;TRAF7;RPLP0;C1QBP;LOC102724159
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.687483416275229,1.4994955170758284,0.05,0.6270077614145156,1.0,5/22,12.00%,ACVR2A;SMAD7;GDF11;BMPR1A;TWSG1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.6241046100586443,1.499484171441509,0.037037037037037035,0.622556704140291,1.0,16/50,15.59%,COL16A1;LRP4;SVEP1;COL5A2;PHLDB1;MAGI1;TIMP3;CDH11;GUCY1A2;FERMT2;RUNX1T1;TJP1;SLIT3;FBXL7;ANTXR1;COL6A1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.918692753011084,-1.4994080676709525,0.03389830508474576,0.33426864003561013,1.0,2/7,1.41%,PID1;TFRC
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6462004603219973,-1.4992944915072541,0.0,0.3322731001611646,1.0,32/91,16.53%,CCL4;JAML;MNDA;AIF1;MS4A4A;LSP1;SIGLEC1;IL10RA;FCER1G;NCF4;SNX20;LILRB4;CD300LF;HLA-DRB5;PLEK;HLA-F;CYTIP;NCF2;ITGB2;NCKAP1L;ITGAL;TYROBP;CSF2RB;HLA-DRA;PTPRC;MS4A6A;MYO1F;LY86;HLA-DPA1;IGSF6;CIITA;HAVCR2
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.7655703943295133,1.4990980257921196,0.08823529411764706,0.6198223055051706,1.0,2/17,2.45%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.9241736685705702,1.4989267729094944,0.020833333333333332,0.6163977207036089,1.0,3/5,5.29%,SLC39A12;SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.689939711461582,-1.4985626625102884,0.043478260869565216,0.3330313063050779,1.0,6/44,6.27%,MX2;CD36;TFRC;MX1;FCER1G;LILRB4
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.9402171277727271,-1.4977077290446186,0.0,0.33445440028645107,1.0,1/9,0.35%,DDX11
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.7788985451174798,1.497167841254453,0.0,0.6220726743896603,1.0,7/14,15.68%,GRID2;INSYN2A;LRRK2;GLRA1;GRIN2B;GRIN2A;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.6675025610291049,1.497156045190323,0.12,0.617691880908043,1.0,2/18,0.65%,COL16A1;NRP1
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5802694344220319,1.4970541951085625,0.03571428571428571,0.6139970635800185,1.0,29/100,14.04%,PLXNB1;SLC39A12;LGI4;PLA2G7;CNTN2;NCAN;LUZP2;GFAP;SLC1A3;CDH20;AANAT;GSTA4;SLC1A2;PLPPR4;NTM;CA10;GRIA3;PSD2;GRM5;SLC4A4;CADM2;RBFOX1;SLC25A46;PTPN5;GRIA2;NTRK2;NFASC;TMEM132C;GRIN2A
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5779442192571236,1.4966770680383301,0.045454545454545456,0.6119487953557654,1.0,43/91,24.32%,LRP4;SERPINE1;CNTN2;ARNT2;PCDH17;SNAP91;KCTD16;PLPPR4;GRIA4;STX1A;ASXL3;PTPRD;GUCY1A2;RBFOX1;TTLL7;CACNA1B;KALRN;GRIA2;UNC5D;NFASC;CSRNP3;SLC12A2;ADGRB3;FAM171B;MAPK4;SYT4;MAP2;DCLK1;CNTN1;RAPGEF2;PCLO;MAP6;PHYHIPL;SYNPR;RAB3C;CRMP1;OPCML;NRXN1;SEMA6D;ASIC2;CADPS;LSAMP;LIFR
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5747979746127135,1.4960631763248684,0.05263157894736842,0.6119530737562922,1.0,35/80,21.47%,CNTN2;NCAN;GFAP;ZNF536;SNAP91;CHST1;OLFM3;PARM1;KCTD16;PLPPR4;CA10;KCNC2;PSD2;GRM5;CADM2;RBFOX1;SNCB;NXPH1;PTPN5;GRIA2;NKAIN2;NTRK2;PPFIA2;ABCC8;GAD1;ADGRB3;LRFN5;MAPK4;MAP2;MAP6;PHYHIPL;SYNPR;VSTM2B;CAMK2B;OPCML
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.9926214534433087,-1.4957565879710926,0.0,0.34098150834860064,1.0,2/5,0.19%,ITK;JAML
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8159899885357595,1.4946222764583434,0.023809523809523808,0.6151914629331516,1.0,4/8,10.55%,CDC14B;BTRC;FZR1;PTEN
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.9832142607476176,1.4934438264308445,0.0,0.6155208855915532,1.0,1/5,0.27%,KLF4
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.9892565026070279,-1.4918179448335178,0.0,0.35188990038149637,1.0,1/5,0.09%,NR4A3
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.9892565026070279,-1.4918179448335178,0.0,0.35188990038149637,1.0,1/5,0.09%,NR4A3
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.5970479502823594,-1.4895782265426727,0.0,0.35964515382511547,1.0,77/291,11.66%,RPS13;HARS2;RPS4X;RPL28;RPS21;RPS27A;RPL31;RPL38;RPS8;RPL37A;WARS1;RPL12;RPL3;RPS14;RPS27;RPL23A;RPL39;RPS11;RPL5;RPS25;RPL19;RPL32;RPLP1;DHX38;RPS15;RPS24;PTMA;RPS20;TSPAN32;RPS23;RPL29;RPLP2;RPL11;RPL10A;RPL13A;RPS12;RPL7A;RPL35;RPL37;RPS18;RPL41;ABCF1;RPL23;MRPS7;RPS26;RPL14;RPL4;RPS3;RPL34;RPS6;RPL30;RPS3A;RPL10;RPL24;RPS2;RPS7;RPL36;RPL6;MRPL51;RNASEL;NUP50;RPL18A;NCBP2;POLR2G;RPL27;RPL27A;MRPS11;CHTOP;U2AF2;RPL15;MRPL52;MRPL32;RPL21;RPL18;RPS5;SRSF7;EIF4A3
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.8705307026004866,-1.4893588268378668,0.01639344262295082,0.35768726529497213,1.0,6/11,9.70%,PYHIN1;MNDA;AIM2;STAT1;IRF1;OAS1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.8187860619363214,1.4891599725367355,0.025,0.6329191525326631,1.0,2/7,5.52%,NCAN;CSPG5
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.8591741600700242,1.4887240613683295,0.047619047619047616,0.6306413241542196,1.0,3/10,6.54%,ABCA2;PICALM;TMED10
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.8745268482206116,-1.4887158354556107,0.014492753623188406,0.35805253855533836,1.0,2/12,1.73%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.8183056403177176,1.4875079264930455,0.08163265306122448,0.6337538470008532,1.0,4/12,11.14%,ACER2;ABCA2;SPTLC2;SPTLC3
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6885926806213497,-1.4870963420586765,0.04054054054054054,0.3626795209928095,1.0,11/54,12.16%,GNLY;OAS3;HAMP;RPL39;NAIP;OAS2;FCER1G;RPL30;OAS1;GBP2;H2BC21
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.7858210424610792,1.486641247685033,0.07142857142857142,0.634458707213743,1.0,2/11,5.73%,UBIAD1;COQ9
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.9096379890031263,1.4860791030794462,0.06382978723404255,0.63221570732513,1.0,3/7,6.68%,LYPLAL1;PPT1;ABHD17B
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.8100309483191873,-1.4859636001893342,0.031746031746031744,0.3649204933665686,1.0,10/17,14.04%,RPL3;RPL23A;RPL5;RPL11;RPL10;RPL24;RPL6;NOP53;TRAF7;RPLP0
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.7492876231776044,-1.4851769944649205,0.030303030303030304,0.3662082620267599,1.0,2/21,6.30%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.5842746686380439,1.4848421669418412,0.05405405405405406,0.6345062127217355,1.0,7/37,11.68%,ZBTB1;RUVBL2;CASP9;PARP1;EIF2S1;PTPRK;ERCC4
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.8988371461826549,1.4843240412323093,0.0,0.6330378570695689,1.0,2/6,2.45%,ANXA1;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.8772919149561443,1.4832746631084535,0.05263157894736842,0.6349641651060217,1.0,4/6,11.03%,ACER2;SERPINE1;PDE3B;WNK1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.8342197334420117,1.4830138056622582,0.0,0.6315483362308039,1.0,1/11,0.06%,LEPR
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.7129680336854967,-1.4829298747943012,0.029850746268656716,0.3730887471199209,1.0,3/27,1.57%,UBC;CCDC88C;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.631948041455165,-1.4811081986665713,0.027777777777777776,0.37885215644355036,1.0,9/94,2.41%,CCL4;CALCR;CD36;CCL3;CCL5;PDGFD;GPR183;GLIPR2;MARCO
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.7099071003366852,-1.4808530344013613,0.04054054054054054,0.37725241809479204,1.0,5/29,9.41%,NR4A3;CCL5;AIF1;IGF1;STAT1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.8587939523049064,-1.4803575479570263,0.017857142857142856,0.37752531700270936,1.0,2/10,1.73%,CCL5;PRKCQ
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.7286347005671047,1.4795092035740418,0.06666666666666667,0.6490664503723169,1.0,1/13,0.21%,IFNLR1
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.8244227743919085,-1.4788617965000868,0.03225806451612903,0.38319960292136424,1.0,5/13,4.74%,RIPOR2;CCL5;AIF1;CD200R1;APOD
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.7167627693443639,1.4787820607102822,0.0,0.6478661998799232,1.0,5/15,11.35%,RAB33B;PDE4DIP;MAP2K1;RBSN;MAPK1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.6561465279754294,1.4785783492376199,0.025,0.6446744654988328,1.0,11/30,12.49%,TCF7L1;LRRK2;WNT5A;FZD3;WNT2B;RYK;DVL3;BCL9L;PTEN;TCF7L2;CSNK1E
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.6837261244096189,-1.4784490026145398,0.030303030303030304,0.37980716481203497,1.0,20/48,20.38%,NDUFC1;DMAC1;NDUFA2;NDUFA1;TMEM126B;NDUFB4;TIMM21;NDUFA12;NDUFB9;NDUFS5;NDUFS8;NDUFB1;BCS1L;NDUFB7;OXA1L;NDUFS6;NUBPL;NDUFS7;NDUFA3;NDUFB3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.6837261244096189,-1.4784490026145398,0.030303030303030304,0.37980716481203497,1.0,20/48,20.38%,NDUFC1;DMAC1;NDUFA2;NDUFA1;TMEM126B;NDUFB4;TIMM21;NDUFA12;NDUFB9;NDUFS5;NDUFS8;NDUFB1;BCS1L;NDUFB7;OXA1L;NDUFS6;NUBPL;NDUFS7;NDUFA3;NDUFB3
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.6165918405429357,-1.478330615592856,0.0,0.3777071703345212,1.0,37/100,16.86%,JAML;ADGRE1;MNDA;AIF1;MARCO;CHIT1;MS4A4A;SIGLEC1;CD14;IL10RA;FCER1G;NCF4;TYMP;LILRB4;CD300LF;PLEK;IRF7;SIRPB2;LILRB3;CLEC12A;C5AR1;TNFRSF1B;NCF2;FTL;ITGB2;TYROBP;CSF3R;CSF2RB;HLA-DRA;MS4A6A;PLTP;MYO1F;LY86;SLC11A1;IGSF6;HAVCR2;IL1B
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.9547873038335132,-1.4779826451631202,0.0,0.37466696014733153,1.0,1/5,1.54%,RSAD2
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.9547873038335132,-1.4779826451631202,0.0,0.37466696014733153,1.0,1/5,1.54%,RSAD2
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.8864778804256878,1.4778747598795159,0.06976744186046512,0.6435964296528753,1.0,2/6,4.72%,SMAD7;DACH1
prerank,GO_Biological_Process_2021__eosinophil chemotaxis (GO:0048245),-0.9838144131491645,-1.4774345530825308,0.0,0.37335456996702676,1.0,3/5,1.13%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__eosinophil migration (GO:0072677),-0.9838144131491645,-1.4774345530825308,0.0,0.37335456996702676,1.0,3/5,1.13%,CCL4;CCL3;CCL5
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.5877308521526297,1.4769482020641398,0.041666666666666664,0.6445927066550605,1.0,30/71,18.30%,KCNQ2;DPYSL5;GRID2;NCAN;SIRT1;B4GALNT4;ADGRB2;NOL4;PBX1;SNAP91;CNR1;CSPG5;PURG;POU6F2;GRM5;BRSK1;SLC35F1;ELAVL2;LINGO1;CACNA1B;UNC5D;CSRNP3;CAMKV;ERBB4;LRRC4B;DAB1;MAPK4;SYT4;MARK2;PPM1E
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.7524633785947789,-1.4769218271692872,0.02857142857142857,0.3731604889634827,1.0,2/25,1.20%,OSBPL5;CH25H
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.8094564709722439,1.4767558525988478,0.0,0.6414802852145142,1.0,2/11,0.36%,KLF4;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.8811242933601658,-1.47668565342114,0.05357142857142857,0.3722854672656602,1.0,1/9,1.12%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.719878129468065,1.4765257551075393,0.11428571428571428,0.6390324018319623,1.0,7/14,10.55%,SPRY2;SMAD7;SPRED1;SPRED2;USF3;HPN;PTEN
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.9545115747244335,-1.4757801098544485,0.01818181818181818,0.3741378266489945,1.0,1/6,0.70%,CD36
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.7483535086143127,1.4751987586482787,0.05555555555555555,0.6426062184480132,1.0,5/15,17.91%,DOC2A;STX1A;SYT17;SYT4;KCNB1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7915045152380981,1.474567214655751,0.06818181818181818,0.6427335540557111,1.0,5/11,11.36%,ZBTB16;BMP1;SOX5;BMPR1B;KAT2A
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.6226095892419415,-1.474441213867385,0.015151515151515152,0.3770573867186059,1.0,20/100,11.93%,CCL4;CCL3;CCL5;CD96;CXCR4;FOS;MGLL;AIF1;NAIP;SIGLEC1;CD14;ABCF1;CHI3L1;TACR1;C5AR1;OLR1;CD44;APOL3;ITGB2;ITGAL
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.9542283912784701,-1.4744048086396637,0.01818181818181818,0.3748846550803581,1.0,1/5,1.68%,PRLR
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.8640115650997447,1.4742621962909759,0.0,0.6407836316775898,1.0,5/8,8.07%,PLXNB1;PLXNA2;PLXNB2;PLXNC1;PLXNA3
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.8977342755347629,1.474142365584319,0.07692307692307693,0.6380164602663531,1.0,2/5,3.86%,SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.8790543689575993,1.4732815036338691,0.075,0.6387005860785694,1.0,2/6,5.09%,ANXA1;AKIRIN1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.6145285451993908,-1.4732038712993196,0.013157894736842105,0.3776099770524661,1.0,18/82,15.58%,TNFRSF11B;CARD14;PSMB3;TNFRSF25;AIM2;EIF5A;PSMA7;TMSB4X;PSMB9;PSMB6;STAT1;TNFRSF1B;PSMA5;TNFSF13B;PSMC4;PSMD8;PSMD12;PSME2
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.8128448003126524,1.473070431196768,0.025,0.6362050298219836,1.0,4/9,10.15%,ZBTB16;BMP1;SOX5;BMPR1B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7618515407657103,-1.472997761320411,0.046875,0.3763267804981815,1.0,4/19,4.13%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.9335602007196203,1.472913129729759,0.0,0.6332884145482456,1.0,3/8,1.65%,PPARGC1A;PLA2G7;ADIPOR2
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7742050859221122,1.4717744399170059,0.029411764705882353,0.6349583872418129,1.0,7/11,18.92%,ADGRB2;NFAT5;PPP3CA;NFATC3;INPP5A;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.922031360628326,-1.4706695673568733,0.031746031746031744,0.38503842608501193,1.0,1/6,0.70%,CD36
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.9120273922503651,1.4700780583628403,0.043478260869565216,0.6353634639500453,1.0,3/6,6.68%,LYPLAL1;PPT1;ABHD17B
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.9120273922503651,1.4700780583628403,0.043478260869565216,0.6353634639500453,1.0,3/6,6.68%,LYPLAL1;PPT1;ABHD17B
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7830372417568386,-1.469783563663855,0.06557377049180328,0.3862434963948869,1.0,11/14,20.25%,RPS14;RPS27;RPS15;MRPS7;MRPS11;RPS5;RPS28;LOC102724159;RRP7A;RPS19;RPS27L
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.6028085001291437,1.4686869248393701,0.0,0.6400731668190185,1.0,10/37,11.00%,COL16A1;NRP1;GRID2;NLGN1;DLG5;NPHP1;CLSTN2;PTPRD;CLSTN3;FERMT2
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.7606077614153157,1.468064978552476,0.02702702702702703,0.6394784516829277,1.0,3/16,4.53%,ANXA1;WNT5A;JAG1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.8320949607232107,-1.466923010638761,0.08333333333333333,0.3984450518725937,1.0,3/12,5.45%,CCL5;PRLR;IL10RA
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.76825987318915,1.4667095783532582,0.058823529411764705,0.6433861490451631,1.0,4/11,11.72%,STK25;TBCCD1;COPG1;RIPOR1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.6654135518954786,-1.4658783218266762,0.0,0.4008992709056525,1.0,10/51,8.13%,CALCR;RPGRIP1L;CCL5;DYNLT1;MGLL;RGS2;RGS16;RGS4;PLEK;CALM1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.5841664729374976,1.4657094079623816,0.0,0.644005151574392,1.0,13/44,21.73%,PKD2;NLGN1;WNT5A;ALOX5AP;SYT17;ADGRV1;PRKAA1;SYT4;ADCY1;RYR1;ITPKB;ADD1;CPNE3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.8494288682856459,1.4655942961667001,0.0625,0.6373086303445135,1.0,4/9,11.14%,ACER2;ABCA2;SPTLC2;SPTLC3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.8494288682856459,1.4655942961667001,0.0625,0.6373086303445135,1.0,4/9,11.14%,ACER2;ABCA2;SPTLC2;SPTLC3
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6566303828938373,-1.4655136595302836,0.06756756756756757,0.399812976194937,1.0,15/48,17.40%,CCL5;NLRC3;DHX58;CDC37;PARP9;RNASEL;IRF1;PLSCR1;ERAP1;TNFAIP3;IFI35;APPL1;HLA-E;TASL;POLR3C
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.5554739607037266,1.465395998541889,0.05,0.6344770189299053,1.0,24/67,21.73%,TRPC1;PKD2;NLGN1;KCNIP2;WNT5A;KCNMB4;ALOX5AP;ANXA11;PPP3CA;AHCYL1;SYT17;KCNMB3;ADGRV1;PRKAA1;NEDD4;SEC31A;SYT4;RYR2;HOMER1;ADCY1;RYR1;ITPKB;ADD1;CPNE3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.8156357617386882,1.4644201179556406,0.05,0.635695623561733,1.0,1/11,0.63%,PLA2G4C
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7635482015482146,1.4643814155944452,0.07142857142857142,0.6322729105617867,1.0,6/13,13.84%,NRP1;PKD2;SMAD7;ROBO1;NF1;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.6613861986937531,1.464015660280961,0.05714285714285714,0.6309099751332802,1.0,7/36,5.64%,KLF4;SPRY2;YJEFN3;AMOT;SPRED1;PPARG;PTPRM
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7497245224096565,1.4638650296090323,0.07142857142857142,0.628798917082874,1.0,5/16,13.84%,NRP1;TGFBR2;ROBO1;BMPR1A;ROBO2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.8283256134583522,1.4637906064430803,0.04081632653061224,0.6257449190870613,1.0,3/9,10.91%,ETNPPL;CHKA;SELENOI
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.7357440229410457,-1.463418126781177,0.03076923076923077,0.408621906766732,1.0,2/24,1.13%,CD36;CCL5
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.8093951777646984,1.4615434906495215,0.08108108108108109,0.6340447624637737,1.0,4/15,11.14%,ACER2;ABCA2;SPTLC2;SPTLC3
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.6576954835397493,1.461532100459913,0.06382978723404255,0.6307223939884139,1.0,3/26,5.60%,PPARGC1A;RUVBL2;RPS6KA4
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.7148996254095761,1.461077324563693,0.03125,0.6296754831556624,1.0,1/19,0.05%,EGR1
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.8691003428965265,-1.4608101209867794,0.031746031746031744,0.4189408116859163,1.0,5/9,9.73%,DDX11;DTX3L;PARP9;MED25;BTAF1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.7836922262485382,1.4607604567482357,0.047619047619047616,0.6284370815766197,1.0,6/14,12.32%,NRP1;PKD2;SMAD7;JAG1;BMPR1A;NF1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.5981621175020626,1.459134043860874,0.02857142857142857,0.6332568062322791,1.0,4/31,2.69%,PPARGC1A;IGF1R;SIRT1;SLC39A14
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5776881697205397,1.4590393029037663,0.0,0.6304758536371992,1.0,50/105,24.82%,COL16A1;RASSF8;FKBP9;MYO1D;DACH1;PHLDB1;RASAL2;MAGI1;NUAK1;TANC1;UNC13B;MERTK;KANK1;KITLG;NFIB;FERMT2;GOLIM4;ENAH;THSD7A;TJP1;ADCY6;PTPRG;RAI14;COL4A5;ANTXR1;NTN4;MYO1E;RBFOX2;SNX7;CORO2B;STARD13;PTPRO;ADCY1;PRICKLE2;HTRA1;CADPS2;CDH13;CD2AP;LIMCH1;LOXL2;ARHGEF17;KIAA1217;PLPP3;CTTN;DAB2IP;LIFR;LGR4;SH2D4A;MAGI2;RND3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7295550448349337,-1.4589147940925107,0.04918032786885246,0.42598107432704724,1.0,4/22,3.37%,UBC;RPS27A;XPA;COPS6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7483906939114962,-1.4587008676364526,0.07142857142857142,0.42462997333944724,1.0,2/19,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.9024883225124374,-1.4586565159594482,0.014492753623188406,0.4199203442802677,1.0,2/7,2.75%,MX2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.9024883225124374,-1.4586565159594482,0.014492753623188406,0.4199203442802677,1.0,2/7,2.75%,MX2;MX1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6675626038681719,-1.4585121526821025,0.07142857142857142,0.41810431644509505,1.0,3/40,1.13%,CCL4;CCL3;CCL5
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.752371326282247,-1.457400499040579,0.07407407407407407,0.4209837828433223,1.0,7/16,18.79%,ANKUB1;ATP5MK;CCDC39;DNAH9;TUBB4B;CCDC60;DNAH12
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.6032396519873525,-1.4572331686787607,0.012987012987012988,0.41969870880191185,1.0,12/96,8.86%,ITK;GRAP2;FOS;PRKCQ;PSMB3;VAV3;BTK;FCER1G;PSMA7;CALM1;PSMB9;PSMB6
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.8373806404860498,-1.456533984058433,0.031746031746031744,0.4215565140023148,1.0,1/11,0.37%,MX2
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5899792947616773,1.4559293249094638,0.0,0.6459361035409842,1.0,31/88,18.93%,AVIL;PLXNB1;PLXNA2;RAP1A;WNT5A;RELN;CHODL;SCARB2;PLXNB2;ROBO1;PLXNC1;ZNF804A;PLXNA3;DVL3;FUT9;NPTN;PTPRD;METRN;PRKCI;NTRK2;ROBO2;PLXNA1;MAP3K13;CAPRIN2;RAPGEF2;TIAM2;IL1RAPL1;MAP6;MARK2;SLIT2;TIAM1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.8376842036753291,-1.4557195636234406,0.03225806451612903,0.4230221974957138,1.0,2/11,10.12%,TFRC;CD226
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.8381780831875287,-1.4556615350170992,0.0425531914893617,0.42100830695569563,1.0,2/9,7.00%,FLNA;CD63
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6762833975135426,-1.4548707188135672,0.014925373134328358,0.4219557249649047,1.0,13/47,19.37%,PSMB3;ATF5;PSMA7;PSMB9;PSMB6;RBX1;PSMA5;PSMC4;PSMD8;PSMD12;PSME2;PSMA3;PSME1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8645863617665205,-1.4546373511816855,0.034482758620689655,0.42120286177741695,1.0,2/10,4.81%,NR4A3;RACK1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.9172068383130242,-1.4540663087459875,0.018518518518518517,0.4219572225079842,1.0,4/9,3.71%,H1-4;H1-3;H1-2;H1-0
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.5085447790988825,1.4536294753851922,0.041666666666666664,0.6552188946944358,1.0,29/86,14.32%,PDZRN4;SCN3A;RCN3;ZNF536;SNAP91;OLFM3;KCTD16;PLPPR4;NTM;GRIA3;CDH11;GRIA4;GRIA1;CADM2;ASXL3;PTPRD;RBFOX1;CPEB4;COL11A1;RUNX1T1;CNTN4;GRIA2;UNC5D;PTPRN;NFASC;CSRNP3;SGIP1;ROBO2;HFM1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.9403401324903414,-1.4534376201709138,0.0,0.4225678881964779,1.0,1/8,0.35%,DDX11
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.8333895745851685,1.4533067741741525,0.08333333333333333,0.6534860469861529,1.0,4/7,12.66%,CDK5R1;GRIN3A;CPEB4;GRIA2
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.8493643617688277,1.452594423198891,0.1282051282051282,0.6530798805437503,1.0,3/6,9.39%,GRAMD1A;PTCH1;GRAMD1C
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.9362685127468022,-1.452540700082485,0.0,0.424340350301196,1.0,1/6,0.35%,DDX11
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.7301922271912576,-1.4513945633226313,0.0847457627118644,0.42716657693195853,1.0,5/26,5.44%,UBC;CD36;RPS27A;BTK;CD14
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.7653749938731135,1.4513362629203614,0.0,0.65625899215909,1.0,3/8,8.28%,SIRT1;WNT5A;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6630460687782522,1.4513165086320003,0.030303030303030304,0.6531868522511048,1.0,10/22,12.24%,ARRDC3;DCUN1D4;CDC14B;BTRC;FZR1;UBE2L3;PTEN;FBXW7;UBE2N;DCUN1D1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.9035869329975045,-1.4511346011500101,0.016129032258064516,0.42609480658605564,1.0,1/12,0.15%,FLNA
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.8577703965352267,1.4502836065983042,0.08571428571428572,0.6547864195399087,1.0,5/10,10.29%,LHFPL2;WNT5A;WNT2B;KITLG;NCOA4
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.7923559352193787,1.4498159361471228,0.09523809523809523,0.6533558037109322,1.0,4/10,6.48%,KCNIP2;KCNJ2;KCND3;KCNJ5
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8842273577290052,-1.4495050053762937,0.03389830508474576,0.42824187242875045,1.0,4/9,3.71%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8842273577290052,-1.4495050053762937,0.03389830508474576,0.42824187242875045,1.0,4/9,3.71%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8842273577290052,-1.4495050053762937,0.03389830508474576,0.42824187242875045,1.0,4/9,3.71%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.9006057218507124,-1.4488747714007442,0.018518518518518517,0.42905873818445606,1.0,1/5,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.874517831080906,1.448403227152083,0.047619047619047616,0.6572994742202769,1.0,2/6,3.05%,GSN;MCU
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.5747555123089766,1.4479963474594142,0.05555555555555555,0.6562515415873532,1.0,6/48,9.83%,LEPR;ATRAID;TIMP3;TAB2;HGF;NELL1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.5918937276821662,1.4476531023994852,0.06666666666666667,0.6544558543722899,1.0,6/48,2.69%,GRB10;FER;PDK4;IGF1R;GAB1;SLC39A14
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.6169363772695451,-1.4467656577357346,0.0,0.43813881174336944,1.0,27/98,19.62%,UBC;RPS27A;XPA;PSMB3;GTF2H5;H2BC18;PSMA7;NPM1;PSMB9;PSMB6;CENPV;H2BC5;RBX1;H2BC9;H2BC21;PSMA5;PSMC4;PSMD8;RPA3;PSMD12;MCM7;PSME2;UBA52;MCM6;PSMA3;PSME1;H2BC11
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.7502141887040492,1.4466152959669951,0.045454545454545456,0.6560097722100335,1.0,5/11,16.31%,CDK5R1;SEMA5A;CNTN4;RTN4;MEGF8
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.5971898761802886,1.4463205990918375,0.08695652173913043,0.654357991166296,1.0,26/77,21.68%,PLXNB1;PDGFA;HIP1R;CDK10;PHLDB1;TPPP;CRK;MAPK1;IQCJ-SCHIP1;TJP1;PTK2;EPHA5;P2RX7;GSK3B;CLASP1;RHOBTB1;PRKAA1;PHLDB2;MAP6;MARK2;RHOB;CORO2B;RHOQ;ARHGAP35;STMN3;TAOK2
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.907334905816437,1.4462131125826077,0.02040816326530612,0.651477265784302,1.0,2/5,6.54%,ZDHHC3;TNFRSF10A
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.5633314044029794,1.4460423308960741,0.06666666666666667,0.6496157208484635,1.0,5/72,4.69%,EGR1;RRAGD;PKD2;RAP1A;AANAT
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.7919578158015885,-1.4459512016923972,0.03773584905660377,0.4393701645473039,1.0,5/15,7.59%,FTH1;NLRC3;EMD;GSTP1;MED25
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.7704935335769687,1.4450763286818682,0.02564102564102564,0.6515945539768998,1.0,2/9,3.08%,STK36;DLG5
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.9059067473861455,-1.4433793733039813,0.04838709677419355,0.45049024358827505,1.0,2/7,2.11%,PRKCQ;NFKBID
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.6725440435943975,-1.443022847180211,0.04477611940298507,0.4498549525352333,1.0,7/45,12.80%,SLC2A3;VNN2;MTHFD1;CYB5A;SLC25A19;FLAD1;MMAB
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.8276745785165424,1.4426169635951525,0.023255813953488372,0.66024206407186,1.0,1/8,0.79%,PDPN
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.5840836568297456,-1.4425831089318026,0.014084507042253521,0.44994738464429,1.0,34/93,16.86%,CCL4;CCL3;BCL2A1;SRGN;GPR183;MNDA;MS4A4A;FCER1G;NCF4;TYMP;LILRB4;PLEK;SAMD9L;CSF2RA;C5AR1;IRF1;TNFRSF1B;NCF2;CFLAR;GBP2;ITGB2;TNFAIP3;TYROBP;APOL6;CSF2RB;PTPRC;MS4A6A;LY86;HLA-E;CARD6;IGSF6;CIITA;HAVCR2;IL1B
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.7347229405739972,-1.4420342908094472,0.04054054054054054,0.45075651380692855,1.0,2/28,1.73%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.8937084980826051,-1.4416520645224526,0.047619047619047616,0.4505914778349062,1.0,1/6,0.38%,MT2A
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.9270518876283654,-1.441628876572358,0.05357142857142857,0.44846389475234405,1.0,1/5,0.09%,NR4A3
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.8871419066625795,-1.44116548004946,0.016129032258064516,0.44856140810193135,1.0,4/8,8.01%,CCL5;CXCR4;GPR183;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.5763342784168151,1.4409379202768828,0.0,0.6656926853805208,1.0,5/41,4.41%,NRP1;SEMA5A;FGF2;SIRT1;WNT5A
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.9182239546306328,-1.4408483109004742,0.0,0.4480372910885904,1.0,1/7,1.22%,PYHIN1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.6780938805056457,-1.4407635298544483,0.046153846153846156,0.4462831229461953,1.0,12/55,12.16%,H1-4;H1-3;H1-2;H1-0;POLE3;H2BC18;NPM1;H2BC5;H1-10;SMARCD1;H2BC9;H2BC21
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.812025317579586,-1.4407448501600961,0.014705882352941176,0.44430032055693675,1.0,2/15,1.70%,MT2A;FOS
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.7709933418975902,1.4402700985879027,0.1,0.6658651114807692,1.0,5/11,9.97%,KCNIP2;KCNJ2;KCND3;KCNJ5;KCNN2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.9721402108539503,-1.439752196248375,0.0,0.4467810249944824,1.0,1/5,0.09%,NR4A3
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5265716162368477,1.4397479494828307,0.0,0.6651286621508136,1.0,21/65,14.80%,PLXNB1;HID1;GCLC;FKBP9;RAP1GAP;TSPAN15;MTUS1;MYO1D;DAG1;PARM1;SCARB2;UNC13B;PLXNB2;UNC5B;GNA11;COBL;RTKN;EPAS1;GPR107;ADCY6;ITGAV
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.5039201273629311,1.4395139603303853,0.0,0.6637369886009211,1.0,53/119,18.35%,KCNQ2;SLITRK5;DPYSL5;CNTN2;GRID2;NCAN;SMAD1;NLGN1;INSYN2A;NRG1;NBEA;ZNF536;GALNT13;NOL4;SNAP91;DACH1;OLFM3;CNR1;CLSTN2;RELN;TMEM170B;CNRIP1;PURG;GNL3L;FUT9;DNM3;CADM2;SLC35F1;ELAVL2;LINGO1;SNCB;RGMB;ZDBF2;SLC25A46;CACNA1B;PTPN5;GRIA2;CSRNP3;CAMKV;PPFIA2;CDH4;ATRNL1;ADGRB3;FAM171B;PREPL;ATP13A2;MAPK4;SYT4;MAP2;DCLK1;RNF138;MAP6;TBCK
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.8810946973049195,1.4392895876544665,0.02702702702702703,0.6615195748683935,1.0,1/6,0.06%,SHROOM3
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.8726057107584747,-1.4387929212791344,0.017543859649122806,0.4496433870155222,1.0,1/10,0.32%,OSBPL5
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.8788982454240777,-1.437841326194323,0.03333333333333333,0.45284149715214334,1.0,3/11,2.62%,GNLY;GAPDH;RPL39
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.9346240565590873,-1.43769795254214,0.03225806451612903,0.45142787194969214,1.0,2/5,2.18%,CCL3;MGLL
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.7443643282856526,-1.4374736602843339,0.015151515151515152,0.45042769230456065,1.0,5/29,6.09%,H1-4;H1-3;H1-2;H1-0;TTN
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7693042419076445,1.436564630869232,0.14285714285714285,0.6721443770486615,1.0,4/10,13.58%,EFL1;LRRK2;MFN1;AK3
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.8427989941359749,1.436002836257854,0.11363636363636363,0.6715704956464569,1.0,3/8,9.48%,ACVR2A;SMAD7;LEMD3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.6786522151652299,1.4359359864531704,0.029411764705882353,0.6685795383293112,1.0,8/23,13.91%,KLF4;JAG1;MYADM;WNK1;FXYD5;ZNF703;GTPBP4;PTK2
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.8601596050700734,-1.43584999799152,0.07142857142857142,0.457317708881206,1.0,1/8,0.38%,MT2A
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.7277794360089104,-1.4351515565762596,0.0410958904109589,0.45847779612361317,1.0,2/30,1.73%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.6943000052674935,1.4348519892059233,0.06818181818181818,0.6710267045661408,1.0,5/23,5.97%,EGR1;KLF4;FGF2;PPARG;SMAD3
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6925933285939674,-1.4341441157865515,0.043478260869565216,0.4611645485674697,1.0,7/34,8.63%,NR4A3;GAPDH;ME1;PDHX;SLC16A3;LDHA;HK2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7632222036592333,1.4338107210201896,0.05263157894736842,0.6738612041540109,1.0,4/10,10.32%,NCAN;CSGALNACT1;CSPG5;UST
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.8033809870199857,1.433582458013786,0.11428571428571428,0.6719496787991069,1.0,3/7,16.68%,HPN;FLRT2;NTN4
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.7490113448337883,-1.4332383367315613,0.0625,0.46327670230525786,1.0,4/17,6.30%,PYHIN1;EDF1;H1-0;IGF1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.865716573147322,1.4330786554784243,0.045454545454545456,0.6712156998175662,1.0,1/5,4.46%,TEX264
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.648913546712552,-1.432637365417732,0.014084507042253521,0.46439268087873375,1.0,2/48,1.73%,NR4A3;PRKCQ
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.8760030669628808,1.4323615544816697,0.021739130434782608,0.6723939799211959,1.0,2/5,6.48%,KCND3;KCNJ5
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.9309014648202443,-1.4321623983126932,0.0,0.4644097571445044,1.0,1/5,1.72%,PLN
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.5998763327530341,-1.4321007160698833,0.0,0.4624144950671222,1.0,29/81,16.53%,JAML;ADGRE1;MNDA;AIF1;MARCO;MS4A4A;SIGLEC1;CD14;FCER1G;NCF4;LILRB4;CD300LF;PLEK;SIRPB2;LILRB3;CLEC12A;C5AR1;NCF2;TYROBP;FCGR1CP;CSF3R;CSF2RB;CASP5;MS4A6A;MYO1F;LY86;SLC11A1;IGSF6;HAVCR2
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.9343515820625272,-1.4318356589168522,0.0196078431372549,0.46159314606522134,1.0,4/6,1.13%,CCL4;MYO1G;CCL3;CCL5
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.8100036304612275,-1.4311199398600642,0.015384615384615385,0.4626963707026704,1.0,2/16,1.70%,MT2A;FOS
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.8575888299118773,1.4308670554893386,0.08333333333333333,0.6771257672735912,1.0,3/9,9.97%,SCN3B;KCNJ5;KCNN2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.579668904956955,1.4307146737949807,0.12,0.6748332936464878,1.0,7/72,1.65%,LEPR;PRKAB2;PPARGC1A;ESRRG;GRB10;IGF1R;ADIPOR2
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.6447479231992421,1.4306138279251337,0.125,0.6724473433770237,1.0,6/26,12.32%,NRP1;CDK5R1;AMOT;PTCH1;CDK6;NF1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.9096376436283293,1.4297418200838763,0.0392156862745098,0.6732021667385446,1.0,2/5,6.19%,WNT5A;RYK
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.9616644177963023,-1.4293180307035636,0.0,0.47012502552536295,1.0,1/5,2.56%,SNX6
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.8073281169528684,1.428667213221398,0.09090909090909091,0.6766607932713448,1.0,1/7,2.03%,TGFBR2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.7872130263591933,1.4283981568384179,0.1590909090909091,0.674804301457066,1.0,3/9,4.31%,KCNIP2;KCNJ2;KCND3
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7363089465554213,1.4276826310568316,0.05,0.6725331754275182,1.0,3/16,1.72%,AVIL;EPS8;GSN
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7363089465554213,1.4276826310568316,0.05,0.6725331754275182,1.0,3/16,1.72%,AVIL;EPS8;GSN
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.6303141687068894,-1.427323545832395,0.05555555555555555,0.4777520926212694,1.0,6/52,11.46%,CALCR;YES1;CD247;PRKAR1B;FYN;KARS1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.6671360991858896,1.4271936749307579,0.125,0.6717730852964797,1.0,5/35,5.38%,ARSA;PGAP1;ABCA2;GLB1;ST6GALNAC3
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.8602758217483346,-1.4271725169637546,0.12903225806451613,0.4763845448232423,1.0,2/6,2.96%,MYBL1;MOV10L1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.8559780701504601,-1.4269229445593363,0.06451612903225806,0.4755940664045323,1.0,1/10,0.88%,INSIG1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.7041677018114464,-1.4267884427316408,0.09230769230769231,0.4742859419648921,1.0,9/33,9.70%,SIGIRR;OAS3;CARD16;PARP14;PADI2;NLRC5;NR1H2;GSTP1;OAS1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.8945852963832046,-1.426029334734871,0.05660377358490566,0.4765343064720857,1.0,2/5,7.18%,OAS3;PHB2
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.862304355284095,1.4257866590674533,0.06666666666666667,0.6764889435630207,1.0,1/5,0.05%,EGR1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.7108424013003013,-1.425692684191105,0.09722222222222222,0.4760880336425965,1.0,5/30,4.62%,UBC;RPS27A;XPA;GTF2H5;OGG1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.7633743857215826,-1.4256203680885322,0.05084745762711865,0.4743143015643877,1.0,4/17,6.27%,CALCR;SNX6;CBLB;LILRB4
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.7038823290800954,1.4250228166033656,0.07894736842105263,0.6778636674725649,1.0,10/18,22.67%,WNT5A;ABHD17B;PDLIM5;CTNNA2;SETD5;TNF;NEDD4;IL1RAPL1;CAMK2B;ABL1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.7307242107218963,-1.4249877261533253,0.045454545454545456,0.47524410438927644,1.0,4/28,7.80%,MX2;RIMS1;MX1;NAPA
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.8984577578376693,1.424798914176424,0.024390243902439025,0.6761045916851357,1.0,2/5,4.36%,NUTF2;TOR1AIP2
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7843417763013529,1.4247295942834888,0.07692307692307693,0.6737606343519301,1.0,4/9,12.54%,CDK5R1;SEMA5A;CNTN4;RTN4
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.7256953935904219,1.424615905550701,0.09803921568627451,0.6716538486993732,1.0,1/10,1.14%,NXF1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.9024829466799316,1.4245595772061703,0.045454545454545456,0.6692404631564606,1.0,3/5,6.09%,SMAD1;SMAD3;SMAD2
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.516913076697295,1.4245062916642037,0.04,0.6664705112341613,1.0,42/114,18.17%,NMNAT2;CNTN2;NCAN;SCN3A;ZNF536;PCDH17;SNAP91;OLFM3;TAFA5;LRRC4C;KCTD16;PLPPR4;PLEKHA5;AHDC1;CA10;CADM2;ASXL3;GUCY1A2;RBFOX1;RGMB;CACNA1B;KALRN;GRIA2;NTRK2;NFASC;CSRNP3;CACNA1E;PPFIA2;STXBP5;ATRNL1;EML5;ADGRB3;FSTL5;PIK3CA;MAPK4;SYT4;MAP2;GCNT2;DCLK1;CNTN1;PCLO;MAP6
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.8330730367135102,-1.4236818268441325,0.05454545454545454,0.4797216889851156,1.0,6/9,15.39%,CYCS;UQCRB;UQCRH;UQCR10;UQCRQ;UQCRC1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.5858622996443792,1.4232605102683291,0.043478260869565216,0.6693004462500172,1.0,36/70,24.76%,COL16A1;LRP4;ARNT2;CHST1;PHLDB1;MAGI1;NUAK1;PLPPR4;NTM;GUCY1A2;GPC6;SHC2;FERMT2;FBXL7;NFASC;EPAS1;ABCC8;ANTXR1;COL6A1;DCLK1;TNFRSF1A;MAP6;RBFOX2;SLIT2;PRICKLE2;HTRA1;NR2F1;CRMP1;LIMCH1;ARHGEF17;SEMA6D;PLPP3;DAB2IP;LIFR;IL6ST;SYNDIG1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.7650031483848709,-1.4232411565908385,0.07246376811594203,0.47981677866836564,1.0,3/20,6.30%,NR4A3;RGS2;IGF1
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.8000969763545315,1.423117066139198,0.125,0.6673009793768896,1.0,4/11,13.70%,ABCA2;ST6GALNAC3;ST6GALNAC5;ST8SIA4
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.8433402111295727,1.4231122213585319,0.1,0.6645205586294859,1.0,3/11,7.97%,EGR1;SAE1;GNL3L
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.8586871574906457,1.422905770523702,0.15789473684210525,0.6625575184010338,1.0,3/7,6.09%,ACVR2A;SMAD3;SMAD2
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5732704145032027,1.4227677011747482,0.06060606060606061,0.6603997618509739,1.0,15/50,11.91%,ATRAID;ACVR2A;CTNNBIP1;PPARG;RANBP3L;PTCH1;TMEM119;HGF;NELL1;BMPR1B;FERMT2;TWIST2;BMPR1A;CDK6;FBN2
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.6976354666982395,-1.4227580379317302,0.02857142857142857,0.4802017645146304,1.0,2/41,1.73%,NR4A3;PRKCQ
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.6444382265299908,1.422344559013285,0.06666666666666667,0.6597827846534808,1.0,8/25,9.93%,CDK5R1;SRCIN1;LRRK2;WNT5A;ABHD17B;PDLIM5;TANC2;SHANK3
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.8420451128757783,1.4221462370983677,0.02564102564102564,0.6578109945770364,1.0,3/8,6.54%,ANXA1;SIRPA;TMED10
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.7818703467003929,1.4219843656072222,0.11764705882352941,0.6561157468190019,1.0,1/12,0.36%,ANXA1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.8572262110284227,1.4219082756890251,0.10204081632653061,0.653707996985825,1.0,2/8,4.45%,ABCA2;BACE2
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.6283201677166041,1.421827965535505,0.075,0.6514747454213967,1.0,7/41,5.56%,LEPR;PDK4;IGF1R;ADIPOR2;MCU;BACE2;PPARG
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.6809280901760395,1.421819899743513,0.07142857142857142,0.6488992902284536,1.0,11/20,22.71%,GRID2;INSYN2A;LRRK2;GLRA1;GRIN2B;GRIN2A;GSK3B;GABRA4;GABRG3;GABRA2;GRIN1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.7013713653026982,1.421552793688452,0.0851063829787234,0.6472158129033877,1.0,5/17,16.26%,SETD7;VCPKMT;SETD3;SETD2;SETD4
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.7093139981082779,-1.421373805714381,0.03076923076923077,0.4841293571351006,1.0,9/20,16.86%,CD55;CLU;PHB2;C5AR1;C3;C1QBP;SERPING1;C5AR2;IL1B
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.6327235371811576,-1.419119004236426,0.056338028169014086,0.49436386072831734,1.0,6/52,11.20%,CALCR;YES1;CD247;PRKAR1B;FYN;SELENOS
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9199480464520768,-1.4189153640037777,0.06557377049180328,0.49310306686501876,1.0,2/6,0.75%,COL18A1;CCDC88C
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.6993610098754123,-1.4188182797323519,0.06666666666666667,0.49156729561226153,1.0,8/27,15.38%,FLNA;PLEK;ACTG1;FERMT3;MYL12A;ACTB;TLN1;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.823090579782745,-1.4185976324909888,0.109375,0.4906848039783992,1.0,4/9,5.01%,RIPOR2;CD200R1;APOD;PADI2
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8009271963411522,-1.4182583136550138,0.12962962962962962,0.4904827040322914,1.0,3/10,3.00%,UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.8244058375907917,1.4179618718494191,0.10526315789473684,0.6619830759490185,1.0,4/9,10.29%,WNT5A;WNT2B;KITLG;NCOA4
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7405113782732368,-1.4178838928742759,0.05970149253731343,0.49031757660516956,1.0,5/17,12.47%,PSMB3;PSMA7;PSMB9;PSMB6;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.9776367893390803,-1.417182561935764,0.0,0.491980017179912,1.0,2/5,1.26%,SIGIRR;CARD16
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.7833759533815661,-1.4167261385340073,0.14285714285714285,0.4923695572650348,1.0,3/10,14.84%,TPP1;BRCA2;TERF2IP
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.7896094752161127,1.416704279741203,0.07317073170731707,0.6647860069617749,1.0,2/7,5.12%,GSN;LCP1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.8956773991725513,1.4166572995551996,0.02702702702702703,0.6624518210033116,1.0,2/9,1.09%,KLF4;PKD2
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.840841254030561,1.416442850109612,0.08771929824561403,0.6603378556069153,1.0,4/6,15.83%,NRP1;PHACTR4;NF1;SOX4
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.72368492268587,-1.4162968636875812,0.04918032786885246,0.4927906773790628,1.0,4/23,4.13%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.722325499767864,-1.416263694396701,0.058823529411764705,0.4909886746088278,1.0,12/28,15.79%,HLA-B;B2M;FCER1G;HLA-C;HLA-F;MFSD6;TAP1;ERAP1;ABCB9;HLA-E;ERAP2;SEC13
prerank,GO_Biological_Process_2021__pantothenate metabolic process (GO:0015939),-0.918739293045548,-1.416047295976315,0.018518518518518517,0.48996140870596977,1.0,1/5,1.93%,VNN2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.8158772895532331,-1.415914031227234,0.09090909090909091,0.4885986352341028,1.0,2/8,4.84%,APOD;CBLB
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.8974442440075636,-1.4159018121418097,0.03389830508474576,0.4866646923610736,1.0,4/7,7.59%,DDX11;DTX3L;PARP9;MED25
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.782384597125452,1.4158502506703943,0.12195121951219512,0.6604512510921683,1.0,1/11,0.36%,ANXA1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.7826376251655682,-1.415708300353522,0.04477611940298507,0.4857017695890884,1.0,5/14,12.58%,FCER1G;ENPP3;KARS1;IFI35;TYROBP
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.8951529736117425,1.4157036550340925,0.023255813953488372,0.6589622691920934,1.0,1/5,0.05%,EGR1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.8673247813048367,-1.4156652894960238,0.07547169811320754,0.4839991863666121,1.0,1/6,1.72%,PLN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.698284166017882,-1.415645254932917,0.1095890410958904,0.4822427108049859,1.0,4/28,4.13%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.8197134568307013,-1.4155821733480154,0.03636363636363636,0.4806689142218302,1.0,3/12,3.18%,PRKCQ;SLC7A5;SLAMF6
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8398451283566996,-1.4146539572238068,0.07407407407407407,0.48190540146940913,1.0,3/7,3.00%,UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8398451283566996,-1.4146539572238068,0.07407407407407407,0.48190540146940913,1.0,3/7,3.00%,UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.7684346399601841,1.4138805313630896,0.20930232558139536,0.6650622728961929,1.0,4/10,13.71%,SMAD1;SMAD3;SMAD2;DROSHA
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.6265143660675312,-1.4136458484019738,0.04,0.4848472521316563,1.0,20/80,9.74%,FOSL2;OAS3;SAT1;CEBPD;ZFP36;JUNB;ZMYND15;BHLHE40;TNFSF10;IER3;CTSB;CD14;DTX3L;ABCC3;HLA-C;TYMP;GBP3;SSH3;OAS1;TNFAIP2
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.798589688705521,-1.4122083434975057,0.07407407407407407,0.48992166216161115,1.0,3/10,10.91%,ZFP36;IFITM3;TRIM13
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.8586554278132692,1.4120212153830747,0.10204081632653061,0.6713630909211069,1.0,2/6,5.48%,NRP1;FZD3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.8382478285502862,-1.4118187733304608,0.08196721311475409,0.4898352685484008,1.0,2/8,7.08%,DUSP1;XRCC3
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.8178209635113527,1.4114125650662313,0.1836734693877551,0.6691845084115297,1.0,2/8,8.71%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.8178209635113527,1.4114125650662313,0.1836734693877551,0.6691845084115297,1.0,2/8,8.71%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.7308504378394939,1.4111725281037018,0.10256410256410256,0.6678378235302836,1.0,1/9,5.61%,TFB1M
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.8183341624127417,1.4108389632991587,0.07692307692307693,0.6671860021577103,1.0,6/10,17.20%,NIPA2;NIPAL2;SLC41A1;NIPA1;MMGT1;MAGT1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.751168938378463,1.4105581829902127,0.08888888888888889,0.6656623876800151,1.0,2/9,4.05%,DAPK2;TSC2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.5954323562046452,1.4104214609603742,0.10256410256410256,0.6635680695448953,1.0,5/25,8.44%,DUSP6;PTPN9;DUSP18;DUSP7;PTPN13
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.8231057052584919,-1.4103089214196167,0.08064516129032258,0.49616635042017815,1.0,2/12,1.31%,MCTP2;RIMS1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.8531756395339483,1.410100822440697,0.06060606060606061,0.6626497863263905,1.0,5/8,12.01%,LARGE1;CHST7;EXTL2;CHST1;RENBP
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.7382226079864291,1.4094152918554286,0.1,0.663279488046471,1.0,5/11,17.46%,PDPN;SMAD3;RUNX1;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.7998453474126099,-1.408634845588463,0.08928571428571429,0.5026444423268629,1.0,2/12,7.50%,MYBL1;APOBEC3G
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.8720975060639659,-1.408325594571096,0.016129032258064516,0.5001638032143173,1.0,1/8,0.88%,INSIG1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.8720975060639659,-1.408325594571096,0.016129032258064516,0.5001638032143173,1.0,1/8,0.88%,INSIG1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.6776288156833495,-1.4079402777771532,0.014084507042253521,0.5001041785981161,1.0,12/48,12.58%,RIC3;PYHIN1;TFRC;DDRGK1;DTX3L;PARP9;LAMTOR5;ENTR1;GPR137B;VPS28;FYN;TYROBP
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7404027702604037,-1.4076448819904168,0.15625,0.499593215100554,1.0,4/19,9.44%,CCL3;LILRB4;LILRB3;GPR137B
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8320973142374896,1.407465963920447,0.02127659574468085,0.6706691992182123,1.0,4/7,13.84%,PKD2;JAG1;ROBO1;ROBO2
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.7940218725570674,-1.4069714860517548,0.11290322580645161,0.5008542812872497,1.0,3/10,12.58%,CCL5;FCER1G;TYROBP
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.8981819042338324,-1.406736411444987,0.018518518518518517,0.4999600701997111,1.0,2/6,6.30%,DUSP1;IGF1
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.9233787441909089,-1.406490173700518,0.047619047619047616,0.4992959981653308,1.0,1/6,0.39%,STAT4
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.6729921921137896,1.4061332912185245,0.125,0.6760438707540918,1.0,7/20,19.48%,PPT1;HACD2;ELOVL6;GCDH;ACACA;FASN;SCD5
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.8372146425992475,1.4060604963023686,0.024390243902439025,0.6738070322267595,1.0,1/9,0.34%,CD180
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.7079241280136245,-1.4060544057050073,0.056338028169014086,0.5000671012788813,1.0,5/27,3.79%,IL4I1;CD2;CCL5;PRKCQ;PRELID1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.9137966969457858,-1.405976264102317,0.08771929824561403,0.4987427909253053,1.0,2/6,5.22%,CHCHD10;RAB3A
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.6940633317223462,-1.405837822362949,0.04838709677419355,0.49746001607291657,1.0,8/21,16.41%,CD55;CLU;PHB2;C5AR1;C3;C1QBP;SERPING1;C5AR2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.547702490444451,1.4049969201012287,0.08695652173913043,0.676283567590258,1.0,30/69,23.65%,DEPP1;PCDH17;PLPPR1;NOL4;MAGI1;PLPPR4;GRIA3;ASXL3;PTPRD;GPC6;SHC2;FXYD5;RUNX1T1;CNTN4;NFASC;CSRNP3;SORBS2;ABCC8;CNTN3;SYT4;MAP6;PEMT;KCNB2;PHYHIPL;UCP2;RAB3C;GLS;SEMA6D;LDB2;CADPS
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.7904516354048786,-1.4049176400869405,0.09090909090909091,0.5007430952817713,1.0,1/12,0.09%,NR4A3
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.6941314049838496,1.4047176761454654,0.125,0.6745823380018331,1.0,3/18,1.23%,PIGQ;PIGU;PGAP1
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.9044040120483114,-1.404661294323011,0.018518518518518517,0.4979106480263744,1.0,1/6,1.60%,CXCR4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.9044040120483114,-1.404661294323011,0.018518518518518517,0.4979106480263744,1.0,1/6,1.60%,CXCR4
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.8103426898922725,1.404554990347471,0.09302325581395349,0.6730820305147472,1.0,2/9,0.57%,ANXA1;RAB33B
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.8197512367262452,1.4039431812842835,0.17647058823529413,0.6738448472129788,1.0,2/7,10.60%,USP30;PEX5
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.6306339309074613,1.4038970784952234,0.08333333333333333,0.6714700445314038,1.0,4/18,9.81%,PDGFA;FGF2;DACH1;HGF
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.8296491394813388,-1.4032101360200802,0.08064516129032258,0.5032993850078564,1.0,1/8,1.94%,TPP1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.7777024800396161,1.4030264862458848,0.0975609756097561,0.673444155570679,1.0,2/7,18.19%,RAP1A;SLC30A1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.7062965234809293,1.4022906857608708,0.16666666666666666,0.67396530003979,1.0,2/11,5.86%,GSN;WASF2
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.638024740863087,-1.4021350622677518,0.06153846153846154,0.5069455913786907,1.0,16/50,9.96%,PPIE;OAS3;CCL5;RSAD2;IFIT1;MX1;OAS2;IFITM3;SHFL;SRPK1;ILF3;APOBEC3G;RNASEL;EIF2AK2;OAS1;PLSCR1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.588328627966686,1.4019770230496844,0.06451612903225806,0.6729105552104615,1.0,15/53,10.93%,B3GNT2;HS3ST5;NCAN;CSGALNACT1;B4GALT7;B4GALT4;HS2ST1;CHST7;CHST1;UGDH;CSPG5;CHST15;GPC6;UST;EXT1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.5729333566008916,-1.4018532205918144,0.024096385542168676,0.5067404323839517,1.0,18/136,8.02%,CCL4;CALCR;CD36;CCL3;TGFBR3;CCL5;APIP;PDGFD;GPR183;GLIPR2;MARCO;EPHB1;SEMA6A;CHI3L1;GSTP1;MAP3K12;PHB2;PRKD2
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.84952377525891,1.4016191683260004,0.0425531914893617,0.672093784307184,1.0,2/6,2.02%,NUFIP1;RUVBL2
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.6913736534478037,-1.4013954669827997,0.078125,0.5069669878652948,1.0,9/22,16.41%,CD55;CLU;PHB2;C5AR1;HLA-DRA;C3;C1QBP;SERPING1;C5AR2
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.9410097018098935,-1.401334569705829,0.038461538461538464,0.5054773631672164,1.0,3/5,3.79%,CCL5;PRKCQ;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.6008975371132583,1.4010820903379106,0.08695652173913043,0.672201008703319,1.0,7/62,1.65%,LEPR;PRKAB2;PPARGC1A;ESRRG;GRB10;IGF1R;ADIPOR2
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.9000263959257514,1.401020010495084,0.047619047619047616,0.6700661346414039,1.0,3/6,6.28%,SLC1A3;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.8039918518240918,1.4008222675138686,0.07317073170731707,0.6689036489977939,1.0,3/7,11.72%,STK25;COPG1;RIPOR1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.6977110839940432,1.4006697071413912,0.10526315789473684,0.6672498627776737,1.0,7/15,12.93%,PKD2;PKD1;KCNC2;TMEM120B;GRIN2B;CPSF7;NUDT21
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.5723494114975486,1.4002227725695153,0.05555555555555555,0.6678705462420055,1.0,12/42,19.23%,CDK5R1;NLGN1;LRRK2;ZC4H2;BRINP3;YWHAG;CNTN4;MMD;MOSMO;ZFHX2;TIAM1;FGFR1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.9008670317937124,-1.3999107260628578,0.07407407407407407,0.510648635691141,1.0,1/6,3.56%,MTHFD1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.7331269149797882,1.3994598264720173,0.11627906976744186,0.6697495005369853,1.0,1/13,0.13%,PPARGC1A
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.6243851340829752,1.398957026616628,0.08571428571428572,0.6700873947403417,1.0,10/30,8.04%,COL5A3;ANXA1;PDGFA;COL5A2;PKD1;WNT5A;JAG1;FA2H;DHCR24;TMEM79
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.9304789938490043,-1.3988911837824782,0.03278688524590164,0.5139890664536485,1.0,2/6,1.69%,CCL3;GPR183
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6498081247965459,-1.3987914510949937,0.0547945205479452,0.5128838784508717,1.0,13/50,8.50%,RBIS;RPL38;RPL5;RPS25;RPS15;RPS24;RPL11;METTL17;GLUL;RPL14;NPM1;RPS6;RPS7
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.6543765797006468,1.398723410711924,0.11904761904761904,0.6685422229562952,1.0,3/22,1.23%,PIGQ;PIGU;PGAP1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.7470737563784009,1.3986736095040635,0.11764705882352941,0.6664723940138921,1.0,2/10,1.07%,PDPN;FER
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.720938416016102,-1.3984560948043714,0.078125,0.5127522484388717,1.0,7/29,6.88%,PYHIN1;TFRC;DTX3L;LILRB4;PARP9;GLUL;LAMTOR5
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.6174898576014246,1.3982959590690587,0.0967741935483871,0.6657065146445149,1.0,7/27,7.49%,GSN;CTSK;EXOC8;BMP1;LCP1;MMP16;HPN
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4790188895535884,1.3982476286223469,0.0,0.663616593718171,1.0,25/106,12.27%,PLXNB1;SLITRK5;LRP4;MAP1S;NLGN1;NYAP2;LRRK2;RAB10;RYK;PLPPR4;TMEM106B;CTNNA2;DOCK10;FLRT1;BRSK1;GPM6A;ALCAM;SHANK3;DCC;BTBD3;PTEN;CELSR2;KLF7;PARD3;CNTN4
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.739750450311703,-1.3976350427781352,0.1044776119402985,0.5145457753869557,1.0,3/15,5.44%,CCL3;CCL5;CD14
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.7745683918297239,-1.397301210110823,0.03389830508474576,0.5143492163028157,1.0,4/11,10.57%,SYCE2;STAG3;MEI4;IHO1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.8967563419776832,1.3956641756560173,0.11538461538461539,0.6732431852426961,1.0,2/5,5.48%,NRP1;FZD3
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6853508116306447,-1.395482917746883,0.05714285714285714,0.5210496480758127,1.0,11/35,16.60%,UBC;RPS27A;XPA;MUS81;FANCB;XRCC3;WDR48;RPA3;SLX4;FANCI;UBA52
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6965791782576719,-1.39544766036275,0.08333333333333333,0.5193441028354626,1.0,4/25,4.13%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.7765850503161306,1.3953343060810188,0.14634146341463414,0.6726819132344802,1.0,2/8,9.23%,TGFBR2;KITLG
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.8789714321448514,1.3945937727333562,0.11904761904761904,0.6739225611728215,1.0,3/5,10.51%,SPRED1;SPRED2;DYRK1A
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.6289570105760007,-1.3943340950221736,0.04878048780487805,0.5226004194299758,1.0,21/76,16.53%,CCL3;OAS3;CD2;ZFP36;NLRC3;OAS2;CLU;CD14;IGF1;GSTP1;OAS1;SELENOS;TNFAIP3;TYROBP;CD47;CYBA;PTPRC;HLA-E;NOD2;C5AR2;HAVCR2
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.793282381906829,-1.3942754758773168,0.1016949152542373,0.5210195860891187,1.0,3/9,9.37%,CD36;NLRC3;EIF2AK2
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.6831494096395287,1.394138580905455,0.11764705882352941,0.6740183817387798,1.0,3/19,5.90%,SIRT1;MAP2K1;HMGA1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.6022944358638656,1.3932762799857368,0.047619047619047616,0.6753331114203361,1.0,7/28,16.11%,PLPPR1;PLPP5;PLPP1;PLPPR4;PTEN;MTMR9;PIP4P2
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.5831229988582406,-1.3930618855242236,0.028985507246376812,0.5249239748210599,1.0,21/90,14.48%,UBC;CARD16;RPS27A;PSMB3;RORA;ELOB;PSMA7;PSMB9;PSMB6;EGLN3;RBX1;FAM162A;PSMA5;VEGFA;NOP53;PGK1;PSMC4;PSMD8;HIF1A;MT3;PSMD12
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.6144771248098579,-1.3927937140400746,0.07575757575757576,0.5244898478257563,1.0,7/65,5.95%,OSBPL5;ABCA9;CD36;SLC51A;PRELID1;ABCA6;ABCC3
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.8268824960509241,-1.392757600902632,0.04477611940298507,0.5228605406996256,1.0,4/9,9.70%,IFIT1;MX1;PHB2;OAS1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.7848101641633465,1.3925756425324032,0.13333333333333333,0.6765954896837475,1.0,2/9,2.45%,ANXA1;SIRT1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.8281794280927405,1.391710261195816,0.046511627906976744,0.678108872655302,1.0,3/8,8.94%,SALL1;WDPCP;HDAC1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.7987600029582074,1.3914457547938655,0.058823529411764705,0.6768527095102369,1.0,1/6,0.54%,ADARB2
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.6577812113348311,-1.390529660953378,0.05084745762711865,0.5329791371225212,1.0,9/34,18.17%,TFRC;GPR183;VAV3;BTK;NCKAP1L;TNFSF13B;PTPRC;NOD2;CD74
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.8243304662386589,-1.3904210724987878,0.10909090909090909,0.5316509080628417,1.0,1/9,0.38%,MT2A
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.7139272175969457,-1.3902030188568462,0.056338028169014086,0.5305921635778568,1.0,2/25,1.73%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.7063055998331096,-1.3900426276769424,0.08,0.5295695424586563,1.0,4/19,9.27%,ITK;TXK;PHB2;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.7149796632751353,-1.3890182741645405,0.12698412698412698,0.5329772356239636,1.0,5/20,15.49%,TFRC;DNAJB9;PHB2;PTPRC;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.8265207044673648,-1.3887012000737247,0.08928571428571429,0.533041172998862,1.0,2/10,6.70%,CARD16;GSTP1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.7449520322980449,-1.3881497185551073,0.08823529411764706,0.5338463649472925,1.0,6/21,10.72%,BTN3A1;PRLR;PADI2;CLDN7;BTN2A2;OVOL2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.5676273904445751,1.3877544848019496,0.05,0.692749723123825,1.0,43/87,23.87%,CNTN2;NCAN;GFAP;ZNF536;SNAP91;SCN3B;OLFM3;PDE10A;LRRC4C;PLPPR4;CA10;KCNC2;PSD2;GRIA4;GRM5;CADM2;RBFOX1;NEGR1;SNCB;NXPH1;PTPN5;GRIA2;NFASC;CSRNP3;PPFIA2;CXCL14;ADGRB3;SYT4;CLASP2;FXYD7;AMER2;PHYHIPL;GRM3;SYNPR;GABRB1;VSTM2B;RAB3C;OPCML;NRXN1;ASIC2;ELAVL3;SFXN5;LSAMP
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.7952764217216857,1.3874168627618033,0.11904761904761904,0.6919667605380878,1.0,3/7,13.68%,MSN;STK10;JAM2
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7549181268171106,1.3871943266104783,0.05555555555555555,0.6904634445960158,1.0,5/11,15.68%,GRID2;LRRK2;GRIN2B;GRIN2A;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.6649873796887934,1.3870978393421174,0.14634146341463414,0.6884171369321258,1.0,5/18,13.18%,SERPINE2;LRRK2;TIMP3;SNX12;BAG6
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.8996795210255314,1.387070389010021,0.024390243902439025,0.6862148332052517,1.0,1/5,0.36%,ANXA1
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.8174866470264919,1.3865601715249376,0.0,0.6859287155650376,1.0,1/6,1.53%,PDIA2
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5463909586958198,1.3861796383093021,0.03571428571428571,0.6852654214137245,1.0,20/55,14.58%,PLXNB1;PLXNA2;RAP1GAP;FGD4;SCARB2;PLXNB2;TBC1D10B;PLXNC1;CRK;TDG;PLXNA3;ARHGAP15;FBXW11;NF1;RABGAP1;NTRK2;VAV1;PTK2;PLXNA1;EPHA5
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.7950307749361132,1.3860844516269368,0.1891891891891892,0.6833470972004294,1.0,2/7,8.48%,SLC3A2;IRAK3
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.8546630847172682,-1.3858787208695895,0.07017543859649122,0.5456198849215532,1.0,1/8,1.42%,GAPDH
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.7061682558359823,-1.3858738061756632,0.11666666666666667,0.5437703259896157,1.0,1/15,1.34%,DYNLT1
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.9445110318770674,1.385627057940385,0.06521739130434782,0.6831150384011893,1.0,1/5,0.73%,BAG3
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.7426622174449246,-1.3854340448138749,0.13846153846153847,0.5438251736592515,1.0,3/15,4.98%,MX2;MX1;FIS1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.7049564968635373,-1.3852485497521643,0.16129032258064516,0.5430353805593117,1.0,7/20,19.04%,PER3;PER2;BHLHE40;PPP1CB;RBM4B;CRTC1;RBM4
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.6724573211334403,-1.385126483799896,0.03076923076923077,0.5416338333313017,1.0,7/44,8.01%,CD36;CCL3;MCTP2;CXCR4;BTK;ACKR4;TRPM4
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.8223688080280458,1.3850885437000726,0.08108108108108109,0.6829262017430273,1.0,6/10,14.37%,RNF139;SERPINE2;LRRK2;SNX12;RUNX1;NLRC4
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.8032357666775445,-1.3848472441343205,0.06779661016949153,0.5412200558130513,1.0,1/11,0.38%,MT2A
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8202174300940732,-1.3848021752808135,0.07936507936507936,0.5397224594876159,1.0,4/12,9.70%,MX1;OAS2;STAT1;OAS1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6922569284442215,-1.3843354873880402,0.07462686567164178,0.5401508332720395,1.0,10/30,11.25%,NDUFC1;NDUFA2;NDUFA1;NDUFB4;NDUFA12;NDUFB9;NDUFS5;NDUFS8;NDUFB1;NDUFB7
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5417225775049144,1.3842622602106385,0.06666666666666667,0.6842350997620331,1.0,11/56,12.24%,UBE2D1;SMAD7;LRRK2;ARRDC3;LAPTM5;DCUN1D4;UBE2L3;FBXW7;TRAF6;UBE2N;DCUN1D1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.794879547025322,1.3837642613130723,0.0625,0.684126721958087,1.0,4/9,8.92%,SMAD7;LRRK2;SCN3B;NEDD4L
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7502715941965773,1.3834184838992107,0.1388888888888889,0.6831517349198574,1.0,2/9,2.45%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.8767837792410192,-1.3830350357661931,0.09433962264150944,0.5444787492239703,1.0,1/8,0.70%,CD36
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.8232230962850382,1.3827548397385734,0.02702702702702703,0.6832945547477793,1.0,4/13,10.49%,SERPINE1;FGF2;CRK;GIT1
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.8709705743300231,1.3824852453909184,0.06382978723404255,0.6824105833250795,1.0,2/5,2.45%,ANXA1;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.6000041776778426,1.382287600100119,0.09375,0.6810823410996836,1.0,9/31,12.72%,DUSP6;SPRY2;SPRED1;SPRED2;SIRPA;TIMP3;PTEN;PTPRR;RPS6KA6
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7581543843583526,-1.3816792453860172,0.09375,0.5501849384781392,1.0,8/11,15.74%,B2M;HLA-F;TAP1;ERAP1;HLA-DRA;ABCB9;HLA-E;ERAP2
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.8148716098346863,-1.3814868290783653,0.11940298507462686,0.5497223435103393,1.0,3/8,10.17%,SLC2A3;SLC5A9;SLC2A8
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8800037454076102,-1.38116094791562,0.03636363636363636,0.5496464410325081,1.0,3/6,5.62%,IFIT1;MX1;SHFL
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.8839774903124932,-1.380661544134513,0.1,0.5508275091818018,1.0,2/5,9.96%,SIGIRR;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.5610486799435012,-1.380405235560729,0.047619047619047616,0.5504217930036264,1.0,22/117,10.91%,UBC;CD36;CARD16;TFRC;RPS27A;PRKCQ;CARD14;TRIM5;DDRGK1;BTK;AIM2;CLU;TRIM22;LAMTOR5;RPS3;NPM1;HSPA1B;PRKD2;EIF2AK2;IL18R1;CFLAR;TRIM13
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.6057340766566449,1.3799895064785903,0.09090909090909091,0.688528718242735,1.0,6/26,6.70%,GSN;CTSK;EXOC8;BMP1;LCP1;MMP16
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.8820071309214799,-1.3799415606788907,0.12280701754385964,0.5507514183327841,1.0,1/5,0.70%,CD36
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.8887061833067242,-1.3799159052307337,0.08620689655172414,0.5491583975930417,1.0,1/7,4.74%,APOD
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.815110808089208,1.3796482177157186,0.0975609756097561,0.6876771659548906,1.0,2/6,9.25%,CD180;SASH1
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.8232896992333142,1.3794922923989204,0.20512820512820512,0.6861827990112738,1.0,1/5,4.87%,NCK2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7805634690700215,-1.3781779732536033,0.09090909090909091,0.5566349591423186,1.0,2/14,6.30%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.8149597624567414,1.3774594664514317,0.13333333333333333,0.693582727636068,1.0,2/5,9.78%,CENPE;CDC23
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7220255096286828,1.3773372594431978,0.125,0.6919583846656107,1.0,6/14,18.27%,SCRIB;MTCL1;PARD3;PRKCI;ERBIN;MARK2
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.8355441986188085,-1.3770231051024022,0.0625,0.5608115018391685,1.0,3/12,1.13%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5246560933926039,1.3766643133026444,0.07407407407407407,0.6927120237160952,1.0,16/62,14.49%,KLF4;SERPINE1;SEMA5A;FGF2;SMAD1;SIRT1;GAB1;WNT5A;TMIGD2;SASH1;RUNX1;SIRT6;TJP1;MTDH;CTSH;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.924657098986404,-1.3764698549219045,0.06060606060606061,0.5616125991070766,1.0,1/5,0.15%,FLNA
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.8718406558923326,-1.3763954184373959,0.08196721311475409,0.56019216275052,1.0,3/8,8.60%,NUDT12;PARP9;NAMPT
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.752848301528809,-1.3763177838676715,0.10909090909090909,0.5568741953170798,1.0,1/12,1.12%,ZFP36
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.752848301528809,-1.3763177838676715,0.10909090909090909,0.5568741953170798,1.0,1/12,1.12%,ZFP36
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.7744315595813466,1.376309215222714,0.2,0.6920207281249652,1.0,3/10,5.29%,TRPC1;SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6706568149556783,1.375014378335866,0.11904761904761904,0.6960396881107715,1.0,4/15,12.00%,ACVR2A;GDF11;BMPR1A;TWSG1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.6562335533188515,1.3743367593048517,0.08571428571428572,0.6962567341113306,1.0,13/24,17.46%,DAG1;PHLDB1;WDPCP;TDG;POGLUT1;RPS6KA6;BAG6;NIPBL;CLASP1;RAB14;TRIP12;PHLDB2;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.8019957750473385,-1.3739797594532008,0.03636363636363636,0.5670145592507924,1.0,1/10,0.35%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.9064758146038486,-1.373847451588785,0.05555555555555555,0.5641580958338133,1.0,1/5,2.43%,CHTF18
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.9064758146038486,-1.373847451588785,0.05555555555555555,0.5641580958338133,1.0,1/5,2.43%,CHTF18
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.8410086713515313,1.3735734710100076,0.125,0.6977406911376255,1.0,3/5,14.47%,PTPN23;PTPRR;PTPRG
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7496472170527829,1.3733870224089446,0.07317073170731707,0.6964892423234056,1.0,4/10,8.16%,SYNGR1;GRIK2;SHISA9;PPFIA3
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.7645940305959035,-1.3733716769729873,0.06779661016949153,0.5647477125856635,1.0,3/13,9.70%,ZFP36;BTG2;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.5357400594710074,1.3731615530984755,0.125,0.695560626096224,1.0,6/47,4.87%,NRP1;FER;SEMA5A;CDC42EP3;VASP;NCK2
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.7673060919971594,-1.3730474607446908,0.05970149253731343,0.5632600209009682,1.0,2/14,12.27%,FOS;DNMT1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.7673060919971594,-1.3730474607446908,0.05970149253731343,0.5632600209009682,1.0,2/14,12.27%,FOS;DNMT1
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.8852069467642896,-1.3725439518135303,0.08620689655172414,0.5641843797555348,1.0,2/5,8.47%,CALCR;PDCD7
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.629475991001035,-1.3724698752748534,0.1076923076923077,0.5627223264379709,1.0,11/48,8.53%,H2AC8;CD37;CYCS;CXCR4;GZMB;MS4A4A;SLAMF6;NCF4;PLEK;CD93;CYTIP
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8616780572108149,-1.3723769437953492,0.1568627450980392,0.5614756756003298,1.0,1/6,0.74%,CCL3
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.5718265677215745,1.371354371985657,0.08108108108108109,0.7014702266379532,1.0,7/34,14.39%,PANK3;PANK1;ADCY9;GUCY1A1;NPR2;GUCY1B1;ADCY6
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.5680947586884751,1.3713348033249275,0.08,0.699318477476487,1.0,15/45,11.00%,PDPN;TGFBR2;SPRY2;SMAD7;SPRED1;SPRED2;DAG1;USF3;PHLDB1;SMAD3;SMAD2;HPN;BCL9L;PTEN;FERMT2
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.9145415914021262,-1.3712808946213877,0.017543859649122806,0.5653031043376141,1.0,1/5,1.13%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.7467879699763728,-1.3708766313005587,0.05084745762711865,0.5656201591359624,1.0,6/18,14.25%,TFRC;GPR183;VAV3;NCKAP1L;TNFSF13B;PTPRC
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4766683131705187,1.3706976155199844,0.0,0.700224001675572,1.0,40/133,13.98%,PLXNB1;NRP1;GRB10;CDK5R1;CNTN2;SEMA5A;PLXNA2;RAP1GAP;GAB1;VASP;WNT5A;DAG1;RELN;PTPRM;SEMA3B;RYK;PLXNB2;ROBO1;PLXNC1;EPHA6;PLXNA3;TNR;UNC5B;NPTN;ALCAM;SHANK3;NFIB;DCC;SPTAN1;KLF7;MAPK1;ENAH;PDLIM7;CNTN4;GAB2;UNC5D;SLIT3;ROBO2;PTK2;PLXNA1
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.5372149947960021,1.3704851477787692,0.09090909090909091,0.6991785992680308,1.0,26/79,13.84%,KCNQ2;CNTN2;GRID2;CPT1C;NCAN;PCDH17;SNAP91;SCN3B;NTM;PURG;CTNNA2;GRIA4;GRIA1;SLC35F1;ASXL3;PTPRD;GUCY1A2;RBFOX1;RUNX1T1;CACNA1B;PTPN5;GRIA2;UNC5D;NFASC;CSRNP3;ROBO2
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.7348875761654623,-1.370463505276604,0.08695652173913043,0.5661653193605208,1.0,3/19,4.98%,MX2;MX1;FIS1
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.8700254663719814,-1.3704006098816064,0.10344827586206896,0.5645411359125618,1.0,3/5,9.70%,OAS3;OAS2;OAS1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.8989357964238012,-1.3692791508975128,0.031746031746031744,0.5682110925413618,1.0,1/5,0.74%,CCL3
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6763718758541521,-1.3690760615975741,0.11940298507462686,0.5675530227412805,1.0,8/28,15.86%,PRELID1;TNFSF10;CLU;IGF1;PDCD5;FAM162A;GPX1;BMF
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.6773033763732658,-1.3689832794948225,0.13432835820895522,0.5663686451174619,1.0,7/26,17.15%,UBC;RPS27A;ACBD5;DYNC1LI2;CFTR;UBA52;VIM
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.771350504902358,-1.3688028307982032,0.12307692307692308,0.56539280680722,1.0,4/13,9.44%,CCL3;LILRB4;LILRB3;GPR137B
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.9208990267312487,-1.3686419849270337,0.07142857142857142,0.5644981292715817,1.0,1/5,0.40%,IL4I1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.7060695933249006,-1.3682314837392229,0.1267605633802817,0.5648850744831088,1.0,5/20,6.30%,TFRC;PRELID1;CLU;SLC25A5;IGF1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.7965138910450286,1.3680021087849576,0.1,0.7083800698200399,1.0,1/9,0.79%,PDPN
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6941275408475888,1.3679002782166472,0.1388888888888889,0.70662018650457,1.0,4/15,9.26%,KLF4;WNT5A;IRAK1;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.7943661718243948,-1.367727455281576,0.08620689655172414,0.5657936619001112,1.0,2/9,1.13%,SKAP1;CCL5
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.8819461134582498,-1.3675565912133527,0.08196721311475409,0.5650799105170515,1.0,2/6,5.02%,SLC2A3;CYB5A
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.9120266486908917,-1.3669734993325389,0.08771929824561403,0.5641101937752909,1.0,1/5,3.00%,B2M
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.9120266486908917,-1.3669734993325389,0.08771929824561403,0.5641101937752909,1.0,1/5,3.00%,B2M
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5780076978106403,1.3664570770849418,0.08823529411764706,0.711810919894543,1.0,6/25,7.57%,NRP1;SEMA5A;FGF2;YJEFN3;ROBO1;RECK
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.9185930749635807,-1.3662262413005497,0.038461538461538464,0.565823984748597,1.0,2/5,4.36%,COL5A1;PLET1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.7532008978783511,-1.3662051897063938,0.18867924528301888,0.5642335461502848,1.0,1/11,0.38%,MT2A
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5201032373579088,1.3658816526687287,0.0,0.7123576642021052,1.0,39/128,18.27%,AVIL;CDK5R1;PTPN9;SRCIN1;RAP1A;LRRK2;WNT5A;KNDC1;RELN;LRRC4C;CIB1;SCARB2;PLXNB2;PDLIM5;KANK1;ZNF804A;CTNNA2;FUT9;NPTN;BRSK1;CSMD3;TANC2;SHANK3;DCC;PTEN;BAG5;FKBP4;MARK1;PRKCI;NTRK2;ADCY6;PPFIA2;GSK3B;CAMSAP2;MYLIP;KIF13B;RAPGEF2;IL1RAPL1;MARK2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6687791788113855,-1.3655815385064665,0.09090909090909091,0.5656182794499283,1.0,7/39,10.14%,H1-4;H1-3;H1-2;H1-0;FANCB;POLR2G;H1-10
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.8791911993745336,-1.365476041977962,0.06779661016949153,0.5644043346794162,1.0,1/5,1.41%,TFRC
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.8233581432014829,-1.3652130267652263,0.05357142857142857,0.5594013137229252,1.0,2/11,5.89%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.8233581432014829,-1.3652130267652263,0.05357142857142857,0.5594013137229252,1.0,2/11,5.89%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.8233581432014829,-1.3652130267652263,0.05357142857142857,0.5594013137229252,1.0,2/11,5.89%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.8233581432014829,-1.3652130267652263,0.05357142857142857,0.5594013137229252,1.0,2/11,5.89%,BBS2;RAB11A
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5466715941345246,-1.3652125988182633,0.02531645569620253,0.5577892061905825,1.0,49/167,20.38%,CYCS;COX7C;MDH2;UQCRB;NDUFC1;PDHX;NDUFA2;ATP5F1E;ISCA1;NDUFA1;CYB5A;UQCRH;UQCR10;ATP6V1F;SLC25A5;NDUFB4;PHB2;LDHA;ACAA1;ATP5PD;COX5B;COX4I1;ETFB;ATP5ME;NDUFS8;MRPS11;NDUFB1;NDUFB7;UQCRQ;IDH3B;GOT2;COX6C;MTRF1;GPX4;COX7A2;MRPS15;OXA1L;UQCRC1;ETFDH;NDUFS6;ATP5F1D;COX5A;NDUFS7;NDUFA3;ATP5F1C;DLST;RHOT2;PDHA1;NDUFB3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.6451854920581525,-1.365207628754041,0.12658227848101267,0.5562343997768595,1.0,13/52,16.53%,CCL3;OAS3;CD2;OAS2;CLU;CD14;OAS1;TYROBP;CYBA;PTPRC;HLA-E;NOD2;HAVCR2
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.8807402129139803,1.3649521411298469,0.11363636363636363,0.7125243113574652,1.0,3/5,11.03%,KLF4;MYADM;WNK1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.8807402129139803,1.3649521411298469,0.11363636363636363,0.7125243113574652,1.0,3/5,11.03%,KLF4;MYADM;WNK1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7095133336872432,-1.3645573882692865,0.08064516129032258,0.5578019055029677,1.0,8/20,15.49%,HLA-B;SLAMF6;HLA-F;KLRD1;CD226;TYROBP;HLA-DRA;HLA-E
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5757649612177548,-1.3641134685440732,0.03896103896103896,0.5583096979599851,1.0,25/99,19.37%,UBC;RPS27A;PSMB3;POLE3;PSMA7;PSMB9;PSMB6;DDX23;PSMA5;CDC7;PSMC4;PSMD8;RPA3;PSMD12;MCM7;PSME2;PRIM1;UBA52;RFC1;RECQL5;MCM6;MGME1;PSMA3;WRN;PSME1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.8203726819575345,-1.363300034440934,0.07692307692307693,0.5606243685801227,1.0,1/7,0.70%,CD36
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.844444006782237,-1.3632476313154853,0.09433962264150944,0.5592928821869473,1.0,1/7,1.26%,CARD16
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.7913444859188263,-1.3627890539868712,0.12698412698412698,0.5600052362017901,1.0,3/11,7.71%,CHRM2;MYBPC3;SRI
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.7814766020496201,-1.3627424036724731,0.109375,0.5586121883505419,1.0,2/13,6.30%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.8192181987567866,1.3625907807741273,0.13725490196078433,0.7208354297551798,1.0,1/5,6.83%,SCARB2
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.7204464426423742,-1.3625764676271082,0.03571428571428571,0.5578862338365111,1.0,5/25,7.14%,CD36;SLC51A;ABCC3;SLC16A3;SLC16A7
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.5832649412257381,1.3623177977082048,0.1724137931034483,0.7196776109072748,1.0,12/46,8.03%,COL16A1;TPM2;SVEP1;COL5A2;ACTA2;GFAP;PHLDB1;RELN;PPARG;TIMP3;VCL;CDH11
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.854416047927179,-1.3621089273160034,0.05084745762711865,0.558314796112635,1.0,3/9,9.41%,STAT4;IL12RB2;STAT1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7038075265463667,1.3620069990284256,0.10810810810810811,0.7190189605641927,1.0,5/13,18.54%,NPHP1;RUNX1;TJP1;TNF;CBFB
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.7345704067862929,-1.361946383740461,0.11594202898550725,0.5571723153614365,1.0,1/12,1.12%,ZFP36
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.8198683197979679,-1.3617501539731882,0.14545454545454545,0.5564564662567109,1.0,2/7,7.50%,MYBL1;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.5913854434540398,-1.3614713070603792,0.04225352112676056,0.5563266585890232,1.0,19/70,16.60%,UBC;RPS27A;PSMB3;ELOB;PSMA7;PSMB9;PSMB6;EGLN3;RBX1;ATF3;PSMA5;VEGFA;PSMC4;PSMD8;HIF1A;HSPA1A;PSMD12;PSME2;UBA52
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.6800300516215934,-1.361418928890092,0.08064516129032258,0.5550366988656715,1.0,5/28,2.66%,TFRC;GPR183;MNDA;VAV3;IKZF3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6093522777093622,-1.3612880756361763,0.07692307692307693,0.5541937955813474,1.0,26/68,22.13%,NDUFC1;DMAC1;NDUFA2;NDUFA1;TMEM126B;NDUFB4;TIMM21;NDUFA12;NDUFB9;NDUFS5;NDUFS8;NDUFB1;BCS1L;NDUFB7;TTC19;COX18;OXA1L;NDUFS6;NUBPL;COX20;NDUFS7;NDUFA3;NDUFB3;UQCC2;SURF1;TMEM126A
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7724458606719687,1.3608245025143217,0.10256410256410256,0.7208379020033775,1.0,6/8,18.92%,ADGRB2;NFAT5;PPP3CA;NFATC3;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7724458606719687,1.3608245025143217,0.10256410256410256,0.7208379020033775,1.0,6/8,18.92%,ADGRB2;NFAT5;PPP3CA;NFATC3;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.7869745158054233,1.360562462034408,0.1,0.7174334593716072,1.0,3/8,10.48%,MPDU1;FUT9;ST6GALNAC5
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.7869745158054233,1.360562462034408,0.1,0.7174334593716072,1.0,3/8,10.48%,MPDU1;FUT9;ST6GALNAC5
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.8199521477109093,1.3603420477045716,0.18421052631578946,0.7160820081787957,1.0,2/6,6.07%,SYCP3;GCNA
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.7583466390534293,-1.3602648037492533,0.09259259259259259,0.5576732279204188,1.0,1/15,0.70%,CD36
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.8716752179169979,-1.3602270041185838,0.03225806451612903,0.5562290403736131,1.0,1/8,0.40%,IL4I1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.751246881996956,-1.3600735963000128,0.08771929824561403,0.5556883186847352,1.0,2/13,1.13%,CCL3;CCL5
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.9066499783107012,-1.359926922481147,0.04838709677419355,0.5531770180456718,1.0,2/5,2.75%,MX2;MX1
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.9066499783107012,-1.359926922481147,0.04838709677419355,0.5531770180456718,1.0,2/5,2.75%,MX2;MX1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.7344014656845049,-1.3599236331697402,0.08064516129032258,0.551692498342843,1.0,3/16,10.01%,RORA;SYNE1;GLMN
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.8383869902524543,1.3597199149508883,0.0784313725490196,0.7172684847330624,1.0,6/7,10.55%,GRID2;NLGN1;WNT5A;PLXNB2;SHANK3;PTEN
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.8638969540323842,-1.3589552942011704,0.10909090909090909,0.5550538596000709,1.0,2/6,5.20%,IL4I1;KMO
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.6578028495450339,1.3586548917691597,0.14285714285714285,0.719449720593498,1.0,11/26,22.38%,RCN3;RNF139;UBXN6;SEL1L;IRAK3;GLRA1;RNF185;IRF5;BRSK2;GLRB;RHBDD1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.6039821795991198,1.3585887947350368,0.05555555555555555,0.7175863044336008,1.0,12/38,11.49%,WIPF3;ADRA1A;L2HGDH;DTNA;SYCP2L;ACACB;CADM2;SLC35F1;PREX2;HIF3A;RBFOX1;LDB3
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.748883328370082,-1.3584391198186034,0.06779661016949153,0.5557468135020395,1.0,3/15,9.70%,ZFP36;BTG2;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.6058207165021439,1.3582009080493684,0.10810810810810811,0.7175778585364061,1.0,3/14,12.65%,TSPAN15;FBXW7;MMP14
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5281700638029855,-1.358189406398989,0.0,0.5554194732752487,1.0,83/368,14.04%,CCL4;MX2;MT2A;STAT4;UBC;CD36;CCL3;OAS3;HLA-B;CEBPD;CCL5;TNFRSF11B;RSAD2;RPS27A;GRAP2;PRLR;FOS;CARD14;JUNB;IFIT1;PSMB3;TRIM5;MX1;XAF1;IL7R;TNFRSF25;B2M;IFIT3;RORA;OAS2;DUOX1;ANXA2;AIM2;EIF5A;IFITM3;RHOU;IL10RA;FCER1G;IL12RB2;HLA-C;F13A1;PSMA7;LILRB4;CD300LF;TMSB4X;HLA-DRB5;TRIM22;IL3RA;HLA-F;IRF7;PSMB9;CSF2RA;OSMR;PSMB6;RNASEL;STAT1;CFL1;IRF1;OAS1;TNFRSF1B;CD44;IL18R1;IFIT2;GBP2;FYN;RBX1;ITGB2;IFI35;SOD1;PSMA5;VEGFA;APPL1;CSF3R;CSF2RB;TNFSF13B;IFNGR2;PSMC4;PSMD8;HLA-DRA;HIF1A;CCND1;MT3;RPLP0
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.7892980862788356,1.3580224385862305,0.13953488372093023,0.7162822422553258,1.0,4/7,19.76%,PKD1;COBL;NIPBL;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7981155566184036,-1.3578237633042793,0.09090909090909091,0.5561752933223476,1.0,3/10,5.45%,CCL5;IL7R;IL10RA
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.48486791532473245,1.3575188410672276,0.07692307692307693,0.7163876082164274,1.0,13/92,4.28%,EGR1;COL5A3;KLF4;COL16A1;PKD2;SVEP1;GSN;FGF2;COL5A2;ACTA2;CTSK;KLF6;PBX1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8700800377616336,-1.3570282863955003,0.04838709677419355,0.5584324402407034,1.0,4/7,7.14%,HLA-B;B2M;HLA-C;HLA-F
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.7547703682400659,-1.3569921969122931,0.07575757575757576,0.5570473437133489,1.0,3/14,9.14%,RIPOR2;RACK1;LLGL2
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.829323368797269,-1.3566240174847337,0.1746031746031746,0.5572116910455437,1.0,2/6,8.83%,GSTP1;OSMR
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.8013265219567552,1.356441514211542,0.13953488372093023,0.7190520552608615,1.0,1/6,12.11%,FHIT
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8321371024836088,1.3560285442542261,0.10869565217391304,0.718966593128291,1.0,2/5,1.60%,NRP1;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.7661789218295204,-1.3557036143239831,0.10909090909090909,0.5600052362017902,1.0,2/10,6.27%,IL4I1;LILRB4
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.7794958502378527,1.3555719746720927,0.1891891891891892,0.718518032273641,1.0,1/8,0.05%,EGR1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.4674160053376958,1.3553997952311791,0.0,0.7172744039619917,1.0,50/128,20.52%,CACNA1A;TRPC1;KCNQ2;PKD2;SCN3A;SLC9C2;SLC39A14;SLC1A3;PKD1;KCNJ2;KCND3;SCN3B;SLC39A8;SLC41A1;HPN;KCNC2;SLC4A4;SCN8A;KCNN2;KCNK13;ABCB8;SLC40A1;SLC9A1;KCNK6;KCNH5;ANO6;SLC9A9;SLC8A1;SLC24A2;HVCN1;ABCC8;SLC12A2;ITGAV;P2RX7;TMEM165;SLC39A13;TRPC4;SLC9A7;KCND2;KCNB1;ORAI1;SLC30A1;SLC25A14;ATP6V0E2;SLC25A27;KCNQ5;KCNB2;SLC4A8;SCN1B;UCP2
prerank,GO_Biological_Process_2021__chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),-0.8465143546569055,-1.3547821245219667,0.12280701754385964,0.5631173643801107,1.0,2/5,8.27%,CXCR4;STK39
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.6222618811443833,-1.3543004840897572,0.0821917808219178,0.563840736651646,1.0,8/47,7.10%,FLNA;PYHIN1;TFRC;DTX3L;JUP;PARP9;LAMTOR5;RBM22
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.8976575100832276,-1.3541520922558081,0.02,0.5629903387401792,1.0,2/5,8.87%,LIPG;ENPP2
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.7437509770595516,1.3533346671986117,0.13636363636363635,0.7248590490329772,1.0,2/11,3.86%,PDGFA;SERPINE2
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.5689563901989194,1.3524900920026248,0.06666666666666667,0.7266688222282255,1.0,12/54,14.64%,UBE2D1;SMAD7;SAE1;LRRK2;LAPTM5;DCUN1D4;UBE2L3;FBXW7;TRAF6;DCUN1D1;UBA2;XIAP
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.6763107561092762,-1.3513764383060234,0.11940298507462686,0.5754206522654712,1.0,4/24,6.31%,CCL5;PARP14;IGF1;PARP9
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.5653711255811518,1.3513595478527247,0.12121212121212122,0.7292233263040683,1.0,7/39,5.26%,CACNA1A;AP3B2;SV2B;SCN3B;AANAT;PDE10A;MGAT4C
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6547870208614781,-1.3512553216074115,0.08,0.5743023062540747,1.0,13/50,16.53%,CCL3;OAS3;CD2;OAS2;CLU;CD14;OAS1;TYROBP;CYBA;PTPRC;HLA-E;NOD2;HAVCR2
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.7841534690656845,1.351011463252073,0.1346153846153846,0.7289673419003354,1.0,5/8,9.83%,PLXNB1;ATRAID;HPSE;TMEM119;NELL1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.755023145088613,-1.3509376639550341,0.1694915254237288,0.5746377230802558,1.0,3/10,11.55%,CXCR4;TNFRSF1B;PTN
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7968369071885845,1.350826029496,0.09090909090909091,0.727497376576088,1.0,2/8,2.81%,NRP1;ZSWIM4
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.9266664436201214,1.3508149477208597,0.08108108108108109,0.725607851586451,1.0,3/5,6.37%,SERPINE2;LRRK2;SNX12
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.8072295265675722,1.3508148330285232,0.08571428571428572,0.723586659799302,1.0,2/8,4.41%,PLXNB1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6798787094429221,1.3503256259825944,0.18421052631578946,0.7235973243042365,1.0,7/21,10.88%,NRP1;TGFA;NCOA3;RELN;HDAC1;SHANK3;FBXW7
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.8725529169091996,-1.350250355454038,0.1320754716981132,0.5756715544451473,1.0,3/5,11.55%,CXCR4;TNFRSF1B;PTN
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.8230423185298457,1.3500281198650854,0.075,0.7232897670719038,1.0,4/6,4.41%,PDGFA;TGFBR2;CTNNBIP1;WNT5A
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.7190061295412473,1.349788929224677,0.1276595744680851,0.7223845952974418,1.0,5/10,14.81%,NRP1;P2RY12;ITGA2;ANKS1A;SHTN1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.8291455170831707,1.3497881895053943,0.1388888888888889,0.7203945550900107,1.0,3/5,16.82%,SNX12;SGSM2;RAB7B
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.8770151648200692,-1.3497704057244095,0.07462686567164178,0.5763289927459209,1.0,1/7,0.97%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6526335543696034,1.3493665115412132,0.08333333333333333,0.7204138719210155,1.0,5/18,15.25%,NLGN1;DLG5;RELN;SHANK3;CAPRIN2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7269581680426837,1.34913793680903,0.10810810810810811,0.7195240190793595,1.0,7/11,22.20%,ZBTB16;SOX5;BMPR1B;SCIN;TGFBR1;SOX6;LOXL2
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.795403702709397,-1.3484466877224808,0.12962962962962962,0.5806179911257288,1.0,3/7,15.42%,DUOX1;CLCA4;CFTR
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.7352632721133593,-1.3484067963242394,0.11290322580645161,0.5793052809772656,1.0,1/12,0.16%,CALCR
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.6350426746655633,-1.3482292964897067,0.057971014492753624,0.5785407122743572,1.0,8/42,6.30%,NR4A3;TGFBR3;ZFP36;NLRC3;RUNX3;B2M;AQP11;IGF1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.8154118167739243,1.3482076519163286,0.13953488372093023,0.7221258751525496,1.0,5/7,15.83%,PKD2;PKD1;RELN;NF1;SOX4
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.8435749325378967,-1.3477729575334125,0.1111111111111111,0.5792919297082191,1.0,2/5,14.46%,VEGFA;C1QBP
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.8598540419681989,-1.3476421483091456,0.07272727272727272,0.5783805426520181,1.0,1/6,1.69%,GPR183
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.7996593901341293,1.3472783241144477,0.13953488372093023,0.724644005265823,1.0,4/8,11.69%,PTCH1;AIDA;BMPR1B;BMPR1A
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.6075996058244741,1.3471961428469934,0.07407407407407407,0.7230910114766714,1.0,20/61,16.07%,KCNQ2;CNTN2;NCAN;B4GALNT4;ADGRB2;SNAP91;CSPG5;NGB;PSD2;PPFIA3;GRM5;BRSK1;LINGO1;CELSR2;SNCB;NXPH1;GRIA2;CAMKV;GAD1;LRRC4B
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.6781431739219839,-1.3471921255136716,0.10344827586206896,0.5792787157272862,1.0,4/16,12.58%,GPR183;ANXA2;OSCAR;TYROBP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.5990572429091616,-1.3463067727707991,0.07142857142857142,0.5824011593487809,1.0,8/49,14.84%,CALCR;TFRC;PRKD2;MTCP1;CD44;VEGFA;CAMK1;TERF2IP
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8854525839993934,1.3462394503626804,0.07894736842105263,0.7254891227030474,1.0,2/7,1.21%,PLA2G4C;PLA2G7
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.46466428709789226,1.3455453297765554,0.038461538461538464,0.7265980854088874,1.0,32/139,12.79%,COL5A3;MMP17;COL16A1;PDGFA;SERPINE1;GSN;NCAN;FGF2;COL5A2;CTSK;EXOC8;COL24A1;DAG1;BMP1;LCP1;SLC39A8;MMP16;ADAMTSL2;RECK;TNR;FLRT2;COL15A1;ADAMTS17;ADAMTSL3;P3H2;COL11A1;FBN2;NF1;ITGA2;P4HB;MMP14;COL25A1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.8709125525500025,-1.3451791136772078,0.15789473684210525,0.5862130622728438,1.0,3/7,8.01%,CCL3;SRGN;TRPM4
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.73645952178423,-1.344248222564898,0.1044776119402985,0.589429818365911,1.0,4/16,9.44%,CCL3;LILRB4;LILRB3;GPR137B
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.5892703671755716,1.3441136236968618,0.1111111111111111,0.7312441192857599,1.0,13/32,18.37%,FER;GSN;LRRK2;PARP1;DVL3;BRSK1;CSNK1E;STXBP2;EPHA5;DYNC1H1;PPM1F;MAP2;UNC13D
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.7329429639471293,1.3438847766426452,0.05128205128205128,0.7303418974186386,1.0,3/11,4.22%,RUVBL2;NCOA3;NRIP1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7625549983622302,1.3435260603836288,0.15,0.7305051501586239,1.0,3/7,10.32%,NCAN;CSPG5;UST
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.5887277104916011,-1.3432939954456142,0.09230769230769231,0.5919496312029329,1.0,4/74,2.28%,NR4A3;SYAP1;INSIG1;USF1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.553342776218194,1.3430641606956335,0.1111111111111111,0.7307698977307874,1.0,14/58,12.54%,CDK5R1;SLITRK5;SEMA5A;MAP1S;RAB10;RYK;PLPPR4;CTNNA2;BRSK1;DCC;KLF7;PARD3;CNTN4;RTN4
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.6146509114971418,1.3424504515922426,0.09302325581395349,0.7309311384553271,1.0,3/29,4.53%,ESRRG;NPHP1;JAG1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8279183542704844,-1.3423904143379417,0.13114754098360656,0.5948597177185543,1.0,4/7,14.87%,DYNLT1;IFIT1;STAT1;TBC1D20
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.7306968691925133,-1.3422898330248396,0.11864406779661017,0.5939039094833041,1.0,5/15,2.73%,CD36;SIGIRR;CARD16;TRIM5;CD55
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.6887231417304989,-1.3420612148305786,0.07575757575757576,0.5933328507036228,1.0,7/16,16.15%,DUOX1;NCF4;NCF2;SOD1;MT3;CYBA;ALOX12
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7689457784961247,1.3417611466199062,0.22857142857142856,0.7322115781650014,1.0,2/8,2.49%,NRP1;GAB1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.6206183551315197,-1.3415561766411706,0.07462686567164178,0.5940278859894548,1.0,2/43,4.59%,NR4A3;CTSB
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.7590055323506617,1.3414772999555036,0.11627906976744186,0.7317249688743106,1.0,2/10,1.60%,SERPINE1;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.6955654601083044,1.3414482587699346,0.1388888888888889,0.7297891885333733,1.0,3/22,5.56%,KLF4;FGF2;PPARG
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.686447165990112,-1.3413955185742072,0.1346153846153846,0.593207376696616,1.0,3/21,8.73%,DTX3L;PARP9;CYREN
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.6836606588511656,-1.3407064516230274,0.14285714285714285,0.5949047507909564,1.0,3/31,1.68%,INSIG1;CH25H;PRLR
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7142300381896901,1.3402455049451047,0.16279069767441862,0.7329481629522747,1.0,3/10,15.62%,IGF1R;TNF;SMCR8
prerank,PanglaoDB_Augmented_2021__Microglia,-0.5494622707033652,-1.3401160316674547,0.05263157894736842,0.5959249750462258,1.0,19/134,7.04%,CCL4;JAML;CCL3;GPR183;FOS;MNDA;AIF1;MS4A4A;LSP1;SIGLEC1;CD14;IL10RA;FCER1G;NCF4;PECAM1;LILRB4;CD300LF;PLEK;CD93
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.819398312922988,1.3400625913270097,0.13043478260869565,0.7317581963828558,1.0,4/6,12.32%,PGM5;PTCH1;POGLUT1;NF1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5483648851058547,-1.3400184763287364,0.06944444444444445,0.5948140628090403,1.0,6/102,2.17%,CCL4;UBC;CCL3;CCL5;RPS27A;PSMB3
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8975324162192719,-1.3398795798228158,0.0784313725490196,0.5941037209189111,1.0,2/5,3.70%,COL5A1;RPS23
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.7968206176673527,1.3396943150321132,0.16666666666666666,0.7312778858295533,1.0,1/5,2.45%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.7295321334408169,1.3387036730612283,0.10526315789473684,0.7325707142092256,1.0,1/12,0.65%,NRP1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5112321747978396,1.3383057394210647,0.041666666666666664,0.7320241487946626,1.0,15/57,12.27%,SLITRK5;LRP4;MAP1S;RAB10;RYK;PLPPR4;TMEM106B;CTNNA2;BRSK1;DCC;BTBD3;CELSR2;KLF7;PARD3;CNTN4
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.7325821224933187,-1.3382932349222767,0.09090909090909091,0.5998470960863735,1.0,3/16,16.03%,FOS;DNMT1;PICK1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.5800633551626121,-1.3380289509428214,0.04819277108433735,0.5995002116676249,1.0,26/103,14.04%,RPL38;RPL3;RPS14;RPS27;RPL23A;RPL5;RPS15;SNRPD2;RPL11;SRPK1;MRPS7;RPL10;EIF2D;RPL24;RPL6;MRPS11;ZRSR2;CRNKL1;DDX23;RPS5;NOP53;RPS28;TRAF7;GCFC2;EIF2S2;RPLP0
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.905570961410678,-1.3375274469999419,0.021739130434782608,0.5993468289663523,1.0,2/5,2.73%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.905570961410678,-1.3375274469999419,0.021739130434782608,0.5993468289663523,1.0,2/5,2.73%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5496279190929431,-1.3364793854068127,0.07692307692307693,0.6029877789928842,1.0,18/146,9.89%,CCL4;CALCR;CD36;CCL3;CCL5;PDGFD;GPR183;GLIPR2;MARCO;TRIM5;IGF1;CHI3L1;MAP3K12;PHB2;PRKD2;C5AR1;EIF2AK2;CD44
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.8640823096854839,1.3363408226744704,0.11764705882352941,0.7383598689221057,1.0,1/5,2.57%,SMAD7
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8355952941609863,-1.3362412751248265,0.12280701754385964,0.6026161116517361,1.0,3/6,9.40%,TOMM7;HK2;ATP5IF1
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.6547263845572614,1.3361822574494568,0.13157894736842105,0.7372044477668394,1.0,4/19,4.53%,NRP1;PDGFA;COL5A2;JAG1
prerank,GO_Biological_Process_2021__folic acid transport (GO:0015884),0.8974414916517018,1.3359005055560988,0.06818181818181818,0.7367162493932845,1.0,1/5,0.79%,PDPN
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.5989538302073334,1.335468844231008,0.11538461538461539,0.7364284322656627,1.0,5/31,4.16%,HID1;FAAH;RAP1GAP;RNF208;PLPPR1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.6517888482549626,1.3352694335760857,0.14285714285714285,0.7352211399376624,1.0,4/20,4.50%,KCNIP2;KCNJ2;KCND3;SCN3B
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.7369906835470812,1.33516203159626,0.175,0.7339216342727508,1.0,6/9,26.18%,NUP153;RTN4;NDC1;NUP205;NUP98;TPR
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.6174957284416769,1.3347276936640455,0.17142857142857143,0.7334468605324992,1.0,7/16,19.19%,TCP1;CCT3;TNF;CEP120;CEP135;CHP1;CORO2B
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5811669315095017,1.3340794387188717,0.15151515151515152,0.7347370224862163,1.0,15/27,26.99%,KNDC1;NEDD4L;PTPRD;CAPRIN2;GSK3B;ADGRB3;NEDD4;SEMA4D;RAPGEF2;IL1RAPL1;RAP2A;CAPRIN1;TNIK;SDC2;NSMF
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.7204981803197736,1.3337348743797037,0.1590909090909091,0.73383936612055,1.0,2/10,5.36%,ARID1A;PLPP1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.7625483316251083,1.333651736188074,0.11904761904761904,0.7324591841802245,1.0,3/8,4.10%,PGAP1;RNF139;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.8772767076638659,-1.333141477606643,0.11538461538461539,0.6159383213196349,1.0,1/5,0.09%,NR4A3
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6791739379689927,1.3324614869705114,0.10256410256410256,0.7360417549615248,1.0,2/13,5.78%,STARD4;LDLR
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.7173943660958821,-1.3317094526364233,0.13559322033898305,0.6220196493261383,1.0,3/21,1.73%,NR4A3;SKAP1;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.5609651360070768,1.331256122784253,0.1282051282051282,0.7393477181424843,1.0,6/31,4.87%,FER;GSN;CDC42EP3;VASP;SPIRE2;NCK2
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.7350055815025737,-1.331246923726006,0.06779661016949153,0.6228042400653602,1.0,1/14,0.35%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.802632861637391,-1.3312438384415075,0.09523809523809523,0.6213128663931323,1.0,2/8,9.97%,TMSB4X;GCLM
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.762298385336136,1.3312226913548815,0.14634146341463414,0.7376418130155019,1.0,1/7,4.45%,BACE2
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.8429706223921108,1.3305445180673372,0.08,0.7388376181950418,1.0,3/5,8.67%,PIGU;PGAP1;PIGT
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.8522067136940586,1.330389983541619,0.08108108108108109,0.7379431913331072,1.0,2/7,5.13%,GRID2;KNDC1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.5654198840661343,1.3302400864998896,0.18518518518518517,0.7366694325485307,1.0,13/74,10.45%,PLXNB1;LRP4;ZNRF3;MTCL1;GFAP;ARNT2;ADGRB2;SEMA3B;NUAK1;TBC1D16;SALL1;ALCAM;GNA11
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.643040358932949,1.3295911158293583,0.17142857142857143,0.7377948908525339,1.0,3/15,5.72%,FLVCR1;COX10;ALAD
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6879087730605593,1.3291112204471405,0.13157894736842105,0.7379281583801665,1.0,6/19,16.31%,SALL1;WDPCP;HDAC1;PTCH1;NIPBL;MEGF8
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5490389525365705,1.3282340642598394,0.03225806451612903,0.7401242473184767,1.0,12/48,15.71%,KLF4;ANXA1;PKD2;PKD1;UBE2E2;SLFN11;PTEN;CDK6;GPNMB;DDX3X;CCND3;ANKRD17
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.8052526557336,-1.3279092155918777,0.07017543859649122,0.6362619573180615,1.0,3/9,13.24%,RPGRIP1L;VEGFA;NRL
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.7506463712033844,-1.3273813617355787,0.125,0.6371881628006597,1.0,4/9,22.39%,MUS81;REXO4;DFFB;ISG20
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.6037199245002703,-1.3271049300857716,0.078125,0.636921618041554,1.0,8/42,9.41%,TGFBR3;NLRC3;RUNX3;B2M;AQP11;BRCA2;ATP5IF1;STAT1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.8826486519331498,-1.3269433136045694,0.13333333333333333,0.6360335016218379,1.0,1/5,0.40%,IL4I1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.6921273101119009,-1.3268166205750986,0.15,0.6352097763152199,1.0,3/14,9.66%,IL4I1;LILRB4;IRF1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.6594983339442356,-1.3267656367588836,0.16176470588235295,0.6337501234085388,1.0,4/30,3.56%,FLNA;CHRM2;MARCO;RGS1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.6196297437915729,-1.326642215077404,0.07575757575757576,0.6329956240927298,1.0,14/50,19.37%,PSMB3;PSMA7;PSMB9;PSMB6;RBX1;PSMA5;NABP1;PSMC4;PSMD8;PSMD12;PSME2;CHFR;PSMA3;PSME1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5617666070504203,1.3264454763326898,0.08333333333333333,0.7458244901341079,1.0,21/52,18.75%,PPARGC1A;ESRRG;FGD4;JAG1;LPP;PLEKHA5;LARP1B;CPEB4;WNK1;SPTLC3;COBL;MAP7;SLC8A1;CXCL14;STON2;CMYA5;ACOT11;NIPSNAP2;BAZ2B;TSC22D2;SCIN
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7727565457609356,-1.3260853024751262,0.13793103448275862,0.6344735941928028,1.0,4/10,6.30%,NR4A3;CCL5;AIF1;IGF1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.8297643921129872,-1.3259076889085006,0.13043478260869565,0.633760667565978,1.0,2/7,12.56%,TIPIN;CDC7
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.8123511500105804,-1.3255214077536235,0.09090909090909091,0.6342196954239768,1.0,2/9,2.31%,CCL5;AIF1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.8468463286403908,1.3252822613071327,0.11764705882352941,0.7486219370966744,1.0,3/6,10.55%,GRIN3A;NLGN1;PTEN
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.7091274741203626,1.325231224552908,0.12244897959183673,0.7470255739447617,1.0,1/10,0.88%,RRAGD
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.627197940654858,-1.325062585296802,0.136986301369863,0.634953186553344,1.0,3/42,1.20%,OSBPL5;INSIG1;CH25H
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.8169062782933438,1.3250044437940418,0.1702127659574468,0.7461286038787527,1.0,2/7,5.78%,ABCA2;LDLR
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.8146378925691697,-1.3238049702548476,0.07272727272727272,0.6391526954861533,1.0,3/9,1.69%,MYO1G;CCL3;GPR183
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.8230772253865841,1.323529170031807,0.18,0.7508801063016937,1.0,3/5,12.52%,E2F3;PPARG;SOD2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.6310672592727112,1.3234017631981738,0.20512820512820512,0.7493837835737153,1.0,3/17,4.96%,PLA2G4C;PLA2G7;PRDX6
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.6685769915603927,1.322963313836055,0.13157894736842105,0.7494549071147617,1.0,10/23,19.91%,MTCL1;MAP1S;TPPP;TOGARAM1;ZNF207;CCDC40;CLASP1;NCKAP5L;CHP1;NAV1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5386497679219667,1.3228704802397857,0.08823529411764706,0.7479382331357378,1.0,4/41,1.10%,SHROOM3;PLXNB1;MFNG;LRP4
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6476872118275364,1.3227752987112056,0.09090909090909091,0.7464599903137203,1.0,6/19,10.10%,NCAN;CSGALNACT1;CHST7;UGDH;CSPG5;CHST15
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8121759707582493,1.3227673433383063,0.11904761904761904,0.7446481942207258,1.0,2/5,18.03%,AUTS2;TMEM108
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.7446719336962206,1.3216604184354688,0.16279069767441862,0.7476347310956952,1.0,1/6,1.12%,DPYSL5
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.61177124648193,-1.3212408942924916,0.12307692307692308,0.6498420726888763,1.0,4/35,3.00%,UBC;CD36;RPS27A;B2M
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.8102819283837821,-1.3210686570016754,0.14285714285714285,0.6490229559357794,1.0,2/9,4.81%,NR4A3;RACK1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.7239147481684969,-1.3209778258502964,0.11864406779661017,0.6479532080377384,1.0,5/13,12.58%,MNDA;BANK1;SAMSN1;TNFAIP3;TYROBP
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.7240634582158113,-1.3209451081997217,0.13636363636363635,0.6467712867124803,1.0,2/14,2.29%,MYO1G;SYNE2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.8233273282486322,-1.3209396283209334,0.06349206349206349,0.645283144522259,1.0,2/9,6.94%,SKAP1;PLEK
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.6469203433353339,1.3207066100680531,0.12,0.749558764996797,1.0,7/17,18.54%,RAP1A;PDLIM5;RUNX1;TJP1;SETD5;RAPGEF2;CBFB
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.5113438296331296,1.320338144448809,0.125,0.7493209239634233,1.0,31/91,18.46%,SERPINE1;SRGAP2B;FGF2;SMAD7;MITF;DLG5;PTPN23;JAG1;DAG1;DACH1;TMEFF2;VCL;ROBO1;RECK;KANK1;PTPRK;PTEN;PTPRR;RNF20;BMPR1A;NF1;AFDN;GTPBP4;PTPRG;SRGAP2;RAP2C;CLASP1;PHLDB2;CLASP2;RHOB;SLIT2
prerank,GO_Biological_Process_2021__regulation of cell activation (GO:0050865),-0.8219906232579204,-1.3202612825340319,0.1864406779661017,0.6475923099374815,1.0,2/6,5.47%,TXK;FCER1G
prerank,MSigDB_Hallmark_2020__Coagulation,0.48849951192616553,1.3199941049497015,0.06666666666666667,0.7489921937698384,1.0,10/66,7.49%,DUSP6;ANXA1;SERPINE1;GSN;CRIP2;CASP9;CTSK;BMP1;TIMP3;HPN
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.8458792522614274,-1.3198477760079572,0.10714285714285714,0.6478545183292309,1.0,2/6,3.79%,CCL5;PRELID1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.563704603254039,-1.3197666046608911,0.0410958904109589,0.6467224649419927,1.0,18/86,12.26%,ITK;BTN3A1;SRGN;HLA-B;GAPDH;BTN3A3;TXK;IRF7;BTN3A2;BTN2A1;LURAP1;EIF2AK2;TNFRSF1B;GLMN;BTN2A2;SOD1;NLRP12;STING1
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.7928280402168214,-1.3196956307066052,0.12903225806451613,0.6456149436422417,1.0,2/7,13.73%,MTHFD1;SEPHS1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.566034885724094,-1.319688139666608,0.07792207792207792,0.644185127784362,1.0,10/77,11.76%,CALCR;NLRC3;YES1;DHX58;CD247;PRKAR1B;ENPP3;SAMSN1;FYN;TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.688663157832295,1.3196239133848542,0.13157894736842105,0.7487262481698512,1.0,2/14,1.60%,SERPINE1;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.7399018451860466,-1.3192123538474283,0.12698412698412698,0.6453942658700267,1.0,1/11,0.35%,DDX11
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.5673752301864359,1.3187379253624403,0.08823529411764706,0.7506597897381612,1.0,4/47,4.96%,PIGQ;PLA2G4C;PLA2G7;PRDX6
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7913307421181678,1.318669122867289,0.11627906976744186,0.7492032757609498,1.0,3/6,10.15%,ZBTB16;SOX5;BMPR1B
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.844368819463164,-1.3185329374022239,0.13114754098360656,0.6471921393322071,1.0,1/10,1.68%,PRLR
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.81651557082412,-1.317359271885722,0.14545454545454545,0.6516212436271317,1.0,1/8,0.09%,NR4A3
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5949926882180523,-1.317264597653363,0.0641025641025641,0.6505533465329254,1.0,7/61,4.16%,UBC;PPIE;RPS27A;XPA;COPS6;GTF2H5;UVSSA
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.7841381879534661,1.3171328612799416,0.20930232558139536,0.753435762721418,1.0,1/7,4.77%,BMP1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5463398206608452,-1.31707352152978,0.07042253521126761,0.649852062762707,1.0,12/80,8.26%,CD36;ME1;VNN2;PER2;PDHX;GNPAT;IGF1;SLC16A3;GATM;LDHA;ACAA1;THEM4
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.5421979331354945,-1.316636537086963,0.07792207792207792,0.6505786746756753,1.0,41/129,14.07%,MT2A;SLC2A3;TPD52;COL5A1;FOSL2;ZFP36;GAPDH;CXCR4;FOS;DUSP1;PPP1R15A;HS3ST1;RORA;BHLHE40;ANKZF1;ANXA2;IER3;PHKG1;DDIT4;JMJD6;ERO1A;ETS1;LDHA;HK2;RBPJ;PFKFB3;CITED2;S100A4;GPC3;TNFAIP3;FAM162A;ATF3;VEGFA;SDC3;MXI1;FBP1;PGK1;CDKN1C;BTG1;AKAP12;VLDLR
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.516677991185169,1.3165237101125973,0.10714285714285714,0.7542530643566386,1.0,8/56,5.86%,AVIL;NRP1;EPS8;NLGN1;CDC42EP3;AUTS2;AKIRIN1;WASF2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7526687563271175,1.3161991213883917,0.1388888888888889,0.7539475618842382,1.0,3/9,14.92%,STK25;ZNF622;MAP3K5
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7652327362235523,-1.3160648705668747,0.09615384615384616,0.6519843004481531,1.0,2/11,6.31%,DTX3L;PARP9
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.8337408948156549,-1.3160546523564765,0.16666666666666666,0.6505281329971562,1.0,2/5,4.95%,DDRGK1;DNAJB9
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8028146742567992,1.315842434235343,0.14634146341463414,0.7537340134961388,1.0,6/6,19.76%,PKD2;PKD1;SALL1;ROBO2;SLIT2;FGFR2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.8256779192030991,1.3157876055885098,0.12195121951219512,0.7503071415038887,1.0,5/5,17.46%,DAG1;PHLDB1;CLASP1;PHLDB2;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.8256779192030991,1.3157876055885098,0.12195121951219512,0.7503071415038887,1.0,5/5,17.46%,DAG1;PHLDB1;CLASP1;PHLDB2;CLASP2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.6972365082518296,1.3155464786857887,0.15555555555555556,0.749504494322631,1.0,2/9,11.30%,MTA2;SUPT16H
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.8676740231542868,-1.3154962069720857,0.17307692307692307,0.65183318959265,1.0,1/5,4.31%,ANXA2
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.6554374719188085,-1.3151281465792743,0.09722222222222222,0.6520405192389876,1.0,4/30,5.38%,OSBPL5;CD36;LIPG;CLU
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.8435634612014098,-1.3149904303283788,0.13559322033898305,0.6513453490191407,1.0,1/5,3.75%,BBS2
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.5639991289601168,1.3146425611686674,0.125,0.7513954594968717,1.0,10/24,17.91%,SCN3A;KCNJ2;GNAQ;SCN3B;KCNMB4;SCN8A;GNA11;KCNMB3;KCND2;KCNB1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.5771353575590331,-1.3145923072937573,0.0875,0.6517964699517522,1.0,12/86,7.59%,SKAP1;CD36;TFRC;XPA;WARS1;MPP7;GTF2H5;RACK1;CLU;PLEK;RPS3;MED25
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.8101539874845516,-1.3143108513386088,0.15,0.6516285176932848,1.0,2/8,2.64%,SIDT2;SIDT1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.8371323331498857,-1.3140199405646837,0.09433962264150944,0.6515919134577399,1.0,2/6,8.74%,TPP1;RAB3D
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.6635536027652994,1.3139407493110187,0.18181818181818182,0.7520848914159521,1.0,8/15,20.79%,SORT1;SORCS3;GLRA1;SORL1;SORCS2;MCHR2;RAPGEF2;GLRB
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.5446771218112906,-1.3131394260985458,0.03571428571428571,0.6540313123263536,1.0,17/126,12.55%,FLNA;PLEKHG5;CARD16;TFRC;GAPDH;TRIM5;TNFSF10;TRIM22;LAMTOR5;LGALS1;LURAP1;S100A4;CFLAR;TRIM13;APOL3;ALPK1;LITAF
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5413329797446659,1.3131356961263956,0.1,0.7541395135085779,1.0,9/33,10.20%,IL1RAPL2;GRID2;NLGN1;DLG5;CLSTN2;PDLIM5;PTPRD;GPC6;CLSTN3
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.5842258448562793,1.3127499190486067,0.1111111111111111,0.7535134927509233,1.0,2/31,0.73%,POLR2D;BAG3
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.8102254049816671,1.3126936223950862,0.15555555555555556,0.7520316904896533,1.0,2/5,15.30%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.8071280787641681,-1.3123828017464525,0.12727272727272726,0.6562927036800681,1.0,1/8,3.01%,PARP14
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.556154767341223,1.3122280899163903,0.12903225806451613,0.7520338152725908,1.0,12/62,12.38%,SHROOM3;PLXNB1;NEO1;MAGI1;SCARB2;UNC13B;SLC31A1;SHANK2;GPC6;SHC2;COBL;TJP1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.5773124480930801,-1.3120909061000594,0.028169014084507043,0.6561533371189854,1.0,6/67,3.56%,CALCR;ADGRE1;CHRM2;ADGRD1;MARCO;RGS1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.5487754655961097,1.3120617412892739,0.12903225806451613,0.750650693969093,1.0,13/60,10.32%,B3GNT2;GCLC;NCAN;CSGALNACT1;B4GALT4;CHST7;CHST1;GSTA4;UGDH;CSPG5;HPGDS;CHST15;UST
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.7143913537869331,-1.3118017228128847,0.17647058823529413,0.656421406508095,1.0,5/18,12.58%,AIF1;CLU;C5AR1;ITGB2;TYROBP
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7482802523867467,1.3115765670069435,0.16216216216216217,0.7508618273924804,1.0,3/6,10.06%,NRP1;RYK;NFIB
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6391095811858549,-1.3115219445921125,0.21052631578947367,0.6562085672800456,1.0,10/24,23.99%,ATP5F1E;MICOS13;ATP5PD;ATP5ME;APOO;SPG7;ATP5F1D;ATP5F1C;ATP5MC2;AFG3L2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.5704464765803394,1.3114834359215102,0.10344827586206896,0.74969312271769,1.0,4/25,5.86%,AVIL;AUTS2;AKIRIN1;WASF2
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.8017227331050201,-1.3108495827200894,0.15,0.6577640567761707,1.0,2/8,12.58%,MNDA;TYROBP
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.7637973748499415,1.310705639192138,0.1388888888888889,0.7515153512576764,1.0,4/9,16.60%,SCRIB;ZNF703;ERBB4;AKT2
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5985096801565846,-1.3105776285634514,0.043478260869565216,0.6576226816725566,1.0,14/55,19.37%,PSMB3;PSMA7;PSMB9;PSMB6;EIF2AK2;TCF3;PSMA5;PSMC4;PSMD8;PSMD12;PSME2;SETD1A;PSMA3;PSME1
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.7452301854822753,1.3103475363922672,0.13636363636363635,0.7511389899236525,1.0,3/9,10.99%,BORA;RCC1;CDK13
prerank,GO_Biological_Process_2021__positive regulation of microglial cell migration (GO:1904141),-0.8617469952602985,-1.3103025809718465,0.16981132075471697,0.6574635970581962,1.0,1/5,0.74%,CCL3
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.8096251302779772,-1.3102167745654059,0.12121212121212122,0.6564273141682763,1.0,2/7,3.64%,HLA-B;NAIP
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.7063283481763395,-1.3101836283804247,0.1076923076923077,0.6551948116442896,1.0,7/18,19.39%,PLN;JUP;SRI;TRPM4;PKP2;FGF13;AKAP9
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7202698187001808,-1.3099893849946225,0.14035087719298245,0.6546596509833369,1.0,7/13,25.53%,TIMM21;BCS1L;COX18;OXA1L;COX20;SURF1;SCO2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.7201841012486421,-1.309655225732621,0.21052631578947367,0.6546537525994256,1.0,3/12,12.23%,SSB;KARS1;DARS2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.7284086994807413,-1.309642258761447,0.11475409836065574,0.6532880717072848,1.0,1/19,0.35%,DDX11
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.632736921638915,-1.3090884386944934,0.11475409836065574,0.6544611171286348,1.0,2/24,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.7911357891792543,1.3084772549986385,0.20833333333333334,0.7568539093090627,1.0,2/5,13.94%,LRRK2;CLUH
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.619425815658556,-1.308379346743115,0.14492753623188406,0.656026249430162,1.0,11/53,11.35%,UBC;RPS27A;XPA;GTF2H5;OGG1;MUS81;MEI4;PNRC2;REXO4;IHO1;RBX1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.6588684921722809,-1.307447075163055,0.13846153846153847,0.6596742072486411,1.0,5/27,7.10%,FLNA;MDFIC;APOD;JUP;RBM22
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.6481684645222787,1.3074332641557143,0.15625,0.7594613418121263,1.0,10/17,21.23%,PKD1;SALL1;COBL;CCDC40;NIPBL;RARB;TNF;MEGF8;FGFR2;BBS7
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.566441630389603,1.3074305789964769,0.16279069767441862,0.7577352933080078,1.0,11/27,14.47%,SMAD7;JAG1;RNASE10;MAGI1;FUT9;PTPRR;CELSR2;AFDN;GTPBP4;PTK2;PTPRG
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8567448238255051,-1.3070596823343479,0.16363636363636364,0.6585828026025665,1.0,2/6,9.41%,STAT4;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8567448238255051,-1.3070596823343479,0.16363636363636364,0.6585828026025665,1.0,2/6,9.41%,STAT4;STAT1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.668326651467422,1.306811399345695,0.16666666666666666,0.7587083487747693,1.0,6/17,11.36%,LRP4;ZNRF3;SALL1;PTCH1;BMPR1B;KAT2A
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.813708642161924,1.3067932760990593,0.13513513513513514,0.7570495600108965,1.0,2/7,4.53%,TGFBR2;JAG1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.7695565046066328,-1.306570318871195,0.15254237288135594,0.6595887682490515,1.0,5/13,10.92%,IL4I1;SKAP1;IRF7;IRF1;SAMSN1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.5681858516938705,1.30643058819885,0.06060606060606061,0.7566369957461261,1.0,12/39,12.57%,PLXNB1;GRID2;NLGN1;WNT5A;RYK;PLXNB2;SHANK2;DNM3;GPM6A;SHANK3;PTEN;NRXN2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.8573114884545912,-1.306222056138155,0.15517241379310345,0.6597867534444041,1.0,3/5,8.50%,SKAP1;CCL5;FERMT3
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.449408921797619,1.3062010568783358,0.18181818181818182,0.755737660197153,1.0,58/254,12.72%,IL1RAPL2;AVIL;KCNQ2;PKD2;DPYSL5;DOC2A;SEMA5A;GSN;NCAN;MAP1S;FGF2;ZBTB16;DPF3;ARNT2;NLGN1;NRG1;PKD1;ADGRB2;GDF11;JAG1;RELN;CSPG5;TMOD2;RYK;PPT1;NUMBL;PDGFC;MERTK;ZC4H2;LIG4;HAPLN2;ROBO1;SH3GL3;WDPCP;POU6F2;SHANK2;DNM3;MOBP;GPM6A;SCN8A;NELL1;SHANK3;ALDH5A1;BTBD3;NPTX1;DYRK1A;PTEN;RBFOX1;CYP46A1;SH3GL1;APAF1;ELP3;CNTN4;NF1;KALRN;FKTN;NRXN2;RPS6KA6
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.7004918236683157,-1.3061867092241093,0.13114754098360656,0.6586116382609348,1.0,6/18,22.80%,TNFSF10;PDCD5;FAM162A;BMF;PINK1;BNIP3
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.7436001288931481,-1.30608069831011,0.14035087719298245,0.6577438445906449,1.0,6/14,15.49%,HLA-B;HLA-F;KLRD1;HLA-DRA;PTPRC;HLA-E
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.5313954363139348,1.3057045928897908,0.10256410256410256,0.7561042131970432,1.0,6/46,5.64%,NRP1;SEMA5A;FGF2;SIRT1;WNT5A;PTPRM
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7404041177918468,-1.3055470491206935,0.13043478260869565,0.6592754232066642,1.0,8/18,13.32%,PARP14;CDC37;TXK;NLRC5;PARP9;NR1H2;STAT1;IFNGR2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6185327912007763,1.3054009705673135,0.08333333333333333,0.7556107015486263,1.0,7/19,21.78%,MAPK11;LAPTM5;LGALS9;IRF5;HSPD1;AGER;SYK
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7826788489325124,1.3053568331848384,0.14285714285714285,0.7540915973962335,1.0,2/7,2.28%,FGF2;SPRY2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.7879638843544362,1.3052250492503625,0.16326530612244897,0.7530065692971383,1.0,2/5,15.33%,ALDH5A1;GAD1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.69929310245836,1.304928637959956,0.14634146341463414,0.7525232540381316,1.0,5/15,11.46%,SYNGR1;SNAP23;STX11;STX1A;STX2
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.5722287591701947,1.3045546595637512,0.06896551724137931,0.7522973239983729,1.0,18/30,21.83%,SLC1A3;ANO4;SLC12A6;ANO3;GLRA1;GABRR2;ANO6;SLC12A2;SLC12A5;GABRD;CLCN3;GABRA4;GABRG3;SLC4A8;GABRB1;GLRB;GABRA2;GABRB2
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.7236106208998438,1.3045168988276896,0.2,0.7508273365903952,1.0,1/11,3.94%,CBFA2T3
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.8537168660961182,-1.3044170084562932,0.14583333333333334,0.6627484179764798,1.0,1/5,0.40%,MYLK
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.8482063513311023,-1.3038549103741832,0.12,0.6640332197150884,1.0,1/5,1.69%,GPR183
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6882532018410911,1.3038225109802972,0.1111111111111111,0.7517355261975113,1.0,7/13,26.18%,NUP153;RTN4;NUP133;NDC1;NUP205;NUP98;TPR
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6819973126140205,-1.3033206825330217,0.1346153846153846,0.6652067992466884,1.0,7/14,22.49%,ATP5F1E;ATP5PD;ATP5ME;ATP5F1D;STOML2;ATP5F1C;ATP5MC2
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.7701417972908239,1.3032591911681886,0.1875,0.7521889562011873,1.0,5/7,17.46%,PTEN;FERMT2;CLASP1;PHLDB2;CLASP2
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7536117580201231,1.303041526926347,0.19148936170212766,0.749808216393401,1.0,2/6,9.81%,NRP1;HGF
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7536117580201231,1.303041526926347,0.19148936170212766,0.749808216393401,1.0,2/6,9.81%,NRP1;HGF
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.8148064423437529,1.3029977625817035,0.14,0.7481918866591424,1.0,2/7,5.51%,ABCA2;STARD4
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.7866335364649875,1.3029935732601712,0.2222222222222222,0.7465547052878969,1.0,1/5,5.40%,NAA20
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6464118498208532,1.3029704950854524,0.2,0.7450082661338067,1.0,4/21,8.94%,ANXA1;WNT5A;JAG1;HDAC1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.6678439528180682,-1.3025489676216004,0.15873015873015872,0.6679239200549112,1.0,3/18,4.36%,FLNA;COL5A1;PLET1
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.8768057199972237,-1.3025040452838075,0.15,0.6667314316625477,1.0,1/5,0.74%,CCL3
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.620777556192752,-1.3022839714314722,0.13432835820895522,0.6664726417890137,1.0,6/45,5.01%,H1-4;H1-3;H1-2;TAF1D;H1-0;PADI2
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.8130634719993166,1.3022423851586082,0.1276595744680851,0.7461655155695724,1.0,4/5,18.65%,PDK4;SLC9A1;SLC9A7;CLCN3
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.5222966135728505,-1.302214127097312,0.03409090909090909,0.6653930947725822,1.0,24/168,12.55%,FLNA;PLEKHG5;CARD16;TFRC;GAPDH;NLRC3;TRIM5;RORA;TNFSF10;LILRB4;TRIM22;GSTP1;LAMTOR5;LGALS1;LURAP1;STAT1;S100A4;CFLAR;TRIM13;APOL3;TNFAIP3;ALPK1;NLRP12;LITAF
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.8427381870032278,-1.3022118666941471,0.06896551724137931,0.6640214145895653,1.0,1/5,8.73%,CYREN
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6846240246117155,-1.3021211466670537,0.1694915254237288,0.662846993820191,1.0,5/17,19.29%,RPS3;PRKD2;CD226;PTPRC;TESPA1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.5729560105591949,1.3020920153220694,0.07142857142857142,0.7449873073208214,1.0,4/26,5.49%,HID1;FAAH;AATK;FA2H
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.8157638007950403,1.3016636812448619,0.1320754716981132,0.7454198239216249,1.0,2/5,14.22%,CA2;AHCYL1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4288728467806326,1.3012335825743166,0.0,0.7456571066778351,1.0,40/162,13.91%,NRP1;GRB10;CDK5R1;SLITRK5;CNTN2;SEMA5A;MAP1S;RAP1GAP;GAB1;VASP;AUTS2;WNT5A;DAG1;RAB10;RELN;SEMA3B;RYK;PLPPR4;ROBO1;EPHA6;CTNNA2;TNR;UNC5B;NPTN;BRSK1;SHANK3;DCC;SPTAN1;PTEN;KLF7;MAPK1;ENAH;PDLIM7;PARD3;CNTN4;GAB2;UNC5D;SLIT3;ROBO2;PTK2
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5780272970402188,-1.301152234947448,0.08045977011494253,0.6665777410463484,1.0,11/66,12.49%,NR4A3;MYO1G;YES1;VAV3;CD247;FCER1G;ACTG1;ACTB;FYN;NCKAP1L;CYFIP2
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.8076175801524658,1.3011213918110283,0.125,0.7444325038685978,1.0,1/7,0.74%,NMNAT2
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.7555110922036665,1.3009383388242393,0.175,0.7436532435739354,1.0,2/8,2.02%,NUFIP1;RUVBL2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.6978502605466774,1.3008677757364155,0.15151515151515152,0.7423284378366042,1.0,5/17,5.77%,HS3ST5;HS3ST4;HS2ST1;UGDH;HPSE
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.8155028071237708,-1.3007948729683325,0.1509433962264151,0.667050270049367,1.0,2/7,9.02%,STK39;SGK1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.7662325736732573,1.3007445610278991,0.11627906976744186,0.7413653354467071,1.0,6/8,17.46%,DAG1;PHLDB1;SMAD3;CLASP1;PHLDB2;CLASP2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.7998060959260624,1.300591041320991,0.1320754716981132,0.7404883396467338,1.0,4/7,15.83%,NRP1;FZD3;NF1;SOX4
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6423088002533027,1.3005393515658108,0.16216216216216217,0.7392333267219715,1.0,4/23,2.49%,ANXA1;NRP1;SPRY2;GAB1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.7536086589577818,-1.3001793643216217,0.15517241379310345,0.6688187130794161,1.0,1/12,3.01%,PARP14
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.8316370417861705,1.2998989777159424,0.14893617021276595,0.7402421607146599,1.0,1/5,0.79%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.7164770674998359,1.2998559029672758,0.25,0.7372343580956114,1.0,1/7,3.28%,NCOA3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.7164770674998359,1.2998559029672758,0.25,0.7372343580956114,1.0,1/7,3.28%,NCOA3
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5062885182771567,1.2996284381993053,0.07142857142857142,0.736591707246746,1.0,10/47,11.35%,CDK5R1;TGFBR2;CDK10;LRRK2;MAP2K1;NLK;MAP3K10;DYRK1A;WNK1;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.7376448689767923,-1.299590834591043,0.15384615384615385,0.6702171955406276,1.0,4/15,12.02%,NLRC3;TMSB4X;IFI35;NLRP12
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.5249110717889922,1.2993058217493942,0.125,0.7361676191088102,1.0,22/43,21.83%,SLC1A3;XPR1;SLC37A2;ANO4;SLC12A6;ANO3;SLC37A4;GLRA1;GABRR2;ANO6;SLC12A2;SLC12A5;GABRD;SLC25A14;CLCN3;GABRA4;GABRG3;SLC4A8;GABRB1;GLRB;GABRA2;GABRB2
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.7133949985088317,-1.2991761761789118,0.11666666666666667,0.670644830490619,1.0,1/13,0.89%,TGFBR3
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.7908666850178299,1.2989316141693883,0.19148936170212766,0.7359337866233563,1.0,3/6,14.81%,NRP1;P2RY12;SHTN1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.6506508306143395,-1.2988798798163652,0.11594202898550725,0.6707611394368349,1.0,8/32,15.38%,FLNA;PLEK;ACTG1;FERMT3;MYL12A;ACTB;TLN1;PIK3CB
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.5960620479827727,-1.2985640100290665,0.1232876712328767,0.6709112963426453,1.0,12/50,6.09%,CD36;SAT1;CEBPD;RUNX3;MARCO;MS4A4A;ZMYND15;TNFSF10;LPCAT1;SIGLEC1;CD14;TYMP
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.8575401157763352,-1.2982562045276191,0.09803921568627451,0.6710779654888164,1.0,3/5,14.25%,APPL1;CD47;PTPRC
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.724841128602898,-1.2977651467233637,0.13333333333333333,0.6724575283902825,1.0,3/10,5.87%,SMUG1;OGG1;NT5C
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.7275188739211003,1.2973247082745893,0.24324324324324326,0.7408594158614805,1.0,3/11,4.31%,KCNIP2;KCNJ2;KCND3
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6463070878795353,1.297058802549841,0.15384615384615385,0.7401609285220406,1.0,4/18,10.65%,NRP1;SEMA5A;SEMA3B;PHACTR4
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8224653223053221,1.2970510170878864,0.17647058823529413,0.7386359828806348,1.0,3/6,10.93%,CSGALNACT1;HS2ST1;EXT1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6757341507433927,1.2968262225968719,0.17307692307692307,0.7378916727221924,1.0,3/9,13.18%,SIRT1;KAT2A;BAG6
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.665813813847572,1.2967719684504366,0.23076923076923078,0.7366975442789926,1.0,5/11,12.93%,PKD2;PKD1;GRIN2B;CPSF7;NUDT21
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.6595009932335141,1.2967029463334037,0.2222222222222222,0.7354552169644251,1.0,7/13,22.19%,FER;LGALS9;GAB2;STXBP2;UNC13D;SYK;CD84
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.60513698870471,1.2964686322377874,0.16666666666666666,0.7346690980351893,1.0,6/19,11.36%,MAML2;WNT5A;JAG1;FBXW11;TCF7L2;KAT2A
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.49548659975127196,1.2962887840381416,0.06666666666666667,0.7337803334785108,1.0,26/59,23.53%,SLC1A3;ATP10D;SLC25A18;SLC1A2;SLC15A4;LASP1;SLC12A6;KCNN2;GLRA1;SLC9A1;WNK1;SLC26A3;ANO6;SLC9A9;SLC8A1;SLC24A2;SLC12A2;SLC12A5;SLC9A7;SLC25A26;GABRB1;GLRB;PIEZO1;SLC17A5;GRIN1;PANX1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.7978397240155375,-1.2959760346719547,0.07272727272727272,0.6796310882116334,1.0,4/10,6.88%,H1-0;DDRGK1;IGF1;LAMTOR5
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.812889483135943,-1.2959685274084265,0.15517241379310345,0.6782809568185648,1.0,1/7,1.71%,DUSP1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.8592158580722378,1.2957697964005928,0.061224489795918366,0.734506995093623,1.0,3/5,8.78%,PGM5;TMOD2;TMOD3
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6699991873570694,1.2954047553978967,0.21212121212121213,0.7321524954910591,1.0,3/10,12.01%,GNPNAT1;GFPT1;RENBP
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.6699991873570694,1.2954047553978967,0.21212121212121213,0.7321524954910591,1.0,3/10,12.01%,GNPNAT1;GFPT1;RENBP
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6699991873570694,1.2954047553978967,0.21212121212121213,0.7321524954910591,1.0,3/10,12.01%,GNPNAT1;GFPT1;RENBP
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.5588485517276406,-1.2947329664131326,0.14492753623188406,0.682678389053784,1.0,15/53,14.29%,JAML;MNDA;AIF1;RGS2;CD14;FCER1G;NCF4;CD300LF;IRF7;TYROBP;CSF3R;CSF2RB;CASP5;PTPRC;MS4A6A
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.8617448736007143,-1.2946881801621544,0.1509433962264151,0.6814801390925844,1.0,1/6,0.74%,CCL3
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.7557668945619491,1.2946051135035248,0.20512820512820512,0.7336626826065248,1.0,3/7,7.04%,PFKP;PFKM;GFPT1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6897475410567048,1.2944745492819982,0.15555555555555556,0.7326823024196879,1.0,7/9,13.84%,PKD2;PKD1;PTCH1;NF1;NIPBL;CTSH;ROBO2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7584076447935734,1.2941363784453315,0.2682926829268293,0.7323844765421202,1.0,2/7,11.69%,TGFBR2;BMPR1A
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6405150372872805,-1.2931879940355733,0.09836065573770492,0.6864623978240083,1.0,2/23,1.57%,UBC;RPS27A
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.5531626844779931,1.2930757868637275,0.16666666666666666,0.7351090407258783,1.0,12/69,5.52%,NPAS3;KCNQ2;DPYSL5;IGF1R;CNTN2;NCAN;GFAP;ARNT2;SLC1A3;ZNF536;SNAP91;CSPG5
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.6090913863558285,1.2929211145684687,0.18604651162790697,0.7345215783516965,1.0,3/18,8.27%,PIR;PPARG;IKZF1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6193359680793239,1.2926681854433313,0.1,0.7340143202406507,1.0,5/31,5.97%,EGR1;KLF4;FGF2;PPARG;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.5442362716430996,1.2925730595969345,0.1111111111111111,0.7327325363467995,1.0,10/48,19.74%,CDKN2AIP;CIB1;HPN;TAF9B;MMP14;DDX3X;PPM1F;MTPN;CSNK2A1;TGFBR1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.521956946658444,1.2924121360173333,0.08,0.7319726162570328,1.0,8/36,9.71%,KCNQ2;DPYSL5;NCAN;SNAP91;CSPG5;PURG;VGF;LINGO1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.8897628438501399,-1.2922598576436395,0.12962962962962962,0.6903100879361249,1.0,2/5,5.20%,IL4I1;KMO
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.604927294991726,1.2922442358101336,0.2,0.7311642034905722,1.0,6/24,13.39%,SRCIN1;TGFA;RELN;GRM5;FBXW7;NTRK2
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.8126442310068718,-1.292135286149177,0.1206896551724138,0.6893396183590103,1.0,1/6,0.62%,SKAP1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.7936422531942402,1.2921176540150328,0.1320754716981132,0.7301789435921208,1.0,2/7,5.33%,CPT1C;CPT1A
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.6101590487647297,-1.29202010814014,0.1282051282051282,0.6885412288829601,1.0,3/43,6.78%,PKIB;PRKCQ;EXOSC10
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.46127540623544633,1.2914030307608104,0.07407407407407407,0.7314829711054611,1.0,24/93,12.65%,COL5A3;MMP17;COL16A1;PDGFA;SERPINE1;NCAN;FGF2;COL5A2;COL24A1;DAG1;SLC39A8;MMP16;ADAMTSL2;RECK;TNR;TEX14;COL15A1;ADAMTS17;ADAMTSL3;COL11A1;FBN2;NF1;ITGA2;MMP14
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.7423995717957187,1.2913663704076983,0.2127659574468085,0.7301935133381822,1.0,1/8,0.06%,LEPR
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.800272352241032,1.2911261282511304,0.1891891891891892,0.7296764696844896,1.0,4/6,18.46%,TWSG1;PCSK6;XIAP;SLIT2
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.8237671240088988,-1.2906424610462948,0.12280701754385964,0.6934692905768016,1.0,2/7,6.41%,NIT2;GLUL
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.557940616654998,1.2897457913792132,0.13793103448275862,0.7339089052220111,1.0,18/38,27.68%,PTPN9;EPB41;CIB1;PRKCI;ARF6;DPP10;TNF;EFCAB7;PLS1;SPTBN1;STX3;PIK3R1;WNK3;SORBS1;PRKCE;KIF5B;EPB41L2;CLIP3
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.7959860770244888,-1.289442918545403,0.09836065573770492,0.6973725960585448,1.0,3/7,11.55%,MEI4;IHO1;PTN
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.47093366835059225,1.2893648214020457,0.09090909090909091,0.7343799476775247,1.0,29/118,13.39%,SLC39A12;LGI4;SRCIN1;CNTN2;NCAN;GFAP;TSPAN15;HEPACAM;MYRF;MYO1D;NDRG2;ASPA;DPY19L1;FA2H;TPPP;SLC1A2;HAPLN2;CA10;PSD2;GRM5;TNR;MOBP;OLIG1;MPPED1;SNCB;PTPN5;GRIA2;KIF6;NTRK2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6987501556190586,-1.289229096506803,0.15384615384615385,0.6968303961513918,1.0,2/15,6.76%,RPS13;RPS26
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.7657468727530717,1.28898554305013,0.15555555555555556,0.7342389848210318,1.0,1/6,2.45%,SIRT1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.6578028460828135,-1.2889205519470401,0.1875,0.696740807325509,1.0,4/21,8.23%,PER3;PER2;BHLHE40;PPP1CB
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.8752506942053899,-1.2888062793098705,0.15625,0.695935626531558,1.0,1/6,0.43%,SYAP1
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.8304995178501671,-1.2884933249249597,0.1016949152542373,0.6960808090113939,1.0,4/8,9.00%,CCL5;THEMIS2;IKZF3;DCAF15
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7845389330449379,1.2884770714365892,0.21739130434782608,0.7345806406913216,1.0,2/6,17.12%,FBXW7;PIK3CA
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.801976903716424,1.288192421481938,0.21951219512195122,0.7342119486970423,1.0,3/8,10.56%,SLC39A14;SLC39A8;SLC40A1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.6055442558245177,1.2879365727085572,0.175,0.7340974269199981,1.0,2/14,2.08%,PKD2;FGF2
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.6839412313819104,1.287929202395273,0.19047619047619047,0.7326718625536968,1.0,7/12,22.81%,SHANK2;NPTN;GRIN2B;GRIN2A;SLC24A2;PLK2;TSHZ3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.630203194632367,1.2878520707440597,0.1,0.7315036348825584,1.0,4/23,6.54%,BAG3;ZDHHC3;SORT1;TNFRSF10A
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.8182749135656027,-1.2873168868650118,0.1206896551724138,0.700785988692817,1.0,1/8,2.51%,SNAPC1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.8268767318938942,-1.2872213076200971,0.15254237288135594,0.6999444787638157,1.0,1/8,1.71%,DUSP1
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5251268772760445,1.287072554634382,0.13333333333333333,0.7332792532571053,1.0,7/30,7.26%,ANXA1;PKD2;ZBTB1;MSN;NRG1;SALL1;PRKCSH
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.5130729016557873,1.2870271080610285,0.08695652173913043,0.7318636984522221,1.0,20/42,21.83%,SLC1A3;ANO4;SLC12A6;ANO3;GLRA1;ANO8;GABRR2;ANO6;SLC12A2;SLC12A5;GABRD;TTYH1;CLCN3;GABRA4;GABRG3;SLC4A8;GABRB1;GLRB;GABRA2;GABRB2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6891788030428804,1.286848472975585,0.21052631578947367,0.7310042063457364,1.0,5/11,23.97%,SLC9A1;WNK1;CHP1;GLRX;WNK3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.6060033929219226,-1.2866434430130094,0.12903225806451613,0.7007250936498183,1.0,4/31,6.63%,DDX11;DTX3L;PARP9;FANCB
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.6977245937244274,-1.2864038414871775,0.13793103448275862,0.700365110823417,1.0,3/16,14.15%,PLN;CALM1;CACNB1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6269018611797891,-1.2863579028081198,0.17142857142857143,0.6991674258772731,1.0,20/45,18.59%,RPL3;RPL23A;RPL5;RPL11;RPL10A;RPL7A;RPL14;NPM1;RPL10;RPL24;RPL6;NSA2;NOP53;TRAF7;SURF6;RPLP0;GTF3A;NHP2;RPL35A;LAS1L
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7174168673507714,-1.2856782758955003,0.1746031746031746,0.7011929622336052,1.0,2/15,6.30%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6789803716305024,-1.2853106786336104,0.15384615384615385,0.7017191746693605,1.0,4/18,12.57%,CD36;IRF7;IRF1;APPL1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.49634560625571217,-1.285045082241764,0.054945054945054944,0.7016544854206909,1.0,43/277,9.82%,CCL4;MT2A;STAT4;UBC;CD36;SIGIRR;CCL3;RIPOR2;CEBPD;ZFP36;CCL5;PYHIN1;PID1;GAPDH;RPS27A;CXCR4;GRAP2;PRLR;FOS;DUSP1;MNDA;JUNB;IFIT1;AIF1;RORA;DUOX1;RPL13A;AIM2;RHOU;IL10RA;IL12RB2;F13A1;CHI3L1;IL3RA;GBP3;RPS3;STK39;CSF2RA;OSMR;STAT1;IRF1;OAS1;TNFRSF1B
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.6081185440374928,1.2848625566530274,0.12903225806451613,0.7373656453985022,1.0,4/17,10.31%,FLVCR1;COX10;ALAD;RSAD1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.5218467616208836,-1.2846574702567022,0.0963855421686747,0.7018512453365078,1.0,32/120,11.20%,CCL5;ADGRE1;GPR183;BTG2;MARCO;CD55;CD69;IL7R;SELL;RGS1;TNFSF10;ADRM1;RGS16;CD14;IL10RA;EMP3;IRF7;SRI;RNF144B;TACR1;NAMPT;LY6E;OSMR;C5AR1;EIF2AK2;OLR1;IRF1;TNFRSF1B;IL18R1;GPC3;BEST1;SELENOS
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.8016331090549371,-1.2845161570305832,0.19230769230769232,0.7011674184616112,1.0,1/6,0.38%,MT2A
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.7305354198355151,1.2843319351282259,0.25,0.7383931029261982,1.0,1/6,1.22%,EPS8
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.7762451118418648,-1.2842798992501359,0.08620689655172414,0.7010391351964509,1.0,3/8,10.12%,CD300LF;PLSCR1;CD226
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.7485279656322867,-1.2841941785546316,0.11864406779661017,0.699970028463904,1.0,2/9,5.38%,LIPG;CLU
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.8242964388930147,-1.283577064492086,0.21818181818181817,0.7015291789501137,1.0,1/5,1.37%,CMPK2
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.5858271974741588,-1.2831750335058612,0.0945945945945946,0.7022254522261312,1.0,9/61,7.59%,DDX11;PYHIN1;EDF1;B2M;RPL11;DTX3L;IGF1;PARP9;MED25
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.656603726209927,-1.2831623174408298,0.140625,0.7009343473925479,1.0,2/18,5.02%,SLC2A3;CYB5A
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.7577777222684398,1.283076507012676,0.23529411764705882,0.7422774000360919,1.0,1/6,2.03%,TGFBR2
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.5137846090803467,1.2826275606286341,0.18518518518518517,0.7422485060313051,1.0,12/38,14.60%,PKD2;SCN3A;SLC9C2;SCN3B;SLC4A4;SCN8A;SLC9A1;ANO6;SLC9A9;SLC8A1;SLC24A2;SLC12A2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.6534073820252367,1.2826174294529604,0.2222222222222222,0.7409063680201492,1.0,9/11,29.08%,PTEN;NTRK2;MAP2;RAPGEF2;ARHGAP35;B4GALT5;GBA2;B4GALT6;MAPT
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.6338359723254858,1.2819758819934046,0.08888888888888889,0.7416964083562251,1.0,1/21,0.06%,SHROOM3
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.6854702200797742,1.2819118197426935,0.2619047619047619,0.7407061124721455,1.0,3/5,21.23%,NIPBL;FGFR2;BBS7
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6980231433624251,1.2816975734909304,0.2,0.7401384655658336,1.0,1/10,0.77%,ACER2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.5710909495825449,1.2816069769258243,0.22857142857142856,0.7393271129140452,1.0,8/20,20.82%,PPP1R10;YLPM1;SIRT6;ERCC4;HNRNPD;NBN;USP7;ERCC1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.6010337305079531,-1.2815905568652715,0.14925373134328357,0.7069758106583379,1.0,3/43,0.70%,FLNA;SKAP1;CD36
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.7671236292228799,-1.281318698111966,0.1568627450980392,0.7068860584868636,1.0,2/9,6.78%,RPS21;EXOSC10
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7680232368461992,1.2810541386611234,0.06521739130434782,0.7400895710120253,1.0,2/8,4.17%,SIRT1;HDAC9
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.737706355319251,-1.2809185786670305,0.12280701754385964,0.7076790036191414,1.0,4/12,12.12%,CLU;AQP11;NR1H2;LPCAT3
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.8359452691152249,-1.2808303286679166,0.14,0.7068196700879403,1.0,2/6,5.67%,MYLK;EMP3
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.8625377678448141,-1.2804236581143458,0.10416666666666667,0.7074179327208766,1.0,1/7,0.99%,TOMM7
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.7693806757872952,1.2803481293692456,0.23076923076923078,0.7398699151080537,1.0,3/7,13.17%,NRP1;ALCAM;SLIT3
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.7693806757872952,1.2803481293692456,0.23076923076923078,0.7398699151080537,1.0,3/7,13.17%,NRP1;ALCAM;SLIT3
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.6259297507604165,1.2803310749954127,0.14285714285714285,0.7384796511357086,1.0,6/13,19.00%,MPDU1;ALG12;MVD;ALG3;NUS1;ALG8
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.655598752945055,-1.2803234423579133,0.1774193548387097,0.7067218866114993,1.0,2/17,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.8118057081989535,-1.2802666531771794,0.1896551724137931,0.7056463989814341,1.0,1/6,0.70%,CD36
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.5883716117892077,1.2802154130442167,0.10810810810810811,0.7375087232447759,1.0,3/27,7.81%,ACER2;WNT5A;BRINP3
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.46092785493628324,1.2801640722787004,0.13333333333333333,0.7364442609262165,1.0,39/160,14.04%,IL1RAPL2;CDK5R1;PKD2;QARS1;GSN;NCAN;MAP1S;AATK;TGFBR2;ZBTB16;ARNT2;MYRF;PKD1;PBX1;RELN;TPPP;PPT1;PDGFC;PLXNB2;LIG4;HAPLN2;CA10;SH3GL3;POU6F2;PTCH1;NFIB;ALDH5A1;GRIN2B;NPTX1;PTEN;SH3GL1;ELP3;CNTN4;NF1;RPS6KA6;BAG6;NIPBL;ROBO2;GRIN2A
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.7688725917184502,-1.2801205453033584,0.18867924528301888,0.705019928488764,1.0,2/8,6.40%,PID1;CHI3L1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.45952985982545635,1.2800244828592418,0.0,0.7355779426860014,1.0,20/76,15.09%,FLVCR1;PDPN;SLC7A8;RCN3;SLC3A2;SCAMP4;PPT1;LMAN2L;SLC44A2;SCARB2;ARRDC3;SLC15A4;RAMP1;RAB7A;SLC19A2;SLC44A1;SLC7A11;SLC35F3;SLC12A2;CHMP1A
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7416204714645347,1.2795721965410576,0.15,0.7359257146071821,1.0,2/8,7.98%,FZD3;BOK
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.8533474995383565,-1.2792927256807733,0.1111111111111111,0.7075044204516032,1.0,2/6,7.33%,CD14;IRF7
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.766941789473889,1.2791643954871252,0.1702127659574468,0.7359579568081508,1.0,3/8,13.92%,PICALM;NEDD4L;LEPROTL1
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.7916845659967386,1.2790710120099706,0.125,0.7350009728374116,1.0,2/5,15.24%,RNF20;CDK9
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5709314375580621,-1.2788425162732757,0.12162162162162163,0.7081115509322274,1.0,17/77,13.34%,MYLK;PROCR;CD36;SRGN;MGLL;SLC7A5;CD55;F8;PECAM1;ETS1;CD93;SGK1;PCDH12;SPARCL1;ABCA8;A2M;CDKN1C
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.6143442438752705,-1.278662795263993,0.08823529411764706,0.7077051754849867,1.0,8/39,19.46%,ZFP36;NUDT12;EXOSC10;HSPA1B;HSPA1A;DDX5;NUDT16;PNPT1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.6024749871155239,1.2786183587689224,0.17777777777777778,0.7351793120247895,1.0,2/15,2.08%,PKD2;FGF2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6915488362562039,-1.2784677597439256,0.11764705882352941,0.7072845631769666,1.0,8/15,22.49%,ATP5F1E;ATP5PD;ATP5ME;VPS9D1;ATP5F1D;STOML2;ATP5F1C;ATP5MC2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7752651024338088,-1.2783629153705947,0.14035087719298245,0.7064562781002485,1.0,4/11,15.49%,HLA-B;HLA-F;HLA-DRA;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.7506371529780573,1.278202193547519,0.23255813953488372,0.7353810131315587,1.0,2/6,17.31%,RAP1A;SYT4
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7942021663638181,1.2781002579156147,0.20833333333333334,0.734454498621647,1.0,2/5,8.12%,MFNG;DOCK10
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7333263370638454,1.2780069277837924,0.16326530612244897,0.7335075172664226,1.0,1/7,5.44%,UGDH
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7277785169822857,-1.2780029764134506,0.15384615384615385,0.7065109265727276,1.0,3/15,3.00%,RSAD2;CD55;B2M
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.6826417291111251,1.2778994760314384,0.20512820512820512,0.7324445896094248,1.0,4/12,13.58%,EFL1;LRRK2;MFN1;AK3
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.533543218061238,1.2778824286798356,0.1,0.7310755343017437,1.0,13/45,14.39%,PTPN9;LRP4;NLGN1;BCL11A;CIB1;KANK1;LINGO1;DCC;PTEN;BAG5;FKBP4;RTN4;ADCY6
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.7070817083676515,-1.2772944396749395,0.0847457627118644,0.7086039765968551,1.0,8/13,22.25%,AIF1;PLEK;CORO1B;PLEKHA1;RAC1;INPP5K;CARMIL1;TPM1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.7131416194795528,-1.277221695465478,0.13114754098360656,0.7076370039880074,1.0,2/13,6.78%,SSB;EXOSC10
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.6511680948897421,1.2771005409053842,0.17647058823529413,0.7324734819584463,1.0,8/15,26.51%,RUVBL2;CHMP7;NIPBL;ESR1;MACROH2A1;LEMD2;WAPL;MCM9
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.525412416088888,1.276875281515756,0.0967741935483871,0.7322026662532893,1.0,8/40,14.38%,ANXA1;RCN3;RAB10;SEL1L;COPG1;PREB;PTPRN;STEAP3
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.8020085030544315,1.2764828401019102,0.17857142857142858,0.7325496013441721,1.0,2/5,5.91%,RAP1A;RIN2
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.8110979537370981,-1.2760038718779572,0.09090909090909091,0.7122354223239897,1.0,2/9,3.00%,HAMP;B2M
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.7610856657609044,-1.275986696998561,0.16129032258064516,0.710953406351972,1.0,1/14,0.35%,DDX11
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.8270131964588181,-1.2759581313280914,0.15254237288135594,0.709769553796321,1.0,1/6,4.93%,LPCAT1
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.710786029353346,1.275696686113095,0.19047619047619047,0.7340790948921855,1.0,2/12,4.49%,PPARGC1A;SLC25A18
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.519366921957634,1.275669436775087,0.11538461538461539,0.7327905883696343,1.0,19/44,22.59%,POLR2D;FGF2;SPRED1;SPRED2;FLRT1;FLRT2;MAPK1;SHOC2;POLR2H;RAB14;RBFOX2;FGFR1;FGFR2;POLR2C;FRS2;CBL;FGFR3;ANOS1;HNRNPH1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.5458590438302205,1.275603410320996,0.08333333333333333,0.7317427391276009,1.0,23/42,22.71%,NETO1;NLGN1;RELN;SHISA9;NPTXR;GRIA3;GRIA4;GRIA1;GRIN2B;NPTX1;CACNG2;GRIA2;PRRT1;GRIN2A;CACNG8;DLGAP1;DLGAP4;CACNG3;CNIH3;CAMK2B;DLG2;DLGAP2;GRIN1
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),-0.8262698194863085,-1.2751171441025728,0.18518518518518517,0.7126915664850725,1.0,1/5,1.12%,ZFP36
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.7799727969096297,-1.2748318680995572,0.16666666666666666,0.7125633596961886,1.0,2/10,9.27%,CD36;C5AR1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.7170235850700155,1.2747484275978356,0.25,0.7321028791018922,1.0,2/7,11.35%,LRRK2;MAPK1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.7170235850700155,1.2747484275978356,0.25,0.7321028791018922,1.0,2/7,11.35%,LRRK2;MAPK1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.7004961501543818,-1.2744533785770151,0.22580645161290322,0.7128225854837215,1.0,2/19,0.82%,FLNA;RIC3
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.7590135470272201,1.2744497445241434,0.21739130434782608,0.7316720143338532,1.0,4/8,18.26%,GRID2;SHANK3;KCNB1;AGER
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.7144144438238729,1.274438149511732,0.2631578947368421,0.7303529131287846,1.0,1/8,0.86%,VAMP1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5989449132574118,-1.2737573318437982,0.17333333333333334,0.7144867755507487,1.0,16/47,18.17%,SKAP1;CCL5;RSAD2;PLSCR1;CD226;KARS1;ITGB2;IFI35;HLA-DRA;CYBA;PTPRC;NOD2;TASL;POLR3C;HLA-DMB;CD74
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.8558699702466687,-1.273732462149561,0.1694915254237288,0.7119321123544982,1.0,1/5,1.12%,ZFP36
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.8558699702466687,-1.273732462149561,0.1694915254237288,0.7119321123544982,1.0,1/5,1.12%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.8073018905808782,1.273541313990625,0.17391304347826086,0.7318434476581309,1.0,1/5,4.45%,BACE2
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.6948015535259785,1.273443984851679,0.2826086956521739,0.7309721381586282,1.0,5/6,27.87%,TNF;TNFRSF1A;RIPK1;TRAF2;TRADD
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.6435737220752616,1.273254972651503,0.10810810810810811,0.7304067534172065,1.0,9/18,15.47%,CACNA1A;SCN3A;SCN3B;SCN8A;CACNG2;CACNA1B;CACNA1E;P2RX7;CACNB4
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5323072751843205,1.2731871569425037,0.17647058823529413,0.7293552698788474,1.0,5/36,6.33%,ANXA1;FGF2;SIRT1;HDAC9;CIB1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.7730108018978579,1.2728813794866116,0.11904761904761904,0.729119728126087,1.0,2/8,8.04%,ACTA2;TMEM79
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.634089550785036,-1.2728011846519287,0.18333333333333332,0.7149869311526094,1.0,2/22,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.7194123040044352,1.2724558419590604,0.21568627450980393,0.7290240089303768,1.0,2/6,14.76%,IDI1;MVD
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.5261397101423907,-1.2721153205324849,0.0975609756097561,0.7172023790490679,1.0,13/72,14.28%,CD36;CXCR4;DHX58;MGLL;TRIM5;CD55;TMSB4X;CALM1;IRF1;ERAP1;APPL1;CASP5;EFNB2
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.47795013600470304,1.2719222274046422,0.10344827586206896,0.729622215759189,1.0,6/47,8.92%,UBE2D1;KBTBD6;UBE2E2;RNF6;UBE2D2;NEDD4L
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.7389211409899831,1.2718904765002395,0.24489795918367346,0.7284412915813767,1.0,4/7,19.82%,IMPA1;IPPK;PPIP5K1;ISYNA1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.7453733698364409,-1.271887913365994,0.1864406779661017,0.7169144721940364,1.0,2/11,4.95%,DDRGK1;DNAJB9
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.7480613458296461,1.2712351376259683,0.14285714285714285,0.729706430130884,1.0,1/8,1.95%,UBIAD1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7393397357422989,1.270922661774598,0.25,0.7293804003028546,1.0,5/7,25.03%,NEDD4L;WNK1;NEDD4;WNK3;CAMK2D
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.852837475241542,-1.270822285136797,0.18,0.7192092523112326,1.0,1/5,0.77%,RPGRIP1L
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.852837475241542,-1.270822285136797,0.18,0.7192092523112326,1.0,1/5,0.77%,RPGRIP1L
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.725080160484765,-1.2707509812293478,0.2028985507246377,0.7182341577102372,1.0,3/10,9.70%,OAS3;NLRC5;OAS1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.7345044494697317,-1.2706833843961385,0.11290322580645161,0.7173993808786406,1.0,6/17,12.02%,CARD16;LILRB4;IGF1;GSTP1;TNFAIP3;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.6261873866754816,-1.2703347658960775,0.12903225806451613,0.7177356705823253,1.0,10/36,10.67%,BTN3A1;CD2;SLC7A5;SLAMF6;TXK;CD14;IL12RB2;BTN3A2;CD226;IL18R1
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.7285311494657913,-1.2700979019736596,0.13432835820895522,0.7173439342704903,1.0,2/8,2.75%,MX2;MX1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.7865665014566999,1.269656006271463,0.23076923076923078,0.7329575500554218,1.0,2/6,14.29%,FNBP1L;SMURF1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.6427288715618772,-1.2691415653791307,0.10144927536231885,0.7201427622485357,1.0,6/31,9.39%,DYNLT1;B2M;PER2;BHLHE40;ZNF335;PRUNE1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.7460697471546287,-1.2690345042107392,0.15384615384615385,0.7193256547127794,1.0,1/13,0.09%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.7080834787705558,1.268944442243048,0.2619047619047619,0.73439106057342,1.0,2/9,8.94%,SIRT1;HDAC1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5614076329904755,1.2688628272670381,0.07692307692307693,0.7333493961115645,1.0,8/27,20.91%,TRPC1;NPR2;SLC8A1;AHCYL1;FXYD7;RYR2;TMEM65;RYR1
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.7865546628916722,-1.2688536006479683,0.17307692307692307,0.7189030511047103,1.0,1/9,1.60%,CXCR4
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.7227662513037701,-1.2686665133286414,0.16417910447761194,0.7185721649963913,1.0,2/13,0.70%,OSBPL5;CD36
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7706568653028711,1.2686401051901004,0.08571428571428572,0.7328137141103472,1.0,4/6,19.10%,RFX3;CLOCK;GSK3B;FOXO1
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7135498654338549,1.2682345252750984,0.23809523809523808,0.7333510297338856,1.0,5/11,15.91%,INPP1;IMPA1;PTEN;NUDT3;INPP5A
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.7759694103198818,-1.2681483481109455,0.21052631578947367,0.7195329745136749,1.0,3/6,19.32%,WARS1;PUM3;HPF1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.7248180139093325,1.2679583775360743,0.17142857142857143,0.7330219902434055,1.0,1/7,0.33%,COL16A1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6493267429369665,1.2678368828167101,0.2631578947368421,0.7320128837633096,1.0,2/16,1.60%,NRP1;SEMA5A
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.8051372041423426,-1.2676185236536188,0.21153846153846154,0.7208198784706186,1.0,1/5,3.05%,SSB
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5066496248158499,1.267254026109351,0.043478260869565216,0.7328207698563586,1.0,19/52,19.74%,CDK5R1;TGFBR2;CDK10;GALNT13;LRRK2;MAP2K1;GALNTL6;NLK;MAP3K10;DYRK1A;WNK1;MAPK1;GALNT1;GSK3B;GALNT2;ULK1;MARK2;CSNK2A1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.7572371306320022,-1.2669117933474725,0.18867924528301888,0.7226255055775589,1.0,3/6,14.25%,KLRD1;NCKAP1L;PTPRC
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.7797098775703364,1.2669009507375744,0.3111111111111111,0.7329469688938556,1.0,3/5,19.74%,PTCH1;BMPR1A;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.7209607567145399,-1.2664815554068976,0.21875,0.723409749153208,1.0,4/14,11.76%,IL4I1;BANK1;SAMSN1;TNFAIP3
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.642858592718413,1.266298992270526,0.20930232558139536,0.7336599925309705,1.0,4/12,16.31%,PTCH1;BMPR1B;NIPBL;MEGF8
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.6577444322967954,-1.2658485030567497,0.21621621621621623,0.7250702323940809,1.0,7/26,7.83%,CXCR4;PARP14;TXK;NLRC5;CD300LF;PARP9;HSPA1B
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.6438462488853678,1.2657613974859447,0.13725490196078433,0.7340773797799163,1.0,6/16,20.29%,SCN3B;NEDD4L;SLMAP;FXYD5;FXYD7;SCN1B
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.7380065500254569,1.2656830270310733,0.15789473684210525,0.7330753105888221,1.0,2/9,10.59%,SEMA5A;PRKX
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6100080572930353,1.2651109163759737,0.23529411764705882,0.7339191506569629,1.0,4/14,13.18%,DDIT3;BOK;RNF185;BAG6
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5934491937219478,-1.2646520764551696,0.10606060606060606,0.7294613274877941,1.0,5/42,5.44%,UBC;CD36;RPS27A;CTSB;CD14
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7808830724616401,1.2645353455775066,0.21739130434782608,0.7335157504519136,1.0,4/5,18.45%,GPHN;CACNG2;CACNG8;CACNG3
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7808830724616401,1.2645353455775066,0.21739130434782608,0.7335157504519136,1.0,4/5,18.45%,GPHN;CACNG2;CACNG8;CACNG3
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.8099563408753258,-1.264528501027242,0.14814814814814814,0.7289376500492536,1.0,1/6,3.06%,PER2
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.680392393264815,-1.264245954915529,0.15384615384615385,0.7290975338905386,1.0,4/20,10.26%,CENPU;NPM1;CENPV;ITGB3BP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.7366672833115333,-1.264213335990296,0.10606060606060606,0.7279254432055285,1.0,4/13,12.54%,AIF1;PTN;NCKAP1L;VEGFA
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.8170272318434824,-1.2640544078335418,0.1896551724137931,0.7273186512686716,1.0,2/7,12.29%,SHFL;MTRF1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6005750080181732,1.2639783521230825,0.13953488372093023,0.7342649856332707,1.0,3/20,4.41%,LRP4;ZBTB16;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.5058139761169151,1.263581164336082,0.17857142857142858,0.7343868947965075,1.0,25/72,16.32%,SERPINE1;SRGAP2B;SMAD7;MITF;DLG5;JAG1;DAG1;DACH1;TMEFF2;VCL;ROBO1;RECK;CRK;KANK1;PTPRK;PTEN;CCDC125;RNF20;NF1;AFDN;GTPBP4;FRMD5;SRGAP2;RAP2C;SPOCK3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7175828010055249,-1.2635164318223644,0.24561403508771928,0.7284976905908622,1.0,5/11,12.04%,CYCS;COX7C;COX5B;COX4I1;COX6C
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.6683493109100259,1.2632328610307608,0.2222222222222222,0.7345306504505733,1.0,1/11,0.36%,ANXA1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5475010958157442,-1.2626978624526781,0.0684931506849315,0.7307909407255966,1.0,10/66,13.24%,CALCR;TFRC;PAQR3;RACK1;DDIT4;PRKD2;MTCP1;CD44;VEGFA;CAMK1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.7717809291134443,-1.2625067344804,0.19117647058823528,0.7302998274796894,1.0,1/12,0.40%,IL4I1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.6915842854710489,1.2621482406272222,0.24390243902439024,0.7368527589455784,1.0,3/9,7.50%,NRP1;FGF2;ROBO1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.6368855300253682,1.2620774094218388,0.23809523809523808,0.73588199937524,1.0,4/16,3.61%,PDPN;FGF2;RCN3;PKD1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.6287240344050953,1.2616726135185643,0.18604651162790697,0.7360888786424545,1.0,4/13,13.39%,DESI2;SAE1;UBA1;UBA2
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.5669545105627676,1.2614830564930843,0.14285714285714285,0.7340496830833881,1.0,2/15,1.62%,PFKP;PFKM
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.5669545105627676,1.2614830564930843,0.14285714285714285,0.7340496830833881,1.0,2/15,1.62%,PFKP;PFKM
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.821851363571162,-1.2612842420065589,0.22,0.7351186829344892,1.0,2/8,7.71%,PLN;SRI
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.7882291264659566,-1.261027864524926,0.22058823529411764,0.7349437462221157,1.0,1/5,2.44%,PPP1R15A
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.7968207748535575,1.2609908166314299,0.13953488372093023,0.7344349846978603,1.0,1/5,9.30%,BRSK1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.6335564607276062,-1.260278877424799,0.13793103448275862,0.7372389150946904,1.0,2/18,9.14%,DYNLT1;LLGL2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.4592969858432504,1.2601312534312656,0.19230769230769232,0.7364031882811587,1.0,23/91,12.65%,COL5A3;MMP17;COL16A1;PDGFA;SERPINE1;NCAN;FGF2;COL5A2;COL24A1;DAG1;SLC39A8;MMP16;ADAMTSL2;RECK;TNR;COL15A1;ADAMTS17;ADAMTSL3;COL11A1;FBN2;NF1;ITGA2;MMP14
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.5479127677998465,-1.2600277331711338,0.08974358974358974,0.7374401478518794,1.0,9/56,9.27%,CALCR;CD36;CXCR4;CD55;FIS1;ACKR4;TRPM4;TACR1;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.6349958457434017,1.2599326911624509,0.22727272727272727,0.7357946728575167,1.0,3/11,12.18%,MSN;PTPN23;SORL1
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.7878241613998285,-1.2591106472087028,0.22727272727272727,0.7405966590364305,1.0,2/7,6.94%,SKAP1;PLEK
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7087193166435564,1.2590704276499298,0.20833333333333334,0.7372275144527699,1.0,5/10,10.55%,LRP4;CNTN2;NLGN1;PTPRD;PTEN
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.7484979027565105,1.258797513885466,0.25,0.7369699122809628,1.0,1/5,1.12%,DPYSL5
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.7485458740201055,1.2585308890821894,0.21621621621621623,0.7365820773333243,1.0,3/5,12.74%,PTAR1;PGGT1B;CHM
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.7398722467228076,-1.258434282664858,0.19047619047619047,0.7423903289629546,1.0,2/9,7.18%,DNAJC19;PHB2
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5623175075878526,-1.2580746843545314,0.11428571428571428,0.7428137448478864,1.0,9/65,9.70%,OAS3;GAPDH;DHX58;OAS2;CD14;IRF7;STAT1;IRF1;OAS1
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.7818789597022517,1.2578795021631486,0.28846153846153844,0.737657182774038,1.0,1/6,5.48%,FZD3
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.7291898666729703,-1.2576952869074536,0.23333333333333334,0.7430908354245953,1.0,3/10,8.99%,HLA-B;HLA-F;KLRD1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6781733953800103,1.2573574621722454,0.2222222222222222,0.7371440252459805,1.0,1/10,0.88%,RRAGD
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6781733953800103,1.2573574621722454,0.2222222222222222,0.7371440252459805,1.0,1/10,0.88%,RRAGD
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.766916959508576,-1.2573354350847525,0.16393442622950818,0.7436706420014837,1.0,5/7,15.74%,B2M;TAP1;ERAP1;ABCB9;ERAP2
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.801920317837275,1.2569263926212384,0.27906976744186046,0.7375615745789053,1.0,2/5,17.03%,LRRK2;ATP13A2
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.7429485378061124,-1.2566305984893449,0.25757575757575757,0.745576532862889,1.0,2/9,7.15%,HLA-B;LGALS1
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.6971317777615934,1.2562180573306916,0.175,0.7384977138660749,1.0,6/8,26.91%,RAB7A;RAB14;RAB7B;ARL8B;RAB20;PIKFYVE
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.8039318998574204,1.255748641722064,0.23809523809523808,0.7390413349924626,1.0,3/6,17.03%,SLC7A8;UNC80;ATP13A2
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7686819880281895,1.2554573003227323,0.17777777777777778,0.7386114014099324,1.0,3/5,20.22%,PRKAA1;SNCA;SCAP
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.6630881035384755,-1.2552768521082271,0.21875,0.7499977486589287,1.0,3/31,3.06%,INSIG1;CH25H;PER2
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.779534677827646,-1.255225530008532,0.2033898305084746,0.7489226652819121,1.0,5/7,16.15%,DUOX1;NCF4;NCF2;CYBA;ALOX12
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.523571246570787,-1.2550120841385402,0.1,0.7487560393868988,1.0,20/80,24.47%,PSMB3;FCER1G;PSMA7;PSMB9;PSMB6;KLRD1;FYN;PSMA5;TYROBP;PSMC4;PSMD8;PSMD12;PSME2;PSMA3;PSME1;CLEC7A;PSME3;PSMB5;LYN;PSMC3
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.7942340818030432,-1.2548659889170264,0.140625,0.7481025378317403,1.0,2/7,6.20%,EPN1;SEMA6A
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.5251678632685052,-1.2548569757504264,0.08695652173913043,0.7455877853285934,1.0,20/79,24.47%,PSMB3;FCER1G;PSMA7;PSMB9;PSMB6;KLRD1;FYN;PSMA5;TYROBP;PSMC4;PSMD8;PSMD12;PSME2;PSMA3;PSME1;CLEC7A;PSME3;PSMB5;LYN;PSMC3
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.5251678632685052,-1.2548569757504264,0.08695652173913043,0.7455877853285934,1.0,20/79,24.47%,PSMB3;FCER1G;PSMA7;PSMB9;PSMB6;KLRD1;FYN;PSMA5;TYROBP;PSMC4;PSMD8;PSMD12;PSME2;PSMA3;PSME1;CLEC7A;PSME3;PSMB5;LYN;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.7333718294954963,-1.254610643453926,0.1694915254237288,0.7452996181359111,1.0,3/11,10.12%,RPS3;PRKD2;CD226
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.7858335723174144,-1.2545843560583179,0.16363636363636364,0.7441865713557517,1.0,2/6,8.87%,CORO1B;ENPP2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5780662682210338,1.2539642739786707,0.2,0.7424943586744726,1.0,7/34,10.48%,ARSA;ABCA2;LARGE1;GLB1;ST6GALNAC3;ST8SIA5;ST6GALNAC5
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5451464467930643,1.2537369736667223,0.18421052631578946,0.7418663645950445,1.0,17/40,19.39%,PDPN;TCF7L1;WNT5A;CDH11;GPR161;P3H2;FERMT2;ENAH;FBXL7;CD276;RAI14;CXCL14;ANTXR1;TNC;SLIT2;SNX7;ZNF462
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.6491969954316852,-1.2537017542435405,0.17142857142857143,0.7455904293966058,1.0,1/18,1.96%,GZMB
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.6491969954316852,-1.2537017542435405,0.17142857142857143,0.7455904293966058,1.0,1/18,1.96%,GZMB
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.48702040541657426,1.2536256805578834,0.13333333333333333,0.7410041542780278,1.0,4/38,4.08%,TULP2;PCDH15;RP2;CRYGS
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5304910756111989,1.253600161767053,0.06451612903225806,0.7398660116453882,1.0,5/44,2.28%,COL5A3;COL16A1;SVEP1;COL5A2;ACTA2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.6067827302874169,-1.2535061415673365,0.14084507042253522,0.7452900448100171,1.0,3/42,1.68%,CALCR;ADGRE1;ADGRD1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4817445176006961,1.2532256344164387,0.08333333333333333,0.7396096013041864,1.0,20/68,12.87%,UBE2D1;ACVR2A;TGFBR2;SMAD1;SPRY2;SIRT1;SMAD7;SPRED1;SPRED2;PPARG;SMAD3;SMAD2;SPART;ADAMTSL2;LEMD3;BMPR1B;BCL9L;BMPR1A;SORL1;ZNF451
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.6724390151286777,1.2529962806364539,0.2692307692307692,0.7392899200215574,1.0,4/13,11.51%,ABCA2;ASXL3;FBXW7;ACADVL
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.7282813041923968,-1.2527650180891923,0.22727272727272727,0.7471544972735452,1.0,7/11,21.70%,PARP14;PARP15;PARP9;PARP11;PARP4;PARP12;PARP8
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7361024545244294,-1.252701428099533,0.13432835820895522,0.7461606678103168,1.0,6/8,25.83%,ZWILCH;MIS12;IK;BUB3;CHAMP1;KNL1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.544321189456651,1.2525335307461416,0.09375,0.7394194667850268,1.0,13/50,11.14%,VAPB;ACER2;PPM1L;LARGE1;PLPP1;FA2H;SPTLC2;HACD2;ELOVL6;ST8SIA5;ST6GALNAC5;SAMD8;SPTLC3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.7993784559900655,1.2523371507563477,0.18181818181818182,0.7390159492199243,1.0,3/6,12.52%,E2F3;PPARG;SOD2
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.7780642276551568,-1.2523125474693697,0.2608695652173913,0.7469602449602041,1.0,5/9,8.99%,MYO1G;CD55;BTN3A3;BTN3A2;KLRD1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.8292922402335132,-1.2521507545755892,0.25396825396825395,0.7463077973182206,1.0,3/5,10.08%,GSTM4;ACAA1;GSTM3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5070461590204496,1.2513488915402058,0.12,0.7413575760912452,1.0,15/55,15.70%,B3GNT2;POGLUT3;LARGE1;GALNT13;GALNTL6;TMTC2;FKRP;POGLUT1;C1GALT1;GALNT7;GXYLT1;FKTN;GALNT1;EOGT;GALNT2
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.731492193240779,1.251242496182327,0.2037037037037037,0.7405274890991775,1.0,2/8,5.56%,PIR;PPARG
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7557109215030934,-1.2504277502171675,0.203125,0.7524003626289749,1.0,4/9,9.25%,PARP14;PARP15;PARP9;PARP2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.74571206910032,-1.249920250531163,0.12903225806451613,0.7532275176900267,1.0,4/11,12.00%,B2M;ACTG1;ACTB;SOD1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.47702482949565767,1.2495527647749272,0.17857142857142858,0.7454875138861872,1.0,26/86,19.00%,B3GNT2;LARGE1;B4GALT7;MGAT4C;SLC39A8;GFPT1;FUT9;POGLUT1;GALNT7;ST8SIA5;FKTN;ALG12;STT3B;ST8SIA4;GALNT1;MGAT5;EOGT;COG3;GALNT2;TMEM165;MAGT1;GCNT2;ALG3;NUS1;MGAT4B;ALG8
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.5489681959587327,-1.2495331379232537,0.1232876712328767,0.7537298906512556,1.0,17/52,16.86%,BTN3A1;CD2;SLC7A5;SLAMF6;TXK;CD14;IL12RB2;LILRB4;BTN3A2;CD226;IL18R1;CD47;C1QBP;SLC11A1;HLA-DPA1;HAVCR2;IL1B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8516356018106246,-1.2494007612538924,0.12280701754385964,0.7519946724487796,1.0,3/5,7.14%,HLA-B;HLA-C;HLA-F
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8516356018106246,-1.2494007612538924,0.12280701754385964,0.7519946724487796,1.0,3/5,7.14%,HLA-B;HLA-C;HLA-F
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.699103894130988,-1.2492306047740576,0.18181818181818182,0.7514935938343724,1.0,3/14,12.26%,IFIT1;NPM1;STING1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.6799853503815751,-1.2489020758558707,0.2459016393442623,0.7517451768855778,1.0,2/12,8.13%,PHKG1;CALM1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.5072302740405733,1.248729501083505,0.14285714285714285,0.7473623157918668,1.0,5/65,6.61%,TULP2;SIRT1;NPHP1;SNAP91;MAST2
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.6226744316158439,1.2486170557448812,0.23684210526315788,0.7465475390296783,1.0,5/17,11.35%,MSN;PTPN23;MAP2K1;SNX12;MAPK1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.69598318071493,1.2485346747403192,0.22727272727272727,0.7443363958164749,1.0,7/10,18.76%,IL1RAPL2;PTPRD;GPC6;LRRC4B;LRFN5;IL1RAPL1;SNCA
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.69598318071493,1.2485346747403192,0.22727272727272727,0.7443363958164749,1.0,7/10,18.76%,IL1RAPL2;PTPRD;GPC6;LRRC4B;LRFN5;IL1RAPL1;SNCA
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.6646321300482285,-1.248499919138585,0.13636363636363635,0.752481871037547,1.0,7/27,15.43%,AIF1;CLU;CD93;C5AR1;ITGB2;IFI35;SLC11A1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.6583482387270152,1.2484808063873076,0.20512820512820512,0.743299361751116,1.0,3/10,13.70%,ST6GALNAC3;ST6GALNAC5;ST8SIA4
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.5816706773204479,-1.248306726860211,0.12857142857142856,0.7521903949834495,1.0,9/45,12.17%,TPD52;GPR183;BTK;DNAJB9;SLC25A5;PHB2;BANK1;TCF3;ITGA4
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.6556746828501012,-1.2482458771138667,0.16071428571428573,0.7511941346737664,1.0,3/22,9.64%,SSB;EXOSC10;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6683291362036312,-1.2482317871853914,0.12280701754385964,0.7499801221771402,1.0,3/15,7.84%,AIF1;DUOX1;SPOCK2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.7340056484764783,-1.2481947723707807,0.20634920634920634,0.7488390790873305,1.0,2/9,14.46%,VEGFA;C1QBP
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.6891070883642113,1.2481924927852648,0.25,0.7429793954909572,1.0,4/15,5.44%,HS3ST5;CSGALNACT1;HS2ST1;UGDH
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.7926881219838631,-1.2479591288407936,0.19230769230769232,0.7487620725600517,1.0,1/8,0.70%,CD36
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.7532148115632646,-1.24790255603551,0.171875,0.7476817750035095,1.0,3/7,15.75%,NT5C;HINT1;GPX1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6361597273496781,-1.247503630659269,0.23076923076923078,0.7484852967061448,1.0,9/18,19.23%,MDH2;UQCRB;UQCRH;UQCR10;NDUFS8;OXA1L;UQCRC1;ATP5F1D;NDUFS7
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.5903549371631285,1.2471124998146357,0.14705882352941177,0.7454265969351642,1.0,8/22,17.01%,SEMA5A;NRG1;SEMA3B;PHACTR4;ERBB4;KLHL12;SEMA4D;NOLC1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.7033190747667009,1.2469395932994187,0.23809523809523808,0.7448949816940568,1.0,1/9,1.12%,DPYSL5
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.7479302191181024,-1.2465191387364138,0.22413793103448276,0.7520129038038378,1.0,2/9,14.08%,ADRM1;OTUD6B
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8043862272481006,1.2464734219335747,0.21428571428571427,0.7453259011154229,1.0,4/5,17.58%,SALL1;SHANK3;ERBB4;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.7660397475850409,-1.245957201471874,0.1896551724137931,0.7532444566279691,1.0,3/12,6.30%,PER2;H1-0;IGF1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5437751683544084,-1.2459153283130704,0.15492957746478872,0.7522185250102965,1.0,19/81,12.60%,FLNA;CD36;SRGN;F8;CLU;PECAM1;F13A1;TTN;IGF1;TMSB4X;PLEK;CD63;CALM1;FERMT3;SELENOP;GTPBP2;SOD1;VEGFA;A2M
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.6836329131966844,-1.245883320926649,0.1320754716981132,0.751182305588591,1.0,4/17,8.26%,CCL3;CCL5;IGF1;THEM4
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.7495629848122378,-1.2458460692135296,0.23636363636363636,0.7500813972471884,1.0,1/6,12.36%,ING4
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.729953169267022,-1.2456035030076502,0.16666666666666666,0.7501256887980003,1.0,3/7,6.88%,DDRGK1;TMSB4X;LAMTOR5
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.7558765651091714,-1.2454112022345338,0.2978723404255319,0.749871326291237,1.0,2/5,15.32%,CFL1;IGF2R
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.6980562874240523,-1.2453379287231452,0.15384615384615385,0.7490352820654971,1.0,3/16,3.18%,PRKCQ;SLC7A5;SLAMF6
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.770549883981797,-1.2450757923996316,0.18181818181818182,0.748986378196854,1.0,2/8,4.84%,SNX6;CBLB
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.6586445645029664,1.2446008342052257,0.25,0.7504472717046737,1.0,4/10,18.53%,PEX13;PEX5;PEX5L;PEX16
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.6373600286378546,-1.2445979865828392,0.18032786885245902,0.7497883142240254,1.0,3/21,7.10%,FLNA;JUP;RBM22
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.6174544113247278,-1.2445365849872214,0.20634920634920634,0.7489025248310507,1.0,4/30,6.31%,CCL5;PARP14;IGF1;PARP9
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.7691825354092615,-1.2444104870445596,0.25,0.7482753168130007,1.0,2/7,5.80%,PLEKHA7;JUP
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.7235299581095197,1.244228513959474,0.225,0.7506179033287946,1.0,4/8,4.82%,NLGN1;ADRA1A;BAIAP3;ZDHHC3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.8328893371820003,-1.243929271593489,0.1864406779661017,0.7489267128001721,1.0,2/7,5.01%,DUSP1;PADI2
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6436352831836799,1.2433858916914853,0.19444444444444445,0.7523468379734602,1.0,2/14,1.09%,TRPC1;PKD2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.8146774342970506,-1.242047525293297,0.20967741935483872,0.7545631211958345,1.0,1/8,1.12%,ZFP36
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.8146774342970506,-1.242047525293297,0.20967741935483872,0.7545631211958345,1.0,1/8,1.12%,ZFP36
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5588153577744595,-1.2419571410945196,0.1232876712328767,0.7537302714643366,1.0,14/59,19.37%,PSMB3;PSMA7;PSMB9;PSMB6;EIF2AK2;TCF3;PSMA5;PSMC4;PSMD8;PSMD12;PSME2;SETD1A;PSMA3;PSME1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5963002232134659,1.2417788752590897,0.23255813953488372,0.7565810196048941,1.0,5/16,15.66%,PKD2;PKD1;SPDYA;CCNYL1;CCND3
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.8212824299515324,-1.2413328409835165,0.1694915254237288,0.7552500163500611,1.0,3/5,4.74%,RIPOR2;CD200R1;APOD
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.5157091000244542,1.2410956390444046,0.15789473684210525,0.7580874874292993,1.0,21/65,17.54%,LGI4;CNTN2;GFAP;ZNF536;NDRG2;PCDH17;CHST1;INTS6;PLPPR4;NTM;LINGO1;PTPRD;SHC2;PTPN5;NTRK2;NFASC;TMEM132C;CXCL14;MAPK4;DCLK1;CNTN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.6956176298082885,1.2410277617143077,0.1875,0.7571277089220064,1.0,1/9,0.25%,VAPB
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.5275332952550217,-1.2409992048694631,0.12345679012345678,0.7558051102604892,1.0,18/94,12.12%,CALCR;NLRC3;YES1;CD200R1;CD247;RORA;IGF1;GSTP1;VPS35;PRKAR1B;ENPP3;TNFRSF1B;METRNL;FYN;SELENOS;TNFAIP3;NLRP12;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.7348535422351485,-1.2407518242190594,0.23809523809523808,0.7556796582627922,1.0,3/12,5.47%,PRKCQ;SLC7A5;FCER1G
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.7574531671245737,-1.2405123864753398,0.20689655172413793,0.7556741990917448,1.0,2/11,4.98%,PID1;FIS1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.6744620732889168,-1.240253243999167,0.26666666666666666,0.7558279627201133,1.0,2/12,7.97%,PKIB;PRKAR1B
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.6996223766205334,-1.2402024307207846,0.2631578947368421,0.7549215512361905,1.0,3/9,13.91%,NT5C;TYMP;DPYS
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.6710506770319377,1.239919224970278,0.15625,0.7598674321336676,1.0,3/10,17.01%,NRG1;KLHL12;NOLC1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.7107721921376322,-1.2398451891608968,0.15151515151515152,0.755380197339355,1.0,1/11,1.41%,TFRC
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.8067517267449712,1.2397544549111013,0.1951219512195122,0.759175898797198,1.0,1/6,1.72%,GSN
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.606529218519539,1.2396120346712034,0.2222222222222222,0.7583836780072052,1.0,5/24,5.44%,B3GNT2;HS3ST5;B4GALT7;HS2ST1;UGDH
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.663515329810264,1.2395498037130002,0.2857142857142857,0.7573679532048023,1.0,3/14,4.50%,GSN;KCNJ2;SCN3B
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6567755673204639,1.2395128515520146,0.23684210526315788,0.756252907119035,1.0,2/17,9.26%,CD22;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.7864259915043684,1.2388717061725905,0.23255813953488372,0.7570260167134439,1.0,3/5,18.75%,GSN;PIK3CA;SCIN
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.74707108430578,1.238545150239765,0.1794871794871795,0.7567127085667015,1.0,1/7,1.58%,MSN
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.6427808470803933,-1.2383980828114736,0.17857142857142858,0.760656943761678,1.0,3/23,2.31%,CXCR4;GPR183;AIF1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.6292020802644229,-1.2381786821664251,0.1016949152542373,0.7603800086729754,1.0,6/17,14.98%,PLN;IFIT1;PARP9;ATP5IF1;MT3;OXA1L
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.6670637303910075,-1.2381664056267254,0.20634920634920634,0.7592483731247305,1.0,6/16,11.76%,IL4I1;THEMIS2;IKZF3;BANK1;SAMSN1;TNFAIP3
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.7575833754593231,-1.2379785366258167,0.288135593220339,0.7590796593216793,1.0,2/6,14.88%,ABCC3;ATP8B1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.7156627452101477,-1.237821482418082,0.22950819672131148,0.7585178353371232,1.0,3/12,16.03%,CD14;MLKL;IPMK
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.8727607402610467,-1.237774487149637,0.1111111111111111,0.7574992458340829,1.0,2/5,9.39%,BNIP2;PRUNE1
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.7824978767978775,1.2375234183781179,0.275,0.7591773832135876,1.0,3/6,13.77%,GUCY1A1;NPR2;GUCY1B1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6857277941343759,1.2375089877722376,0.2,0.757985026143872,1.0,7/9,25.23%,RAP1A;RAPGEF3;RAP2C;RAPGEF2;PLK2;RAP2A;RAP2B
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7468655186555713,1.2374790008314085,0.2558139534883721,0.7568982416451241,1.0,2/11,6.06%,NLGN1;TMEM230
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.7264066748142967,-1.2372382127296924,0.23529411764705882,0.7585636059853413,1.0,4/9,8.99%,IL4I1;LILRB4;HLA-F;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.5952945321094011,1.2370173139650356,0.14285714285714285,0.7573187040083011,1.0,3/26,5.60%,PPARGC1A;RUVBL2;RPS6KA4
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.489764629763666,1.2365407786219107,0.1891891891891892,0.7574740708656659,1.0,12/62,13.93%,ANXA1;ACER2;FER;ABCA2;PPARG;IRAK1;IRAK3;TAB2;LGALS9;MAPKAPK2;CTSH;PCK2
prerank,GO_Biological_Process_2021__negative regulation of production of molecular mediator of immune response (GO:0002701),0.7746539182387115,1.23639916440466,0.20408163265306123,0.7568794385740459,1.0,3/5,15.58%,CD22;TNF;CR1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.7211007827614295,1.2363237160190668,0.20512820512820512,0.7559024195482336,1.0,2/8,6.28%,SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.7133182284794408,1.236230797517135,0.2,0.7548881067295553,1.0,3/6,17.91%,STX1A;SYT4;KCNB1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5748910703095371,1.2356743240377104,0.16666666666666666,0.7554092280357927,1.0,8/23,18.51%,TCF7L1;TLE2;HDAC1;BCL9L;TCF7L2;RBBP5;BCL9;TLE1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.681750227781025,1.2354016380620931,0.275,0.7551235409106852,1.0,1/12,0.12%,PIGQ
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.760980202554745,-1.2351947496841376,0.18518518518518517,0.7664418679331729,1.0,1/7,3.56%,MTHFD1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6619921401286708,1.2343162947681632,0.37209302325581395,0.7582352164687812,1.0,3/12,12.91%,AANAT;NAA20;NAA35
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.7832862687225272,1.2343116179292082,0.28888888888888886,0.7570630885459868,1.0,3/5,14.87%,PDE10A;RUNDC3A;CGAS
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.48613076047592746,1.2342653335974514,0.08333333333333333,0.7559547437135535,1.0,31/69,23.30%,LRP4;PBX1;PRDX6;PLPPR4;NTM;CDH11;ASXL3;PTPRD;GUCY1A2;SHC2;COL11A1;RUNX1T1;COL25A1;MARK1;FBXL7;NFASC;CSRNP3;LRFN5;MAPK4;MAP2;DCLK1;MAP6;SLIT2;PRKG1;PRICKLE2;MEGF10;CRMP1;OPCML;SEMA6D;LDB2;PLPP3
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.7619716871961137,-1.2342018632187703,0.21052631578947367,0.7699403725989499,1.0,3/8,19.54%,MTHFD1;TYMS;SHMT1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.7494914218675071,-1.2340468434383605,0.19298245614035087,0.7695482751348773,1.0,3/10,16.15%,GSTP1;FADS2;ALOX12
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.6920622939155326,-1.2338011501752129,0.26229508196721313,0.7694953684324266,1.0,4/11,12.58%,GSTP1;ITGB2;SOD1;TYROBP
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.5896423296367683,-1.2337243254542385,0.19736842105263158,0.7685470952749884,1.0,7/54,8.01%,CCL3;MCTP2;CXCR4;BTK;FIS1;ACKR4;TRPM4
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.43871587377973537,1.2336508841055902,0.10526315789473684,0.7571502081450511,1.0,30/136,16.18%,PFKP;PLA2G4C;PANK3;PFKM;INPP1;DUSP18;LRRK2;PLPPR1;PLPP1;PLCB4;PLPPR4;PPA2;GFPT1;IMPA1;IPPK;PTPRD;PPP3CA;PTEN;ACYP1;NUDT3;NUDT4;PIP4K2A;ENPP1;AGPAT2;LCAT;PPM1A;PLD4;PPIP5K1;INPP5A;PLCB3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.6163945215340726,-1.2336453681238255,0.2033898305084746,0.7677443069307245,1.0,1/18,1.34%,DYNLT1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.6170386556733753,-1.2331657970583338,0.1875,0.7687295204402097,1.0,4/29,11.64%,FLNA;RAB11A;WRAP73;ABRAXAS1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6410011856539999,1.2326504245609113,0.21875,0.7592007100518404,1.0,2/13,4.32%,KBTBD6;AUTS2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6335619711798065,1.2324341727187162,0.23684210526315788,0.7574291879099394,1.0,3/8,8.23%,SIRT1;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6335619711798065,1.2324341727187162,0.23684210526315788,0.7574291879099394,1.0,3/8,8.23%,SIRT1;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.7266732925185243,1.2323074454499319,0.2647058823529412,0.7567065921719872,1.0,4/7,24.24%,RELN;CAMK2B;NRXN1;DAB2IP
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.7747134544500451,-1.2321974143914116,0.21428571428571427,0.771804489876116,1.0,1/7,8.08%,GLA
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.7090954028199614,-1.232195892882555,0.25,0.7706392307470091,1.0,4/10,22.80%,BLOC1S2;BMF;RHOT2;BNIP3
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.778244671176819,-1.2320628654526802,0.2962962962962963,0.7700828622377951,1.0,2/6,2.62%,ME1;MDH2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6870207383917862,1.2319371962465164,0.21212121212121213,0.7567404439911002,1.0,5/14,11.69%,ACVR2A;UBE2O;SMAD2;BMPR1B;BMPR1A
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5733288090738045,1.2313787197048538,0.17073170731707318,0.757547036092279,1.0,3/24,6.09%,SMAD1;SMAD3;SMAD2
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.7261408786314952,-1.231198965426133,0.2222222222222222,0.7726272013130783,1.0,1/10,0.70%,CD36
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.716192515271876,1.2309959168113436,0.2391304347826087,0.7579158389674496,1.0,3/5,26.55%,CLOCK;PER1;LMO3
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.5074646104730217,1.2309600788847916,0.10344827586206896,0.7568413706220782,1.0,11/45,17.46%,COL16A1;NRP1;VCL;PTEN;SLC9A1;FERMT2;PTK2;CLASP1;PHLDB2;PPM1F;CLASP2
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.44703732012922204,1.2306038701441246,0.058823529411764705,0.7566775582040327,1.0,30/92,17.46%,CDK5R1;SRCIN1;FGF2;LRRK2;MARCHF5;DAG1;KNDC1;PHLDB1;LRRC4C;PDLIM5;NEDD4L;ZRANB1;POGLUT1;BRSK1;TANC2;SHANK3;BCL9L;FERMT2;NF1;GPNMB;STRIP1;PPFIA2;GSK3B;CLASP1;ADGRB3;PHLDB2;NEDD4;SEMA4D;KIF13B;CLASP2
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.7676663421010015,-1.230552604259085,0.1875,0.774136591622233,1.0,3/7,7.68%,DDX11;RPS3;NPM1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.7059868633604578,-1.2304459545325495,0.1791044776119403,0.7732825714890619,1.0,3/13,6.27%,NLRC3;APOD;LILRB4
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.670852303444842,1.2303445422363446,0.32558139534883723,0.7562976149087489,1.0,5/10,28.13%,LTBP3;NTN4;QSOX1;TGFB1;GPM6B
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4421448624929147,1.2300714370115,0.058823529411764705,0.756154809020936,1.0,37/138,16.90%,CDK5R1;POGLUT3;CSNK1G1;TGFBR2;STK32B;PKD1;GALNT13;LRRK2;RPS6KA4;TLK1;PARP1;MAST2;CAB39;STK38L;MAP3K10;POGLUT1;BRSK1;MAST3;DYRK1A;PRKX;WNK1;MAPK1;MAPKAPK2;CSNK1E;RPS6KA6;MARK1;PRKCI;GALNT1;CAMKV;MAP3K13;GSK3B;GALNT2;MAST1;RPS6KB2;STK32C;AKT2;ULK1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.7135303232277631,1.2299040664909329,0.2222222222222222,0.7555805027411272,1.0,4/5,18.65%,SHANK3;ANO6;P2RX7;CLCN3
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.6525867035212265,1.229866850617415,0.23255813953488372,0.7545374776146876,1.0,3/11,7.50%,NRP1;FGF2;ROBO1
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7791273857098769,1.2294420228442768,0.18867924528301888,0.7548090698311063,1.0,2/5,17.57%,COPRS;PRMT7
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7475689777848051,1.2293649315427408,0.3333333333333333,0.7539463114754272,1.0,5/5,25.27%,MAP2;MARK2;ABL1;PPP2CB;TTBK2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.6240383853561247,-1.2292593308850832,0.21666666666666667,0.7775894973659745,1.0,3/21,13.81%,RPGRIP1L;TBC1D32;CSNK1D
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.6512601766114576,1.2287839845378827,0.1891891891891892,0.7534172067671155,1.0,3/11,14.42%,MEPCE;TCP1;CCT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.6512601766114576,1.2287839845378827,0.1891891891891892,0.7534172067671155,1.0,3/11,14.42%,MEPCE;TCP1;CCT3
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.7197775470322634,1.2279313935169203,0.25,0.7552257207062946,1.0,2/7,7.45%,SIRT1;LIG4
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.713731684665048,-1.227560011046285,0.23809523809523808,0.7837747300321142,1.0,3/11,6.30%,PRELID1;CLU;IGF1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6581764697992154,-1.2274181444395613,0.20588235294117646,0.7833437720113774,1.0,8/24,15.44%,RPS21;RPS8;RPS14;UTP3;WDR46;MRPS11;LOC102724159;KRI1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5932671631801107,-1.2273415619446597,0.23333333333333334,0.7823789936515044,1.0,6/27,7.61%,PLEKHG5;CXCR4;PRKCQ;EPHB1;CORO1B;ACKR4
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.5342536090340224,-1.2270068414398843,0.14285714285714285,0.7826384544378093,1.0,10/90,8.13%,CCL4;CCL3;CCL5;RGS1;RACK1;RGS16;GNB5;ITGA6;RPS3;CALM1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6452051110863132,1.2266515808334533,0.225,0.7583884401281628,1.0,5/13,15.89%,DLG5;SHANK2;IQCJ-SCHIP1;MOB3B;WWC2
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.6111576515657796,-1.2265516985950526,0.1746031746031746,0.7832146906893339,1.0,4/36,6.77%,CH25H;LIPG;PER2;GATM
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4906458050220082,1.225630379097381,0.10714285714285714,0.761037278492732,1.0,10/61,13.91%,PLXNB1;RAB33B;MSN;PDE4DIP;SCARB2;RBSN;MAPK1;PREB;TJP1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.780065317080483,-1.2254256181545151,0.24561403508771928,0.7870107333942717,1.0,1/7,2.07%,DHX58
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.7989786981528597,-1.2251069456240615,0.14545454545454545,0.7871226922407523,1.0,2/6,14.46%,DHX58;C1QBP
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7043406188292259,1.2248113027972325,0.30952380952380953,0.7627098034198133,1.0,7/9,24.04%,GRM5;GRM1;HOMER1;GRM3;GRIK3;HOMER2;GRM7
prerank,GO_Biological_Process_2021__protein de-ADP-ribosylation (GO:0051725),-0.7730443163901113,-1.2247049841599305,0.25806451612903225,0.7876895291782716,1.0,2/5,19.78%,ADPRH;ADPRS
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.6632514653412649,-1.2245809247433235,0.2,0.7871183305968346,1.0,4/22,7.97%,MPP7;PECAM1;CLDN7;ACTG1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.5391152792540077,-1.2241573991605141,0.18181818181818182,0.78769607096554,1.0,15/62,19.37%,CARD14;PSMB3;PSMA7;CHI3L1;PSMB9;PSMB6;PSMA5;PSMC4;PSMD8;PSMD12;COPS8;PSME2;REL;PSMA3;PSME1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.8030988814616008,1.2238633487177097,0.22580645161290322,0.7649960168202797,1.0,1/5,2.03%,TGFBR2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4693362435357559,-1.223781929097789,0.1,0.7880077277348557,1.0,66/346,15.81%,SLC2A3;CD36;FTH1;PPIE;NIT2;HLA-B;RNASET2;DYNLT1;SRP14;MNDA;CHIT1;CD55;ENPP4;B2M;SELL;RAB37;ANXA2;CTSB;FCAR;LPCAT1;PADI2;RAB3A;NBEAL2;CD14;FCER1G;JUP;PECAM1;HLA-C;CHI3L1;GSTP1;CD63;CD93;AGA;ACAA1;HSPA1B;LILRB3;GLA;CYSTM1;CLEC12A;RAB3D;C5AR1;COMMD9;OLR1;OSCAR;PTGES2;TNFRSF1B;CD44;FTL;ITGB2;NCKAP1L;ITGAL;STING1;PSMA5;TYROBP;CD47;C3;CYBA;PTPRC;HSPA1A;PSMD12;PTPRB;IGF2R;SLC11A1;OSTF1;PRDX4;TIMP2
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.8183384542297709,1.2236528239905777,0.17777777777777778,0.7644178923275791,1.0,3/5,14.98%,SETD3;SETD2;SETD5
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.7460072585135016,1.2235723388322939,0.30434782608695654,0.763378848903261,1.0,3/6,21.71%,BMPR1B;FGFR2;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5965891022140346,1.223464719902837,0.26666666666666666,0.762593172349649,1.0,5/15,15.66%,PKD2;PKD1;SPDYA;CCNYL1;CCND3
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.6828687215129337,-1.2232771672563802,0.23809523809523808,0.7888212013023084,1.0,5/9,22.42%,MEI4;IHO1;SGO2;ZCWPW1;FANCD2
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.7933511574164723,1.2227439635624893,0.3137254901960784,0.7635588518082571,1.0,1/5,4.55%,C17ORF75
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.6374501671160204,-1.222623165453079,0.2,0.7905860305349776,1.0,8/22,14.32%,UBXN1;RACK1;CLU;AQP11;NR1H2;SELENOS;LPCAT3;HSPA1A
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.5104151725113475,1.222574554088042,0.17647058823529413,0.7629096028534463,1.0,4/42,6.07%,TULP2;MYO1D;UBE3D;GCNA
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.732713972180935,1.2225665337560485,0.17777777777777778,0.7618024168358629,1.0,1/6,4.67%,CHST1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6817236240057446,1.2224903888597114,0.2857142857142857,0.7609090161336046,1.0,4/8,18.76%,GFAP;EEF1A2;ATP13A2;SNCA
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.47981337437697097,1.2223678644287852,0.15789473684210525,0.760304858941791,1.0,21/71,14.90%,SCN3A;SLC7A8;KCNIP2;KCNJ2;SLC3A2;ATP10D;KCND3;SCN3B;SLC41A1;KCNJ5;SLC4A4;NEDD4L;KCNMB4;SCN8A;KCNN2;KCNK6;ANO6;SLC8A1;ABCC8;SLC12A2;KCNMB3
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7714829475206288,1.222334503115331,0.20512820512820512,0.7592637594334438,1.0,3/6,20.29%,LRRK2;ARFIP1;USP7
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.8365351994696727,-1.2222952491700492,0.16129032258064516,0.7908418281164264,1.0,2/5,10.17%,SLC5A9;SLC2A8
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.468518051851988,-1.2220977494463883,0.1111111111111111,0.7906464132262694,1.0,66/349,15.81%,SLC2A3;CD36;FTH1;PPIE;NIT2;HLA-B;RNASET2;DYNLT1;SRP14;MNDA;CHIT1;CD55;ENPP4;B2M;SELL;RAB37;ANXA2;CTSB;FCAR;LPCAT1;PADI2;RAB3A;NBEAL2;CD14;FCER1G;JUP;PECAM1;HLA-C;CHI3L1;GSTP1;CD63;CD93;AGA;ACAA1;HSPA1B;LILRB3;GLA;CYSTM1;CLEC12A;RAB3D;C5AR1;COMMD9;OLR1;OSCAR;PTGES2;TNFRSF1B;CD44;FTL;ITGB2;NCKAP1L;ITGAL;STING1;PSMA5;TYROBP;CD47;C3;CYBA;PTPRC;HSPA1A;PSMD12;PTPRB;IGF2R;SLC11A1;OSTF1;PRDX4;TIMP2
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.6852985969656826,-1.221813485406907,0.3,0.790526544752294,1.0,1/13,4.93%,LPCAT1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.5747647199117798,-1.221344139142432,0.19444444444444445,0.791504838968478,1.0,8/55,13.81%,FLNA;GOLGA8A;RAB11A;RPS3;WRAP73;ABRAXAS1;TUBGCP2;CSNK1D
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.7207128882129594,-1.2211764661005813,0.2711864406779661,0.7911972014998578,1.0,4/10,8.01%,CCL5;CXCR4;GPR183;TRPM4
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.7435802158903919,-1.2211688759736707,0.19230769230769232,0.7900322626391547,1.0,2/6,4.62%,SMUG1;OGG1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.7830287300459262,1.2211685305585134,0.14893617021276595,0.7620543249562739,1.0,4/5,19.76%,WNT5A;ROBO2;RAPGEF2;FGFR2
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.5889936614169133,-1.2201830691733413,0.19718309859154928,0.7931927528885971,1.0,5/39,7.83%,ZFP36;RNASET2;SIDT2;NUDT12;HSPA1B
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.7318890990928377,1.2199144627331868,0.2542372881355932,0.7651218602742262,1.0,2/6,5.91%,RAP1A;RIN2
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.7042538986261409,1.2197788528322222,0.3076923076923077,0.7645340210023504,1.0,5/9,17.58%,RAB1B;TJP1;AFDN;RAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.661161817742111,1.2197012717420672,0.2894736842105263,0.7637583022398782,1.0,2/8,11.28%,PRKX;KLF7
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.5662634302954739,1.2196717131924972,0.2222222222222222,0.7627198022185393,1.0,2/16,1.62%,PFKP;PFKM
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.6322839121682835,-1.2193569480427242,0.18333333333333332,0.7954509914284872,1.0,4/21,10.15%,OSBPL5;PRELID1;SLC25A19;PCTP
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.7866482646598602,-1.2193194555962032,0.22033898305084745,0.7944954331714597,1.0,3/6,20.10%,BTG1;STK17B;PRDM11
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.841485104107059,-1.2191699658522486,0.22641509433962265,0.7938889032510055,1.0,2/5,8.13%,SRI;CALM1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7070106478388182,1.2186222692396291,0.25,0.7651253541646913,1.0,2/9,10.15%,GSN;LGALS9
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.6692035342167842,1.2185149367677535,0.25,0.7642955677253117,1.0,5/11,23.78%,CEP120;CEP135;CORO2B;DNAJA1;CEP290
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.6647346363688335,-1.218303102167265,0.21875,0.7952700609205626,1.0,5/10,15.49%,SLAMF6;HLA-F;KLRD1;CD226;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.6647346363688335,-1.218303102167265,0.21875,0.7952700609205626,1.0,5/10,15.49%,SLAMF6;HLA-F;KLRD1;CD226;HLA-E
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.7331483179462653,-1.2182948677847443,0.16393442622950818,0.7941480625221966,1.0,1/13,1.68%,PRLR
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.631014057293035,1.2181610441055044,0.2564102564102564,0.764354210944336,1.0,3/10,9.34%,IGF1R;TSC2;GIGYF1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.461211173351729,1.2180324029964347,0.14285714285714285,0.7634338956380559,1.0,28/97,14.45%,CNTN2;PCDH15;AP3B2;FAM135B;CDH20;ZNF536;SV2B;SNAP91;SCN3B;OLFM3;LIN7A;SLC1A2;NLK;CA10;CTNNA2;GRIA4;GRM5;TNR;GRIA1;CADM2;RBFOX1;CACNA1B;CNTN4;PTPN5;GRIA2;SGIP1;SLC24A2;PPFIA2
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7184731477396538,1.2178347282794824,0.20512820512820512,0.7628546025216134,1.0,2/6,19.12%,ZFYVE19;BLM
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.7550690843992252,1.2176950535861786,0.23076923076923078,0.7622770132084545,1.0,2/5,11.69%,PPP1R10;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.8149543062383346,-1.2172326926286896,0.24,0.7973805900544891,1.0,2/7,9.51%,RACK1;CFL1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6134887859946603,1.217165642833796,0.2777777777777778,0.763144090872729,1.0,8/15,21.71%,RAB33B;FBN2;ANKRD11;MEGF8;FGFR1;TGFBR1;FGFR2;FGFR3
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.6424520238177096,1.2169318223094805,0.27906976744186046,0.7629420189227744,1.0,3/7,25.44%,CCDC40;DNAAF2;CABYR
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.6251334185210025,1.216604664320923,0.19444444444444445,0.7631516087743907,1.0,6/18,13.91%,ACER2;SERPINE1;CIB1;PDE3B;P2RY12;PTK2
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.7501591793408829,-1.2163413346691283,0.21568627450980393,0.8001985969852963,1.0,2/7,6.09%,OBSCN;TTN
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6463385002224309,-1.2162495511490823,0.2711864406779661,0.7993439296360432,1.0,4/13,8.50%,RPL5;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.5954423003025505,1.2158280116057263,0.32432432432432434,0.765151723694956,1.0,1/16,1.07%,FER
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.563621372664275,1.2156868940013439,0.24242424242424243,0.7644632142065614,1.0,7/29,13.84%,MAML2;JAG1;ROBO1;MAML3;POGLUT1;PRKCI;ROBO2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.7427944140959547,-1.2155398943056208,0.19402985074626866,0.8010861381308403,1.0,4/9,21.82%,ZNF335;CHTOP;TET1;PIH1D1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.640837292109701,1.2154505977344536,0.23255813953488372,0.7640557613982676,1.0,3/15,5.88%,NRP1;SEMA5A;SEMA3B
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4675266421217953,-1.2154485162556532,0.11235955056179775,0.8001960130801699,1.0,66/350,15.81%,SLC2A3;CD36;FTH1;PPIE;NIT2;HLA-B;RNASET2;DYNLT1;SRP14;MNDA;CHIT1;CD55;ENPP4;B2M;SELL;RAB37;ANXA2;CTSB;FCAR;LPCAT1;PADI2;RAB3A;NBEAL2;CD14;FCER1G;JUP;PECAM1;HLA-C;CHI3L1;GSTP1;CD63;CD93;AGA;ACAA1;HSPA1B;LILRB3;GLA;CYSTM1;CLEC12A;RAB3D;C5AR1;COMMD9;OLR1;OSCAR;PTGES2;TNFRSF1B;CD44;FTL;ITGB2;NCKAP1L;ITGAL;STING1;PSMA5;TYROBP;CD47;C3;CYBA;PTPRC;HSPA1A;PSMD12;PTPRB;IGF2R;SLC11A1;OSTF1;PRDX4;TIMP2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.5996177509722069,-1.2154144799091393,0.24242424242424243,0.7992840831767787,1.0,3/24,3.54%,CATIP;AIF1;PSTPIP1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.5399855478289106,1.215270777741343,0.14285714285714285,0.7636680709818052,1.0,5/25,13.31%,PDPN;ZRANB1;BCL9L;FERMT2;STRIP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.6649099264890495,-1.2150383391147022,0.2,0.7998247189083703,1.0,3/19,4.74%,INSIG1;MDFIC;APOD
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.6645649424407655,1.2149565538959777,0.2777777777777778,0.7640049268242406,1.0,5/12,11.81%,ANXA1;RELN;METRN;NFIB;CDK6
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.6851444411823424,1.2149029403121228,0.2702702702702703,0.7629886777110814,1.0,2/11,8.71%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5642523212352111,-1.2148613813136797,0.2028985507246377,0.7994878030486917,1.0,4/52,5.44%,UBC;NLRC3;RPS27A;CD14
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.732819398706954,-1.2147131510888143,0.2,0.7988845957869125,1.0,7/10,21.26%,CD200R1;IGF1;TNFRSF1B;CD200;IL1B;IL18;NR1D1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.46487891071559856,1.214260418664611,0.12121212121212122,0.763787927931594,1.0,7/46,4.32%,ANXA1;NRP1;FER;GSN;GAB1;MCU;AUTS2
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.8170059705770498,-1.2141906401984184,0.13333333333333333,0.7998116506297299,1.0,2/5,14.46%,DHX58;C1QBP
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7253634770515553,1.2137957099331727,0.23255813953488372,0.7641785538872528,1.0,4/7,17.61%,PIP4K2A;RUBCNL;ATP13A2;ARL8B
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.7002275479459229,1.213660759851339,0.24,0.7636643933213579,1.0,1/6,13.19%,PRKCI
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.49800566264346297,1.2135386557556016,0.23529411764705882,0.7629675628354298,1.0,12/64,13.39%,AVIL;RAP1A;WNT5A;RELN;SCARB2;PLXNB2;ZNF804A;FUT9;NPTN;COBL;PRKCI;NTRK2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.6745985802653963,-1.2131112944411906,0.2708333333333333,0.8033888660042208,1.0,5/11,8.50%,RPL5;RPL11;DTX3L;RPL23;RPS7
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6736269970513935,-1.213056480292965,0.15714285714285714,0.8024318501067144,1.0,5/20,9.70%,OAS3;CDC37;NLRC5;RNASEL;OAS1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.7383377013495985,-1.212332568293971,0.2711864406779661,0.804316035801773,1.0,3/6,15.75%,FYN;SOD1;GPX1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.6786838487589392,-1.212211260377857,0.25806451612903225,0.8035051761918386,1.0,2/14,3.00%,DYNLT1;B2M
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6911660425052947,1.2118476772044244,0.3111111111111111,0.7675871163540205,1.0,1/6,3.52%,PICALM
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.6609396503870579,1.2116793617095387,0.2619047619047619,0.7671804450897949,1.0,3/9,9.40%,SORT1;LAPTM5;RBSN
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.5896201785214328,1.2116036413744964,0.3142857142857143,0.7663532143692241,1.0,5/25,6.47%,PLA2G7;PLPPR1;PLPP5;PLPP1;PLPPR4
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6999754144301785,1.2114331875134212,0.275,0.7646875803303059,1.0,4/10,15.91%,INPP1;IMPA1;PTEN;INPP5A
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.6999754144301785,1.2114331875134212,0.275,0.7646875803303059,1.0,4/10,15.91%,INPP1;IMPA1;PTEN;INPP5A
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7383068095765637,1.2112973962121918,0.19444444444444445,0.7628856143993645,1.0,4/5,22.40%,SHANK3;NRXN2;CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7383068095765637,1.2112973962121918,0.19444444444444445,0.7628856143993645,1.0,4/5,22.40%,SHANK3;NRXN2;CNTNAP2;NRXN1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.44574386694866097,1.2112584407984577,0.13043478260869565,0.7619611794546344,1.0,26/80,15.32%,SLC39A12;PDK4;TGFA;GFAP;SLC1A3;CDH20;NDRG2;LRRK2;SIRPA;KCND3;PLXDC2;VSIG4;SLC1A2;CA10;GRIA3;GRM5;P2RY12;MAPK1;GRIA2;NTRK2;SLC8A1;TMEM132C;SLCO2B1;GRIN2A;P2RX7;TNF
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7431759260378997,-1.2107738438465283,0.23076923076923078,0.8083932957188816,1.0,4/12,13.32%,CDC37;PARP9;STAT1;IFNGR2
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.7038219749895109,1.2107483140399597,0.24390243902439024,0.7623664659808574,1.0,2/9,18.97%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.5689216865086382,1.2107234583934139,0.23684210526315788,0.7613727857843804,1.0,3/20,4.69%,PKD2;RAP1A;AANAT
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.7338547118579343,-1.210487611511848,0.234375,0.8084568237609607,1.0,1/6,3.76%,DDRGK1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.654259030944991,1.2104018831850587,0.25,0.7611795446412261,1.0,5/9,19.76%,SALL1;NIPBL;RARB;TNF;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.6947147957933204,-1.2103891872475216,0.2459016393442623,0.80779962725917,1.0,2/9,12.00%,PLEK;SOD1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6693532634600293,-1.2102084861268905,0.3125,0.8062992895353748,1.0,3/18,10.26%,CENPU;NPM1;ITGB3BP
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6693532634600293,-1.2102084861268905,0.3125,0.8062992895353748,1.0,3/18,10.26%,CENPU;NPM1;ITGB3BP
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.7797882451606734,1.2101305496957226,0.2,0.7608239343691962,1.0,4/6,9.98%,ANXA1;LARGE1;AKIRIN1;PPP3CA
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.47000437047121957,1.2099826182141382,0.14285714285714285,0.7603247212076081,1.0,6/41,4.76%,GLIS3;SLC7A8;ARNT2;SPRED2;NOL4;FOXP4
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6312601673966559,1.2098868886870209,0.21428571428571427,0.7594659058888676,1.0,5/10,18.75%,PPARG;TAFA5;PTEN;SOD2;PRKG1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.617772131076339,-1.2098294952018804,0.2222222222222222,0.8066165570957263,1.0,8/29,14.99%,OAS3;NLRC3;DHX58;NLRC5;OAS1;TNFAIP3;A2M;SERPING1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.5947362578664601,-1.2097534457681933,0.17391304347826086,0.8057985792127463,1.0,7/31,12.26%,OAS3;DHX58;OAS2;IRF7;IRF1;OAS1;STING1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.423961684194118,1.209524815472386,0.26666666666666666,0.7598352317360871,1.0,10/178,4.10%,LEPR;PRKAB2;ACER2;CDK5R1;RRAGD;DAPK2;GFAP;DEPP1;EXOC8;LRRK2
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.78960811536609,-1.2085832039370596,0.2033898305084746,0.809466124736588,1.0,3/7,18.44%,SOD1;VEGFA;EIF2B2
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.5705448123835307,1.2084808745239113,0.14285714285714285,0.7627954868338032,1.0,11/24,18.46%,HIP1R;MYADM;KANK1;SHANK3;IQCJ-SCHIP1;FKBP4;TJP1;SSH2;CLASP1;PIK3CA;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.5652715550458894,-1.2084617174934822,0.208955223880597,0.8089083586833656,1.0,10/56,13.24%,DDX11;CARD16;IFIT1;B2M;RACK1;DVL1;IFIT2;ACTB;ITGA4;CAMK1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5381954839329818,-1.2083277710586584,0.14492753623188406,0.8082570638040358,1.0,8/71,12.26%,GAPDH;DHX58;NLRC5;CD14;IRF7;IRF1;TNFAIP3;STING1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.6416508092172475,-1.2082528172459541,0.2608695652173913,0.8073701678559688,1.0,3/30,6.30%,PYHIN1;EDF1;IGF1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.6897280698605386,-1.2081757373129758,0.21818181818181817,0.8065569222831371,1.0,1/11,1.45%,CHRM2
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.6235321506118461,-1.2073947908241485,0.27692307692307694,0.8090016872566304,1.0,4/15,18.06%,G6PC3;HK2;TALDO1;H6PD
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6779644464755179,1.2073216090111625,0.2682926829268293,0.7659451221048869,1.0,3/9,4.41%,LRP4;NLGN1;WNT5A
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.6472284978291566,-1.2071591186774926,0.19402985074626866,0.808897765867949,1.0,3/20,6.13%,MPP7;PECAM1;CLDN7
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte mediated immunity (GO:0002887),0.754838936145797,1.2069754011446154,0.2,0.7658012001240335,1.0,2/5,22.19%,LGALS9;CD84
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.735172264058241,-1.2068984013109132,0.25,0.8088413600035722,1.0,3/9,13.24%,RIPOR2;TYROBP;CAMK1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.44872633580384247,1.2068788097515852,0.11538461538461539,0.7649765720424002,1.0,25/79,18.46%,SERTAD2;CDKN2AIP;SIRT1;SMAD3;PPT1;DNAJB2;DIP2B;OSGIN2;RNF6;NDRG3;NME6;DCC;RTN4;SLIT3;DCBLD2;ENPP1;DDX3X;CAPRIN2;EI24;KIAA0319;ULK1;MAP2;CGRRF1;SESN2;SLIT2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.6365404724523515,-1.206653945181491,0.18571428571428572,0.808631858341355,1.0,2/23,2.92%,SNAPC1;GTF3C6
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.5977784567942177,-1.206366128043181,0.16417910447761194,0.8087054804733692,1.0,5/40,4.13%,DDX11;UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7120012383935895,1.2063349133452572,0.23809523809523808,0.7653176802837837,1.0,3/7,17.01%,NRG1;KLHL12;NOLC1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6636055467863541,1.2061093426434732,0.3023255813953488,0.7651216205368926,1.0,3/10,13.18%,AUP1;RNF185;BAG6
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.8009696764769947,1.2059384787833045,0.26666666666666666,0.7646226804274537,1.0,1/5,2.45%,SIRT1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.6054102119057283,-1.2058256237970266,0.16923076923076924,0.809719349756347,1.0,6/28,14.25%,TPD52;DNAJB9;SLC25A5;TCF3;ITGA4;PTPRC
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6415116595924977,1.2057725874899001,0.1875,0.7640003672415042,1.0,11/16,29.08%,RAP1A;CIB1;NTRK2;RAPGEF2;TMEM108;WASF1;ACAP2;MAGI2;NTRK3;KIDINS220;MAPT
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.7827329278653268,-1.2057637609261318,0.17307692307692307,0.8088051476570295,1.0,1/6,6.08%,NLGN2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5686399376317479,-1.2054176299416774,0.22388059701492538,0.8092181753576349,1.0,6/36,11.00%,IL4I1;TPP1;PDXDC1;TXN2;ENPP2;ERAP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.612611708768815,-1.2053940933674172,0.2222222222222222,0.808190173128797,1.0,4/25,9.27%,ITK;TXK;PHB2;C5AR1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.6779736485358636,1.205129145946726,0.2,0.7650350936378723,1.0,5/12,18.46%,JAG1;ROBO1;SLIT3;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.7621722935140729,-1.204973576619764,0.19298245614035087,0.8089185332364361,1.0,3/7,19.54%,MTHFD1;TYMS;SHMT1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.49319810740810754,1.2049637508995732,0.21428571428571427,0.7646272296218664,1.0,11/50,15.66%,CDK5R1;CCNG2;PKD2;PKD1;CDK7;CCNG1;PTEN;SPDYA;GTPBP4;CCNYL1;CCND3
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.7346971542679914,-1.2046958287656753,0.22448979591836735,0.8091779154048088,1.0,2/7,8.95%,MYLK;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.7044230332677381,-1.2045481419094413,0.2413793103448276,0.8086671919756485,1.0,3/12,8.13%,PPP1R15A;PLEK;CALM1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6157630723423386,1.2044961110805918,0.2916666666666667,0.7650902233931144,1.0,9/15,28.43%,HDAC9;HDAC1;TMEM119;MMP14;PIEZO1;HDAC3;MAPK14;ATP11A;NOTCH1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6603682594511411,1.2043053540039599,0.23809523809523808,0.7644707181374124,1.0,7/11,18.65%,PDK4;SLC12A6;SLC9A1;SLC12A2;SLC12A5;SLC9A7;CLCN3
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.688410386841684,1.2040346810763125,0.2558139534883721,0.764242336150898,1.0,3/9,13.17%,TGFBR2;BMPR1A;SLIT3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.6040054749550295,-1.2040334303112885,0.16923076923076924,0.8094849729714356,1.0,5/23,12.58%,IL4I1;MNDA;LILRB4;GLMN;TYROBP
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6689849642398389,1.2040293731268432,0.2571428571428571,0.763201504463115,1.0,3/11,7.48%,NUTF2;HMGA1;XPO1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.7227895615823161,-1.2039937925257498,0.2459016393442623,0.8085451226525877,1.0,2/9,7.55%,FIS1;VPS35
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.574965402169305,-1.2036198212656362,0.21311475409836064,0.8093143666468491,1.0,3/34,5.34%,NLRC3;DHX58;NLRC5
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.6489144832962394,-1.2035187100519895,0.2878787878787879,0.80864399054497,1.0,7/20,16.37%,CD2;CD200R1;JUP;ITGB2;ITGA4;CD200;PKP2
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.7173669240386156,1.2034908055542295,0.2972972972972973,0.7636286061664942,1.0,2/7,6.27%,MARCHF5;NUAK1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.46861203042569827,1.2034467148608061,0.13636363636363635,0.7626972586483092,1.0,11/75,6.37%,RAB33B;NRP1;CD22;HIP1R;PICALM;RNF139;TSC2;LRRK2;MAP2K1;RAB10;SNX12
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.4576821643672549,1.2034330124020651,0.14285714285714285,0.761680467553819,1.0,17/86,17.12%,PLA2G4C;PGAP1;FGF2;PIP5K1B;PI4KB;IMPA1;PIK3C2B;PTPN13;PTEN;PIP4K2A;MTMR9;RAB14;PIP4P2;PLCB3;PLEKHA8;SBF1;PIK3CA
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.6315146216979366,-1.2033338429076947,0.20408163265306123,0.8083574984136602,1.0,4/12,13.91%,NT5C;TYMP;DHODH;DPYS
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.6372397556506694,-1.2032914742480836,0.25757575757575757,0.8074244072591735,1.0,6/22,10.96%,FIS1;CLU;VPS35;THEM4;HK2;IFIT2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.6667585581860931,-1.2032144243025227,0.20588235294117646,0.8066786072317986,1.0,4/13,16.75%,TPP1;ERAP1;ERAP2;TRHDE
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.7735490396189451,-1.2031764732612082,0.2978723404255319,0.805692762474489,1.0,2/6,2.96%,MYBL1;MOV10L1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.7237396222665882,1.2027214623320623,0.225,0.7628813453797124,1.0,4/9,16.26%,SETD7;SETD3;SETD2;SETD4
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.6595498729924975,1.202651600148183,0.2682926829268293,0.7620426396651022,1.0,2/7,11.69%,SMAD1;BMPR1A
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5433374589412605,1.202646264454212,0.25925925925925924,0.7609958777974304,1.0,8/26,14.04%,NLGN1;RELN;GRIA3;GRIA4;GRIA1;GRIN2B;GRIA2;GRIN2A
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.7350889824445711,1.2021402859907506,0.3191489361702128,0.7615975495860776,1.0,3/6,9.50%,CARNS1;UGDH;SLC35D1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.7792149262925463,-1.2020762095823265,0.32075471698113206,0.8095910574184056,1.0,3/5,11.51%,MYLK;STK39;TRPV4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.743781117234608,1.201917252055581,0.2857142857142857,0.761323473125201,1.0,5/8,24.46%,PPARG;TNF;POU5F1;TGFB1;ESR1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.5679963878156009,1.2019124839760635,0.24390243902439024,0.7602994490273164,1.0,6/14,24.22%,PPT1;GCDH;ACACA;FASN;SCD5;ACAT1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.646158172389176,-1.201813035914309,0.22950819672131148,0.8096616385939943,1.0,3/14,8.27%,CCL5;AIF1;STK39
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.7510048223740622,-1.201780618250082,0.26153846153846155,0.8086872399768184,1.0,2/7,11.95%,EIF2D;MTIF3
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.7455028497583911,1.201629202892797,0.14705882352941177,0.7603417109404392,1.0,3/8,10.32%,NCAN;CSPG5;UST
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7953229732168214,1.20140705424456,0.2608695652173913,0.7599485963690955,1.0,2/5,6.55%,ADRA1A;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.7325958956527585,1.201323970779493,0.3181818181818182,0.7591740449620158,1.0,1/5,3.40%,NRG1
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.8246869348965353,-1.2013117951385326,0.25925925925925924,0.8096761004715971,1.0,1/5,0.74%,CCL3
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.5370295393815007,1.2011871754731895,0.17647058823529413,0.7585925949645969,1.0,4/22,4.10%,LEPR;NRP1;EPB41;LRRK2
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6735740209563443,-1.200806665856356,0.2,0.8105935535093424,1.0,6/13,9.82%,CD55;B2M;LILRB4;HLA-F;TRPM4;TNFRSF1B
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.7270260227984752,-1.2007316496610692,0.2982456140350877,0.8097819555767641,1.0,6/7,24.16%,MUS81;CDC7;MCM7;MCM6;MCM5;MCM3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.7972807104440729,-1.2006778392111734,0.2698412698412698,0.8089383198498455,1.0,4/5,19.92%,IL18R1;SLC11A1;IL1B;IL18
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5520561835561771,-1.2006261036858255,0.25925925925925924,0.8079943603677923,1.0,13/62,16.22%,DDX11;CARD16;PLN;IFIT1;RACK1;DVL1;BTAF1;IFIT2;ACTB;CAMK1;DAB2;SUMO3;GTF2F1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.5693776313143217,-1.2004802290074355,0.19444444444444445,0.8075426274042489,1.0,4/38,11.84%,ZFP36;BTG2;POLR2G;PRR5L
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.6036131515219905,1.1999973330036504,0.2692307692307692,0.7600318216125134,1.0,10/13,28.97%,RAP1A;FXYD5;RAP2C;RAPGEF2;RAP2A;STK26;RAP2B;TNIK;MAP4K4;RAPGEF6
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.6036131515219905,1.1999973330036504,0.2692307692307692,0.7600318216125134,1.0,10/13,28.97%,RAP1A;FXYD5;RAP2C;RAPGEF2;RAP2A;STK26;RAP2B;TNIK;MAP4K4;RAPGEF6
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5759390265387593,-1.1996457422313356,0.16666666666666666,0.810117027551616,1.0,8/42,12.26%,OAS3;NLRC3;DHX58;OAS2;IRF7;IRF1;OAS1;STING1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.6124364487409851,-1.1996451819705245,0.2459016393442623,0.8090163250685296,1.0,3/22,7.10%,FLNA;JUP;RBM22
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.6388022216165327,-1.1996408167145154,0.19642857142857142,0.8079412914852817,1.0,2/13,1.72%,CCL3;PLN
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.7043792164123249,-1.1992937794253904,0.27419354838709675,0.8084434286000118,1.0,2/8,7.97%,PKIB;PRKAR1B
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5829874941026808,1.1990097165441769,0.17073170731707318,0.7622183713234715,1.0,8/20,26.89%,BICDL1;FBXW11;DYNC1H1;NDE1;TRAK2;PAFAH1B1;TRAK1;KIF5B
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.5995981685925293,-1.198972051527459,0.1643835616438356,0.8075912543047196,1.0,20/41,11.88%,MX2;OAS3;HLA-B;RSAD2;IFIT1;MX1;XAF1;IFIT3;OAS2;IFITM3;HLA-C;HLA-F;IRF7;RNASEL;STAT1;IRF1;OAS1;IFIT2;GBP2;IFI35
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.5995981685925293,-1.198972051527459,0.1643835616438356,0.8075912543047196,1.0,20/41,11.88%,MX2;OAS3;HLA-B;RSAD2;IFIT1;MX1;XAF1;IFIT3;OAS2;IFITM3;HLA-C;HLA-F;IRF7;RNASEL;STAT1;IRF1;OAS1;IFIT2;GBP2;IFI35
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.6554708921979574,1.1985739220239766,0.23529411764705882,0.7625857489851336,1.0,8/16,18.58%,SCRIB;PKD2;PKD1;PRKX;MEGF8;RHOB;SLIT2;RYR2
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.6860805346596658,-1.198265466408889,0.18333333333333332,0.8092198048291462,1.0,1/14,3.56%,MTHFD1
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.5501970648119257,1.1977751448601335,0.25,0.7642283194913471,1.0,7/26,19.85%,MSN;TRERF1;NCOA4;PCK2;ADCY6;NR3C1;ADCY1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.5715981475881503,1.1977408550288764,0.1875,0.7633691970301103,1.0,11/19,21.22%,KCNJ2;KCNJ5;NEDD4L;WNK1;ANO6;AHCYL1;P2RX7;NEDD4;CHRM3;KCNJ6;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.6434893118377766,-1.1975614693579721,0.24615384615384617,0.8110692564871324,1.0,5/14,17.73%,RAB11A;NPM1;CDC7;CCND1;ATAD5
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.7507579574347936,-1.197538029124808,0.2711864406779661,0.8101351336917322,1.0,2/7,8.88%,CMPK2;ENPP3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5464114180945749,1.1971991908353874,0.24242424242424243,0.7640431252006612,1.0,9/22,12.24%,SMAD7;FEM1B;ARRDC3;DCUN1D4;UBE2L3;FBXW7;BAG5;UBE2N;DCUN1D1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.5133182939461268,1.197056756978374,0.13636363636363635,0.7633411496537674,1.0,23/42,28.32%,KHDRBS2;KHDRBS3;SRSF12;RBFOX1;CELF5;TRA2B;RBFOX2;THRAP3;HNRNPU;CELF2;PUF60;WTAP;NOVA1;RNPS1;RBM15;RBM5;CELF1;MBNL1;MBNL3;KHDRBS1;HNRNPL;RBM8A;RBFOX3
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.7641419477411273,1.1970264225342018,0.23809523809523808,0.7624352247254701,1.0,2/5,4.21%,SLC7A8;SLC3A2
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.7186699015046946,-1.196409331013765,0.2807017543859649,0.8137758645231319,1.0,3/11,16.03%,CD14;MLKL;IPMK
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.8149963185005307,-1.1961629964211797,0.1836734693877551,0.8138391231909818,1.0,3/6,12.86%,ODC1;AZIN1;AZIN2
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.8230209772541071,-1.1958579858822878,0.25,0.814182315719893,1.0,1/5,5.44%,CD14
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.7346336911267111,-1.19585569659315,0.3103448275862069,0.8131147578330054,1.0,4/9,19.92%,RSAD2;NOD2;CD74;IL18
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5777791000244,-1.195675254749684,0.19718309859154928,0.8128210728420947,1.0,2/33,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.802508501231487,-1.1956454957869587,0.2641509433962264,0.8118586163472219,1.0,1/6,0.48%,SLC2A3
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5481849624133256,-1.1955553617038788,0.2328767123287671,0.811032458996722,1.0,5/42,5.77%,TOMM7;GZMB;USP36;RHOU;ARIH2
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.691829367719846,-1.194983878956752,0.3050847457627119,0.8122897264182612,1.0,1/11,2.07%,DHX58
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.7091057321723735,-1.1948522341989862,0.27419354838709675,0.8118208648018965,1.0,2/9,3.29%,INSIG1;RORA
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6118379695365253,-1.1947959273946667,0.2916666666666667,0.8109980490497987,1.0,2/22,1.31%,MCTP2;RIMS1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5194157657545324,-1.1945720415820065,0.16666666666666666,0.8107427641650565,1.0,18/88,15.00%,UBC;PPIE;RPS27A;XPA;COPS6;GTF2H5;UVSSA;OGG1;HUS1;BRCA2;POLR2G;RBX1;BRIP1;RPA3;SLX4;COPS8;RAD23A;ERCC8
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5721763445357911,-1.194458553096989,0.2361111111111111,0.8101671087421054,1.0,12/34,21.59%,XPA;SMUG1;OGG1;APEX1;PARG;RPA3;POLQ;RFC1;WRN;ADPRS;POLG;LIG3
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.6498473022336262,-1.1944234587111933,0.2753623188405797,0.8092281303512957,1.0,1/16,1.31%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.7388421486100715,-1.1942710308591613,0.2542372881355932,0.8088657819292718,1.0,1/10,0.82%,RIC3
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.6319469543015377,-1.1940934378253436,0.26865671641791045,0.8085484966276625,1.0,6/19,12.26%,AIM2;DTX3L;PARP9;APOBEC3G;STAT1;STING1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.5157199183726205,-1.1935739597724964,0.19718309859154928,0.8095425034688651,1.0,11/61,9.27%,CALCR;CD36;CXCR4;PLN;CD55;FIS1;CDH23;ACKR4;TRPM4;TACR1;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.7331420660316257,1.193527516166984,0.4,0.7726833684265756,1.0,2/5,18.44%,RAMP1;CHP1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.4840252788726839,-1.1933901306360475,0.15384615384615385,0.8092141649593032,1.0,33/115,24.47%,PSMB3;SSNA1;RAB11A;PSMA7;CEP164;PSMB9;PSMB6;CEP72;RBX1;PSMA5;CDC7;PSMC4;PSMD8;CSNK1D;CCND1;PSMD12;CENPF;PSME2;PRKAR2B;TUBB4B;PSMA3;PSME1;AKAP9;DCTN2;NINL;DYNC1I2;SFI1;PSME3;HAUS5;TUBB4A;PSMB5;CEP250;PSMC3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5613524876325202,-1.193094301995792,0.25396825396825395,0.8093040545536883,1.0,2/25,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.7287926277301681,-1.1930655936187808,0.24193548387096775,0.808307789026249,1.0,2/7,2.75%,MX2;MX1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5209671609236589,1.1927599710343504,0.23529411764705882,0.7741110147025406,1.0,11/31,25.45%,TGFA;GAB1;NCK2;PTK2;PIK3CA;ERBIN;CBL;GAREM1;PIK3R1;TGFB1;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.6135070347655874,-1.1927420998139755,0.22580645161290322,0.808376721900489,1.0,7/29,14.23%,CD36;PID1;GSTP1;ITGB2;SOD1;TYROBP;CYBA
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.6600644491042913,1.1924434227097749,0.3,0.7740997703110918,1.0,6/12,26.60%,B4GALT4;ARV1;CERK;SERINC1;MGST2;TEX2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.6516225426977348,1.1924283779449938,0.2558139534883721,0.7730990001838618,1.0,3/10,13.54%,TMED5;VTI1A;STX6
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.7235452274713388,-1.1922082644603638,0.35384615384615387,0.809222226134524,1.0,1/7,0.48%,SLC2A3
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.5824300586506967,1.1920438333048928,0.23529411764705882,0.7733106378374477,1.0,5/14,10.55%,LRP4;NLGN1;WNT5A;PTPRD;PTEN
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.6998333691876598,-1.191835995884335,0.3148148148148148,0.8098579284554734,1.0,3/8,13.91%,NT5C;TYMP;DPYS
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.6376874219144213,-1.1916082719662846,0.28125,0.8097172472395121,1.0,2/16,1.12%,CALCR;ZFP36
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5283192752982524,1.19156072405276,0.25806451612903225,0.7738279957056735,1.0,9/22,17.58%,MSN;RAP1A;MYADM;RAB1B;TJP1;AFDN;RAPGEF3;RAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.43723224353732054,1.1914426970565508,0.08823529411764706,0.7730694893480682,1.0,7/92,4.10%,PRKAB2;CDK5R1;RRAGD;SIRT1;EXOC8;TSC2;LRRK2
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.57306689879157,1.191302649353978,0.23076923076923078,0.772482705847418,1.0,11/24,20.63%,LCP1;SNX12;DISP1;STXBP5;TNF;PPM1F;ATP13A2;ARFIP1;CHP1;STXBP5L;DNAJA1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5193720704909438,1.1912288346370596,0.1388888888888889,0.77157546852624,1.0,11/25,18.71%,IGF1R;SLC39A14;UNC13B;PTPRN;PCK2;SOX4;PRKAA1;KCNB1;TRA2B;AGER;ZBTB20
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.720873802337569,1.19109303937395,0.36363636363636365,0.7709752973999289,1.0,1/7,0.36%,DUSP6
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5533152583642659,-1.1910414608581585,0.24615384615384617,0.8112551287054091,1.0,3/36,1.34%,SPON2;COL5A1;DYNLT1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6095822265195581,-1.1910153614134986,0.29508196721311475,0.8102967556002814,1.0,14/21,31.37%,RPL39;GBP2;H2BC21;HLA-E;H2BC11;TNFRSF14;MPEG1;FGR;TLR2;RNASE6;PPP1R11;HLA-A;MYD88;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.7554763602515316,1.1909104324192212,0.2727272727272727,0.7705288442344073,1.0,3/6,7.01%,FGF2;VEZF1;RFX3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.7309194017474014,-1.1908263906080179,0.13114754098360656,0.8099821480160279,1.0,5/14,11.76%,CARD16;LILRB4;IGF1;GSTP1;TNFAIP3
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.6481557302864479,1.1908229580333773,0.24324324324324326,0.7698134799381806,1.0,10/16,26.94%,SLC4A4;NEDD4L;UNC80;WNK1;SLC12A5;SLC4A8;WNK3;SLC4A2;CAMK2D;SLC4A10
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6454797356039295,1.1903056884427234,0.2682926829268293,0.770667842831838,1.0,6/16,10.15%,HS3ST4;CSGALNACT1;B4GALT7;HPSE;CANT1;BMPR1B
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.751950223599777,1.1901265405206323,0.3076923076923077,0.7702740709153654,1.0,1/5,0.65%,NRP1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.7833891481148849,1.190016452355663,0.2702702702702703,0.7686668318330719,1.0,2/5,19.87%,ADGRV1;GRM3
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.7833891481148849,1.190016452355663,0.2702702702702703,0.7686668318330719,1.0,2/5,19.87%,ADGRV1;GRM3
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5222618116276736,1.189932570888478,0.1935483870967742,0.7679921541978509,1.0,5/34,8.92%,KLF4;SPOPL;LDLR;MDM2;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.6435504878195621,1.1896224121116667,0.22857142857142856,0.7678719262412786,1.0,4/9,15.24%,ZC3H14;RNF20;BARD1;CDK9
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.7614477647420534,-1.1895321447188176,0.26666666666666666,0.8139234855763253,1.0,4/8,9.70%,OAS3;APOD;GSTP1;OAS1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.7178714738165279,-1.1892928641614198,0.22033898305084745,0.8137459210758459,1.0,2/9,1.30%,CD36;PID1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.7697730081286124,1.189256259350755,0.2608695652173913,0.7672983344856069,1.0,2/5,17.55%,EXOSC6;EXOSC7
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.7697730081286124,1.189256259350755,0.2608695652173913,0.7672983344856069,1.0,2/5,17.55%,EXOSC6;EXOSC7
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.6561067326760617,1.1891147147995238,0.2857142857142857,0.7666289734620049,1.0,2/9,8.94%,HDAC9;HDAC1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6429063936723142,1.1891142998336224,0.17391304347826086,0.7656281523478247,1.0,4/14,11.04%,EPS8;NLGN1;KANK1;P2RY12
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.516216595840204,1.1888749222530377,0.1891891891891892,0.765495151619494,1.0,12/30,15.83%,LRP4;ZBTB16;PKD1;SALL1;C1GALT1;PRKX;NF1;BAG6;NIPBL;CTSH;ROBO2;SOX4
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.6939333297061504,-1.18880448102964,0.4032258064516129,0.8144133067351916,1.0,4/10,12.58%,GSTP1;ITGB2;SOD1;TYROBP
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.432431625382075,1.1887188244121991,0.15,0.7649138381919784,1.0,18/81,10.67%,CACNA1A;GRID2;EIF4EBP2;NLGN1;BAIAP3;LRRK2;GRIK2;GRID1;CLSTN2;RELN;LRRC4C;NPTXR;GRM5;KCNMB4;CLSTN3;NPTX1;PTEN;NRG3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5543089890445737,1.1885847973705082,0.24324324324324326,0.7643340366329349,1.0,5/16,10.51%,SIRT1;SPRED1;SPRED2;MDM2;DYRK1A
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.5565865185977392,-1.1884217902657168,0.2028985507246377,0.8149383993754999,1.0,8/35,9.81%,NR4A3;CYCS;MDH2;UQCRB;UQCRH;UQCR10;ETFB;NDUFS8
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.694524725991408,1.1881708644832607,0.28,0.7645678592610626,1.0,3/8,11.04%,EPS8;NLGN1;P2RY12
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.7730139784722972,1.1879555867202032,0.18604651162790697,0.7642548479785344,1.0,2/6,18.97%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.6333108196288303,-1.1870748524273032,0.2,0.8192201247394847,1.0,1/23,0.15%,FLNA
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.5652303854800049,1.1869727289369074,0.17857142857142858,0.7660751341691782,1.0,10/42,11.14%,VAPB;ACER2;PPM1L;PLPP1;FA2H;SPTLC2;HACD2;ELOVL6;SAMD8;SPTLC3
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.5059414458848588,1.186936403538626,0.2,0.7651831497076771,1.0,12/78,6.89%,VAPB;ACER2;ARSA;ABCA2;PPM1L;GLB1;PLPP1;ST6GALNAC3;FA2H;PPT1;SPTLC2;HACD2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.5843484423936732,1.1868077490113411,0.225,0.7646232338771234,1.0,1/13,1.58%,MSN
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.6628383763814758,1.186682589801834,0.2564102564102564,0.7630472520652185,1.0,3/9,19.49%,CHMP7;CHMP1A;VTA1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.6628383763814758,1.186682589801834,0.2564102564102564,0.7630472520652185,1.0,3/9,19.49%,CHMP7;CHMP1A;VTA1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.7353961649491731,1.1866253615743656,0.2727272727272727,0.7622294545409584,1.0,2/5,23.60%,SORL1;PLEKHJ1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.511739859788925,1.1866041224630108,0.21212121212121213,0.761282531996745,1.0,6/49,8.92%,CD22;HIP1R;PICALM;TSC2;SNX12;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.7642922403685439,-1.1863780076939638,0.3275862068965517,0.8206543753163759,1.0,3/5,11.76%,GSTP1;ENPP3;TNFAIP3
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.730216285102966,1.1861879658709342,0.2926829268292683,0.7614356586211828,1.0,3/7,9.81%,NRP1;HPN;HGF
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6393052192980379,-1.1859593505395651,0.27419354838709675,0.8212232502879151,1.0,9/19,16.41%,NLRC3;CD200R1;LILRB4;SELENOS;TNFAIP3;NCKAP1L;NLRP12;CD200;C5AR2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7977491185453846,-1.1856466646521062,0.26666666666666666,0.821317347418177,1.0,3/5,20.10%,BTG1;STK17B;PRDM11
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.731397400309889,1.1852430295219891,0.25,0.7633881417579493,1.0,4/6,24.24%,RELN;CAMK2B;NRXN1;DAB2IP
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.6174083907449661,1.185009429975656,0.28205128205128205,0.763211372077086,1.0,4/13,20.97%,NSUN2;TRMT10C;WTAP;ZC3H13
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.4886821805350814,1.1847583110663658,0.17857142857142858,0.7629371374268271,1.0,4/44,6.49%,PIGQ;PIGU;ZDHHC3;HHAT
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.5647295291319352,-1.184699009481838,0.2833333333333333,0.8242152038553723,1.0,4/44,3.94%,OSBPL5;ATP10A;PRELID1;ABCB1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.6341640179903852,-1.184509801487744,0.20689655172413793,0.8239833333847963,1.0,5/20,10.13%,RPL5;RPL11;RPL23;RPS7;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.7530748469137283,1.18441227886984,0.23255813953488372,0.7632503553204695,1.0,2/5,17.03%,LDLR;ATP13A2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.5761333010368174,-1.184395176765795,0.29577464788732394,0.823323427345812,1.0,6/30,17.35%,IFT46;DYNC2I1;IFT81;IFT27;IFT52;IFT43
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4254991988457691,1.1839892191948098,0.15789473684210525,0.7637092751048722,1.0,19/137,12.19%,VAPB;PGAP1;TGFA;BET1;HYOU1;CTSC;SEC24B;TMED3;TMED5;LMAN2L;TMED10;RAB1B;COPG1;GRIA1;VTI1A;SPTAN1;COG1;PREB;YKT6
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.5698294703783812,1.1838568155038578,0.20689655172413793,0.7631428256324935,1.0,3/17,5.52%,NCAN;GLB1;CSPG5
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.6070180096871575,-1.1838156753585058,0.23333333333333334,0.8244096424471593,1.0,8/31,10.87%,TOMM7;DNAJC19;FIS1;TIMM44;TIMM21;PITRM1;HK2;TOMM40
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.7699630979095728,-1.1838017030426171,0.24193548387096775,0.8223572441721184,1.0,2/6,4.74%,MDFIC;APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.7699630979095728,-1.1838017030426171,0.24193548387096775,0.8223572441721184,1.0,2/6,4.74%,MDFIC;APOD
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.489446499191979,1.1834006778789048,0.19230769230769232,0.7637468426284265,1.0,17/45,15.55%,LRP4;MTCL1;FKBP9;COL5A2;DAG1;MAGI1;NUAK1;BOK;GNA11;FERMT2;ENAH;TJP1;CD276;ADCY6;RAI14;COL4A5;ANTXR1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.5853593215764287,-1.1829783047802644,0.24285714285714285,0.8245173043445446,1.0,2/34,5.38%,FLNA;CLU
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.5285233209065856,1.1825753140177115,0.25925925925925924,0.7653384902188574,1.0,8/43,5.64%,KLF4;SERPINE1;SPRY2;YJEFN3;AMOT;SPRED1;PPARG;PTPRM
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.44342024460239243,1.1823938531117588,0.17647058823529413,0.7648369107510333,1.0,52/124,22.97%,CACNA1A;KCNQ2;DOC2A;NLGN1;SLC1A3;KCNIP2;GRIK2;SLC1A2;UNC13B;DTNA;GRIA3;GRIA4;PDE7B;SLC12A6;GRM5;GRIA1;KCNMB4;GLRA1;GRIN2B;NPTX1;HTR7;GABRR2;MAPK1;SNCB;CACNA1B;NRXN2;GRIA2;CACNA1E;GRIN2A;GAD1;CACNB4;SLC12A5;DLGAP1;GABRD;CHRM3;KCND2;GRM1;SNCA;GABRA4;GABRG3;HOMER1;GRM3;NOVA1;GABRB1;GLRB;GABRA2;DLG2;GABRB2;NRXN1;GRIN1;PAFAH1B1;SYPL1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7381808307036877,-1.181926670212617,0.2833333333333333,0.8281625111089503,1.0,4/9,23.77%,SOD1;VEGFA;EIF2B2;CYP19A1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5341856899616871,1.1815067416593188,0.2727272727272727,0.766552539960309,1.0,10/23,20.26%,ZNF804A;CTNNA2;BRSK1;PTEN;MARK1;GSK3B;IL1RAPL1;HOMER1;FBXO7;BRSK2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.5006375843173774,-1.1812967227772335,0.16883116883116883,0.8297354556438623,1.0,10/135,6.57%,CCL4;USP6;CCL3;CCL5;RGS1;GMIP;RACK1;RGS16;GNB5;ITGA6
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.7047749088582953,-1.180618339034663,0.28846153846153844,0.8313575050662809,1.0,1/8,0.70%,CD36
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.7101011097160174,1.1804497338925475,0.3023255813953488,0.7685061395558557,1.0,4/7,21.78%,FER;STXBP2;UNC13D;SYK
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7450695668759363,1.1801772513731537,0.32653061224489793,0.7683735358316615,1.0,2/5,18.84%,CPEB4;CPEB2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.5635037021157484,-1.1798997349809832,0.2857142857142857,0.8333254674020273,1.0,1/30,0.35%,DDX11
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.7952558444248137,1.1794855674309688,0.24489795918367346,0.7694497762050821,1.0,2/5,13.88%,MITF;ENPP1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.7707609586805853,-1.1792441273363876,0.24615384615384617,0.8349282615675253,1.0,2/9,8.95%,TGFBR3;RBPJ
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.7170140539339938,1.1790830288590726,0.3,0.7696864591075507,1.0,1/5,10.46%,PEX13
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.497386601482331,-1.1789885440897325,0.15789473684210525,0.8351304234716059,1.0,18/107,16.65%,FLNA;STIL;RPS27;CENPU;RAB11A;ZWILCH;WRAP73;ITGB3BP;DCTN6;EFHC1;ABRAXAS1;STMN1;DYNC1LI2;SGO2;CENPF;SEC13;MIS12;SMC1A
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.5586460173773505,-1.1787787255035012,0.2727272727272727,0.8349622385077091,1.0,7/34,7.59%,FTH1;NLRC3;EMD;IGF1;GSTP1;S100A6;MED25
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.765731191198591,1.1785716212948043,0.375,0.770356513280329,1.0,2/5,14.63%,HDAC1;ANKRD11
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.7029782055857956,1.1779589351724056,0.3,0.7716990931256322,1.0,3/7,7.04%,CSGALNACT1;EXTL2;GFPT1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.6873426787053415,-1.1778108259620936,0.25,0.8377810884192505,1.0,1/13,3.56%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.701509681970279,1.1778081244057745,0.2857142857142857,0.7712105964347019,1.0,1/8,0.87%,STPG1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.609950817038745,1.1775678266762315,0.30303030303030304,0.771011548212616,1.0,6/12,24.75%,LRRK2;MFN1;MARK1;MARK2;TRAK2;TRAK1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.6500801641507507,1.1767068150914617,0.3333333333333333,0.772876005909287,1.0,2/9,3.94%,IFNLR1;CBFA2T3
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.47023350641677175,1.1766024068718048,0.2692307692307692,0.772164258368905,1.0,22/48,19.85%,NLGN1;ADRA1A;BAIAP3;GRIK2;ZDHHC3;CLSTN2;RELN;SHANK2;NPTN;SHANK3;CLSTN3;GRIN2B;CACNG2;GRIN2A;SLC24A2;CACNG8;TNF;RIMS2;AGER;CACNG3;PLK2;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.7613280160554069,-1.176417600617146,0.3333333333333333,0.8422160020315869,1.0,1/6,6.43%,NR1H2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7516871593875782,1.176346594675028,0.21428571428571427,0.7719647645002339,1.0,3/5,18.46%,ROBO1;SLIT3;SLIT2
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.48868380550690504,1.1761712853391333,0.16129032258064516,0.771622377085488,1.0,12/58,9.25%,COL16A1;PLA2G7;GSN;PLXNA2;KCNT1;JAG1;DACH1;PHLDB1;RIN2;TIMP3;CDH11;SASH1
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.7703771753398261,-1.1758849565067238,0.3333333333333333,0.8432395849601149,1.0,1/5,6.13%,CLDN7
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.6825420174443626,1.1756212051557902,0.3333333333333333,0.7723788088069803,1.0,2/7,7.45%,EXOSC6;LIG4
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.6995178557131585,-1.1755989667448927,0.27586206896551724,0.8430515324380541,1.0,3/10,13.69%,SLC25A5;THEM4;SPG7
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.7778271532344725,1.1754997562206484,0.23076923076923078,0.7717824749531043,1.0,2/5,5.50%,RAB10;LIN7A
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.42574117088214614,1.1748798853131766,0.14285714285714285,0.7727431743202668,1.0,31/99,19.76%,KLF4;CDK5R1;SMAD7;NLGN1;NSUN2;DAG1;PHLDB1;ANP32B;PLEKHB2;RUNX1;YWHAG;BMPR1B;SMYD5;CDK6;NF1;PTK2;CDK9;TNF;CLASP1;PHLDB2;MOSMO;ZFHX2;CLASP2;OCIAD1;CBFB;SCIN;SMOC1;TIAM1;FGFR1;TGFBR1;FGFR2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6200258741110058,1.1748645681067085,0.2682926829268293,0.771878364346489,1.0,3/11,18.84%,ZNF385A;CPEB4;CPEB2
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.6944471274078616,1.1748238182287989,0.2619047619047619,0.771015700303167,1.0,2/8,8.01%,DDIT3;EIF2S1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5991327014755979,1.17451834610073,0.2972972972972973,0.7708668019584874,1.0,5/16,10.57%,KCNIP2;KCND3;SLC4A4;SLC40A1;SLC9A1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.6369819326782661,-1.1743911740772366,0.2711864406779661,0.8467595862249411,1.0,3/12,6.09%,TGFBR3;MYBPC3;TTN
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.72419138111797,1.174354926026026,0.28888888888888886,0.7704181789885983,1.0,2/8,5.78%,PDGFA;LDLR
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.7222257091312294,1.1742171753368853,0.27906976744186046,0.7699391153892862,1.0,2/5,13.47%,RUVBL2;NIPBL
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5841065218567996,-1.1737172894812695,0.3088235294117647,0.8485286927905586,1.0,6/25,19.29%,LILRB4;RPS3;PRKD2;CD226;EZR;TESPA1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5742167280232746,-1.1736598020428572,0.24285714285714285,0.8477691209024968,1.0,4/39,1.52%,ITK;JAML;CD2;NLRC3
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6098027305010012,1.1731671469028864,0.23076923076923078,0.7718560523801805,1.0,1/10,0.73%,BAG3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.46674542943321196,1.1731149406550907,0.21428571428571427,0.7710144703217593,1.0,9/65,7.65%,NUTF2;NXF1;U2AF1;PKD1;NUP153;NUP188;XPO1;NUP42;RANBP3L
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.7487160239188888,-1.1726604594805388,0.3148148148148148,0.8508610744203577,1.0,2/7,12.30%,PRELID1;ABCB4
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.7779628500821915,-1.1725157829652701,0.23076923076923078,0.8505079524814687,1.0,1/6,4.81%,RACK1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.5036656345130361,1.17244565459418,0.2,0.7721395327960406,1.0,12/47,13.62%,ESRRG;COL16A1;SVEP1;FKBP9;TIMP3;CDH11;PTCH1;SASH1;FAM114A1;TJP1;TACC2;EPAS1
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.710380923930455,1.172352405518118,0.275,0.7714566447836416,1.0,1/8,2.22%,DR1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.5703752166956034,-1.1718167613563497,0.21739130434782608,0.8521591967954086,1.0,5/36,9.96%,COL5A1;CXCR4;RAB3A;EPB41L3;PLSCR1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.5994778283500855,-1.1717720893344026,0.3283582089552239,0.8512738248303611,1.0,4/18,17.27%,ISCA1;NFS1;CIAO2B;NUBPL
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4397396032436485,1.1714948883089022,0.19230769230769232,0.7730800944113357,1.0,13/57,19.66%,PCBP4;ACER2;MDM2;CNOT7;ZNF385A;CNOT2;RPS6KA6;PLAGL1;SOX4;SESN2;NBN;E2F4;PLK2
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.7932685551927674,-1.1713473334007354,0.3389830508474576,0.850871548366524,1.0,1/5,5.97%,GNPAT
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.7932685551927674,-1.1713473334007354,0.3389830508474576,0.850871548366524,1.0,1/5,5.97%,GNPAT
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.7171859684143544,-1.1712015720651245,0.2962962962962963,0.8503233303788228,1.0,2/10,2.96%,MYBL1;MOV10L1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4569880151364007,1.170920555577491,0.2222222222222222,0.7741515048804309,1.0,15/45,20.79%,LRP4;MAGI1;SALL1;GPR161;GPC6;FERMT2;ENAH;CD276;PTPRG;RAI14;ANTXR1;RBFOX2;SLIT2;NR2F1;GLRB
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5489958362437136,1.1707768308147957,0.15555555555555556,0.7735624990216858,1.0,5/24,9.07%,ABCA2;SIRT1;YJEFN3;PPARG;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6746674093399911,-1.1707413467241155,0.296875,0.850917181892113,1.0,4/13,8.95%,CCL3;SRGN;TRPM4;RBPJ
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.7593013476790627,-1.1706330472927935,0.3584905660377358,0.8503806232471097,1.0,2/5,15.81%,DDRGK1;TIMP2
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.6389890676432398,-1.1706316374813839,0.2711864406779661,0.8493385163954518,1.0,6/12,17.42%,CD200R1;IGF1;TNFRSF1B;PTPRC;CD200;CST7
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5473151418669026,-1.1705324377689816,0.19718309859154928,0.8487639090908153,1.0,10/41,12.00%,RIPOR2;MYO3B;CEMIP;SLC26A5;CDH23;CRYM;ZNF354A;NDUFB9;USP53;SOD1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.7608860961354087,-1.1704713766953128,0.23076923076923078,0.8480152997291195,1.0,1/7,7.33%,IRF7
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.49398123660936455,1.1703725512138825,0.22727272727272727,0.773959019526126,1.0,8/57,8.86%,VAPB;TGFA;BET1;CTSC;SEC24B;TMED10;RAB1B;GRIA1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5109377380042086,-1.170337058526296,0.21428571428571427,0.8474952717917,1.0,22/76,25.81%,POLE3;HUS1;ING5;TIPIN;ING4;CDC7;BRIP1;RPA3;MCM7;KAT5;BRCA1;RAD9A;RFC1;RECQL5;MCM6;WRN;POLG;MCM5;NT5M;MCM3;WDHD1;DONSON
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.7166169916242848,1.1701531235981133,0.23255813953488372,0.7737929239992911,1.0,2/5,20.22%,PRKAA1;SCAP
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.7784822113702143,-1.1698203269780996,0.25,0.8486749451210424,1.0,3/6,14.94%,DCAF15;TYROBP;PRDM1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.6817333419041632,-1.1697980441784794,0.25806451612903225,0.8477441532551893,1.0,3/10,7.48%,SAT1;ODC1;SAT2
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.5512149082041596,1.1697271887077587,0.30952380952380953,0.7741570303631581,1.0,6/18,12.43%,LARGE1;DPY19L1;TMTC2;FKRP;DPY19L3;FKTN
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.5912791255647185,1.1692887953474194,0.35555555555555557,0.7742245470848466,1.0,2/10,5.76%,NRG1;SORT1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.7331513681090588,1.16914699031884,0.3076923076923077,0.7736856722368249,1.0,1/5,2.45%,SIRT1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.785301219142474,-1.1687726337862125,0.25,0.850635406091692,1.0,4/6,16.10%,GSTP1;NAMPT;SELENOS;NOD2
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.6693460293286493,-1.1686031928114002,0.32786885245901637,0.8501659934192107,1.0,3/16,6.30%,DYNLT1;B2M;IGF1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.5284514066190665,-1.1682198109992,0.23529411764705882,0.8504864421837657,1.0,24/62,21.31%,AURKAIP1;MRPL57;MRPS7;MRPL19;MRPL51;GADD45GIP1;MRPS11;MRPL52;MRPL32;MRPL50;CHCHD1;MTRF1;MRPS10;MRPL16;MRPS15;OXA1L;MRPL45;MRPL43;MRPS18C;MRPS25;MRPS21;MRPL47;MRPS9;MRPL13
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.48835893831236,-1.168051747102936,0.23376623376623376,0.8500797437241336,1.0,15/115,11.84%,FLNA;TOMM7;GZMB;EMD;CEMIP;USP36;FIS1;RHOU;ARIH2;JUP;RBM22;HPS4;FYN;ITGB2;PRR5L
prerank,PanglaoDB_Augmented_2021__Interneurons,0.3998254290364749,1.1679331448597465,0.13333333333333333,0.7763308102256088,1.0,73/199,20.04%,KCNQ2;CNTN2;NCAN;NBEA;KCNIP2;SV2B;NOL4;SNAP91;CHST1;OLFM3;SLC22A15;CDK17;PARM1;RELN;SHISA9;PLCB4;PCF11;NPTXR;CA10;KCNC2;ELMO1;CTNNA2;DEPTOR;PSD2;GRIA4;DNAJC6;GRM5;DNM3;CADM2;SCN8A;SLC35F1;VGF;LINGO1;RBFOX1;FBXW11;SNCB;CACNG2;CACNA1B;NXPH1;PTPN5;TMEM132D;GRIA2;OXR1;CSRNP3;HLF;CACNA1E;CAMKV;PPFIA2;CDH4;FBXO11;GAD1;CXCL14;SLC12A5;EML5;ADGRB3;CELF5;SPOCK3;TRIM9;DLGAP1;RGS17;MAPK4;SYT4;MAP2;GRM1;PIANP;KCNQ5;GABRA4;AMER2;PTPRO;PHYHIPL;ADCY1;GRM3;SYNPR
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6580939081209065,-1.1672622238003496,0.3064516129032258,0.8523511438208357,1.0,6/8,29.48%,MCM7;MCM6;MCM5;MCM3;DONSON;MCMDC2
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.7821100149405589,-1.167150605856707,0.3148148148148148,0.8519125452805685,1.0,2/5,3.06%,PID1;PER2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6784609263374145,1.1670264278417954,0.3157894736842105,0.7779305840184412,1.0,4/10,20.63%,SNX12;PPM1F;CORO2B;DNAJA1
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.7349287326973409,1.1669912966444833,0.32608695652173914,0.777079419651221,1.0,1/5,8.83%,FUT9
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.46782601150977837,1.1669091436753494,0.21052631578947367,0.7763695389771862,1.0,30/124,11.66%,CPA1;PDK4;FPR3;GSN;MITF;STK32B;NEO1;HS2ST1;TCF7L1;KCTD12;SPRED1;GRIK2;CHST1;MRC1;VSIG4;NCEH1;ST6GALNAC3;RIN2;UNC13B;HPGDS;SLC4A4;DNM3;GPM6A;HGF;COL15A1;RBFOX1;EXT1;OAF;ENAH;COBL
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.6077089355029602,-1.1668333131025723,0.2898550724637681,0.8522802661044134,1.0,2/14,10.16%,PRLR;SLC5A9
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.609325163451666,1.1666648132261899,0.2727272727272727,0.7761403330562564,1.0,4/11,19.00%,MPDU1;ALG12;ALG3;ALG8
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.7349361203251543,-1.1663238046381932,0.2692307692307692,0.853278289436196,1.0,1/5,7.03%,ETS1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.5961587729473522,1.1662875442972787,0.3157894736842105,0.7763746266987933,1.0,2/9,6.95%,TSPOAP1;DTNA
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6132024514471722,1.1662639705420121,0.23809523809523808,0.7755602791551618,1.0,4/13,15.83%,TGFBR2;BMPR1A;SLIT3;SOX4
prerank,PanglaoDB_Augmented_2021__Pericytes,0.5118180281476604,1.1657723760409553,0.16666666666666666,0.7760718042849161,1.0,8/47,10.18%,COL16A1;SVEP1;COL5A2;ACTA2;LHFPL6;TIMP3;CDH11;COL15A1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.556298630266551,1.1656605689363746,0.24390243902439024,0.775382789726915,1.0,7/19,18.46%,PDGFA;SEMA3B;ROBO1;SLIT3;ITGAV;SEMA4D;SLIT2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7097381288632428,1.1656481438044177,0.32558139534883723,0.7744957894657688,1.0,4/8,21.78%,FER;STXBP2;UNC13D;SYK
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.7153651233983608,-1.1655357915519209,0.38181818181818183,0.8554330629913244,1.0,1/6,3.05%,SSB
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.7180823545963229,1.1654382243078674,0.2978723404255319,0.7741171008637356,1.0,5/6,15.70%,POGLUT3;GALNT13;POGLUT1;GALNT1;GALNT2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6369578001304446,1.1650135101197052,0.2647058823529412,0.7743521357671815,1.0,2/8,8.92%,KCNJ2;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6806563058723385,1.1648718673839384,0.34285714285714286,0.7738827156129584,1.0,2/8,12.18%,SIRT1;SORL1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.6270468535647344,-1.1647202344017462,0.23880597014925373,0.8579075882357959,1.0,1/24,0.15%,FLNA
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6885574757689263,1.1646680461121752,0.28846153846153844,0.7735825400977713,1.0,4/5,28.09%,FGFR1;FGFR2;FGFR3;RHOA
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.4574162543267251,1.1642384169361635,0.12903225806451613,0.7739547594201158,1.0,3/39,4.08%,TULP2;RP2;CRYGS
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.7020921687440327,-1.1641162241792409,0.24074074074074073,0.8594226134334312,1.0,1/6,4.04%,BTK
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.6234832932628367,-1.16406609245554,0.22807017543859648,0.8586341704810115,1.0,3/15,8.13%,CEMIP;CHI3L1;CALM1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.6821261881752303,1.1639701771397755,0.32653061224489793,0.773777192229654,1.0,3/7,25.64%,PTCH1;MEGF8;MBNL1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.5713677851756469,1.1638898799563078,0.2727272727272727,0.77311272252379,1.0,9/18,21.99%,LRRK2;SHANK2;PTEN;PRRT1;SLC24A2;ATAD1;SLC30A1;PLK2;GRIK3
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6512418309296912,-1.1636783235024943,0.2727272727272727,0.8591327485316864,1.0,2/11,4.62%,SMUG1;OGG1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.4461037808948417,-1.163641572203643,0.08791208791208792,0.858245495276645,1.0,30/347,8.31%,CCL4;FLNA;CALCR;PLEKHG5;CCL3;CCL5;CARD16;TFRC;GAPDH;PDGFD;DHX58;TRIM5;RPS15;RPS20;TNFSF10;RACK1;RPL37;FIS1;CD14;IGF1;CHI3L1;TRIM22;RPL23;LAMTOR5;LGALS1;PHB2;RPS3;PRKD2;THEM4;LURAP1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.6492751236246499,-1.1635483589327027,0.3181818181818182,0.8575925597872824,1.0,5/14,14.03%,AIM2;PSMB9;FYN;NLRP12;MT3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5817069353540878,-1.1628507630509968,0.28125,0.8590786625823188,1.0,6/33,8.50%,UBXN1;RPL5;DDRGK1;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6858789899391065,1.162403636089496,0.3,0.7766936487677008,1.0,5/8,16.87%,LRRC4C;PTPRD;GPC6;LRRC4B;LRFN5
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.6861190489773873,-1.1618486620134156,0.37037037037037035,0.8616991198804347,1.0,1/10,0.74%,CCL3
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5428913183933037,-1.16159284240454,0.208955223880597,0.8616378138991425,1.0,5/37,6.75%,MYLK;ANXA2;TYMP;CLDN7;SLC16A3
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.44061369309494014,1.1615161840712949,0.30434782608695654,0.7781542654224131,1.0,9/58,7.42%,NUTF2;BACH2;E2F3;TSC2;IPO13;NUP153;NUP188;PPP1R10;GEMIN2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.6976706367105403,-1.1613604973910634,0.25,0.8615264251972071,1.0,3/9,8.91%,CLU;RPS3;TPT1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.4637882160433667,1.1612015244594531,0.18181818181818182,0.7782760417684431,1.0,6/60,5.91%,NRP1;SEMA5A;FGF2;SIRT1;WNT5A;RIN2
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.656946132187159,1.1603204308357002,0.32558139534883723,0.779761622899204,1.0,1/10,2.22%,DR1
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.7541194595465516,-1.1597953320607401,0.35185185185185186,0.8663419773682387,1.0,1/6,5.22%,RAB3A
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6029214163342539,-1.1596541321108904,0.3076923076923077,0.8658944917111325,1.0,4/18,19.49%,RSAD2;CD200;IL1B;OPRM1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.670589108348814,-1.1595678575301906,0.3220338983050847,0.865257889307047,1.0,2/11,4.19%,CALCR;CEMIP
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.572164086648882,1.1594095739001073,0.3,0.7814858974568716,1.0,6/26,11.69%,KLF4;ACVR2A;TGFBR2;CIB1;BMPR1B;BMPR1A
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.5656443591311126,1.1590672939381246,0.32558139534883723,0.7815276900956387,1.0,7/16,14.71%,NLGN1;RELN;SHISA9;SHANK3;CACNG2;PRRT1;CACNG8
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.46579067144373115,1.1589981119662773,0.18518518518518517,0.7807840387355942,1.0,11/58,7.83%,CACNA1A;TRPC1;PKD2;GRIN3A;NIPA2;NIPAL2;SLC3A2;SLC39A8;SLC41A1;NIPA1;RAMP1
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.7398634399372661,-1.1587326449594446,0.2553191489361702,0.8674022402769925,1.0,1/5,2.73%,CD55
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.4656144434196397,-1.158701504019667,0.21621621621621623,0.8664757634764018,1.0,45/171,17.88%,PSMB3;SSB;SNRPD2;POLE3;RACK1;HDGF;PSMA7;SRPK1;ODC1;RANBP1;RPL14;PHB2;RPS3;LDHA;NPM1;RPL34;RPS6;RPS2;LSM7;RPL6;NCBP2;RPL18;RPS5;KARS1;SRSF7;XPOT;GOT2;APEX1;PGK1;PSMC4;PSMD8;EEF1B2;EIF2S2;RPLP0;C1QBP;MCM7;SRSF2;SNRPA1;TYMS;PRDX4;CBX3;NHP2;SNRPA;COX5A;MCM6
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7316056594416248,1.158574422153115,0.23529411764705882,0.7810980910785347,1.0,2/8,6.55%,ADRA1A;ADCY9
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.7210877143761915,-1.1585079919994794,0.2982456140350877,0.8661100468567422,1.0,4/8,16.49%,PLSCR1;ITGB2;NOD2;UHRF1
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.7224842000256673,1.1585060599511279,0.35714285714285715,0.780311501500099,1.0,2/5,4.32%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.6383368355959673,1.158383627063733,0.1794871794871795,0.7796471619685134,1.0,2/11,8.01%,DDIT3;EIF2S1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.621070328680358,-1.1581036028237077,0.234375,0.8667115355799503,1.0,10/20,21.05%,PRKCQ;ZNF335;NCKAP1L;TYROBP;CD47;HLA-DPA1;NOD2;HLA-DPB1;TNIP2;CLEC7A
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.671105443552561,1.1580538492055823,0.37209302325581395,0.7794503680950902,1.0,2/11,7.43%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5767300320820354,1.1580426621140911,0.25,0.7785333676620372,1.0,2/18,2.33%,HIP1R;TGFA
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.7106847486859946,-1.1574842627994266,0.3492063492063492,0.8678986623530338,1.0,3/8,12.89%,CMPK2;ENTPD5;ENTPD4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.6611163827867144,-1.157473194166812,0.21739130434782608,0.8669461862941835,1.0,8/18,22.48%,JUP;TRPM4;CALM1;PKP2;FGF13;NOS1AP;AKAP9;DSC2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6737489790382696,1.15739095704409,0.25,0.7793880866112443,1.0,5/9,26.11%,DAG1;CLASP1;CLASP2;PCM1;BICD2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.5429694113330336,-1.1570684393900013,0.24,0.8674750519587698,1.0,7/46,14.32%,CARD16;RACK1;GSTP1;HSPA1B;CFLAR;TNFAIP3;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6985804878613504,1.1570185107169166,0.30434782608695654,0.7794319490501704,1.0,1/5,3.64%,KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.44485534584585557,-1.1568815066726492,0.17647058823529413,0.8672887878451017,1.0,38/238,12.54%,FLNA;UBC;BCL2A1;APIP;TFRC;RPS27A;PRLR;CARD14;STIL;IFIT3;PTMA;NAIP;DDRGK1;PRELID1;BNIP2;ATF5;IGF1;GSTP1;TNFAIP8;PHB2;NPM1;HSPA1B;BNIP1;RNF144B;RPS3A;RPL10;TPT1;CITED2;NAA38;CFL1;CD44;KANK2;CFLAR;NCKAP1L;ZNF16;PIM3;GPX4;VEGFA
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.6592215826660913,-1.1568630240395144,0.32142857142857145,0.8663503231485641,1.0,6/12,19.30%,CLDN7;C3;ATP8B1;SERPING1;CFTR;GPRC5C
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.782727345601276,-1.1566585143581642,0.2857142857142857,0.8661064821525205,1.0,3/5,19.97%,SLC38A1;SLC38A6;SLC1A4
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6401655827512619,-1.1565279594071416,0.3076923076923077,0.8655273053649135,1.0,1/11,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.5392852060903391,1.1565133726331671,0.2727272727272727,0.7799993487577069,1.0,13/32,14.95%,SMAD7;CDH20;CADM1;VCL;CDH11;CADM2;FERMT2;CDH8;TJP1;ZNF703;AFDN;CDH4;CDH19
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5314068353638977,1.156406897792591,0.2894736842105263,0.7793549858625424,1.0,4/18,15.63%,CDK17;CDK18;POLA1;HINFP
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.6485844709295898,-1.156300952517599,0.3,0.8654034291210134,1.0,2/12,4.19%,CALCR;CEMIP
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.7419155252931127,-1.1561919273008998,0.3088235294117647,0.8638471855521384,1.0,1/6,8.08%,GLA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.7419155252931127,-1.1561919273008998,0.3088235294117647,0.8638471855521384,1.0,1/6,8.08%,GLA
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.6822076443652736,1.1558059959548086,0.3958333333333333,0.780264449766473,1.0,4/5,26.73%,MMP14;PIEZO1;MAPK14;ATP11A
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.5174859327148885,-1.1557185640166474,0.23943661971830985,0.8644435524934042,1.0,24/66,21.31%,AURKAIP1;MRPL57;MRPS7;MRPL19;MRPL51;GADD45GIP1;MRPS11;MRPL52;MRPL32;MRPL50;CHCHD1;MTRF1;MRPS10;MRPL16;MRPS15;OXA1L;MRPL45;MRPL43;MRPS18C;MRPS25;MRPS21;MRPL47;MRPS9;MRPL13
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5700716369436163,1.1556872925817794,0.3076923076923077,0.7796212826946514,1.0,7/18,20.97%,NSUN2;TRUB1;PUS1;TRMT10C;PUS7;WTAP;ZC3H13
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.44341764929339755,1.1554778789789022,0.08695652173913043,0.7793370081734243,1.0,17/103,9.60%,KLF4;SERPINE1;SEMA5A;FGF2;SPRY2;SIRT1;GAB1;YJEFN3;AMOT;SPRED1;WNT5A;PPARG;PTPRM;TMIGD2;SASH1;RUNX1;PDE3B
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.47760135671516135,1.1552873700265864,0.18518518518518517,0.7791872619356309,1.0,9/38,17.09%,BAG3;DDIT3;DNAJB2;STT3B;HSPH1;HSPA14;ERP44;HSPD1;TM7SF3
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.7518862045669148,-1.155256412134296,0.3275862068965517,0.8651563785550079,1.0,2/10,5.20%,IL4I1;KMO
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.6742439504348666,-1.155075466243885,0.3125,0.864827650525629,1.0,4/13,19.53%,DHX58;NOP53;C1QBP;DDX60
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.7309350586045951,-1.1550660558325356,0.3275862068965517,0.8638431806672432,1.0,2/8,12.54%,NKD1;VEGFA
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.7237800410048697,1.1548015406536172,0.3404255319148936,0.7796024168389233,1.0,1/5,13.19%,PRKCI
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.6760447488260667,-1.1543596572739558,0.3088235294117647,0.865415481154023,1.0,5/8,31.60%,ATG10;WIPI1;UGCG;WIPI2;WDR45B
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5024848647067437,1.154131725140509,0.2631578947368421,0.7803875904974261,1.0,12/36,16.18%,INPP1;FGF2;PLCB4;IMPA1;IPPK;PTEN;NUDT3;NUDT4;PLD4;PPIP5K1;INPP5A;PLCB3
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5656170872444298,1.153906520560028,0.20588235294117646,0.7801926794323096,1.0,3/27,3.10%,PIGQ;PIGU;LARGE1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5325029631409922,-1.1537844063695282,0.2857142857142857,0.866387781506849,1.0,6/43,4.73%,CCL5;TFRC;GPR183;AIF1;VAV3;ZNF335
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.5076840663612472,-1.1534696343275408,0.2878787878787879,0.8667133627594417,1.0,5/63,1.72%,SPON2;MYLK;COL5A1;PDGFD;PLN
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7161538401518424,-1.1534299378749755,0.2982456140350877,0.8658873348624554,1.0,3/7,8.50%,EIF5A;PTTG1IP;RPS7
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.48176782479150104,-1.1533037362103613,0.2191780821917808,0.8653554802393838,1.0,15/71,21.02%,TFRC;GRAP2;TSPAN32;BTK;ETS1;FERMT3;CD44;P2RY8;CSF2RB;TALDO1;WRN;RAC2;ITGB1;USE1;RELT
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5968059986964867,-1.1529202550246136,0.18181818181818182,0.8657492379381486,1.0,5/26,11.81%,IL4I1;RIPOR2;LILRB4;GLMN;NCKAP1L
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.7178043390050384,-1.152892114642128,0.39285714285714285,0.8648203042857322,1.0,2/7,10.05%,CALM1;PTS
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.8153939573979048,-1.1528239878756978,0.29411764705882354,0.864107096746753,1.0,2/6,6.18%,UBXN1;AQP11
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.4873374543227364,-1.1526601689340317,0.20987654320987653,0.8636573464780525,1.0,35/151,20.25%,MIF4GD;RPS4X;GAPDH;GZMB;BTG2;RPL5;RPL13A;RACK1;SHFL;EIF1;ILF3;RPS3;NPM1;RPL10;EIF2AK2;NCBP2;EIF4A3;MTRF1;EIF2A;RBM4B;PUM3;TYMS;PATL2;ZCCHC4;CNOT8;VIM;PASK;EIF2B2;EIF5B;EEF2;RBM4;SHMT1;YBX1;NCL;RPS27L
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.5272501901743466,1.1524278016113505,0.25,0.7835217961214254,1.0,7/22,15.70%,B3GNT2;GALNT13;C1GALT1;GALNT7;GXYLT1;GALNT1;GALNT2
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.6439135928270938,-1.1523171862525898,0.2857142857142857,0.864148098352995,1.0,3/18,10.51%,H1-0;MUS81;REXO4
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.7295613472593602,1.1518041202580491,0.4222222222222222,0.7844032132361767,1.0,4/6,26.44%,PLPPR1;PHYHIPL;FGL1;RIMBP2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.6550293149689873,-1.1516930665511926,0.29310344827586204,0.8653535860406738,1.0,5/6,29.48%,MCM7;MCM6;MCM5;MCM3;MCMDC2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",-0.7642729816305865,-1.1516642937754469,0.32786885245901637,0.864449804867303,1.0,1/5,1.82%,RUNX3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5406346426508128,1.1516441782372215,0.2564102564102564,0.7841895605656032,1.0,4/12,8.23%,SIRT1;MDM2;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.6974086921368786,1.1507127572605818,0.3181818181818182,0.7862484551451483,1.0,1/7,0.21%,IFNLR1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.7181907752401883,-1.1506248804947448,0.34375,0.8671095519907108,1.0,2/6,14.84%,APEX1;TERF2IP
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.614671529791651,1.1504487825132843,0.34375,0.786092111358776,1.0,5/13,13.55%,SCN3A;KCNJ2;SCN3B;SCN8A;SLC8A1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.6125037961679795,1.1498600030574937,0.2631578947368421,0.7867751430846855,1.0,4/12,19.87%,NF1;ADGRV1;ORAI1;GRM3
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.46312650890197954,-1.149175806670246,0.18681318681318682,0.8714984481165423,1.0,40/198,17.88%,UBC;RPS27A;XPA;SMUG1;BTG2;OGG1;POLE3;HUS1;MUS81;XRCC3;THAP9;NPM1;PARP2;REXO4;DDX23;DNMT1;APEX1;CDC7;NOP53;PARG;NABP1;RPA3;GLRX2;SLX4;MCM7;KAT5;TERF2IP;BRCA1;TYMS;RAD9A;PARP4;PRIM1;UHRF1;UBA52;SMC1A;DFFB;POLQ;RFC1;RECQL5;MCM6
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.7313807783715347,-1.1489812363354752,0.38461538461538464,0.8712358785994458,1.0,2/8,12.30%,PRELID1;ABCB4
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.5437008781866834,-1.1487590957749207,0.25396825396825395,0.8710508596414906,1.0,7/37,10.01%,PYHIN1;RPL5;RPL11;CLU;RPL23;RPS7;GLMN
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.6494581630596113,-1.1487529744713485,0.32142857142857145,0.8700880806630867,1.0,1/10,1.72%,PLN
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.5634653776646711,1.1487494916733254,0.28125,0.7891179949052126,1.0,13/28,26.11%,PHLDB1;TPPP;GSK3B;CLASP1;PRKAA1;PHLDB2;CLASP2;MAP6;MARK2;STMN3;MAPRE2;TRAF3IP1;BICD2
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.7405356277265547,1.1480167164002202,0.27906976744186046,0.790633056475285,1.0,2/5,21.73%,HDHD5;CPNE3
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.6716431032336824,-1.1475650835980198,0.30612244897959184,0.873618532366958,1.0,3/13,14.88%,SLC51A;ABCC3;ATP8B1
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.4861596708355093,-1.1475515857465173,0.20238095238095238,0.8726646022100435,1.0,29/114,16.17%,TGFBR3;CD2;SAT1;BTG2;PRF1;CD69;GADD45B;H1-0;TNFSF10;IER3;CLU;IFITM3;CD14;FEZ1;RNASEL;IRF1;CD44;TAP1;CFLAR;ATF3;SOD1;GPX4;CCND1;BRCA1;IGF2R;GPX1;TIMP2;BMF;PEA15
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.6332191323000672,-1.1472245393717524,0.3076923076923077,0.8728904855405687,1.0,3/16,10.86%,CDC37;MLKL;CFLAR
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.36023663370229264,1.1470952651579667,0.0,0.7922766543614531,1.0,123/716,13.77%,B3GNT2;SPSB2;DUSP6;ANXA1;FBXO30;HS3ST5;PTPN9;DAPK2;FER;PDK4;PIGU;PGAP1;ACVR2A;FBXO32;FBXL14;DCAF16;GOLM1;KBTBD6;AATK;TGFBR2;ZBTB16;SIRT1;FAM20C;STK36;PPM1L;LARGE1;B4GALT7;MAP3K11;CDK10;DCAF13;NEK10;LRRK2;DDA1;MAP2K1;FEM1B;CDK17;UBE2E2;RPS6KA4;PTPRM;TLK1;PARP1;DUSP7;RYK;NUAK1;CDK18;KCTD6;STK25;NLK;PPP4R2;MAST2;MERTK;CDK7;PTAR1;RAB1B;PRKCSH;MAP4K5;PPP2R1B;IRAK1;STK38L;PTPN13;IRAK3;UBE2D2;PIGT;PRKAB1;FUT9;ILKAP;CDC14B;BRSK1;GPS1;VGF;NTAQ1;PTPRD;BTRC;PPP3CA;BMPR1B;ST8SIA5;PTPRK;UST;HIF3A;UBE2L3;PGGT1B;DYRK1A;PTEN;ANO8;SIRT6;FBXW7;PTPRR;FBXW11;CDK13;WNK1;CILK1;MAPK1;FNIP2;DCAF5;BMPR1A;PIM1;CDK6;SETD3;FEM1C;DCUN1D1;PTPN5;MAPKAPK2;CSNK1E;P4HB;FBXO27;CHM;KLHL21;CDKL2;MARK1;DNAJC3;STT3B;COP1;KLHL42;STK10;FBXL12;PRKCI;SSH2;FBXL7;CTDSP2;PRRT1;EPAS1;ST8SIA4;PPP2R5E
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6683514343983221,1.1470926672002826,0.23076923076923078,0.791367037077456,1.0,2/15,8.71%,HACD2;ELOVL6
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.5000606870138492,-1.1470580711554699,0.2625,0.8725994360673578,1.0,12/84,9.02%,TPD52;INSIG1;SAT1;B2M;H1-0;ADRM1;DNAJB9;TNFAIP8;MAK;STK39;SELENOP;SGK1
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.7290847890524703,-1.147003229800086,0.35,0.8718027784595749,1.0,4/8,19.62%,RPL39;H2BC21;HLA-E;H2BC11
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.6016080553116967,1.14677901474009,0.2894736842105263,0.790372684213595,1.0,4/9,23.02%,MGMT;ASCC1;ALKBH5;FTO
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.6016080553116967,1.14677901474009,0.2894736842105263,0.790372684213595,1.0,4/9,23.02%,MGMT;ASCC1;ALKBH5;FTO
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.6633011775644215,-1.1461886470768823,0.34285714285714286,0.8739562396091318,1.0,1/14,1.54%,RSAD2
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.6516814673562358,-1.145864928919638,0.36538461538461536,0.8742463337025205,1.0,3/12,15.17%,STIL;NPM1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.7004193407240515,1.1457815615768339,0.32608695652173914,0.792359497846254,1.0,2/8,4.09%,MSN;PTPN23
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.6074290816406609,1.1457596963901295,0.3684210526315789,0.7915122840547566,1.0,1/11,2.76%,EIF4EBP2
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.7023525744408985,-1.1456992267627366,0.34375,0.8738313099893706,1.0,3/10,23.83%,ACAA1;FADS2;SCP2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.41553608912536627,1.1452161809837005,0.21052631578947367,0.792386067547529,1.0,32/133,16.90%,CDK5R1;CSNK1G1;TGFBR2;STK32B;PKD1;LRRK2;RPS6KA4;TLK1;NLK;MAST2;CAB39;STK38L;MAP3K10;BRSK1;MAST3;DYRK1A;PRKX;WNK1;MAPK1;MAPKAPK2;CSNK1E;RPS6KA6;MARK1;PRKCI;CAMKV;MAP3K13;GSK3B;MAST1;RPS6KB2;STK32C;AKT2;ULK1
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7052901531107354,1.145037217503966,0.3333333333333333,0.7920209622597275,1.0,4/7,11.76%,TTLL11;TTLL1;CEP41;TTLL7
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.5160099640565069,-1.143778433784011,0.25757575757575757,0.8800449053448742,1.0,9/66,10.91%,CALCR;CD36;CCL5;EPHB1;CLU;VPS35;HSPA1B;TNFRSF1B;TRIM13
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5686190379795546,1.1436880432321042,0.2926829268292683,0.794592787997005,1.0,2/11,2.08%,SEMA5A;FGF2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.4729940887084656,-1.14361600160596,0.19736842105263158,0.8796812239026661,1.0,18/124,8.50%,MYLK;CCL3;CCL5;PDGFD;SYNE2;AIF1;DDRGK1;DUOX1;CEMIP;PLET1;RACK1;PECAM1;SEMA6A;IGF1;ITGA6;SPOCK2;ACTG1;FERMT3
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.3549363815861921,1.1434955228921617,0.0,0.7942840773854402,1.0,83/366,17.65%,CDK5R1;DAPK2;FER;PDK4;IGF1R;ACVR2A;CSNK1G1;AATK;TGFBR2;SMAD7;FAM20C;STK36;STK32B;MAP3K11;PKD1;CDK10;NEK10;LRRK2;MAP2K1;TLR7;CDK17;RELN;RPS6KA4;TLK1;SMAD2;RYK;NUAK1;CDK18;STK25;NLK;MAST2;MERTK;CDK7;CAB39;MAP4K5;IRAK1;STK38L;MAP3K10;IRAK3;PRKAB1;BRSK1;MAST3;BMPR1B;DYRK1A;PRKX;CDK13;WNK1;CILK1;MAPK1;FNIP2;BMPR1A;PIM1;CDK6;MAPKAPK2;CSNK1E;RPS6KA6;CDKL2;MARK1;STK10;PRKCI;NTRK2;PRRT1;PTK2;CAMKV;MAP3K13;MAP3K5;ERBB4;CDK9;GSK3B;ABI1;PRKAA1;MAST1;RPS6KB2;STK32C;AKT2;MAP3K7;ULK1;ATP13A2;TYRO3;GTF2H3;CDK12;DCLK1;SIK2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6051198962865213,1.142916828633299,0.3125,0.794962211928518,1.0,5/14,13.08%,CDK5R1;NLGN1;CNTN4;NRXN2;NCAM2
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7328365797367221,-1.1426736776732604,0.3076923076923077,0.8823258334660863,1.0,2/6,14.84%,OGG1;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.657388365822695,-1.1426536816658686,0.4444444444444444,0.8813633701043675,1.0,5/9,27.37%,CFL1;TBC1D20;IGF2R;NUCKS1;YTHDC2
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.7073147623637771,-1.1423333461124623,0.3333333333333333,0.8816620359748336,1.0,2/7,15.75%,NT5C;GPX1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6683781696562492,-1.1422627230012037,0.3442622950819672,0.8809861533115755,1.0,3/9,3.29%,CCL3;INSIG1;RORA
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.5230250331733824,1.1418416946767507,0.24324324324324326,0.7972322284963168,1.0,9/19,18.71%,IGF1R;SLC39A14;UNC13B;PCK2;SOX4;PRKAA1;KCNB1;TRA2B;ZBTB20
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.723990334338884,-1.1416404971442586,0.38095238095238093,0.8822856760390426,1.0,1/5,6.41%,GLUL
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.6964332115588335,1.141310848248214,0.3617021276595745,0.7980791134596451,1.0,3/6,23.10%,HOMER1;CD84;HOMER2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5983047384784593,-1.1412394121388636,0.2857142857142857,0.8827332293702016,1.0,6/15,16.86%,RORA;SULF2;HIF1A;C3;BRCA1;IL1B
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.5199653849278006,1.1411673417024875,0.3,0.7976233246388715,1.0,3/26,4.53%,ACER2;SERPINE1;JAG1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.5577725821101431,1.1408893951676857,0.34146341463414637,0.7975439157666281,1.0,8/19,17.34%,SEMA5A;SEMA3B;DIP2B;RNF6;RTN4;KIAA0319;SEMA4D;MAP2
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.5053051499342714,1.1408407191137064,0.36666666666666664,0.7967148370910246,1.0,13/40,14.49%,GRIN3A;ZNF706;MARCHF5;ANP32B;BCL11A;KANK1;SFMBT1;NFIB;DCC;KLF7;CDK6;RPS6KA6;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.7062954886088635,1.140539737355867,0.37777777777777777,0.7965069977302358,1.0,2/5,26.17%,DDX3X;EIF2AK4
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5323350848201858,1.1401938375331082,0.2972972972972973,0.7965154419571517,1.0,3/16,8.94%,SVEP1;EDA2R;HDAC1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7328222208141519,-1.1401242076865772,0.30303030303030304,0.8857711252581781,1.0,1/7,1.31%,RIMS1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.5750712296291463,1.1398310801232447,0.28888888888888886,0.7965957244716845,1.0,8/17,16.14%,DUSP6;HPSE;TDG;KAT2A;BAG6;NIPBL;RAB14;TRIP12
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.7383794305845902,-1.1397843760434332,0.453125,0.8861102081906166,1.0,1/5,1.82%,RUNX3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5655329288643489,1.1396884066243318,0.25,0.7960872592635394,1.0,4/14,4.06%,SPRY2;SMAD7;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.724877757261491,-1.1395949622788404,0.3333333333333333,0.8859032182118073,1.0,1/6,3.72%,ATP10A
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.5742752186170992,-1.139489777106545,0.3088235294117647,0.8852740833567291,1.0,1/29,0.15%,FLNA
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.7380159201159086,1.139343011680781,0.37777777777777777,0.7962108599695091,1.0,1/5,1.58%,MSN
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.6459990218633174,1.1392883402599139,0.3783783783783784,0.7954891219570384,1.0,1/9,7.55%,FOLH1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.49494693368291964,-1.1391954178621204,0.24675324675324675,0.8855844400622107,1.0,16/69,16.86%,HLA-B;NLRC3;AIF1;CD200R1;LILRB4;SELENOS;TNFAIP3;NCKAP1L;NLRP12;TYROBP;CD47;CYBA;CD200;NOD2;C5AR2;IL1B
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.7103741600633235,-1.1391159321998836,0.37735849056603776,0.884854000150717,1.0,1/8,7.03%,ETS1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.648881044804176,1.138919857027079,0.3333333333333333,0.7957848002714754,1.0,2/9,12.18%,SIRT1;SORL1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.7006548004035962,1.13878849853785,0.2926829268292683,0.7952223567371787,1.0,1/5,2.45%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7119583597601793,1.1385387224684163,0.32075471698113206,0.7950037716690841,1.0,1/5,2.69%,SLC39A14
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.6931313842040505,1.1385153799091312,0.2564102564102564,0.7941582764747215,1.0,1/7,2.45%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.764723390810655,-1.1384940585415588,0.3389830508474576,0.8862217877777455,1.0,2/6,12.54%,PRKD2;VEGFA
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.6984756857607284,1.1384712814797118,0.37209302325581395,0.7934286137033061,1.0,2/5,13.84%,ROBO1;ROBO2
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6546600669627435,-1.1378197737350737,0.3695652173913043,0.8876706593071382,1.0,5/9,22.49%,ATP5PD;VPS9D1;ATP5F1D;ATP5F1C;ATP5MC2
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.6687257559344264,1.1373365616056934,0.3829787234042553,0.7958305763402224,1.0,4/7,18.44%,ABCA2;RAMP1;FKTN;CHP1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.5615570133063027,-1.137071875870385,0.328125,0.8892563761589369,1.0,3/36,5.76%,FTH1;TFRC;ATP6V1F
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.8125551939917983,1.137025745889393,0.24324324324324326,0.7951673546916094,1.0,1/5,3.60%,EPB41
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.8125551939917983,1.137025745889393,0.24324324324324326,0.7951673546916094,1.0,1/5,3.60%,EPB41
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.6239578661107104,-1.1366565543061897,0.34328358208955223,0.8899336942572424,1.0,3/16,6.27%,MDFIC;APOD;LILRB4
prerank,GO_Biological_Process_2021__regulation of dendritic cell antigen processing and presentation (GO:0002604),-0.7805268963141957,-1.1364556627000246,0.29310344827586204,0.8896311073583539,1.0,2/5,16.10%,SLC11A1;NOD2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.6841725603547574,-1.1362352487384053,0.3191489361702128,0.8895711937763835,1.0,4/11,7.60%,MYO1G;CD55;BTN3A3;BTN3A2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.4965056701573024,-1.136186090340291,0.23880597014925373,0.8887025469895325,1.0,7/65,10.42%,RPS13;JMJD6;SRPK1;RPS26;RBM22;FAM50A;U2AF2
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.6912654483184554,-1.1361659781943336,0.3333333333333333,0.8868318877933097,1.0,1/10,2.91%,IL7R
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.6912654483184554,-1.1361659781943336,0.3333333333333333,0.8868318877933097,1.0,1/10,2.91%,IL7R
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.6827423120012525,1.1358958293365196,0.375,0.7967166776242935,1.0,3/7,12.32%,LGI4;PARD3;NF1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.6827423120012525,1.1358958293365196,0.375,0.7967166776242935,1.0,3/7,12.32%,LGI4;PARD3;NF1
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.6644976703638324,1.1358072921342848,0.3488372093023256,0.7960597741248698,1.0,3/10,11.66%,SPIRE2;LCP1;COBL
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.7048584861453162,1.1356523956060673,0.30434782608695654,0.7956304492834115,1.0,2/6,7.43%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.5977541352831951,1.135609177717211,0.3170731707317073,0.7948491467985854,1.0,3/11,14.67%,CENPE;CDC23;ANAPC1
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5737692706278753,-1.135331941287448,0.3114754098360656,0.8887490851068918,1.0,4/21,14.88%,ATP10A;ABCB1;ABCB4;ATP8B1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.6178061069438783,-1.134921291603909,0.2413793103448276,0.8891162621086486,1.0,6/16,15.92%,DNAH11;DNHD1;DNAH17;DNAH1;CCDC39;DNAH9
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.482758842581268,1.1347905827191853,0.23333333333333334,0.7961565929607781,1.0,11/53,11.83%,RNF122;UHRF2;RNF208;MARCHF5;UBE3D;MDM2;UBE2D2;RNF19B;TRAF6;RNF185;RNF10
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.43254828163680004,1.1339679835253595,0.25,0.797193520153674,1.0,8/111,3.79%,ADARB2;POLR2D;NUFIP1;TBRG4;SYNCRIP;RNASEH2C;NOL9;WDR74
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.5703595513028712,-1.1338978127591193,0.3142857142857143,0.8918958047974093,1.0,2/30,5.21%,DDX11;TIPIN
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.4547302600278166,1.1338672377218673,0.2,0.7965537826217687,1.0,8/44,10.15%,PIR;TGFBR2;SIRT1;CBFA2T3;PPARG;PARP1;RUNX1;LGALS9
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.597963087603744,-1.1337527878965343,0.2909090909090909,0.891445953800102,1.0,3/20,8.13%,PER2;PHKG1;CALM1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.6733265290710359,-1.133700199457328,0.3559322033898305,0.8906834294477618,1.0,1/10,3.29%,RORA
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.6527212500566276,1.1334993792176826,0.3673469387755102,0.7968430782118712,1.0,5/7,15.70%,GALNT13;GALNTL6;GALNT1;EOGT;GALNT2
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.5642782493351606,1.1333211833652084,0.35294117647058826,0.7964438043716283,1.0,4/11,6.28%,SLC7A8;SLC1A3;SLC3A2;SLC1A2
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.6308507958616227,1.1330999518494789,0.38,0.7960734560949277,1.0,4/7,28.43%,SALL1;TMEM65;PDE2A;NOTCH1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.6957420504517269,-1.132827635639588,0.3620689655172414,0.8930557922676938,1.0,2/7,15.65%,MTHFD1;SMS
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6473311527837634,1.132693436445445,0.3333333333333333,0.7961241796334835,1.0,4/9,10.55%,LRP4;NLGN1;PTPRD;PTEN
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6784596601287409,-1.13260575888397,0.3148148148148148,0.892937535875443,1.0,3/11,18.89%,IFIT1;STING1;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.7318355107674119,-1.1325802547304948,0.29310344827586204,0.892065546776889,1.0,1/7,0.62%,SKAP1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.6359485137669851,1.1324524284080026,0.3469387755102041,0.7950930803748631,1.0,1/6,1.19%,GCLC
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.6359485137669851,1.1324524284080026,0.3469387755102041,0.7950930803748631,1.0,1/6,1.19%,GCLC
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.7105456270529265,-1.1319046767339842,0.3389830508474576,0.8935743712377162,1.0,2/8,9.89%,SKAP1;CD44
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.7100291015071815,-1.1314400820211357,0.40476190476190477,0.8931819571509896,1.0,1/5,5.44%,CD14
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.7100291015071815,-1.1314400820211357,0.40476190476190477,0.8931819571509896,1.0,1/5,5.44%,CD14
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.637677609855459,1.1311913906734565,0.34146341463414637,0.7979930896351816,1.0,2/8,2.92%,SERTAD2;ARID1A
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.8088621965530708,-1.131185388054235,0.32,0.8930459006961571,1.0,2/5,10.86%,RIPOR2;CFLAR
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.6640129113253004,-1.1311334019212866,0.328125,0.892297444762887,1.0,1/12,0.66%,MYO1G
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.7175102564802391,1.1309924545268455,0.36585365853658536,0.7976649140675897,1.0,3/7,17.31%,TANC2;PPFIA2;SYT4
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.47011091893057905,1.1309351735924755,0.3055555555555556,0.7969891510675171,1.0,4/41,4.10%,PLXNB1;MAP1S;NYAP2;LRRK2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.6929957894086098,-1.1308547073954838,0.323943661971831,0.8922814039995247,1.0,3/11,8.27%,RIPOR2;DUSP1;STK39
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.5201685056093954,-1.13062741238376,0.29850746268656714,0.8922562734920787,1.0,23/61,21.31%,AURKAIP1;MRPL57;MRPS7;MRPL19;MRPL51;GADD45GIP1;MRPS11;MRPL52;MRPL32;MRPL50;CHCHD1;MRPS10;MRPL16;MRPS15;OXA1L;MRPL45;MRPL43;MRPS18C;MRPS25;MRPS21;MRPL47;MRPS9;MRPL13
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5697773641495701,-1.1305782910331101,0.2647058823529412,0.8914746679912772,1.0,6/22,18.78%,EMD;CYB5A;COX18;MAIP1;OXA1L;SERP1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.6901415999059036,-1.1304964050288973,0.32786885245901637,0.8908131288776209,1.0,1/10,0.15%,FLNA
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.525798047994115,1.1303558308193695,0.19047619047619047,0.7977761433248143,1.0,13/39,15.57%,SLC39A12;SLC9C2;SLC39A14;KCNJ2;SLC39A8;KCNJ5;SLC12A6;SLC9A1;SLC9A9;SLC8A1;SLC24A2;SLC12A2;SLC12A5
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.5915063457946402,-1.130319814116112,0.29508196721311475,0.8904804487564527,1.0,5/24,17.72%,OGG1;FANCB;CYREN;PARPBP;POLQ
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.4726974348948627,1.1300407181431265,0.32,0.7977690180809234,1.0,4/47,9.81%,LEPR;LRRK2;TAB2;HGF
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.583277977359606,-1.129927662607716,0.375,0.8908117037647295,1.0,6/24,15.95%,CENPU;NPM1;CENPV;ITGB3BP;CENPF;MIS12
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.4338700171007783,1.1298936350205144,0.19047619047619047,0.7972619879163731,1.0,17/72,14.55%,NCAN;SCN3A;PLPPR1;NOL4;SNAP91;OLFM3;CA10;GRIA4;ALCAM;ASXL3;CACNA1B;GRIA2;UNC5D;PTPRN;NFASC;CSRNP3;ABCC8
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.533184694665205,1.1294346834992133,0.28205128205128205,0.7967223524932641,1.0,6/21,15.88%,WDR33;SSU72;PCF11;SCAF8;AHCYL1;PAPOLA
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.533184694665205,1.1294346834992133,0.28205128205128205,0.7967223524932641,1.0,6/21,15.88%,WDR33;SSU72;PCF11;SCAF8;AHCYL1;PAPOLA
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.7046670645612183,-1.1293525072669577,0.37777777777777777,0.8917321294048958,1.0,2/6,6.08%,CHCHD10;NLGN2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.5814104613851211,-1.1290872833662202,0.3088235294117647,0.8915899081439159,1.0,2/23,1.20%,INSIG1;CH25H
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.6175437055181481,1.1288000069102038,0.3333333333333333,0.7978237206306396,1.0,12/18,29.12%,PTPN23;PTPRM;PTEN;DNAJA4;PTPRR;PTPRG;SLIT2;SVBP;DAB2IP;CORO1C;DUSP10;SP100
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.5564649720355355,1.128696303985507,0.38235294117647056,0.7971943900326817,1.0,2/16,5.55%,RNF2;RYBP
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5558176588922308,1.128685558983213,0.2972972972972973,0.7963454370754726,1.0,4/17,7.98%,LRRK2;DDIT3;TXNDC12;BOK
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5412865811840887,-1.1286686467876812,0.323943661971831,0.8918645510752075,1.0,8/38,14.02%,HARS2;WARS1;NARS1;KARS1;LARS1;DARS2;TARS2;FARSA
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.6423660421380119,1.128444228983565,0.37777777777777777,0.7961881498312252,1.0,1/5,0.21%,IFNLR1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.624630929039104,-1.128141830698391,0.3333333333333333,0.8928260777016361,1.0,3/21,11.84%,SYAP1;RPS6;PRR5L
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5370178856760914,-1.1279737687226299,0.28125,0.8926018111774333,1.0,5/38,9.64%,FLNA;EMD;JUP;RBM22;NCBP2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.6339315634324186,-1.1276895886894487,0.3333333333333333,0.8925405011337741,1.0,3/9,19.16%,LIPG;PLTP;ABCA5
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.634279976188114,1.1276607226558002,0.34782608695652173,0.7971888654060867,1.0,5/10,29.66%,PRKAA1;ULK1;KCNB1;RPS6KB1;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5389247459713691,1.127487183193977,0.3023255813953488,0.7968382719484163,1.0,3/20,5.45%,ANXA1;CDK10;UBE2E2
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.7333401856342516,-1.1273821854598487,0.3230769230769231,0.8929030984408585,1.0,1/6,12.56%,CDC7
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.5946913658698731,-1.1272260011556996,0.38596491228070173,0.892445297772301,1.0,1/15,0.97%,RIPOR2
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.6343006842095953,1.1270160406994478,0.35294117647058826,0.7970935221546053,1.0,1/7,0.54%,ADARB2
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.5070770861188428,1.1269820296676898,0.3076923076923077,0.7963591445399539,1.0,12/47,22.67%,PDGFA;HIP1R;CDK10;CRK;EPHA5;RHOBTB1;RHOB;CORO2B;RHOQ;ARHGAP35;TAOK2;ABL1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.6209730243510054,1.1269250331403835,0.24390243902439024,0.795640068659497,1.0,2/9,5.71%,SIRT1;PARP1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.6510940286472431,1.1268017537864046,0.325,0.7950870297743343,1.0,1/8,5.40%,NAA20
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.7809956387082453,1.1265399142499097,0.38636363636363635,0.795014431975838,1.0,1/5,2.17%,HIP1R
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6835761980017188,-1.1263106933340075,0.3389830508474576,0.8946966036922163,1.0,2/11,4.80%,ITK;TXK
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.4715729603395742,1.1262169660677783,0.25,0.7952155558783353,1.0,5/25,5.28%,SCRIB;CDKN2AIP;PTPN23;GRIK2;CLSTN2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.49146662347223125,1.1261755278908385,0.28125,0.7944597929737551,1.0,9/28,18.05%,WNT5A;FZD3;NLK;PPP3CA;TCF7L2;PLCB3;MAP3K7;PPP3CB;TNRC6C
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.74943992854755,-1.1256239067380531,0.37254901960784315,0.8959544534899128,1.0,3/5,11.51%,MYLK;STK39;TRPV4
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.6948627429193268,1.1255239180371177,0.2972972972972973,0.7954936716388821,1.0,2/6,6.09%,UBXN6;LYST
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.6132523367972608,1.125429348573149,0.34210526315789475,0.7948073987961675,1.0,4/11,18.51%,PDK4;PTK2;PIK3CA;TLE1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3697229774845934,1.1253833861443816,0.16666666666666666,0.7941362106954561,1.0,46/288,13.67%,UBE2D1;SPSB2;RNF122;ZNRF3;FBXL14;KBTBD6;SIRT1;SPOPL;OTUD7A;PTPN23;FEM1B;UBE3D;DDIT3;KCTD6;UBA1;MDM2;APPBP2;RNF6;CLOCK;UBE2D2;UBR3;NEDD4L;KCTD10;SHARPIN;ZRANB1;FBXO45;RMND5A;ANAPC16;CDC23;BTRC;FZR1;RNF19B;UBE2L3;GID4;TBL1XR1;FBXW7;FBXW11;RNF20;RNF185;RNF217;FEM1C;COP1;KLHL42;BAG6;FBXL7;MVB12B
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.5458214837742938,-1.1252686741099132,0.3188405797101449,0.8963567147002762,1.0,4/46,4.80%,ITK;PRLR;BTK;TXK
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.549018186842288,1.1249240607451452,0.28205128205128205,0.7946229120081552,1.0,6/19,13.90%,CACNA1A;MCU;MICU1;CACNA1B;SLC8A1;CACNA1E
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.46485332975166016,1.1248874806258546,0.29411764705882354,0.7938038500306631,1.0,10/53,14.19%,FER;TBC1D1;TBC1D16;TBC1D5;TBC1D10B;TBC1D22B;RABGAP1;ARF6;TBC1D2;EVI5
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.7350288067680579,-1.1247593809183924,0.3673469387755102,0.8971527099345764,1.0,1/5,2.73%,CD55
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5994880502417056,-1.1246869950421645,0.34545454545454546,0.8963523845948124,1.0,4/25,10.36%,CENPU;NPM1;ITGB3BP;HIRA
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.760080684107102,-1.124417124699887,0.3090909090909091,0.8963412775806786,1.0,3/5,22.48%,JUP;PKP2;DSC2
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.5835764356525295,1.123741349948078,0.3,0.7954665185961253,1.0,1/15,0.67%,POLR2D
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.5835764356525295,1.123741349948078,0.3,0.7954665185961253,1.0,1/15,0.67%,POLR2D
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.7082417783715277,1.1236549416748758,0.3170731707317073,0.7948930266989215,1.0,2/5,10.55%,DEPTOR;PTEN
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.7949377196729652,-1.1232403785756706,0.40425531914893614,0.8996377517898596,1.0,1/6,0.70%,CD36
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.5583944991588475,1.1232097407230592,0.34146341463414637,0.7952680788248349,1.0,4/16,16.26%,SETD7;SETD3;SETD2;SETD4
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6804788994697655,-1.1230673356427794,0.33962264150943394,0.8992391773624899,1.0,4/8,15.49%,RUNX3;LILRB4;NCKAP1L;HLA-E
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.5661997703456982,-1.1230041566689855,0.32786885245901637,0.8984935633958061,1.0,2/27,7.62%,DDX11;BRCA2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.6688043551507641,-1.1229655951910418,0.3387096774193548,0.8976960747012847,1.0,2/9,2.31%,FLNA;AIF1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4999207222216139,1.1228914235323253,0.21428571428571427,0.7953854769273263,1.0,3/24,4.24%,ANXA1;SIRT1;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4052223116360601,1.1227847933607866,0.2222222222222222,0.794908423676007,1.0,22/96,12.27%,ZBTB16;COL5A2;SPRY2;SIRT1;SMAD7;SPRED1;SPRED2;WNT5A;JAG1;USF3;ANP32B;PPARG;SMAD3;HPN;RANBP3L;PTCH1;PTEN;FERMT2;TWIST2;RUNX1T1;CDK6;CNTN4
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6012168816714033,-1.1227637010843587,0.2765957446808511,0.8973809528663944,1.0,6/14,16.86%,RORA;SULF2;HIF1A;C3;BRCA1;IL1B
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.6325395746690441,-1.1224382680237701,0.2631578947368421,0.8975110912432532,1.0,1/11,1.12%,ZFP36
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.4427839068148874,1.1223971842644078,0.25925925925925924,0.7949719924219,1.0,5/40,9.95%,PCBP4;MDM2;CNOT7;ZNF385A;CNOT2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.6249582304807377,1.122328251074798,0.3333333333333333,0.7942807658547032,1.0,5/10,20.29%,LRRK2;MAP2K1;MAPK1;MAP2K2;USP7
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.6829264023584917,-1.1222711226169955,0.30158730158730157,0.8972323651315911,1.0,5/7,26.41%,SOD1;TESPA1;TOX;CAMK4;VNN1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.3550849005053142,1.1222696907420402,0.14285714285714285,0.7935909975714034,1.0,48/306,13.19%,DAPK2;PANK3;FER;PDK4;ACVR2A;AATK;TGFBR2;FAM20C;STK36;MAP3K11;CDK10;NEK10;LRRK2;MAP2K1;CDK17;RPS6KA4;TLK1;RYK;NUAK1;CDK18;STK25;NLK;MAST2;MERTK;CDK7;MAP4K5;IRAK1;STK38L;IRAK3;PRKAB1;BRSK1;FGGY;BMPR1B;DYRK1A;CDK13;WNK1;CILK1;MAPK1;FNIP2;BMPR1A;PIM1;CDK6;MAPKAPK2;CSNK1E;CDKL2;MARK1;STK10;PRKCI
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.5053794153467701,-1.1222298165099696,0.2602739726027397,0.8964129829038636,1.0,11/62,12.48%,ABCA9;CH25H;NUDT12;ABCA6;GNPAT;GSTK1;DIO2;GCLM;EFHC1;SOD1;ABCA8
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.6034871585729363,-1.1220789212193558,0.37142857142857144,0.8960385138466875,1.0,3/18,10.86%,CDC37;MLKL;CFLAR
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.4813227564156423,-1.1220002495871917,0.26582278481012656,0.895346089919008,1.0,10/124,6.57%,CCL4;CCL3;CCL5;VAV3;RGS1;GMIP;RACK1;RGS16;GNB5;ITGA6
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.4477157234799546,1.1219888226628658,0.25,0.793588515139224,1.0,16/47,21.73%,TGFA;GAB1;NRG1;NCK2;PTPRR;MAPK1;PTK2;NRG2;ERBB4;PIK3CA;ERBIN;PTPN12;PTPN18;CBL;GAREM1;CPNE3
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.7316697991562943,-1.121904536594542,0.39655172413793105,0.894787802662723,1.0,2/5,18.17%,FCER1G;CD74
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.5301276027358738,1.1214887920141818,0.25806451612903225,0.7942577146475073,1.0,5/27,12.36%,MAP1S;COPG1;BICDL1;FBXW11;RAB6A
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5824942575246372,-1.1210329137731596,0.3382352941176471,0.8969431630983107,1.0,11/18,27.11%,DHX58;HLA-DRA;PTPRC;IL1B;HLA-DMB;DDX60;RPS19;HLA-DRB1;LILRB1;MYO18A;XBP1
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.658654617588288,1.1209730889837113,0.3888888888888889,0.7948181515274115,1.0,1/7,1.21%,PLA2G7
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7157574589566877,-1.1207487311929025,0.3389830508474576,0.8970021932642616,1.0,2/5,19.95%,MCEE;MMAA
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.6388510185341285,1.120061054940377,0.4,0.796423025399771,1.0,2/7,2.92%,SERTAD2;ARID1A
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5275249901310518,-1.1199827529343058,0.3220338983050847,0.8986304819162896,1.0,17/38,28.33%,ATP5F1E;MICOS13;ATP5PD;ATP5ME;APOO;SPG7;MAIP1;ATP5F1D;ATP5F1C;MTX3;TIMM29;ATP5MC2;AFG3L2;MICOS10;TIMM9;DNAJC11;GHITM
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.6494817849977705,-1.1199182834239139,0.2982456140350877,0.8978597076910352,1.0,1/8,1.13%,CCL5
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.7227183144775731,-1.119740571432568,0.36538461538461536,0.8975568605869886,1.0,2/5,7.48%,SAT1;SAT2
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.6365532963690878,-1.1197231385798097,0.3958333333333333,0.8967009468230431,1.0,1/8,3.86%,RGS2
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.45192265089815353,1.1195065996940503,0.2857142857142857,0.7962382456719275,1.0,9/47,17.89%,POLR2D;NUP153;NUP188;NUP42;IPO8;POLR2H;NUP133;NDC1;NUP205
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.45192265089815353,1.1195065996940503,0.2857142857142857,0.7962382456719275,1.0,9/47,17.89%,POLR2D;NUP153;NUP188;NUP42;IPO8;POLR2H;NUP133;NDC1;NUP205
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6065098991329421,-1.119503905623368,0.3283582089552239,0.8964087328515422,1.0,5/18,19.39%,ABCB1;STK39;CFTR;ATP1B3;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.5619926695665138,-1.1193136326042525,0.3382352941176471,0.8960732796275813,1.0,4/20,7.14%,HLA-B;CD55;B2M;HLA-F
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.6714182953977171,-1.1192133744088968,0.3389830508474576,0.8954406452136762,1.0,1/7,4.81%,RACK1
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5872923918230567,1.1188556121019284,0.25,0.7971817941654751,1.0,5/9,22.55%,CRK;CCDC125;FRMD5;SPOCK3;SPINT2
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.5528771866180822,1.118848232681379,0.3333333333333333,0.7963746204426483,1.0,2/13,6.58%,SCRIB;TBC1D16
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7227641402247107,1.1185198113820847,0.4,0.7963692500654179,1.0,1/6,2.45%,SIRT1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6966416083110574,-1.118176904122664,0.39655172413793105,0.8985027358554658,1.0,2/8,10.05%,CALM1;PTS
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5298675279982927,-1.1181716319140618,0.2361111111111111,0.8975803653934986,1.0,10/41,12.00%,RIPOR2;MYO3B;CEMIP;SLC26A5;CDH23;CRYM;ZNF354A;NDUFB9;USP53;SOD1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5312849461586466,-1.1178157490512353,0.3181818181818182,0.8978651928017067,1.0,13/36,26.65%,SNRPD2;SRPK1;ZRSR2;CRNKL1;DDX23;GCFC2;SNRNP200;LUC7L3;SF3A3;SF3A1;DDX1;YTHDC1;SNRPG
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.46521641787443335,-1.117796690413738,0.2564102564102564,0.8970152112550189,1.0,26/162,14.48%,SLC2A3;INSIG1;TFRC;GAPDH;CXCR4;ME1;WARS1;BTG2;SLC7A5;PPP1R15A;BHLHE40;DDIT4;ERO1A;LDHA;GLA;NAMPT;HK2;EGLN3;TOMM40;ITGB2;ARPC5L;PGK1;PSMC4;EIF2S2;VLDLR;PSMD12
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.6862611694306843,1.1177049867243292,0.37777777777777777,0.7978025971813784,1.0,3/6,20.82%,ERCC4;NBN;ERCC1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.7320920847371479,-1.1176708272322675,0.39215686274509803,0.8965853524864886,1.0,3/5,17.54%,TMEM70;OXA1L;ATP5F1D
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5817104519931585,1.1174711264998392,0.40540540540540543,0.7975695220964318,1.0,5/12,14.60%,KCNJ2;NEDD4L;SLC9A1;SLC8A1;SLC12A2
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.7134958269883034,-1.1169549278613766,0.39285714285714285,0.8979325252674007,1.0,3/5,19.53%,DHX58;C1QBP;DDX60
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.656313615521303,-1.1167491626127304,0.39215686274509803,0.8977287412838022,1.0,2/8,14.25%,EIF2AK2;PTPRC
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.4846707637587883,-1.1166152573525308,0.2597402597402597,0.897308169764112,1.0,7/90,6.67%,DDX11;CD36;TFRC;DHX16;DHX38;HDGF;ILF3
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.6100596791140493,1.116346092165675,0.37254901960784315,0.7998893040988797,1.0,3/10,14.43%,PDPN;SLC19A2;SLC35F3
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.6983098973526151,-1.1162799605409943,0.38181818181818183,0.8976696200333247,1.0,2/6,19.40%,NOTCH2;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.47501900891144183,1.1158393759493792,0.28205128205128205,0.8002255727379987,1.0,11/43,9.25%,PDGFA;FGF2;MAP3K11;NEK10;LRRK2;PDGFC;ROBO1;IRAK1;MAP3K10;DVL3;SASH1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.7122102945434553,-1.1154003686626117,0.46153846153846156,0.8996603598001198,1.0,2/5,19.97%,SFXN3;SLC1A4
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.6891075019407307,-1.1150754539733094,0.38461538461538464,0.8998627175734681,1.0,3/7,16.86%,DARS2;TARS2;GARS1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.6700216618491909,-1.1149572077763896,0.3888888888888889,0.8993118913986815,1.0,3/12,10.05%,DEGS2;CALM1;PTS
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.46458327322048865,1.1149409680013536,0.3333333333333333,0.8018877386950721,1.0,13/29,18.18%,LRP4;TMEM106B;CTNNA2;DOCK10;SHANK3;BTBD3;PTEN;CELSR2;KLF7;MAP2;PHACTR1;MAP6;FARP1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.6451370773319159,-1.1148936907575677,0.30158730158730157,0.8985806904804534,1.0,1/11,1.13%,CCL5
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.560110478193782,1.11467303650341,0.36363636363636365,0.8015718765004651,1.0,5/19,15.32%,SERPINE1;SEMA5A;ANO6;PRKCI;TNF
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.45183666335882566,1.1142212071495374,0.18518518518518517,0.802196598965574,1.0,18/67,12.97%,PKD2;TGFBR2;PKD1;TSC2;HDAC9;SALL1;PDLIM5;TAB2;PTEN;FBXW7;SMYD4;KAT2A;LDB3;ALPK3;PDLIM7;NF1;HEG1;CACYBP
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.610607005841919,1.1137992028228716,0.3617021276595745,0.8024100602600643,1.0,6/9,25.68%,FGF2;IPPK;PPIP5K1;ITPKB;IP6K2;IP6K1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6307010653814094,1.1136132554551779,0.3191489361702128,0.8012651712474154,1.0,1/8,7.86%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6307010653814094,1.1136132554551779,0.3191489361702128,0.8012651712474154,1.0,1/8,7.86%,KANK1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.70927300872947,1.113586449894594,0.3170731707317073,0.8005428878686185,1.0,4/5,29.08%,NTRK2;TMEM108;WASF1;MAPT
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6443277810325636,1.1135519087943846,0.46153846153846156,0.7998089251391364,1.0,4/7,22.24%,PICALM;SORL1;AGER;BIN1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.636225760069931,1.1134531776000447,0.35,0.7992475109394365,1.0,4/7,9.26%,YJEFN3;WNT5A;WNT2B;RUNX1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5857973479253231,1.1133327085575058,0.32432432432432434,0.7987398251214927,1.0,5/14,20.38%,INTS6;EXOSC6;INTS7;EXOSC7;INTS6L
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.4527440110449592,1.113196665461543,0.24242424242424243,0.7984038672048509,1.0,14/64,12.65%,COL16A1;LRP4;SVEP1;COL5A2;ACTA2;WNT5A;BMP1;TIMP3;TNFRSF10A;CDH11;COL11A1;FAM114A1;ITGA2;MMP14
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5597382171077595,1.1128846248159678,0.3888888888888889,0.7985670074419093,1.0,6/14,16.13%,TTLL11;PARP1;TTLL1;CEP41;TTLL7;VKORC1L1
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.4988424979279157,-1.112669745202336,0.28378378378378377,0.9052422128740513,1.0,4/58,1.85%,MT2A;FTH1;TFRC;HAMP
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.7009939383835926,-1.1125799055774468,0.4745762711864407,0.9046616633988532,1.0,1/7,11.74%,KDM7A
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.6991594399105002,-1.1124502209114733,0.2708333333333333,0.9042287963770342,1.0,3/6,24.03%,LILRB4;CD200;LYN
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.5557782693264779,1.112388651808313,0.3548387096774194,0.799227708569361,1.0,5/16,6.28%,SLC7A8;SLC1A3;SLC3A2;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5460526906892892,-1.11237911671883,0.32786885245901637,0.903616054694851,1.0,7/25,14.30%,TOMM7;USP36;RHOU;ARIH2;HPS4;PDCD5;ABLIM3
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.622065507572114,1.1123304836454835,0.34285714285714286,0.798656680451709,1.0,1/9,0.63%,PLA2G4C
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.5111655382379185,1.1121433034695265,0.2962962962962963,0.7983614116222095,1.0,6/19,15.09%,SORT1;UBXN6;LYST;CHMP7;LEPROTL1;CHMP1A
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.6907448228103545,1.1119014024764067,0.35714285714285715,0.7980798095227308,1.0,5/6,26.91%,RAB7A;RAB7B;ARL8B;RAB20;PIKFYVE
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.44402331316212984,-1.111745667807992,0.25882352941176473,0.9050253530884128,1.0,30/179,12.54%,UBC;CD36;CARD16;TFRC;RPS27A;PRKCQ;CARD14;TRIM5;BEX1;DDRGK1;BTK;AIM2;CLU;JUP;TRIM22;LAMTOR5;PHB2;RPS3;NPM1;HSPA1B;PRKD2;EIF2AK2;ESR2;IL18R1;TCF3;CFLAR;TRIM13;BUD31;STING1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.419574296938954,1.1116218239353803,0.38095238095238093,0.7980336641108657,1.0,10/119,5.97%,EGR1;PPARGC1A;KLF4;PKD2;FGF2;SIRT1;SAMD4A;STARD4;LDLR;SMAD3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.515876152907283,1.1115655383972916,0.2765957446808511,0.7973879751265129,1.0,10/26,20.29%,NETO1;SCN3B;NEDD4L;WNK1;SLMAP;FXYD5;NEDD4;FXYD7;GLRX;SCN1B
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7197247689157262,-1.1113255742711652,0.4,0.9054438790111132,1.0,3/5,22.54%,ANXA2;FLOT1;EMP2
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.4488271191136334,1.1112599875695088,0.16,0.7973686744497123,1.0,10/37,14.60%,PKD2;SCN3A;SCN3B;SLC4A4;NEDD4L;SCN8A;ANO6;SLC8A1;SLC24A2;SLC12A2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5603397284081126,1.1112323423901873,0.42857142857142855,0.7966469255491524,1.0,8/14,29.41%,RIDA;YTHDF1;YTHDF2;FTO;CELF1;METTL16;YTHDF3;PUM1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.4670334743227958,1.1109006342175167,0.23076923076923078,0.7965504441243901,1.0,11/49,9.85%,PLXNB1;ACER2;SERPINE1;SEMA5A;PLXNA2;JAG1;PLXNB2;PLXNC1;PLXNA3;PDE3B;CD164
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.6227980087863622,-1.110674232805374,0.3,0.9069170581806061,1.0,2/12,3.15%,GCNT1;SELL
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.736813798455753,1.1101060855162153,0.3170731707317073,0.7977264499883938,1.0,4/7,16.18%,SIRT1;DIP2B;SETD5;PRKAA1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6794946414306148,1.1100895676753557,0.45,0.7969287217440678,1.0,2/7,11.69%,SMAD2;BMPR1A
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.47664809592542295,-1.1095661714544773,0.3194444444444444,0.9095187989294317,1.0,11/75,12.69%,UBC;RPS27A;XPA;COPS6;POLE3;PADI2;FAM50A;HMGN3;CENPV;RBX1;GATAD1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.5922883537409158,1.1095581429115826,0.4444444444444444,0.797454145711703,1.0,3/11,14.42%,TCP1;GNL3L;CCT3
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.5609950920445619,1.1091652826354386,0.3783783783783784,0.7978490733064678,1.0,4/14,18.51%,PDK4;PTK2;PIK3CA;TLE1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.4282451112458936,-1.1091234427072214,0.21839080459770116,0.9099999450091513,1.0,46/291,12.58%,ITK;CALCR;BTN3A1;CD36;CCL3;RPS4X;PID1;RIMS1;TFRC;GAPDH;WARS1;RPL5;TAF1D;DDRGK1;RPL11;TXK;CLU;TTN;MUSK;IGF1;RPL23;LAMTOR5;ETS1;RBM22;RPS3;VPS35;NPM1;SNF8;HSPA1B;ACTG1;LURAP1;RPS7;RBPJ;EIF2AK2;CITED2;PLSCR1;GLMN;U2AF2;OVOL2;ACTB;EIF4A3;PDCD5;SOD1;DNMT1;VEGFA;TYROBP
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.7342715795298842,-1.1085410438771386,0.36507936507936506,0.9109762992363375,1.0,1/6,2.40%,CD200R1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.5477573701891187,-1.1085002265509434,0.2833333333333333,0.9101901178269213,1.0,4/30,6.30%,CALCR;CD36;SNX6;IGF1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.6998177078842386,1.108466148752399,0.42,0.7987991883585631,1.0,1/5,3.86%,SERPINE2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.6679671760896199,-1.1083609377382453,0.4166666666666667,0.9098153461662063,1.0,4/12,18.30%,GNB5;SRI;CACNB1;NOS1AP
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.6913344659627016,-1.108293113126474,0.328125,0.9091087136341945,1.0,4/10,21.49%,HUS1;TIPIN;RAD9A;NAE1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.4219801789264905,-1.1080493083823377,0.26744186046511625,0.909016974004123,1.0,43/214,16.10%,ITK;BTN3A1;CD2;GAPDH;PRKCQ;DHX58;AIF1;SLC7A5;SLAMF6;RORA;TXK;CD14;FCER1G;IL12RB2;CHI3L1;LAMTOR5;RPS3;IRF7;BTN3A2;HSPA1B;PRKD2;LURAP1;EIF2AK2;IRF1;GLMN;CD226;IL18R1;SOD1;STING1;APPL1;TYROBP;SULF2;HIF1A;C3;CYBA;PTPRC;HSPA1A;BRCA1;SLC11A1;HLA-E;HLA-DPA1;CD200;NOD2
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.45663637104417043,1.1080487153704879,0.24242424242424243,0.7991015371063269,1.0,13/31,16.99%,KNDC1;BCL11A;NEDD4L;CSMD3;DCC;COBL;MARK1;GSK3B;ADGRB3;KIAA0319;NEDD4;CAMSAP2;SEMA4D
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5403070723236587,-1.1076722583405731,0.27692307692307694,0.9093935533864465,1.0,10/26,28.33%,SLC25A5;MICOS13;APOO;SPG7;MAIP1;MTX3;BNIP3;MICOS10;DNAJC11;GHITM
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.7102319011199909,-1.1075676902948348,0.3584905660377358,0.9089020773834918,1.0,3/5,18.77%,AIF1;RAC1;INPP5K
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6259226035099034,-1.1075371374031713,0.36065573770491804,0.9080633383526904,1.0,1/10,0.88%,INSIG1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5039287431744877,1.1074463680414957,0.2777777777777778,0.799867811208063,1.0,4/26,12.23%,ACER2;BOK;FHIT;ZNF385B
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.7157219115176444,1.107306173279017,0.5,0.7994465868807268,1.0,1/5,1.65%,ADIPOR2
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.49246879777141184,-1.107288156203232,0.28169014084507044,0.9080663738413846,1.0,25/75,21.31%,AURKAIP1;MRPL57;MRPS7;MRPL19;MRPL51;GADD45GIP1;MRPS11;MRPL52;MRPL32;MRPL50;CHCHD1;MTIF3;MTRF1;MRPS10;MRPL16;MRPS15;OXA1L;MRPL45;MRPL43;MRPS18C;MRPS25;MRPS21;MRPL47;MRPS9;MRPL13
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.4629233306800724,1.1070135549071463,0.21052631578947367,0.799348156587641,1.0,4/44,6.73%,BAG3;SIRT1;TSC2;SPTLC2
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.44319945115037224,-1.1069972334233786,0.24691358024691357,0.9082474194297538,1.0,32/134,16.44%,YES1;IFIT1;DHX58;TRIM5;RPL39;MX1;B2M;BTK;NLRC5;IFITM3;FCER1G;SHFL;SRPK1;TRIM22;PHB2;IRF7;APOBEC3G;KLRD1;OAS1;NCF2;TRIM13;FYN;ALPK1;H2BC21;STING1;TYROBP;C3;CYBA;SLC11A1;HLA-E;NOD2;CIITA
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5614321270069135,1.1060940387397287,0.3939393939393939,0.8013082888671628,1.0,4/11,17.48%,ACACB;HMGCS1;MVD;ACACA
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.5877762386330377,1.1058603639403697,0.38461538461538464,0.8011696265356933,1.0,5/10,13.70%,LARGE1;ST6GALNAC3;ST8SIA5;ST6GALNAC5;ST8SIA4
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.5381176124750366,1.1055760302743218,0.4,0.8012109876757171,1.0,4/19,8.20%,PRKAB2;CPT1A;PPARG;ACACB
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.553179584717339,1.1054780246856748,0.4166666666666667,0.8006494442648455,1.0,5/15,18.55%,RUVBL2;TCP1;NAF1;CCT3;SHQ1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.6547200114351633,1.1052235499411025,0.43243243243243246,0.8004349824214965,1.0,1/7,1.72%,GSN
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.6322038067075355,1.1045966016735491,0.3695652173913043,0.8013217730102798,1.0,2/10,11.51%,SIRT1;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.46076815236552665,1.104225429593729,0.2647058823529412,0.8014779028147412,1.0,6/41,9.40%,PPARGC1A;HIP1R;MCU;MARCHF5;BOK;DDHD1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.4481152427966204,-1.1040967930585934,0.2716049382716049,0.917370703208936,1.0,17/119,8.58%,FLNA;CD36;SRGN;RIMS1;F8;RAB3A;CLU;PECAM1;F13A1;TTN;IGF1;TMSB4X;PLEK;CD63;CALM1;FERMT3;SELENOP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.4865023166827462,-1.1040445007846516,0.32894736842105265,0.9166367658610242,1.0,12/55,18.80%,DDX11;IGF1;RANBP1;XRCC3;CENPV;PLSCR1;ZNF16;CDC7;SVIL;IL1B;NUDT16;USP19
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5047604076426914,1.1040338136252779,0.3235294117647059,0.8011993825520954,1.0,8/21,29.20%,AUP1;RNF185;BAG6;KLHL15;TOR1A;FBXL17;ZER1;VCP
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.6780265194909123,-1.103559922494714,0.39344262295081966,0.9172903178562108,1.0,4/7,28.05%,FCER1G;CD74;CARD9;ZP3
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6167131180455834,-1.1032772610541897,0.3389830508474576,0.9173515595468371,1.0,4/8,23.57%,TNFRSF1B;SNX9;IL1B;NRDC
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6772407514003765,-1.1029213870939638,0.39705882352941174,0.9176319667081129,1.0,5/8,26.73%,NOD2;VIM;TRIM41;PTPN22;ARHGEF2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.38088320697448413,1.102048997815994,0.2,0.8055029261981446,1.0,21/201,6.33%,SHROOM3;COL5A3;COL16A1;AVIL;TPM2;CORO6;CLIP2;GSN;HIP1R;COL5A2;TSPAN33;GFAP;TSPAN15;B4GALT7;MYO1D;COL24A1;PGM5;BMP1;TMOD2;TPPP;CIB1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.5941931311645717,-1.1020440049629607,0.3114754098360656,0.9200182316945393,1.0,1/25,0.09%,NR4A3
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.7512610851234649,1.1019322178426314,0.47619047619047616,0.8051189485494548,1.0,2/5,19.68%,MAP2;LAMP1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6268333713496892,-1.1018699915873102,0.3793103448275862,0.9196135948052845,1.0,3/12,12.00%,BBS2;IGF1;SOD1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.6215241420666519,-1.1015751731159238,0.3559322033898305,0.9198152013219829,1.0,2/10,5.78%,TGFBR3;MYBPC3
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6104517937407568,1.1014904590805839,0.3953488372093023,0.8053980293329162,1.0,1/11,0.06%,LEPR
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.6540391495261625,-1.1014605057412017,0.36363636363636365,0.9193611800925331,1.0,2/10,6.18%,UBXN1;AQP11
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.5179252437028723,-1.1012633335605084,0.34285714285714286,0.9191010832063876,1.0,6/56,7.97%,PKIB;DUSP1;PAQR3;RGS2;GSTP1;PRKAR1B
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.500155531631348,1.1012387446294656,0.32142857142857145,0.8053202904019519,1.0,10/42,6.10%,COL16A1;TPM2;SVEP1;FKBP9;COL5A2;ACTA2;INTS6;PHLDB1;WNT2B;TIMP3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4302083596911266,1.1011625056728198,0.25806451612903225,0.804696132748166,1.0,8/47,15.71%,PKD2;PKD1;MDM2;CCPG1;SPDYA;CCNYL1;CCND3;ANKRD17
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.6565495600124085,-1.1004462999597653,0.31666666666666665,0.920794848998093,1.0,4/11,16.15%,GSTM4;GSTP1;GPX4;ALOX12
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.5563094778449075,-1.1003526695452697,0.38461538461538464,0.9202825856907472,1.0,3/25,6.13%,MPP7;PECAM1;CLDN7
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6240668430476063,1.1001972641451228,0.42857142857142855,0.8066382870792074,1.0,5/10,26.75%,SLC8A1;RYR2;BLM;RYR1;CASP3
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.3772498212044352,1.1001305837730389,0.25,0.8060394316458722,1.0,23/190,7.01%,LEPR;PRKAB2;PPARGC1A;ESRRG;GRB10;PDPN;SERPINE1;IGF1R;ADIPOR2;TGFBR2;FGF2;ZBTB16;SIRT1;NLGN1;NCOA3;ADRA1A;WNT5A;BMP1;CADM1;SMAD3;SMAD2;PDGFC;RFX3
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.6085172580242839,1.1000805662783348,0.3409090909090909,0.8053910730154972,1.0,3/13,3.86%,PDGFA;SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.7241143936616268,-1.1000571942510933,0.4067796610169492,0.9205410800816034,1.0,2/6,12.61%,WDR48;NOP53
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.681899742441158,1.0998780750596024,0.45714285714285713,0.8050098728437155,1.0,1/5,3.15%,MYRF
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7159908140784728,-1.0997801894109722,0.41379310344827586,0.920715474612603,1.0,2/5,18.77%,PPP1R3B;INPP5K
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.46600880563607205,1.0994413535425613,0.3235294117647059,0.8054136058431693,1.0,4/24,5.52%,PDGFA;GSN;NPHP1;CSPG5
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.5547630299589646,-1.0992692402596946,0.31746031746031744,0.9214322666190518,1.0,8/33,15.03%,RPS8;RPS14;UTP3;NOB1;WDR46;MRPS11;RPS28;LOC102724159
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.4712152226685378,-1.0988742049376548,0.3918918918918919,0.9219807958249391,1.0,23/104,19.98%,UBC;ZFP36;RPS27A;PSMB3;PSMA7;PSMB9;PSMB6;EXOSC1;PRR5L;APEX1;PSMA5;PSMC4;PSMD8;HSPA1A;PSMD12;PSME2;UBA52;CNOT8;VIM;PSMA3;PSME1;PNPT1;CARHSP1
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5338840111295351,-1.0987819948320279,0.3235294117647059,0.9213782376138321,1.0,7/39,15.17%,CD2;NKD1;CLDN7;OVOL2;ITGAL;ITGA4;BRCA1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.6666450220201658,-1.0987466345816084,0.3673469387755102,0.9205854050132329,1.0,3/6,26.49%,PHB2;SLC30A5;SPHK2
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.6007823144708956,1.0986824112052758,0.3541666666666667,0.8065746695241001,1.0,1/10,4.10%,LRRK2
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.6261334553677134,-1.0986072705888514,0.4,0.9201684018504829,1.0,1/13,1.71%,DUSP1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.6385193741233147,1.0985173527898426,0.375,0.8054724591547723,1.0,3/7,14.39%,GCLC;SCPEP1;ADCY6
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.6385193741233147,1.0985173527898426,0.375,0.8054724591547723,1.0,3/7,14.39%,GCLC;SCPEP1;ADCY6
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5188716392344732,-1.0981840768060414,0.34782608695652173,0.9208655582093321,1.0,2/36,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.6535158661846592,-1.0981250356679484,0.3770491803278688,0.9201668987322571,1.0,1/9,0.88%,INSIG1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.5054599191715309,1.0980277725197045,0.34146341463414637,0.8058741412970606,1.0,6/17,25.56%,PTPRK;FERMT2;PEAK1;TAOK2;CTTN;SORBS1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.7685911169980206,-1.0980225183008692,0.40350877192982454,0.919544253047763,1.0,3/6,21.82%,ZNHIT6;FBL;PIH1D1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.5961332041862004,1.0975678013178982,0.35,0.8060988319499154,1.0,5/12,18.29%,TLR7;IRAK1;TRAF6;PIK3AP1;IRAK2
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.47454404783588705,-1.097549429796256,0.2898550724637681,0.9201902527733926,1.0,11/109,9.29%,PLEKHG5;ARHGAP4;RASGRF2;VAV3;GMIP;CGNL1;ARHGEF1;RHOU;OBSCN;ARHGEF3;SRGAP3
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.5959673770484478,1.097503536466396,0.30952380952380953,0.8055183913063348,1.0,3/8,15.24%,ZC3H14;RNF20;CDK9
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.5216455473441083,-1.0973760766005491,0.36231884057971014,0.9198584605404725,1.0,3/29,2.41%,CD36;AIF1;MARCO
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.639898391785606,-1.0972408638759403,0.39655172413793105,0.9195355920183077,1.0,3/10,16.53%,CD300LF;CD200;HAVCR2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.4927703593667751,-1.0972023148774581,0.33783783783783783,0.9187591068421234,1.0,11/55,17.15%,UBC;RPS27A;DDRGK1;PHB2;ACBD5;ATG2A;STING1;DYNC1LI2;CFTR;UBA52;VIM
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.641934249500067,-1.0971990091378636,0.41935483870967744,0.917852138325991,1.0,2/13,4.98%,PID1;FIS1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.6248510375369607,1.0970725970767643,0.35135135135135137,0.8061951816060979,1.0,2/9,3.61%,PKD2;PKD1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.7085616423079307,-1.0969522629447268,0.34545454545454546,0.9178371904653232,1.0,2/5,20.12%,ABCC3;SLCO3A1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5655756319346531,-1.096852524810238,0.38181818181818183,0.9172952470586869,1.0,3/25,10.26%,CENPU;NPM1;ITGB3BP
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.5920389120940777,1.096842693198432,0.36585365853658536,0.8060173407402157,1.0,3/9,13.93%,GPAT4;GPAT3;PCK2
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.6614053050310401,-1.0967836465454126,0.40350877192982454,0.9166062905800807,1.0,5/8,25.12%,AGA;NGLY1;PARK7;MAN2A2;MAN2A1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.5989031013407141,-1.0966212335856993,0.3333333333333333,0.9163049618369802,1.0,1/13,0.15%,FLNA
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.6840283813668295,-1.096418653479358,0.38461538461538464,0.9161520140618764,1.0,1/9,0.70%,CD36
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.5843306892109565,1.0959946432143959,0.3793103448275862,0.8075071646471639,1.0,1/20,0.36%,ANXA1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6330391551465778,-1.0959108152104275,0.35714285714285715,0.9171313032999071,1.0,4/13,7.60%,MYO1G;CD55;BTN3A3;BTN3A2
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.6053992270870459,1.0956915365757043,0.3333333333333333,0.8074786721517906,1.0,2/11,5.31%,PLA2G7;NCEH1
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.6528816128268526,1.0956757415098286,0.48717948717948717,0.8067495845201295,1.0,1/6,1.90%,MAP1S
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.511313879653465,-1.0955050805593587,0.2916666666666667,0.9176252028145868,1.0,7/41,12.49%,CYCS;TNFSF10;AIM2;FIS1;FYN;PDCD5;CYFIP2
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",-0.7413114389318138,-1.0954166971776034,0.40816326530612246,0.916988415336257,1.0,3/5,11.81%,RUNX3;LILRB4;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.49477146823985335,1.0947984455792101,0.25925925925925924,0.8081343187345482,1.0,15/62,22.67%,PDGFA;EPS8;HIP1R;CDK10;CRK;RAPGEF3;EPHA5;RHOBTB1;PIK3CA;RHOB;CORO2B;RHOQ;ARHGAP35;TAOK2;ABL1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6396236286407835,1.09399571682956,0.38095238095238093,0.8095038559567943,1.0,2/8,3.06%,LRP4;NLGN1
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.6802571494450448,-1.0939787064105133,0.4426229508196721,0.9211126813525604,1.0,3/6,16.68%,CRACD;NOD2;PBLD
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.4828449356740587,1.093834679621833,0.3103448275862069,0.8091741246510161,1.0,8/48,10.21%,B3GNT2;CSGALNACT1;LARGE1;B4GALT7;FUT9;CANT1;BMPR1B;ST8SIA5
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.6697937842582047,1.0936389830858566,0.3684210526315789,0.8090693668793184,1.0,2/7,6.24%,LRRK2;PPT1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.6036414947437617,-1.0933463689713405,0.35384615384615387,0.9223529145302823,1.0,3/12,13.97%,RAB11A;CDC7;CCND1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.46351753054014977,-1.0931691540379704,0.36231884057971014,0.9219500850371444,1.0,3/57,1.57%,UBC;ZFP36;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.5499577251016873,-1.0931492528503086,0.3114754098360656,0.9211240113775641,1.0,7/31,12.02%,NLRC3;RORA;LILRB4;GSTP1;STAT1;TNFAIP3;NLRP12
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.5632019700147626,1.0924452889995475,0.3829787234042553,0.8115420862128351,1.0,3/13,10.80%,FGF2;PPARG;SIRT6
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.6468729898575777,1.0922650225692803,0.35,0.8112610862851731,1.0,1/7,0.41%,RNF122
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5635960396782798,1.0922407061764665,0.3023255813953488,0.8105332851182523,1.0,4/10,21.01%,FGF2;SIRT6;FGFR1;AKT3
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5675346572655563,1.092195658856678,0.3684210526315789,0.8098813854569373,1.0,6/16,25.41%,RELN;PTPRD;CAPRIN2;IL1RAPL1;CAMK2B;CAPRIN1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.4983184238299327,1.091688192539227,0.2972972972972973,0.8105081788269027,1.0,9/20,16.74%,TULP3;KCTD6;PTCH2;GPR161;PTCH1;BTRC;ENPP1;MEGF8;MOSMO
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.3779469989086476,1.091563400457735,0.2222222222222222,0.8100558118129259,1.0,36/226,13.62%,SPSB2;FBXO30;FBXO32;FBXL14;DCAF16;GOLM1;KBTBD6;ZBTB16;FAM20C;DCAF13;DDA1;FEM1B;KCTD6;RAB1B;PRKCSH;GPS1;VGF;BTRC;HIF3A;ANO8;FBXW7;FBXW11;DCAF5;FEM1C;DCUN1D1;P4HB;FBXO27;CHM;KLHL21;DNAJC3;STT3B;COP1;KLHL42;FBXL12;FBXL7;EPAS1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.45330019937339466,1.0915553566066771,0.25,0.8092701126744071,1.0,12/36,14.79%,CNTN2;PKD1;IGSF11;PTPRM;CADM1;PLXNB2;ROBO1;NPTN;CELSR2;CNTN4;ROBO2;CDH4
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.4041500562618526,1.091539862989238,0.3,0.8084983023496948,1.0,13/55,19.52%,ANXA1;SIRT1;LIG4;CLOCK;BRSK1;INTS7;COP1;PRKAA1;RHOB;EEF1D;RFWD3;BLM;IKBIP
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.5993352900758764,-1.0912518177099446,0.3548387096774194,0.9265804830466324,1.0,3/14,12.58%,APOD;SOD1;TYROBP
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5967740741814165,1.0909050672213454,0.3157894736842105,0.8096305285077136,1.0,3/18,7.86%,RAP1GAP;CDK10;KANK1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.6048001149722255,1.0908572137995256,0.3333333333333333,0.8089586002578448,1.0,3/10,12.82%,NEK10;RFX3;CCDC40
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.7367496186025588,-1.0907698053276598,0.46296296296296297,0.9273873572525975,1.0,3/5,22.46%,HIF1A;PINK1;PARK7
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.4811007124935301,1.090761778758387,0.35714285714285715,0.8084236036889292,1.0,8/31,10.93%,HS3ST5;B4GALT7;GLB1;HS2ST1;UGDH;HPSE;GPC6;EXT1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.6145997456761485,-1.0907038545964682,0.4126984126984127,0.9266641033217727,1.0,6/11,17.73%,DDRGK1;PHB2;NPM1;ZNF16;STXBP4;ATAD5
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4905550928319008,-1.0906279953261082,0.3548387096774194,0.9260965869642268,1.0,16/63,19.37%,PSMB3;PSMA7;PSMB9;PSMB6;DVL1;PFN1;PSMA5;PSMC4;PSMD8;FZD2;PSMD12;AP2S1;PSME2;RAC1;PSMA3;PSME1
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.6984242995824932,-1.0905328286015363,0.45161290322580644,0.9254733686872274,1.0,3/5,22.51%,KDM7A;KDM6B;UTY
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.5870853015433644,1.0904964507573107,0.375,0.8082715101874405,1.0,2/10,9.93%,RELN;SHANK3
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7413595588651594,-1.090283379911789,0.4,0.9253377776294356,1.0,4/5,25.78%,DNMT1;BRCA1;PIH1D1;SMARCB1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.4241436571181915,1.089924142314457,0.3157894736842105,0.8088088749415036,1.0,15/73,17.89%,BAG3;SIRT1;NUP153;NUP188;NUP42;BAG5;MAPK1;FKBP4;MAPKAPK2;HSPH1;GSK3B;NUP133;IER5;NDC1;NUP205
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.5571119316272073,1.0898087800298768,0.3939393939393939,0.8083739261332767,1.0,2/13,4.47%,HIP1R;SNAP91
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.4837547664636843,1.0895475935609924,0.40625,0.8082468852527729,1.0,1/26,0.65%,NRP1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6482212648230716,-1.089534536633477,0.35185185185185186,0.9269356600436578,1.0,3/11,18.72%,DNMT1;BRCA1;SUPT6H
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.509791474192159,1.0894167197180833,0.26666666666666666,0.8076906030903058,1.0,6/29,16.67%,PGAP1;RIPOR1;SORL1;CEP131;DYNC1H1;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.6129843427253763,-1.0893398031170634,0.4,0.926734185727298,1.0,2/11,8.27%,HAMP;STK39
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.5363104352393264,-1.0891669726025492,0.34375,0.9264926838607405,1.0,8/28,20.20%,MRPL57;MRPS7;MRPL51;MRPS11;MRPL16;MRPS15;MRPS21;MRPL47
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.5411597436865416,-1.0889632338230562,0.3333333333333333,0.9263081781424779,1.0,4/38,3.56%,NIT2;ME1;MDH2;MTHFD1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.7176692107987581,1.088604959612564,0.4186046511627907,0.8089374963623593,1.0,1/5,8.65%,UBR3
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.4870150315968631,-1.0884904556050408,0.3466666666666667,0.9269227452379973,1.0,11/60,14.14%,TFRC;WARS1;MPP7;RACK1;CLU;PLEK;RPS3;SNF8;PFN1;VEGFA;SLX4
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.6050514077208953,1.0881435534778026,0.37777777777777777,0.8093981586640479,1.0,3/10,11.81%,SIRT1;MARCHF5;CDK6
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.682818237319241,-1.0881106655111505,0.39285714285714285,0.9271653640778411,1.0,1/7,3.86%,RGS2
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.42644166223869256,1.0881090879809607,0.20833333333333334,0.8087444869641928,1.0,34/96,18.40%,KCNQ2;CNTN2;NCAN;SNAP91;OLFM3;GALNTL6;CA10;TTLL1;KCTD8;PURG;PSD2;POU6F2;BRSK1;SLC35F1;LINGO1;NELL1;RBFOX1;NKAIN3;GPHN;SNCB;CACNA1B;NXPH1;PTPN5;GRIA2;SYT16;DPP10;CAMKV;LRRC4B;ADGRB3;CELF5;MAPK4;SYT4;MAP6;FXYD7
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),-0.7007977257575646,-1.0878479371173029,0.39655172413793105,0.9273511493459777,1.0,2/6,9.70%,OAS3;OAS1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.4467389181894095,1.0877907064594023,0.2857142857142857,0.8086910435827315,1.0,12/53,9.73%,ABCA2;IDI1;JAG1;STARD4;PPARG;LDLR;CHKA;SEMA3B;FDFT1;TM7SF2;ALCAM;HMGCS1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.4078404110497238,1.0877872069051286,0.3181818181818182,0.8079293888592757,1.0,12/62,9.93%,GRB10;CTNNBIP1;TCF7L1;TSC2;LRRK2;GNAQ;NLK;SALL1;KANK1;ZRANB1;RUNX1;BTRC
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6598381724112067,-1.0875646242084465,0.3709677419354839,0.9272871959511032,1.0,1/9,0.70%,CD36
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5895737247941097,1.0874436852889313,0.4146341463414634,0.8079012281738096,1.0,3/12,8.80%,SLC39A8;CA2;SLC4A4
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.524520043636877,-1.0872758577614534,0.375,0.9273037336887909,1.0,3/29,6.08%,MX2;MX1;NLGN2
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.49627983216063254,1.0872561779712018,0.3333333333333333,0.807641530742892,1.0,8/26,18.72%,RAB33B;COPG1;VTI1A;COG1;RAB6A;COG3;COPB1;COPZ1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.6460321280577467,1.0870804294013203,0.4,0.8073823289177587,1.0,4/5,32.83%,PNP;PRTFDC1;HPRT1;AMPD3
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.35056014494935384,1.0868485056367914,0.2727272727272727,0.8072087814364297,1.0,61/390,13.70%,UBE2D1;MKRN3;SPSB2;RNF122;FBXO30;ZNRF3;FBXO32;FBXL14;MSL2;ZNF598;SIRT1;UHRF2;RNF25;UBE2J1;KLHL18;RNF139;UBE2O;RNF208;DDA1;MARCHF5;TRIM26;UBE2E2;UBE3D;UBA1;MDM2;RNF6;UBE2D2;UBR3;NEDD4L;KCTD10;FBXO45;SASH1;RMND5A;ANAPC16;CDC23;BTRC;RNF19B;HIF3A;UBE2L3;PEX13;PEX5;FBXW7;FBXW11;RNF20;TRAF6;RNF185;UBE2N;MARCHF1;RNF10;BLMH;RNF217;RNF38;FBXO27;KLHL21;LZTR1;KLHL42;FBXL12;BARD1;FBXL7;EPAS1;TRIM35
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.7391417982352695,1.0867123175607891,0.4375,0.8059762684739318,1.0,1/5,1.11%,PDK4
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.7391417982352695,1.0867123175607891,0.4375,0.8059762684739318,1.0,1/5,1.11%,PDK4
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.6851212721641617,-1.086321291818083,0.4067796610169492,0.9296888224555218,1.0,2/7,6.32%,PER2;TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.5905959065803732,-1.0861970085733983,0.43548387096774194,0.9292778900217348,1.0,7/15,18.52%,ZFP36;LILRB4;TNFAIP3;PTPRC;KAT5;HAVCR2;EZR
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5624821800983693,-1.085715989075776,0.2987012987012987,0.9299015126231668,1.0,9/23,20.21%,CCL5;NLRC5;PLSCR1;IFI35;HLA-E;TASL;POLR3C;GBP5;RPS19
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.6461650967955725,-1.0855401948319412,0.4838709677419355,0.9294991697121838,1.0,4/7,12.00%,CXCR4;CLU;EPB41L3;SOD1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.6655328272029766,-1.0852717287732416,0.44642857142857145,0.9294175312702165,1.0,1/9,1.27%,DEGS2
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.7363803523041934,-1.0850217145447514,0.43548387096774194,0.9293120767819409,1.0,1/5,6.22%,JMJD6
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.673060065455621,-1.084990126574707,0.45454545454545453,0.9285442279088085,1.0,1/7,5.22%,RAB3A
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),0.6753468396763114,1.0849102370056376,0.4782608695652174,0.8098199277977886,1.0,2/5,15.32%,LCP1;TNF
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.5067602576570408,-1.0848739781377899,0.32142857142857145,0.9280091328752407,1.0,6/32,9.51%,PLEKHG5;ARHGAP4;ARHGEF1;RHOU;ARHGEF3;CFL1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.6558741332926886,1.084525999837091,0.3783783783783784,0.810032549388951,1.0,2/6,4.41%,ADRA1A;WNT5A
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.7120271895789139,1.0844428821063747,0.48,0.8095182860679003,1.0,3/5,25.01%,BMPR1A;SOX4;ACVR1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.6319371758104811,1.0843999871875083,0.38,0.8088719356315468,1.0,1/8,1.89%,ABCA2
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6494732898926723,-1.0842268095976362,0.42424242424242425,0.9291801804833025,1.0,2/8,9.96%,SIGIRR;PLSCR1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.45296861409924516,-1.084045416488994,0.29577464788732394,0.9288843072123225,1.0,15/89,15.58%,CCDC88C;PSMB3;PSMA7;CALM1;PSMB9;PSMB6;DVL1;PFN1;PSMA5;PSMC4;PSMD8;FZD2;PSMD12;AP2S1;PSME2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.42804357293855483,1.0839854553853983,0.2727272727272727,0.8091694465507331,1.0,9/54,9.26%,SERPINE1;SEMA5A;FGF2;SIRT1;GAB1;WNT5A;TMIGD2;SASH1;RUNX1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.6859066956245962,-1.0839120214935003,0.3787878787878788,0.9266744808773508,1.0,1/5,3.76%,DDRGK1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.6859066956245962,-1.0839120214935003,0.3787878787878788,0.9266744808773508,1.0,1/5,3.76%,DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.6859066956245962,-1.0839120214935003,0.3787878787878788,0.9266744808773508,1.0,1/5,3.76%,DDRGK1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.6219181832582135,1.0839035378406816,0.4634146341463415,0.808802343289909,1.0,1/6,3.32%,GLB1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.6818567403919158,-1.0838282255716103,0.37735849056603776,0.9260411150514067,1.0,4/8,25.08%,ITGB2;TYROBP;STX4;CAMK4
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.733345051511999,-1.0837037723095553,0.41379310344827586,0.9256149361415256,1.0,4/5,26.49%,BRCA1;PIH1D1;SMARCB1;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6059320374008461,-1.0834878229090816,0.3939393939393939,0.9254903360838268,1.0,6/14,8.50%,RPS15;RPS20;RPL37;EIF5A;RPL23;RPS7
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.6545412679028225,1.0834228250296316,0.5,0.8093526647757351,1.0,1/6,2.09%,MEPCE
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6712020888352224,1.0833909923365155,0.30434782608695654,0.8086366069527986,1.0,2/7,14.22%,CA2;AHCYL1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.7041698190088701,-1.0832653946622266,0.47619047619047616,0.925508307802902,1.0,2/6,11.43%,NDUFA12;COA6
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.6029066181100721,-1.08302083548686,0.41818181818181815,0.9254551448079834,1.0,4/13,6.94%,PRKCQ;TXK;FCER1G;PLEK
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5884491094661473,1.0826679014973226,0.3055555555555556,0.8096435470056836,1.0,3/14,12.26%,MEPCE;INTS6;INTS7
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.5170988180039962,1.0824272771798098,0.3333333333333333,0.8096502532616408,1.0,9/27,13.01%,ACER2;ABCA2;PLPP1;ST6GALNAC3;FA2H;SPTLC2;SAMD8;SPTLC3;SGMS1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.501746753348384,1.0824072389006791,0.34210526315789475,0.8089840052459256,1.0,9/27,13.05%,PDPN;TGFBR2;JAG1;SMAD3;SMAD2;BCL9L;FERMT2;TCF7L2;ZNF703
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.6742872926078105,-1.0823837874554707,0.4153846153846154,0.926672794419576,1.0,2/8,17.93%,GLA;GUSB
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.6558555648597906,-1.0822639265506544,0.45614035087719296,0.926177063274991,1.0,1/8,0.40%,MYLK
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.6619310383098458,1.0821701295221626,0.4375,0.8081230411067722,1.0,1/7,7.55%,EIF4E2
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.6619310383098458,1.0821701295221626,0.4375,0.8081230411067722,1.0,1/7,7.55%,EIF4E2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.6109125294502762,-1.0815776616767585,0.41509433962264153,0.9275492920802308,1.0,3/18,14.88%,SLC51A;ABCC3;ATP8B1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.6292728623484377,-1.0815117299105605,0.3870967741935484,0.92695135493963,1.0,3/15,5.47%,PRKCQ;SLC7A5;FCER1G
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.6473714453997369,-1.081418563495637,0.41509433962264153,0.9255310420275322,1.0,1/7,7.78%,DIO2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.6473714453997369,-1.081418563495637,0.41509433962264153,0.9255310420275322,1.0,1/7,7.78%,DIO2
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.4407972497584693,1.0814179592813158,0.3448275862068966,0.8092695315412908,1.0,28/82,18.76%,LRP4;CNTN2;NLGN1;LRRK2;RYK;LRRC4C;UNC13B;ZC4H2;PPFIA3;SHANK2;GRM5;DNM3;GPM6A;PTPRD;SHANK3;GPC6;PTEN;GPHN;SNCB;NRXN2;PPFIA2;CACNB4;LRRC4B;NEDD4;LRFN5;PPFIBP1;FARP1;SNCA
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.5078555119130466,1.0812188297427774,0.39473684210526316,0.8090610661723863,1.0,2/17,1.72%,PDGFA;GSN
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.7002974742586476,1.081130842565961,0.45098039215686275,0.8085898604699905,1.0,3/5,14.12%,IRAK1;LGALS9;PIK3AP1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5840806899075001,-1.0807253553834102,0.42424242424242425,0.9270085977112051,1.0,1/16,0.77%,PPIE
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.6786974370379566,-1.0805697970626942,0.46774193548387094,0.9265467049643743,1.0,1/9,8.13%,CALM1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.6689435994194015,1.0801255736474231,0.38461538461538464,0.8103182092662476,1.0,1/6,0.41%,RNF122
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5421258638585508,-1.079909349400492,0.3787878787878788,0.9277777023775353,1.0,9/34,16.04%,STAT4;ANXA2;IL12RB2;CFL1;SOD1;RPLP0;SNRPA1;PSME2;TALDO1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.703662107766321,-1.0796962156229135,0.46153846153846156,0.9275507378086557,1.0,1/5,1.54%,RSAD2
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.6256881325545909,-1.07948558503257,0.3939393939393939,0.9273632918222598,1.0,6/10,25.83%,ZWILCH;MIS12;IK;BUB3;CHAMP1;KNL1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.48711213406768994,-1.0789628428894904,0.375,0.9282307464447276,1.0,2/53,0.19%,NR4A3;JAML
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.47057397333549855,1.0788480122087736,0.36666666666666664,0.8130938796422054,1.0,5/47,4.24%,ANXA1;FER;PKD2;SIRT1;SIRPA
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.5796151836821306,-1.0786007001309896,0.3793103448275862,0.9285658962748943,1.0,7/19,16.10%,SLC7A5;CD55;B2M;HLA-F;CD226;HLA-E;NOD2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.5681267890020544,1.078494049818536,0.3488372093023256,0.8131688666986194,1.0,2/12,10.15%,TGFBR2;LGALS9
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7099057822450637,1.0783037813279897,0.4375,0.81299348122178,1.0,1/5,10.65%,PHACTR4
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.7010670038084829,1.0782635557770528,0.48,0.812306520087645,1.0,1/5,4.10%,LRRK2
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.44448728389812225,-1.078058189946412,0.3375,0.9293994230408998,1.0,23/149,13.96%,MYLK;UBC;CD36;ME1;MGLL;MDH2;CHCHD10;DNAJB9;UQCR10;ETFB;ENPP2;MTCH2;PFKFB3;NDUFB7;UQCRQ;SOD1;LPCAT3;PIM3;GPX4;SPARCL1;NABP1;ELMOD3;C3
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5114948334699276,1.0778334700530097,0.36363636363636365,0.8124771802651749,1.0,8/20,17.58%,LRP4;LRRK2;UNC13B;ZC4H2;GPHN;CACNB4;NEDD4;PPFIBP1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.718707959815633,-1.0778191145783196,0.43283582089552236,0.9294991697121837,1.0,1/6,5.15%,HUS1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.7386718698953962,-1.0769355007338843,0.4146341463414634,0.9316999759976947,1.0,2/5,19.27%,JMJD6;VIPAS39
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",-0.718130529606315,-1.0768858488038278,0.4489795918367347,0.9309265801551757,1.0,3/6,11.81%,RUNX3;LILRB4;NCKAP1L
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5346122155580815,1.0768707674726687,0.3333333333333333,0.8140971936115767,1.0,4/13,22.36%,PRDX6;TRA2B;THRAP3;NUP98
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.4320250805809727,1.076560071535405,0.2857142857142857,0.8140640551169256,1.0,13/98,6.12%,SHROOM3;AVIL;TPM2;CORO6;EPS8;GSN;HIP1R;MCU;GAS2;MYO1D;SPIRE2;LCP1;TMOD2
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.6376623337811588,1.0759304272134174,0.3953488372093023,0.814884931512737,1.0,3/6,15.32%,SERPINE1;SLC12A2;TNF
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.5330451393700364,-1.0758260160986113,0.41935483870967744,0.9332773276294746,1.0,2/31,1.12%,SYAP1;ZFP36
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.5920486568590768,-1.0757035927106895,0.45454545454545453,0.9328453747514708,1.0,2/14,4.81%,RIPOR2;RACK1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.692765181067535,-1.075690765120676,0.43859649122807015,0.9320187941028492,1.0,2/7,8.13%,SRI;CALM1
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.7201860980818097,-1.0755389984101982,0.3673469387755102,0.9290908181876832,1.0,1/5,6.78%,EXOSC10
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.7201860980818097,-1.0755389984101982,0.3673469387755102,0.9290908181876832,1.0,1/5,6.78%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.7201860980818097,-1.0755389984101982,0.3673469387755102,0.9290908181876832,1.0,1/5,6.78%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.7201860980818097,-1.0755389984101982,0.3673469387755102,0.9290908181876832,1.0,1/5,6.78%,EXOSC10
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.6478966265098187,-1.0755075712509257,0.373134328358209,0.9283178268118704,1.0,2/10,12.58%,IFI35;TYROBP
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.5703799545308679,1.0748781149937716,0.2777777777777778,0.8166640889767935,1.0,3/15,6.01%,DUSP6;DUSP18;DUSP7
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.6303572003241714,-1.074812214996122,0.375,0.9297514923507195,1.0,2/13,3.63%,COL5A1;NKD1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.6343840820278983,1.0745012503990594,0.4722222222222222,0.816877269154796,1.0,4/8,25.41%,RELN;CAPRIN2;CAMK2B;CAPRIN1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.6096265261180344,1.07448097358063,0.42857142857142855,0.8161675102679852,1.0,3/10,13.19%,GSN;ANO6;PRKCI
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.6547808028814135,1.074388680882469,0.4146341463414634,0.8148345711773622,1.0,3/6,25.73%,GABRB1;GABRB2;GABRB3
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.6547808028814135,1.074388680882469,0.4146341463414634,0.8148345711773622,1.0,3/6,25.73%,GABRB1;GABRB2;GABRB3
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5588690766426964,-1.0743403039529877,0.39285714285714285,0.9303890556746847,1.0,1/20,0.19%,JAML
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.4424280962596715,1.0739896331263703,0.3,0.8149189125049032,1.0,9/85,7.63%,POLR2D;NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.5309909049951109,1.0739081046351953,0.2682926829268293,0.8144139079771993,1.0,4/21,9.93%,PKD2;KCNIP2;RELN;SHANK3
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.517318029247978,-1.0732496758184573,0.4166666666666667,0.9331573468090796,1.0,6/34,13.58%,PADI2;BASP1;CALM1;ACTB;CASP5;INA
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.5634222738177976,1.0732162623545238,0.4444444444444444,0.8153343598841885,1.0,8/16,16.81%,MAP3K11;MAP3K10;DVL3;SASH1;TRAF6;MAP3K5;TNF;MAP3K7
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.6802799038011665,1.0731677902048893,0.4166666666666667,0.8147358066939078,1.0,1/6,6.18%,DDIT3
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4771818852571184,-1.0731481682564907,0.3783783783783784,0.9326833422171433,1.0,4/57,1.70%,UBC;TGFBR3;RPS27A;FOS
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.4584946583503972,-1.0725888063270077,0.3902439024390244,0.9336391073045978,1.0,19/106,12.41%,IL4I1;CD36;ME1;MGLL;MDH2;GABARAPL1;BPHL;GLUL;ODC1;LGALS1;LDHA;EPHX1;ACAA1;PTS;UROS;IDH3B;MCEE;ECI2;APEX1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.7191191648836053,-1.0725451964095036,0.45161290322580644,0.9320486984780938,1.0,1/5,0.70%,CD36
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.7191191648836053,-1.0725451964095036,0.45161290322580644,0.9320486984780938,1.0,1/5,0.70%,CD36
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.5137054618713894,-1.0725034341529607,0.3787878787878788,0.9312863251937783,1.0,9/40,17.26%,TNFSF10;RACK1;FIS1;ING5;RPS3;TRAF7;BMF;DEDD2;AGT
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.4706014353826747,1.07163719267816,0.38461538461538464,0.8176402283311487,1.0,9/29,22.67%,NRP1;FERMT2;RAPGEF3;PPM1F;PPM1E;TGFBR1;LIMCH1;ARHGEF10L;ABL1
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.7355688219423661,-1.071595894996497,0.532258064516129,0.9332042863730067,1.0,1/5,12.15%,ADGRG6
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.6372782436125946,-1.0709475735870726,0.46153846153846156,0.9345375579433349,1.0,1/8,1.52%,NLRC3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.3909373461818964,1.0708198701192573,0.25925925925925924,0.8190013084917184,1.0,13/97,8.94%,PPARGC1A;ESRRG;POLR2D;MAML2;DR1;E2F3;HDAC9;PPARG;CDK7;TAF2;MAML3;TAF9B;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4632959158648946,1.070802321843507,0.2413793103448276,0.8182954685301324,1.0,7/41,12.00%,ACVR2A;UBE2O;GDF11;SMAD2;BMPR1B;BMPR1A;TWSG1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.3972411181416943,1.0707430769370567,0.23529411764705882,0.8177784269166337,1.0,30/173,13.18%,SPSB2;RNF122;KBTBD6;SIRT1;SPOPL;RCN3;RNF139;FEM1B;UBE3D;UBXN6;SEL1L;DDIT3;MDM2;APPBP2;CLOCK;NEDD4L;KCTD10;SHARPIN;FBXO45;RMND5A;BTRC;GID4;TBL1XR1;FBXW7;FBXW11;RNF185;FEM1C;COP1;KLHL42;BAG6
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6165877791611423,1.0706716191123533,0.34782608695652173,0.8172155014984936,1.0,3/8,16.01%,HPN;COL11A1;ADGRV1
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.669588028488848,-1.070478740731777,0.43859649122807015,0.9351502211670049,1.0,2/6,7.68%,RPS15;NPM1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.46813581810083243,1.0703004904379023,0.3783783783783784,0.8173671490984086,1.0,3/22,2.15%,KLF4;FGF2;SMAD1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.6863381008750219,-1.0702411486989138,0.4528301886792453,0.9350060846189038,1.0,2/6,7.48%,SAT1;SAT2
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.4546792109325487,1.0699657852382758,0.34375,0.8174367121761621,1.0,7/31,10.57%,NCAN;FGF2;GLB1;CSPG5;HPSE;GPC6;SLC9A1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.479130052710037,1.0693352519078985,0.3333333333333333,0.8183701712595293,1.0,19/31,25.19%,NLGN1;LRRK2;RELN;GRM5;SHANK3;CACNG2;CACNG8;TNF;GRM1;ATAD1;CACNG3;HOMER1;GRM3;GRIK3;NRXN1;TSHZ3;GRM7;CDH2;DGKI
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5076963385399633,-1.0689900537674255,0.36,0.9383702513030487,1.0,9/60,14.25%,SIGIRR;CDC37;RACK1;RNASEL;STAT1;CFLAR;TNFAIP3;IFNGR2;PTPRC
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.48556730072311177,-1.0689635631743044,0.30864197530864196,0.9376139044307553,1.0,9/52,6.70%,CD36;CCL3;PYHIN1;CARD16;MNDA;AIM2;LILRB4;IGF1;GSTP1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.5045799685153702,-1.0688932639006035,0.391304347826087,0.9369731194895705,1.0,4/45,5.97%,PRLR;LIPG;LPCAT1;GNPAT
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.618132902338905,1.0688445132469848,0.43902439024390244,0.8181224803167273,1.0,1/6,5.50%,LIN7A
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.618132902338905,1.0688445132469848,0.43902439024390244,0.8181224803167273,1.0,1/6,5.50%,LIN7A
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5080722369759562,-1.0683939293971394,0.37142857142857144,0.9377024648934542,1.0,2/32,1.57%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.6767831395855459,-1.0681113621994147,0.4528301886792453,0.9378302072316111,1.0,1/6,6.43%,NR1H2
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.665407469930944,1.0680211102972628,0.46153846153846156,0.8197048243258368,1.0,2/5,20.89%,FBN2;CD46
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.6568821094740468,1.0679735245230226,0.41025641025641024,0.8190506675676291,1.0,2/7,9.51%,IPPK;FGGY
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.4510533572138173,1.0678345139606762,0.29411764705882354,0.8186998957004737,1.0,6/48,9.73%,LEPR;SAMD5;PRRG4;TM7SF2;GPAT4;HMGCS1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.4705911514309575,1.0676236431920203,0.4090909090909091,0.8185587825958494,1.0,12/46,17.12%,IGF1R;NYAP2;PLCL1;PLCB4;PI4KB;PIK3C2B;PTEN;NF1;GAB2;PLCB3;TYRO3;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.6635166059062849,1.0675903385462233,0.425,0.8179306551350485,1.0,1/5,3.52%,PICALM
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.666594669230763,1.067562803257084,0.4318181818181818,0.8172225306278547,1.0,3/6,16.60%,ZNF703;ERBB4;AKT2
prerank,MSigDB_Hallmark_2020__Complement,-0.42258941039192377,-1.0675181003105205,0.3625,0.9387472378299885,1.0,31/137,16.11%,CD36;CCL5;ME1;GZMB;CD55;F8;CTSB;CBLB;CLU;FCER1G;PLEK;IRF7;APOBEC3G;SPOCK2;CALM1;PSMB9;OLR1;IRF1;PLSCR1;PFN1;FYN;TNFAIP3;CASP5;C3;LAP3;MT3;HSPA1A;SERPING1;ERAP2;TIMP2;AKAP10
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.6875905666851896,-1.0673864306796728,0.5,0.9382973666674358,1.0,1/5,9.96%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5193208881752706,1.0673018299363342,0.37777777777777777,0.8173494968594652,1.0,12/23,24.71%,SCN3B;NKAIN3;WNK1;SLMAP;NKAIN2;AHCYL1;P2RX7;NEDD4;SCN1B;PER1;WNK3;SPTBN4
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.43755106231893315,-1.067290980271455,0.38271604938271603,0.937727066809149,1.0,29/160,13.92%,CD2;GAPDH;CXCR4;GZMB;PRF1;PPP1R15A;MX1;TNFRSF25;CSRNP1;IER3;BNIP2;DDIT4;CD14;SEMA6A;BNIP1;HK2;IRF1;EGLN3;PLSCR1;CFLAR;IFIT2;ITGB2;FAM162A;ING4;CYFIP2;CASP5;BCL2L14;TRAF7;GLRX2
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.7234113507587927,-1.0667711574380925,0.39344262295081966,0.9386341279886131,1.0,1/5,0.98%,SRGN
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.6856826968832584,1.0663273714180745,0.43902439024390244,0.8192696036088635,1.0,1/5,4.10%,LRRK2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.5032903447373926,1.06615362016136,0.4186046511627907,0.819047695988491,1.0,5/20,17.93%,SCAF8;CDK13;SUPT16H;CDK12;EAPP
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5418648478000471,-1.0656200501874757,0.34782608695652173,0.9415440235220373,1.0,3/28,2.59%,RNASET2;ADPRM;SIDT2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5195331822493541,-1.0654338404773478,0.3582089552238806,0.9412443950729638,1.0,6/32,10.91%,ZFP36;MDFIC;CTDP1;IFITM3;POLR2G;TRIM13
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.6613729836924296,1.0652019707718496,0.4117647058823529,0.819398871372845,1.0,2/6,19.47%,TMED10;GBF1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.6613729836924296,1.0652019707718496,0.4117647058823529,0.819398871372845,1.0,2/6,19.47%,TMED10;GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.6613729836924296,1.0652019707718496,0.4117647058823529,0.819398871372845,1.0,2/6,19.47%,TMED10;GBF1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6181912593891765,-1.0649360423838203,0.4482758620689655,0.9418589057358183,1.0,3/13,11.49%,CD36;FCER1G;ITGB2
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.46890961566857126,1.0647484374655705,0.42105263157894735,0.819811133905135,1.0,9/24,16.79%,CPSF4;WDR33;SSU72;PCF11;SCAF8;CPSF7;NUDT21;PAPOLA;SNRPB
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.5232194685759836,-1.0643194449167857,0.36619718309859156,0.9428117682926361,1.0,7/35,14.02%,HARS2;WARS1;NARS1;KARS1;LARS1;DARS2;FARSA
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.6635042608216792,1.0642690972277584,0.38235294117647056,0.8204412961387724,1.0,1/6,3.52%,PICALM
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.6435355291049657,-1.0642506831453984,0.43548387096774194,0.9422178728853882,1.0,2/7,14.03%,HIF1A;MT3
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.5127547062803489,-1.0642349437882968,0.38596491228070173,0.941391617920016,1.0,3/25,2.41%,CD36;AIF1;MARCO
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.6647860437039267,1.0642335411634622,0.37254901960784315,0.8198746173706946,1.0,2/7,12.37%,PPT1;MAPKAPK2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.4579082392357759,1.0638789705722078,0.34146341463414637,0.8200326284176853,1.0,11/22,23.34%,GAB1;NRG1;PTPRR;NRG2;ERBB4;PIK3CA;ERBIN;PTPN12;PTPN18;CPNE3;PIK3R1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.6389736753472567,1.0637675347758762,0.46808510638297873,0.8195706247785651,1.0,1/6,4.85%,TOMM70
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.4508564648089761,-1.0631263494681822,0.37349397590361444,0.9441478986640013,1.0,12/88,13.24%,DDX11;CARD16;IFIT1;B2M;RPL11;RACK1;DTX3L;DVL1;IFIT2;ACTB;STING1;CAMK1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.40679971794233405,1.0629840447343581,0.25806451612903225,0.820817912051783,1.0,6/44,12.15%,MAP3K11;E2F3;CDK7;RCC1;CDK6;SPDYA
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.5819311928292443,1.062827436323423,0.4166666666666667,0.8204591359187559,1.0,2/7,28.33%,RYR2;PTK2B
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.7053641119925732,-1.06273478614811,0.5,0.9446367720511136,1.0,1/5,5.01%,PADI2
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),-0.7215578029445398,-1.0625314414115885,0.4528301886792453,0.9445465206816666,1.0,2/5,1.54%,ITK;RSAD2
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.43695285927009425,1.0624784135829652,0.3125,0.8207305119998084,1.0,8/39,18.61%,ACER2;CASP9;CLOCK;INTS7;TIPRL;HINFP;SESN2;NBN
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5523763914533028,1.062157282930177,0.4444444444444444,0.8209327896063169,1.0,4/10,24.75%,LRRK2;CLUH;TRAK2;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.5339999148571073,-1.0621073368463636,0.36923076923076925,0.9451391998593651,1.0,1/21,1.12%,ZFP36
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.6770191417028892,-1.0616916891106065,0.40298507462686567,0.9455359141732521,1.0,1/8,5.15%,HUS1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.7070589240923486,1.0616635272431119,0.4782608695652174,0.821511733949304,1.0,3/5,15.83%,JAG1;BMPR1A;SOX4
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.529398131074354,-1.0613910023616935,0.39436619718309857,0.9457371904105955,1.0,6/31,12.61%,UBXN1;DDRGK1;RPL11;AQP11;GABARAPL2;NOP53
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.6272789829470471,-1.0612172080120976,0.42424242424242425,0.9454666898885419,1.0,3/8,19.45%,SLC25A5;CD47;SLC17A9
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.46101020034212237,1.0611254328904192,0.4,0.8220553979153675,1.0,8/47,10.23%,CDK5R1;FER;CDC42EP3;VASP;NCK2;TPPP;TOGARAM1;SLAIN2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.4813616027281349,-1.0611061978906486,0.4027777777777778,0.945054627243055,1.0,23/70,21.83%,GAPDH;GZMB;BTG2;RPL13A;RACK1;CLU;IGF1;ILF3;RPS3;EIF2AK2;ORMDL1;EIF4A3;TYMS;PATL2;RTN1;CNOT8;RBM4;SHMT1;YBX1;NCL;ZNF540;MRPL13;PAIP2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5685381880633709,1.0610467401018153,0.3695652173913043,0.8208723047398826,1.0,1/8,0.13%,PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.5685381880633709,1.0610467401018153,0.3695652173913043,0.8208723047398826,1.0,1/8,0.13%,PPARGC1A
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.5387809762685413,-1.0605269794303018,0.36666666666666664,0.9458608174338613,1.0,1/27,0.15%,FLNA
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.46410865065195644,-1.0603421888289892,0.3466666666666667,0.9455386917910849,1.0,17/59,19.37%,UBC;RPS27A;PSMB3;PSMA7;PSMB9;PSMB6;PSMA5;PSMC4;PSMD8;ANAPC11;PSMD12;PSME2;CDC26;UBA52;PSMA3;BUB3;PSME1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.6114265006721049,1.0603064707577199,0.41025641025641024,0.8219843017263623,1.0,4/9,18.46%,JAG1;ROBO1;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.5544590371833732,-1.0600236131510261,0.484375,0.9457017873019858,1.0,4/19,17.27%,ISCA1;NFS1;CIAO2B;NUBPL
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.38018449185181885,1.0598067274874945,0.3333333333333333,0.822263999607055,1.0,24/93,14.04%,CDK5R1;QARS1;MAP1S;AATK;TGFBR2;ARNT2;PBX1;RELN;PPT1;PLXNB2;CA10;CTNNA2;PTCH1;SHANK3;NFIB;GRIN2B;PTEN;FBXW11;CNTN4;NF1;BAG6;NIPBL;ROBO2;GRIN2A
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6265086004808903,-1.059519909785268,0.4482758620689655,0.9465275934738001,1.0,2/9,4.15%,RPL5;RPL11
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.46185316872535703,1.0595168889064268,0.35714285714285715,0.8223841022947271,1.0,3/34,4.73%,EGR1;WNT5A;TLR7
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.5125829545300276,1.0594796209867905,0.45454545454545453,0.8218000453962705,1.0,7/25,13.70%,ST6GAL2;MPDU1;ST6GALNAC3;FUT9;ST8SIA5;ST6GALNAC5;ST8SIA4
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.7136903499748969,-1.059471998858188,0.45901639344262296,0.9449846684454146,1.0,2/5,14.32%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.7136903499748969,-1.059471998858188,0.45901639344262296,0.9449846684454146,1.0,2/5,14.32%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.4629856571189783,1.0590354435818943,0.32432432432432434,0.8219430347185901,1.0,7/47,7.86%,FER;HIP1R;CDC42EP3;VASP;NCK2;MYADM;KANK1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.5994584060543424,1.058859715399571,0.46875,0.821519080117979,1.0,5/14,10.29%,WNT5A;WNT2B;SALL1;KITLG;NCOA4
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.6133106797615638,1.0582997667852745,0.4722222222222222,0.8222508995914537,1.0,3/9,21.87%,JAG1;HNRNPU;YTHDF2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.48331300440278435,1.058114440419121,0.34210526315789475,0.8219518744922744,1.0,9/31,14.23%,KCNQ2;DPYSL5;GRID2;FRAS1;BCL11A;LINGO1;CACNA1B;UNC5D;CAMKV
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.6729709378749732,-1.0581000527610738,0.4915254237288136,0.9484241250724977,1.0,2/5,13.46%,NFS1;MOCOS
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.5692510002587462,1.0580228876855713,0.4878048780487805,0.8213594833641661,1.0,4/12,15.32%,SIRT1;FBXW7;ITGAV;TNF
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.5487120757099917,-1.0579392174682838,0.4262295081967213,0.9480049405610007,1.0,3/23,6.09%,TGFBR3;MYBPC3;TTN
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.5983801828881048,1.0577201604854614,0.38636363636363635,0.8212989436414709,1.0,1/10,2.29%,MSR1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.6420719891821873,1.0577169490398397,0.47058823529411764,0.8205840567395523,1.0,3/8,19.85%,ADCY9;ADCY6;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.6193987845234847,-1.0575654592479196,0.46153846153846156,0.9474503747447033,1.0,1/12,1.31%,RIMS1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.6193987845234847,-1.0575654592479196,0.46153846153846156,0.9474503747447033,1.0,1/12,1.31%,RIMS1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.44104984729204233,1.0575135742275854,0.375,0.8203890242741116,1.0,12/47,17.89%,SAE1;NUP153;NUP188;BCL11A;NUP42;STX1A;ZNF451;UBA2;NSMCE2;NUP133;NDC1;NUP205
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.43579456037733233,1.0575106043604423,0.3225806451612903,0.8196874661901478,1.0,12/35,17.76%,TBRG4;WDR74;RABEPK;RCL1;PUS1;RRP12;WDR43;PPRC1;SRM;HSPD1;NOLC1;PES1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.6931233551410934,-1.0574509508664693,0.5,0.9468776980052214,1.0,2/5,20.98%,GLA;GALC
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6483444939160372,1.0574454926424304,0.5111111111111111,0.8192009684324858,1.0,2/6,18.47%,PPARG;OSBPL8
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.49544249885108743,-1.0573810763888245,0.410958904109589,0.9462838447101256,1.0,9/32,14.32%,ZFP36;ETS1;HSPA1B;STAT1;ANKRD54;NCKAP1L;ZNF16;HIF1A;HSPA1A
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.671542139218323,-1.0573447611235547,0.42592592592592593,0.9455284577193851,1.0,1/7,8.13%,CALM1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.6697891531549679,-1.0572290189807334,0.4807692307692308,0.9451509712732232,1.0,1/8,0.74%,CCL3
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.6200465446898253,1.0571912113990354,0.4444444444444444,0.8190638896882442,1.0,1/8,0.27%,KLF4
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.48306248228745013,1.0571784658742485,0.391304347826087,0.8183765848317531,1.0,7/44,6.10%,COL16A1;TPM2;FKBP9;ZBTB16;COL5A2;PHLDB1;TIMP3
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.5453352950406427,-1.0571533825750057,0.4142857142857143,0.9445454601779532,1.0,6/24,19.90%,RAB11A;SNF8;VPS28;VPS37B;MVB12A;CHMP6
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6023263620816337,-1.0567864000909837,0.4153846153846154,0.9449729043007069,1.0,5/14,13.90%,RACK1;CD300LF;PLSCR1;APPL1;CD47
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5342631906272431,-1.056750145477635,0.390625,0.9442802475172193,1.0,5/24,14.88%,ATP10A;ABCB1;PLSCR1;ABCB4;ATP8B1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.5433853018224073,-1.0567495255126118,0.373134328358209,0.9434490149049681,1.0,1/23,0.70%,CD36
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.5367342389415791,1.056600046878527,0.3939393939393939,0.8190149385532309,1.0,6/16,12.66%,GRID2;GRIK2;GRID1;UNC13B;CDH8;GRIA2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.4417455239616482,1.0564632738084228,0.3939393939393939,0.8187101703560361,1.0,4/44,4.28%,LEPR;KLF6;HDAC9;PBX1
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.6542462998258464,-1.0563919890082403,0.38596491228070173,0.9437072184907233,1.0,1/8,11.55%,PTN
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.5694189920924013,1.0563727689077438,0.4222222222222222,0.8182602795846227,1.0,2/11,5.88%,SEMA5A;SEMA3B
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.4600429825076986,-1.0562187296138923,0.42857142857142855,0.943384735706827,1.0,13/90,10.87%,TOMM7;SRP14;CDC37;RPL11;DNAJC19;FIS1;TIMM44;AQP11;NACA;PITRM1;ZDHHC4;HPS4;TOMM40
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.5290375348641048,-1.0559325179988783,0.42592592592592593,0.9434370708404459,1.0,7/36,10.87%,TOMM7;DNAJC19;FIS1;TIMM44;TIMM21;PITRM1;TOMM40
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.545643581651581,-1.0555413408205632,0.4262295081967213,0.9438192465438628,1.0,1/19,0.77%,PPIE
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.6016389793926853,1.05536242081612,0.42105263157894735,0.819971738192896,1.0,3/10,14.37%,GSN;HPN;NLRC4
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.6905041127251297,-1.0548437467410283,0.44,0.9444571671844552,1.0,2/5,6.43%,PARP14;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.6905041127251297,-1.0548437467410283,0.44,0.9444571671844552,1.0,2/5,6.43%,PARP14;NR1H2
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.6186598360377076,1.0547624751029585,0.5116279069767442,0.8209084456270674,1.0,3/8,16.54%,EXOSC6;LIG4;HSPD1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.585226797988017,-1.0547305097851905,0.4153846153846154,0.9439379991103782,1.0,3/15,2.31%,CCL5;DUSP1;AIF1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.4889632181472151,-1.0547275178058504,0.3225806451612903,0.9431201846768092,1.0,5/43,6.53%,DDX11;CD36;SNX6;IGF1;RPL23
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.522685491676019,1.0546546745295196,0.3611111111111111,0.8204801617840131,1.0,3/20,8.92%,KCNJ2;SCN3B;NEDD4L
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.6459110407954414,-1.0544649758178657,0.5,0.9430556795890381,1.0,2/7,8.87%,PDXDC1;ENPP2
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.4911839924782857,-1.054339160228614,0.323943661971831,0.9426266148632226,1.0,4/57,4.59%,UBC;RPS27A;GZMB;CTSB
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.6420538500069208,1.0536010113767023,0.46875,0.8226317954096407,1.0,3/9,19.85%,ADCY9;ADCY6;ADCY1
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.649831142495803,-1.0533615725914756,0.44642857142857145,0.9446686202846526,1.0,2/5,26.96%,IRAK4;CARD9
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.746867489899214,-1.05329046958724,0.49056603773584906,0.9441151255134786,1.0,4/5,21.76%,RBPJ;VEGFA;HIF1A;NFE2L2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.5757256205154203,1.0525275427879597,0.4318181818181818,0.824378070521435,1.0,1/10,2.08%,FGF2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.6595505880868036,1.0524531493460945,0.475,0.8238252755808683,1.0,1/5,0.96%,SCRIB
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.685032510251703,-1.0521359850631353,0.42857142857142855,0.9469670139936952,1.0,3/7,15.35%,NKD1;CSNK1D;DAB2
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.5979434528445337,1.0516749063615918,0.4411764705882353,0.8248547575731415,1.0,6/9,17.37%,SLC9C2;SLC9A1;SLC9A9;SLC8A1;SLC12A2;SLC9A7
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.6436984252322593,-1.0513257593169592,0.423728813559322,0.9479648267470738,1.0,2/7,8.27%,CCL5;STK39
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.6436984252322593,-1.0513257593169592,0.423728813559322,0.9479648267470738,1.0,2/7,8.27%,CCL5;STK39
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.5452496168926649,-1.0511366737036214,0.4264705882352941,0.9476860999296385,1.0,6/25,19.90%,RAB11A;SNF8;VPS28;VPS37B;MVB12A;CHMP6
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.5800365415262012,1.0511347765557748,0.4411764705882353,0.8254596453616644,1.0,3/11,6.32%,ADRA1A;WNT5A;MYADM
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.5804808675570979,-1.0510864426130182,0.45901639344262296,0.9470019033599184,1.0,3/11,9.40%,PLN;IFIT1;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.5264434324627285,-1.0509095515178448,0.423728813559322,0.9466665509620343,1.0,5/25,19.54%,PPP1R15A;CALM1;CNEP1R1;SYMPK;PPP1R16B
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.6446731544034802,-1.0508961175447988,0.425531914893617,0.9458975825280868,1.0,4/5,32.53%,TBC1D20;NUCKS1;YTHDC2;PPIB
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.6043794423092537,-1.050755677083055,0.4032258064516129,0.9455276138586544,1.0,2/10,7.68%,RPS15;NPM1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.5147018800856833,-1.050009026766199,0.42028985507246375,0.9467403632651763,1.0,4/41,3.00%,FTH1;TFRC;HAMP;B2M
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.6500563748715378,-1.0495212368030478,0.4576271186440678,0.9466859923851159,1.0,2/5,12.54%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.6500563748715378,-1.0495212368030478,0.4576271186440678,0.9466859923851159,1.0,2/5,12.54%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.5803914265199006,-1.0493978960048551,0.4262295081967213,0.9462877981263651,1.0,4/13,8.13%,PLN;GNB5;SRI;CALM1
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.6725165118331558,-1.0491594272221203,0.4375,0.9462070552209711,1.0,1/5,12.00%,AMPD2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5249239866430018,1.0487929618433338,0.3953488372093023,0.830665752016934,1.0,5/14,15.43%,SIRT1;BAG5;SOD2;P4HB;SFPQ
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.658538257539283,1.0487144148026666,0.425,0.8300760884301988,1.0,4/8,26.46%,PIP4K2A;SH3GLB1;RAB3GAP2;PIP4K2B
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.5342463361757332,1.0485682776773422,0.47619047619047616,0.8296650066246091,1.0,4/18,14.80%,ABCA2;PICALM;ARF6;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6152037616586148,1.0483687342567727,0.3541666666666667,0.8293544277571208,1.0,3/8,15.32%,TMEM39A;IRAK3;TNF
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.6898847736254714,1.0483363851101375,0.5531914893617021,0.8287785160563157,1.0,1/5,11.68%,ERCC4
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.591906310972809,1.048142462053557,0.38636363636363635,0.8286352706770111,1.0,2/7,5.22%,SCRIB;RAB10
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.42233228678589,-1.0480125593900287,0.38461538461538464,0.9487878680088488,1.0,49/208,20.04%,PPIE;FRG1;ZCRB1;DHX16;RAVER2;DHX38;SNRNP27;SNRPD2;CSTF2T;RNPC3;WDR83;RBM22;PDCD7;LSM7;PNN;NCBP2;POLR2G;U2AF2;ZRSR2;CRNKL1;DDX23;ZCCHC8;BUD31;SRSF7;EIF4A3;SMNDC1;PRPF3;GCFC2;CCAR1;RBM4B;DDX5;SRSF2;SNRPA1;PPWD1;CWF19L2;EFTUD2;HNRNPH2;GTF2F1;SLU7;SNRPA;CWC25;IK;SNRNP200;PRPF4;RBM4;LSM4;SYMPK;SF3A3;YBX1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.5194294773214063,-1.048006879162868,0.44776119402985076,0.9479936177881384,1.0,4/22,16.54%,TFRC;FANCB;WDR48;ZCWPW1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.6228357023814151,-1.0478679737639833,0.4915254237288136,0.9475956685050165,1.0,1/9,0.97%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.500597835895127,-1.047670650537935,0.4166666666666667,0.9474208117531381,1.0,5/49,7.97%,SKAP1;CD36;PLET1;JUP;ACTG1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.41241301097918165,-1.0476100712867746,0.37037037037037035,0.9467946493629507,1.0,51/226,20.04%,PPIE;FRG1;ZCRB1;DHX16;RAVER2;DHX38;SNRNP27;SNRPD2;CSTF2T;RNPC3;WDR83;SRPK1;RBM22;PDCD7;LSM7;PNN;NCBP2;POLR2G;U2AF2;ZRSR2;CRNKL1;DDX23;ZCCHC8;BUD31;SRSF7;EIF4A3;SMNDC1;PRPF3;GCFC2;CCAR1;RBM4B;DDX5;SRSF2;SNRPA1;PPWD1;CWF19L2;EFTUD2;HNRNPH2;GTF2F1;SLU7;SCNM1;SNRPA;CWC25;IK;SNRNP200;PRPF4;RBM4;LSM4;SYMPK;SF3A3;YBX1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6324450073820879,-1.0472894576454486,0.515625,0.9469932130585746,1.0,4/9,22.48%,JUP;TRPM4;PKP2;DSC2
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6963768286710017,1.047246075781825,0.48936170212765956,0.8293218560556904,1.0,2/5,5.29%,SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6963768286710017,1.047246075781825,0.48936170212765956,0.8293218560556904,1.0,2/5,5.29%,SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.5424128212337129,-1.0472134630873475,0.41818181818181815,0.9463756450267627,1.0,2/27,5.76%,TFRC;ATP6V1F
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.43771709576637396,1.0470342184957069,0.38461538461538464,0.8291012347188927,1.0,26/73,20.26%,CDK5R1;PBX1;MAP2K1;WNT5A;UGDH;FZD3;WNT2B;RYK;PPT1;FUT9;RUNX1;BRSK1;PTPRD;OLIG1;WNK1;NTRK2;EPHA5;SOX4;PBX3;MTPN;IL1RAPL1;ERCC2;MANF;HS6ST1;TGFBR1;BRSK2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.5698193104156946,-1.0470033162150811,0.45614035087719296,0.9461237808260419,1.0,4/13,22.46%,MT3;BRCA1;PINK1;PARK7
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.45837476180444103,-1.0467750838709355,0.3918918918918919,0.9460723745461853,1.0,4/71,2.04%,FLNA;MYLK;COL5A1;PER3
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.6091170429108793,1.04604387763237,0.4722222222222222,0.8308553875808615,1.0,1/7,1.34%,ACADS
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.5935404704741154,-1.0459560243864863,0.4838709677419355,0.9477555255504276,1.0,5/12,15.75%,DUOX1;SOD1;CYBA;PRDX4;GPX1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5221044360608975,-1.0458155866068113,0.42028985507246375,0.946531480145322,1.0,5/25,7.33%,UBC;RPS27A;CD14;CD300LF;IRF7
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5221044360608975,-1.0458155866068113,0.42028985507246375,0.946531480145322,1.0,5/25,7.33%,UBC;RPS27A;CD14;CD300LF;IRF7
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5778809517530739,1.045753387745697,0.40540540540540543,0.8307660702181627,1.0,3/11,6.83%,PDK4;SIRT1;SCARB2
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6389589142834458,-1.0456915214935343,0.38333333333333336,0.946152404971816,1.0,1/8,4.74%,APOD
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.6336991766077834,1.045581534398862,0.5227272727272727,0.8297407741748086,1.0,3/6,28.33%,SYK;STAT5A;PTK2B
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.6336991766077834,1.045581534398862,0.5227272727272727,0.8297407741748086,1.0,3/6,28.33%,SYK;STAT5A;PTK2B
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.6201347160337687,-1.0452055296688672,0.45161290322580644,0.9467840829213829,1.0,1/11,0.33%,BTN3A1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.420220170777884,-1.0451795610431602,0.4117647058823529,0.946099819994432,1.0,35/218,16.65%,UBC;RPS27A;XPA;SMUG1;BTG2;UBXN1;GTF2H5;OGG1;HUS1;DTX3L;MUS81;PARP9;FANCB;XRCC3;BRCA2;NPM1;PARP2;REXO4;ABRAXAS1;APEX1;WDR48;BRIP1;NOP53;NABP1;RPA3;SLX4;KAT5;RAD23A;ERCC8;BRCA1;FANCI;RAD9A;PARP4;UBA52;SMC1A
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5576973964577048,-1.0447099499491372,0.4393939393939394,0.9467162665547579,1.0,5/14,15.49%,SLAMF6;HLA-F;KLRD1;CD226;HLA-E
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5251188798305235,-1.0444457275425927,0.3888888888888889,0.9466221345039889,1.0,9/26,21.59%,SMUG1;OGG1;APEX1;PARG;RPA3;RFC1;ADPRS;POLG;LIG3
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5678717097361339,1.0441832829424424,0.43243243243243246,0.8327304427600127,1.0,1/8,0.96%,SCRIB
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.6997897117698062,-1.0441661131833657,0.5074626865671642,0.9467124839874831,1.0,4/5,27.60%,VEGFA;NOS1AP;ATP2B4;EGFR
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6204763873727368,1.0441648408307997,0.4186046511627907,0.8320247899328281,1.0,1/7,1.41%,IGF1R
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.4045409820045942,1.0438354001809895,0.34615384615384615,0.8319348510606378,1.0,24/72,19.84%,RAB33B;NCAN;ZBTB16;PKD1;GDF11;WNT5A;BMP1;MMP16;HAPLN2;CDH11;SOX5;BMPR1B;EXT1;MMP14;ANKH;ANKRD11;SOX4;SLC10A7;CHD7;FGFR1;CREB3L2;TGFBR1;FGFR2;DYM
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.63565528759935,-1.043698903245658,0.5892857142857143,0.9472701777507463,1.0,2/7,12.54%,PRKD2;VEGFA
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.6016041685949738,1.0436976730918355,0.38461538461538464,0.8315380804579858,1.0,1/9,6.18%,DDIT3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6568456456296128,1.0435741454725018,0.45454545454545453,0.8311529453907645,1.0,2/5,18.81%,ACADVL;SIRT4
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.6747073966903187,1.0435315284365951,0.5348837209302325,0.830505791188396,1.0,3/6,21.43%,SAE1;UBA2;PIAS1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.4842441451269025,-1.0434668700504042,0.36065573770491804,0.947076733647015,1.0,3/36,6.84%,UBC;RPS27A;MAP3K12
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5410378968525894,1.0433309946446392,0.47619047619047616,0.8303190417215954,1.0,7/13,25.68%,FGF2;IPPK;PPIP5K1;ISYNA1;ITPKB;IP6K2;IP6K1
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),-0.6880698298719674,-1.0433084491120173,0.5098039215686274,0.9467280480643012,1.0,3/6,29.12%,CLEC7A;CARD9;BCL10
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6313935663752613,1.0432988273325112,0.5,0.8296190783790011,1.0,1/7,0.96%,SCRIB
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.629235653524789,1.0432728591803035,0.47368421052631576,0.8289967308872929,1.0,3/7,27.70%,SLC25A46;SH3GLB1;CORO1C
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.34399527610236486,1.0432474859728598,0.36363636363636365,0.8283754472374506,1.0,42/258,13.32%,UBE2D1;SPSB2;RNF122;FBXL14;KBTBD6;SIRT1;SPOPL;UBE2J1;FEM1B;UBE3D;SEL1L;DDIT3;DNAJB2;MDM2;AUP1;FAM8A1;APPBP2;CLOCK;UBR3;NEDD4L;KCTD10;SHARPIN;DNAJC18;FBXO45;RMND5A;ANAPC16;CDC23;BTRC;FZR1;GID4;TBL1XR1;FBXW7;FBXW11;RNF185;FEM1C;FBXO27;STT3B;COP1;KLHL42;FBXL12;BAG6;FBXL7
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6421316997799114,1.0427352747756649,0.46153846153846156,0.829171997961302,1.0,2/7,19.07%,SORL1;ARHGAP1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.603016215719351,-1.0427265239160004,0.5161290322580645,0.9475810583221949,1.0,2/12,1.47%,NR4A3;PDGFD
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5133291016488204,-1.042555155303563,0.4057971014492754,0.9472890106983917,1.0,3/37,5.38%,NLRC3;RPL13A;CLU
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.623704324663177,1.0424161665499336,0.40476190476190477,0.8292267403094625,1.0,2/5,9.12%,OTUD7A;ZRANB1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5898414215925399,1.0420442162466215,0.4594594594594595,0.8294337047559218,1.0,3/10,9.14%,FGF2;SPRY2;NPTN
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.6377878034412944,-1.0419470116951628,0.46774193548387094,0.9484363509776902,1.0,3/9,27.64%,CDC7;STOML2;SSBP1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.6503326688721656,-1.0418741411583434,0.5,0.9478480813843065,1.0,1/6,0.63%,COL5A1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7199891610175326,-1.0418479950862318,0.47619047619047616,0.9471270140522072,1.0,3/5,16.44%,NLRC5;NLRP12;CIITA
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.5777356330580008,1.0416771314531623,0.5128205128205128,0.8296729278427744,1.0,1/8,0.36%,ANXA1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.4756250597700213,-1.04153012563741,0.40540540540540543,0.9472092184919243,1.0,3/41,3.54%,CATIP;AIF1;PSTPIP1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.5033695998191343,1.0413947512286532,0.39285714285714285,0.8298031321875938,1.0,6/16,25.02%,TIPRL;MTMR9;PTPA;CHP1;SH2D4A;HSP90B1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3682832944577287,1.0413055268161402,0.30434782608695654,0.8293471114324552,1.0,30/132,17.12%,PLA2G4C;FGF2;ETNPPL;PIP5K1B;CHKA;SLC44A2;PI4KB;ABHD8;IMPA1;PIK3C2B;PTPN13;GPAT4;DDHD1;AGPAT5;PTEN;SELENOI;SLC44A5;CHPT1;SLC44A1;GPAT3;PIP4K2A;MTMR9;AGPAT2;LCAT;HDHD5;RAB14;PLEKHA8;STARD7;SBF1;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.35828902274256447,1.0410364077856162,0.3,0.8294231578502257,1.0,25/156,9.93%,CD180;NRP1;GRB10;PKD2;CDKN2AIP;MAML2;SIRT1;STK36;SLC39A14;NLGN1;DLG5;SPRING1;LRRK2;JAG1;RELN;SALL1;ROBO1;MAML3;KANK1;CTBP2;ZRANB1;NPTN;SASH1;POGLUT1;SHANK3
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.6422699271754653,-1.0409994502319344,0.4262295081967213,0.9478114808265741,1.0,2/10,17.77%,ZNF335;SETD1A
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.4982008920111064,-1.0409748083694303,0.4406779661016949,0.9471273809214423,1.0,6/36,16.15%,LIPG;GSTM4;FADS3;GPX4;ACSM5;ALOX12
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.588384597983527,-1.0409516890206452,0.45,0.9463672331923205,1.0,9/16,31.37%,H1-0;DEDD2;DFFB;DICER1;DNASE2;TOP2A;CECR2;ACIN1;HMGB2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5110617829997355,-1.0407424707391855,0.43283582089552236,0.9461833437167829,1.0,10/36,16.04%,STAT4;ANXA2;IL12RB2;CFL1;SOD1;CD47;RPLP0;SNRPA1;PSME2;TALDO1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5540277481091271,1.0404005189810845,0.48484848484848486,0.8302682533297459,1.0,10/17,31.25%,AMOT;MOB1B;TJP1;YWHAE;SAV1;STK3;CASP3;DVL2;AMOTL1;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5065400158897599,1.0403347685081872,0.43902439024390244,0.8297480525879186,1.0,6/20,10.20%,GRID2;NLGN1;DLG5;CLSTN2;PTPRD;CLSTN3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.6991181010295362,-1.0401481707736289,0.45614035087719296,0.9469806176729298,1.0,3/6,21.38%,DDX5;NR1D2;UQCC2
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.49395160647753694,1.0401046222117738,0.42105263157894735,0.8295423724147841,1.0,6/28,13.18%,SPOPL;RNF139;SERPINE2;BTRC;FBXW11;BAG6
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.5644124220367486,1.0400850275623963,0.358974358974359,0.8288939955438636,1.0,2/9,10.80%,FGF2;SIRT6
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.5800301353342681,-1.039958124781332,0.4166666666666667,0.9467895222571604,1.0,1/14,1.30%,PID1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.39590677167057925,1.0399104881064911,0.35294117647058826,0.8286138081070994,1.0,9/52,13.91%,NRP1;FGF2;WNT5A;PTPRM;RIN2;SASH1;DNAJA4;NF1;PTK2
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.4615872446975824,1.0393329232508135,0.3684210526315789,0.8290460830326284,1.0,4/22,11.73%,SEL1L;TECPR2;AUP1;PREB
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.33930568842939396,1.039066221375843,0.3125,0.8289710337556979,1.0,50/300,13.74%,UBE2D1;MKRN3;SPSB2;ZNRF3;FBXO32;MSL2;ZNF598;SIRT1;UHRF2;RNF25;KLHL18;SAE1;RNF139;TRIM26;NUP153;NUP188;BCL11A;UBA1;MDM2;NUP42;RNF6;UBE2D2;DCUN1D4;UBR3;NEDD4L;KCTD10;FBXO45;ANAPC16;STX1A;CDC23;BTRC;HIF3A;UBE2L3;PEX13;PEX5;FBXW7;FBXW11;RNF20;UBE2N;DCUN1D1;RNF38;KLHL21;ZNF451;LZTR1;BARD1;FBXL7;UBA2;EPAS1;TRIM35;NSMCE2
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.6012769385268548,1.0383337197136684,0.4878048780487805,0.8299084441498862,1.0,1/6,1.13%,ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.5651524323851925,-1.0382265219204647,0.375,0.9513549267777291,1.0,1/16,1.30%,PID1
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.6158356074482131,1.0380317534175891,0.43902439024390244,0.8298865964119896,1.0,1/5,1.49%,CNTN2
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.5930820838138156,1.038002387502064,0.43478260869565216,0.8293057150614205,1.0,3/10,15.89%,DLG5;SHANK2;WWC2
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.6656364955548087,-1.0377692093083968,0.4727272727272727,0.951859346907508,1.0,1/8,3.94%,ABCB1
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.6878022960032038,-1.037636505897874,0.5166666666666667,0.9514761218385307,1.0,1/5,14.23%,CYBA
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.5867292488328174,-1.0375954465761128,0.4153846153846154,0.9508493461863948,1.0,2/14,7.71%,PLN;SRI
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.5333871269689019,-1.0372765790745135,0.417910447761194,0.9509486050717761,1.0,1/30,0.15%,FLNA
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.6950406615788856,-1.0372081219637077,0.5,0.9503442093608017,1.0,1/5,4.98%,FIS1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7036084673604149,-1.036937333553672,0.5272727272727272,0.9503045347548466,1.0,3/5,23.55%,BUD23;EMG1;NSUN5
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.4460416477094677,1.0368027751250595,0.3225806451612903,0.8314006454095094,1.0,5/37,6.31%,ANXA1;SIRT1;SIRPA;CAT;STK25
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.5792499722298903,-1.0366154123845508,0.43103448275862066,0.9503900918603281,1.0,4/11,13.85%,DNAH11;STIL;CITED2;MMP21
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.6069894670797609,-1.036590222481896,0.5166666666666667,0.949627866637194,1.0,3/12,18.30%,FYN;CACNB1;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.6699983408115959,-1.0365807801422648,0.5254237288135594,0.9488530233710626,1.0,1/5,7.20%,RPS3
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6019755408017382,1.0364349016272367,0.5121951219512195,0.831678129340205,1.0,5/10,21.76%,HDAC1;TMEM119;SOX6;FRS2;HDAC3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5459406390063094,1.036260164722988,0.42105263157894735,0.831386761658169,1.0,2/13,10.57%,PKD2;SLC9A1
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.47719887737335154,-1.0360873803328228,0.35384615384615387,0.9495430334378876,1.0,13/47,19.37%,PSMB3;PSMA7;ODC1;PSMB9;PSMB6;PSMA5;AZIN1;PSMC4;PSMD8;PSMD12;PSME2;PSMA3;PSME1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.6689075417891087,-1.036082650428447,0.5517241379310345,0.9479904143777771,1.0,1/6,9.41%,STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.6689075417891087,-1.036082650428447,0.5517241379310345,0.9479904143777771,1.0,1/6,9.41%,STAT1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.6576093389048097,-1.0358496870445242,0.5102040816326531,0.9479390799564329,1.0,3/5,31.40%,DDX23;DDX21;SIRT7
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.6280295768850159,-1.0358356211839412,0.4727272727272727,0.9464136845537321,1.0,3/7,21.38%,BCS1L;TTC19;UQCC2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.6280295768850159,-1.0358356211839412,0.4727272727272727,0.9464136845537321,1.0,3/7,21.38%,BCS1L;TTC19;UQCC2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.5167413854190652,-1.0355726879191776,0.47692307692307695,0.9464949167617275,1.0,8/30,19.62%,H2BC18;NPM1;H2BC5;HIRA;H2BC9;H2BC21;HAT1;H2BC11
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.5378344019488297,-1.0353254973333754,0.5074626865671642,0.9463967117344005,1.0,8/25,19.95%,GAPDH;LDHA;HK2;PGK1;ENOSF1;ENO4;PGM1;PFKL
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5946969162497873,-1.0347009885870748,0.4,0.9475320844501034,1.0,3/11,11.55%,CXCR4;TNFRSF1B;PTN
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.6069062013061461,-1.034555587125387,0.4603174603174603,0.9471371355156466,1.0,2/13,6.30%,GDPD1;IGF1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.5732290655893043,-1.0345358691992423,0.43103448275862066,0.9464401497623743,1.0,2/17,12.21%,FIS1;TMCO1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.5944536432006282,-1.0344455719112138,0.4426229508196721,0.9459024029687886,1.0,1/9,6.24%,SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.5261197817083532,1.0343931043443826,0.4375,0.8351783918519572,1.0,3/16,9.99%,LHFPL2;RNASE10;GLRA1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5717372748727652,1.0339343825513592,0.34146341463414637,0.8354305956539804,1.0,3/12,7.66%,MAML2;PBX1;MAML3
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.6026582544208275,-1.0339260220217503,0.46153846153846156,0.946519354390195,1.0,1/15,1.20%,CH25H
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.3892547468573455,1.033761888612911,0.36666666666666664,0.8350940261332572,1.0,7/69,5.56%,PPARGC1A;FAAH;CPT1C;ADIPOR2;CPT1A;FA2H;PPARG
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.5339908394252968,-1.0337410401732172,0.453125,0.9463255408021379,1.0,5/28,7.14%,SLC38A4;SLC7A5;ABCB1;SLC38A1;SLC16A7
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.4208715450388146,-1.0335344302691116,0.375,0.9463308887836404,1.0,17/134,10.96%,MX2;TOMM7;PID1;CYCS;MX1;CHCHD2;DNAJC19;CHCHD10;FIS1;TIMM44;TYMP;PHB2;PITRM1;HK2;BCS1L;TOMM40;IFIT2
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6561000217745023,-1.0334363843706504,0.5178571428571429,0.945877207312549,1.0,2/8,10.72%,CLDN7;OVOL2
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.5353522710880876,-1.0333180508599027,0.5254237288135594,0.9454790325243421,1.0,2/15,8.00%,ENTR1;WRAP73
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.48558560022369424,1.0329252005452936,0.34285714285714286,0.8364147104338273,1.0,11/29,18.27%,PHLDB1;TPPP;MEMO1;KLHL42;GSK3B;CLASP1;PRKAA1;PHLDB2;CLASP2;MAP6;MARK2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.45493915861872913,1.0326721497395315,0.4117647058823529,0.8362594301206163,1.0,12/43,13.62%,COL16A1;SVEP1;FKBP9;COL5A2;FRAS1;TIMP3;CDH11;FAM114A1;TWSG1;TJP1;PCSK6;EPAS1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.5297189161070375,-1.0321390438350575,0.46153846153846156,0.9482688758553385,1.0,2/27,5.78%,MX2;MYBPC3
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5402944617059471,-1.0320488016844511,0.4383561643835616,0.9477737171436065,1.0,3/32,3.84%,STAT4;TGFBR3;EIF2B1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.5419880959080057,1.0320445492450763,0.48717948717948717,0.8373741929609467,1.0,2/9,14.42%,TCP1;CCT3
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.5872804100076376,-1.0319077815357653,0.47692307692307695,0.9474227694994241,1.0,10/17,31.28%,EIF2D;EIF2S2;RBM4;EIF3D;EIF2S3;EIF3I;EIF4H;DENR;EIF4A2;MCTS1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.3903874231090082,-1.0311928124878607,0.41304347826086957,0.948614413513675,1.0,71/482,12.61%,FLNA;PLEKHG5;UBC;BCL2A1;APIP;TFRC;RPS27A;PRLR;MNDA;CARD14;RASGRF2;STIL;VAV3;IKZF3;TNFRSF25;IFIT3;PTMA;NAIP;GADD45B;DDRGK1;PRELID1;TNFSF10;USP36;CTSB;BNIP2;RACK1;ING5;ATF5;CLU;ARHGEF1;ING3;OBSCN;MTCH1;IGF1;ITGA6;GSTP1;TNFAIP8;LGALS1;PHB2;RPS3;ARHGEF3;NPM1;RPS6;HSPA1B;BNIP1;RNF144B;RPS3A;RPL10;TPT1;SGK1;MTCH2;TMEM219;STAT1;CITED2;NAA38;CFL1;EGLN3;CD44;ITGB3BP;CFLAR;IFIT2;PDCD5;FAM162A;NCKAP1L;SOD1;ZNF16;PIM3;ING4;APEX1;VEGFA;NOP53
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.4820445575815423,-1.0311625825635793,0.4473684210526316,0.9479156588192776,1.0,12/45,16.75%,TPP1;GSTM4;GSTK1;GSTP1;GSTM3;ERAP1;SOD1;GLRX2;ABCB9;ERAP2;GPX1;TRHDE
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.4849136954906551,1.0309250647404091,0.4074074074074074,0.8392973698779297,1.0,6/20,19.30%,MAP1S;CIB1;CLASP1;CAMSAP2;CLASP2;ATXN7
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.5873420385578065,-1.0308582920020504,0.43636363636363634,0.9480899752407297,1.0,4/10,10.87%,DNAJC19;TIMM44;TIMM21;TOMM40
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.4536452067941639,1.0301788341624594,0.3076923076923077,0.8404183884712931,1.0,15/35,21.96%,INPP1;PLCB4;IMPA1;IPPK;PTEN;NUDT3;NUDT4;PLD4;PPIP5K1;INPP5A;PLCB3;ISYNA1;ITPKB;INPP4B;PLCH1
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.6109169145350078,-1.0301106936630937,0.41379310344827586,0.9495572280771494,1.0,1/7,6.09%,TTN
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.6236691205866856,1.0300766053930328,0.4791666666666667,0.8399196869745351,1.0,2/5,15.24%,RNF20;CDK9
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.44968319647727767,1.0298089371883647,0.3333333333333333,0.8396770537983685,1.0,4/27,9.85%,CDK5R1;CCNG2;CDK7;CCNG1
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.5627315302785132,1.0296977606348814,0.4375,0.8393073123586668,1.0,1/9,1.07%,FER
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.39300404995438565,1.0296537385600613,0.44,0.8386515221073584,1.0,11/98,12.19%,PIGQ;PIGU;FGF2;PIP5K1B;PI4KB;IMPA1;PIK3C2B;PTPN13;PTEN;PIGC;PIP4K2A
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.4501565295606546,1.0295597728064971,0.38235294117647056,0.8381347307994683,1.0,1/23,0.73%,BAG3
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.4213041098041635,-1.0286413392910048,0.41025641025641024,0.9530351550210905,1.0,15/116,11.36%,CALCR;MYBL1;BCL11B;FOS;SLC7A5;ZNF185;BHLHE40;GREB1;CLDN7;SLC37A1;GLA;CD44;DYNLT3;OVOL2;SH3BP5
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.6191503020840723,-1.0285564917516135,0.5230769230769231,0.952504962485195,1.0,3/9,12.15%,TGFBR3;RBPJ;ADGRG6
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.5646642038370671,-1.0282007653313363,0.4461538461538462,0.9527360928909003,1.0,2/18,4.67%,CHCHD10;SYNE1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.6234031513610463,1.028003326293285,0.475,0.8397323445992071,1.0,3/8,26.89%,DLG2;HSPB1;KIF5B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.6234031513610463,1.028003326293285,0.475,0.8397323445992071,1.0,3/8,26.89%,DLG2;HSPB1;KIF5B
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.6234031513610463,1.028003326293285,0.475,0.8397323445992071,1.0,3/8,26.89%,DLG2;HSPB1;KIF5B
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.6910872461508737,-1.0279028962438368,0.5714285714285714,0.9526344162113147,1.0,1/6,6.09%,TTN
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.6614204780839004,-1.0276776883146053,0.4827586206896552,0.9517339044145472,1.0,1/5,7.08%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.6614204780839004,-1.0276776883146053,0.4827586206896552,0.9517339044145472,1.0,1/5,7.08%,XRCC3
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.6883048522882864,-1.0275495604634033,0.4909090909090909,0.9512678226456585,1.0,2/5,24.77%,TAP1;STX4
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.6524625133352462,-1.0275378918285014,0.47368421052631576,0.9505320003259917,1.0,3/7,18.93%,XRCC3;SLX4;WRN
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.5670149954934576,-1.0274507431021054,0.453125,0.9500473730488603,1.0,4/12,9.82%,SLC7A5;BTK;TRPM4;TNFRSF1B
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.5064269480304513,-1.0274320581942686,0.417910447761194,0.9493137252802729,1.0,3/39,1.85%,FTH1;TFRC;HAMP
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.39039284466388147,1.027285085866603,0.34375,0.8407600583022358,1.0,16/72,14.19%,SCRIB;RAP1GAP;SGSM1;TBC1D1;ARHGEF26;TBC1D16;TBC1D5;TBC1D10B;TBC1D12;SGSM2;CCDC125;ARHGAP42;TBC1D22B;RABGAP1;TBC1D2;EVI5
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4533462779427057,-1.0272419667555974,0.44594594594594594,0.9490737193634882,1.0,9/53,12.17%,CD96;SIGLEC1;CD63;FERMT3;CD44;SGCE;ITGB2;ITGAL;ITGA4
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.6657297713294862,-1.0271281202167366,0.41818181818181815,0.9486723272541664,1.0,2/6,7.48%,SAT1;SAT2
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.5988222019671015,-1.0266106694758572,0.4626865671641791,0.9494771689695498,1.0,3/14,10.13%,PPP1R15A;DDRGK1;GABARAPL2
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.590578497891273,1.026547753556564,0.46153846153846156,0.8418283282990393,1.0,1/13,0.45%,PCBP4
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.5549980862818068,1.0263876514049965,0.38095238095238093,0.8415859226309466,1.0,3/11,7.45%,CD180;EXOSC6;LIG4
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5585130689211092,1.0261610284586207,0.4444444444444444,0.8413228236539222,1.0,4/10,22.15%,BACE2;DYRK1A;IDE;APEH
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6204068721007501,-1.026042453071129,0.453125,0.950146120648234,1.0,1/8,7.18%,PHB2
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.5630826804637048,1.0260031118732391,0.38636363636363635,0.8409547763880779,1.0,3/7,13.42%,GINS3;POLA1;GINS1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5612866958961151,-1.0257201546172074,0.4057971014492754,0.9501617402651451,1.0,5/16,22.95%,GAPDH;FAM162A;NAE1;BNIP3;SIAH1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.5906652445999965,1.025431762531914,0.5306122448979592,0.841629765421005,1.0,4/7,19.66%,SHANK2;PRRT1;SLC24A2;PLK2
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.4383276075527062,1.0254121802295886,0.36,0.8410306120431998,1.0,15/57,15.47%,NETO1;NLGN1;RELN;SHISA9;GRIA3;GRIA4;GRIA1;GRIN2B;SLMAP;CACNG2;GRIA2;PRRT1;GRIN2A;CACNG8;CACNB4
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.6520936325690802,1.025361496681808,0.5128205128205128,0.8404429579770318,1.0,5/6,19.76%,PKD2;SALL1;ROBO2;SLIT2;FGFR2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.39806398335535853,1.0252925690046883,0.37037037037037035,0.8399718106939243,1.0,8/55,12.64%,E2F3;CDK17;CDK18;CDK7;RCC1;CDK6;SPDYA;POLA1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.665539965605129,1.02513641562963,0.5348837209302325,0.8395958928620585,1.0,1/5,0.36%,ANXA1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.5676310481341976,-1.0249089565751544,0.43333333333333335,0.9519376814117415,1.0,5/18,19.92%,PSTPIP1;ENTPD5;C3;IL1B;IL18
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.4418182764732339,1.0248776565993858,0.46875,0.8394408056338619,1.0,5/36,8.04%,IGF1R;PLCL1;PLCB4;PI4KB;PIK3C2B
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.4032256761768553,-1.024834990232451,0.41975308641975306,0.9514080447590109,1.0,37/236,14.28%,NR4A3;TGFBR3;RPS4X;CCL5;PID1;PDGFD;PRLR;AIF1;IL7R;DDRGK1;TIPIN;IL12RB2;TSPAN31;AQP11;SLC25A5;IGF1;RPL23;S100A6;NPM1;RPS6;TRPM4;NAMPT;OSMR;RBPJ;C5AR1;STAT1;CHTOP;PTN;MEIS1;ZNF16;VEGFA;CDC7;CD47;RPS9;PTPRC;CCAR1;EFNB2
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.5372304922541156,-1.0243504664421275,0.4861111111111111,0.9518519321061931,1.0,3/26,3.84%,CALCR;STAT4;EIF2B1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.38510692635321586,1.0242467563569855,0.3,0.8402184897507556,1.0,40/120,23.51%,PLXNB1;CDK5R1;MAP1S;NLGN1;NYAP2;LRRK2;PTPRM;RYK;BICDL1;DOCK10;GPM6A;SHANK3;PTEN;CNTN4;SRGAP2;SHTN1;GSK3B;ADGRV1;NEDD4;ULK1;CAMSAP2;MAP2;DCLK1;RAPGEF2;TMEM108;AGER;MARK2;MANF;ZFYVE27;CNTNAP1;CNTNAP2;STMN3;TAOK2;SVBP;TOR1A;UHMK1;STX3;MICALL2;CTTN;DTNBP1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6680604053183772,-1.024061501410196,0.4666666666666667,0.951758890228601,1.0,3/5,16.65%,MUS81;SLX4;SMC1A
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5233788509832744,1.0240171271527176,0.42857142857142855,0.840000331507086,1.0,3/14,7.84%,ABCA2;PICALM;SLC2A13
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.611566618192745,-1.0236961285986181,0.4909090909090909,0.9521080222555359,1.0,1/8,1.54%,RSAD2
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.46565064770942954,1.0236746487965975,0.3333333333333333,0.840138189225645,1.0,8/31,12.57%,LRP4;NLGN1;PICALM;CHMP7;PTPRD;PTEN;STX2;NRXN2
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5020820051491074,-1.0236696734814783,0.44642857142857145,0.9513724939338181,1.0,6/31,10.07%,TOMM7;USP36;RHOU;ARIH2;ATP5IF1;HPS4
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.6323477783979071,-1.0235681506044976,0.43103448275862066,0.9509524140526566,1.0,4/8,22.93%,APOBEC3G;INPP5K;RESF1;SETDB1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.6323742174023801,-1.022694257514551,0.48333333333333334,0.9525240285901955,1.0,4/9,18.41%,ADPRM;ENTPD5;ENTPD4;NUDT16
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5128622768683602,-1.0224409037312505,0.45454545454545453,0.9524508493118259,1.0,4/25,9.40%,PYHIN1;DDRGK1;CLU;ATP5IF1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.5503662738645964,-1.0223003353639954,0.423728813559322,0.9520375852098925,1.0,1/16,1.00%,CD2
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6390083934278838,-1.022278283593688,0.546875,0.9513050457866231,1.0,2/10,5.38%,FIS1;CLU
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.6104929670331001,-1.0222645727757351,0.42857142857142855,0.9505536937876755,1.0,1/8,1.12%,ZFP36
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.522968211744503,-1.0221621783745294,0.4492753623188406,0.9501695460044206,1.0,8/24,24.16%,POLE3;CDC7;RPA3;MCM7;PRIM1;MCM6;MCM5;MCM3
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.5736795616543344,-1.0221527329603228,0.5079365079365079,0.9494269422082475,1.0,1/13,0.97%,RIPOR2
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.3925108133328514,-1.022135342113209,0.4588235294117647,0.9487187395592366,1.0,37/209,16.88%,UBC;CCL3;ZFP36;CCL5;RPS27A;PRKCQ;RASGRF2;PSMB3;PAQR3;WDR83;PSMA7;IGF1;IL3RA;NEFL;CALM1;PSMB9;PPP1CB;CSF2RA;PSMB6;FYN;RBX1;KARS1;PSMA5;CSF2RB;PSMC4;PSMD8;PEBP1;MT3;PSMD12;PIK3CB;FGF20;PSME2;RASA2;PEA15;UBA52;IL1B;FGF13
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.40840892307083393,1.0220953945397255,0.39473684210526316,0.8430769495762476,1.0,14/48,21.68%,MAP3K11;ANKRD6;EDA2R;MAP3K10;MFHAS1;TRAF6;SH3RF1;ZNF622;MAP3K5;TPD52L1;AGER;MTURN;MAP4K2;TAOK2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5299393601474787,-1.0220058277314583,0.5074626865671642,0.9483635199300786,1.0,3/27,4.15%,UBXN1;DDRGK1;RPL11
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.4566152712089283,1.0219469525872062,0.39473684210526316,0.8427629969764094,1.0,13/40,14.95%,PKP4;CDH20;CADM1;SMAD3;MYADM;CDH11;CADM2;CDH8;TJP1;PRKCI;AFDN;CDH4;CDH19
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.5692850564351062,1.0216231086221068,0.4897959183673469,0.8427834739329801,1.0,3/7,17.01%,NRG1;KLHL12;NOLC1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.6516839481700122,1.0214713788513023,0.5238095238095238,0.8425641112832943,1.0,1/5,7.98%,BOK
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.7150877093004019,-1.0214093018770647,0.5740740740740741,0.9492029051569575,1.0,3/5,21.53%,HLA-DRA;HLA-DMB;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.40219365755717373,1.0211386279548116,0.34615384615384615,0.8426680599070911,1.0,23/71,20.56%,IGF1R;RAP1A;RELN;RYK;MERTK;EPHA6;CENPE;TAB2;SPDYA;NTRK2;PTK2;EPHA5;ZNF622;EEF1A2;ERBB4;TNF;MMD;TYRO3;RAPGEF2;NBN;FGFR1;FGFR2;LCP2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3336595828488443,1.0207723555157417,0.1875,0.8428342950302201,1.0,44/316,11.96%,EGR1;PPARGC1A;ESRRG;KLF4;NPAS3;FGF2;ZBTB16;ACTA2;MITF;ARID1A;ARNT2;MYRF;KLF6;PICALM;MAP2K1;WNT5A;RYBP;PPARG;HMGA1;SMAD3;SMAD2;DDIT3;RFX3;SALL1;PHF5A;RNF6;CLOCK;DVL3;MMS19;HDAC1;RUNX1;ZBTB48;BTRC;NFIB;TRERF1;DYRK1A;TBL1XR1;FBXW11;KAT2A;RNF20;NSD3;RGMB;RNF10;SETD3
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.3904516915848417,1.02071017742261,0.3103448275862069,0.842261797995384,1.0,7/55,10.58%,VAPB;LRRK2;TOR1AIP2;RAB10;LMAN2L;STX1A;REEP3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.49772746299097437,1.0205466676203248,0.35135135135135137,0.8419604355622817,1.0,5/18,11.81%,PDGFA;WNT5A;PDGFC;LIG4;CDK6
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5060343829448122,-1.020072848274881,0.34328358208955223,0.9521421303859143,1.0,1/25,0.15%,FLNA
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.6213498173301988,-1.0198302335838576,0.4090909090909091,0.9519175034748314,1.0,4/8,20.99%,NPM1;TMEM67;BRCA1;CENATAC
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.6835321983405108,-1.0197643002655519,0.5490196078431373,0.9513491064324995,1.0,2/5,21.24%,LNPK;TMEM33
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.624310588798628,-1.0197396340620863,0.4444444444444444,0.9506691950810359,1.0,1/5,13.96%,C3
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.4142188185639611,1.0195801675914813,0.44,0.8433209933377284,1.0,3/49,4.75%,COL16A1;NRP1;ADAM11
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.41907692915701067,1.0194728985651946,0.28125,0.8429362558387331,1.0,3/35,4.16%,PPARGC1A;LRRK2;MARCHF5
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.5344431208224618,1.0193650167246804,0.42857142857142855,0.8425728775518752,1.0,2/14,3.52%,HIP1R;PICALM
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.46051656457666634,1.0193637244318974,0.39473684210526316,0.8418889709954207,1.0,4/18,14.77%,FGF2;P2RY12;PTK2;EEF1A2
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.6117864813124827,1.0192231866857315,0.5526315789473685,0.8414752802621391,1.0,3/8,25.96%,ALOX5AP;MGST3;MGST2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.40865152187522025,1.0191747378023468,0.42857142857142855,0.8409071320879287,1.0,5/62,3.61%,CACNA1A;TRPC1;PKD2;MCU;PKD1
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.5877949008359129,-1.0188779733726243,0.5166666666666667,0.9524350750754014,1.0,1/12,1.12%,ZFP36
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.5317100269435557,-1.0188567664659103,0.5,0.9517289715482901,1.0,3/19,12.54%,TTN;IGF1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.39659982883533984,1.0183903093935773,0.38461538461538464,0.8421689313521834,1.0,12/107,9.13%,EGR1;SRCIN1;TGFBR2;BORA;RAP1A;MAP2K1;RELN;CIB1;CAB39;GRM5;CENPE;TAB2
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.5566714281763435,-1.0181078324263373,0.4782608695652174,0.9529370870174108,1.0,2/14,3.56%,NIT2;MTHFD1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.6473415015710715,1.0178776246867058,0.475,0.8428711319858642,1.0,3/5,26.17%,DNAJC3;FOXO1;EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.4069736896250881,-1.0173482319055924,0.46153846153846156,0.9542817228322092,1.0,19/166,8.87%,MYLK;CCL3;CCL5;PDGFD;GLIPR2;SYNE2;AIF1;DDRGK1;CEMIP;PLET1;RACK1;RAB11A;PECAM1;SEMA6A;IGF1;ITGA6;ACTG1;FERMT3;ENPP2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.6589546625337647,1.0171316820046628,0.46153846153846156,0.8439436013918218,1.0,1/6,9.95%,CNOT2
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5126273334482144,1.017108855548662,0.375,0.8432928275399014,1.0,6/11,29.03%,SLFN11;GTPBP4;RAD17;GMNN;WAPL;TSPYL2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.6572168619476219,-1.0170882970766186,0.52,0.9533975618420041,1.0,1/5,1.54%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.6572168619476219,-1.0170882970766186,0.52,0.9533975618420041,1.0,1/5,1.54%,RSAD2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.45016468002511734,1.017074873611283,0.38235294117647056,0.8426946048062713,1.0,10/41,8.03%,COL16A1;TPM2;SVEP1;COL5A2;ACTA2;GFAP;PHLDB1;TIMP3;NTM;CDH11
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.463385536859318,-1.0167956966826306,0.40625,0.953456312237267,1.0,27/75,21.31%,RACK1;AURKAIP1;MRPL57;MRPS7;MRPL19;MRPL51;GADD45GIP1;MRPS11;MRPL52;GTPBP2;MRPL32;MRPL50;CHCHD1;MRPS10;MRPL16;EEF1B2;MRPS15;OXA1L;MRPL45;MRPL43;MRPS18C;EEF2;MRPS25;MRPS21;MRPL47;MRPS9;MRPL13
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.45558788886835283,-1.01628063781438,0.46774193548387094,0.9542377781050404,1.0,16/65,19.37%,PSMB3;PSMA7;PSMB9;PSMB6;DVL1;PFN1;PSMA5;PSMC4;PSMD8;FZD2;PSMD12;AP2S1;PSME2;RAC1;PSMA3;PSME1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.4966398357542292,-1.016250949892123,0.4393939393939394,0.9535669703023576,1.0,2/23,6.92%,PPP1R15A;ERO1A
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.3736136315483127,1.0158774325689834,0.2857142857142857,0.8449275976191174,1.0,24/84,18.76%,QARS1;SIRT1;RAP1A;SPRED1;TSC2;GNAQ;RELN;CEP85;DEPTOR;CENPE;TAB2;YWHAG;SPDYA;NF1;PTK2;TNF;SMCR8;RAP2C;MMD;PPM1F;RAPGEF2;PPM1E;CHP1;SNCA
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.44892300874213437,1.015596975573913,0.5416666666666666,0.8450900027143988,1.0,8/26,18.64%,XPR1;ANO4;GLRA1;ANO8;ANO6;ENPP1;SLC25A14;TTYH1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.6677370365640917,1.0155382429487962,0.5319148936170213,0.8445123284575554,1.0,2/6,13.87%,PPARG;RARB
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.554604759757105,1.0154711443917297,0.46153846153846156,0.8440382534961495,1.0,2/11,8.92%,SCN3B;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6277358679352617,-1.0154289953229427,0.4909090909090909,0.9550622349965956,1.0,4/10,15.49%,HLA-F;KLRD1;PTPRC;HLA-E
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.4563080213594298,-1.0153968496571804,0.4523809523809524,0.9544442769629901,1.0,10/65,12.49%,MYO1G;YES1;VAV3;CD247;FCER1G;ACTG1;ACTB;FYN;NCKAP1L;CYFIP2
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.37442959666009296,1.0153731338917815,0.3181818181818182,0.8435649407131384,1.0,15/144,11.26%,SYNGR1;VAPB;GOLPH3L;EXOC8;LRRK2;TOR1AIP2;TMED3;TMED5;LMAN2L;TMED10;LEMD3;REEP3;BLZF1;COG1;BAG5
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.5400905938279061,1.0153624634709644,0.5128205128205128,0.8428976289997715,1.0,2/10,14.42%,TCP1;CCT3
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.6183850017261562,-1.015345989600056,0.5,0.9530279973164466,1.0,4/9,33.35%,MMAB;MMAA;MTRR;LMBRD1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.6183850017261562,-1.015345989600056,0.5,0.9530279973164466,1.0,4/9,33.35%,MMAB;MMAA;MTRR;LMBRD1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.48919227097064033,1.015326450948218,0.41379310344827586,0.8423030842418037,1.0,3/28,7.86%,ACER2;JAG1;KANK1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6455279027005837,-1.0153052354240832,0.5373134328358209,0.9523934612315569,1.0,3/9,18.30%,SRI;CALM1;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.5151281557094644,-1.014777860368978,0.46551724137931033,0.9531192009797612,1.0,4/25,6.24%,PPIE;CCL5;IFIT1;SRPK1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4030701132034267,1.0145316911694686,0.34782608695652173,0.8434697492607524,1.0,27/107,14.47%,DUSP6;PTPN9;DUSP18;PPM1L;PLPPR1;PLPP5;PLPP1;PTPRM;DUSP7;PLPPR4;PPP4R2;PPP2R1B;PTPN13;ILKAP;CDC14B;PTPRD;BTRC;PPP3CA;PTPRK;PTEN;PTPRR;FBXW11;PTPN5;SSH2;CTDSP2;PPP2R5E;PTPRG
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.41270220995944196,1.0144212050108499,0.3695652173913043,0.843069989970023,1.0,10/38,18.76%,FER;IRAK1;IRAK3;TAB2;LGALS9;MAPKAPK2;IRF5;ERBIN;PELI1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6116651949665546,-1.014179158305717,0.4909090909090909,0.95408541349631,1.0,2/6,22.46%,FYN;PARK7
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.4195169120622679,1.013859130767244,0.4117647058823529,0.8438765547081319,1.0,17/48,21.20%,UBE2J1;B4GALT7;MGAT4C;SLC39A8;MPDU1;GFPT1;OSTC;ALG12;STT3B;MGAT5;TMEM165;MAGT1;ALG3;MGAT4B;ALG8;ALG5;RPN2
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.4124701073872959,1.013753248568349,0.23809523809523808,0.843385224213395,1.0,17/80,18.81%,SIRT1;SAE1;HDAC9;NUP153;NUP188;VCPKMT;BCL11A;NUP42;STX1A;ZNF451;UBA2;NSMCE2;NUP133;NDC1;NUP205;HDAC10;SIRT4
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.4885649846515616,-1.0137480799394338,0.4117647058823529,0.9545672812267643,1.0,13/43,16.18%,TOMM7;DNAJC19;FIS1;TIMM44;SLC25A5;PITRM1;BCS1L;TOMM40;COX18;SPG7;MAIP1;OXA1L;STARD3
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.6320809449177777,-1.0130820313963842,0.5862068965517241,0.9556873302373066,1.0,1/6,7.18%,PHB2
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.4322834571339244,-1.0127650058778743,0.43902439024390244,0.9558414660834452,1.0,15/109,7.04%,CCL3;CEBPD;PID1;TNFRSF11B;MARCO;MS4A4A;ZMYND15;EPHB1;CTSB;SIGLEC1;CD14;FCER1G;F13A1;CHI3L1;CD93
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.45862283651778735,-1.012725447805687,0.463768115942029,0.9551946848065986,1.0,12/85,12.91%,CD36;TFRC;WARS1;MPP7;RACK1;CLU;RPS3;NAPA;EIF2AK2;VEGFA;NOP53;ANKRA2
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.40331673714242916,-1.0125634599125224,0.4470588235294118,0.9548936488832546,1.0,29/236,12.54%,RPS13;CCL3;SRGN;ZFP36;GAPDH;GZMB;BTG2;SLC7A5;PARP14;PARP15;DDRGK1;NUDT12;RPL13A;RACK1;IGF1;PARP9;ILF3;RPS26;RPS3;HSPA1B;EIF2AK2;CITED2;CENPV;BTN2A2;OVOL2;EIF4A3;NLRP12;DNMT1;VEGFA
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.6545324475476505,-1.0124591395331377,0.5409836065573771,0.9544500933296476,1.0,4/6,27.75%,RAC1;RAC2;CLEC7A;NOXA1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.5968911642526512,-1.0119473161341508,0.5263157894736842,0.9550917911234046,1.0,3/10,9.71%,TYMP;ENPP3;SLC25A19
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3906521699396661,1.0118698451232735,0.5384615384615384,0.8473016516178419,1.0,5/48,9.95%,PCBP4;MDM2;CNOT7;ZNF385A;CNOT2
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.4759093164265502,-1.0117384313291524,0.4266666666666667,0.9549602594440417,1.0,6/41,10.38%,CARD14;NBEAL2;PRKD2;SSH3;LLGL2;SLC14A1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.6261787082107064,-1.0116678469023994,0.5,0.9543750295225024,1.0,2/6,9.01%,ZFP36;PNRC2
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.6112948693509965,-1.0115137702684667,0.5,0.9540693165044244,1.0,2/6,11.81%,BTK;NCKAP1L
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.65999927427223,-1.0107646256542078,0.46808510638297873,0.9553179027364109,1.0,1/5,2.31%,AIF1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.6323070677253531,-1.0107581760941913,0.5079365079365079,0.9545849618574411,1.0,5/6,36.79%,GK;GK5;PGP;TPI1;GOT1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.5309548072058711,1.0100926471050642,0.3953488372093023,0.8510487319168951,1.0,2/12,5.71%,PPARGC1A;PARP1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.4910279146364743,-1.00999940081942,0.4090909090909091,0.9556178974379476,1.0,2/35,0.63%,MYLK;COL5A1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.6308608054582112,-1.0099247664896271,0.5166666666666667,0.9550990132526437,1.0,1/7,0.09%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5336437904354477,-1.0097231782437162,0.45161290322580644,0.9549617327026388,1.0,1/19,1.30%,PID1
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.41059309060714827,1.0097199065778732,0.4117647058823529,0.8511232161374651,1.0,14/72,10.18%,COL5A3;PPARGC1A;SVEP1;GSN;ZBTB16;ACTA2;GULP1;PPARG;TIMP3;DEPTOR;PDE3B;MPZL1;METRN;COL15A1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.5615959013432865,1.0096943730483876,0.5,0.8505259048491355,1.0,1/9,0.65%,NRP1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.47131944400361575,1.0096508773604507,0.4146341463414634,0.8500007271270028,1.0,3/19,8.92%,NETO1;CAB39;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation involved in immune response (GO:0033007),0.6393488922736014,1.0094431883841972,0.5555555555555556,0.8498523321163269,1.0,2/5,10.15%,FER;LGALS9
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5632620909329821,1.0092194033690032,0.45454545454545453,0.849724478478097,1.0,5/13,14.39%,ADCY9;GUCY1A1;NPR2;GUCY1B1;ADCY6
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.6066475243872571,-1.0091733516535655,0.5102040816326531,0.9557082175035801,1.0,3/7,27.64%,MGME1;POLG;SSBP1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.6973435067165076,-1.0090033048303226,0.4727272727272727,0.9546735080184509,1.0,3/5,23.68%,IL18R1;IL18;PDGFB
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.6973435067165076,-1.0090033048303226,0.4727272727272727,0.9546735080184509,1.0,3/5,23.68%,IL18R1;IL18;PDGFB
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.4250232754981947,1.0089105212165688,0.35294117647058826,0.8497084182743366,1.0,2/49,1.34%,FAAH;ACADS
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.40029890398995926,1.0088220050398737,0.4,0.8492767869506208,1.0,34/96,23.51%,LGI4;CDK5R1;NLGN1;PBX1;UGDH;PTPRM;RYK;PPT1;BICDL1;RUNX1;GPM6A;WNK1;CNTN4;NTRK2;EPHA5;GSK3B;PBX3;NEDD4;ULK1;MAP2;RAPGEF2;TMEM108;AGER;MANF;ZFYVE27;HS6ST1;CNTNAP2;STMN3;TOR1A;UHMK1;TENM2;STX3;MICALL2;DTNBP1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.5476971689877358,1.0086983398919982,0.47619047619047616,0.8489268684231109,1.0,4/9,14.90%,SCN3A;KCNMB4;SCN8A;KCNMB3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.5522662426792552,-1.0085632770427884,0.4925373134328358,0.9551546802704115,1.0,7/16,19.95%,GAPDH;LDHA;HK2;PGK1;ENO4;PGM1;PFKL
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4847861644642515,1.0085242819433928,0.4186046511627907,0.8486787091444273,1.0,3/17,7.84%,ABCA2;PICALM;SLC2A13
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.6765523975708085,-1.0084655411849277,0.5283018867924528,0.9547092712239243,1.0,4/6,22.55%,PHB2;ITGB1;TNIP2;ITGA5
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.4580746097083377,1.0080847877141903,0.4,0.8490579123760373,1.0,9/30,19.42%,PDPN;MYADM;NF1;PTK2;PPM1F;GCNT2;RSU1;CORO2B;PTPRO
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.6499820933103522,-1.0080632043947624,0.5423728813559322,0.9550740351164353,1.0,3/5,26.47%,TNFAIP3;FLOT1;PTPN22
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.44286016949493273,-1.0079099949308168,0.45,0.9547320854070963,1.0,15/93,12.73%,IFIT1;RPS14;SLC7A5;DDIT4;DNAJB9;EXOSC10;ERO1A;NPM1;FKBP14;EXOSC1;EIF4A3;XPOT;ATF3;VEGFA;NABP1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5947899062792978,-1.007844412439123,0.5409836065573771,0.9541469039167394,1.0,3/9,13.56%,RUNX3;NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.46358096639523505,1.007844188108527,0.4358974358974359,0.8489413995130577,1.0,8/31,10.20%,GRID2;NLGN1;DLG5;CLSTN2;NUMBL;LIG4;PTPRD;CLSTN3
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.5619282519903259,-1.0071653893147303,0.4642857142857143,0.9551842814763639,1.0,1/16,2.55%,EMD
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5641223229629895,-1.0070188036253076,0.5344827586206896,0.9548366285606344,1.0,3/12,14.25%,PPP1R15A;CALM1;PTPRC
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.6712975452502552,-1.0069677370374788,0.5,0.9542591111502357,1.0,1/6,3.05%,SSB
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.4767165956026953,-1.0069305440763154,0.4626865671641791,0.9536888724865301,1.0,8/39,11.81%,IL4I1;CCL5;TFRC;AIF1;LILRB4;TNFRSF1B;GLMN;NCKAP1L
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.5256922594247416,-1.0067682505146784,0.5294117647058824,0.953445402263046,1.0,10/23,22.63%,RPL10A;RPL7A;RPL35;NSA2;NHP2;ZNHIT6;LAS1L;RPL7;DDX18;WDR12
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5736781121236962,1.0067460060873819,0.42105263157894735,0.8511068588311584,1.0,8/12,37.08%,ENPP1;ANKH;TGFB1;NOTCH1;CEBPB;ROCK1;ROCK2;NBR1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.46709590892901576,-1.006710372029474,0.44776119402985076,0.9528894269762922,1.0,8/51,7.14%,SLC2A3;CD36;TFRC;SLC7A5;ABCB1;SLC38A1;ABCC3;SLC16A7
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.4479582537292685,-1.0065067370778655,0.4142857142857143,0.9528000676509277,1.0,9/65,11.76%,CCL3;ZFP36;CCL5;CARD16;CD14;GSTP1;TNFRSF1B;SELENOS;TNFAIP3
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.42620552949637136,-1.0058564588649876,0.4358974358974359,0.9537373009593973,1.0,19/115,13.04%,MT2A;CD36;GABARAPL1;MTHFD1;CYB5A;GSTM4;BPHL;NFS1;JUP;ABCC3;IGF1;SLC35B1;EPHX1;COMT;PTS;KARS1;ENTPD5;CYFIP2;FBP1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5086624318289686,1.0054800392421397,0.37209302325581395,0.8534202208725291,1.0,3/16,5.19%,ANXA1;NPY1R;CNR1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.606286002547067,1.005459187640921,0.5555555555555556,0.8527763546417566,1.0,1/5,3.40%,NRG1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.4482040290189012,1.0051923147690442,0.43902439024390244,0.8525364047766679,1.0,11/37,17.34%,ABCA2;LCP1;PARP1;DVL3;GPC6;CSNK1E;SETD2;PRKAA1;PPM1F;ATP13A2;MAP2
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.6764557557162866,-1.004778391363769,0.5471698113207547,0.9558453043602155,1.0,2/7,8.95%,PRKD2;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5212574219071741,-1.0042840372494328,0.5,0.9563268193991058,1.0,4/31,7.52%,EPN1;SNX6;CBLB;RNF126
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6188900340759745,1.0039588474378447,0.5,0.8546116813636112,1.0,1/6,2.08%,FGF2
prerank,PanglaoDB_Augmented_2021__Neurons,0.3630491245504502,1.0038705996727655,0.4166666666666667,0.8541091911329979,1.0,48/199,16.72%,KCNQ2;CNTN2;NCAN;LUZP2;PNMA8A;NBEA;NOL4;SNAP91;SCN3B;OLFM3;CHODL;CNRIP1;COPG1;CA10;GRIA3;CTNNA2;GNL3L;PSD2;GRIA4;GRM5;DNM3;CADM2;SCN8A;VGF;STX1A;CLSTN3;RBFOX1;FBXW7;SNCB;CACNG2;CACNA1B;NXPH1;PTPN5;CSPP1;GRIA2;CSRNP3;SGIP1;PPFIA2;GAD1;CACNB4;RNF220;SLC12A5;EML5;ADGRB3;CELF5;SPOCK3;DLGAP1;RGS17
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.5517324195727905,1.0037093374949186,0.5238095238095238,0.8538888560145607,1.0,2/6,9.25%,LRRK2;SASH1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.47805863052241104,1.003168722495217,0.3333333333333333,0.8544319684536931,1.0,9/21,24.28%,FGF2;PPARG;PTPRM;DNAJA4;TNF;SLIT2;SVBP;DAB2IP;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.6285832838072625,1.0028876260789577,0.5,0.8544424828769702,1.0,2/7,19.87%,ADGRV1;GRM3
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.544008562080011,1.0028510436753868,0.3953488372093023,0.8538815543226964,1.0,4/9,14.04%,GRIN3A;GLRA1;GRIN2B;GRIN2A
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.4827176804725867,1.002471451815718,0.5405405405405406,0.8541929989755103,1.0,7/15,25.07%,DROSHA;HENMT1;SNIP1;MRPL44;AGO1;TSN;ZC3H7A
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.5198018765592346,-1.0022770997108137,0.5,0.9611712126158193,1.0,6/28,12.00%,RACK1;FIS1;EIF5A;RPS3;RPS7;SOD1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4791075022221575,1.001972136008474,0.47368421052631576,0.8547942247893183,1.0,4/20,15.32%,CTNNBIP1;RUNX1;TRAF6;TNF
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.4442629868327168,-1.0016403127451328,0.44285714285714284,0.9621373658059971,1.0,6/67,5.44%,UBC;CD36;RPS27A;BTK;CTSB;CD14
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.4849912305329896,-1.001542056399101,0.4507042253521127,0.9616666609470313,1.0,5/39,12.93%,OSBPL5;BBS2;STXBP6;GOLGA4;STEAP2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.36654793199135277,1.0014542611891057,0.4117647058823529,0.8551644747600449,1.0,39/166,14.04%,CACNA1A;KCNQ2;DOC2A;GRID2;NLGN1;SLC1A3;KCNIP2;GRIK2;GRID1;LIN7A;SLC1A2;TSPOAP1;UNC13B;DTNA;GRIA3;PPFIA3;GRIA4;PDE7B;SLC12A6;GRM5;GRIA1;KCNMB4;BRSK1;STX1A;GLRA1;GRIN2B;NPTX1;PTEN;HTR7;GABRR2;MAPK1;SNCB;CACNA1B;CDH8;NRXN2;GRIA2;STXBP2;CACNA1E;GRIN2A
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5606887720382863,1.0014008413830162,0.5294117647058824,0.8545947442204638,1.0,3/13,20.38%,INTS6;INTS7;INTS6L
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6906138466690563,-1.0013956913582382,0.509090909090909,0.9613489859288383,1.0,3/5,24.96%,ATP5IF1;PINK1;SREBF1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.6214161713352317,1.0013628846534697,0.5625,0.8540358910820178,1.0,1/5,3.63%,TMEM39A
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.46208361399358466,1.0012987234642472,0.42424242424242425,0.8535577358066282,1.0,6/24,14.37%,PKD2;FGF2;GRIN2B;SLC8A1;GRIN2A;SLC24A2
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.538800242443799,-1.0010934255134243,0.4482758620689655,0.9613679001115052,1.0,7/15,21.78%,TIMM21;BCS1L;COA6;COX18;OXA1L;COX20;SURF1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.5770911944647975,-1.000886304545924,0.5522388059701493,0.9610826174711812,1.0,4/13,19.95%,EIF2B1;SELENOS;EIF2B2;PFKL
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.45912637161907477,-1.0004704104665925,0.44594594594594594,0.9615006230385937,1.0,8/49,8.64%,CD36;CXCR4;PLN;HAMP;OBSCN;MYBPC3;TTN;COL21A1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6280943845628812,-1.0003248679662928,0.48148148148148145,0.9611397449380606,1.0,3/11,11.46%,CD2;CD226;KARS1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.6285856243677764,1.0001127733419473,0.5714285714285714,0.8556925203705233,1.0,1/5,9.51%,FGGY
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5443631984980892,-0.9998234821335322,0.45901639344262296,0.9617720384200366,1.0,3/14,12.17%,DUSP1;ITGB2;ITGA4
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.4869565468695991,0.9997674589785138,0.4,0.8558514131558973,1.0,3/14,14.86%,WNT5A;DVL3;MAP3K13
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.6159049105225038,-0.9995960323026033,0.5138888888888888,0.9615504896144272,1.0,4/8,27.12%,TIPIN;ZRANB3;DONSON;TIMELESS
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.6950685190343171,-0.9994856225194786,0.5084745762711864,0.9610704463422051,1.0,1/5,8.88%,ENPP3
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.5246136957361403,-0.9992653575192092,0.5405405405405406,0.960900226583048,1.0,2/26,1.73%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.4304042699995122,0.9992081251155724,0.4583333333333333,0.8564082439422773,1.0,9/26,19.30%,CIB1;DYRK1A;FKBP4;CLASP1;CAMSAP2;MAP2;CLASP2;SNCA;ATXN7
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.5367538035974816,0.999154133013321,0.4722222222222222,0.8559396772294852,1.0,3/13,1.24%,NRP1;PDGFA;SERPINE1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.5670339708594552,-0.9990066945229925,0.5714285714285714,0.9608878481641666,1.0,3/15,7.71%,PLN;PER2;SRI
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.5691994107958895,-0.9989836584814844,0.5,0.9602204304820289,1.0,2/11,19.45%,SLC25A5;SLC17A9
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.46382287874132283,0.9988139802515984,0.47368421052631576,0.8559588583005167,1.0,6/23,10.93%,CSGALNACT1;B4GALT7;UGDH;CANT1;BMPR1B;EXT1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5563912945772079,-0.9987172286986511,0.5211267605633803,0.9602652276180467,1.0,2/18,7.75%,CH25H;ACAA1
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.6738914827542553,-0.9985526993017682,0.5079365079365079,0.9599829212748611,1.0,3/5,18.52%,PIK3CB;RAC1;EZR
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.5291302131158588,-0.9983978979871325,0.4576271186440678,0.9596004886301464,1.0,1/16,1.72%,PLN
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.3920654802467818,0.9983767607251839,0.3235294117647059,0.8562759517178539,1.0,17/79,13.57%,COL16A1;LRP4;SEMA5A;SLC1A3;KCNJ2;PCDH17;PRDX6;TIMP3;PLPPR4;NTM;CDH11;CA2;PTPRD;COL11A1;FBXL7;NTRK2;NFASC
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5901736927489216,-0.9981207844567496,0.49122807017543857,0.9595954129288868,1.0,1/9,3.86%,RGS2
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6182644771429529,-0.9980610657710016,0.5636363636363636,0.9590130457392742,1.0,3/7,23.68%,PLEK;FLOT1;PDGFB
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5584140376763971,-0.9980054497972299,0.49230769230769234,0.9577005567217866,1.0,4/18,13.70%,XPA;GTF2H5;RBX1;RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5584140376763971,-0.9980054497972299,0.49230769230769234,0.9577005567217866,1.0,4/18,13.70%,XPA;GTF2H5;RBX1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.5802274009952928,0.997917618684644,0.5,0.8568803388231684,1.0,4/9,16.18%,PDE3B;SORL1;TNF;PRKAA1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5682878819131227,-0.9971710554580098,0.47540983606557374,0.9593122288171153,1.0,4/9,13.56%,PRKCQ;CD55;NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.5357544400392036,0.9970707597267371,0.5227272727272727,0.8581580728909163,1.0,5/15,13.18%,PDPN;FGF2;HECA;CCDC40;BAG6
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.5016879382868613,-0.9968986113459928,0.5512820512820513,0.9593699499043247,1.0,2/33,1.73%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4842253866504568,0.9968849852053708,0.4878048780487805,0.8578782238011629,1.0,1/15,0.68%,GRB10
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.4654031543867988,-0.9968816375258847,0.46153846153846156,0.9586836533341178,1.0,5/38,4.49%,CD36;CCL3;PYHIN1;MNDA;AIM2
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.43254223131068303,0.9967168828545525,0.4117647058823529,0.8575889083348447,1.0,8/40,13.39%,PPARGC1A;PPT1;LIG4;UNC5B;CPEB4;SOD2;PRKCI;NTRK2
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.50214793513912,0.9966658385562738,0.43243243243243246,0.8571021831627148,1.0,2/12,17.14%,TFB1M;FASTKD1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.41382752759431807,0.9964863232292053,0.45714285714285713,0.8568435727655567,1.0,5/44,4.77%,COL5A3;COL16A1;COL5A2;COL24A1;BMP1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.45459756426395687,0.9964065871874171,0.34375,0.8562791571331647,1.0,7/21,17.12%,IGF1R;NYAP2;PIK3C2B;PTEN;NF1;TYRO3;PIK3CA
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.39141743631750187,0.9963939478362709,0.32,0.8556267848983915,1.0,21/101,11.87%,VAPB;PLA2G4C;ACER2;PPM1L;LARGE1;PLPP1;GSTA4;FA2H;CHKA;SLC44A2;SPTLC2;HACD2;HPGDS;ELOVL6;GPAT4;SAMD8;SPTLC3;SLC44A5;GPHN;CHPT1;SLC44A1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.6621396970295665,-0.9963654615131228,0.6724137931034483,0.9586686898290628,1.0,2/5,16.49%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.6621396970295665,-0.9963654615131228,0.6724137931034483,0.9586686898290628,1.0,2/5,16.49%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.4889850029797035,-0.9963185710680376,0.463768115942029,0.9580593034044348,1.0,4/25,11.80%,MTHFD1;KMO;GLUL;GOT2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5506356233761809,-0.9962531971360761,0.48333333333333334,0.9575505518542058,1.0,3/16,11.51%,MYLK;STK39;TRPV4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.41618419408224544,-0.995853684831274,0.5063291139240507,0.9577837180900359,1.0,13/144,6.94%,SIGIRR;RPGRIP1L;CCL5;CARD16;PID1;PRKCQ;NKD1;RGS2;APOD;RACK1;DDIT4;SEMA6A;PLEK
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5428954500282794,0.9956060530481295,0.47619047619047616,0.8565336694184614,1.0,1/8,0.68%,GRB10
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.4218132050246517,-0.9954089295918555,0.5,0.9582094685163802,1.0,18/137,10.09%,FLNA;PYHIN1;GAPDH;PER3;RPL5;CDC37;RPL11;USP36;CLU;IGF1;RPL23;PHB2;IFT46;HSPA1B;RPS7;DVL1;HPS4;PFN1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.6059690617272309,0.9950587485420683,0.5128205128205128,0.8571927854378923,1.0,2/8,4.81%,OTUD7A;USP30
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.3981532941899746,0.9949046235822953,0.4166666666666667,0.8568366317336321,1.0,16/37,27.68%,PTPN9;CIB1;PRKCI;ARF6;DPP10;TNF;PLS1;SPTBN1;STX3;PIK3R1;ATP2C1;WNK3;SORBS1;PRKCE;KIF5B;CLIP3
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.5741283817239748,-0.9948298616110416,0.5081967213114754,0.9590699128390577,1.0,4/12,25.13%,H1-0;DFFB;DICER1;DNASE2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.35921496154184795,0.9944363397242907,0.43478260869565216,0.8573075469140401,1.0,16/121,11.37%,UBE2D1;SCRIB;SIRT1;BORA;CDK10;SMAD3;MDM2;BRINP3;ANAPC16;CDC23;BTRC;FZR1;HECA;RCC1;CDK13;RNF20
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.6671245259008923,-0.9939197369014025,0.5692307692307692,0.9608363713097262,1.0,2/5,24.62%,TYROBP;LILRB1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.593493317250777,0.9939185227717171,0.5454545454545454,0.8578170642515556,1.0,2/8,9.21%,HDAC1;TMEM119
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5273089214476449,-0.9937357424289083,0.417910447761194,0.9597758413889558,1.0,4/13,16.86%,EYA2;HSPA1B;HSPA1A;IL1B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5273089214476449,-0.9937357424289083,0.417910447761194,0.9597758413889558,1.0,4/13,16.86%,EYA2;HSPA1B;HSPA1A;IL1B
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.5927710969440462,-0.993684706031055,0.44642857142857145,0.9592312552691588,1.0,2/10,12.58%,LILRB4;TYROBP
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.5249425458032495,-0.9934650838581163,0.4827586206896552,0.9592017373496293,1.0,6/18,15.22%,DNAH11;STIL;ENKUR;CITED2;MMP21;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.6445247433630727,-0.9933576820262416,0.49056603773584906,0.9580477794450568,1.0,2/5,18.94%,NCBP2;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.6445247433630727,-0.9933576820262416,0.49056603773584906,0.9580477794450568,1.0,2/5,18.94%,NCBP2;NRDE2
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.4057510785518712,-0.9930923776170398,0.4605263157894737,0.9580501132009119,1.0,22/128,10.67%,SLC2A3;GLIPR2;GABARAPL1;SELL;RORA;BHLHE40;GADD45B;ABCB1;TNFSF10;RGS16;IFITM3;IL10RA;COCH;IL3RA;ODC1;ITGA6;SCN9A;HK2;TNFRSF1B;CD44;PLSCR1;IL18R1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.604837760885549,0.9925464453081343,0.47619047619047616,0.8595503746948128,1.0,2/6,14.67%,CDC23;ANAPC1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.604837760885549,0.9925464453081343,0.47619047619047616,0.8595503746948128,1.0,2/6,14.67%,CDC23;ANAPC1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.48920395763883223,0.9922074277386855,0.48484848484848486,0.8595763390724533,1.0,6/21,13.68%,LGI4;MYRF;TPPP;RNF10;PARD3;JAM2
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.5250226704682127,0.9921559619567072,0.46511627906976744,0.859112176869963,1.0,2/15,1.58%,ATRAID;MSN
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5638667718154942,-0.9917841179741292,0.5522388059701493,0.9608570719968919,1.0,3/12,8.95%,TGFBR3;IGF1;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.4040347026330673,0.9915943050174676,0.4375,0.8597358845944427,1.0,17/56,19.30%,HIP1R;LDLR;MYADM;CIB1;PFDN4;KANK1;SHANK3;DYRK1A;SSH2;CLASP1;CAMSAP2;PIK3CA;MAP2;CLASP2;SLIT2;SNCA;ATXN7
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.47480089969493927,-0.9913574660263319,0.5333333333333333,0.9610486915284255,1.0,3/23,12.00%,MUSK;IGF1;SOD1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5536263266744913,0.9912187408943762,0.4166666666666667,0.8600063144906838,1.0,3/10,12.32%,LGI4;PARD3;NF1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.4848819940446747,0.9908504852423267,0.4634146341463415,0.8602958883373849,1.0,4/14,8.36%,SYCP3;CIB1;CDYL;RFX2
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.6187916237610334,0.9908390498608675,0.4772727272727273,0.85968602110884,1.0,1/6,1.37%,TBRG4
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.4786155356744843,0.9906364921252776,0.5,0.8595067135341611,1.0,6/15,23.51%,STX1A;SYT17;SYT4;KCNB1;SNCA;DTNBP1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.6500620643857344,0.9905147553113166,0.5365853658536586,0.8590349769747762,1.0,2/5,18.07%,NF1;ORAI1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.6011884803704947,-0.9904376625235838,0.47058823529411764,0.9616529841450919,1.0,1/9,3.06%,PER2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.6011884803704947,-0.9904376625235838,0.47058823529411764,0.9616529841450919,1.0,1/9,3.06%,PER2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.43951859255341896,0.9903845266321761,0.40625,0.858671203674677,1.0,6/49,2.49%,PLXNB1;PDGFA;IGF1R;FGF2;SIRT1;GAB1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.5605360782284883,0.9902318788898083,0.5208333333333334,0.8584443720177849,1.0,1/8,2.45%,SIRT1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.6417727528664147,-0.9898436487504075,0.5178571428571429,0.9625519229445832,1.0,1/7,2.92%,GTF3C6
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.5678988426215987,-0.989638639544618,0.5483870967741935,0.9623785938248536,1.0,1/12,0.09%,NR4A3
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.4581749018503409,-0.9894437955284634,0.5074626865671642,0.9621255656071412,1.0,3/49,3.29%,SYAP1;ZFP36;RORA
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.45606703825746936,-0.9891800685755461,0.47761194029850745,0.961319701751467,1.0,4/33,6.43%,INSIG1;LIPG;RORA;NR1H2
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.45606703825746936,-0.9891800685755461,0.47761194029850745,0.961319701751467,1.0,4/33,6.43%,INSIG1;LIPG;RORA;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.5716102962849441,-0.9891499669020828,0.5166666666666667,0.9607120753872734,1.0,5/10,22.53%,PRKD2;AKAP8;VEGFA;CTBP1;AKAP8L
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.5184822548163164,-0.9890820746436189,0.5689655172413793,0.9601850601640377,1.0,3/19,9.41%,NLRC3;IRF7;STAT1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.44963155195668575,0.9890019905684106,0.4827586206896552,0.8603691987793645,1.0,10/39,15.43%,SIRT1;MIER3;MTA2;HDAC9;HDAC1;TRERF1;TBL1XR1;SIRT6;BRMS1L;SFPQ
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.5937542674471116,-0.9886367241798711,0.5555555555555556,0.9605044508435001,1.0,2/14,5.71%,PRLR;NFS1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5186994685819396,-0.9885634960960376,0.4626865671641791,0.9599293736115689,1.0,2/16,5.87%,MTHFD1;NT5C
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.47901576491476633,0.988048932358646,0.5172413793103449,0.8618339211511696,1.0,6/19,19.30%,CIB1;CLASP1;CAMSAP2;PIK3CA;CLASP2;ATXN7
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.4179731973534741,0.9879390275803944,0.4594594594594595,0.861469124354516,1.0,7/28,10.90%,PKD2;ARNT2;PKD1;WNT5A;LIG4;PTCH1;PTPRR
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.4838133355431524,-0.9878352134024501,0.5151515151515151,0.9611173540966366,1.0,1/38,0.15%,FLNA
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.46542340842486507,-0.9868819478332642,0.46875,0.9628110857660144,1.0,9/39,11.76%,UBXN1;RPL5;PER2;RPL11;RPS3;HSPA1B;VPS28;U2AF2;TNFAIP3
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5439500052647517,-0.9865771434005557,0.47692307692307695,0.9629504370343385,1.0,2/15,8.13%,SRI;CALM1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.4378619221073722,0.986533061576995,0.4864864864864865,0.8643099155275653,1.0,12/39,17.58%,PTPN9;SPRY2;CIB1;KANK1;DCC;GRIN2B;PTEN;BAG5;FKBP4;ADCY6;MYLIP;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.5445776508449807,-0.9864012328871447,0.48214285714285715,0.9626683123983871,1.0,1/11,0.09%,NR4A3
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.33313170890800503,0.9862445874157142,0.47368421052631576,0.8642446405437889,1.0,23/142,14.49%,SERTAD2;RAB33B;CDKN2AIP;SIRT1;SMAD3;PPT1;CIB1;DNAJB2;PTCH2;HPN;OSGIN2;TAF9B;NDRG3;NME6;NRG3;CHPT1;RTN4;MMP14;ATAD3A;SLIT3;DCBLD2;ENPP1;DDX3X
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5608153239447486,0.9862311673081156,0.5555555555555556,0.8636170120727941,1.0,6/9,23.02%,SIRT1;NAPEPLD;PIM1;HNRNPU;ZBTB7B;FTO
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.6079755274791517,-0.9860517852217591,0.546875,0.9628929776012629,1.0,3/8,26.16%,MED1;CYP19A1;HSD17B7
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5469216985365835,-0.9859672389718236,0.4745762711864407,0.9624162187722155,1.0,2/13,3.15%,GCNT1;SELL
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.5208281055109651,-0.985900564249522,0.5573770491803278,0.9618609583289265,1.0,1/15,1.13%,CCL5
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.5096389526985109,0.985620724068695,0.5405405405405406,0.8643178799907422,1.0,2/12,1.82%,GCLC;AHCY
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.5266266673135093,0.9854619596475831,0.5,0.8640687753913585,1.0,2/11,14.68%,WNT5A;AGPAT2
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.533166523838799,-0.9854077450310632,0.45454545454545453,0.9624388019809613,1.0,1/25,1.12%,ZFP36
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.4639501718054654,0.9852634734514323,0.5,0.8638684255281814,1.0,11/27,28.56%,LCP1;RIPOR1;CEP131;ATP13A2;UHMK1;CEP290;TGFB1;PCM1;TPR;B3GAT3;PTPN14
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.6237261951707493,-0.985203662922609,0.5692307692307692,0.962340571720161,1.0,1/5,1.89%,XPA
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.47036946374169614,0.9848173848832077,0.42857142857142855,0.8640744383299508,1.0,5/23,18.60%,NSUN2;TENT5A;NAF1;THRAP3;HNRNPU
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.5487334637682317,-0.9844083724368972,0.532258064516129,0.9638533542186382,1.0,1/14,2.55%,EMD
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.5215245357157612,0.984368327044744,0.5238095238095238,0.8645796226374832,1.0,2/14,5.29%,SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.5822254511302764,-0.9829691780925224,0.5074626865671642,0.9667914069971029,1.0,2/9,13.89%,NEFL;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.5331990639771177,0.9829369013514249,0.475,0.8673622562780413,1.0,3/9,18.60%,LTBP3;FERMT2;HNRNPU
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5914410067850954,-0.9828207143954513,0.5614035087719298,0.9664838523529417,1.0,1/8,1.82%,RUNX3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.41179601975416213,0.9826363624378623,0.5,0.8674494072808588,1.0,4/46,2.33%,FER;HIP1R;SPRY2;TGFA
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4581598573505534,0.982548258315411,0.5294117647058824,0.8669580947215196,1.0,1/23,0.43%,TRPC1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.5624602349108689,0.9825097576489602,0.5348837209302325,0.8663615762692233,1.0,1/7,3.86%,SERPINE2
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5489229408742349,0.9822560826432237,0.4318181818181818,0.8663049198538115,1.0,3/9,10.55%,ABCA2;MYRF;PTEN
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.5502555979885662,-0.9816506434434248,0.5344827586206896,0.9686636074499694,1.0,3/12,5.83%,HUS1;TIPIN;MUS81
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.44971453306960113,0.9810687420590573,0.4,0.8685468295818966,1.0,6/38,8.01%,EGR1;CDK5R1;PICALM;WNT5A;DDIT3;EIF2S1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4642732827852165,0.9807521411501758,0.5357142857142857,0.8684693933053214,1.0,3/27,4.73%,EGR1;WNT5A;TLR7
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5839725129386891,0.9804271209877198,0.5853658536585366,0.8683632657569921,1.0,5/7,21.92%,NPTXR;NPTX1;DLGAP1;DLGAP4;DLGAP2
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4909967553417132,0.9803036432325027,0.5142857142857142,0.8679406502050816,1.0,4/21,9.95%,SIRT1;CLOCK;HDAC1;CNOT2
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.6344603342304623,0.9801958339495749,0.4772727272727273,0.8674323761354854,1.0,1/5,3.49%,RAP1A
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.5884402699128316,-0.980102714861297,0.5081967213114754,0.971761491720416,1.0,2/7,11.13%,VPS35;FYN
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.6465560125247766,-0.9800906719509914,0.5964912280701754,0.9711057705647201,1.0,1/5,6.09%,TTN
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.4601751321729633,-0.9799177766554561,0.4838709677419355,0.9707838779631323,1.0,4/50,8.00%,FLNA;CTDP1;RAB11A;WRAP73
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5540058252152003,0.9799073733953639,0.5277777777777778,0.8666957556136907,1.0,3/8,18.76%,SLC9A1;RYR2;SNCA
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5540058252152003,0.9799073733953639,0.5277777777777778,0.8666957556136907,1.0,3/8,18.76%,SLC9A1;RYR2;SNCA
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.4544705094801498,-0.9795720931994001,0.4805194805194805,0.9709341924379461,1.0,5/41,4.49%,CD36;CCL3;PYHIN1;MNDA;AIM2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.5183374788846993,-0.9794098922824637,0.47058823529411764,0.9705584970737859,1.0,4/22,8.13%,PLN;RGS2;SRI;CALM1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.33188755326654923,0.9793645599201308,0.391304347826087,0.867394950637655,1.0,23/162,12.05%,UBE2D1;SPSB2;ZNRF3;FBXL14;KCTD6;UBA1;MDM2;RNF6;UBE2D2;UBR3;NEDD4L;KCTD10;FBXO45;ANAPC16;CDC23;BTRC;FZR1;RNF19B;UBE2L3;RNF20;RNF185;RNF217;FEM1C
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.436172386439698,-0.978918009852257,0.5058823529411764,0.9713187188822676,1.0,9/64,12.49%,MYO1G;YES1;VAV3;CD247;ACTG1;ACTB;FYN;NCKAP1L;CYFIP2
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.42691298131501093,-0.9785298207279222,0.5,0.9716252280722087,1.0,4/71,1.70%,UBC;TGFBR3;RPS27A;FOS
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.49934042043441884,-0.9779117551507559,0.46875,0.972449918844303,1.0,7/20,23.06%,RBPJ;ATF3;VEGFA;HIF1A;MT3;NFE2L2;KLF2
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.6019693519618083,0.9776205146280612,0.5789473684210527,0.8703682458203982,1.0,1/5,7.45%,LIG4
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.5737942374186082,0.977532240362424,0.5476190476190477,0.8699842366633485,1.0,4/7,32.85%,BMPR1A;ACVR1;NOTCH1;MDM4
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.5862577151913357,-0.977399476146138,0.5,0.973201106496834,1.0,2/7,12.58%,PTN;TYROBP
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.6056214746012932,-0.9772768255600222,0.509090909090909,0.972873305844217,1.0,1/7,6.70%,GSTP1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.5455194081803011,-0.9771991382072387,0.484375,0.972353417656586,1.0,1/17,0.39%,STAT4
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.5959404503573904,0.9771391123731445,0.5853658536585366,0.8701448751501955,1.0,4/5,36.05%,TGFB1;NOTCH1;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.46416462921997875,-0.9768389162245786,0.5061728395061729,0.9726580799078767,1.0,3/45,2.43%,PKIB;PRKCQ;CHTF18
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.6751879935202603,0.976538633339796,0.5849056603773585,0.8710110862703142,1.0,1/5,5.45%,UBE2E2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.5243572575227066,0.9765316535190056,0.5227272727272727,0.8703701234408153,1.0,4/17,17.52%,ABCA2;UBE2L3;PAQR7;NR3C1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.42319817848890756,-0.9760423023042808,0.5526315789473685,0.9741881061026795,1.0,19/120,17.15%,UBC;ZFP36;RPS27A;PSMB3;PSMA7;NPM1;PSMB9;PSMB6;EXOSC1;APEX1;PSMA5;PSMC4;PSMD8;HSPA1A;PSMD12;SLC11A1;PSME2;UBA52;VIM
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.409104306934457,-0.9758430381562639,0.4533333333333333,0.9740166557861253,1.0,7/101,6.27%,MX2;CD36;TFRC;MARCO;MX1;FCER1G;LILRB4
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.5323817652889193,0.9756873197666077,0.5333333333333333,0.8716253483593676,1.0,1/10,3.15%,MYRF
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5744648731427033,0.9756863709961242,0.5306122448979592,0.8709753667423957,1.0,1/7,3.64%,KCNIP2
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.41060017139737354,-0.9753770133082946,0.525,0.9745114745073058,1.0,11/103,7.15%,FLNA;MYLK;COL5A1;TGFBR3;SAT1;TNFRSF11B;GADD45B;EMP3;RGS4;BASP1;LGALS1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.5892803289087494,-0.9753624995651002,0.5892857142857143,0.9738423783530946,1.0,6/10,28.69%,APOBEC3G;INPP5K;RESF1;SETDB1;TOP2A;MORC2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3765643500416923,-0.9750978724857049,0.6046511627906976,0.973653569769427,1.0,35/294,9.89%,FLNA;UBC;BCL2A1;APIP;CARD16;TFRC;RPS27A;PRLR;CARD14;STIL;SNX6;IFIT3;PTMA;NAIP;DDRGK1;PRELID1;BNIP2;RNF213;ATF5;IGF1;GSTP1;LAMTOR5;TNFAIP8;PHB2;NPM1;HSPA1B;BNIP1;RNF144B;RPS3A;RPL10;TPT1;CITED2;NAA38;CFL1;CD44
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.544825605211254,-0.9750652601094304,0.5,0.9730099959973625,1.0,2/13,8.27%,PLN;STK39
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.46948987365623185,0.9741691311027482,0.4634146341463415,0.8736547071174208,1.0,4/20,12.52%,SIRT1;LRRK2;BAG5;SOD2
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.5963950268043425,0.9741271457862832,0.5319148936170213,0.8730897048918259,1.0,4/6,13.84%,NRP1;PTPRM;ALCAM;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.45833989959694255,0.9739603784277405,0.4358974358974359,0.8729528377816842,1.0,7/21,15.32%,SIRT1;WNT5A;SMAD3;FERMT2;RUNX1T1;ENPP1;TNF
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.5921380259910923,-0.9736650259514331,0.5223880597014925,0.9759392100210859,1.0,1/8,2.44%,PPP1R15A
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.4091109793610627,0.9729951552477412,0.4,0.8747518016595027,1.0,6/66,4.41%,EGR1;PPARGC1A;GRID2;PICALM;LRRK2;WNT5A
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.5385273396522797,-0.9727702959961968,0.5645161290322581,0.9775070580924142,1.0,2/18,6.43%,CD36;NR1H2
prerank,GO_Biological_Process_2021__membrane raft distribution (GO:0031580),-0.645258370801878,-0.9718994811962824,0.5882352941176471,0.9791085116151385,1.0,1/5,1.00%,CD2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.49462678637261775,-0.9715773618625592,0.5217391304347826,0.9793166195642264,1.0,6/29,16.10%,NLRC3;APOD;LILRB4;APPL1;HIF1A;NOD2
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.4234358641169595,-0.9715079874322982,0.4722222222222222,0.9788562447353439,1.0,6/50,9.82%,OAS3;OAS2;USP36;FAM50A;OAS1;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.4452086511522832,-0.9714004415723383,0.5324675324675324,0.9784442201536206,1.0,7/58,11.98%,MIF4GD;CCL5;EIF1;NPM1;NCBP2;POLR2G;ATF3
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.5491110052748395,0.971317369019347,0.5714285714285714,0.8778565147327985,1.0,4/10,12.09%,MYRF;TPPP;RNF10;PARD3
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.43905451444273025,-0.9712109811243443,0.5384615384615384,0.9782353358504563,1.0,2/73,0.73%,OSBPL5;FTH1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.5901232906706168,0.9711027026057731,0.5217391304347826,0.8776500936423216,1.0,2/5,31.10%,CEP120;CCP110
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.35389950373898504,-0.9710039772148361,0.5869565217391305,0.9780981874546256,1.0,70/645,10.72%,CALCR;MYBL1;BTN3A1;CD36;CCL3;PPIE;PID1;RIMS1;TFRC;PRKCQ;RUNX3;WARS1;NFKBID;CHD3;EDF1;AIF1;SLC7A5;TRIM5;RPL5;PARP14;TAF6L;RORA;BHLHE40;PARP15;DDRGK1;RPL11;USP36;BTN3A3;OGG1;ZNF335;TXK;RACK1;ATF5;CLU;ZNF331;TTN;MUSK;IGF1;PARP9;TRIM22;RPL23;LAMTOR5;ETS1;RPS3;VPS35;BTN3A2;BRCA2;MSL3;SNF8;HSPA1B;FAM50A;BTN2A1;ACTG1;PLAG1;HNRNPAB;RPS7;RPL6;RBPJ;CITED2;HINT1;DVL1;ZNF513;PLSCR1;MLX;GLMN;ESR2;REXO4;BTN2A2;TCF3;OVOL2
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.3889074291351541,0.9709115830401115,0.48148148148148145,0.8774818478281556,1.0,14/39,22.07%,ANXA1;RAB10;STXBP5;CLASP1;CLASP2;IL1RAPL1;RIMS2;UNC13D;SNCA;RALA;CADPS2;STXBP5L;RAB3C;SEPTIN4
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.5198740396863306,-0.9705815409316791,0.5,0.9784906916206156,1.0,5/16,18.77%,IGF1;PPP1R3B;SELENOS;PASK;INPP5K
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.39543343484411986,0.9698954838186888,0.5,0.8793383418300981,1.0,6/30,14.38%,RCN3;RAB10;SEL1L;COPG1;PREB;STEAP3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.32229176959438965,0.9697437534192817,0.46153846153846156,0.8789611237025006,1.0,33/238,12.26%,PPARGC1A;ESRRG;POLR2D;ZBTB1;GLIS3;PIR;MAML2;CPSF4;E2F3;HDAC9;INTS6;POU2F1;PPARG;PARP1;NFIX;WDR33;SSU72;PCF11;CDK7;TAF2;MAML3;TAF5L;TAF9B;HDAC1;SCAF8;SOX5;TBL1XR1;CDK13;CPSF7;SUPT16H;TAF1A;TAF3;INTS7
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.5668236741997745,-0.9694901046242939,0.5230769230769231,0.9808265634080969,1.0,6/10,9.70%,SIGIRR;OAS3;APOD;LILRB4;GSTP1;OAS1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6131687017512794,0.9690676650990598,0.575,0.8800580759800918,1.0,3/9,26.89%,TMEM230;TOR1A;KIF5B
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.4387136091114367,-0.9689851446772381,0.4626865671641791,0.9813710235659202,1.0,3/59,2.28%,SYAP1;INSIG1;USF1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.62678047017747,0.9689578342526541,0.5208333333333334,0.8796431265446684,1.0,4/5,27.68%,PEX16;SPTBN1;SERINC1;CLIP3
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.4283021239800095,-0.9688876282091246,0.5694444444444444,0.9808521156040301,1.0,15/66,19.37%,PSMB3;PSMA7;PSMB9;PSMB6;EIF2AK2;TCF3;PTN;PSMA5;PSMC4;PSMD8;PSMD12;PSME2;SETD1A;PSMA3;PSME1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5099017373769767,-0.9687677489996066,0.5588235294117647,0.9804703818219811,1.0,1/21,0.35%,DDX11
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.49899210298972785,0.9681247578069087,0.5263157894736842,0.8810397857955711,1.0,2/11,4.50%,KCNJ2;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.46139227439957786,-0.9676796849635259,0.532258064516129,0.982395128289845,1.0,6/35,8.02%,CD2;CD14;CHI3L1;LAMTOR5;HSPA1B;PRKD2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.5268338194549029,0.9675664073905476,0.475,0.881614380846162,1.0,6/11,18.58%,GSN;SLC9A1;SLC8A1;PTK2;PIK3CA;RYR2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5236376300147021,0.9673171454335106,0.5526315789473685,0.88159477204649,1.0,1/9,9.06%,CTBP2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.5309433992568764,-0.9672894524644237,0.5,0.9826585211907121,1.0,8/11,30.15%,APPL1;HIF1A;NOD2;GBP5;CLEC7A;CARD9;STAT3;MYD88
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.5095100999535092,-0.9669530669835361,0.5294117647058824,0.982809071144806,1.0,1/12,1.13%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.4243552864755641,0.9663885333138967,0.4864864864864865,0.8831939528632619,1.0,4/23,15.92%,PKP4;CDC14B;CSPP1;CDC14A
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.5910699226608029,-0.9663835452945735,0.5967741935483871,0.9834562913162535,1.0,3/9,21.38%,COX7A2;PINK1;UQCC2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.43438658497210814,0.9663620152460841,0.47058823529411764,0.8826277500373817,1.0,9/31,11.39%,SVEP1;FKBP9;COL5A2;TCF7L1;PPARG;TIMP3;FERMT2;TWIST2;ENAH
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.590810440034555,0.9663088227277127,0.5957446808510638,0.8820811761664309,1.0,5/7,32.73%,GSK3B;PHKB;PRKAG2;PHKG2;UGP2
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5230872644487659,-0.9662820469720501,0.5079365079365079,0.983032688003402,1.0,1/19,1.12%,ZFP36
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.3622554047260868,0.9657796004202563,0.4090909090909091,0.8826528908891161,1.0,28/111,12.38%,CACNA1A;NRP1;SERPINE1;IGF1R;ACVR2A;TGFBR2;COL5A2;SMAD7;PPARG;PTPRM;PLCB4;LDLR;SMAD3;MMP16;PDLIM5;SCAF8;RUNX1;SCN8A;SFMBT1;NFIB;TOGARAM1;DYRK1A;PTEN;CDK13;COL11A1;BMPR1A;KALRN;TJP1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.59059830421229,-0.9657734877822579,0.5967741935483871,0.9833893964254019,1.0,3/9,12.54%,IKZF3;BTK;VEGFA
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.5495287643522055,-0.9656331433508615,0.5666666666666667,0.9829900496449987,1.0,4/14,18.43%,RBM22;NCBP2;DDX23;SNRNP200
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.5603949145781092,-0.9656027299845837,0.5283018867924528,0.9823671204958421,1.0,1/8,6.09%,TYMP
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.5601966007434755,-0.9655349518529907,0.6226415094339622,0.9818747471821315,1.0,6/10,34.92%,TALDO1;H6PD;RPE;PGLS;TKT;RBKS
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.37947665662602836,0.9651571435568603,0.3181818181818182,0.8835146601377359,1.0,12/63,14.19%,MSN;GSN;TBC1D1;TBC1D16;TBC1D5;RAB1B;TBC1D10B;TBC1D12;TBC1D22B;RABGAP1;TBC1D2;EVI5
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.41065739387218747,-0.9651115400295441,0.5882352941176471,0.9822783882355572,1.0,15/112,10.72%,CALCR;ZFP36;PRLR;FOS;STIL;SLC7A5;XRCC3;GLA;ETFB;SGK1;LLGL2;CD44;SLC2A8;DYNLT3;OVOL2
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.47975686526914985,-0.9650466587772608,0.5384615384615384,0.9817279097160813,1.0,7/36,16.54%,DDX11;EYA2;RPS3;ABRAXAS1;ERCC8;BRCA1;ZCWPW1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.44189024683472977,-0.9648975905392797,0.4838709677419355,0.9813546652361997,1.0,5/36,13.62%,GABARAPL1;RPL23;DVL1;GABARAPL2;FZD2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.5144695355602393,0.9646975336695671,0.5,0.8838781913336098,1.0,2/10,2.08%,SEMA5A;FGF2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5213446389052486,-0.9646827270378089,0.6142857142857143,0.9812229371138195,1.0,3/15,4.83%,PAQR3;RACK1;DDIT4
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4172882510305356,0.9645925137231323,0.43478260869565216,0.8835290733093476,1.0,10/64,8.20%,IFNLR1;KLF4;SCRIB;TGFBR2;STARD4;PPARG;TBC1D5;RAB1B;HPN;ACACB
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.3456059819729202,0.9645242662643252,0.5384615384615384,0.8830774738491068,1.0,44/305,11.59%,KLF4;CDK5R1;GCLC;QARS1;ZBTB16;ZBTB33;SIRT1;DPF3;ZNF706;SPINDOC;NRG1;CBFA2T3;HDAC9;WNT5A;DACH1;SAMD1;FOXN3;TLE2;ZNF12;POU2F1;PPARG;HMGA1;SMAD2;DDIT3;RFX3;SALL1;MDM2;CNOT7;MAP3K10;IKZF1;CLOCK;NACC2;HDAC1;CTBP2;SFMBT1;BTRC;TRERF1;PTPRK;ZBTB38;FBXW11;TWIST2;TCF7L2;TRAF6;RUNX1T1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.4038967215855027,0.9644922791305164,0.3448275862068966,0.8824955497502442,1.0,6/60,4.87%,CDK5R1;FER;SEMA5A;CDC42EP3;VASP;NCK2
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.5600076022162552,0.9644908608612921,0.5555555555555556,0.8818583822101868,1.0,1/14,0.45%,PCBP4
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3694063049921166,0.9644796278293521,0.5,0.8812595175730323,1.0,12/66,14.92%,MAP3K11;ANKRD6;EDA2R;STK25;MAP3K10;SASH1;KLHDC10;MFHAS1;TRAF6;SH3RF1;ZNF622;MAP3K5
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5814561786533644,0.9643611243486608,0.5238095238095238,0.8808575781284722,1.0,1/7,3.19%,CTNNBIP1
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.610569466484031,-0.9642924369096629,0.5573770491803278,0.981355711012579,1.0,2/8,13.46%,NFS1;MOCOS
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5199098156298421,-0.9641924497372323,0.5254237288135594,0.9809189488177823,1.0,12/19,27.11%,SLC7A5;DNAJB9;PHB2;PTPRC;HLA-E;NOD2;TNFRSF14;EPHB2;STX4;PTPN22;SPHK2;XBP1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.6331224033300166,-0.964154724971119,0.5614035087719298,0.9803068356834521,1.0,3/5,26.96%,IL1B;IL18;CARD9
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6270709372357,0.9640188139535918,0.5952380952380952,0.8803817318556189,1.0,2/6,10.49%,CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6270709372357,0.9640188139535918,0.5952380952380952,0.8803817318556189,1.0,2/6,10.49%,CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.44487435886567717,0.9638346594878727,0.4411764705882353,0.8801117264329944,1.0,4/18,5.28%,CDKN2AIP;PTPN23;GRIK2;CLSTN2
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.47430501308475875,0.9631825125124975,0.5128205128205128,0.8811452950956038,1.0,4/18,15.92%,PKP4;CDC14B;CSPP1;CDC14A
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.3813723218433447,0.9630994673580671,0.5,0.88067049053379,1.0,15/83,12.24%,UBE2D1;SPRY2;SMAD7;SPOPL;LRRK2;DNAJB2;GNL3L;LAPTM5;SASH1;UBE2L3;FBXW7;BAG5;TRAF6;UBE2N;DCUN1D1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.46083781620077435,0.9628774975054514,0.5,0.8805124032090883,1.0,3/23,8.94%,SIRT1;RNF6;HDAC1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.4204853016914022,0.9624314182204884,0.46511627906976744,0.8808746799299858,1.0,5/21,19.24%,ZNRF3;SMURF1;NEDD4;MYLIP;SH3GLB1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.5862484378381819,0.9621413964903622,0.5217391304347826,0.8809023010683263,1.0,2/7,3.64%,CNTN2;KCNIP2
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.464453201265956,-0.9620492186786319,0.45901639344262296,0.984877015697291,1.0,9/30,16.03%,B2M;ANXA2;CLU;CD63;VEGFA;DGKD;C3;DAB2;PICK1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.5219617398380195,-0.9612899091462543,0.5081967213114754,0.9858092991682633,1.0,7/22,12.17%,FLNA;MUSK;DVL1;ITGB2;PTN;ITGAL;ITGA4
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.5395260186919886,-0.9611714701339644,0.5333333333333333,0.9853999073489295,1.0,2/10,14.03%,LIPG;MT3
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.5871725707564169,-0.961066110493935,0.5490196078431373,0.9849852394599885,1.0,2/5,14.03%,SOD1;MT3
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.5786253208219247,0.9610087254601656,0.6511627906976745,0.882627134919827,1.0,1/5,11.90%,BLMH
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.4235729618282214,-0.9609944986855024,0.5882352941176471,0.9844659423177905,1.0,16/75,19.03%,RPS4X;CCL5;RPL5;EIF5A;NPM1;POLR2G;EIF4A3;TRUB2;RPS9;C1QBP;ZCCHC4;RPUSD4;VIM;PASK;EEF2;RPUSD3
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.47844868803591123,-0.9609596822756251,0.5076923076923077,0.9838363943993819,1.0,2/23,5.44%,ZFP36;DTX3L
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4826515413431297,0.9608824290725844,0.6206896551724138,0.8822734605914295,1.0,3/14,13.96%,PARP1;ERCC4;NAF1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.4700552214108217,-0.9608183545249085,0.5737704918032787,0.9835170757495022,1.0,1/37,0.15%,FLNA
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.6649847380760023,-0.9607612780354067,0.639344262295082,0.982935730384663,1.0,1/5,3.94%,ABCB1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.4560607319778911,0.9606361742572932,0.5714285714285714,0.8822259173577467,1.0,6/20,12.49%,ADGRB2;CSPG5;VGF;LINGO1;ENAH;CSNK1E
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.4832448909911133,-0.9605119026306042,0.5769230769230769,0.9828040020337752,1.0,6/27,11.81%,SLC7A5;SLC38A1;SLC16A3;SLC16A7;LLGL2;SLC36A4
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.46951527417797023,-0.9603580325328156,0.5373134328358209,0.9825792638313067,1.0,7/38,10.67%,FIS1;NR1H2;GSTP1;RBPJ;PCTP;BTN2A2;IL18R1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.405484076457563,0.9602937275349068,0.4,0.882382040514956,1.0,15/44,14.15%,PPARGC1A;SEMA5A;NTM;GRIA3;CDH11;SLC4A4;PTPRD;SLC26A3;CNTN4;KALRN;NFASC;SGIP1;PDE1C;GRIN2A;SORBS2
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.4016235890704595,0.9600414454736114,0.5,0.8822790011661387,1.0,10/36,19.12%,SIRT1;MDM2;LIG4;CLOCK;INTS7;NIPBL;TMEM109;RHOB;EEF1D;BLM
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.46697694326309497,-0.9596893789874719,0.5,0.9832570214352909,1.0,3/37,8.27%,FLNA;CD63;STK39
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.5366393040463266,0.9595537786071648,0.6428571428571429,0.8827120905775276,1.0,5/9,30.08%,PPARG;AKT2;PPM1K;PRKCE;IRS2
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.5726188914118315,-0.9595521670035739,0.5370370370370371,0.9828461532881905,1.0,3/6,19.78%,SOD1;MT3;ADPRS
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.4015250396271124,0.9595133602709021,0.4230769230769231,0.8821380101957786,1.0,12/57,13.39%,PPARGC1A;CDK5R1;GRID2;DDIT3;PPT1;LIG4;UNC5B;CPEB4;NF1;SOD2;PRKCI;NTRK2
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.6253115932511726,0.9592175183706698,0.6444444444444445,0.8823029730291301,1.0,1/5,5.51%,STARD4
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.42012136938929845,0.9591773388550587,0.5555555555555556,0.8816931338670533,1.0,2/38,2.45%,KLF4;SIRT1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5118906652271522,-0.9589587801441753,0.5614035087719298,0.9837785299659331,1.0,5/12,23.63%,DNAH17;DNAH1;CCDC39;TTC12;DNAI4
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.5768114906155106,-0.9588522518440021,0.5555555555555556,0.9833969124535101,1.0,3/8,10.90%,OAS2;SGK1;POFUT2
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.6436683386257865,-0.9588389180009036,0.6153846153846154,0.9820552325947475,1.0,1/6,2.92%,GTF3C6
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.6436683386257865,-0.9588389180009036,0.6153846153846154,0.9820552325947475,1.0,1/6,2.92%,GTF3C6
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.6014254264479114,-0.9585981121794952,0.5714285714285714,0.9820407719739198,1.0,1/10,4.31%,ANXA2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.5015116091514699,-0.9585774685632302,0.5671641791044776,0.9814007631296915,1.0,4/23,13.56%,IL4I1;LILRB4;NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.6076197493586839,-0.9584394299630246,0.5535714285714286,0.9811147262600097,1.0,2/9,1.83%,CMPK2;ME1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.4201636535181427,-0.9583980092699316,0.5362318840579711,0.9805861454562277,1.0,9/57,11.66%,ZFP36;SIDT2;SIDT1;DHX38;NCBP2;CHTOP;U2AF2;SRSF7;EIF4A3
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.5272108890121755,-0.9583330093441429,0.53125,0.9793752158686496,1.0,4/16,22.30%,CITED2;CDKN1C;DAB2;RNF111
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.5272108890121755,-0.9583330093441429,0.53125,0.9793752158686496,1.0,4/16,22.30%,CITED2;CDKN1C;DAB2;RNF111
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5539257423487474,-0.9582117108352776,0.5344827586206896,0.9789355159760658,1.0,2/11,2.76%,MGLL;LIPG
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.41712852276255863,0.9577441814895011,0.41935483870967744,0.8845303376003308,1.0,1/27,0.73%,BAG3
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.37313160790518446,0.9576669515211842,0.47058823529411764,0.8840578867335825,1.0,28/114,15.69%,ZBTB16;SIRT1;MCU;NLGN1;DLG5;NCOA3;MARCHF5;WNT5A;DAG1;BMP1;PHLDB1;RELN;TMEM79;DVL3;TMEM119;DDHD1;SOX5;SHANK3;BMPR1B;COBL;BMPR1A;SORL1;RTN4;ZNF703;RAPGEF3;MAP3K13;TNF;CLASP1
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.6119862029242885,0.957620332618046,0.5555555555555556,0.8835125087155447,1.0,4/7,23.13%,DCP1B;LSM1;DCP2;DCP1A
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.4640406886716279,-0.9574603128017322,0.5285714285714286,0.979886586678851,1.0,5/47,11.07%,FLNA;NLGN2;ACTG1;DVL1;ACTB
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.487540831108769,-0.9572868481107234,0.5079365079365079,0.9795739559899496,1.0,2/28,6.27%,RIPOR2;LILRB4
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5027455407581116,0.9572306662921046,0.5909090909090909,0.8836391093421434,1.0,3/14,8.20%,PRKAB2;CPT1A;ACACB
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.44750348790267236,-0.9570876581632045,0.5,0.9793654427575008,1.0,7/39,13.89%,GLIPR2;RAB11A;GLUL;ENPP2;PFN1;PTN;HIF1A
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.41753104280249653,-0.9569100626776211,0.5526315789473685,0.9790938963764861,1.0,4/74,1.70%,UBC;TGFBR3;RPS27A;FOS
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.518362873229147,0.9567947659023033,0.5789473684210527,0.8839033447148326,1.0,3/14,15.69%,MSN;PARD3;CLASP1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.5900537784203587,-0.956789774848556,0.5535714285714286,0.9786731604758343,1.0,2/5,37.51%,ABCA7;APOC1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.4561460618259682,-0.9565759935649915,0.5555555555555556,0.9784484515583023,1.0,1/20,1.94%,TPP1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.5800995793257135,0.9565099849217701,0.5277777777777778,0.8839652136577962,1.0,3/6,12.18%,SIRT1;KLF7;SORL1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.4971187636465803,-0.9561754704060969,0.5230769230769231,0.9788214823500583,1.0,2/16,5.22%,RIMS1;RAB3A
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5313112266758959,-0.956174614224028,0.5797101449275363,0.9781549554302488,1.0,5/19,18.24%,TERF2IP;NHP2;RFC1;NOP10;ANKRD28
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6112362757302083,-0.9560004665610191,0.5510204081632653,0.9778909083672435,1.0,4/7,28.00%,CHTOP;MSH6;SSBP1;MSH3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5387589255285744,-0.9557953694393494,0.6031746031746031,0.9777189468240229,1.0,4/14,22.48%,FANCB;PARPBP;POLQ;SMCHD1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.3510699487560612,0.9555532287193373,0.45161290322580644,0.885504102968212,1.0,7/58,7.09%,NUTF2;E2F3;TSC2;IPO13;NUP153;NUP188;PPP1R10
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.6111324878687752,-0.9551323221301005,0.56,0.9785955873807043,1.0,2/7,16.15%,FADS3;ALOX12
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.35967255360477546,0.9547119992707821,0.5161290322580645,0.886884925211576,1.0,14/67,12.93%,PKD2;ZBTB1;MCU;TIFA;UGDH;ALAD;KCNC2;BOK;NACC2;TMEM120B;SLC9A1;CPSF7;MICU1;NUDT21
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.5426524075283061,-0.954694860431952,0.5789473684210527,0.9791160861005517,1.0,2/13,8.55%,USP36;BUD23
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.3878033423955603,-0.9546819463924671,0.5421686746987951,0.9784859642139341,1.0,10/187,2.91%,MX2;UBC;EPN1;RIMS1;TFRC;CHRM2;RPS27A;EMD;MX1;IL7R
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.46505584431146396,0.9544517506224053,0.46875,0.8866788393398236,1.0,5/16,19.30%,CIB1;CLASP1;CAMSAP2;CLASP2;ATXN7
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.5003002736322167,-0.954448935232681,0.5964912280701754,0.9782969150708528,1.0,1/21,0.75%,CCDC88C
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5729687293694973,0.9543768344489775,0.5333333333333333,0.8862899521913954,1.0,1/7,2.45%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.4383150274318562,0.9543216762605943,0.47368421052631576,0.8858101397372907,1.0,3/26,2.08%,NRP1;SEMA5A;FGF2
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.5686142366271808,-0.9543074208048958,0.5,0.9779767227253205,1.0,2/6,25.05%,LRPAP1;ABCA7
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.5321159091205844,-0.9540418292166952,0.5254237288135594,0.9778682086637144,1.0,2/14,2.31%,CCL5;AIF1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.30858629312110364,0.9538795894255837,0.36363636363636365,0.8860349280410041,1.0,37/254,13.32%,UBE2D1;MKRN3;FBXO30;FBXO32;FBXL14;KBTBD6;UBE2J1;UBE2O;DDA1;MARCHF5;UBE2E2;UBE3D;MDM2;RNF6;UBE2D2;NEDD4L;SHARPIN;SASH1;RMND5A;CDC23;BTRC;FZR1;RNF19B;UBE2L3;FBXW7;FBXW11;RNF20;TRAF6;UBE2N;MARCHF1;BLMH;RNF217;FBXO27;KLHL42;FBXL12;BARD1;FBXL7
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.5583235185493234,0.9537162081962118,0.5294117647058824,0.8857660943794574,1.0,4/7,24.55%,DROSHA;HENMT1;MRPL44;TSN
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.5802063263661349,0.9536861069275708,0.5957446808510638,0.8851507564830079,1.0,2/10,6.22%,ABCA2;TPPP
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.40365373808328997,-0.9536690163596271,0.6052631578947368,0.978159214824393,1.0,13/85,15.95%,STIL;RPS27;CENPU;ZWILCH;ITGB3BP;DCTN6;EFHC1;STMN1;DYNC1LI2;SGO2;CENPF;SEC13;MIS12
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.35696563580775537,0.9535868878638761,0.5,0.8849103055316794,1.0,25/109,14.47%,DUSP6;PTPN9;DUSP18;PPM1L;PTPRM;DUSP7;SSU72;PPP4R2;PPP2R1B;PTPN13;ILKAP;CDC14B;PTPRD;BTRC;PPP3CA;PTPRK;PTEN;PTPRR;FBXW11;PTPN5;PPP1R15B;SSH2;CTDSP2;PPP2R5E;PTPRG
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.35795524684090874,0.953577835980872,0.6153846153846154,0.8843146891922183,1.0,14/119,8.94%,PPARGC1A;ESRRG;POLR2D;MAML2;E2F3;HDAC9;PPARG;TFB1M;CDK7;TAF2;MAML3;TAF9B;RRN3;HDAC1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.38934737269706887,0.9534553650092161,0.45,0.8839749780952131,1.0,8/42,11.87%,PLA2G4C;PLA2G7;CHKA;SLC44A2;GPAT4;SLC44A5;CHPT1;SLC44A1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.46991932378144907,0.9531400492031253,0.5945945945945946,0.8840635742222129,1.0,2/19,2.45%,PDK4;SIRT1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.4934194013677951,0.9530515815874361,0.47619047619047616,0.8836062768021391,1.0,5/15,12.57%,LRP4;NLGN1;SHANK3;GPHN;NRXN2
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.5229038068427503,-0.9529447595475232,0.5294117647058824,0.979225217597826,1.0,3/18,8.88%,CMPK2;ME1;ENPP3
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.6032263958699694,-0.9527969034057487,0.5636363636363636,0.978871080292655,1.0,2/6,27.76%,BBIP1;ARL13B
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5055827583837416,-0.9526754842176073,0.5409836065573771,0.9785003444951732,1.0,8/16,19.90%,SNX6;CBLB;LILRB4;SH3BP5;PTPRC;SH3BP5L;MVP;CHMP6
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.6112909991431734,0.9524999926732851,0.5526315789473685,0.884204029291705,1.0,1/8,2.77%,UBE2J1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.6314721323598809,-0.9523365837395397,0.5892857142857143,0.9785340878373964,1.0,2/5,14.98%,MT3;OXA1L
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.5906179780883628,0.9521568399277159,0.5454545454545454,0.8843104395650149,1.0,3/7,18.44%,SLC9A1;HVCN1;CHP1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.6194700356148305,-0.952057489995379,0.6065573770491803,0.978437009349581,1.0,4/7,32.38%,POLQ;MSH6;PMS2;SAMHD1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4515031862544028,0.9515264430562111,0.5675675675675675,0.8852971395708202,1.0,7/19,22.67%,MSH4;TDG;SETD2;MLH3;ERCC1;PMS1;ABL1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.4807679653106638,-0.9509228610190443,0.5909090909090909,0.980556060113225,1.0,4/21,12.54%,PLEKHG5;CORO1B;STAT1;VEGFA
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.5593651993888971,-0.9505811833791769,0.5967741935483871,0.9805599472182324,1.0,1/8,3.12%,MYO3B
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.5131129939396811,-0.9501062517786243,0.5070422535211268,0.9810404727094029,1.0,1/17,1.71%,DUSP1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.552447538323705,-0.9500768031490139,0.5735294117647058,0.980420273132843,1.0,7/16,30.73%,CLU;HSPA1A;PFDN6;CCT2;PSMG1;HSP90AA1;NDUFAF1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.46258911508665324,0.949909981668856,0.5,0.8882869647530938,1.0,7/19,13.93%,ANXA1;PKD2;PRKCSH;COBL;NF1;CCDC40;PCK2
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.6061843506789615,0.9492823367738961,0.6,0.8892059922246665,1.0,1/5,5.56%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.48334796862907603,-0.9487968313929702,0.5757575757575758,0.9830082301000065,1.0,7/24,16.53%,NLRC3;IGF1;GSTP1;SELENOS;TNFAIP3;C5AR2;HAVCR2
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.6265638256025698,-0.9482844511061921,0.6557377049180327,0.9834861201851102,1.0,2/6,12.00%,AK9;AMPD2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.5867298085116529,-0.9481912918338472,0.6296296296296297,0.9830239754428517,1.0,2/8,11.81%,HLA-F;NCKAP1L
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5018645978291951,0.9479360369026891,0.5428571428571428,0.8914642083872532,1.0,7/20,18.76%,SLC7A8;TMTC2;SLC12A6;SLC8A1;SLC12A2;SLC12A5;SNCA
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.5568079626564901,0.9478938182389689,0.525,0.8909134229331797,1.0,2/8,4.50%,ADRA1A;SCN3B
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.5952406254642765,-0.9478186990788605,0.5932203389830508,0.9833089336692492,1.0,3/8,19.52%,NCKAP1L;RAC1;RAC2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.4829224924487932,0.9475415593712051,0.5769230769230769,0.891096026589099,1.0,10/20,25.60%,UBE2E2;CDC23;FZR1;UBE2L3;ANAPC1;UBE2D3;ANAPC4;UBE2D4;UBE2E3;RNF4
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.517515330136797,0.947304217422635,0.5555555555555556,0.8910524180307126,1.0,6/15,18.46%,JAG1;ROBO1;SLIT3;ROBO2;TNFRSF1A;SLIT2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.47662011682298155,-0.9471899873694127,0.5862068965517241,0.9842942689645282,1.0,3/25,10.13%,GABARAPL1;CALM1;GABARAPL2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5504430188951059,-0.946994739733494,0.6031746031746031,0.9840810045723895,1.0,6/12,29.75%,ABCA8;NPC1;ABCA5;STX12;ABCA7;NPC2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.3641255065109293,0.9468050901759356,0.7272727272727273,0.8914514267675285,1.0,29/201,12.09%,PPARGC1A;COL16A1;TGFA;BET1;TSPAN33;MITF;MCU;TCF7L1;PICALM;LRRK2;PDE4DIP;CTSC;TLE2;LIN7A;SEC24B;MAGI1;TMED10;RAB1B;MDM2;BOK;GRIA1;HDAC1;BCL9L;SLC9A1;FERMT2;TCF7L2;PREB;ANO6;PARD3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4885015413626107,0.9467890018819968,0.5116279069767442,0.8908841577266748,1.0,1/13,1.09%,PKD2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.4425953981055492,0.9467546160553699,0.5116279069767442,0.8903086714989027,1.0,3/17,5.77%,CTBS;GLB1;HPSE
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.44297045292544945,0.946703058698855,0.5,0.8897790611611821,1.0,6/27,17.57%,VCPKMT;NSD3;SETD3;RAB6A;SNRPB;PRMT7
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.6030531588742322,0.9465360463295379,0.58,0.8896284608719289,1.0,2/5,31.99%,CBL;CTNNB1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3579110513291957,0.9461971435303783,0.4642857142857143,0.8897120703834078,1.0,26/115,20.26%,RRAGD;PDK4;SIRT1;MAP1LC3A;XPR1;LRRK2;NUAK1;EIF2S1;ATP6V1B2;BRSK1;CPEB4;MAPK1;RIPOR1;TBL2;MAP3K5;LAMTOR3;PRKAA1;ATP6V0B;SIK2;SESN2;ATP6V0E2;FOXO1;SH3GLB1;TCIRG1;MIOS;BRSK2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.5133069298150387,0.9461364752423249,0.5333333333333333,0.8892289679526542,1.0,3/14,4.58%,MSN;ABCA2;CTSC
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),-0.6207065453759844,-0.9461320041583305,0.5625,0.9855385568666795,1.0,2/5,16.51%,HPS4;TRAPPC6A
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6004200635826006,-0.9459737308733617,0.6415094339622641,0.985319100810421,1.0,2/5,26.47%,IFI35;PTPN22
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.5172881195173018,-0.9457218361903952,0.6,0.9851619374515969,1.0,6/22,11.55%,PER2;BHLHE40;TYMP;PRUNE1;TNFRSF1B;PTN
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6058741419199175,-0.9449341501885802,0.5925925925925926,0.9863398336420938,1.0,2/5,15.22%,BBOF1;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4081540659678484,-0.9448778217364037,0.631578947368421,0.985776944304917,1.0,23/117,16.53%,SIGIRR;SRGN;ZFP36;NLRC3;DHX58;CD200R1;APOD;NLRC5;LILRB4;TMSB4X;BTN2A2;SELENOS;TNFAIP3;NCKAP1L;NLRP12;TYROBP;PTPRC;C1QBP;KAT5;SLC11A1;CD200;C5AR2;HAVCR2
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5237777019784385,-0.9446830870122287,0.5409836065573771,0.9856254148180238,1.0,2/12,8.13%,PHKG1;CALM1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.5656867421036119,0.9437822112673881,0.6363636363636364,0.8937793911873255,1.0,1/6,3.62%,VEZF1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.4619117736816832,0.9436082533511327,0.5666666666666667,0.8936353805734436,1.0,9/21,22.67%,MAP1S;FKBP4;CLASP1;CAMSAP2;MAP2;CLASP2;STMN3;MAPRE2;ABL1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5141595640051911,-0.9434530091334918,0.5735294117647058,0.9877505560355737,1.0,5/20,18.24%,TERF2IP;NHP2;RFC1;NOP10;ANKRD28
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.4926137035319858,-0.9431483477845648,0.6,0.9878169718742419,1.0,7/23,16.53%,NLRC3;IGF1;GSTP1;SELENOS;TNFAIP3;C5AR2;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4711837053592846,-0.9431333739852826,0.48484848484848486,0.9872040824263527,1.0,5/19,18.89%,RSAD2;IFI35;CYBA;TASL;FLOT1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.3918160068361438,-0.9426498831126688,0.5975609756097561,0.9878541730979808,1.0,27/127,14.79%,COL5A1;CXCR4;ME1;MDH2;ANKZF1;IER3;DDIT4;CYB5A;SLC16A3;ERO1A;LDHA;XYLT2;HK2;CITED2;EGLN3;CD44;GPC3;FAM162A;GOT2;SOD1;VEGFA;SDC3;MXI1;PGK1;PSMC4;VLDLR;STMN1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.5826291700407258,-0.9426287614881479,0.6111111111111112,0.9872420808182155,1.0,1/6,2.27%,EDF1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5744718608326168,0.942552133720319,0.6190476190476191,0.8953582858499276,1.0,3/8,11.74%,ACADS;ACADVL;GCDH
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.5691270282534696,0.9425242335223623,0.575,0.894136608082081,1.0,3/6,17.27%,NSUN2;SETD2;IWS1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.5691270282534696,0.9425242335223623,0.575,0.894136608082081,1.0,3/6,17.27%,NSUN2;SETD2;IWS1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5794557746628447,0.9424893951686526,0.5238095238095238,0.8935897450014222,1.0,2/7,14.98%,PARP1;SETD5
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.3855835426935226,0.9423392454224532,0.5526315789473685,0.8933031817775202,1.0,12/45,17.09%,MYOM1;GOLPH3L;MCU;PTPN23;TMED10;UNC13B;CD33;TCF7L2;ARF6;SOX4;ATP13A2;TM7SF3
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5559678626558029,-0.94219152621475,0.6,0.9875663545783361,1.0,3/13,11.55%,MEI4;IHO1;PTN
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.485673738045851,-0.9420170497906207,0.55,0.987330362257901,1.0,1/16,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.6238682851424163,-0.9419681594447369,0.6,0.9867702008159179,1.0,2/5,31.48%,PRPSAP1;TKT
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.5331271812812742,-0.941865222007577,0.49206349206349204,0.9864288310261594,1.0,3/18,16.79%,SRP14;SST;PCSK2
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.4983230937754384,-0.9416886727958681,0.5517241379310345,0.9862220077806249,1.0,5/18,9.89%,CLU;RPS3;PTTG1IP;TPT1;CD44
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.3899467713865493,0.9415940481798615,0.5,0.8940901967141145,1.0,14/52,15.68%,BAG3;CASP9;SORT1;SMAD3;CIB1;TNFRSF10A;SIVA1;BOK;DCC;DDX3X;ITGAV;P2RX7;TNF;GSK3B
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5229871237462055,0.9415176871576396,0.5,0.8936517575070329,1.0,3/10,6.44%,SIRT1;SETD7;HP1BP3
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.40624377776795795,-0.9414180342743506,0.573170731707317,0.9861997116700524,1.0,20/105,15.02%,TFRC;FOS;JUNB;BTG2;ABCB1;POLE3;ATP6V1F;HLA-F;EPHX1;ACAA1;PARP2;IRF1;TAP1;ATF3;PRPF3;CDKN1C;BTG1;CCK;AP2S1;CLTB
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.48350247798041535,0.9412505728264109,0.47058823529411764,0.893624740501983,1.0,8/17,21.00%,PDE7B;RAPGEF3;EPHA5;RAPGEF2;RIMS2;ADCY1;KSR1;DGKQ
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.40503008691696135,0.9412036909622497,0.5128205128205128,0.8930979962312029,1.0,2/29,1.42%,DAPK2;QARS1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.587344494181712,0.9410242409148324,0.5283018867924528,0.8928662867531559,1.0,4/6,22.32%,LGALS9;TWSG1;CD274;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.4465730973725736,0.9407501057335936,0.5454545454545454,0.8928576986844974,1.0,5/29,6.24%,SERPINE1;HIP1R;PICALM;SNAP91;PPT1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.4671045719077139,0.9401619987299746,0.6097560975609756,0.8935259552435924,1.0,2/15,2.03%,PKD2;TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3587047442283032,0.9401118865601086,0.5161290322580645,0.8930452465726725,1.0,14/74,8.08%,PDGFA;PKD2;FGF2;SIRT1;PKD1;NEK10;LRRK2;MAP2K1;WNT5A;CIB1;PDGFC;CAB39;ROBO1;IRAK1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.43172038497415643,-0.9401106870676733,0.6619718309859155,0.9888724070582373,1.0,11/58,18.78%,USP6;YES1;ERO1A;ADPRH;SEPHS1;PIGH;GGCX;PARP4;UBA52;RPN1;SERP1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.4615746505773853,0.9391215277775452,0.4864864864864865,0.894477263194585,1.0,5/22,8.03%,TPM2;COL5A2;ACTA2;TIMP3;CDH11
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.4566054413092821,0.9390810272035213,0.5217391304347826,0.8938899165142865,1.0,5/18,13.18%,PDPN;FGF2;DISP1;CCDC40;BAG6
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.4793520469446661,-0.9389235989690696,0.5833333333333334,0.9910174010595777,1.0,7/17,18.90%,PHB2;SMDT1;MICU2;SPG7;MAIP1;MCUR1;STOML2
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.5487331069911264,-0.9387470475054939,0.6296296296296297,0.9907077708507193,1.0,3/11,21.38%,SRPK1;SUPT6H;CDK11B
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.6010980806532729,-0.9385945992432236,0.6153846153846154,0.9904542379979515,1.0,1/6,5.18%,ING5
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.5940040569854647,0.9384228085804768,0.6097560975609756,0.8945822373243549,1.0,4/5,40.58%,PSPH;SRR;PSAT1;SERINC5
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.4941893503510043,-0.9382069390090018,0.5,0.9906128358453571,1.0,3/14,9.25%,SMUG1;OGG1;PARP2
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5193452504106866,0.9379092832701043,0.42424242424242425,0.8951493490609731,1.0,3/6,14.48%,SMAD2;ITGA2;TBX19
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.41989532823975223,-0.9376495809751337,0.5609756097560976,0.9912828410235639,1.0,9/75,12.86%,FLNA;NKD1;ODC1;SNF8;VPS28;GPC3;TNFAIP3;AZIN1;AZIN2
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5196640292176873,0.9374275298851807,0.5348837209302325,0.8955471699585839,1.0,3/9,18.75%,SERPINE2;ZNF703;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.5821192248992605,-0.9369808282639639,0.5857142857142857,0.9921853648508119,1.0,2/8,7.20%,IGF1;RPS3
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.4382042350497517,0.936813987319587,0.5806451612903226,0.8962989343708232,1.0,7/18,19.64%,KCNJ2;KCNJ5;NEDD4L;PIM1;NEDD4;SNCA;KCNJ6
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.5547534009747032,0.9367704031047096,0.6086956521739131,0.8957300740037571,1.0,1/7,1.30%,FPR3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.48035536370529375,-0.9361230692067846,0.6111111111111112,0.9935809667544132,1.0,2/23,4.30%,GZMB;CHCHD10
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.44760846915991215,0.9360239670031203,0.4594594594594595,0.8966222706547443,1.0,8/24,17.03%,SCARB2;LAPTM5;RAB7A;NCOA4;SORL1;RTN4;NEDD4;ATP13A2
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.4758433213988043,0.9358618366573541,0.56,0.8962750740601926,1.0,4/27,7.48%,NUTF2;BACH2;GEMIN2;XPO1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.6108773706443306,-0.9358365794490829,0.6440677966101694,0.9936704672808121,1.0,2/5,22.60%,WRAP73;SEPTIN9
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.48159453987171474,0.9354272967983505,0.5526315789473685,0.8965646836556251,1.0,2/17,8.28%,CD22;LAPTM5
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.518883302589364,0.9350917436601991,0.5813953488372093,0.8967214163771731,1.0,1/9,1.72%,GSN
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.559321395164088,-0.9350228657920838,0.5409836065573771,0.9946916288775531,1.0,2/12,4.98%,PID1;FIS1
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.610076872006055,-0.9349938358947463,0.6226415094339622,0.9940819027204509,1.0,4/6,32.28%,NCKAP1L;PPP2R3C;ZC3H8;AKT1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.591689848586744,-0.9349209986659206,0.6271186440677966,0.993628075497294,1.0,1/6,8.13%,CALM1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.5018205591666701,0.934630237900719,0.5909090909090909,0.8970544448704962,1.0,4/11,18.61%,GINS3;POLA1;GINS1;NBN
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5049405460945011,0.9344117054777774,0.47368421052631576,0.8968931194723259,1.0,1/8,5.86%,WASF2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.5649079542362918,-0.934021542820055,0.59375,0.9951509477124288,1.0,3/10,15.49%,CD55;HLA-DRA;HLA-E
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.4973597578839793,-0.9339418424180265,0.5507246376811594,0.9947025453049982,1.0,2/11,9.41%,DUOX1;STAT1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5160806191172893,0.9338007821314644,0.6571428571428571,0.8977103084672726,1.0,6/11,24.46%,MAP2K1;TNF;MAP2K2;RIPK1;TGFB1;ESR1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.4153323083221775,0.9337869117549528,0.5185185185185185,0.8971083853524869,1.0,1/35,0.27%,KLF4
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.4187939759396604,0.933262116301005,0.5769230769230769,0.8976514590173738,1.0,8/23,19.12%,SIRT1;LIG4;CLOCK;INTS7;OPN3;RHOB;EEF1D;BLM
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.5332367595303853,0.9330942010633863,0.5217391304347826,0.8974637812516856,1.0,1/10,1.89%,ABCA2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.5636523934541937,0.9330717283779806,0.6904761904761905,0.8962899377833423,1.0,2/8,10.69%,AP3B2;AP3S1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.5636523934541937,0.9330717283779806,0.6904761904761905,0.8962899377833423,1.0,2/8,10.69%,AP3B2;AP3S1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.3879093808803551,0.9330374656041552,0.5714285714285714,0.895770055042973,1.0,7/31,13.57%,LGI4;MYRF;TPPP;SCN8A;PARD3;NF1;NFASC
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.43127781424621203,0.9326626343022467,0.5434782608695652,0.8959876539531103,1.0,11/28,23.32%,DIP2B;RNF6;RTN4;SHTN1;MAP3K13;GSK3B;KIAA0319;MAP2;ZFYVE27;ABL1;CTTN
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.5832599661379311,-0.9321834108841597,0.65,0.9982182888373062,1.0,1/6,2.11%,NFKBID
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.39114579808694167,-0.9319987365860392,0.5405405405405406,0.9979562785153641,1.0,22/113,18.70%,CMPK2;EDF1;GTF2H5;ADRM1;NT5C;RNMT;NCBP2;POLR2G;VPS28;RBX1;DCTN4;GPX4;VPS37B;RPA3;ERCC8;TAF1C;TYMS;GTF2F1;PRIM1;POLR3C;NELFE;NME3
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.4416539648591252,0.9319371991518365,0.5853658536585366,0.8968360348325665,1.0,1/14,0.77%,LGI4
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),-0.6262576260474084,-0.9315801860221035,0.673469387755102,0.9982411601645488,1.0,3/5,24.32%,NLRP12;GBP5;TLR2
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.5200129741281285,-0.931274148134832,0.6290322580645161,0.9982994678634326,1.0,5/19,13.89%,IGF1;PFKFB3;ENTPD5;PFKFB4;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4743624931588515,-0.931053430776496,0.5901639344262295,0.9981592168873381,1.0,6/23,15.10%,PARP14;LILRB4;SAMSN1;SH3BP5;PTPRC;SH3BP5L
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.5171510166964948,-0.9310529467057784,0.6153846153846154,0.9975012345426528,1.0,2/12,6.40%,CARD14;CHI3L1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.5350638461449395,-0.9307166116276298,0.6153846153846154,0.9975654205614528,1.0,1/9,2.29%,SYNE2
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5581784701853939,-0.9303837946522049,0.6271186440677966,0.9976625370283158,1.0,3/11,28.54%,ARPC5L;IQGAP2;ARPC3
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.43799402341248267,0.9300209387134358,0.5625,0.9005299249426193,1.0,10/30,15.96%,PDGFA;TGFBR2;PBX1;SALL1;KITLG;COBL;BMPR1A;RARB;TNF;PBX3
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.4742400629870349,-0.9298588840915083,0.5483870967741935,0.9980619637306906,1.0,1/28,0.66%,MYO1G
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.5638503488163525,-0.9298090369904144,0.6333333333333333,0.9975486524230401,1.0,2/9,8.99%,GZMB;KLRD1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.42696446888297823,-0.9295750803697373,0.5,0.9973984643556723,1.0,5/43,9.96%,MT2A;HAMP;TTN;CALM1;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.40886549701682967,-0.9292548947963517,0.5507246376811594,0.9975009234209894,1.0,13/56,16.86%,TNFSF10;EYA2;IGF1;ITGA6;GSTP1;HSPA1B;CFLAR;TNFAIP3;HSPA1A;BRCA1;GPX1;PEA15;IL1B
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.614878891677653,-0.9291487302341949,0.5081967213114754,0.9970767417511033,1.0,3/6,33.20%,MID1;CHAMP1;MAPRE1
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.5159114170895314,0.929083994356841,0.6041666666666666,0.9012985373716728,1.0,3/11,11.30%,ARID1A;HMGA1;SUPT16H
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.5159114170895314,0.929083994356841,0.6041666666666666,0.9012985373716728,1.0,3/11,11.30%,ARID1A;HMGA1;SUPT16H
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.41587423444984717,0.9290415540094981,0.5454545454545454,0.9007336555963695,1.0,9/64,13.96%,EPS8;KBTBD6;SPRY2;KANK1;SHOC2;LZTR1;SYNGAP1;VAV1;ARF6
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.35471780699500594,0.9286129537964486,0.5333333333333333,0.9010954587397043,1.0,23/98,19.84%,BET1;GOLPH3L;LRRK2;TMED3;TMED5;LMAN2L;STK25;TMED10;VTI1A;BLZF1;COG1;BAG5;STX6;PLEKHM2;UBXN2A;COG3;CLASP1;CLASP2;TRAPPC8;TRAPPC12;HACE1;GBF1;DYM
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.5351135565340819,0.9284798125457214,0.5405405405405406,0.9008457340880376,1.0,1/13,2.56%,BORA
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.578128685745964,-0.9284626537467542,0.640625,0.9979082296621711,1.0,2/7,14.32%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.515542655527708,0.928401567942962,0.5454545454545454,0.9003869970423773,1.0,3/10,18.76%,SIRT1;ZNF451;SNCA
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),-0.6271450759927563,-0.9278833698968143,0.6458333333333334,0.9984428561842307,1.0,2/5,25.40%,SOD1;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.4032895017623947,-0.9272692532372043,0.6486486486486487,0.999190255426754,1.0,8/86,7.18%,FLNA;SIGIRR;NLRC3;BHLHE40;AIM2;NLRC5;TMSB4X;PHB2
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.5428540945583857,-0.9270800829442677,0.639344262295082,0.9983424566080329,1.0,5/17,13.89%,IGF1;PFKFB3;ENTPD5;PFKFB4;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5428540945583857,-0.9270800829442677,0.639344262295082,0.9983424566080329,1.0,5/17,13.89%,IGF1;PFKFB3;ENTPD5;PFKFB4;HIF1A
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.5390112758694159,0.9270671115040058,0.4864864864864865,0.9025527385507566,1.0,3/9,13.05%,SMAD7;VCL;ZNF703
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.3924472861856141,0.9270312193388544,0.52,0.9020324844174704,1.0,15/60,12.72%,DUSP6;QARS1;SPRY2;SPRED1;SPRED2;SIRPA;DAG1;DUSP7;TIMP3;IRAK3;PTEN;PTPRR;SORL1;NF1;RPS6KA6
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.3878640856641531,0.926815496742085,0.6060606060606061,0.9019220855462082,1.0,6/26,12.36%,RAB33B;ARL5A;TMED10;RIPOR1;SORL1;RAB6A
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5202584503829032,0.9257385764483935,0.5555555555555556,0.9035864922252728,1.0,8/11,22.81%,NLGN1;RELN;SHANK3;CACNG2;CACNG8;CACNG3;NRXN1;TSHZ3
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.5117828198737507,-0.9253538188726091,0.5833333333333334,1.0,1.0,2/13,8.13%,PHKG1;CALM1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.45666123873248565,-0.9251741096613877,0.5384615384615384,1.0,1.0,6/28,14.41%,TGFBR3;HNRNPAB;RBPJ;S100A4;HIF1A;DDX5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.37417299175349716,0.925146865752191,0.625,0.904266281248385,1.0,8/45,13.59%,POLR2D;DCP1B;SAMD4A;EXOSC6;CNOT7;CNOT2;LSM6;LSM1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.6341851411074999,-0.9251032285523684,0.64,1.0,1.0,2/5,22.25%,SRI;TPM1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.559611424852449,-0.9250783978623649,0.6274509803921569,1.0,1.0,1/6,2.24%,STIL
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.443214097924666,0.9246822553105952,0.55,0.9047974581838445,1.0,7/23,8.07%,PLXNB1;NRP1;SEMA5A;PLXNA2;SEMA3B;PLXNB2;PLXNA3
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.4838337916245212,-0.9246703686438129,0.5671641791044776,1.0,1.0,5/21,16.86%,PER2;BHLHE40;PRUNE1;NOTCH2;IL1B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.40453005001744713,-0.924491650232298,0.6,0.9999288401029524,1.0,4/68,2.56%,UBC;TGFBR3;RPS27A;SNX6
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.4484726949274957,-0.9243699138443067,0.6582278481012658,0.9995281580501147,1.0,5/41,9.14%,MCTP2;RIMS1;RAB3A;RAB3D;LLGL2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.4580029861137021,0.924263928702137,0.575,0.9050327402136564,1.0,5/14,18.58%,ADRA1A;GRIN2B;SLC8A1;GRIN2A;RYR2
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.46363251469225336,-0.9241868906273134,0.6825396825396826,0.9994434044399187,1.0,4/22,13.89%,CCL5;EIF5A;OAS1;HIF1A
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.6117631631528916,0.9238445404081665,0.5945945945945946,0.9053544586891891,1.0,3/6,13.01%,ABCA2;SAMD8;SGMS1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.389171690565004,-0.9237732423143719,0.5897435897435898,0.9997554807816521,1.0,14/106,10.67%,MX2;SIGIRR;PID1;CXCR4;MX1;XAF1;IFITM3;SHFL;CHI3L1;OSMR;EIF2AK2;STAT1;PLSCR1;IL18R1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.5483394725897559,0.9237498517818947,0.6046511627906976,0.9049214726499992,1.0,2/6,11.28%,TMEM79;KLF7
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.6162828920113961,-0.9235052822918152,0.6428571428571429,0.9997032755191714,1.0,1/7,3.00%,B2M
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.3242045777903392,0.9234228894134556,0.6666666666666666,0.9049915780644586,1.0,13/118,6.41%,GRB10;LRP4;ZNRF3;RUVBL2;CTNNBIP1;ANKRD6;TSC2;WNT5A;TLE2;INVS;TMEM170B;DDIT3;NLK
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.4719472046035112,0.923237642102314,0.5714285714285714,0.9047239272671693,1.0,1/10,1.13%,ZBTB1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.42402235273630096,0.9231745981820734,0.6086956521739131,0.9042230325018558,1.0,3/25,10.71%,RRAGD;GLRA1;CPEB4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.6162529202295259,-0.92303812173605,0.6607142857142857,1.0,1.0,1/6,5.35%,ATF5
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.5201938633676346,0.9229591393473896,0.5833333333333334,0.9039994962946848,1.0,2/10,12.91%,AANAT;NAA35
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.502481383147029,0.9229519049898045,0.6888888888888889,0.9034306471352826,1.0,2/11,15.62%,TMEM39A;SMCR8
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4778928298586668,0.9229027798822323,0.5555555555555556,0.9029748168167115,1.0,1/11,0.27%,KLF4
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.37395840228419674,0.92288803449949,0.6153846153846154,0.9024074297112623,1.0,9/41,15.71%,ANXA1;KLHL18;UBE2E2;CDC23;RAD51B;NSMCE2;DDX3X;CCND3;ANKRD17
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.35670961521793043,-0.9226962789578215,0.6404494382022472,1.0,1.0,53/400,12.74%,NR4A3;STAT4;COL18A1;FTH1;RPS4X;TFRC;PDGFD;PRLR;H2AC6;WARS1;JUNB;BTG2;AIF1;IL7R;IFIT3;DDRGK1;ING5;TIPIN;ATF5;CLU;IL12RB2;JUP;TSPAN31;AQP11;SLC25A5;IGF1;RPL23;ETS1;RNF126;NPM1;RPS6;HSPA1B;TRPM4;NAMPT;BEX4;OSMR;SGK1;EIF2AK2;STAT1;IRF1;EGLN3;GLMN;KANK2;CHTOP;PTN;MEIS1;PDCD5;IFI35;ZNF16;ING4;VEGFA;CDC7;SST
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.3888681414455813,0.9226591214980053,0.5757575757575758,0.9021943472913825,1.0,5/48,6.18%,KLF4;ANXA1;SERPINE1;TLR7;DDIT3
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.5144306050439644,0.9224162652991965,0.5365853658536586,0.9021194254967451,1.0,3/8,19.27%,DGUOK;ADK;PNP
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.34586636549337685,0.9222343216401985,0.5882352941176471,0.9019757148917277,1.0,26/116,12.92%,HS3ST5;LRP4;SPRY2;SMAD7;ZNF706;SPRED1;PLCL1;SPRED2;PTPN23;HDAC9;USF3;RPS6KA4;DDIT3;ARRDC3;HPN;ROBO1;PTCH1;NPTN;SFMBT1;NFIB;PTEN;PTPRR;KLF7;TWSG1;RPS6KA6;GPNMB
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.4420302746474395,0.9222307477448073,0.43243243243243246,0.9013933209994978,1.0,2/15,6.16%,RRAGD;GPR137C
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.46734362841311183,-0.9221454346938903,0.5757575757575758,1.0,1.0,3/22,10.18%,PLEKHG5;STAT1;KANK2
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.34601763647506883,0.9220405260780447,0.6666666666666666,0.9012244944598395,1.0,13/76,13.18%,UBE2J1;RCN3;RNF139;UBXN6;SEL1L;DNAJB2;AUP1;FAM8A1;DNAJC18;RNF185;FBXO27;STT3B;BAG6
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.5040867869701113,0.9213957721751634,0.6363636363636364,0.9022762210705064,1.0,4/9,19.08%,FGD4;DNM3;SRGAP2;ARHGEF4
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.40406134422068657,0.9212052184296499,0.625,0.9021929082110118,1.0,4/27,4.21%,PDPN;SLC38A10;SLC7A8;SLC3A2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.5973128436161197,0.9208535649375601,0.6739130434782609,0.9023757582368137,1.0,3/5,36.25%,AGO1;MOV10;AGO3
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.38767388056452445,0.9205578073529042,0.5757575757575758,0.9023439495668231,1.0,15/39,19.91%,NRP1;CDK5R1;AUTS2;RELN;GPM6A;PEX13;ELP3;MARK1;NTRK2;SH3RF1;KIAA0319;RAPGEF2;MARK2;FGFR1;NAV1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.521429681620997,-0.9201414672235589,0.49122807017543857,1.0,1.0,2/10,15.75%,NT5C;GPX1
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.5674390412361179,0.9197310590574315,0.5909090909090909,0.9034949481246413,1.0,2/7,5.68%,MAP1S;TLK1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.4474095616634684,0.9197134299976378,0.5641025641025641,0.902317253647134,1.0,6/24,11.66%,SCRIB;TSC2;VASP;PLXNB2;PHACTR4;COBL
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.4474095616634684,0.9197134299976378,0.5641025641025641,0.902317253647134,1.0,6/24,11.66%,SCRIB;TSC2;VASP;PLXNB2;PHACTR4;COBL
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.5855372681659494,0.9193840807417974,0.6181818181818182,0.9026362639447716,1.0,1/6,4.10%,LRRK2
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.5543126248693859,-0.9193060346475137,0.5614035087719298,1.0,1.0,1/10,4.59%,CTSB
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.43569355466319415,0.9192220041600419,0.6046511627906976,0.9023308578838591,1.0,2/18,2.03%,PKD2;TGFBR2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.497525975883614,0.9191044202055026,0.6,0.9013968898079531,1.0,3/11,9.75%,XPR1;SLC37A2;SLC37A4
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.497525975883614,0.9191044202055026,0.6,0.9013968898079531,1.0,3/11,9.75%,XPR1;SLC37A2;SLC37A4
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.46923796544653895,0.9184908332719702,0.5957446808510638,0.9022957467884188,1.0,1/8,18.39%,SLC25A14
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5261195446330595,-0.9181769447786251,0.6231884057971014,1.0,1.0,1/17,3.06%,PER2
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.609681109129347,0.9180766224536385,0.5833333333333334,0.9024943565846332,1.0,2/5,11.70%,SPIRE2;SNX18
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.5871234741693719,-0.9180321575249496,0.6212121212121212,1.0,1.0,5/9,26.97%,EIF2D;EIF2S2;EIF2S3;EIF4H;DENR
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3622569007983484,0.9179788382156596,0.5675675675675675,0.9021304297858462,1.0,8/49,11.68%,ZBTB1;RUVBL2;SIRT1;CASP9;PARP1;EIF2S1;PTPRK;ERCC4
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.5041873704412456,-0.9177430411910192,0.6481481481481481,1.0,1.0,1/15,2.44%,PPP1R15A
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.5864393261024359,0.9175422635515735,0.65,0.9023459120387339,1.0,2/5,11.69%,SMAD3;BMPR1A
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.49949616773823635,-0.9174017810739494,0.6268656716417911,1.0,1.0,1/16,0.86%,BCL2A1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.4154573828247311,0.9172526012727887,0.4444444444444444,0.9023739330709023,1.0,3/28,4.10%,TMEM39A;CDK10;LRRK2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.3824465516694433,-0.9171130649009976,0.589041095890411,1.0,1.0,29/114,15.49%,PROCR;CD36;CXCR4;MNDA;AIF1;MS4A4A;ABCB1;SIGLEC1;CD14;FCER1G;PECAM1;F13A1;CD300LF;IL3RA;ITGA6;CD93;CLEC12A;CD44;MEIS1;ITGA4;TYROBP;CSF3R;CSF2RB;PTPRC;MS4A6A;NOTCH2;SERPING1;DAB2;HLA-E
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.4406189133184238,-0.9170735020994875,0.6857142857142857,1.0,1.0,5/41,5.35%,NR4A3;PID1;PER2;BBS2;ATF5
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.6212335172181979,-0.9170170826174471,0.6923076923076923,1.0,1.0,2/5,7.52%,SLC7A5;CRYM
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.5490525325725398,-0.9168210325014654,0.6101694915254238,1.0,1.0,2/7,19.40%,NOTCH2;ZFPM1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.48264540793000044,-0.916674813723237,0.5892857142857143,1.0,1.0,4/20,10.87%,DNAJC19;TIMM44;TIMM21;TOMM40
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.5773485299784432,0.9166208208579896,0.5757575757575758,0.9028865442693006,1.0,1/6,2.03%,TGFBR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.5902857760236326,-0.9160670881201808,0.6111111111111112,1.0,1.0,1/6,4.75%,RNF213
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5510592985581718,-0.915724292393211,0.6071428571428571,1.0,1.0,4/12,10.08%,GSTM4;GSTK1;GSTP1;GSTM3
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5510592985581718,-0.915724292393211,0.6071428571428571,1.0,1.0,4/12,10.08%,GSTM4;GSTK1;GSTP1;GSTM3
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.3809702663283192,0.915583197681787,0.5405405405405406,0.9045370141176222,1.0,6/43,6.67%,PLA2G4C;ABCA2;PLPPR1;PLPP1;PLPPR4;FDFT1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.5640225638326677,-0.9155399159447227,0.6515151515151515,1.0,1.0,1/9,6.30%,IGF1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5757230381608154,-0.9151218246690902,0.6428571428571429,1.0,1.0,1/7,5.38%,CLU
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.4736987182560032,-0.9146087814722262,0.546875,1.0,1.0,2/23,1.41%,FTH1;TFRC
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.45523509202557616,0.9144391752372866,0.5581395348837209,0.906363597119174,1.0,3/13,10.51%,SIRT1;MDM2;DYRK1A
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.32316230797491996,0.9143339513311222,0.72,0.9059646084121241,1.0,6/69,4.21%,CACNA1A;TRPC1;PKD2;GRIN3A;PKD1;SLC3A2
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.47505100009525036,-0.9139538759642831,0.582089552238806,1.0,1.0,3/17,7.10%,TFRC;AIM2;RBM22
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6040618260856359,-0.9138166385658898,0.64,1.0,1.0,2/5,17.20%,TRPV4;AKNA
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.49267043689457907,-0.9136632114071577,0.5555555555555556,1.0,1.0,6/18,27.17%,PSMC4;MED12;MED30;MED1;PSMC3;DHX36
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.5441539409484588,-0.9136423707659415,0.5737704918032787,1.0,1.0,2/8,13.04%,SELENOS;FBP1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.42211051450245285,0.9134249098318015,0.6470588235294118,0.9073214353161807,1.0,4/26,8.56%,SRCIN1;NCK2;RELN;GRM5
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.588996522901635,-0.9132655001519058,0.6610169491525424,1.0,1.0,3/7,27.68%,MCCC2;BCAT1;HMGCL
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.5326410365063269,0.9131630394768171,0.6153846153846154,0.9072274047842909,1.0,2/8,18.44%,SLC9A1;CHP1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.5474398831144036,0.9130897919826717,0.65,0.9067524216779793,1.0,2/9,19.47%,STK25;GBF1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.4885649649720241,0.9130576547515751,0.525,0.9062357546713724,1.0,4/10,17.46%,EPS8;CHMP7;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.6064044128464376,-0.9128375733283367,0.6551724137931034,1.0,1.0,3/6,15.49%,HLA-F;KLRD1;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.4757926002963966,-0.9127949658613169,0.5740740740740741,1.0,1.0,1/15,1.12%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.40207493903374547,-0.9125382191971712,0.5822784810126582,1.0,1.0,3/49,2.21%,DUSP1;RUNX3;BTG2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.46833270849455005,-0.9123256617439471,0.639344262295082,1.0,1.0,2/26,1.13%,SKAP1;CCL5
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.39642639095290716,-0.9121529187782138,0.6060606060606061,1.0,1.0,7/56,11.51%,FLNA;NLGN2;ITGA6;SPOCK2;ACTG1;ACTB;TRPV4
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.5997905837814481,-0.9121457496684234,0.65,1.0,1.0,1/5,9.71%,SLC25A19
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.49736357236000656,-0.9120527989780789,0.609375,1.0,1.0,4/15,11.55%,MYLK;DUOX1;ACTG1;PTN
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.5129144778207653,-0.9120278463236545,0.6,1.0,1.0,2/10,14.67%,COPS6;COPS8
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),-0.5817427326557723,-0.9116143101013621,0.6415094339622641,1.0,1.0,2/5,34.68%,KIFAP3;FYCO1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.4115927035052014,-0.9111217300868536,0.6,1.0,1.0,3/54,1.13%,MT2A;CCL3;CCL5
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.5649377661994789,0.9106948527449887,0.6666666666666666,0.9108025268526297,1.0,1/6,2.45%,SIRT1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.510047713057829,-0.9106018003460145,0.6129032258064516,1.0,1.0,7/17,12.17%,CCL5;PECAM1;FERMT3;OLR1;ITGB2;ITGAL;ITGA4
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.46495873558836076,0.9105409698808585,0.6666666666666666,0.9105374088234957,1.0,4/14,12.43%,LARGE1;TMTC2;FKRP;FKTN
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.4938416772923888,-0.9105322826894399,0.6231884057971014,1.0,1.0,3/16,1.48%,NR4A3;PID1;CYCS
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5151756293790969,-0.9104246865923394,0.6461538461538462,1.0,1.0,2/17,8.63%,CHCHD10;HK2
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.46344403855791383,-0.9103528262429099,0.5645161290322581,1.0,1.0,6/34,12.54%,TGFBR3;RPS14;SLC25A5;ATP5IF1;NCKAP1L;VEGFA
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.5190529886519732,-0.910318744724732,0.66,1.0,1.0,1/11,1.89%,XPA
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.5902090681887294,-0.9103005871280342,0.6666666666666666,1.0,1.0,1/5,4.50%,PDHX
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.44183224094062923,-0.9102876022183864,0.6619718309859155,1.0,1.0,5/36,7.20%,CCL5;TFRC;AIF1;IGF1;RPS3
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.5727091589315543,-0.9102633760588522,0.631578947368421,1.0,1.0,3/10,15.37%,DUOX1;STAT1;TYMS
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.5811501630911915,0.9101058391451001,0.5957446808510638,0.9109060893078764,1.0,2/5,18.44%,SLC9A1;CHP1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.36923183176298385,0.9097673676921186,0.6206896551724138,0.9108944649300308,1.0,16/52,18.76%,MYOM1;GOLPH3L;BAIAP3;TMED10;UNC13B;CD33;STX1A;ARF6;SLC12A2;STXBP5;CLASP1;ATP13A2;CLASP2;KCNB1;UNC13D;SNCA
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.4240412089748804,-0.909754677731082,0.6909090909090909,1.0,1.0,5/34,12.36%,TAF6L;POLE3;ING5;BRCA2;ING4
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5078917375186288,0.9096678088792378,0.5319148936170213,0.9104695505506993,1.0,4/10,27.74%,PPARG;OSBPL8;LPL;ABHD5
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.4725815126251568,0.909458547821028,0.5333333333333333,0.9103992252379213,1.0,2/6,19.40%,RENBP;GNPDA1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.4925368880617955,-0.9094303004371629,0.6,1.0,1.0,2/25,1.22%,CCDC88C;PYHIN1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3836983964640033,0.9093018558259033,0.5263157894736842,0.9101436720598314,1.0,8/81,7.63%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.4882863632120313,0.9091228342287616,0.5952380952380952,0.910006309589101,1.0,1/9,1.72%,GSN
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.440582388936735,0.9090999641443044,0.5348837209302325,0.9094400875196855,1.0,3/21,10.23%,CDK5R1;TOGARAM1;SLAIN2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.36592782254996636,0.9088988510585841,0.6363636363636364,0.9092949625008064,1.0,19/74,14.12%,PLXNB1;PDGFA;IGF1R;FGF2;SIRT1;GAB1;TSC2;PIP5K1B;PDGFC;PTPN13;UNC5B;HGF;PTEN;MAPK1;DIPK2A;PIP4K2A;NTRK2;PTK2;PIK3AP1
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5309341195408429,-0.9087012573811791,0.6,1.0,1.0,5/10,33.32%,OAS1;TNIP2;COLEC12;RFTN1;TLR3
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.4785972750693166,-0.9081508623668613,0.5588235294117647,1.0,1.0,4/18,11.81%,CCL5;ITGA6;GLMN;NCKAP1L
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.5940204734329411,-0.9080005085864006,0.6304347826086957,1.0,1.0,1/6,7.00%,CD63
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.5940204734329411,-0.9080005085864006,0.6304347826086957,1.0,1.0,1/6,7.00%,CD63
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.36812150139528294,-0.9077298155419787,0.6153846153846154,1.0,1.0,9/97,6.30%,MYLK;CD36;BHLHE40;GADD45B;LSP1;APOD;CLU;MYBPC3;IGF1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.38782744462452334,-0.9071104735055878,0.581081081081081,1.0,1.0,5/99,3.29%,NR4A3;CCL3;INSIG1;CCL5;RORA
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.43819284961195504,0.9070124080800143,0.5555555555555556,0.9128298795269281,1.0,6/15,14.19%,NCOA3;ZNF706;TAF5L;CNOT2;KAT2A;WDR43
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3228873305661619,0.9070095967380978,0.7619047619047619,0.9122377295124838,1.0,35/152,20.26%,CCNG2;EPS8;BORA;E2F3;CDK7;TAF2;CEP41;BRSK1;YWHAG;CHMP7;CDC23;CCNG1;BTRC;RCC1;FBXW11;CDK6;SPDYA;CSNK1E;FBXL12;FBXL7;ANAPC1;CEP131;DYNC1H1;HINFP;CCND3;CLASP1;TPD52L1;ALMS1;CLASP2;CEP135;PLK2;NDE1;CCNI;NEDD1;BRSK2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.39227804984243014,0.9069372474890032,0.7142857142857143,0.9118225573475006,1.0,14/45,16.81%,SERPINE1;SMAD1;SMAD7;SMAD3;TGIF1;HDAC1;BMPR1A;TJP1;SMURF1;XIAP;CDK9;PPM1A;TRIM33;MAP3K7
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.44664400352860645,-0.9068451006433431,0.5909090909090909,1.0,1.0,4/23,12.07%,STIL;XRCC3;NPM1;TMEM67
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.46401551642348055,0.9068274316736027,0.5777777777777777,0.9114833950790178,1.0,3/9,10.51%,SIRT1;MDM2;DYRK1A
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.4061737447383156,-0.9066626663185999,0.6029411764705882,1.0,1.0,10/35,24.17%,PID1;MT3;BRCA1;AGT;RAC1;RAC2;PINK1;PDK3;PDGFB;CDKN1A
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4817130646587968,-0.9065698601578135,0.5645161290322581,1.0,1.0,2/17,6.78%,RPS21;EXOSC10
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.4427869604618961,0.9064107285351348,0.6,0.9110241278061401,1.0,8/30,11.77%,ACVR2A;SMAD1;SMAD7;SMAD3;SMAD2;BMPR1B;BMPR1A;RGMB
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.4427869604618961,0.9064107285351348,0.6,0.9110241278061401,1.0,8/30,11.77%,ACVR2A;SMAD1;SMAD7;SMAD3;SMAD2;BMPR1B;BMPR1A;RGMB
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.567819590448139,-0.9061694393634511,0.6666666666666666,1.0,1.0,1/10,1.96%,GZMB
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4299893288506333,0.9053693276041704,0.46808510638297873,0.91251047430286,1.0,3/16,13.91%,FGF2;P2RY12;PTK2
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.5986003604323258,-0.905247989634932,0.703125,1.0,1.0,2/5,27.68%,MCCC2;HMGCL
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.448547252545528,0.9051474134646238,0.6176470588235294,0.9123390092057722,1.0,10/25,21.61%,PLXNB2;CTNNA2;NIPBL;SRGAP2;SHTN1;ZNF609;PHACTR1;RAPGEF2;CAMK2B;CX3CL1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5053153264081149,-0.9048340292779476,0.6271186440677966,1.0,1.0,5/10,32.53%,TBC1D20;NUCKS1;YTHDC2;CCNK;PPIB
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.5655011632338172,-0.9047855245209845,0.6379310344827587,1.0,1.0,1/7,4.75%,RNF213
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.5558449757323491,0.903731341138682,0.6857142857142857,0.9149758788003799,1.0,1/7,0.36%,ANXA1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.4785966903017237,-0.9036198240895043,0.647887323943662,1.0,1.0,1/25,1.94%,TPP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.6172618437752797,-0.9034753523986994,0.6909090909090909,1.0,1.0,2/5,25.41%,NOS1AP;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.45402449389921,-0.903187673043015,0.5882352941176471,1.0,1.0,4/21,7.97%,MYLK;ENPP4;DUOX1;ACTG1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.550427903196974,0.9028541253814263,0.6530612244897959,0.9161560488160408,1.0,2/6,11.40%,NCOA3;SMYD5
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.5383499336855603,-0.9027981845216986,0.5789473684210527,1.0,1.0,1/7,1.13%,CCL5
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.5309996048387748,-0.9027002756096616,0.7,1.0,1.0,5/10,18.17%,LILRB4;GPR137B;PLSCR1;CD200;CD74
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.4235998889695318,-0.9025909318692579,0.5909090909090909,1.0,1.0,6/52,6.24%,PPIE;CCL5;IFIT1;MDFIC;CTDP1;SRPK1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.4294806594613456,0.9025268536051714,0.6,0.9162913577875753,1.0,7/27,11.66%,SCRIB;TSC2;VASP;PLXNB2;DVL3;PHACTR4;COBL
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.526376191012847,0.9024315592924387,0.6216216216216216,0.9159010016316929,1.0,1/6,7.45%,LIG4
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3329640276621073,0.9023250167474284,0.5909090909090909,0.9155444979530136,1.0,12/118,6.69%,VAMP1;SMAD1;HIP1R;IMMP2L;NRG1;PICALM;PDE4DIP;NCK2;NUP153;SMAD3;SMAD2;TCP1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.44296105688216736,-0.9021078927323348,0.5454545454545454,1.0,1.0,2/36,2.59%,RNASET2;SIDT2
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.3688417950191922,0.9018442878432149,0.6666666666666666,0.9159714979421402,1.0,3/44,3.64%,TRPC1;SMAD7;KCNIP2
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.4437106490772979,-0.9016129353735141,0.6714285714285714,1.0,1.0,4/36,7.17%,JAML;RAB3A;IGF1;CORO1B
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.456401130327755,0.9013370278657797,0.5609756097560976,0.916339667531411,1.0,2/14,3.86%,PDPN;SERPINE2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.5270484842883173,0.9011322489264559,0.6571428571428571,0.9161998777653754,1.0,4/13,6.32%,YJEFN3;FA2H;PPT1;MYADM
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.34267018820594086,0.9011132826926614,0.6666666666666666,0.9156778301043839,1.0,10/79,11.80%,ZBTB1;RUVBL2;DR1;SIRT1;ARID1A;MTA2;SATB2;HDAC1;KAT2A;HNRNPC
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.35347068793508557,0.9009538715031123,0.56,0.9154804937328526,1.0,13/105,10.68%,PRKAB2;NFYC;IDI1;PLPP1;PPARG;LDLR;FDFT1;ACACB;TM7SF2;ELOVL6;PRKAB1;HMGCS1;TBL1XR1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.5417068352924368,-0.9003149630137228,0.6440677966101694,1.0,1.0,2/9,12.00%,MTHFD1;AMPD2
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3992974607677922,0.9001523337509193,0.5945945945945946,0.9166534248772881,1.0,7/27,12.09%,SPRY2;SMAD7;SPRED1;SPRED2;CAB39;MAPK1;PARD3
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.4956275737487955,0.8999905135156798,0.7105263157894737,0.9164225200062014,1.0,1/11,1.07%,FER
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.342220914979856,0.8998798103536838,0.5806451612903226,0.9161089921552755,1.0,12/66,19.47%,GOLPH3L;TMED3;TMED10;RAB1B;COPG1;CENPE;RAB6A;COG3;COPB1;SCYL1;COPZ1;GBF1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.606492955381359,-0.899656958487056,0.6296296296296297,1.0,1.0,2/5,18.72%,RPL23;SUPT6H
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.45103851059825095,0.8995782505308371,0.47058823529411764,0.9162267913494273,1.0,3/24,9.12%,STAMBPL1;OTUD7A;ZRANB1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6007705989751326,0.8994841325049283,0.6888888888888889,0.9158475450843461,1.0,4/5,30.08%,AKT2;SNCA;PRKCE;IRS2
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.45299710009842803,-0.8994803640471012,0.625,1.0,1.0,9/32,16.86%,FCER1G;CD300LF;NCKAP1L;CD47;C3;CYBA;PTPRC;SLC11A1;IL1B
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.4472792000327822,-0.8994231984135495,0.5735294117647058,1.0,1.0,6/26,5.95%,FOSL2;CD55;BHLHE40;ANXA2;IER3;ABCC3
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.5116491122390773,0.8993874749715242,0.5853658536585366,0.9154687907080651,1.0,6/8,17.46%,DAG1;PHLDB1;POGLUT1;CLASP1;PHLDB2;CLASP2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.3512498779702272,0.899252879069367,0.7037037037037037,0.9151401521154404,1.0,11/101,6.33%,KLF4;ANXA1;NRP1;ACVR2A;TGFBR2;SPRY2;SMAD7;RAP1A;WNT5A;SMAD3;CIB1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3754530362608585,-0.8987333204541338,0.6329113924050633,1.0,1.0,18/113,12.12%,CCL3;CCL5;NLRC3;MGLL;CD200R1;SNX6;RORA;TMSB4X;ETS1;VPS35;ENPP3;TNFRSF1B;METRNL;SELENOS;TNFAIP3;IFI35;NLRP12;LPCAT3
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.31974184529226835,0.8987247744537913,0.6666666666666666,0.9157707316286964,1.0,6/151,2.18%,PPARGC1A;ADARB2;NUFIP1;SYNCRIP;U2AF1;NOL9
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.3297005793766566,0.8985297291781356,0.7419354838709677,0.9156405654748939,1.0,13/80,8.12%,PLXNB1;SRCIN1;PLXNA2;FGF2;AMOT;NRG1;SERPINE2;TBCCD1;PLXNB2;PLXNC1;CRK;PLXNA3;DOCK10
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.3547289167352455,0.8984792401654894,0.5833333333333334,0.9151638678296973,1.0,10/36,24.54%,LCP1;CNOT2;PIP4K2A;TNF;DYNC1H1;CEP120;SH3GLB1;ARHGAP35;G3BP1;RAB3GAP2
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.559618017025001,-0.8980181426348218,0.5714285714285714,1.0,1.0,3/5,30.67%,BCL6;BCL10;NOC2L
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.39210566762734045,0.8978486458026099,0.59375,0.9159581976320135,1.0,6/32,15.62%,TMEM39A;LRRK2;RAB1B;TBC1D12;PIP4K2A;SMCR8
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.46257747513560044,0.8976931617690693,0.5365853658536586,0.9157292335076685,1.0,5/12,15.63%,NRG1;JAG1;TCF7L2;EPAS1;HINFP
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.41766353562749065,0.8975917474567429,0.5172413793103449,0.9153605058904464,1.0,6/25,6.33%,SIRT1;TSC2;DAG1;PHLPP1;DDIT3;CIB1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.4265774143575745,-0.8973241163028318,0.5967741935483871,1.0,1.0,3/30,8.01%,APIP;B2M;TRPM4
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.4134489791265612,0.8972173644026715,0.5897435897435898,0.9155768294621347,1.0,2/22,2.45%,PDK4;SIRT1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.6356171295254338,-0.8970283986816135,0.6730769230769231,1.0,1.0,1/5,6.27%,LILRB4
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.5875983085496306,0.8969571114187906,0.627906976744186,0.9156365392743118,1.0,1/5,1.42%,QARS1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5359300112019935,-0.8968698814705109,0.6521739130434783,1.0,1.0,5/9,29.24%,VLDLR;AP2S1;CLTA;AP2A1;AP2M1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5359300112019935,-0.8968698814705109,0.6521739130434783,1.0,1.0,5/9,29.24%,VLDLR;AP2S1;CLTA;AP2A1;AP2M1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.31121333594296563,0.8962484581763992,0.7142857142857143,0.916526679624567,1.0,29/144,11.91%,PDPN;ATRAID;ACVR2A;TGFBR2;ZBTB16;MSR1;MAPK11;CTNNBIP1;RAP1A;AKIRIN1;PPARG;RIN2;SMAD3;SMAD2;ZC4H2;RANBP3L;BRINP3;CTNNA2;ZNF385A;TMEM119;KITLG;SOX5;HGF;NELL1;BMPR1B;BCL9L;FERMT2;BMPR1A;FBN2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.4301188255404196,0.896181634102948,0.5675675675675675,0.9160515600665352,1.0,2/15,7.43%,SEL1L;AUP1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.4732030744591093,0.8961331902318682,0.6153846153846154,0.9155770519879859,1.0,5/14,10.06%,MYRF;RELN;TPPP;METRN;NFIB
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.43409666223918436,0.8958833720108541,0.5757575757575758,0.9154478474683824,1.0,3/21,11.37%,RNF2;RYBP;RNF20
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.483733799115315,-0.8958736865791246,0.6190476190476191,1.0,1.0,2/14,6.08%,RIMS1;NLGN2
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.3616150793623473,-0.8956553113435515,0.6621621621621622,1.0,1.0,24/145,13.45%,PROCR;H1-2;SAT1;FOS;BTG2;PPP1R15A;IER3;RPS12;RACK1;DDIT4;RGS16;EPHX1;WRAP73;H2AJ;RPL36;HINT1;TAP1;S100A4;RPL18;FAM162A;ATF3;CYFIP2;ANKRA2;BTG1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.47883808323946003,0.8956516836297116,0.5806451612903226,0.9153926243929834,1.0,5/16,6.28%,SLC7A8;SLC1A3;SLC3A2;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.5044731733797734,0.8955522019204009,0.5581395348837209,0.9150997754836584,1.0,2/11,8.69%,FAAH;FAH
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.4548857603612277,-0.895399143999667,0.6666666666666666,1.0,1.0,5/24,17.50%,ERO1A;HSPA1B;ENTPD5;HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.37944667045268743,0.8952881333872938,0.5263157894736842,0.9151922879374141,1.0,8/83,7.63%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.5090114388922046,0.8949903118458779,0.5555555555555556,0.9152683098587446,1.0,2/9,11.81%,SIRT1;CDK6
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.3858840185127292,0.8947420329824967,0.7333333333333333,0.9151642594016035,1.0,4/36,7.63%,NUP153;NUP188;SCARB2;NUP42
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5089125356895327,-0.8946528911748303,0.6,1.0,1.0,3/13,12.54%,TGFBR3;GLMN;VEGFA
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.5872204913154928,-0.8945922775733587,0.6271186440677966,1.0,1.0,1/5,1.73%,PRKCQ
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.3539776319601283,-0.8944425871595366,0.6708860759493671,1.0,1.0,42/248,16.22%,PPIE;FRG1;ZCRB1;DHX16;RAVER2;DHX38;SNRNP27;SNRPD2;GTF2H5;CSTF2T;RNPC3;AURKAIP1;WDR83;RBM22;RNMT;PDCD7;LSM7;PNN;NCBP2;POLR2G;CHTOP;U2AF2;ZRSR2;CRNKL1;DDX23;ZCCHC8;BUD31;SRSF7;EIF4A3;SMNDC1;PRPF3;GCFC2;CCAR1;RBM4B;DDX5;SRSF2;SNRPA1;PPWD1;CWF19L2;EFTUD2;HNRNPH2;GTF2F1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.450273391771412,-0.8943202640732468,0.6619718309859155,1.0,1.0,1/31,0.98%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.5464239022621584,0.8941755833050606,0.5434782608695652,0.9155263421811634,1.0,2/6,15.24%,RPS6KA4;CDK9
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3871333458021405,-0.8941733080420966,0.6231884057971014,1.0,1.0,4/70,2.78%,COL5A1;PROCR;PER3;ENPP4
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.43526252579028546,-0.894132046791966,0.6166666666666667,1.0,1.0,2/37,0.63%,MYLK;COL5A1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.5724709854185218,-0.8940289110694583,0.5789473684210527,1.0,1.0,1/5,0.09%,NR4A3
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.5606938410084098,-0.8935790206154558,0.6071428571428571,1.0,1.0,4/8,16.15%,GPX4;PON2;GPX1;ALOX12
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.5386446370907041,-0.8935635375067313,0.6825396825396826,1.0,1.0,1/10,6.30%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.5868130332043042,0.8931059626792177,0.6346153846153846,0.9172523852993157,1.0,2/5,28.85%,SMCR8;CALCOCO2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.34955730001414526,-0.8930163502846283,0.6966292134831461,1.0,1.0,21/217,7.79%,PLEKHG5;UBC;CCL3;RPS27A;MNDA;RASGRF2;VAV3;GADD45B;TNFSF10;RACK1;ING5;CLU;ARHGEF1;ING3;OBSCN;MTCH1;ITGA6;TNFAIP8;RPS3;ARHGEF3;RPS6
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.5153723594474503,-0.8929893444261239,0.711864406779661,1.0,1.0,2/10,2.31%,CCL5;AIF1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5509139061330335,0.8929658849373465,0.6666666666666666,0.9169431407517356,1.0,3/6,24.46%,TNF;TGFB1;ESR1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5366070292675167,-0.8929605591402665,0.639344262295082,1.0,1.0,2/8,10.13%,GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5366070292675167,-0.8929605591402665,0.639344262295082,1.0,1.0,2/8,10.13%,GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5093525194710065,-0.8929346491908972,0.7121212121212122,1.0,1.0,7/16,22.45%,DDRGK1;PRELID1;PSME2;APH1B;PSME1;PINK1;PSME3
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.5176755545029301,0.8928768949235698,0.627906976744186,0.9165037355698527,1.0,2/7,13.72%,LIG4;MGMT
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.4713385936074946,0.892653259961767,0.5,0.916399228132887,1.0,1/9,3.01%,IMMP2L
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.5530055796275456,-0.8926054846468386,0.6290322580645161,1.0,1.0,1/7,12.54%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.5556272641223252,-0.8923753958297456,0.6226415094339622,1.0,1.0,1/8,1.52%,NLRC3
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5258809829789739,0.8923179670798348,0.6,0.9165067368592248,1.0,2/6,16.67%,TRERF1;NEDD4
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.427981895635393,0.8922876434342072,0.7073170731707317,0.9159625776703276,1.0,2/17,2.03%,PKD2;TGFBR2
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.35000500285618,0.8917560521886051,0.5909090909090909,0.9165992588298016,1.0,33/114,15.32%,PDGFA;IGF1R;SEMA5A;FGF2;SPRY2;TGFA;SIRT1;GAB1;NRG1;RCN3;TSC2;DAG1;PHLPP1;HPSE;DDIT3;CIB1;KITLG;HGF;MFHAS1;PTEN;FERMT2;P2RY12;TCF7L2;RTN4;GAB2;MTDH;NTRK2;VAV1;PTK2;PIK3AP1;NRG2;ERBB4;TNF
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.5514304162641098,0.8917240986820076,0.5833333333333334,0.9148895271374834,1.0,3/5,25.96%,ACY3;MGST3;MGST2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.5514304162641098,0.8917240986820076,0.5833333333333334,0.9148895271374834,1.0,3/5,25.96%,ACY3;MGST3;MGST2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.5514304162641098,0.8917240986820076,0.5833333333333334,0.9148895271374834,1.0,3/5,25.96%,ACY3;MGST3;MGST2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.5807301545054845,-0.8915489871055865,0.6833333333333333,1.0,1.0,2/7,11.81%,LGALS1;NCKAP1L
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.4610792407873612,-0.8909415672119969,0.5675675675675675,1.0,1.0,5/29,12.26%,DDRGK1;EIF2D;ATG2A;MTIF3;STING1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.4984457670043157,-0.8907300962920413,0.6521739130434783,1.0,1.0,7/11,27.42%,ZWILCH;MIS12;IK;BUB3;CHAMP1;KNL1;RB1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.3708518232397257,0.8906426719064934,0.6296296296296297,0.9166131136662172,1.0,13/35,29.79%,SLFN11;ZBTB38;GTPBP4;BRPF3;FAF1;ANKRD17;BLM;RAD17;GMNN;WAPL;TSPYL2;CCDC88A;ORC3
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.4214068107403595,-0.8902602749049517,0.6029411764705882,1.0,1.0,8/23,17.01%,PLN;STAT1;OLR1;GCLM;SOD1;SERPING1;GPX1;TBC1D8
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.5436642000102441,-0.8902045537497436,0.7,1.0,1.0,3/9,18.93%,XRCC3;SLX4;WRN
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.5436642000102441,-0.8902045537497436,0.7,1.0,1.0,3/9,18.93%,XRCC3;SLX4;WRN
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.5436642000102441,-0.8902045537497436,0.7,1.0,1.0,3/9,18.93%,XRCC3;SLX4;WRN
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.5640653297756953,0.8900513368525425,0.7027027027027027,0.9172798097579815,1.0,3/9,5.77%,SERPINE1;SERPINE2;HPSE
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.4871413641559398,0.8899456842788711,0.6756756756756757,0.9169402773039709,1.0,2/13,5.56%,MSR1;PPARG
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.4938810654905519,0.8898833342599364,0.6896551724137931,0.9159224047669652,1.0,1/13,0.52%,TPM2
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.4938810654905519,0.8898833342599364,0.6896551724137931,0.9159224047669652,1.0,1/13,0.52%,TPM2
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.3401741786698316,0.8897349644514241,0.7096774193548387,0.9156976738401288,1.0,11/71,8.55%,FLVCR1;ABCA2;RCN3;SCAMP4;CHKA;PPT1;LMAN2L;ARRDC3;DISP1;RAMP1;RAB7A
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.500854769906581,0.8893841742006663,0.6326530612244898,0.9158856832162078,1.0,1/8,4.28%,PBX1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3530975272412485,-0.8893836603955236,0.7294117647058823,1.0,1.0,12/165,7.97%,FLNA;SYCE2;RIMS1;AIF1;STAG3;CD247;CHCHD10;ELOB;RHOU;NLGN2;CORO1B;ACTG1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.530166086566751,0.8892984295305081,0.6176470588235294,0.9154511219451952,1.0,3/6,20.91%,SLC8A1;RYR2;RYR1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.3920538377509226,-0.8892736941511626,0.6708860759493671,1.0,1.0,12/67,12.12%,SIGIRR;CARD16;NLRC3;DHX58;RORA;VPS35;ENPP3;METRNL;SELENOS;TNFAIP3;NLRP12;LPCAT3
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.5690110604525946,-0.889138506704339,0.6595744680851063,1.0,1.0,2/5,15.22%,DNAH1;CCDC39
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.5107078455846588,0.8884893874417197,0.5897435897435898,0.9160366115034204,1.0,4/9,14.60%,NEDD4L;SLC9A1;SLC8A1;SLC12A2
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5107078455846588,0.8884893874417197,0.5897435897435898,0.9160366115034204,1.0,4/9,14.60%,NEDD4L;SLC9A1;SLC8A1;SLC12A2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.4334774219690667,-0.8882784177230308,0.6086956521739131,1.0,1.0,5/27,18.78%,EMD;CYB5A;EMC2;EMC1;SERP1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.40463811914639114,-0.8881693857429119,0.717948717948718,1.0,1.0,8/73,9.37%,GAPDH;GZMB;BTG2;RPL13A;RACK1;ILF3;RPS3;EIF2AK2
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.26380016155040337,0.8879448146132323,1.0,0.9166030762086356,1.0,153/1271,11.83%,EGR1;PPARGC1A;ESRRG;KLF4;ZNF426;NPAS3;CDK5R1;ZNF175;ZBTB1;GLIS3;GCLC;TFEC;HOMEZ;QARS1;ZNF471;ABCA2;RUVBL2;FGF2;ZBTB16;SMAD1;ZNF189;ZBTB34;ZBTB33;ACTA2;TGFA;BACH2;ZSCAN2;SIRT1;SMAD7;CSRNP2;DPF3;MITF;ARID1A;ZNF787;ARNT2;ZNF555;NFYC;BNC2;MYRF;ZNF706;KLF6;SPINDOC;NRG1;TCF7L1;MXD4;PICALM;ZNF536;VEZF1;ZNF212;E2F3;BBX;CHD5;CBFA2T3;HDAC9;PBX1;MAP2K1;WNT5A;TULP3;DACH1;ZBTB26;FOXP4;SAMD1;FOXN3;TLE2;CDK17;SLC39A8;ZNF12;POU2F1;RYBP;PPARG;RPS6KA4;SNAI3;HMGA1;BCL11A;ZNF75A;SMAD3;NFIX;SMAD2;DDIT3;CDK18;NLK;HP1BP3;RFX3;NFAT5;SALL1;ZBTB40;ZFY;ZNF3;PHF5A;MDM2;SATB2;CNOT7;ZBTB2;CRK;TAF5L;TGIF1;PURG;MAP3K10;RNF6;POU6F2;IKZF1;CLOCK;RFX2;ZNF665;ZFP3;NACC2;DVL3;ZNF280D;MMS19;HDAC1;CTBP2;RUNX1;SFMBT1;SOX5;DMTF1;TADA1;ELAVL2;ZNF90;ZBTB48;ZNF316;HSF4;BTRC;CNOT2;AEBP2;NFIB;MED13L;TRERF1;ZNF493;ZBTB10;PTPRK;JMJD1C;HIF3A;UBE2L3;ZKSCAN4;DYRK1A;OLIG1;LCORL;TBL1XR1;ZBTB38;FBXW11;CELSR2;TWIST2;KLF7;TCF7L2;KAT2A;RNF20;TRAF6;TGFBRAP1;RUNX1T1;NSD3;PHF14;RGMB;RNF10
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.6039292598506069,-0.8872020713725474,0.6851851851851852,1.0,1.0,1/5,6.41%,GLUL
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.4192889998006671,0.8869586048102006,0.6,0.9180233779152205,1.0,7/18,23.00%,AUP1;DNAJC18;RNF185;BAG6;KLHL15;TOR1A;DNAJB14
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5156147541850384,-0.8869509163377549,0.676923076923077,1.0,1.0,2/10,8.95%,TGFBR3;RBPJ
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.5285744719111265,0.8866831413731869,0.6111111111111112,0.9178788810281915,1.0,2/7,13.18%,KAT2A;BAG6
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.5482612141932874,0.8862439019751591,0.6046511627906976,0.9181371487293954,1.0,1/5,17.61%,ARL8B
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.35310455754145487,-0.8859641818380593,0.7093023255813954,1.0,1.0,19/140,15.45%,MT2A;STIL;SLC7A5;HUS1;ATF5;SLC38A1;ODC1;ILF3;BRCA2;NUP50;HIRA;MEIS1;CDC7;HIF1A;CCND1;STMN1;NOTCH2;SRSF2;CENPF
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.41784601301933677,-0.8859286170763335,0.5512820512820513,1.0,1.0,12/54,18.52%,NLRC3;CD14;TMSB4X;PHB2;RPS3;EIF2AK2;IFI35;NLRP12;TERF2IP;NOD2;IL1B;EZR
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.4553340902532494,-0.8858138008496473,0.6571428571428571,1.0,1.0,2/21,16.33%,TCEA2;PRIM1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.4535849177106085,-0.885586627655786,0.6363636363636364,1.0,1.0,2/29,3.67%,DUSP1;GADD45B
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.41852263758814207,-0.8852570819649164,0.7083333333333334,1.0,1.0,4/44,2.31%,CCL5;TFRC;PRKCQ;AIF1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.39876419742240116,-0.884862456005352,0.6805555555555556,1.0,1.0,5/42,8.29%,DDX11;TPP1;DNAJB9;HDGF;FKBP14
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.48888712356521596,-0.8847925330088331,0.6,1.0,1.0,1/17,1.12%,ZFP36
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.3608240894485427,0.8847388107794426,0.5357142857142857,0.9206803161877899,1.0,12/67,12.71%,NUTF2;E2F3;GDAP1;TSC2;IPO13;NUP153;NUP188;PPP1R10;PEX13;PEX5;PEX11B;IPO8
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.4537037278010614,0.8846134095356439,0.5483870967741935,0.9204218372884028,1.0,2/18,1.09%,KLF4;PKD2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.4575073291632461,-0.8845799611507676,0.6060606060606061,1.0,1.0,4/34,6.70%,DUSP1;PAQR3;RGS2;GSTP1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.4286009275179785,0.8835730259704652,0.5588235294117647,0.9219397358960059,1.0,2/21,0.83%,PLA2G4C;FAAH
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.5521844744814316,-0.8829693785075776,0.6833333333333333,1.0,1.0,1/8,12.77%,VPS37B
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.4996580625358625,-0.8826522093933207,0.5806451612903226,1.0,1.0,1/11,4.39%,EPHB1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.5720645991675929,-0.8824302702577899,0.640625,1.0,1.0,2/6,25.08%,CLEC7A;CAMK4
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.4119851103913501,-0.8823878250495318,0.6438356164383562,1.0,1.0,9/40,13.26%,GAPDH;MDH2;PER2;APOD;G6PC3;OAS1;GOT2;FBP1;PGK1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.3995638281134207,-0.8822463266122892,0.6385542168674698,1.0,1.0,15/55,13.32%,CD36;CD14;IL3RA;CSF2RA;OSMR;STAT1;IRF1;TNFRSF1B;CD44;IL18R1;ITGA4;A2M;CSF3R;CSF2RB;IFNGR2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.35118868019622146,-0.8817157929667857,0.8023255813953488,1.0,1.0,29/215,9.96%,CALCR;CD36;CCL3;PID1;RIMS1;TFRC;WARS1;RPL5;DDRGK1;RPL11;ANXA2;CLU;DTX3L;TTN;MUSK;IGF1;RPL23;LAMTOR5;CD63;ETS1;RPS3;VPS35;SNF8;HSPA1B;ACTG1;RPS7;RBPJ;CITED2;PLSCR1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.4184284133935926,0.8816645703794109,0.5833333333333334,0.9252708151291249,1.0,9/25,16.81%,MAP3K11;MAP3K10;DVL3;AIDA;SASH1;TRAF6;MAP3K5;TNF;MAP3K7
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.42330497314540694,0.8816554545183273,0.6764705882352942,0.924712962775405,1.0,2/17,3.40%,SMAD1;NRG1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.4058909043183282,-0.8816126888014458,0.6428571428571429,1.0,1.0,3/55,1.57%,UBC;CCDC88C;RPS27A
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.344775854555378,0.8813835688448207,0.6666666666666666,0.9247654290138547,1.0,10/90,5.71%,GRB10;FER;PDK4;IGF1R;GAB1;SLC39A14;HDAC9;RAB10;PPARG;PARP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3827751429075327,0.8813737957271363,0.5714285714285714,0.9242166111754576,1.0,6/43,11.53%,RNF2;RYBP;ZFYVE19;PPP1R10;NME6;APAF1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.4842311162809928,0.8813630251055962,0.6,0.9236364375337908,1.0,2/11,4.10%,TMEM39A;LRRK2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.38443605130159547,0.8812712870048598,0.6857142857142857,0.9232491402591247,1.0,9/33,20.26%,NUAK1;BRSK1;CPEB4;TBL2;PRKAA1;SIK2;SESN2;SH3GLB1;BRSK2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.4068627397927186,-0.8812694196932416,0.6764705882352942,1.0,1.0,15/56,22.46%,PRELID1;CLU;SLC25A5;IGF1;ITGA6;GSTP1;CFLAR;HSPA1A;GPX1;CSNK2A2;PINK1;TMEM14A;PIH1D1;PSME3;PARK7
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.3922242208610449,0.8810763027323621,0.6829268292682927,0.9230783600684587,1.0,8/25,10.06%,FGF2;ZBTB16;SLC39A14;PKD1;WNT2B;RUNX1;SOX5;NFIB
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.5851273517602424,-0.8809212918964973,0.6730769230769231,1.0,1.0,1/6,4.31%,ANXA2
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5084965878107601,-0.8808586232203875,0.6166666666666667,1.0,1.0,1/17,1.44%,SRP14
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.4441542531005508,0.8808223277263487,0.6,0.9229477746448594,1.0,7/24,18.75%,HPN;FAH;SLC4A4;FUT9;GCDH;NME4;SCIN
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3194941442814532,0.8808165403300905,0.64,0.9223778398188899,1.0,21/112,12.98%,QARS1;SPRY2;SMAD7;SPRED1;TSC2;SPRED2;LRRK2;SIRPA;GNAQ;NCK2;CEP85;MYADM;CIB1;DEPTOR;PTPN13;YWHAG;PTEN;PARD3;NF1;PPP1R15B;DNAJC3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.35824434658255067,0.8807313187813446,0.6538461538461539,0.922000285750973,1.0,14/51,18.76%,QARS1;SPRED1;TSC2;GNAQ;CEP85;DEPTOR;YWHAG;NF1;SMCR8;PPM1F;PPM1E;CHP1;HNRNPU;SNCA
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.5452224412197606,-0.8806118406901944,0.7377049180327869,1.0,1.0,2/9,14.32%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.40858776414674786,-0.8798986767198549,0.7123287671232876,1.0,1.0,11/58,14.03%,CARD16;CYCS;NAIP;TNFSF10;FIS1;LAMTOR5;CD44;PDCD5;NLRP12;VEGFA;MT3
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5276321573615121,-0.8797041442534582,0.6212121212121212,1.0,1.0,2/12,4.74%,MDFIC;APOD
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.3249787540991475,-0.8795906970754933,0.8387096774193549,1.0,1.0,68/739,10.69%,NR4A3;H1-4;MYBL1;IL4I1;H1-3;UBC;SKAP1;H1-2;BCL11B;FOSL2;PYHIN1;PID1;RPS27A;FOS;RUNX3;JUNB;EDF1;USF1;BEX1;TAF6L;RORA;MDFIC;CHCHD2;H1-0;DDRGK1;CSRNP1;CHCHD10;ZNF335;TXK;PADI2;ING5;EIF5A;NLRC5;ATF5;DTX3L;JUP;JMJD6;IGF1;PARP9;NR1H2;ITGA6;ILF3;MAP3K12;ETS1;IRF7;MED25;BRCA2;NPM1;VENTX;PRKD2;ZNF76;PLAG1;HNRNPAB;NAMPT;RBPJ;RNASEL;STAT1;CITED2;DVL1;IER2;IRF1;ZNF513;PLSCR1;MLX;H1-10;ESR2;SMARCD1;TCF3
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3455053002190411,-0.8793984227652882,0.7931034482758621,1.0,1.0,34/274,16.67%,DDX11;BCL2A1;MNDA;XPA;BTG2;VAV3;PPP1R15A;OGG1;POLE3;HUS1;DTX3L;MUS81;XRCC3;RPS3;IRF7;NPM1;PARP2;TNFRSF1B;REXO4;APEX1;WDR48;NOP53;NABP1;ZDHHC16;CCND1;SLX4;MCM7;ERCC8;BRCA1;RAD9A;PARP4;CBX3;SMC1A;STXBP4
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.39119510712842226,-0.8793421916517487,0.7105263157894737,1.0,1.0,3/79,3.00%,MT2A;FOS;B2M
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.5039113017825118,-0.8790004189725842,0.6153846153846154,1.0,1.0,2/9,12.54%,ZNF335;VEGFA
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.42787377370771684,0.878871710862351,0.55,0.9250630792261791,1.0,2/19,7.81%,WNT5A;BRINP3
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.5915431413811368,-0.8788182545502634,0.6888888888888889,1.0,1.0,1/5,5.44%,DTX3L
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.5407290295913121,-0.8783568862713221,0.6551724137931034,1.0,1.0,2/7,9.51%,LLGL2;CFL1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.43802484006614173,0.8783076791163359,0.7272727272727273,0.9256255058221157,1.0,3/21,2.28%,COL16A1;FKBP9;ACTA2
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.41435443807412,0.8781520521752526,0.6097560975609756,0.9253582272084159,1.0,5/18,18.76%,NLGN1;STX1A;SNCB;STON2;SNCA
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.34892244548994494,-0.8781252961598838,0.7272727272727273,1.0,1.0,27/204,12.36%,PLEKHG5;UBC;RPS27A;MNDA;RASGRF2;PRF1;VAV3;GADD45B;TNFSF10;RACK1;ING5;CLU;ARHGEF1;ING3;OBSCN;MTCH1;ITGA6;TNFAIP8;ARHGEF3;RPS6;MTCH2;ITGB3BP;IFIT2;PDCD5;FAM162A;SOD1;ING4
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.5354672375879024,-0.8779884097148327,0.6875,1.0,1.0,1/7,7.25%,IQSEC1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.397362644254399,0.8779054198430305,0.5945945945945946,0.9252904373565856,1.0,8/22,13.70%,ST6GALNAC3;FA2H;SPTLC2;ST6GALNAC5;SAMD8;SPTLC3;SGMS1;ST8SIA4
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.5649858667901017,-0.8774585321171948,0.6842105263157895,1.0,1.0,2/6,13.56%,CD55;HLA-DRA
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.3821154660783802,-0.8774173586150885,0.7125,1.0,1.0,9/101,11.10%,FLNA;TSPAN32;RAB3A;JUP;RAB11A;TMEM150A;RAB3D;EPB41L3;EFR3B
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.3754585198784939,0.8773616587661031,0.6,0.9259870105157146,1.0,10/50,16.19%,CDK10;TBC1D1;TBC1D16;TBC1D5;TBC1D10B;TBC1D22B;RABGAP1;TBC1D2;EVI5;CEP120
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.5004668890100608,-0.8772067718819169,0.6229508196721312,1.0,1.0,4/14,19.89%,ANXA2;NCKAP1L;EVI2B;MED1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.38860707349207335,-0.8768531556594965,0.676056338028169,1.0,1.0,17/69,24.47%,PSMB3;PSMA7;PSMB9;PSMB6;RBX1;PSMA5;PSMC4;PSMD8;PSMD12;PSME2;PSMA3;PSME1;FBXO4;PSME3;PSMB5;CUL4A;PSMC3
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.42555512702930676,0.8768072931268908,0.65625,0.9266429337782255,1.0,4/23,6.48%,KCNJ2;KCND3;SCN3B;KCNJ5
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5230169038907583,-0.876251512076477,0.7017543859649122,1.0,1.0,1/8,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.37218393340988554,0.8761303910463085,0.6333333333333333,0.9274570659534497,1.0,17/51,24.03%,RRAGD;SIRT1;TSC2;DEPTOR;GPAT3;LAMTOR3;SMCR8;PRKAA1;PIK3CA;TBCK;MIOS;DGKQ;HDAC3;TMEM127;UBR1;TTI1;TBC1D7
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.4504318373466776,0.8755671122968672,0.7142857142857143,0.9280874179365848,1.0,11/23,20.19%,SLC9C2;LRRK2;CA2;SLC4A4;SLC9A1;SLC26A3;SLC9A9;TMEM165;SLC9A7;CHP1;SLC4A8
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5292755285732402,0.8754367105654507,0.574468085106383,0.9277243082517647,1.0,2/8,7.83%,ABCA2;RAMP1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.4296253762421418,-0.8753597443946163,0.7,1.0,1.0,9/32,18.79%,CATIP;NME9;ENKUR;EFHC1;PLTP;DNAH9;HSPA2;CCDC60;DNAH12
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.4521657675893791,-0.875320376055646,0.6349206349206349,1.0,1.0,4/22,10.64%,IL4I1;LILRB4;GLMN;BTN2A2
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.3964684049347765,-0.8751352494266721,0.6375,1.0,1.0,10/48,12.12%,NLRC3;DHX58;RORA;VPS35;ENPP3;METRNL;SELENOS;TNFAIP3;NLRP12;LPCAT3
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.5204782839835024,0.8750021676570106,0.6111111111111112,0.927893394261385,1.0,1/6,0.96%,SCRIB
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.5907222699596807,0.8749848614171191,0.75,0.9273404994064771,1.0,1/5,0.73%,BAG3
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3546629098870702,-0.8748318678584502,0.7,1.0,1.0,7/107,7.56%,PLEKHG5;ARHGAP4;GRAP2;AIF1;ARHGEF1;IGF1;ARHGEF3
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.5036251086761181,0.8745074415265722,0.575,0.9277236324914122,1.0,1/6,0.36%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.4449920736764547,0.8744609561192765,0.5833333333333334,0.9272190596085146,1.0,4/14,18.81%,PPARG;EEF1A2;ZBTB20;SIRT4
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.36182007151075385,0.8743943488754371,0.72,0.9268338645229734,1.0,14/65,11.00%,PLXNB1;FKBP9;SLC39A14;DAG1;CHKA;MAGI1;FKBP5;TBC1D16;UNC13B;DHCR24;BOK;GPC6;GNA11;FERMT2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.33989149518576117,0.8743171028128887,0.64,0.9263700282808643,1.0,2/68,1.09%,KLF4;PKD2
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.4363225869507649,0.8742897616773918,0.6451612903225806,0.9258197900803895,1.0,8/17,20.19%,SLC9C2;CA2;SLC4A4;SLC9A1;SLC9A9;SLC9A7;CHP1;SLC4A8
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.40242472020736747,-0.8741274493914997,0.6176470588235294,1.0,1.0,7/50,7.14%,SLC2A3;TFRC;SLC7A5;ABCB1;SLC38A1;ABCC3;SLC16A7
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5168462161308652,0.8740842829128508,0.6875,0.9256416310020581,1.0,1/8,0.36%,ANXA1
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.5541413573959941,-0.8737055518842449,0.6612903225806451,1.0,1.0,3/6,26.16%,CYP3A5;CYP19A1;HSD17B7
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.5231597506229039,0.8733514205569858,0.6410256410256411,0.9259726044738374,1.0,3/5,19.10%,KCNC2;GUCY1B1;FOXO1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.5231597506229039,0.8733514205569858,0.6410256410256411,0.9259726044738374,1.0,3/5,19.10%,KCNC2;GUCY1B1;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.3937668954281433,-0.8728938582413073,0.6363636363636364,1.0,1.0,5/45,5.38%,CALCR;CD36;FOS;DDIT4;CLU
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3510708932155936,0.8717599644934937,0.7777777777777778,0.9283817574760341,1.0,10/59,8.28%,ACER2;HIP1R;CASP9;ANP32B;PPARG;SMAD3;TNFRSF10A;ROBO1;BOK;LAPTM5
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.38105626666982856,-0.8717084008008459,0.7014925373134329,1.0,1.0,7/81,4.81%,SIGIRR;CCL3;CCL5;PID1;CXCR4;EMD;RACK1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.4042524311134229,-0.8715033582960396,0.7323943661971831,1.0,1.0,11/64,9.02%,RSAD2;BTG2;IFI44L;SIDT1;STAG3;MX1;SLC16A7;MFSD6;PLAG1;SELENOP;SGK1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.44798821623310775,-0.8712935310438694,0.6176470588235294,1.0,1.0,4/26,10.19%,EMD;IGF1;SRI;SGCE
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.3413788694519169,0.8710591047710161,0.6956521739130435,0.9292350709182614,1.0,7/58,7.09%,NUTF2;E2F3;TSC2;IPO13;NUP153;NUP188;PPP1R10
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.4447842193695918,-0.8709741267876033,0.6440677966101694,1.0,1.0,1/19,2.44%,PPP1R15A
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.5122522452281066,0.8706343211423142,0.6382978723404256,0.9293783387997976,1.0,1/7,9.60%,PDE3B
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.4411161111085926,-0.8704478611204152,0.6714285714285714,1.0,1.0,4/50,7.52%,IL4I1;KMO;GLUL;CRYM
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.32196101370494523,0.870327926323873,0.6470588235294118,0.9295529212368692,1.0,14/188,4.69%,EGR1;CD180;RRAGD;FER;PKD2;PDK4;SERPINE1;RUVBL2;NCOA3;RAP1A;NRIP1;SIRPA;WNT5A;AANAT
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.4993648664230922,-0.870309869566418,0.7068965517241379,1.0,1.0,2/14,7.03%,WARS1;ETS1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.46495640339059296,0.8701280072796874,0.6060606060606061,0.929373229471973,1.0,2/18,4.32%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.45676714608697394,-0.8701049389551834,0.5454545454545454,1.0,1.0,2/17,11.00%,PRKCQ;ERAP1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.4442957148589442,0.8696548166306752,0.5952380952380952,0.9298463988050216,1.0,1/13,1.89%,ABCA2
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3310173586390237,0.8695772107795166,0.6842105263157895,0.9294231407354732,1.0,5/49,8.48%,KLF4;SIRT1;DDIT3;IRAK1;IRAK3
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.4915574104707869,0.8694116374946957,0.5945945945945946,0.9292909812790233,1.0,3/11,18.97%,SIRT1;POLA1;WRNIP1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.3417561752920774,-0.8694114522591564,0.8048780487804879,1.0,1.0,44/336,14.73%,CALCR;CD36;RPS4X;ZFP36;CCL5;PDGFD;PRLR;AIF1;IL7R;DDRGK1;TIPIN;FCER1G;IL12RB2;TSPAN31;AQP11;SLC25A5;IGF1;RPL23;ETS1;NPM1;RPS6;TRPM4;PRKD2;NAMPT;OSMR;CITED2;TNFRSF1B;CHTOP;POFUT2;TRIM13;PTN;MEIS1;ZNF16;VEGFA;CDC7;CD47;CCND1;MT3;RPS9;CYBA;CCAR1;EFNB2;C1QBP;RAD23A
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4560749480521833,0.8693815282201427,0.65625,0.9287822505774814,1.0,2/17,1.09%,KLF4;PKD2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.5370467984398717,-0.8691911425885517,0.734375,1.0,1.0,3/9,18.03%,HSPA1B;HSPA1A;CASP4
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.4505662917085416,-0.8691637490447951,0.6666666666666666,1.0,1.0,8/24,19.42%,PARP14;PARP15;PARP9;PARP2;PARP11;PARP4;HPF1;PARP12
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.3782520728563298,-0.8691520578722832,0.6962025316455697,1.0,1.0,9/103,11.10%,FLNA;TSPAN32;RAB3A;JUP;RAB11A;TMEM150A;RAB3D;EPB41L3;EFR3B
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.34934175091521513,0.8690888219684523,0.6296296296296297,0.9287055540663733,1.0,6/36,12.84%,SIRT1;SPRED1;SPRED2;NACC2;UBE2N;NSMCE1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.44336223750365605,-0.8683198417454819,0.71875,1.0,1.0,4/20,17.50%,ERO1A;HSPA1B;HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.45355525008391834,0.8679745492086854,0.6486486486486487,0.9304554338496035,1.0,5/18,11.81%,PPARG;RANBP3L;PTCH1;TWIST2;CDK6
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.4336782817535863,-0.8676774704032391,0.7384615384615385,1.0,1.0,3/33,11.51%,PPP1R15A;CALM1;CNEP1R1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.4649563108976864,-0.8674243250524566,0.6229508196721312,1.0,1.0,2/24,4.13%,TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.4425396954838057,-0.8672832665233756,0.703125,1.0,1.0,1/19,2.20%,GCNT1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.3292918068595707,0.8670143623831861,0.7741935483870968,0.9320308135553999,1.0,21/95,13.39%,NRP1;CDK5R1;AUTS2;MAP2K1;WNT5A;RELN;FZD3;WNT2B;RYK;PLXNB2;FUT9;RUNX1;BRSK1;GPM6A;PTPRD;PEX13;OLIG1;CDK6;ELP3;MARK1;NTRK2
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.43051357404286567,0.8668034166643293,0.5357142857142857,0.9317956780106265,1.0,4/26,5.97%,KLF4;PKD2;SIRPA;SMAD3
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.5527599750440871,0.8667030080701649,0.6938775510204082,0.9315530062387027,1.0,2/5,24.52%,PLCB3;PRCP
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.48751284443077514,-0.8666553105610101,0.6666666666666666,1.0,1.0,2/15,6.30%,CLU;IGF1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.39946506284231315,0.8666037997129769,0.6511627906976745,0.931162056310949,1.0,8/22,24.49%,FGF2;P2RY12;PTK2;FGFR3;PIK3R1;DAB2IP;TGFB1;PRKD1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.3615062412148164,0.8662299996302752,0.5483870967741935,0.9312795587053038,1.0,7/31,18.97%,CASP9;FEM1B;UBE2N;NSMCE1;CDK9;RFWD3;WRNIP1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.47053399244953475,0.866168134089283,0.6097560975609756,0.9308580138675762,1.0,1/9,0.36%,ANXA1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.29927339493384564,0.8660773684076319,1.0,0.9304213738460765,1.0,36/256,10.91%,NRP1;POLR2D;GRB10;CDK5R1;PDGFA;FER;PDK4;IGF1R;FGF2;GAB1;MAPK11;SLC39A14;NRG1;SPRED1;TSC2;SPRED2;NCK2;SORT1;WASF2;RYK;PDGFC;MERTK;HPN;CRK;EPHA6;ELMO1;ATP6V1B2;FLRT1;GIGYF1;MPZL1;HGF;FLRT2;GRIN2B;GIT1;AP3S1;SHC2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.3377582083554196,0.866055775663762,0.7142857142857143,0.9299306630892727,1.0,6/83,7.37%,PPARGC1A;MITF;PICALM;LIN7A;MAGI1;MDM2
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.49614154854644504,0.8657273798447257,0.5945945945945946,0.9299784676616976,1.0,4/9,18.58%,KCNIP2;KCNMB4;KCNMB3;RYR2
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.3764717553850126,-0.8656960571632757,0.6716417910447762,1.0,1.0,18/76,23.94%,RPGRIP1L;SSNA1;RAB11A;CEP164;CEP72;TMEM67;CSNK1D;PRKAR2B;TUBB4B;AKAP9;DCTN2;NINL;DYNC1I2;SFI1;HAUS5;TUBB4A;CC2D2A;CEP250
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.44030987747277334,-0.8654357581299241,0.6307692307692307,1.0,1.0,5/28,17.48%,TPP1;HPS4;ZKSCAN3;TASL;HOOK2
prerank,GO_Biological_Process_2021__regulation of hippocampal neuron apoptotic process (GO:0110089),-0.5737096224075164,-0.865305375330421,0.6326530612244898,1.0,1.0,1/5,12.58%,TYROBP
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.5413644044062361,-0.8652544798910224,0.7068965517241379,1.0,1.0,3/7,24.96%,ATP5IF1;PINK1;SREBF1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.4207389157057641,0.8652399032230084,0.631578947368421,0.9303456498600606,1.0,8/29,15.32%,ABCA2;PICALM;TMED10;SLC2A13;SORL1;RTN4;NTRK2;TNF
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.517173561975509,0.8651556436817381,0.75,0.9299571062812226,1.0,1/10,1.13%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.5252516114048442,0.8645878574623875,0.6153846153846154,0.9306584634018773,1.0,3/7,14.86%,WNT5A;DVL3;MAP3K13
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.4807183171693545,0.8642684089940085,0.6521739130434783,0.9306357160323487,1.0,4/12,17.03%,RCN3;HDAC1;CTSH;ATP13A2
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.28522987504779196,0.8641650579316035,0.9,0.9302477056840613,1.0,30/171,15.83%,LRP4;ZNRF3;SEMA5A;CSNK1G1;RUVBL2;ANKRD6;LRRK2;GNAQ;WNT5A;TLE2;INVS;TMEM170B;DDIT3;KANK1;DVL3;HDAC1;BTRC;TBL1XR1;WNK1;TCF7L2;CSNK1E;ZNF703;DDX3X;XIAP;GID8;CAPRIN2;PPM1A;RNF220;GSK3B;SOX4
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.549436780193091,-0.8639636688199896,0.603448275862069,1.0,1.0,1/5,4.30%,CHCHD10
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.5567079706226352,-0.8639135405259296,0.6779661016949152,1.0,1.0,1/5,9.82%,TNFRSF1B
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.47170728435214826,0.8636425013712455,0.6486486486486487,0.9305514673044656,1.0,2/15,2.93%,NOL9;RPF1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.3928875493716508,0.8635788948039816,0.625,0.9300941160506315,1.0,2/24,4.85%,IFNLR1;TOMM70
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.4727077415211512,-0.8632728471966946,0.6615384615384615,1.0,1.0,3/19,8.95%,TGFBR3;MYBPC3;RBPJ
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.6088223501946723,-0.8629677797604792,0.8064516129032258,1.0,1.0,3/5,20.31%,CRACR2A;STIM2;ORAI2
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.42470657798179146,-0.8627874279106863,0.6911764705882353,1.0,1.0,2/28,1.13%,CCL3;CCL5
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.4001146167466444,-0.8627331972039743,0.7049180327868853,1.0,1.0,10/39,16.03%,CARD16;RORA;EGLN3;FAM162A;VEGFA;NOP53;PGK1;HIF1A;MT3;PICK1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.33452249144918844,0.8621356087976102,0.7083333333333334,0.9322595140744118,1.0,12/83,8.28%,ACER2;GSN;HIP1R;SIRT1;CASP9;ANP32B;PPARG;SMAD3;TNFRSF10A;ROBO1;BOK;LAPTM5
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.5509415536640392,-0.8620124798611217,0.7096774193548387,1.0,1.0,1/5,5.11%,CTDP1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.5048469116636125,0.8618234730273666,0.6,0.9324762140140518,1.0,1/8,1.60%,SEMA5A
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.3119156891968888,0.8617740550827793,0.8333333333333334,0.9320107786372548,1.0,13/77,14.19%,UBE2O;BAIAP3;SNX12;TBC1D5;TBC1D10B;SGSM2;RAB7A;RBSN;VTI1A;YKT6;RAB6A;STX6;EVI5
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.4084380688063761,-0.8614400742387853,0.6212121212121212,1.0,1.0,3/33,7.52%,TRIM5;ARIH2;RNF126
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.48181501525827847,-0.8610281927043045,0.7014925373134329,1.0,1.0,5/16,15.84%,SLC7A5;SLC38A1;LLGL2;SLC36A4;SLC38A6
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.4896255659633907,0.8610003142209034,0.5714285714285714,0.9330559580039025,1.0,3/6,19.76%,NIPBL;CHD7;FGFR2
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.37289308509412056,0.8609062927245255,0.5454545454545454,0.9315073858778254,1.0,7/50,8.86%,TGFA;BET1;CTSC;SEC24B;TMED10;RAB1B;GRIA1
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.37289308509412056,0.8609062927245255,0.5454545454545454,0.9315073858778254,1.0,7/50,8.86%,TGFA;BET1;CTSC;SEC24B;TMED10;RAB1B;GRIA1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.37289308509412056,0.8609062927245255,0.5454545454545454,0.9315073858778254,1.0,7/50,8.86%,TGFA;BET1;CTSC;SEC24B;TMED10;RAB1B;GRIA1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.4202960302150466,-0.8607463155972447,0.7611940298507462,1.0,1.0,2/34,4.16%,USF1;UVSSA
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.5144173237755436,0.8606027728206073,0.6666666666666666,0.9314688259074771,1.0,5/9,28.77%,P2RY12;P2RX7;DGKQ;HSP90B1;P2RX4
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.4147010190662933,-0.8603918974651983,0.65,1.0,1.0,3/24,6.30%,DUSP1;AURKAIP1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.516020981979588,-0.8602855748393226,0.6724137931034483,1.0,1.0,2/6,12.54%,TRPV4;VEGFA
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.5655035041643475,-0.8599370574669531,0.6909090909090909,1.0,1.0,2/6,7.78%,DUOX1;DIO2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.46666678637803505,-0.8597122473333647,0.7058823529411765,1.0,1.0,3/16,12.77%,TRIM5;TRIM13;VPS37B
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5378698759315255,0.8596817761174237,0.6086956521739131,0.9329898378363327,1.0,2/6,28.72%,TRIP12;UBR5
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.468965689957901,-0.8596553972382425,0.6557377049180327,1.0,1.0,1/12,2.29%,SYNE2
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.455703162647349,-0.8593679335520029,0.6271186440677966,1.0,1.0,3/16,7.68%,ATF5;XRCC3;NPM1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.348091101208604,-0.8593509112750386,0.7857142857142857,1.0,1.0,33/203,13.45%,COL18A1;FTH1;TGFBR3;NLRC3;H2AC6;RUNX3;WARS1;BTG2;AIF1;EMD;B2M;IFIT3;PER2;APOD;ING5;ATF5;AQP11;GSTP1;ETS1;MED25;NPM1;HSPA1B;EIF2AK2;IRF1;GLMN;KANK2;TNFAIP3;PDCD5;IFI35;ING4;SST;CDKN1C;BTG1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.5385178682904548,-0.8592887498304465,0.6545454545454545,1.0,1.0,2/7,24.47%,PSMC4;PSMC3
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3793437957297,-0.8590166857489457,0.6933333333333334,1.0,1.0,4/54,5.95%,SLC38A4;SLC51A;SLC38A1;ABCC3
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.5252764654878215,0.8589616057105983,0.7111111111111111,0.9339611920194603,1.0,2/6,12.32%,WNT5A;NF1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.47185035814318677,0.8588506515954175,0.7435897435897436,0.9336436199652419,1.0,2/11,17.95%,STARD4;ARV1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.5268716652075456,-0.8588419216141794,0.6779661016949152,1.0,1.0,2/9,12.26%,ACAA1;ECI2
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.4634867133651876,-0.8587903003739207,0.6190476190476191,1.0,1.0,5/18,14.46%,RPS13;RPS26;U2AF2;SRSF7;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.3283836747556389,0.8587361747097203,0.7333333333333333,0.9332185413519096,1.0,18/67,19.74%,CDKN2AIP;CIB1;HPN;TAF9B;NEDD4L;MMP14;SMURF1;SYT17;DDX3X;SHTN1;MAP3K13;SEMA4D;SYT4;MTPN;RIMS2;ZFYVE27;CSNK2A1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.38972659690838773,0.858647396691853,0.5666666666666667,0.9328016775936157,1.0,3/24,7.93%,SIRT1;TSC2;DEPTOR
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.4612731768191114,-0.8586210304225071,0.6507936507936508,1.0,1.0,4/20,11.80%,NIT2;GLUL;GCLM;GOT2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.47873800331066907,0.858575111169558,0.6190476190476191,0.932331436708974,1.0,4/10,11.46%,SNAP23;STX11;STX1A;STX2
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.5645332649837652,0.8583038469997788,0.6964285714285714,0.9322694652234036,1.0,1/5,3.06%,NLGN1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.3786047992228992,-0.8582253212065795,0.7971014492753623,1.0,1.0,20/69,18.01%,COL18A1;MRO;PRLR;CD55;PADI2;CLU;NR1H2;SLC16A3;EPHX1;PFKFB3;TSPAN9;C3;ABLIM3;NOTCH2;SERPING1;VASN;DOCK6;AGT;CRYAB;MATN2
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.5714974814379427,-0.8581048046100123,0.7090909090909091,1.0,1.0,2/5,19.35%,PLSCR1;CSNK2A2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.5674578790298614,-0.8577037200355783,0.7017543859649122,1.0,1.0,2/5,13.67%,ENTPD4;DHODH
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.4532381719397962,-0.8569531914475906,0.7230769230769231,1.0,1.0,7/24,19.72%,WDR83;DDX23;SMNDC1;PRPF3;SLU7;PRPF4;SF3A3
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.4298474625925033,-0.8568893203869649,0.6911764705882353,1.0,1.0,2/33,0.98%,CCL3;SRGN
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.42360310513083643,0.8567211745476538,0.7027027027027027,0.9346830612565051,1.0,5/17,15.24%,ZC3H14;CPSF7;RNF20;NUDT21;CDK9
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.35010323489498907,0.8565792662478547,0.75,0.934396934713048,1.0,7/43,6.60%,ANXA1;SCRIB;JAG1;RAB10;CPT1A;PPARG;PTER
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.5079158852103686,-0.8558238827090101,0.6896551724137931,1.0,1.0,2/9,10.29%,IFIT1;CHTOP
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.3759462921056986,0.8557261009604386,0.625,0.9355624106570161,1.0,3/28,10.71%,RRAGD;GLRA1;CPEB4
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.5130982822525454,-0.8555838760732928,0.6896551724137931,1.0,1.0,2/11,17.35%,DYNC2I1;IFT43
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.5635086020579668,-0.8555777420742411,0.7407407407407407,1.0,1.0,2/5,7.17%,PLEKHG5;CORO1B
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.29822575658561157,0.8550986219632887,0.9375,0.936196979129955,1.0,17/161,9.81%,LEPR;NRP1;IGF1R;ACVR2A;FGF2;SIRT1;LRRK2;KNDC1;RYK;CIB1;MERTK;EPHA6;DVL3;SLC4A4;NPTN;TMEM119;HGF
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.38046447337939515,-0.8548525320456237,0.6956521739130435,1.0,1.0,9/67,17.47%,TAF1D;ZNF335;GLMN;ACTB;DNMT1;TAF1C;GPX1;CGGBP1;KDM1B
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.42572506896289386,-0.8546087429507611,0.6349206349206349,1.0,1.0,1/30,1.31%,RIMS1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5240187334814967,-0.854338949048124,0.6909090909090909,1.0,1.0,2/9,24.44%,PTN;SCARF1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.38363105033487543,0.8540509480277271,0.7096774193548387,0.9375286989863441,1.0,7/32,9.93%,STK36;DLG5;TULP3;KCTD6;PTCH2;PTCH1;BTRC
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.40451909298714805,-0.8539096094424903,0.6617647058823529,1.0,1.0,8/40,11.76%,UBXN1;PER2;DTX3L;RPS3;HSPA1B;VPS28;U2AF2;TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.42679718645368714,-0.8538134009222348,0.625,1.0,1.0,6/22,14.80%,LIPG;NR1H2;LPCAT3;ABCB4;ABCA8;PLTP
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.5720603717938939,-0.8537648897593284,0.7704918032786885,1.0,1.0,4/5,35.96%,ALDH2;ACSS1;ADH5;ALDH1A1
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.5720603717938939,-0.8537648897593284,0.7704918032786885,1.0,1.0,4/5,35.96%,ALDH2;ACSS1;ADH5;ALDH1A1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.38062264865536194,-0.8536425752452937,0.7205882352941176,1.0,1.0,4/65,3.17%,PID1;WARS1;PPP1R15A;PAQR3
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.5136308704677177,-0.853494269375144,0.7843137254901961,1.0,1.0,1/9,5.44%,DTX3L
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.34121512721294656,0.8534884904560881,0.75,0.938038687791764,1.0,3/43,3.82%,MSL2;RUVBL2;CHD5
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.445012453367342,0.8533824521318546,0.5909090909090909,0.9376594836464605,1.0,1/10,1.41%,IGF1R
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.5277048699428679,0.8532894536009175,0.6666666666666666,0.9366729095871045,1.0,4/6,27.03%,GSK3B;CHP1;HOMER2;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5277048699428679,0.8532894536009175,0.6666666666666666,0.9366729095871045,1.0,4/6,27.03%,GSK3B;CHP1;HOMER2;DYRK2
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.4911936643248964,-0.8532154420086544,0.6825396825396826,1.0,1.0,1/15,2.92%,GTF3C6
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.4031134039338354,0.8530406257878981,0.7058823529411765,0.9366469402164741,1.0,2/17,7.43%,SEL1L;AUP1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.528583816799097,-0.8529190686047562,0.6,1.0,1.0,1/7,6.70%,GSTP1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.3667141012346827,-0.8528271499439397,0.7763157894736842,1.0,1.0,8/97,6.70%,TGFBR3;APIP;DUSP1;TRIM5;EPHB1;LILRB4;IGF1;GSTP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.560995976203785,-0.8527187135311823,0.6842105263157895,1.0,1.0,2/5,19.39%,FGF13;AKAP9
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.37696130473456313,-0.852706480367582,0.7910447761194029,1.0,1.0,8/77,8.01%,APIP;PRF1;B2M;RNF213;AQP11;JMJD6;MLKL;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.35753138950953284,0.8526684947901234,0.75,0.9369419588438945,1.0,21/78,19.66%,KLF4;ABCA2;WNT5A;RAB1B;RAB7A;NEDD4L;FZR1;SORL1;BARD1;SMURF1;TNF;GSK3B;IDE;TIPARP;NEDD4;MTPN;HACE1;FOXO1;CSNK2A1;CD86;PLK2
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.49971837595439683,0.852537564633599,0.6428571428571429,0.9360578282619739,1.0,2/7,8.04%,FA2H;TMEM79
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.49971837595439683,0.852537564633599,0.6428571428571429,0.9360578282619739,1.0,2/7,8.04%,FA2H;TMEM79
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.47422369395620645,-0.8524471877644182,0.6545454545454545,1.0,1.0,5/10,26.49%,HLA-F;ITGB2;FGR;STX4;SPHK2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.3282525185066792,0.8523389905218641,0.6153846153846154,0.9358568416974783,1.0,12/84,12.37%,CD180;FER;SERPINE1;SIRPA;WNT5A;IRAK1;IRAK3;TAB2;LGALS9;GIT1;TRAF6;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.5281340951210438,-0.8520117458431495,0.6481481481481481,1.0,1.0,2/9,2.78%,USF1;ENPP4
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3885077839142125,-0.8519691132269163,0.6962025316455697,1.0,1.0,17/85,15.35%,UBXN1;DDRGK1;RPL11;RACK1;ELOB;CLU;ARIH2;HSPA1B;RNF144B;DVL1;GLMN;RBX1;NOP53;CSNK1D;HSPA1A;RAD23A;DAB2
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4254684780148158,0.8518137345042848,0.6764705882352942,0.9364032052017617,1.0,1/17,0.63%,PLA2G4C
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.39337019704124476,0.8516966707943012,0.6486486486486487,0.9360498720371222,1.0,3/23,4.10%,TMEM39A;TSC2;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.41383938936942033,0.8510926957944285,0.6666666666666666,0.9365345525951525,1.0,4/18,11.42%,NRP1;NLGN1;GPM6A;FNBP1L
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.44011504812189156,-0.8509112202815939,0.7,1.0,1.0,1/26,0.63%,COL5A1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.42602870495793155,0.8508864044658901,0.7142857142857143,0.9363794207517979,1.0,2/12,6.71%,CPSF4;ZBTB8OS
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.49121879060245954,0.8504709674519767,0.6363636363636364,0.936581927507697,1.0,1/6,1.60%,SEMA5A
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.43932182663928593,-0.8503640713458283,0.8,1.0,1.0,3/24,9.19%,RIMS1;RAB3A;STX19
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.4531755393608833,-0.8503486028299314,0.6764705882352942,1.0,1.0,4/15,17.65%,ARHGEF3;P2RY8;LPAR6;RAC1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.3997798725220354,0.8503223799485307,0.6590909090909091,0.9362825357446973,1.0,1/22,0.36%,ANXA1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.4242390492675539,-0.8503100651032507,0.6984126984126984,1.0,1.0,11/27,28.92%,GLA;CALM1;HIF1A;PIK3CB;IL1B;NOS1AP;ZDHHC21;ATP2B4;IL1A;EGFR;HSP90AA1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.4910159261794332,0.8501370806049099,0.6341463414634146,0.9356089025904187,1.0,3/7,9.02%,SLC1A2;DISP1;ALOX5AP
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.4910159261794332,0.8501370806049099,0.6341463414634146,0.9356089025904187,1.0,3/7,9.02%,SLC1A2;DISP1;ALOX5AP
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4117341174279918,-0.8500167788036653,0.746031746031746,1.0,1.0,1/35,0.15%,FLNA
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.42047397308902795,0.8499975500483812,0.7647058823529411,0.9353409725577949,1.0,4/21,10.55%,IGF1R;DOCK10;SHANK3;PTEN
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.37370572344654157,-0.8498327495363709,0.6666666666666666,1.0,1.0,11/76,13.88%,CCL3;CCL5;PLN;ATP13A1;CDH23;TPT1;SMDT1;TRPV4;TMCO1;MICU2;MAIP1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.4485443663495538,0.849708237044654,0.6857142857142857,0.9354297526653528,1.0,1/11,0.36%,ANXA1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.35402219148039504,-0.8495889865304564,0.7530864197530864,1.0,1.0,20/127,12.37%,CD36;DYNLT1;MGLL;TRIM5;CD55;RORA;MDFIC;RGS2;RGS16;CLU;MTCH1;RGS4;CD63;LLGL2;PLSCR1;ANKRD54;OVOL2;FYN;NLRP12;IFT81
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.46540562867084445,-0.8493558669763057,0.7101449275362319,1.0,1.0,1/15,2.24%,STIL
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.40221664801700796,-0.8492868620049838,0.7258064516129032,1.0,1.0,6/45,12.21%,CCL3;CCL5;ATP13A1;TPT1;TRPV4;TMCO1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.44381842309780556,-0.8492711045723333,0.746268656716418,1.0,1.0,10/32,13.04%,CEBPD;ZMYND15;ABCC3;CLDN7;SSH3;LLGL2;TNFAIP2;GALNT3;ANKRD22;FBP1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.5118262308943481,0.849167081227542,0.6363636363636364,0.9359503904459276,1.0,1/6,4.32%,AUTS2
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.5249092451488971,-0.8486223704192136,0.7142857142857143,1.0,1.0,2/7,19.49%,SCN9A;OPRM1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.48471605022285685,-0.8481766865654885,0.631578947368421,1.0,1.0,2/12,3.86%,PLN;RGS2
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.3709279828063067,0.8478404042028153,0.7352941176470589,0.938098777842118,1.0,1/27,0.67%,POLR2D
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.2988377464221478,0.8478317182722738,0.9285714285714286,0.9375423728730539,1.0,24/97,20.47%,PRKAB2;MAP1LC3A;TOMM70;UBXN6;TBC1D5;PRKAB1;MFN1;PIP4K2A;RUBCNL;ILRUN;ATG13;ATG16L1;PRKAA1;EI24;ULK1;ATP13A2;ARL8B;HDAC10;MTERF3;CSNK2A1;VTA1;TCIRG1;DYNLL2;SNAP29
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.4642594630418214,-0.8477741937665493,0.7241379310344828,1.0,1.0,2/18,0.89%,CCL3;TGFBR3
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.5280271195964346,-0.8477203904890349,0.6470588235294118,1.0,1.0,4/5,43.31%,BNIP3;PISD;BNIP3L;AFG1L
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.5518823465397261,-0.8475538696703186,0.7377049180327869,1.0,1.0,2/6,6.41%,SLC38A1;GLUL
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.4062678082507458,-0.8473660550590738,0.6571428571428571,1.0,1.0,10/30,16.15%,MGLL;GSTP1;EPHX1;ACAA1;FAAH2;FADS3;GPX4;GPX1;FADS2;ALOX12
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.560977671759787,-0.8472418627515919,0.7407407407407407,1.0,1.0,2/5,5.60%,PLEKHA7;MMP24
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4057145215443957,0.8470556250772968,0.6060606060606061,0.9384617681626629,1.0,5/24,13.59%,DCP1B;EXOSC6;CNOT7;LSM6;LSM1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.408344766423918,0.8465352984342325,0.6829268292682927,0.9388962122229141,1.0,6/18,10.15%,SLC39A14;WNT2B;RUNX1;SOX5;NFIB;BMPR1B
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.38461083290898346,0.8464446280239166,0.6153846153846154,0.9385292200542136,1.0,10/20,26.76%,RELN;SHANK3;CYP46A1;GSK3B;AGER;ADCY1;YTHDF1;ABL1;EIF2AK4;EPHA4
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.2995205262608241,0.8463587042366723,0.7857142857142857,0.9381098024306826,1.0,34/163,17.08%,PKD2;CLIP2;GSN;MAP1S;FGD4;MAP3K11;EPB41;NCK2;RASAL2;TLK1;WASF2;ARAP3;PPP4R2;PDLIM5;VCL;STK38L;SASS6;CENPE;SPTAN1;SMC4;NF1;RABGAP1;SSH2;TUBGCP6;ARF6;SORBS2;CEP131;DYNC1H1;CLASP1;ABI1;PREX1;NIN;ALMS1;MYO1E
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.56039221950938,-0.8460987689381051,0.6666666666666666,1.0,1.0,3/7,7.71%,PLN;MYBPC3;SRI
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.32798591664405946,-0.8460591678071161,0.8390804597701149,1.0,1.0,26/252,9.42%,FLNA;MYLK;CCL3;CCL5;ARHGAP4;PDGFD;SYNE2;AIF1;NKD1;DDRGK1;CEMIP;PLET1;TMSB10;RACK1;PECAM1;SEMA6A;IGF1;TMSB4X;ITGA6;ACTG1;FERMT3;BEX4;ENPP2;SGK1;SRGAP3;CITED2
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.3975699090805593,0.8459140304298415,0.574468085106383,0.9383021821451405,1.0,1/14,1.19%,GCLC
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.3783272719488717,-0.845878318983381,0.8142857142857143,1.0,1.0,15/78,15.86%,TFRC;WARS1;PPP1R15A;MPP7;ATP10A;RACK1;CLU;RPS3;GPC3;ABCB4;VEGFA;CAMK1;DAB2;GPX1;BMF
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.41910986696834585,-0.8458149797908804,0.6851851851851852,1.0,1.0,7/25,17.42%,GAPDH;UBXN1;SPOCK2;SERPING1;TIMP2;AGT;CST7
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.571696977027369,-0.845741884853964,0.7017543859649122,1.0,1.0,3/6,28.05%,C1QB;C1QC;ZP3
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.4167559124449093,-0.8448942500002281,0.7532467532467533,1.0,1.0,3/26,5.80%,SKAP1;CD36;JUP
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.44112628882415306,-0.8448351421542973,0.676923076923077,1.0,1.0,4/25,18.26%,MGLL;DGKD;LMF1;GK
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.42173514050816924,-0.8446112413708711,0.696969696969697,1.0,1.0,6/32,14.41%,TGFBR3;HNRNPAB;RBPJ;S100A4;HIF1A;DDX5
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.44338876215521317,-0.8444411746568218,0.6333333333333333,1.0,1.0,4/24,17.48%,TPP1;HPS4;ZKSCAN3;HOOK2
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.4070282409962857,0.844360149872947,0.7,0.9407269052885202,1.0,3/22,2.57%,NRP1;TGFBR2;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.3338582476347422,-0.844004392168902,0.7407407407407407,1.0,1.0,21/142,14.45%,NLRC3;DUSP1;RORA;RACK1;DDIT4;CGNL1;LILRB4;TMSB4X;GSTP1;PLEK;THEM4;STAT1;BANK1;TNFAIP3;IFI35;NLRP12;NOP53;DGKD;PEBP1;PLEKHA1;PRDM15
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.41405281713399317,-0.8439917356379882,0.7205882352941176,1.0,1.0,1/32,1.12%,ZFP36
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.4532940191918593,0.8439851551039192,0.7105263157894737,0.9407215235386273,1.0,2/12,13.88%,PPA2;ENPP1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.5128916274816637,-0.8439338232001758,0.6885245901639344,1.0,1.0,4/11,11.07%,MPP7;CGNL1;ACTG1;ACTB
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.37829439678116117,-0.8438722978346832,0.7361111111111112,1.0,1.0,8/69,9.37%,GAPDH;GZMB;BTG2;RPL13A;RACK1;ILF3;RPS3;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.4806450548229399,0.8438249397223703,0.6904761904761905,0.9404750740916928,1.0,1/9,0.96%,SCRIB
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.49441727256823487,-0.8437871396422155,0.6551724137931034,1.0,1.0,1/7,2.40%,CD200R1
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.5280062709327802,-0.8436592063919532,0.6833333333333333,1.0,1.0,3/6,17.12%,ZWILCH;NABP1;CHFR
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.3932680004490673,-0.8436358594703832,0.631578947368421,1.0,1.0,4/42,7.82%,ARL4C;VPS35;ENTR1;SNF8
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.43715685329447385,-0.8435253495289445,0.6507936507936508,1.0,1.0,10/21,25.41%,DDRGK1;PHB2;APPL1;PSME2;STXBP4;PSME1;PSME3;TAF1;CDKN1A;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.386291008082614,0.8435249789113953,0.6176470588235294,0.9405225511015033,1.0,1/25,0.13%,PPARGC1A
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3344902001775495,0.8430114479190866,0.8181818181818182,0.9408258112501174,1.0,18/73,22.36%,PCBP4;KHDRBS2;PRDX6;KHDRBS3;SRSF12;RBFOX1;CELF5;TRA2B;RBFOX2;THRAP3;HNRNPU;CELF2;PUF60;WTAP;NOVA1;RNPS1;NUP98;RBM15
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.4179742083247058,-0.8429376436131172,0.6296296296296297,1.0,1.0,5/32,14.30%,DNAJC19;TIMM44;TIMM21;TOMM40;SEC62
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.48082164913425324,-0.8428631878772577,0.6964285714285714,1.0,1.0,3/9,22.46%,GSTP1;CIITA;PARK7
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.4740490396993554,0.842821294322024,0.7027027027027027,0.9406549384893024,1.0,2/12,12.07%,GPAT4;GPAT3
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.3652798153939899,0.8427499132059754,0.6956521739130435,0.9402061817563881,1.0,6/25,19.48%,PPT1;ALOX5AP;GCDH;ACACA;FASN;SCD5
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.4130811800419199,-0.8426980179659497,0.6617647058823529,1.0,1.0,8/37,16.86%,RACK1;FCER1G;PLSCR1;CD47;CYBA;PTPRC;SLC11A1;IL1B
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.53029426490401,0.8424715334889333,0.6976744186046512,0.9403288191899836,1.0,1/6,0.39%,CTBS
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.5397630708440696,0.8424517415409533,0.6470588235294118,0.9398207264407126,1.0,2/6,8.28%,ABCA2;LAPTM5
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3376634624498706,-0.8414876529227242,0.7631578947368421,1.0,1.0,29/144,20.44%,UBC;RPS27A;PSMB3;SSNA1;PSMA7;CEP164;PSMB9;PSMB6;CEP72;PSMA5;APPL1;PSMC4;PSMD8;CSNK1D;ANAPC11;PSMD12;CENPF;PSME2;CDC26;UBA52;PRKAR2B;TUBB4B;PSMA3;BUB3;PSME1;AKAP9;DCTN2;NINL;DYNC1I2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.4289457953580996,0.841397364927865,0.6666666666666666,0.9413839381448413,1.0,4/20,9.40%,MCU;LRRK2;MARCHF5;DDHD1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.3360005860258816,0.8411319987394871,0.75,0.94136320250996,1.0,19/54,23.34%,NRP1;TMEFF2;WASF2;SLC9A1;FERMT2;TJP1;RAPGEF3;CLASP1;PHLDB2;PPM1F;ALMS1;CLASP2;PPM1E;TGFBR1;ARAP1;LIMCH1;ARHGEF10L;ABL1;PIK3R1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.4687097772800934,-0.8410790167875644,0.65,1.0,1.0,2/15,3.56%,ME1;MTHFD1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.411865037840556,0.8409471812838996,0.7567567567567568,0.9411926162114497,1.0,5/17,24.28%,TRAF6;SPPL2B;RHBDD1;ADAM10;TGFB1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3224163034236189,0.8408491300817217,0.8,0.9408574643648311,1.0,10/69,10.68%,NFYC;IDI1;PLPP1;PPARG;FDFT1;ACACB;TM7SF2;ELOVL6;HMGCS1;TBL1XR1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.5549547566253469,-0.8408151104956268,0.7166666666666667,1.0,1.0,4/7,19.03%,NHP2;RPUSD4;NOP10;RPUSD3
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.4447409154413612,-0.8405456526409782,0.65,1.0,1.0,5/20,16.34%,RNF126;SNF8;VPS28;VPS37B;MVB12A
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.4312330930209889,-0.8402221541927211,0.6923076923076923,1.0,1.0,4/27,6.41%,SLC7A5;IL10RA;SLC38A1;GLUL
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.297460809379592,0.8400055532178712,0.8928571428571429,0.9418250887769429,1.0,15/101,14.19%,MYO1D;UBE2O;BAIAP3;PTPN23;SORT1;TBC1D5;TBC1D10B;LAPTM5;RAB7A;RBSN;VTI1A;YKT6;RAB6A;STX6;EVI5
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.3395439590475674,0.839915928684829,0.7391304347826086,0.9414600368135845,1.0,12/57,20.73%,POLR2D;WDR74;MMS19;HNRNPC;LSM1;ENPP1;POLR2H;HNRNPD;RBFOX2;HNRNPU;WTAP;POLR2C
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.4549428897135408,-0.8399058839523487,0.7413793103448276,1.0,1.0,7/16,26.47%,TNFAIP3;IFI35;APPL1;FLOT1;NR1D1;LYN;PTPN22
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.3438265446006789,0.8397314609226042,0.7407407407407407,0.941289793520868,1.0,23/73,17.91%,CACNA1A;MYOM1;GOLPH3L;RAP1A;TMED10;UNC13B;RFX3;DISP1;KCNC2;CLOCK;CD33;STX1A;CACNA1E;ARF6;RAPGEF3;ABCC8;SLC12A2;STXBP5;TNF;ATP13A2;PPP3CB;ARFIP1;KCNB1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.40777596328858967,0.8395783699398937,0.7058823529411765,0.9410076723727728,1.0,5/23,13.18%,LRP4;PKD1;SALL1;C1GALT1;BAG6
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.421482468101703,0.8394676176895448,0.6363636363636364,0.9406885441763677,1.0,2/9,19.40%,RENBP;GNPDA1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.5032941006233641,0.8394666349725004,0.6739130434782609,0.9401384339166153,1.0,1/5,9.26%,RUNX1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.450010750135639,-0.839450411894469,0.6825396825396826,1.0,1.0,2/20,3.79%,CD2;PRELID1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.46651079788583577,-0.8393534865434363,0.7352941176470589,1.0,1.0,2/13,8.95%,TGFBR3;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3645930637988127,-0.8391420660361824,0.75,1.0,1.0,21/98,19.46%,TRIM5;DTX3L;IGF1;TRIM22;VPS35;PTTG1IP;PFKFB3;TNFRSF1B;ENTPD5;PRR5L;PFKFB4;HIF1A;KAT5;PIK3CB;SNX9;IL1B;CNOT8;EZR;TP53INP1;TPCN1;PNPT1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.5478500203464057,-0.8388633805385836,0.6949152542372882,1.0,1.0,1/5,12.54%,VEGFA
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.380687027854805,0.8388507843014016,0.6585365853658537,0.9407599845915479,1.0,4/23,11.81%,ANXA1;RYK;BTBD3;CDK6
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.43399125905929165,0.8386912422338924,0.6666666666666666,0.9406130104818923,1.0,5/14,22.71%,TMTC2;SLC8A1;ATP13A2;SNCA;GRIN1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.49687465258649743,-0.8383809980675205,0.7627118644067796,1.0,1.0,3/14,8.13%,MYBPC3;SRI;CALM1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.43770324648485937,0.838367570036943,0.7777777777777778,0.9406375580723907,1.0,8/22,18.76%,HIP1R;MYADM;KANK1;DYRK1A;SSH2;MAP2;SLIT2;SNCA
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.5653781950704244,-0.8382974988760707,0.7241379310344828,1.0,1.0,2/6,6.60%,TPP1;CDH23
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.37602385126576054,0.8382928783153143,0.6666666666666666,0.9402674571526962,1.0,6/38,10.59%,FLVCR1;ZBTB16;IKZF1;RUNX1;MFHAS1;PRKX
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.4995951810512277,-0.8382917450424117,0.7575757575757576,1.0,1.0,4/9,21.05%,PRF1;CYBA;RAC1;CLEC7A
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.4818223271803938,0.8380533622361314,0.6428571428571429,0.9401656752268289,1.0,1/9,3.16%,MTUS1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.4602187351246582,0.8378061441273451,0.627906976744186,0.940026827028231,1.0,1/12,0.66%,HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.5194545767112637,-0.837757973648879,0.7313432835820896,1.0,1.0,4/9,26.49%,RACK1;SMPD3;NSMAF;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.5194545767112637,-0.837757973648879,0.7313432835820896,1.0,1.0,4/9,26.49%,RACK1;SMPD3;NSMAF;SPHK2
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.4955595910673906,-0.837680656300327,0.68,1.0,1.0,1/7,8.32%,COMT
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.5225529879064404,-0.8376605719032544,0.7301587301587301,1.0,1.0,1/7,0.09%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.5157636501905628,-0.837660034835146,0.7301587301587301,1.0,1.0,1/6,6.43%,NR1H2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.47463241580817217,-0.8372719872253596,0.7592592592592593,1.0,1.0,1/16,0.38%,MT2A
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.43391912878021716,-0.837141556430068,0.6610169491525424,1.0,1.0,8/20,15.75%,GSTM4;GSTK1;GSTP1;GCLM;GSTM3;SOD1;GLRX2;GPX1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.5178306316104178,-0.8368661006750622,0.7142857142857143,1.0,1.0,3/7,14.99%,CD55;A2M;SERPING1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.4038008338037659,0.836673949867429,0.631578947368421,0.9416645435681225,1.0,6/20,16.67%,SCARB2;LAPTM5;RAB7A;NCOA4;SORL1;NEDD4
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.3289864685694484,-0.8366206019352556,0.7972972972972973,1.0,1.0,27/210,15.58%,UBC;USP6;RPS27A;PSMB3;COPS6;USP36;ADRM1;PSMA7;PSMB9;PSMB6;JOSD1;ACTB;ABRAXAS1;TNFAIP3;PSMA5;WDR48;PSMC4;PSMD8;HIF1A;OTUD6B;PSMD12;COPS8;RAD23A;OTUD1;BRCA1;CFTR;PSME2
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.4063496200567689,-0.8365411624201518,0.7205882352941176,1.0,1.0,3/26,5.88%,SLC38A4;SLC7A5;SLC38A1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.3964643385886638,0.8362055426008541,0.6829268292682927,0.9419781122146453,1.0,8/28,11.67%,COL16A1;SVEP1;SEMA5A;ACTA2;TIMP3;CDH11;COL15A1;FAM114A1
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.5333905249181236,0.836185610264665,0.75,0.9414598279319643,1.0,3/5,20.12%,TRUB1;PUS1;PUS7
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.39601645998188145,-0.8355266433690394,0.684931506849315,1.0,1.0,5/36,11.66%,SSB;NPM1;NUP50;NCBP2;XPOT
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.5224144252694638,-0.8354603463580779,0.7142857142857143,1.0,1.0,2/7,13.96%,NCKAP1L;C3
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.5136344393271175,-0.8354370280678453,0.7213114754098361,1.0,1.0,2/6,16.03%,CORO1B;PICK1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.48955165130708755,0.8353747620691743,0.7209302325581395,0.9425744769250369,1.0,4/10,17.93%,CDK13;SUPT16H;CDK12;EAPP
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.4567306882986699,-0.8352217924152698,0.7205882352941176,1.0,1.0,4/17,19.75%,STIL;CSNK1D;GOLGB1;DCTN2
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.4501125744049136,-0.835138169231566,0.6865671641791045,1.0,1.0,1/20,0.39%,STAT4
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.5084299121303794,-0.8351149108533341,0.7575757575757576,1.0,1.0,1/8,5.21%,TIPIN
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.5601056618277322,0.8344859496044139,0.8292682926829268,0.9435543538470615,1.0,2/7,5.12%,MYOM1;LCP1
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.508248698608316,-0.8338374442790689,0.7254901960784313,1.0,1.0,1/9,4.39%,EPHB1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.506018874317098,0.8337905997554921,0.6739130434782609,0.9445405037677668,1.0,2/7,22.49%,DDX3X;AGO1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.3767493342487339,-0.8337481317614616,0.725,1.0,1.0,8/77,15.17%,BCL2A1;PPP1R15A;ERO1A;HINT1;TNFRSF1B;DDX5;C1QBP;BRCA1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2824650523339271,0.8337290338246096,0.9,0.944081189656966,1.0,47/257,14.29%,NUTF2;BAG3;ARL5A;SGSM1;NLGN1;PKD1;E2F3;TBC1D1;TSC2;C17ORF75;IPO13;NUP153;NUP188;TMED3;TLK1;TMED5;TECPR2;TMED10;TBC1D16;TBC1D5;PPP1R10;RAB1B;TBC1D10B;XPO1;NUP42;RANBP3L;TBC1D12;SGSM2;LAPTM5;RAB7A;STX11;STX1A;SNX27;STX2;AP4E1;PREB;SORL1;RAB6A;IPO8;TBC1D22B;RABGAP1;STXBP2;STX6;ARF6;TBC1D2;EVI5;SMURF1
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.42242315709236267,0.8336443507534669,0.7368421052631579,0.9436520182715177,1.0,1/10,10.29%,NCOA4
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.45294290465419873,-0.8336236803002776,0.6984126984126984,1.0,1.0,1/19,0.88%,INSIG1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.4965753023976705,0.8330611592850886,0.6363636363636364,0.9441111258723599,1.0,1/5,10.44%,SRSF12
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.3830178642043958,0.8329851771035798,0.7,0.9437046161203241,1.0,5/21,7.86%,ANXA1;SERPINE1;FGF2;CRK;KANK1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.4422933284735454,0.8323355003596375,0.6388888888888888,0.9443405122380545,1.0,1/16,1.89%,ABCA2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.37712595318838615,-0.8321092131329973,0.746268656716418,1.0,1.0,7/58,9.70%,GTF2H5;TCEA2;ADRM1;ELOB;CTDP1;NCBP2;POLR2G
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.37151236349613853,-0.8318350780373908,0.765625,1.0,1.0,15/52,22.46%,DHX58;MGLL;TMSB4X;IRF1;ERAP1;APPL1;CASP5;NOD2;AKNA;CASP4;NR1D2;BCL6;HERC5;UFL1;PARK7
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.4713696165757917,0.8318237008007306,0.75,0.9447098003321679,1.0,2/8,10.76%,TSPOAP1;CYP46A1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3863687735363991,0.8317760249967976,0.75,0.9437135486256739,1.0,5/30,17.05%,RNF2;RYBP;APAF1;PHC1;YAF2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.3863687735363991,0.8317760249967976,0.75,0.9437135486256739,1.0,5/30,17.05%,RNF2;RYBP;APAF1;PHC1;YAF2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.44295701765455664,-0.8315777228365536,0.6984126984126984,1.0,1.0,1/20,0.88%,INSIG1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.3873666699209312,0.8313227066193841,0.6388888888888888,0.9441415391807361,1.0,7/23,17.03%,SLC39A14;NEO1;PICALM;SLC40A1;XIAP;CYBRD1;ATP13A2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3371125054286581,0.8309524270460354,0.7105263157894737,0.9442227264523281,1.0,8/45,14.49%,SIRT1;HYOU1;LRRK2;MDM2;TXNDC12;BAG5;SOD2;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.47651503107598503,0.8309090824335807,0.6923076923076923,0.9437294259771684,1.0,3/7,12.93%,LTBP3;SOX5;NUDT21
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4554684121776943,0.830337569627049,0.6666666666666666,0.9442597038199952,1.0,3/15,12.52%,SIRT1;BAG5;SOD2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.47751796850243705,-0.830331596455068,0.78,1.0,1.0,1/14,0.38%,MT2A
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.37383406520885676,-0.830318376753434,0.8260869565217391,1.0,1.0,13/66,20.25%,RPS4X;RPL5;RACK1;CLU;NPM1;EIF4A3;GSAP;ZCCHC4;VIM;PASK;EEF2;SMPD3;RPS27L
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3191522677213177,0.8301721856425184,0.7419354838709677,0.9439876168034685,1.0,14/74,14.92%,IGF1R;MAP3K11;ANKRD6;EDA2R;SIRPA;PHLPP1;MAP3K10;AIDA;MFHAS1;TRAF6;FKTN;SH3RF1;ZNF622;MAP3K5
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4630928169083425,-0.8294938601099556,0.7575757575757576,1.0,1.0,2/20,1.73%,PID1;PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.4035939592981422,0.8294527969252814,0.6285714285714286,0.944634755806798,1.0,1/22,0.36%,ANXA1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.3727049424537081,0.8293589598349553,0.6944444444444444,0.9442305189259986,1.0,10/23,23.32%,VCL;P2RY12;ARHGEF6;SNX1;ARHGEF4;PTPRO;CDH13;ABLIM1;WASF1;CTTN
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.4083413719821871,0.828981849608702,0.6382978723404256,0.9443260604045919,1.0,5/14,21.58%,SEC24B;SEC31A;SEC31B;SCAP;SEC23B
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.38134124919476303,-0.828867619214311,0.7183098591549296,1.0,1.0,17/57,23.99%,SRGN;PITRM1;TMEM208;SPG7;XPNPEP3;PCSK2;CASP4;PIDD1;STOML2;APH1B;C1RL;LONP2;PCSK5;CASP2;SPCS2;SEC11A;AFG3L2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.36847158797387775,0.8287028443250362,0.6206896551724138,0.9442673810137434,1.0,5/40,6.31%,PFKP;GCLC;PRDX6;CAT;STK25
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4768389062501827,0.828689370675034,0.5714285714285714,0.9437320330117651,1.0,1/12,2.77%,UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5009253871471485,-0.8285177123288586,0.6981132075471698,1.0,1.0,3/9,11.81%,RUNX3;LILRB4;NCKAP1L
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.45787566793905815,0.8283634530454919,0.7105263157894737,0.9437397339220758,1.0,6/13,9.39%,ABCA2;TGFBR2;GRAMD1A;SMAD2;PTCH1;GRAMD1C
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.46384695274236537,0.8281029900140134,0.6363636363636364,0.943710796089747,1.0,2/9,7.86%,PDPN;KANK1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.375781638500613,-0.8277100595537635,0.75,1.0,1.0,23/67,25.68%,HUS1;MUS81;FANCB;XRCC3;BRCA2;CDC7;NABP1;RPA3;SLX4;MCM7;BRCA1;POLQ;RECQL5;MCM6;WRN;ZSWIM7;LIG3;NUCKS1;MCM5;FANCM;MCM3;AP5Z1;EXD2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.4602959830151224,0.8275761281307731,0.65,0.9441870940853576,1.0,5/12,18.46%,JAG1;ROBO1;ROBO2;TNFRSF1A;SLIT2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.37808403640305266,0.8275561094652482,0.6666666666666666,0.9436822902973828,1.0,6/33,16.28%,MFNG;NOSIP;FAM110A;CNPY3;CCND3;RPS6KB2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.40882852341623815,0.8274847311131488,0.7142857142857143,0.943243885549935,1.0,4/24,10.49%,CDK5R1;TOGARAM1;SLAIN2;GIT1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.37661149005705186,-0.8270776297618319,0.7230769230769231,1.0,1.0,5/43,9.51%,CATIP;AIF1;PSTPIP1;VILL;CFL1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.44717750045221943,0.8269465845288281,0.7,0.9437634877620302,1.0,4/14,10.80%,SIRT1;HDAC9;HDAC1;SIRT6
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.39494786371105867,-0.8266714818303261,0.8450704225352113,1.0,1.0,3/41,9.82%,BCL2A1;DDIT4;TNFRSF1B
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.49150977331275486,0.8264256003915912,0.723404255319149,0.9440560397227568,1.0,1/7,7.45%,LIG4
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.5029004032244968,-0.8263716375556129,0.6842105263157895,1.0,1.0,2/8,14.07%,PTN;VLDLR
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.4025254232543622,0.8257923384908231,0.6551724137931034,0.9448593153254078,1.0,6/25,14.49%,PKD2;RAP1A;AANAT;VGF;SLC26A3;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.5656562317098575,-0.8253973042730991,0.7636363636363637,1.0,1.0,1/5,12.00%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.5656562317098575,-0.8253973042730991,0.7636363636363637,1.0,1.0,1/5,12.00%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.5656562317098575,-0.8253973042730991,0.7636363636363637,1.0,1.0,1/5,12.00%,SOD1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.4259631750575128,0.8253910705133012,0.7027027027027027,0.9449903796943345,1.0,2/15,8.48%,IGF1R;IRAK3
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.3822085430111727,0.8252624402479416,0.7222222222222222,0.9446108199725509,1.0,4/22,13.55%,MCU;ADRA1A;MICU1;SLC8A1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.45256269838817087,-0.8250939181458917,0.7169811320754716,1.0,1.0,1/18,4.98%,FIS1
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5202298698233618,0.8250703965365079,0.6888888888888889,0.9444357668935119,1.0,3/6,3.86%,HS3ST5;SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3413866200007489,-0.824714743317988,0.7837837837837838,1.0,1.0,15/104,15.58%,CCDC88C;PSMB3;EMD;NKD1;PSMA7;PSMB9;PSMB6;DVL1;RBX1;PSMA5;PSMC4;PSMD8;PSMD12;DAB2;PSME2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.36260996766091647,-0.8242109424070571,0.7647058823529411,1.0,1.0,15/64,23.96%,VNN2;MTHFD1;NIT1;THEM4;ACOT9;ORMDL1;ABCB9;ACSM5;MCCC2;SHMT1;SMPD3;NSMAF;BTD;ACSM3;FOLR2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.35871516464194503,-0.8241755851816294,0.75,1.0,1.0,6/59,7.77%,TAF6L;POLE3;ING5;ING3;BRCA2;MSL3
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.40931328338440165,0.8239081469488309,0.6216216216216216,0.9462276382725001,1.0,1/17,1.72%,GSN
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.392394453325493,0.823498948024263,0.7073170731707317,0.9464959432081329,1.0,1/17,1.24%,SERPINE1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4576114498106605,0.823110440659588,0.75,0.9467639422088335,1.0,2/8,8.93%,BOD1;CENPE
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.42129796702403455,0.8230716641973861,0.6896551724137931,0.9463044644259718,1.0,4/15,11.64%,MMRN1;TMEM236;SLC40A1;SLC26A3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.46048154500709176,-0.8229340892527156,0.6491228070175439,1.0,1.0,2/15,14.32%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.3983947163527486,0.8228813102539352,0.7352941176470589,0.9461071425816864,1.0,10/23,33.93%,SETD3;SETDB2;RBBP5;SETD1B;KDM6A;CXXC1;WDR82;SMYD2;SUV39H2;DPY30
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.36749731594806045,-0.8227339334126947,0.7058823529411765,1.0,1.0,7/64,10.57%,TIPIN;ATF5;RAB11A;KLHL13;ENTR1;CALM1;IHO1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.48496724510268874,-0.8227240129123767,0.6785714285714286,1.0,1.0,2/11,3.86%,PLN;RGS2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.4486781056850938,0.8224471784839398,0.7428571428571429,0.9463676418362588,1.0,2/12,3.14%,SLC7A8;SLC1A3
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.46348599178045097,-0.8220623766628508,0.6896551724137931,1.0,1.0,2/14,6.98%,BHLHE40;BASP1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.43819714265057497,-0.8218481130467231,0.6865671641791045,1.0,1.0,3/18,10.09%,PLEK;ACTG1;PFN1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.533794259411546,0.8215594859092606,0.6585365853658537,0.9475279985085542,1.0,1/5,5.71%,PARP1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.46413510778344447,-0.8215447548926496,0.7377049180327869,1.0,1.0,1/17,2.96%,MOV10L1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.4628913745977101,-0.8213469404675986,0.703125,1.0,1.0,2/8,23.57%,MCCC2;BTD
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.37086587318852043,0.8210772721373238,0.6857142857142857,0.9479397525411628,1.0,10/36,15.32%,CACNA1A;RAP1A;RFX3;KCNC2;CLOCK;STX1A;CACNA1E;RAPGEF3;ABCC8;TNF
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.4302295039087099,-0.8210759365414113,0.746268656716418,1.0,1.0,4/26,15.55%,HUS1;TIPIN;BRIP1;RAD9A
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.42629723391681407,-0.8209689892636798,0.7428571428571429,1.0,1.0,3/22,8.74%,RIMS1;RAB3A;RAB3D
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.4357687331238839,0.8208449683904846,0.6956521739130435,0.9479087242897218,1.0,3/9,18.06%,SLC44A2;SLC44A1;SLC25A26
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.31704373255754265,0.8208207649046704,0.8695652173913043,0.9474066803167336,1.0,17/103,12.79%,RAB33B;CD22;HIP1R;GFAP;RAP1A;PICALM;TSC2;WNT5A;SNX12;PTCH2;STK38L;IRAK3;NRG3;BAG5;CHPT1;TJP1;ATAD3A
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.4188623198397028,-0.8205508848345922,0.6470588235294118,1.0,1.0,3/21,7.17%,AIF1;SEMA6A;CORO1B
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.43024042272045654,-0.8205191023332163,0.7096774193548387,1.0,1.0,1/19,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.4442013696829488,0.8204644328742954,0.7297297297297297,0.9475063606719979,1.0,4/9,24.28%,BMPR1A;KIAA0319;TGFBR1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.5098734068275207,-0.8204342280861956,0.6481481481481481,1.0,1.0,3/7,33.85%,TERF2IP;H3-3A;TERF2
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.5098734068275207,-0.8204342280861956,0.6481481481481481,1.0,1.0,3/7,33.85%,TERF2IP;H3-3A;TERF2
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.5175939469099836,-0.820219327707578,0.7666666666666667,1.0,1.0,1/7,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.3474556590452422,-0.8201785160358254,0.8452380952380952,1.0,1.0,9/125,9.37%,ITK;EPHB1;TXK;MUSK;MAP3K12;MAK;PRKD2;STK39;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3290908581527546,0.8200044347713525,0.84,0.947714508697632,1.0,14/60,17.15%,PPARGC1A;FGF2;LRRK2;TXNDC12;FERMT2;SORL1;GPNMB;SRGAP2;GSK3B;SOX4;INPP5A;ATP13A2;TM7SF3;TMEM109
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.54432516944166,-0.8199680686744849,0.75,1.0,1.0,1/6,23.77%,CYP19A1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.4844330760678006,-0.8199084953518291,0.7068965517241379,1.0,1.0,1/11,3.05%,SSB
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.4427473387464816,-0.8196336638083926,0.7538461538461538,1.0,1.0,2/17,2.31%,CCL5;AIF1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4630785470453507,-0.8193543067440673,0.8153846153846154,1.0,1.0,2/21,1.73%,PID1;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.36224905804683194,-0.8192491512306411,0.8142857142857143,1.0,1.0,17/87,17.40%,CCL3;CCL5;DHX58;USF1;AIF1;ETS1;PLSCR1;PTN;IFI35;NLRP12;CD47;CYBA;LY86;TASL;IL1B;AGT;POLR3C
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.36654163503703885,0.8191881791761749,0.8620689655172413,0.9486386474282138,1.0,6/29,13.30%,GOLPH3L;RAB10;GOLGA7;RAB7A;BLZF1;AFDN
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.44633381074839634,0.8191659358625247,0.7435897435897436,0.9481373276777486,1.0,4/6,18.76%,PIM1;AHCYL1;CHRM3;SNCA
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.507663013208117,0.8189806148969446,0.7,0.9474036166706775,1.0,1/6,1.09%,PKD2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.507663013208117,0.8189806148969446,0.7,0.9474036166706775,1.0,1/6,1.09%,PKD2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.3552126636525333,0.8188919438047993,0.8484848484848485,0.9470482110273613,1.0,7/36,17.32%,ACADS;ACOX3;ACADVL;GCDH;ECHDC1;ECI1;AUH
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.33544268650053827,0.8184591609787863,0.7894736842105263,0.9472054129017743,1.0,11/64,15.09%,NCAPH2;NSL1;BOD1;CENPE;TEX14;CHMP7;CDC23;SMC4;ZNF207;NIPBL;CHMP1A
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3723599883666155,-0.8183938441557285,0.7857142857142857,1.0,1.0,18/77,21.53%,FCER1G;HLA-DRB5;HLA-F;MFSD6;DCTN6;DCTN4;HLA-DRA;AP2S1;DYNC1LI2;HLA-E;HLA-DPA1;SEC13;HLA-DMB;CD74;HLA-DPB1;DCTN2;DYNC1I2;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.5106108632891068,-0.8180309188413717,0.7301587301587301,1.0,1.0,3/9,17.65%,CD55;CYBA;RAC1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.5033641474386679,0.8177238108124176,0.7021276595744681,0.9476436306188655,1.0,4/7,24.96%,NUMBL;CEP120;HOOK3;PCM1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.3866518708418465,0.8177028785254469,0.6216216216216216,0.9471445711367867,1.0,4/14,21.19%,PPT1;ATP6V0E2;TCIRG1;ATP6V0D1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.4722931829140619,-0.8176275704243462,0.7142857142857143,1.0,1.0,1/14,4.74%,APOD
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.4722931829140619,-0.8176275704243462,0.7142857142857143,1.0,1.0,1/14,4.74%,APOD
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.4284133394584068,0.8173560627694477,0.7058823529411765,0.9472150290740718,1.0,2/14,3.61%,PKD2;PKD1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.34461112576194086,0.8173207035183181,0.6944444444444444,0.9467455658417367,1.0,10/39,13.70%,LARGE1;B4GALT7;ST6GALNAC3;HPSE;PRKCSH;ST8SIA5;PCSK6;FBXO27;STT3B;ST8SIA4
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.37170663276713467,-0.8173104523360455,0.7619047619047619,1.0,1.0,6/60,8.39%,SRP14;FIS1;AQP11;NACA;ACBD5;ZDHHC4
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.42203349945239976,0.8172096480314848,0.7560975609756098,0.9463701516933327,1.0,3/17,9.07%,SIRT1;PPARG;PTCH1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3837354883002625,-0.8171834494323801,0.7534246575342466,1.0,1.0,10/44,13.26%,TPP1;STIL;MTHFD1;CTSB;GSTK1;STAT1;DVL1;KANK2;VEGFA;PGK1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.5084738634779143,0.8169667793135006,0.7142857142857143,0.9462971312611541,1.0,2/7,9.83%,ATRAID;NELL1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5083434694492416,-0.8167110600250234,0.74,1.0,1.0,1/8,1.56%,RPS21
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.4905182337537767,-0.8162730168316741,0.7230769230769231,1.0,1.0,1/7,3.76%,DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.4975856399286855,0.8160982677910718,0.6829268292682927,0.9473164241126089,1.0,1/9,3.73%,CDK10
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.3175206158033226,0.8158299062063855,0.84,0.9472142266056743,1.0,24/83,16.31%,PKD2;TGFBR2;PKD1;TSC2;HDAC9;SALL1;PDLIM5;TAB2;FLRT2;PTEN;SMYD4;KAT2A;LDB3;ALPK3;PDLIM7;NF1;HEG1;CACYBP;NIPBL;PTK2;TBX19;ERBB4;SOX4;MEGF8
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3673568045759898,0.8157713033743421,0.7441860465116279,0.9462425996777476,1.0,3/17,11.50%,ZDHHC3;GOLGA7;ZDHHC11B
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3673568045759898,0.8157713033743421,0.7441860465116279,0.9462425996777476,1.0,3/17,11.50%,ZDHHC3;GOLGA7;ZDHHC11B
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.556405286857914,-0.8156098145999245,0.7254901960784313,1.0,1.0,3/5,22.46%,OSMR;IL1B;PARK7
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.3005880562768987,0.8155153062007574,0.7647058823529411,0.9461268385201461,1.0,16/120,12.19%,PRKAB2;CDK5R1;MAPK11;CHD5;MTA2;NUAK1;TAF2;MDM2;ZNF385A;TAF9B;PRKAB1;HDAC1;CCNG1;SUPT16H;TAF3;PIP4K2A
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.32884368854241186,0.8154846668838979,0.8620689655172413,0.9456385983780399,1.0,9/62,16.49%,POLR2D;INTS6;POU2F1;CDK7;INTS7;CDK9;POLR2H;GTF2E1;RPRD2
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4281197345997856,-0.815468039268674,0.6833333333333333,1.0,1.0,4/11,16.86%,TNFRSF1B;TIMP2;SNX9;IL1B
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.5017769832073761,0.8154121554316848,0.6888888888888889,0.945222521567022,1.0,2/6,23.34%,PTK2;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.32045128778386484,0.8153688075192593,0.7941176470588235,0.9447496513140804,1.0,13/57,16.90%,SPRY2;TMEFF2;DNAJB2;IRAK3;AIDA;PEX5;DNAJA4;SORL1;DDX3X;RAPGEF3;TNF;GSK3B;ULK1
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.5296139348460925,0.8153609159550628,0.7777777777777778,0.9442272366314892,1.0,3/6,16.99%,DCC;ULK1;SEMA4D
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.3606048499721187,0.8153485723928066,0.7428571428571429,0.9437340052876381,1.0,9/39,14.95%,PKP4;SMAD7;CDH20;VCL;CDH11;CDH8;TJP1;ZNF703;CDH19
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.34033419646738666,0.8151989884763309,0.8387096774193549,0.9434985641650985,1.0,7/47,12.41%,NRP1;EPS8;ROBO1;KANK1;KCTD10;CCDC125;HEG1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.39186875108815955,-0.8148496218551518,0.6933333333333334,1.0,1.0,15/64,15.35%,PYHIN1;DDRGK1;RACK1;ELOB;CLU;ARIH2;HSPA1B;RNF144B;DVL1;RBX1;NOP53;CSNK1D;HSPA1A;RAD23A;DAB2
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.35223266841152756,-0.8145827870448742,0.7903225806451613,1.0,1.0,7/86,6.60%,JAML;EMB;SELL;MMP24;PECAM1;CLDN7;CDH23
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.3383071557660456,-0.8145602656335656,0.8356164383561644,1.0,1.0,23/116,12.99%,CD37;CXCR4;PPP1R15A;IL7R;PCSK1N;ABCB1;APOD;RGS16;IL10RA;FCER1G;JUP;PECAM1;F13A1;ERO1A;ETS1;CSF2RA;TNFRSF1B;EPB41L3;ITGB2;GALNT3;TNFAIP3;SPARCL1;ATG10
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.5396275586004726,-0.8145153699647966,0.7241379310344828,1.0,1.0,1/6,8.32%,COMT
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.5323182725563427,-0.8143258467491148,0.7547169811320755,1.0,1.0,1/6,12.00%,AMPD2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.36055887712042173,-0.8140138461945635,0.691358024691358,1.0,1.0,12/62,17.40%,CCL3;CCL5;ETS1;PLSCR1;IFI35;NLRP12;CD47;CYBA;TASL;IL1B;AGT;POLR3C
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.39478371202907664,0.8135785331775487,0.675,0.9456772129929858,1.0,3/23,10.71%,RRAGD;GLRA1;CPEB4
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.5011210184238963,0.8134973152734598,0.6585365853658537,0.9453124733459788,1.0,3/6,19.10%,KCNC2;GUCY1B1;FOXO1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.3887244591815728,0.8134277066535287,0.75,0.9448839398259427,1.0,1/19,1.80%,MSL2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.4546771432572081,-0.8131891805994661,0.7741935483870968,1.0,1.0,2/21,5.45%,CCL5;IL10RA
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.3623268771579192,0.8131128408992239,0.8055555555555556,0.9450333769932425,1.0,7/33,10.88%,ABCA2;SIRT1;RCN3;PPARG;ABHD8;ACOX3;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.5465911373695662,-0.8130542352902261,0.8,1.0,1.0,1/5,9.82%,TNFRSF1B
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.4250303275784039,0.8128471291504836,0.7837837837837838,0.944976006374999,1.0,4/12,13.57%,ADGRB2;SCN8A;NF1;NFASC
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.4388439314941147,0.8128299721576769,0.6590909090909091,0.9444629191589098,1.0,4/10,15.68%,SIRT1;DDX3X;RAPGEF3;GSK3B
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5183848756603946,-0.8127063950951798,0.7166666666666667,1.0,1.0,3/8,12.89%,ENPP3;ENTPD5;ENTPD4
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.5266881013637934,0.8125125438690988,0.6818181818181818,0.9444059306929645,1.0,2/5,13.91%,PPARG;PTK2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.49272378059936106,-0.8121504646288054,0.7166666666666667,1.0,1.0,3/9,16.10%,IRF7;SELENOS;NOD2
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.5235049595875271,-0.8119241171659916,0.7288135593220338,1.0,1.0,1/6,16.95%,DENND3
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.39017089319376475,0.8118116228136828,0.6216216216216216,0.9450603690576115,1.0,4/19,11.80%,DACH1;GNL3L;ERCC4;HNRNPC
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.5091676868219366,0.8109742023943723,0.7045454545454546,0.9461619874502669,1.0,3/6,32.21%,SNCA;CTTNBP2NL;NDFIP2
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.469999476738058,-0.8108652470053709,0.6909090909090909,1.0,1.0,3/13,11.49%,CD14;OAS1;ITGB2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.36980376506469015,0.8106670485191269,0.7380952380952381,0.9461538881269203,1.0,1/14,4.84%,SPIRE2
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.4166639893951376,-0.8104578699659369,0.7611940298507462,1.0,1.0,1/27,1.12%,ZFP36
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.39586644189742815,0.8099159967710247,0.7428571428571429,0.9469696016454998,1.0,1/12,1.90%,MAP1S
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.504366159501436,-0.8096688963233158,0.7872340425531915,1.0,1.0,1/8,6.78%,EXOSC10
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.504366159501436,-0.8096688963233158,0.7872340425531915,1.0,1.0,1/8,6.78%,EXOSC10
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.3113331933586444,0.809505603913908,0.90625,0.9471314095335922,1.0,3/78,1.86%,PPARGC1A;TBRG4;U2AF1
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.49643056034842103,-0.809496515078905,0.7627118644067796,1.0,1.0,4/8,18.17%,FCER1G;ITGAL;SLC11A1;CD74
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.4086922516260387,-0.8091514025023328,0.7878787878787878,1.0,1.0,3/31,9.54%,RIMS1;RAB3A;DVL1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.427377463495992,0.8090854003567073,0.7317073170731707,0.9473426945685577,1.0,10/19,25.14%,KCNIP2;KCNN2;WNK1;SLMAP;DPP10;DPP6;HOMER1;KCNIP4;WNK3;KCNE1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.49940587610600107,0.8090712247452172,0.6938775510204082,0.9468234829924483,1.0,4/7,23.97%,SCN3B;AHCYL1;SCN1B;WNK3
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2910370490202548,0.8090285935603903,1.0,0.9464040517767792,1.0,49/369,11.59%,KLF4;CDK5R1;GCLC;QARS1;SYNCRIP;ZBTB16;ZBTB33;SIRT1;DPF3;ZNF706;SPINDOC;NRG1;RNF139;CBFA2T3;SAMD4A;HDAC9;WNT5A;DACH1;SAMD1;FOXN3;TLE2;ZNF12;POU2F1;PPARG;HMGA1;SMAD2;DDIT3;RFX3;SALL1;MDM2;EIF4E2;CNOT7;MAP3K10;IKZF1;CLOCK;NACC2;HDAC1;CTBP2;SFMBT1;SLFN11;BTRC;TRERF1;PTPRK;ZBTB38;FBXW11;TWIST2;TCF7L2;TRAF6;RUNX1T1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.4737199902484747,0.8088539590028679,0.7209302325581395,0.9462471219998323,1.0,4/6,25.60%,RNF6;BARD1;UBE2D4;RNF4
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.3299203220268153,-0.8086757209927007,0.810126582278481,1.0,1.0,16/122,13.44%,IKZF3;TNFRSF25;PRELID1;USP36;CTSB;CLU;LGALS1;RPS3;TPT1;SGK1;TMEM219;STAT1;KANK2;APEX1;NOP53;BCL2L14
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.3621469703069112,0.808499391567978,0.7352941176470589,0.9461682256631737,1.0,4/23,11.06%,GOLPH3L;RAB10;GOLGA7;BLZF1
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.44338542122069047,0.8081922863231138,0.6666666666666666,0.9461177135964484,1.0,2/7,19.40%,RENBP;GNPDA1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.3520241093174609,-0.8075983068008072,0.7857142857142857,1.0,1.0,18/64,23.94%,SSNA1;ATF5;CEP164;NPM1;CEP72;CSNK1D;CENPF;PRKAR2B;TUBB4B;ATAD5;AKAP9;DCTN2;NINL;DYNC1I2;SFI1;HAUS5;TUBB4A;CEP250
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.4968037013107896,0.8074859651485811,0.6938775510204082,0.946915691243138,1.0,1/8,4.10%,LRRK2
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.31855157937849776,-0.8072565824958917,0.8904109589041096,1.0,1.0,26/200,15.58%,UBC;USP6;RPS27A;PSMB3;USP36;ADRM1;PSMA7;PSMB9;PSMB6;JOSD1;ACTB;ABRAXAS1;TNFAIP3;PSMA5;WDR48;PSMC4;PSMD8;HIF1A;OTUD6B;PSMD12;RAD23A;OTUD1;BRCA1;MINDY1;CFTR;PSME2
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.5558713628430362,-0.8072097331268248,0.8518518518518519,1.0,1.0,2/5,24.51%,IDH3B;IDH3G
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.5231406422592975,-0.8069342881801389,0.7358490566037735,1.0,1.0,2/6,13.96%,NCKAP1L;C3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.45286539840605167,-0.8064874454674262,0.7377049180327869,1.0,1.0,3/18,11.76%,AIF1;APOD;TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3529553513921013,-0.8062084391842284,0.8117647058823529,1.0,1.0,6/97,6.21%,PKIB;PRKCQ;CHTF18;EPHB1;DTX3L;MUSK
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.49626386203819817,0.8056804017820219,0.6578947368421053,0.9495783059017785,1.0,2/5,9.93%,CTNNA2;SHANK3
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.47915798582292685,-0.8051800201647314,0.7142857142857143,1.0,1.0,1/8,1.68%,PRLR
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.4487697405581336,-0.8051092914096946,0.7666666666666667,1.0,1.0,1/19,0.74%,CCL3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.433084024241704,-0.8049456302580069,0.6885245901639344,1.0,1.0,2/14,4.84%,SNX6;CBLB
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.34105634779349653,0.8049348083165888,0.78125,0.950408797516514,1.0,12/61,16.49%,POLR2D;U2AF1;CPSF4;WDR33;SSU72;PCF11;SCAF8;CPSF7;NUDT21;AHCYL1;PAPOLA;RPRD2
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.4959434519604873,-0.8048358043605005,0.7878787878787878,1.0,1.0,2/8,19.89%,NCKAP1L;MED1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.49605155650143445,0.8046941834983702,0.6486486486486487,0.9503489932035729,1.0,1/7,5.71%,PARP1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3727520478975181,-0.8045998731037147,0.7361111111111112,1.0,1.0,6/47,10.44%,RACK1;RAB11A;KLHL13;ENTR1;CALM1;EFHC1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.4904850783439616,0.8045858276446203,0.7272727272727273,0.9500352876944195,1.0,1/7,1.19%,GCLC
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.34220353171128964,0.804563960972615,0.75,0.9495315585701214,1.0,3/31,5.82%,ZNF598;UBE2O;UBE3D
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.5075569518295936,-0.8044214718133639,0.7083333333333334,1.0,1.0,2/7,15.49%,IRF1;HLA-E
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.36620964638302034,0.8042357944485343,0.7142857142857143,0.9495639468581271,1.0,8/34,18.76%,CDK5R1;TOGARAM1;SLAIN2;DYRK1A;CLASP1;CAMSAP2;MAP2;SNCA
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.29290706593482496,0.8036173054532564,0.8421052631578947,0.9501386079145822,1.0,26/141,16.99%,LEPR;ACVR2A;FGF2;SIRT1;LRRK2;KNDC1;CIB1;RAMP1;DVL3;NPTN;TMEM119;HGF;DYRK1A;UBE2N;GPNMB;NTRK2;PTK2;DDX3X;RAPGEF3;PTPA;ERBB4;TNF;CCND3;WDFY2;AKT2;SEMA4D
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.3652579799365657,0.8033685458080737,0.725,0.9501354302269797,1.0,12/26,23.97%,SCN3B;NEDD4L;FXYD5;AHCYL1;NEDD4;CHRM3;FXYD7;HOMER1;SCN1B;YWHAE;RIPK1;WNK3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.3362034284186153,-0.803076207611419,0.8554216867469879,1.0,1.0,21/125,19.72%,UBXN1;HUS1;DTX3L;PARP9;XRCC3;BRCA2;CYREN;POLM;PARP2;ABRAXAS1;BRIP1;NABP1;RPA3;SLX4;KAT5;BRCA1;POLQ;RECQL5;WRN;HPF1;ZSWIM7
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.35236037891834066,-0.8028122863143046,0.8311688311688312,1.0,1.0,10/77,12.30%,ABCB1;FIS1;GNPAT;GSTK1;ACAA1;SLC25A19;ESR2;SOD1;ECI2;ABCB4
prerank,MSigDB_Hallmark_2020__Apical Junction,0.28954603716429733,0.802578922322997,0.9230769230769231,0.9509272339401241,1.0,25/123,14.79%,COL16A1;MSN;CERCAM;MAPK11;PKD1;VASP;SIRPA;BMP1;VCL;CDH11;CADM2;MPZL1;PTEN;NEGR1;CDH8;NF1;TJP1;ITGA2;NRXN2;NFASC;CD276;PTK2;SKAP2;MVD;CDH4
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4412828536040292,-0.8024390573884009,0.7368421052631579,1.0,1.0,5/17,24.96%,USP36;CSNK2A2;PINK1;PARK7;SREBF1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.48052557859293266,-0.8022477961923419,0.7619047619047619,1.0,1.0,2/10,24.47%,PSMC4;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.30075889263352457,-0.8021297422654934,0.978021978021978,1.0,1.0,47/564,9.98%,NR4A3;MYBL1;IL4I1;UBC;SKAP1;BCL11B;FOSL2;PID1;RPS27A;FOS;JUNB;USF1;BEX1;TAF6L;RORA;CHCHD2;DDRGK1;CSRNP1;ZNF335;TXK;EIF5A;NLRC5;ATF5;JUP;JMJD6;IGF1;NR1H2;ITGA6;ETS1;IRF7;MED25;NPM1;VENTX;PRKD2;ZNF76;PLAG1;NAMPT;RBPJ;RNASEL;STAT1;CITED2;DVL1;IER2;IRF1;ZNF513;PLSCR1;MLX
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.4421440912470323,-0.8020207452753971,0.7230769230769231,1.0,1.0,3/16,16.86%,GADD45B;VEGFA;IL1B
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.42309006386772086,0.8019980874625802,0.6458333333333334,0.9513736301444918,1.0,3/8,15.31%,PLPP1;PARD3;PRKD3
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.5118727229862147,-0.801902411969609,0.7678571428571429,1.0,1.0,1/5,4.81%,RACK1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.38562704481753596,-0.8017245907418594,0.7571428571428571,1.0,1.0,5/32,10.34%,GABARAPL1;FIS1;PHB2;GABARAPL2;ATG2A
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.47573665177702146,0.8015871918376148,0.6410256410256411,0.9515665463571289,1.0,4/7,24.28%,MAP2K1;MAP2K2;RIPK1;TGFB1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.45217756792841557,-0.8013155499510998,0.75,1.0,1.0,3/15,15.17%,ZNF335;DNMT1;BRCA1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.515347319030847,-0.8012535428370212,0.7586206896551724,1.0,1.0,1/6,7.25%,IQSEC1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.515347319030847,-0.8012535428370212,0.7586206896551724,1.0,1.0,1/6,7.25%,IQSEC1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.3413210236253567,-0.8009455666814629,0.8589743589743589,1.0,1.0,17/148,12.17%,FLNA;ARL5C;TSPAN32;RAB3A;JUP;RAB11A;TMEM150A;NLGN2;RAB3D;TM9SF2;DVL1;EPB41L3;EFR3B;ITGB2;PTN;ITGAL;ITGA4
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.3433504853792203,-0.8008192785356665,0.7922077922077922,1.0,1.0,20/88,22.97%,TPD52;CD63;NAPA;GLA;SOD1;GOLGA4;AP2S1;COPE;IGF2R;ATP1A1;SCAMP3;YIPF6;SSPN;STX12;GALC;ICA1;RAB9A;CLTA;BNIP3;ERGIC3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.36445121347238535,-0.8008000578113449,0.7972972972972973,1.0,1.0,8/48,17.26%,TNFSF10;IGF1;ITGA6;GSTP1;CFLAR;BCL2L14;DEDD2;AGT
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.3838108806591731,0.8007506790950832,0.7105263157894737,0.9524054202275275,1.0,6/13,21.36%,RAP1A;SORT1;NTRK2;RAPGEF2;ZFYVE27;FRS2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.3210035517900866,0.8001718146135904,0.75,0.9530047006407361,1.0,6/59,8.92%,ANXA1;HIP1R;SIRPA;MERTK;BOK;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.4065416436434081,-0.7999213298651301,0.7534246575342466,1.0,1.0,2/27,3.00%,DYNLT1;B2M
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.3344069396111256,0.7998948849143225,0.7878787878787878,0.952894719824946,1.0,17/56,17.91%,CACNA1A;MCU;RAP1A;RFX3;KCNC2;CLOCK;STX1A;TCF7L2;CACNA1E;RAPGEF3;ABCC8;EPHA5;TNF;SOX4;TM7SF3;PPP3CB;KCNB1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.37574227355209944,-0.7997616890146251,0.7611940298507462,1.0,1.0,4/37,9.96%,HAMP;RACK1;NR1H2;PLSCR1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.4667879382625887,-0.7996570732745225,0.7285714285714285,1.0,1.0,5/12,26.49%,RACK1;ORMDL1;SMPD3;NSMAF;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.5183804907132148,0.7995028782181526,0.6190476190476191,0.9524508594798056,1.0,2/5,5.77%,SERPINE1;HPSE
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.5183804907132148,0.7995028782181526,0.6190476190476191,0.9524508594798056,1.0,2/5,5.77%,SERPINE1;HPSE
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.3629297835009518,0.7994611544355679,0.6285714285714286,0.9520051567211925,1.0,5/31,13.96%,NRP1;NLGN1;GPM6A;FNBP1L;ARF6
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.49356047792606994,-0.7993180731523668,0.7377049180327869,1.0,1.0,1/6,6.43%,NR1H2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5082360460130577,-0.7993100992071254,0.7543859649122807,1.0,1.0,2/7,18.30%,CACNB1;NOS1AP
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.5459890878317433,-0.7992723610507648,0.7777777777777778,1.0,1.0,1/5,12.53%,WDR48
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.5267126160053354,-0.799233716353896,0.8,1.0,1.0,1/7,0.09%,NR4A3
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.40014461426586956,-0.7989095320658263,0.8055555555555556,1.0,1.0,7/33,12.60%,CALCR;CGNL1;SLC6A16;S100A6;ITGA4;ABCA8;A2M
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.32632171462234294,0.7989079744115047,0.64,0.9523719975082794,1.0,9/45,13.56%,FER;PKD2;SIRT1;CAT;STK25;PTPRK;MAPK1;SOD2;PTPRN
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.39239271797464087,-0.79888633357704,0.8125,1.0,1.0,12/28,28.00%,CHTOP;SOD1;AZIN2;MT3;NOD2;WRN;MSH6;STX4;YWHAB;MAPK3;SSBP1;MSH3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.32938099123637654,0.7988536619082156,0.8846153846153846,0.9519548132243235,1.0,9/61,16.49%,POLR2D;INTS6;POU2F1;CDK7;INTS7;CDK9;POLR2H;GTF2E1;RPRD2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.33737172403841903,0.7986012607607996,0.7,0.9518877260620897,1.0,24/76,21.78%,FER;IGF1R;ACVR2A;RYK;MERTK;EPHA6;MPZL1;PTPRD;SHC2;NPR2;NTRK2;PTK2;PTPRG;EPHA5;ERBB4;ABI1;TYRO3;FGFR1;FGFR2;LCP2;MTSS1;FRS2;FGFR3;SYK
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.4991094112570682,0.7985772559629042,0.725,0.9514153521721328,1.0,1/7,0.83%,FAAH
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.485668379597898,0.7981270759601229,0.8,0.9517467869129927,1.0,4/8,28.77%,P2RY12;P2RX7;HSP90B1;P2RX4
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.39760207077787313,-0.7979922991059616,0.7794117647058824,1.0,1.0,6/47,9.54%,RIMS1;RAB3A;SLC38A1;GLUL;SLC6A16;DVL1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.5267498447483299,-0.7972687424086925,0.75,1.0,1.0,2/5,30.58%,DHX36;PKM
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.5153435620605729,0.796936004626574,0.7560975609756098,0.9531390200572372,1.0,3/5,34.49%,LRRC8D;ABCC5;ABCC4
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.4675824267612977,0.7961230047203777,0.6578947368421053,0.9540482829233394,1.0,1/5,13.47%,NIPBL
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.3987165846496176,-0.7956415928782384,0.7941176470588235,1.0,1.0,3/32,9.54%,RIMS1;RAB3A;DVL1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.39988933177796193,-0.7956308717583088,0.7575757575757576,1.0,1.0,2/26,1.57%,UBC;RPS27A
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.39004698989664416,-0.7954345779911121,0.7878787878787878,1.0,1.0,4/42,7.25%,CXCR4;PRKCQ;TTN;IQSEC1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.511777263065187,0.7953971595969987,0.7209302325581395,0.9547054991237005,1.0,1/5,13.79%,MTMR9
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.44331675646778257,-0.794909842356525,0.6949152542372882,1.0,1.0,3/12,16.03%,CD63;VEGFA;PICK1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.48327045510552674,0.7948695753510239,0.65,0.9550204731321421,1.0,3/5,25.00%,PTPRK;FGFR2;KLF9
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3455110598047058,-0.7947436056148891,0.8108108108108109,1.0,1.0,10/70,14.25%,CCL5;PARP14;PECAM1;IGF1;PARP9;ENPP2;CD44;BANK1;VEGFA;PTPRC
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.44733587500980204,0.7947360851251496,0.6382978723404256,0.9547708508462013,1.0,3/9,17.52%,TRERF1;UBE2L3;NR3C1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.4599298010586956,-0.7944336664511078,0.7407407407407407,1.0,1.0,4/15,26.62%,ING4;KAT8;KANSL1;OGT
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.4599298010586956,-0.7944336664511078,0.7407407407407407,1.0,1.0,4/15,26.62%,ING4;KAT8;KANSL1;OGT
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.3464280030235383,-0.7940543256638735,0.7837837837837838,1.0,1.0,7/88,11.76%,CCL3;ARHGAP4;RHOU;SEMA6A;CFL1;EPB41L3;TNFAIP3
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.4013029826902211,0.793770516009982,0.7058823529411765,0.955900032184772,1.0,4/11,23.51%,SYT17;SYT4;SNCA;DTNBP1
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation (GO:0033004),0.5116060939824666,0.7933843346603399,0.6842105263157895,0.9560259606046003,1.0,1/6,1.07%,FER
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.37259968545518224,0.7930456385710613,0.7878787878787878,0.9560126579572515,1.0,8/20,21.76%,VCL;P2RY12;SRGAP2;ARHGEF6;ARHGEF4;PTPRO;CDH13;ABLIM1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.38699684898623726,0.7928595106115798,0.6944444444444444,0.9558186463275694,1.0,6/17,24.85%,SLC26A3;SLCO2B1;SLC17A5;SLC13A3;LRRC8D;SLC4A2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.498016477006843,0.7927112718685472,0.725,0.9545022836717889,1.0,2/5,24.81%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.498016477006843,0.7927112718685472,0.725,0.9545022836717889,1.0,2/5,24.81%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.498016477006843,0.7927112718685472,0.725,0.9545022836717889,1.0,2/5,24.81%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.4632793996597896,-0.7926613226838404,0.75,1.0,1.0,3/8,27.17%,NCBP2;LEO1;DHX36
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.34090983406978637,0.7924980799308075,0.8333333333333334,0.9543441936229011,1.0,13/60,10.99%,TGFBR2;ZBTB16;YJEFN3;WNT5A;JAG1;WNT2B;SELPLG;ARMC6;KITLG;RUNX1;CD164;PRKX;CDK13
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.461787613333491,0.79170584010539,0.6382978723404256,0.9551428947336902,1.0,1/7,5.41%,SLC41A1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.3930515762247728,0.7913307789396942,0.75,0.9552756155355294,1.0,3/15,4.10%,NLGN1;RAP1A;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.43642396605961625,0.791218966885353,0.7560975609756098,0.9549234771558118,1.0,1/12,0.36%,ANXA1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.3441014918947904,-0.7911769870558906,0.8529411764705882,1.0,1.0,23/84,19.72%,ZCRB1;DHX16;SNRPD2;RNPC3;WDR83;SRPK1;PDCD7;NCBP2;ZRSR2;DDX23;SRSF7;SMNDC1;PRPF3;USB1;SRSF2;SNRPA1;SLU7;SCNM1;PRPF4;LUC7L3;NRDE2;LSM4;SF3A3
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.44803636714578404,-0.7907280298155177,0.7,1.0,1.0,4/12,26.47%,LILRB4;EZR;PTPN2;PTPN22
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.32666499556336137,0.790393868954796,0.8214285714285714,0.9559074248867556,1.0,5/56,7.63%,POLR2D;NUP153;NUP188;PPARG;NUP42
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.45078249241442403,0.790225253651171,0.5833333333333334,0.9557074996961878,1.0,4/7,28.43%,BMPR1A;SOX4;ACVR1;NOTCH1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.37476137055075265,0.790109881210308,0.7714285714285715,0.9553902658770531,1.0,5/20,19.57%,AK6;NUDT13;NME4;GLRX;DUT
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.42103088311188985,0.7899829967729181,0.71875,0.9550111900164971,1.0,1/16,0.66%,HS3ST5
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.3543826474551416,0.78977184872827,0.78125,0.954749922451632,1.0,7/42,8.12%,SLC7A8;SLC1A3;SLC3A2;SLC25A18;SLC39A8;SLC1A2;SLC25A21
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.49849146075302353,-0.789736920580288,0.7272727272727273,1.0,1.0,2/8,11.20%,GSTP1;SELENOS
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.38978600163435695,-0.7895096118094163,0.8059701492537313,1.0,1.0,2/27,8.13%,PPP1R15A;CALM1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.4797172722937342,-0.789115304069123,0.7704918032786885,1.0,1.0,5/9,24.03%,TNFAIP3;NCKAP1L;PPP2R3C;CAMLG;LYN
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.41494525303652485,-0.7890604823080061,0.7868852459016393,1.0,1.0,2/17,11.81%,PPP1R15A;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.40182865776658316,-0.788945937498075,0.7333333333333333,1.0,1.0,6/23,20.63%,CD63;VEGFA;ANKRD13D;PICK1;FLOT1;LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.5139299383327856,-0.7887679209511327,0.7962962962962963,1.0,1.0,2/5,16.03%,CORO1B;PICK1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.4260074418245984,-0.7885248020101417,0.8225806451612904,1.0,1.0,8/21,24.03%,PRELID1;AIM2;FYN;PSME2;APH1B;PSME1;PSME3;LYN
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.32365324788143307,0.7881940294850951,0.88,0.9568701386062358,1.0,8/42,11.35%,IGF1R;QARS1;MAP2K1;PHLPP1;STK25;KLHDC10;LGALS9;MAPK1
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.3273904596697182,-0.7880944897526656,0.8732394366197183,1.0,1.0,7/82,8.53%,RIPOR2;CCL5;CXCR4;DUSP1;PRKD2;PPP1CB;CYTIP
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.4393698528623791,-0.7880657963931276,0.7333333333333333,1.0,1.0,2/13,12.54%,ZNF335;VEGFA
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.478948505540358,0.7877784517617358,0.6792452830188679,0.9570565382460667,1.0,2/5,10.88%,HPN;FBXW7
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.4094400749931656,-0.7877235927177816,0.746268656716418,1.0,1.0,2/23,9.41%,PID1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.5044999384886525,0.7876952856886564,0.7045454545454546,0.9566911705142066,1.0,2/5,27.65%,NIPSNAP2;CACNA2D1
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.5041964306665335,0.7875036328834709,0.7619047619047619,0.9564984686434433,1.0,1/5,0.83%,FAAH
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.4955480537165692,-0.7874451750533162,0.7169811320754716,1.0,1.0,3/5,18.77%,SELENOS;PASK;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.4955480537165692,-0.7874451750533162,0.7169811320754716,1.0,1.0,3/5,18.77%,SELENOS;PASK;INPP5K
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.40240388053361115,-0.7874254617738707,0.7424242424242424,1.0,1.0,7/24,24.62%,LILRB4;TYROBP;CD47;NOD2;CLEC7A;HLA-DRB1;LILRB1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.46300111781544856,0.7873746310012846,0.7209302325581395,0.9561820063665574,1.0,2/7,10.15%,TMEM119;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.4440437395458588,-0.7872337382309905,0.8064516129032258,1.0,1.0,3/15,9.82%,RIMS1;NLGN2;TNFRSF1B
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.30711514749238444,-0.7870648374608116,0.9518072289156626,1.0,1.0,17/207,12.46%,FLNA;RPGRIP1L;BBOF1;BBS2;SSNA1;RAB11A;MAK;IFT46;CEP164;TBC1D32;DYNC2I1;DZIP1L;CEP72;TMEM138;TMEM67;IFT81;IFT27
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.4208481683210214,-0.7865977208264894,0.8448275862068966,1.0,1.0,3/18,8.95%,TGFBR3;MYBPC3;RBPJ
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3086004564118379,0.7864481848542251,0.896551724137931,0.9573114033208306,1.0,7/70,10.88%,UBE2D1;NEK10;ANAPC16;CDC23;BTRC;FZR1;FBXW7
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.33933260507253243,0.7859931723877661,0.7666666666666667,0.9575177017799611,1.0,7/37,17.89%,NUP153;NUP188;NUP42;RUBCNL;NUP133;NDC1;NUP205
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.4017336380279258,0.7859047842932685,0.7837837837837838,0.9571461938635935,1.0,2/13,6.71%,CPSF4;ZBTB8OS
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.4209557621951631,-0.7857327625321534,0.7580645161290323,1.0,1.0,8/23,14.32%,ETS1;HSPA1B;STAT1;ANKRD54;NCKAP1L;ZNF16;HIF1A;HSPA1A
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.31091981107716554,-0.7854350722549882,0.9024390243902439,1.0,1.0,38/272,18.44%,USP6;CD36;TFRC;ARL5C;ARL4C;SNX6;BBS2;RAB3A;CLU;IL10RA;ATP6V1F;VPS35;NPM1;NAPA;ARL17A;EIF2D;RAB3D;STX19;ADPRH;GOLGA4;IFT27;STX10;TRIM23;VLDLR;DENND10;TBC1D17;CENPF;TBC1D2B;SEC13;PICK1;SNX9;TMEM167A;TBC1D8;SLU7;AP4M1;SCAMP3;CD74;VPS26A
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.49366806666856855,-0.7849139567490593,0.7288135593220338,1.0,1.0,1/5,13.67%,DHODH
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.3663435215383129,-0.7848042264359016,0.7671232876712328,1.0,1.0,3/46,2.56%,UBC;RPS27A;SNX6
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.4560238954255348,0.7847318991565694,0.717948717948718,0.9585618835694248,1.0,3/7,20.89%,LGALS9;BMPR1A;CD46
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.39581252196809713,0.7845989134377647,0.7142857142857143,0.9582451623562948,1.0,4/14,15.57%,KCNJ2;SLC12A6;SLC12A2;SLC12A5
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.4387467332720014,-0.7844852267815169,0.8548387096774194,1.0,1.0,3/17,10.08%,COL18A1;PECAM1;GSTM3
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.4160872938341356,-0.7842824104857018,0.8285714285714286,1.0,1.0,2/29,7.52%,EPN1;RNF126
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.3269220496703595,-0.784076615071682,0.8518518518518519,1.0,1.0,18/106,11.51%,XPA;PPP1R15A;EMD;SSB;PAQR3;BBS2;DDRGK1;RPL11;CYB5A;OBSCN;RAB11A;VPS35;MTCH2;DVL1;GABARAPL2;WASHC2A;GBP2;CNEP1R1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.4058272648396919,-0.7836185712881799,0.7714285714285715,1.0,1.0,1/21,4.73%,ZNF335
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.39535974483974,-0.783616304641111,0.8,1.0,1.0,10/30,19.86%,CCL5;DHX58;PLSCR1;IFI35;CYBA;LY86;TASL;POLR3C;DDX60;GBP5
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.4094754037900181,0.7834468014871484,0.675,0.9597891710217571,1.0,4/16,7.86%,GSN;HIP1R;MYADM;KANK1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.41518382681211197,-0.7834243710142755,0.7540983606557377,1.0,1.0,1/18,2.44%,PPP1R15A
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.3408243900892749,0.7832599702437186,0.8378378378378378,0.9596024935983218,1.0,1/32,0.65%,NRP1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.3555685972352636,0.7830047257674175,0.8888888888888888,0.9594708770106839,1.0,4/36,8.20%,PDK4;ABCA2;TBC1D16;ACACB
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.4181772644584914,0.7828678631314661,0.696969696969697,0.959216032601826,1.0,1/11,2.88%,DGUOK
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.39237423304928587,-0.7828525570160392,0.8387096774193549,1.0,1.0,2/16,7.77%,ING3;MSL3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3315431986744647,0.7828205150065041,0.8611111111111112,0.9587422564949161,1.0,3/31,6.54%,SERPINE1;FEM1B;TNFRSF10A
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.42888174159130354,-0.7825671060937658,0.7878787878787878,1.0,1.0,3/17,17.26%,TNFSF10;DEDD2;AGT
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.39101595276167156,0.7825601873160303,0.7692307692307693,0.9587071640987308,1.0,1/14,1.13%,ZBTB1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3795644670121172,0.7825368039870868,0.7142857142857143,0.9582204832763112,1.0,4/18,14.42%,RUVBL2;TCP1;NAF1;CCT3
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.33561870361445506,-0.782347190853181,0.8311688311688312,1.0,1.0,15/96,15.58%,PSMB3;JUP;PSMA7;TRPM4;PSMB9;PSMB6;GPC3;CSNK1G2;PSMA5;PSMC4;PSMD8;CSNK1D;PRDM15;PSMD12;PSME2
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.28663998831892473,0.7822019562051299,0.9411764705882353,0.9582951345452677,1.0,58/304,18.12%,PPARGC1A;VAPB;PKD2;ATAD3B;FGD4;GOLPH3L;LRRK2;TOR1AIP2;SYNE3;CSPG5;TFB1M;TMED3;PARP1;SORT1;TMED5;LMAN2L;ARAP3;TMED10;MAST2;AUP1;LIG4;WDPCP;RAB7A;ZRANB1;CHMP7;MAST3;BLZF1;COG1;BAG5;FNBP1L;NCKIPSD;PEX11B;ATAD3A;MARK1;PRKCI;STRIP1;CLUH;ESRRA;PLEKHM2;NRF1;CHMP1A;UBXN2A;COG3;CLASP1;RAB14;PPRC1;MAST1;BRWD1;SEC31A;GABPB1;CENPT;CLASP2;TRAPPC8;SEC31B;TRAPPC12;ALAS1;NIPSNAP2;PCLO
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.29439664711914904,-0.7815533015510758,0.9534883720930233,1.0,1.0,23/281,10.69%,MYBL1;PPIE;PRKCQ;RUNX3;CHD3;EDF1;TAF6L;RORA;BHLHE40;OGG1;ATF5;ZNF331;TRIM22;BRCA2;MSL3;PLAG1;RPL6;HINT1;DVL1;MLX;ESR2;REXO4;TCF3
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.3760428817613424,-0.7812122309507813,0.7297297297297297,1.0,1.0,10/36,16.15%,MGLL;GSTM4;GSTP1;EPHX1;ACAA1;FAAH2;GPX4;GPX1;FADS2;ALOX12
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.4208359625945226,-0.7809894852292726,0.7857142857142857,1.0,1.0,4/18,14.03%,LIPG;ACBD5;ENPP2;MT3
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.4042654820563346,-0.7809530938834456,0.7931034482758621,1.0,1.0,2/20,6.08%,RIMS1;NLGN2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.4891246812145919,0.7808171501728418,0.7115384615384616,0.9599008553340307,1.0,2/5,4.41%,PKD1;WNT5A
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.3492124043255277,-0.7805201390919234,0.7910447761194029,1.0,1.0,4/35,8.42%,TFRC;HDGF;EIF5A;HNRNPAB
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.36024266236111,-0.7804200625883877,0.85,1.0,1.0,14/69,15.35%,DDRGK1;RACK1;ELOB;CLU;ARIH2;HSPA1B;RNF144B;DVL1;RBX1;NOP53;CSNK1D;HSPA1A;RAD23A;DAB2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.4132018666437941,-0.7801306782871684,0.8387096774193549,1.0,1.0,4/20,20.96%,CITED2;GSTM3;BRCA1;WBP2
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.47295840456944793,-0.7798626427819537,0.7818181818181819,1.0,1.0,2/8,10.91%,TRIM5;TRIM13
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.3189003126963181,-0.779744243335494,0.8142857142857143,1.0,1.0,15/82,16.86%,UBC;RPS27A;PSMB3;PSMA7;PSMB9;PSMB6;RBX1;PSMA5;PSMC4;PSMD8;PSMD12;PSME2;NOD2;UBA52;IL1B
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.48702085876588397,0.7793921286442468,0.75,0.9615868388900747,1.0,2/5,11.86%,SIRT1;DIPK2A
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.4720595206605768,0.7789194410813565,0.7391304347826086,0.9617619917931415,1.0,1/5,15.24%,CDK9
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.4196934362808582,0.7789137334969533,0.6923076923076923,0.9612545050903492,1.0,4/7,21.83%,GABRA4;GABRG3;GABRA2;GABRB2
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.46746644398130544,-0.7784195305756182,0.75,1.0,1.0,3/8,12.99%,SELENOS;TMCO1;ATG10
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.40925121265729864,-0.7782623986841147,0.7910447761194029,1.0,1.0,4/23,16.94%,CD14;CD300LF;TNFAIP3;GRAMD4
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.31775437050468025,0.777066397078722,0.8214285714285714,0.9634349857080153,1.0,4/42,4.10%,HIP1R;EPB41;PKD1;LRRK2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.34633974036625187,0.7769207433977965,0.8125,0.9631657506048455,1.0,6/37,14.49%,DAPK2;DDIT3;BOK;P4HB;SGMS1;DDX3X
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.41805857762216514,0.776653437691959,0.813953488372093,0.9631625330753516,1.0,6/13,25.29%,DROSHA;HENMT1;MRPL44;AGO1;TSN;CELF1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.41949741560116327,0.7764414831312996,0.7142857142857143,0.9630094999473977,1.0,2/12,7.46%,LRRK2;TXNDC12
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.40873551360715266,-0.7763430018833872,0.7818181818181819,1.0,1.0,1/25,0.82%,RIC3
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.4795451097306073,-0.7761762751989938,0.7377049180327869,1.0,1.0,3/8,8.82%,TRIM5;IFITM3;LY6E
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.512506952241151,-0.7761240008789544,0.8214285714285714,1.0,1.0,3/5,19.52%,CD44;IL1B;RAC2
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.40277457775043907,-0.7758927503218782,0.7727272727272727,1.0,1.0,4/20,11.48%,VAV3;LAMTOR5;PLEK;LARS1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.49294042157197704,0.7755922587641557,0.8,0.9639864798451107,1.0,3/6,32.88%,SMC6;SIRT2;RAD18
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.4308189137002898,-0.7753374742021929,0.7966101694915254,1.0,1.0,7/19,31.96%,ZNF76;POLR3C;DHX36;POLR3F;PRDX5;MAF1;ZC3H8
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.4425220661215343,-0.7752630533194634,0.7246376811594203,1.0,1.0,3/13,12.26%,DDRGK1;ATG2A;STING1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.4269565198989099,0.774740094378974,0.6875,0.9648535750514912,1.0,2/10,6.24%,ACER2;PPT1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.4616619952737778,-0.7746619296615478,0.7321428571428571,1.0,1.0,3/10,8.82%,TRIM5;IFITM3;LY6E
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.4724975470217712,-0.7741983559897594,0.7727272727272727,1.0,1.0,3/6,24.62%,TYROBP;NOTCH2;LILRB1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.4507787271028776,0.7739928986358028,0.7619047619047619,0.9655225732626741,1.0,3/7,22.51%,LGALS9;RAPGEF2;CXCL12
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.2865687265918951,0.7739160426990451,0.9615384615384616,0.9651307686103973,1.0,9/71,11.68%,ZBTB1;RUVBL2;CASP9;CAT;PARP1;EIF2S1;BRSK1;PTPRK;ERCC4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.5386693298848573,-0.7738234530839653,0.8,1.0,1.0,3/5,26.54%,NPM1;ADAR;ADARB1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.35451340311725626,-0.7735322010329143,0.8414634146341463,1.0,1.0,2/60,1.60%,CALCR;CXCR4
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.46256628073556455,0.7734744802170572,0.7083333333333334,0.9652963114462355,1.0,1/6,2.73%,UHRF2
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.5210497079078207,-0.7732635099276939,0.8035714285714286,1.0,1.0,2/5,27.17%,EFNB2;DHX36
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.4301766848880978,-0.7726712365388845,0.7894736842105263,1.0,1.0,1/16,2.05%,IFIT1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.3020898649300452,0.7726433129550491,0.9354838709677419,0.9660386770522366,1.0,11/67,13.55%,SRCIN1;QARS1;SPRED1;TSC2;GNAQ;CEP85;DEPTOR;YWHAG;SORL1;NF1;SLC8A1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.4485547223090589,0.7723992599536775,0.7647058823529411,0.9659321766679929,1.0,4/8,12.57%,NLGN1;SHANK3;PTEN;NRXN2
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.481658522720563,-0.7718368204628308,0.7962962962962963,1.0,1.0,3/8,27.48%,C3;C1QB;C1QC
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.3513410632693782,-0.7716062974924058,0.8285714285714286,1.0,1.0,10/35,23.95%,RBM22;BUD23;U2AF2;HSPA1A;DDX5;IL1B;PNPT1;ERN1;HEATR1;NMD3
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.43825382240306116,0.7713997265274076,0.7142857142857143,0.9671819911164111,1.0,1/8,1.60%,SEMA5A
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.4573802968752526,-0.7712270868935401,0.7575757575757576,1.0,1.0,1/10,1.65%,EMB
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.3034986182899188,-0.7709877767562963,0.9102564102564102,1.0,1.0,28/180,15.52%,CCDC88C;PID1;TFRC;WARS1;CARD14;MARCO;PAQR3;RACK1;PECAM1;TTN;MUSK;NPM1;ANKRD54;FYN;AKAP8;ITGB2;PRR5L;ATF3;SOD1;VEGFA;NOP53;CSNK1D;C3;CCND1;MT3;TERF2IP;DAB2;FGF20
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),-0.4444415850112088,-0.7705814523292686,0.7457627118644068,1.0,1.0,3/9,9.54%,NLGN2;C5AR1;DVL1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.472576562574,0.7698847637620936,0.7435897435897436,0.968986225475592,1.0,1/7,1.13%,ZBTB1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.30502698906351183,0.7698001765210805,0.875,0.9685667349132382,1.0,11/98,8.94%,ZBTB1;RUVBL2;DR1;SIRT1;ARID1A;SETD7;TCF7L1;MTA2;HP1BP3;SATB2;HDAC1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.5109074079399258,-0.7697640862759113,0.8181818181818182,1.0,1.0,2/6,18.77%,PPP1R3B;INPP5K
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.42775267111996007,0.769676306037079,0.75,0.9682695533256387,1.0,1/11,4.32%,AUTS2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.4016949342326241,0.7690984041539273,0.775,0.9686222830265013,1.0,5/12,23.14%,PARP1;ERCC4;NBN;ERCC1;TNKS2
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.4931595106552506,-0.7688498688868136,0.8181818181818182,1.0,1.0,2/5,6.32%,TMSB10;TMSB4X
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.49595628582674844,-0.7686647682774909,0.7368421052631579,1.0,1.0,3/6,26.96%,IL1B;IL18;CARD9
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.38135372682011504,-0.768465756086045,0.7941176470588235,1.0,1.0,3/31,5.97%,LPCAT1;DDHD2;GNPAT
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.42710170107706213,0.7683451579917332,0.6744186046511628,0.969245160498142,1.0,3/10,19.76%,HDAC1;ANKRD11;FGFR2
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.4699133137776361,0.767850231034019,0.717948717948718,0.9694956079266811,1.0,3/6,9.06%,SIRT1;PPARG;CTBP2
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3708450744441041,0.7674881321138309,0.7931034482758621,0.9695904049481254,1.0,2/20,4.58%,PKD1;CTSC
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.40553653676932633,-0.7672227644225748,0.8,1.0,1.0,2/28,4.13%,TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.516171720631565,-0.7671192943517482,0.7636363636363637,1.0,1.0,2/5,17.91%,EGLN3;P4HA3
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.4293849868416101,0.767035323598673,0.6585365853658537,0.9697728816279756,1.0,1/7,2.49%,GAB1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4136194130485845,-0.7668136372722174,0.7894736842105263,1.0,1.0,2/11,13.67%,TYMP;DHODH
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3948257402115546,-0.7667832646275496,0.8285714285714286,1.0,1.0,6/30,20.80%,HUS1;APEX1;RPA3;TERF2IP;WRN;CTC1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.36600080444837174,0.7667485918897018,0.7631578947368421,0.9696852159195551,1.0,3/23,4.21%,PKD2;SLC7A8;SLC3A2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.41162401189877373,-0.7666227391878503,0.8125,1.0,1.0,2/26,4.13%,TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.40553231256562255,0.7665239713181331,0.7906976744186046,0.9694694846918736,1.0,2/16,8.71%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.46130734652814875,-0.7651966910837698,0.7017543859649122,1.0,1.0,2/8,11.51%,NR1H2;CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.45538941227658053,0.765157983259284,0.8780487804878049,0.971182080314644,1.0,1/9,6.18%,DDIT3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.4044655097320675,-0.7649861183265384,0.726027397260274,1.0,1.0,3/16,15.76%,THEM4;ACOT9;ACSM5
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.4044655097320675,-0.7649861183265384,0.726027397260274,1.0,1.0,3/16,15.76%,THEM4;ACOT9;ACSM5
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.4338542660365459,-0.7649313944812689,0.7931034482758621,1.0,1.0,5/17,16.32%,FIS1;SMDT1;MICU2;MAIP1;MCUR1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.33939872055769954,-0.764300098861461,0.8732394366197183,1.0,1.0,17/76,18.64%,RPS4X;RPL5;AURKAIP1;NR1H2;VPS35;NPM1;PTTG1IP;EIF4A3;CYFIP2;ATG10;UHRF1;ZCCHC4;VIM;PASK;AGT;EZR;EEF2
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.38110224793424596,-0.7637520864333099,0.7857142857142857,1.0,1.0,3/32,5.97%,LPCAT1;DDHD2;GNPAT
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.36316305880390426,-0.7635875928240058,0.8243243243243243,1.0,1.0,14/63,15.35%,DDRGK1;RACK1;ELOB;CLU;ARIH2;HSPA1B;RNF144B;DVL1;RBX1;NOP53;CSNK1D;HSPA1A;RAD23A;DAB2
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.43398606471471,-0.7634247635955962,0.7424242424242424,1.0,1.0,4/12,20.85%,SNF8;VPS28;CHMP6;TMEM50B
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.4712038681865335,0.7633787078368062,0.717391304347826,0.9733914828376496,1.0,3/8,16.18%,PDE3B;TNF;PRKAA1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5028459284746765,-0.76303811555871,0.8615384615384616,1.0,1.0,1/7,1.22%,PYHIN1
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.3207539552633442,-0.7627675158609905,0.8933333333333333,1.0,1.0,8/144,4.97%,H4C3;TFRC;BTG2;SIDT2;H1-0;CTSB;ISCA1;HDGF
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.38154750678625127,-0.7626218327717424,0.765625,1.0,1.0,4/21,19.54%,CALM1;CNEP1R1;SYMPK;PPP1R16B
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.4224655201643489,-0.7624939791164131,0.7719298245614035,1.0,1.0,1/9,6.09%,TYMP
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.31403001955683185,-0.7620906741548267,0.925,1.0,1.0,9/144,8.72%,FLNA;CATIP;BBS2;RAB11A;MAK;IFT46;CEP164;DYNC2I1;DZIP1L
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.4226125809633017,0.7619895340210062,0.6888888888888889,0.9751877496789096,1.0,3/10,9.07%,PKD2;PKD1;PTCH1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.5003516926746531,-0.7619570163101672,0.8392857142857143,1.0,1.0,2/6,18.93%,SLX4;WRN
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.4298935034847359,-0.7619328691952619,0.8245614035087719,1.0,1.0,3/10,16.10%,MT3;OXA1L;NOD2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.47253640584472734,-0.7619059432079942,0.7547169811320755,1.0,1.0,3/7,32.84%,KDM1B;KDM5D;KDM5C
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.38945663715735557,0.7617759835624693,0.75,0.97496284046261,1.0,3/18,7.93%,MAPK11;NRG1;CTNNA2
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.3818212551451249,-0.7617335342524038,0.7719298245614035,1.0,1.0,6/27,14.15%,CD36;SNX6;IGF1;FYN;ITGA4;CACNB1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.28674245753692756,-0.7615625715939581,0.9886363636363636,1.0,1.0,36/310,15.09%,MYBL1;PPIE;PRKCQ;RUNX3;CHD3;EDF1;TAF6L;RORA;BHLHE40;OGG1;ATF5;ZNF331;TRIM22;BRCA2;MSL3;RPL10;PLAG1;RPL6;HINT1;DVL1;MLX;ESR2;REXO4;TCF3;GLI4;EIF2A;BTG1;GCFC2;HIF1A;GLRX2;CCAR1;RBM4B;TERF2IP;ZNF22;ZNF217;PUM3
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.3213774671486993,0.7613185470291255,0.9615384615384616,0.9751283569487772,1.0,15/59,17.09%,PPARGC1A;LRRK2;PPT1;LIG4;UNC5B;CPEB4;SORL1;SOD2;GPNMB;PRKCI;NTRK2;GSK3B;INPP5A;ATP13A2;TYRO3
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.497000902203536,0.7609976283590656,0.75,0.9751928413503579,1.0,1/5,5.37%,RELN
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4530196769316125,-0.7606446069285897,0.7636363636363637,1.0,1.0,4/8,26.88%,ING4;KAT5;RPS27L;TFAP4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4530196769316125,-0.7606446069285897,0.7636363636363637,1.0,1.0,4/8,26.88%,ING4;KAT5;RPS27L;TFAP4
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.3867472975636596,-0.7603005771711672,0.7758620689655172,1.0,1.0,1/14,4.35%,USP36
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.5526816544790951,-0.75990927744894,0.875,1.0,1.0,1/5,1.48%,CYCS
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.33241299128201557,0.7595698493170048,0.8529411764705882,0.9769306135700017,1.0,3/43,3.40%,PDPN;ZSWIM4;NRG1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.33828694510834595,0.7594153268256766,0.8571428571428571,0.9766313761114321,1.0,10/30,18.71%,IGF1R;SLC39A14;UNC13B;TCF7L2;PCK2;SOX4;PRKAA1;KCNB1;TRA2B;ZBTB20
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.33551679055435424,0.7589727216122489,0.8275862068965517,0.9766211225300285,1.0,6/35,17.89%,NUP153;NUP188;NUP42;NUP133;NDC1;NUP205
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.4963227413185281,0.7584507198199241,0.813953488372093,0.9767786223379256,1.0,3/5,27.81%,ANTXR1;ADAM10;RAB40B
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.36765440317941345,0.75841593717281,0.8529411764705882,0.9763391067367425,1.0,5/18,15.57%,KCNJ2;KCNJ5;SLC12A6;SLC12A2;SLC12A5
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.3302592573050468,0.7582313721313826,0.8717948717948718,0.9760676192188,1.0,3/32,6.99%,CPSF4;KHDRBS2;KHDRBS3
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.45102805178489513,-0.7581749239500507,0.7777777777777778,1.0,1.0,2/11,14.25%,FIS1;PTPRC
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.3190750623781398,0.7580187713899248,0.8,0.9759103020702807,1.0,6/40,13.88%,EFL1;LRRK2;GPAT4;MFN1;AK3;ENPP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.36557727264697504,0.7580094760115124,0.8333333333333334,0.975411673220896,1.0,4/28,6.94%,RNF122;LRRK2;SPART;PPA2
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.4232079232466432,-0.7579773546849652,0.7894736842105263,1.0,1.0,8/16,28.92%,CALM1;IL1B;NOS1AP;ZDHHC21;IL1A;EGFR;POR;HSP90AA1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.42072499914527595,-0.7579701963046889,0.8448275862068966,1.0,1.0,2/12,13.51%,ISCA1;CIAO2B
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.47552333372309535,-0.7574411999364499,0.7377049180327869,1.0,1.0,1/6,2.28%,USF1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3150696998066988,0.7572649618809957,0.8947368421052632,0.9760311500202474,1.0,8/85,7.63%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.31208186403465316,-0.7571900828498543,0.9135802469135802,1.0,1.0,36/240,18.44%,FLNA;USP6;RIC3;ARL5C;ARL4C;SNX6;BBS2;CD63;CORO1B;VPS35;NPM1;NAPA;ARL17A;EIF2D;STX19;TM9SF2;EPB41L3;ADPRH;IFT27;STX10;TRIM23;COX18;ARMCX3;OXA1L;TBC1D17;TBC1D2B;SEC13;PICK1;SNX9;TBC1D8;SLU7;PIGK;AP4M1;CD74;WIPI1;VPS26A
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.4601419548030314,0.7569569881170617,0.717948717948718,0.9759075423625571,1.0,1/7,0.27%,KLF4
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.4267907577568517,-0.756642559092336,0.7931034482758621,1.0,1.0,1/11,5.38%,CLU
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.29861044115751845,-0.7564664525668104,0.9666666666666667,1.0,1.0,25/190,16.30%,MX2;DUSP1;RUNX3;JUNB;PPP1R15A;PER2;GADD45B;RACK1;RPL23;MED25;GADD45GIP1;CITED2;IRF1;DYNLT3;PIM3;ING4;NOP53;CCND1;PTPRC;RAD23A;NOTCH2;BRCA1;CENPF;CDC26;NUDT6
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.4331210076940173,-0.7563658877571134,0.8245614035087719,1.0,1.0,1/8,6.09%,TYMP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.4331210076940173,-0.7563658877571134,0.8245614035087719,1.0,1.0,1/8,6.09%,TYMP
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.34174306251184644,-0.7563382352793503,0.8507462686567164,1.0,1.0,9/52,15.87%,CCL3;CCL5;ATP13A1;TPT1;TRPV4;TMCO1;MT3;ATP1B3;ATP1A1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4186276643167341,0.7560380540329982,0.7674418604651163,0.976653127318597,1.0,5/15,23.04%,ABCA2;ACADVL;ARV1;DGKQ;KPNB1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.35247020678635044,0.7558977948069137,0.975,0.9763756466315205,1.0,2/24,5.45%,ANXA1;UBE2E2
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.4821047629149964,-0.7557261554690409,0.6779661016949152,1.0,1.0,2/5,29.63%,RDH11;RDH10
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.47489297095012356,-0.7555905377942356,0.7796610169491526,1.0,1.0,3/7,9.82%,IKZF3;ZNF335;TNFRSF1B
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.4371338324122521,0.755523220909276,0.7105263157894737,0.9764323615697447,1.0,2/6,28.04%,ADGRV1;NLRP1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.33092898259992903,-0.7546258530864478,0.9444444444444444,1.0,1.0,12/54,17.61%,MYLK;EMD;MYBPC3;TTN;CALM1;MYL12A;SNTB1;TLN1;MYOT;CALD1;VIM;CRYAB
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.37236070909246477,0.754270621528701,0.7777777777777778,0.9778706618047389,1.0,6/25,13.89%,PICALM;SNAP91;DNAJC6;FNBP1L;SGIP1;GPR107
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.2792451529176256,-0.7542210805904725,0.989010989010989,1.0,1.0,70/599,15.45%,NR4A3;FLNA;UBC;ZFP36;SCML4;RPS27A;RUNX3;HAMP;PER3;RPS14;CHD3;SNX6;PER2;ZMYND15;BHLHE40;PARP15;MDFIC;H1-0;L3MBTL3;HDGF;ATF5;HESX1;PARP9;NR1H2;RPL23;ILF3;BASP1;PHB2;TCF25;IRF7;CRYM;MED25;RPL10;EID1;RBPJ;STAT1;CITED2;IRF1;BTAF1;ZNF589;MLX;KANK2;ESR2;TCF3;ZNF266;SCML1;ATF3;ING4;VEGFA;NOP53;MXI1;ZKSCAN3;FBP1;UXT;CDKN1C;ZNF558;GCFC2;MAX;ZNF20;CCND1;MT3;DDX5;C1QBP;KAT5;ATP8B1;ZNF217;PRDM1;BRCA1;DAB2;CENPF
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.3730934109287395,0.7541513180432645,0.75,0.9775195974659577,1.0,4/18,17.34%,MAP1S;CAMSAP2;PIK3CA;MAP2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3421809893372971,0.7541315426098456,0.8378378378378378,0.977055550133426,1.0,4/24,10.08%,FOXN3;CDC14B;BRSK1;FZR1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.4131672504016353,0.7541298253351945,0.7837837837837838,0.9765453383578996,1.0,4/12,17.27%,NSUN2;NUP153;SETD2;IWS1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.433344552952525,-0.7540554214137332,0.7966101694915254,1.0,1.0,2/11,7.17%,AIF1;CORO1B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.3695778320868187,-0.7540075520697349,0.8428571428571429,1.0,1.0,2/26,2.31%,CCL5;AIF1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.4895568222739447,0.753966181607627,0.8292682926829268,0.976288764897231,1.0,3/6,29.20%,SETD2;WAPL;VCP
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.348932839157335,0.7539010372005439,0.7741935483870968,0.9758460574433019,1.0,5/26,13.59%,DCP1B;EXOSC6;CNOT7;LSM6;LSM1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.3233252199551144,-0.7537337389970946,0.9090909090909091,1.0,1.0,17/109,15.58%,PSMB3;JUP;PSMA7;TRPM4;PSMB9;PSMB6;GPC3;TNFAIP3;CSNK1G2;PSMA5;SULF2;PSMC4;PSMD8;CSNK1D;PRDM15;PSMD12;PSME2
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.457067704773899,-0.7536888580370464,0.803921568627451,1.0,1.0,2/8,24.49%,ITFG2;SZT2
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.5049903889462124,0.753294134054715,0.8333333333333334,0.9762554892928452,1.0,1/5,1.81%,ZNF598
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.33898546584151945,-0.7528812290557729,0.8507462686567164,1.0,1.0,13/46,21.75%,APIP;B2M;KCNC3;TRPM4;FARSA;KCNC1;OXA1L;KRT10;SHMT1;GBP5;TRPM2;HLA-DRB1;CUTC
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.42129599481605595,-0.7528536943647423,0.8,1.0,1.0,3/13,8.87%,LIPG;GDPD1;ENPP2
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.46706212198988206,0.7526182519067,0.8372093023255814,0.9761890490085428,1.0,2/6,18.53%,ZFAND6;PEX16
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.46706212198988206,0.7526182519067,0.8372093023255814,0.9761890490085428,1.0,2/6,18.53%,ZFAND6;PEX16
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.41592585007801974,-0.7525677284255412,0.803030303030303,1.0,1.0,6/22,20.80%,TERF2IP;NHP2;RFC1;NOP10;ANKRD28;CTC1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.30577658467019664,-0.7519721444963848,0.9523809523809523,1.0,1.0,11/168,9.70%,CEBPD;GTF3C6;PTMA;BTF3;GTF2H5;TCEA2;ELOB;CTDP1;RNMT;NCBP2;POLR2G
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.3689414708785903,0.7517898731686254,0.78125,0.9767305297203017,1.0,3/22,4.25%,HS3ST5;GSN;TRIM26
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.3766907388672138,-0.7517684454795839,0.8,1.0,1.0,3/30,8.74%,RAB3A;SNF8;RAB3D
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.3878337348383174,0.7516438742447707,0.8055555555555556,0.9764016221369044,1.0,5/13,21.78%,LGALS9;HSPD1;CD46;CD274;SYK
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.42883201161700835,0.751065340421678,0.7297297297297297,0.9766437897309985,1.0,2/8,14.60%,KCNJ2;SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.4487074618652829,0.7510503351410017,0.7368421052631579,0.9761428115957804,1.0,3/8,26.31%,NF1;ORAI1;MAPK14
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.49049272549341966,0.7507972921845346,0.825,0.9759672012409646,1.0,2/7,7.29%,MITF;RALY
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.5131239734129435,0.7505626516543581,0.7755102040816326,0.9757188862067214,1.0,2/5,30.85%,BIN1;MYOF
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.4924910294850085,0.7501692743447883,0.7857142857142857,0.9758814335489711,1.0,1/5,5.97%,SMAD3
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.4719135535466532,-0.75005180615431,0.7962962962962963,1.0,1.0,3/5,32.22%,MT3;HEBP2;ASAH1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.28184917610921517,-0.7498705232179377,0.9887640449438202,1.0,1.0,51/426,14.94%,NR4A3;UBC;ZFP36;RPS27A;RUNX3;HAMP;PER3;RPS14;CHD3;PER2;BHLHE40;PARP15;H1-0;HDGF;HESX1;LILRB4;PARP9;NR1H2;RPL23;TCF25;IRF7;CRYM;MED25;RPL10;EID1;RBPJ;STAT1;CITED2;ZNF589;MLX;KANK2;ESR2;TCF3;ZNF266;ATF3;VEGFA;NOP53;MXI1;ZKSCAN3;FBP1;UXT;ZNF558;MAX;ZNF20;CCND1;HSPA1A;DDX5;C1QBP;KAT5;ZNF217;PRDM1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.4046174384473449,0.7496567824026411,0.775,0.976110004480967,1.0,3/12,17.60%,USP30;PEX5;TRAPPC8
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.4769884031028361,0.7492959834071425,0.7777777777777778,0.9761795594857569,1.0,1/6,6.24%,PPT1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.4810415951252628,-0.7490960498956012,0.8113207547169812,1.0,1.0,4/7,27.88%,NCKAP1L;C3;ABCA7;RAB31
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.3546959676273256,0.7488486000994097,0.8,0.9762953289428736,1.0,4/21,12.07%,SIRT1;SEL1L;GPAT4;GPAT3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4084574352462362,-0.748295305421266,0.7936507936507936,1.0,1.0,4/16,16.86%,EYA2;HSPA1B;HSPA1A;IL1B
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.48291886171655335,-0.7479586422976712,0.7222222222222222,1.0,1.0,3/5,33.79%,SHMT1;GART;PAICS
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.4123175922018557,-0.74789536780439,0.8333333333333334,1.0,1.0,2/14,6.08%,CGNL1;NLGN2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.3700992319831494,-0.747659522341113,0.746031746031746,1.0,1.0,3/23,11.44%,MOV10L1;TDRKH;ZCCHC8
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.3459245370611602,-0.7474967672531513,0.8611111111111112,1.0,1.0,8/48,18.52%,CCDC88C;RAB11A;TRPV4;TUBGCP2;WDR73;HOOK2;TUBGCP5;EZR
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3011418676298831,0.7472435649762076,0.9615384615384616,0.978049994898602,1.0,5/58,9.81%,NRP1;PDGFA;RELN;CNOT7;HGF
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.3644976667129714,0.7470086193817754,0.8461538461538461,0.9780193550177788,1.0,1/18,2.08%,FGF2
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.4512419116540437,-0.7467565541450123,0.8064516129032258,1.0,1.0,1/8,8.55%,BUD23
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.4016295858182604,-0.7466151511186824,0.7966101694915254,1.0,1.0,5/18,24.83%,PFN1;FCHSD1;WAS;BRK1;WDR1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.3318545473265466,-0.7465399660857328,0.8974358974358975,1.0,1.0,5/113,7.58%,PKIB;PDE4A;SEZ6L2;ATF5;SCN9A
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.30469841395054315,0.7463568799995219,0.8518518518518519,0.9784112811816207,1.0,8/34,18.97%,PDGFA;YLPM1;UBE2N;WDR18;CDK9;HNRNPD;NBN;WRNIP1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.396356554291725,-0.7463228752120313,0.8852459016393442,1.0,1.0,4/18,11.49%,CEMIP;FIS1;FYN;ITGB2
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.46041258008403685,-0.7462287011997697,0.7346938775510204,1.0,1.0,3/5,25.40%,SOD1;KLF2;KCNMA1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.3705311247130232,-0.7461971325798806,0.8939393939393939,1.0,1.0,8/35,22.70%,HUS1;XRCC3;APEX1;RPA3;TERF2IP;WRN;CTC1;TEP1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.5193350931457162,0.7460757964976684,0.8918918918918919,0.9783540914368849,1.0,3/5,30.24%,APEH;ETF1;PEX14
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.4136289781873924,-0.7452826910240559,0.7931034482758621,1.0,1.0,2/17,7.97%,RAB11A;PRKAR1B
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.36912163673824566,0.7452689486826066,0.8095238095238095,0.9790290363536095,1.0,2/17,7.32%,PDPN;DISP1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.3086183323464442,-0.7452563613796223,0.8648648648648649,1.0,1.0,6/85,7.97%,PRLR;CARD14;IGF1;CHI3L1;PHB2;PRKAR1B
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.46504118688648877,0.7451958248749437,0.7708333333333334,0.9785628907487931,1.0,2/5,37.33%,SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.41799825869764773,-0.7448245131106366,0.8307692307692308,1.0,1.0,5/9,28.23%,BRCA1;LRIF1;SMCHD1;YTHDC1;METTL3
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.35791611936325773,-0.7446359798129565,0.8985507246376812,1.0,1.0,14/35,22.45%,GAPDH;PRELID1;SPOCK2;PSMB9;SERPING1;PSME2;TIMP2;AGT;PSMA3;APH1B;PSME1;SERPINF1;SPOCK1;PSME3
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.4413186338855827,-0.7446348833497011,0.8888888888888888,1.0,1.0,6/12,28.00%,TIPIN;ZRANB3;LIG3;DONSON;TIMELESS;MSH3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.4548060339228724,0.7444450978503745,0.7804878048780488,0.9781282625742084,1.0,1/6,1.58%,MSN
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.4548060339228724,0.7444450978503745,0.7804878048780488,0.9781282625742084,1.0,1/6,1.58%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.4548060339228724,0.7444450978503745,0.7804878048780488,0.9781282625742084,1.0,1/6,1.58%,MSN
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.48660957580519815,-0.7439030749064537,0.7894736842105263,1.0,1.0,1/5,10.34%,ATG2A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.3149162603802331,0.7438383789602654,0.8421052631578947,0.9783542615060963,1.0,24/89,15.32%,PDGFA;IGF1R;SEMA5A;FGF2;SPRY2;TGFA;GAB1;NRG1;HPSE;KITLG;HGF;MFHAS1;FERMT2;P2RY12;TCF7L2;RTN4;GAB2;MTDH;VAV1;PTK2;PIK3AP1;NRG2;ERBB4;TNF
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.4409622061847712,0.7436078595575935,0.8292682926829268,0.9782249836184453,1.0,2/6,12.82%,TCF7L2;CCDC40
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.4638765566564057,-0.7434194597994828,0.8709677419354839,1.0,1.0,2/10,8.01%,PER2;TRPM4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.29943109827331554,0.7433384565692405,0.8181818181818182,0.9781286963814807,1.0,12/53,15.98%,NRP1;MAPK11;NCK2;WASF2;CRK;ELMO1;SHC2;MAPKAPK2;VAV1;PTK2;ITGAV;ABI1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.37819738040421097,-0.7433047908565378,0.8064516129032258,1.0,1.0,1/19,3.70%,RPS23
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.516661722111701,-0.7432863161213891,0.8035714285714286,1.0,1.0,1/5,3.86%,RGS2
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3480530220831952,0.7431837462568557,0.8604651162790697,0.9777763515681832,1.0,7/28,18.84%,SLC39A14;LRRK2;LRCH1;WNK1;MAP2;CHP1;CPEB2
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.29122419584562814,-0.7431505929873646,0.9764705882352941,1.0,1.0,31/332,10.64%,MYBL1;COL18A1;FTH1;TGFBR3;RIPOR2;DUSP1;H2AC6;RUNX3;WARS1;BTG2;IFIT3;RACK1;ING5;ATF5;CLU;AQP11;NR1H2;ETS1;APOBEC3G;VPS35;NPM1;HSPA1B;TP53TG5;EIF2AK2;IRF1;TNFRSF1B;PLSCR1;GLMN;KANK2;ESR2;BTN2A2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.41280059288194976,-0.7426362177848154,0.796875,1.0,1.0,4/18,15.75%,MYBPC3;TTN;SOD1;GPX1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.33917055121285705,0.7425615682262406,0.8222222222222222,0.9781267965953064,1.0,7/22,18.53%,GDAP1;ZFAND6;PEX13;PEX5;PEX11B;ATAD1;PEX16
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.26993690978522034,-0.7420812242676417,1.0,1.0,1.0,142/1260,14.94%,NR4A3;MYBL1;STAT4;IL4I1;UBC;SKAP1;BCL11B;FOSL2;CEBPD;ZFP36;PID1;RPS27A;FOS;RUNX3;HAMP;JUNB;PER3;CTDSP1;RPS14;CHD3;USF1;IKZF3;ZSCAN9;PER2;BEX1;TAF6L;RORA;BHLHE40;PARP15;CHCHD2;H1-0;DDRGK1;ZNF790;CSRNP1;GTF2H5;ZNF335;TXK;BRD9;HDGF;CTDP1;ZNF689;EIF5A;NLRC5;ATF5;SP110;HESX1;JUP;JMJD6;IGF1;PARP9;NR1H2;RPL23;ITGA6;ZNF600;ZSCAN30;ETS1;SP140;TCF25;IRF7;CRYM;MED25;NPM1;SNF8;ZNF354A;BRD3;VENTX;PRKD2;ZNF76;RPL10;PLAG1;NAMPT;EID1;ZNF649;ZNF789;ZNF449;ZNF805;RBPJ;RNASEL;ZNF32;ZFP30;STAT1;CITED2;ZNF821;ZNF70;DVL1;IER2;IRF1;ZNF513;ZNF589;PLSCR1;MLX;KANK2;ZNF394;HIRA;ESR2;ZNF570;SMARCD1;ZNF260;TCF3;OVOL2;ZNF232;ZNF266;BUD31;MEIS1;KDM7A;ATF3;ZNF16;STING1;APEX1;ZNF546;VEGFA;LITAF;BRIP1;NOP53;MXI1;TEF;ZKSCAN3;FBP1;ZSCAN29;ZNF528;UXT;NRL;CAMK1;ZNF558;ZNF681;ZNF586;MAX;HIF1A;ZNF20;CCND1;KDM6B;ZNF333;GMEB1;DDX5;PRDM15;C1QBP;KAT5;ATF1;MYNN;ZNF22;ZNF217;PRDM1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.38155568500808135,0.7419670396346129,0.8979591836734694,0.9783653380395143,1.0,2/11,15.49%,PPAT;ADK
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.4553676377872026,-0.7418442563291103,0.7962962962962963,1.0,1.0,2/10,14.90%,P2RY8;LPAR6
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.432132787414514,0.7418062032317901,0.7450980392156863,0.9780986687355753,1.0,3/7,12.52%,E2F3;PPARG;SOD2
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.41211246153426057,0.7416845054417783,0.7959183673469388,0.9777208447114989,1.0,1/8,4.73%,TLR7
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.3896188332888216,0.7414146086214756,0.918918918918919,0.9775202926599472,1.0,2/11,15.09%,CHMP7;CHMP1A
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.402264877173863,0.7413453413104288,0.8205128205128205,0.977084221999637,1.0,1/8,2.85%,CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.45893315970813153,-0.7411753434713529,0.8166666666666667,1.0,1.0,2/6,13.89%,PADI2;HIF1A
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.3973120863902538,-0.7407148981205807,0.803921568627451,1.0,1.0,3/14,10.86%,OBSCN;TTN;CFLAR
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.4203546403808148,-0.7405734265882212,0.8108108108108109,1.0,1.0,3/17,11.07%,PECAM1;ACTG1;ACTB
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.2942644799621625,-0.7402651749067117,0.9523809523809523,1.0,1.0,11/189,8.72%,FLNA;MYLK;AIF1;BBS2;EMP3;RAB11A;MAK;IFT46;CEP164;DYNC2I1;DZIP1L
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4332557684171665,-0.7396762770762008,0.8448275862068966,1.0,1.0,4/11,22.93%,DNMT1;TET1;RESF1;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.34054743510928753,0.7392239033366084,0.8666666666666667,0.9795805535615595,1.0,4/27,11.51%,ABCA2;SIRPA;FBXW7;ACADVL
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.42728063542253725,-0.7391634151316104,0.8,1.0,1.0,5/9,22.53%,AKAP8;PARG;HPF1;PARK7;AKAP8L
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.43420471131719207,0.7390538739252773,0.7560975609756098,0.9793401095581244,1.0,2/7,10.57%,SLC4A4;SLC9A1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.40877515473945375,-0.738908421292963,0.803030303030303,1.0,1.0,5/13,16.53%,CD55;ENPP3;APPL1;CD47;HAVCR2
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.42326295831762134,-0.7386019766023034,0.8214285714285714,1.0,1.0,1/10,4.07%,NYNRIN
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.3798464912974143,-0.7384037987564372,0.8870967741935484,1.0,1.0,5/20,25.64%,KDM7A;KDM6B;KDM1B;UTY;KDM5D
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.42504779108501484,0.7382887255233918,0.8292682926829268,0.9799498307044348,1.0,5/8,32.89%,FOXO1;ATP6V0D1;ATP6V1G1;ATP6V1A;FAS
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.39764056970624495,0.73821424331916,0.7884615384615384,0.9795918230423091,1.0,1/10,6.17%,PPAT
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.41784032157381,0.7381278883917523,0.7804878048780488,0.9791819326548774,1.0,1/6,8.18%,ZNF385A
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.3139480787972391,-0.737703755384316,0.9315068493150684,1.0,1.0,19/113,17.15%,INSIG1;ZFP36;CARD16;PID1;RORA;CD14;GSTP1;TNFRSF1B;SELENOS;TNFAIP3;ABCB4;KAT5;BRINP2;CFTR;ATP1A1;NOD2;ZNF35;IL1B;VIM
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.35300765888084223,0.7374300794622283,0.7567567567567568,0.9796471873801602,1.0,4/11,23.26%,RNF185;BAG6;UBQLN1;SGTA
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.39638019758344395,0.7373701620142395,0.8,0.9792311633316169,1.0,1/18,1.39%,NCAPH2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.43472416942495334,-0.7373533248613536,0.8360655737704918,1.0,1.0,3/11,8.13%,GNB5;SRI;CALM1
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.4764749217374369,-0.7371795664312494,0.8214285714285714,1.0,1.0,1/5,5.01%,PADI2
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.41896396403577196,0.7370667370821038,0.8333333333333334,0.9791155365730001,1.0,1/7,2.03%,TGFBR2
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.37403806167050757,-0.7369202814275589,0.8059701492537313,1.0,1.0,1/25,1.27%,DEGS2
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.3500564855954706,0.736770740847263,0.7380952380952381,0.9789283320923359,1.0,4/23,12.91%,SIRT1;AANAT;CLOCK;NAA35
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.48256695428959473,-0.7367441214676947,0.8793103448275862,1.0,1.0,2/6,11.76%,GPR137B;TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.48256695428959473,-0.7367441214676947,0.8793103448275862,1.0,1.0,2/6,11.76%,GPR137B;TNFAIP3
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.32576802810562716,-0.7366164170480561,0.8481012658227848,1.0,1.0,12/80,12.61%,XPA;RANBP6;RPL11;CHCHD10;PHB2;PTTG1IP;NUP50;DVL1;GBP2;CNEP1R1;APPL1;NOP53
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.40144638837282887,0.73616216637405,0.8478260869565217,0.9792364188747626,1.0,3/10,12.59%,HDAC9;SORT1;PCSK6
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.47340904253509997,0.7361125861055469,0.8048780487804879,0.9788019199751914,1.0,2/6,8.92%,CAB39;NEDD4L
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.4189127062737912,-0.7355714461136263,0.8484848484848485,1.0,1.0,4/13,14.86%,PADI2;ESR2;DDX5;DDX54
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.3861699308242335,-0.735422833294838,0.7692307692307693,1.0,1.0,7/21,13.89%,CEBPD;TNFSF10;CLDN7;OVOL2;UXT;BTG1;HIF1A
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.33811379920358375,0.7350268918744893,0.875,0.9796889540102526,1.0,7/26,13.62%,EPS8;MSN;PICALM;HP1BP3;PTEN;PEX11B;VAV1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.37134919134567684,0.7349420621941556,0.7631578947368421,0.9793132080060977,1.0,4/17,9.07%,STK36;PTCH2;MAP3K10;PTCH1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.39652403445231726,0.7348079369937892,0.7777777777777778,0.9790483652473448,1.0,2/13,17.15%,MDM2;TMEM109
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.39424793229599464,0.7345744400634032,0.825,0.9789137500023126,1.0,2/9,13.00%,FBXO27;STT3B
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.4044808863897018,0.7344551944121428,0.7906976744186046,0.9785844342500768,1.0,1/11,10.11%,TRERF1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.37225133414663014,-0.7344299924914285,0.8387096774193549,1.0,1.0,4/24,12.57%,PID1;IGF1;SELENOS;APPL1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.4362515722379282,-0.7343799794753949,0.7592592592592593,1.0,1.0,2/10,19.27%,EGLN3;VIPAS39
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.48721806718941263,-0.7339478429030044,0.7924528301886793,1.0,1.0,1/5,19.92%,IL18
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.4980633361217462,-0.733798297322622,0.7846153846153846,1.0,1.0,2/5,16.59%,RAB3A;TMEM167A
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.39083191450622,0.7335153630553362,0.7435897435897436,0.9794628316920446,1.0,3/10,14.16%,TRUB1;PUS1;PUS7L
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.40572518559162957,-0.733515053091418,0.8253968253968254,1.0,1.0,1/14,5.89%,RAB11A
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.3739685528173668,-0.7332711768579789,0.8548387096774194,1.0,1.0,2/21,6.08%,RAB3A;NLGN2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.37470605266126195,0.7330823432083572,0.8461538461538461,0.9795552903637859,1.0,2/16,4.50%,GSN;SCN3B
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.3876045617441936,0.7329921980052149,0.8157894736842105,0.9791742731615111,1.0,2/8,18.81%,KCNB1;SIRT4
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.38672331348358724,0.7329717134568077,0.8076923076923077,0.9787029035104824,1.0,1/15,2.86%,MITF
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.3870361135862679,0.7329430201524066,0.8709677419354839,0.9782384905076127,1.0,3/13,10.59%,DAG1;VCL;PRKX
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.28970420066806835,0.7329414177609863,0.9473684210526315,0.9777421746829007,1.0,11/104,12.37%,BAG3;SIRT1;CASP9;NUP153;NUP188;NUAK1;NUP42;BAG5;MAPK1;FKBP4;MAPKAPK2
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.48152127123789357,-0.7324249921068517,0.8135593220338984,1.0,1.0,1/5,2.28%,USF1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.3688683967703608,-0.7322032409312772,0.8208955223880597,1.0,1.0,1/29,0.97%,RIPOR2
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.44567851217580234,-0.7321906971706693,0.8,1.0,1.0,3/13,15.42%,OVOL2;TRPV4;CFTR
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.42125420333836494,-0.7321262566662743,0.9152542372881356,1.0,1.0,4/12,17.80%,SLC25A19;VLDLR;PLTP;SLC15A3
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.4311348719684802,0.7320875416124545,0.8529411764705882,0.9783529938867771,1.0,1/9,4.50%,L2HGDH
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.3297818161059594,0.7316971630061128,0.9375,0.9784263291490201,1.0,11/31,18.61%,PDGFA;NEK10;PDGFC;MOB1B;GPNMB;PPP2R5E;ENPP1;DDX3X;RAP2C;CHP1;NBN
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.46369640774575516,0.7311385423676603,0.8214285714285714,0.9785771697913713,1.0,1/5,9.02%,ALOX5AP
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.3982625561196046,0.7308506230310632,0.8333333333333334,0.9784758513822929,1.0,4/12,11.64%,BACE2;FCGBP;OTOGL;SLC26A3
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.43764894201403004,0.7306503048559608,0.8,0.9782325500634198,1.0,2/7,8.92%,CAB39;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.4253573328229521,0.7304638784569273,0.813953488372093,0.9774821575609014,1.0,2/8,5.90%,SIRT1;HMGA1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.4253573328229521,0.7304638784569273,0.813953488372093,0.9774821575609014,1.0,2/8,5.90%,SIRT1;HMGA1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.37008552083937096,-0.7303800011623156,0.8676470588235294,1.0,1.0,7/31,16.49%,MYBPC3;PLSCR1;PFN1;GABARAPL2;CHTOP;ATP1B3;UHRF1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.45368222899831057,0.7302736701235912,0.7719298245614035,0.9772848676623306,1.0,2/5,18.84%,DPH5;CPEB2
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.4370678673899052,0.729930676351883,0.8292682926829268,0.9767427164443138,1.0,3/7,15.57%,SLC12A6;SLC12A2;SLC12A5
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.4370678673899052,0.729930676351883,0.8292682926829268,0.9767427164443138,1.0,3/7,15.57%,SLC12A6;SLC12A2;SLC12A5
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.48156906171076064,-0.729818391347734,0.8867924528301887,1.0,1.0,3/5,30.37%,AKR1A1;CRYL1;SORD
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.48156906171076064,-0.729818391347734,0.8867924528301887,1.0,1.0,3/5,30.37%,AKR1A1;CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.48156906171076064,-0.729818391347734,0.8867924528301887,1.0,1.0,3/5,30.37%,AKR1A1;CRYL1;SORD
prerank,GO_Biological_Process_2021__positive regulation of gliogenesis (GO:0014015),0.4833652453520871,0.7294667569909266,0.9,0.9768616033024614,1.0,2/5,15.32%,PRKCI;TNF
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.337471688579733,-0.7294322497681659,0.8840579710144928,1.0,1.0,3/61,3.17%,PID1;WARS1;PAQR3
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.4741305101252852,0.7293432095362744,0.8292682926829268,0.9765427473020217,1.0,1/7,2.02%,RUVBL2
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.30780814017655117,-0.729266833758888,0.925,1.0,1.0,5/85,10.09%,CXCR4;VAV3;THEM4;CFL1;PFN1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.3680308248509334,-0.7292501067648954,0.847457627118644,1.0,1.0,4/23,17.52%,TAF6L;MSL3;KAT5;KAT8
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.2741500935141524,-0.7290972676655789,1.0,1.0,1.0,18/226,10.50%,CALCR;TFRC;PDGFD;CARD14;MARCO;DDRGK1;CEMIP;RACK1;PECAM1;MUSK;IGF1;CHI3L1;PRKD2;CALM1;ENPP2;MTCP1;CD44;BANK1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.3730187603146678,-0.7289520002273246,0.8181818181818182,1.0,1.0,8/30,14.32%,ETS1;HSPA1B;STAT1;ANKRD54;NCKAP1L;ZNF16;HIF1A;HSPA1A
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.420500475132511,0.7288026707127553,0.7674418604651163,0.9767516685358887,1.0,2/8,14.49%,SASH1;DDX3X
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.3794730114282201,-0.7286290596953411,0.8955223880597015,1.0,1.0,7/27,13.26%,GAPDH;MDH2;PER2;G6PC3;GOT2;FBP1;PGK1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.3318212538444295,-0.7282439172273791,0.8656716417910447,1.0,1.0,6/57,9.70%,GTF2H5;ADRM1;ELOB;CTDP1;NCBP2;POLR2G
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.29219592336683803,0.7280097891204973,0.8611111111111112,0.9774297070293283,1.0,5/46,8.55%,CTSF;CTSK;CTSC;MDM2;RAB7A
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.44252714763392414,0.7278133773760473,0.7941176470588235,0.9772202871029018,1.0,1/7,2.37%,GFAP
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.33378495361641947,0.7275208548668528,0.8064516129032258,0.9771202634616127,1.0,3/20,12.65%,GSN;GPC6;MMP14
prerank,GO_Biological_Process_2021__regulation of interleukin-23 production (GO:0032667),-0.48626050070531934,-0.7265406704958902,0.9016393442622951,1.0,1.0,3/5,30.15%,RAC1;CLEC7A;MYD88
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.35857929468641375,0.7264485392306652,0.8444444444444444,0.9781437434029674,1.0,5/17,20.80%,KCNIP2;KCNN2;DPP10;DPP6;KCNIP4
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.4313113117963848,0.7259208937926441,0.7291666666666666,0.9782230101603635,1.0,2/7,8.12%,MFNG;DOCK10
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.36488083307594876,0.7258645362142633,0.7894736842105263,0.9777891577523149,1.0,2/23,4.41%,NRG1;WNT5A
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.33677909495484065,0.7256521537597211,0.9210526315789473,0.9776121320683627,1.0,3/21,16.11%,PTEN;MTMR9;PIP4P2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.3305028799922984,-0.7253109081808846,0.9047619047619048,1.0,1.0,7/60,11.76%,ZFP36;CARD16;CD14;GSTP1;TNFRSF1B;SELENOS;TNFAIP3
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.33115126946491547,-0.7252974358301475,0.8648648648648649,1.0,1.0,8/63,14.82%,YES1;VAV3;EPHB1;ACTG1;ACTB;FYN;EFNB2;AP2S1
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.4252725976947693,-0.7251313461583262,0.8214285714285714,1.0,1.0,4/8,30.53%,AACS;SLC27A5;HMGCL;BDH1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.3226856609753567,-0.7251036902052516,0.961038961038961,1.0,1.0,18/93,14.32%,CYCS;FOS;AIF1;CHCHD2;NCF4;GSTP1;ERO1A;RPS3;ERMP1;HSPA1B;NCF2;SELENOS;PRR5L;SOD1;HIF1A;MT3;CYBA;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.4617626207963522,-0.7250652026442171,0.8490566037735849,1.0,1.0,1/7,4.75%,RNF213
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.3573306678088043,0.725025282743202,0.8695652173913043,0.9779029626364626,1.0,6/25,17.39%,PICALM;TMED10;GRM5;SAMD8;NOLC1;MTPN
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.3887182694691542,-0.7250050076967175,0.8135593220338984,1.0,1.0,4/15,21.87%,PLEK;PTPRC;FLT1;UFL1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.43087141908875876,0.724941890348409,0.8297872340425532,0.9774635205380862,1.0,2/7,15.32%,LDLR;TNF
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.3690276152514209,-0.7248155410870434,0.8225806451612904,1.0,1.0,4/22,11.49%,CEMIP;FIS1;FYN;ITGB2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.4280540684984018,0.7243695377591378,0.782608695652174,0.9777093330256411,1.0,2/6,18.90%,RYK;MANF
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.30694561028602324,0.7243324972620822,0.8846153846153846,0.9772704285281707,1.0,4/44,5.61%,MEPCE;NSUN2;TRUB1;TFB1M
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.3110137317608437,-0.7241273867743058,0.9324324324324325,1.0,1.0,20/72,18.79%,CCDC170;MGLL;ANKUB1;CD14;SGK1;CFLAR;APOL6;SMIM14;HLA-DRA;C3;MS4A6A;HLA-DPA1;RASSF4;GSAP;ALDH2;HSPA2;HLA-DMB;CD74;HLA-DPB1;DNAH12
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.4438532244013954,0.724014015164085,0.8571428571428571,0.9767134639526388,1.0,1/6,20.84%,GCH1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.4438532244013954,0.724014015164085,0.8571428571428571,0.9767134639526388,1.0,1/6,20.84%,GCH1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.4197698268614885,0.723228094831195,0.8043478260869565,0.977265750899687,1.0,1/7,9.26%,RUNX1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.29543519779723254,-0.7229415880543894,0.9736842105263158,1.0,1.0,15/113,15.83%,NFKBID;AIF1;TRIM5;ZNF335;TXK;IGF1;TRIM22;HNRNPAB;ZNF513;ANKRA2;HIF1A;KDM6B;PTPRC;PRDM1;CGGBP1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.32739179164504106,-0.7227663466738086,0.9594594594594594,1.0,1.0,6/52,11.74%,ZFP36;CCL5;NCBP2;POLR2G;CD44;GALNT3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.36649257265091245,0.7226786105458728,0.8888888888888888,0.9775174316037364,1.0,4/17,17.15%,MDM2;LIG4;PRKAA1;TMEM109
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.33139657287364,-0.7226420238310195,0.8923076923076924,1.0,1.0,11/53,19.46%,DHX38;CSTF2T;NCBP2;CHTOP;U2AF2;SRSF7;EIF4A3;SRSF2;SLU7;SYMPK;PNPT1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.4201423483266536,-0.7225574134107439,0.8666666666666667,1.0,1.0,1/9,6.88%,LAMTOR5
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.45309925900626213,-0.7223587875541579,0.8983050847457628,1.0,1.0,1/8,9.95%,SAMD9
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.36511766250689454,-0.7219470283563939,0.8970588235294118,1.0,1.0,5/24,15.17%,CRYBG1;GSTM3;SULF2;ATP8B1;BRCA1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.34927569064482394,-0.7219282279282264,0.875,1.0,1.0,6/34,15.17%,EYA2;RPS3;ABRAXAS1;PARG;ERCC8;BRCA1
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.35121490528635296,-0.7216567765924486,0.8688524590163934,1.0,1.0,3/26,10.72%,PLEKHA7;CLDN7;OVOL2
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3497516592728631,-0.7214109379220456,0.8888888888888888,1.0,1.0,4/29,10.34%,GABARAPL1;FIS1;GABARAPL2;ATG2A
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.372840645673449,-0.7213256915590655,0.8939393939393939,1.0,1.0,2/26,8.95%,NKD1;RBPJ
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.41902905574049537,-0.720823825147117,0.8518518518518519,1.0,1.0,2/11,13.62%,DVL1;FZD2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.41339237778070753,-0.7206434080341739,0.8076923076923077,1.0,1.0,1/7,2.73%,CD55
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.316825802040146,0.7205315811416572,0.9069767441860465,0.9796257109037355,1.0,7/22,23.91%,SIRPA;AIDA;FKTN;DNAJA1;HDAC3;PER1;HIPK3
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.37978031833757236,-0.7198511392576384,0.8387096774193549,1.0,1.0,2/28,3.00%,RSAD2;B2M
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.31889636167133595,0.7197966115082467,0.8,0.9799461158016252,1.0,7/30,10.47%,SCRIB;FZD3;SMAD3;BRINP3;PRCC;NME6;HECA
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.4097750002889197,0.7196482937007087,0.8,0.9796669925169388,1.0,5/10,15.32%,NFAT5;IRAK1;FUT9;TRAF6;TNF
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.3406805000405555,0.7189170352903088,0.84375,0.9800953701993051,1.0,9/20,28.13%,VCL;SLC9A1;PTK2;CLASP1;PEAK1;LIMCH1;CORO1C;RHOA;GPM6B
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.47664751244280423,-0.7187521852757782,0.8275862068965517,1.0,1.0,2/5,18.89%,USP19;FLOT1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.360589078378027,-0.7186668825472211,0.7931034482758621,1.0,1.0,1/23,2.05%,OST4
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.31742435366414207,-0.7185791968502765,0.961038961038961,1.0,1.0,16/76,14.32%,CYCS;AIF1;CHCHD2;NCF4;GSTP1;ERO1A;ERMP1;HSPA1B;NCF2;SELENOS;TRPV4;PRR5L;SOD1;MT3;CYBA;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.4258427760925878,0.718569797284985,0.8181818181818182,0.9799756558125525,1.0,2/6,13.91%,MAPK1;PTK2
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.3512359977520001,-0.7184753575553839,0.8450704225352113,1.0,1.0,1/30,1.08%,HLA-B
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.41997386440775053,0.7180684343048656,0.8205128205128205,0.980129756540188,1.0,4/7,22.32%,NAPEPLD;PIM1;HNRNPU;ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.31489592858568477,0.7177034471611636,0.9285714285714286,0.980061039114056,1.0,2/33,6.16%,RRAGD;GPR137C
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.36934189336154166,0.7175454795191992,0.9375,0.979833423329959,1.0,3/14,9.40%,MCU;MARCHF5;DDHD1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.3098322552237415,-0.7173384773471578,0.9210526315789473,1.0,1.0,12/63,17.65%,GLIPR2;RAB11A;ETS1;IQSEC1;PRKD2;ENPP2;PFN1;VEGFA;HIF1A;PIK3CB;AGT;RAC1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.3611191594438223,0.7172776041093538,0.8205128205128205,0.9796060342548105,1.0,5/14,15.68%,BAG3;ANP32B;TCF7L2;RAPGEF3;GSK3B
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.397052360649794,-0.7171788572610541,0.8679245283018868,1.0,1.0,1/13,4.84%,CBLB
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.43174741428596713,-0.7169976873881342,0.8225806451612904,1.0,1.0,1/7,1.73%,PRKCQ
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.47612014704389705,-0.7169211931630556,0.8181818181818182,1.0,1.0,2/6,12.89%,ENTPD5;ENTPD4
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.40251052363511847,-0.7168457712198958,0.8235294117647058,1.0,1.0,6/13,31.59%,RECQL5;NELFE;LARP7;NELFCD;RNF8;HEXIM1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.3928090777977206,-0.7167040766932198,0.875,1.0,1.0,1/16,1.13%,CCL5
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.44163683640364815,-0.7166903046055609,0.8305084745762712,1.0,1.0,1/8,9.88%,CEP72
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.44495426583697995,0.7166672441018294,0.8372093023255814,0.9799823441579811,1.0,2/6,10.45%,GNAQ;GNA11
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.40571692541970605,-0.7162851797166032,0.8260869565217391,1.0,1.0,6/12,31.59%,RECQL5;NELFE;LARP7;NELFCD;RNF8;HEXIM1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.3973990510483917,0.7162729223548604,0.8269230769230769,0.9799836778340247,1.0,1/9,2.33%,TGFA
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.3779905968370589,0.7161787120865779,0.8918918918918919,0.9795788645424263,1.0,1/14,0.27%,KLF4
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.3976543875572604,-0.7157114426374408,0.875,1.0,1.0,1/16,1.30%,PLEKHA7
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.38547468762341874,0.715532053877619,0.7692307692307693,0.9797833693191417,1.0,3/13,11.03%,LRRK2;LRCH1;WNK1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.3703777986926032,-0.7147204051242135,0.875,1.0,1.0,2/19,6.09%,MYBPC3;TTN
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.3547065172192719,-0.7147165135359449,0.8524590163934426,1.0,1.0,12/36,18.90%,ZFP36;LILRB4;RPS3;PRKD2;GLMN;TNFAIP3;PTPRC;KAT5;HAVCR2;IL1B;EZR;STOML2
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.44356951952497914,-0.7145315761723464,0.8571428571428571,1.0,1.0,2/8,15.49%,IRF1;HLA-E
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.3733451568964011,-0.7142727432063859,0.8169014084507042,1.0,1.0,2/30,1.73%,PID1;PRKCQ
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.4310366011569237,-0.7141208924028966,0.8620689655172413,1.0,1.0,2/12,4.06%,MGLL;GDPD1
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.3728479201524527,0.7138034171824618,0.868421052631579,0.9815472421798295,1.0,8/14,19.76%,ARNT2;PKD1;LIG4;PTPRR;HINFP;CHD7;TGFBR1;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.36524127722794797,-0.7137647633529017,0.8153846153846154,1.0,1.0,2/16,12.57%,IGF1;APPL1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.424542029870326,-0.7135635742248235,0.8793103448275862,1.0,1.0,4/15,14.09%,NUDT12;PARP9;NAMPT;QPRT
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.4497505684628381,-0.7132533204868374,0.8059701492537313,1.0,1.0,3/9,19.49%,NLRP12;IL1B;OPRM1
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.36165305213307736,0.7131606161207742,0.8157894736842105,0.9818012591081742,1.0,1/13,1.19%,GCLC
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.36461619123753797,0.7126798186619625,0.8,0.9818523542121292,1.0,4/12,18.60%,TLK1;SETD5;CDK9;HNRNPU
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.42893924095331426,-0.7125763013961304,0.847457627118644,1.0,1.0,1/11,4.59%,CTSB
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.2944091376056496,0.7119732067336084,0.9666666666666667,0.9820616557888422,1.0,11/53,18.44%,MYOM1;GOLPH3L;TMED10;UNC13B;CD33;RIPOR1;ARF6;CEP131;TNF;ATP13A2;CHP1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.3644250579349748,-0.7119624932058986,0.8275862068965517,1.0,1.0,1/22,2.05%,OST4
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.4654633178910965,0.7116051765980268,0.8648648648648649,0.9819923553148364,1.0,2/5,16.90%,DCC;ULK1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.4070562882529246,-0.7113673342897969,0.8448275862068966,1.0,1.0,1/12,3.29%,RORA
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.3862099482193875,0.7113566948762878,0.8857142857142857,0.9817903192570578,1.0,2/10,6.22%,MYRF;TPPP
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.36133665566037865,-0.7111892556428976,0.8970588235294118,1.0,1.0,7/30,13.26%,GAPDH;MDH2;PER2;G6PC3;GOT2;FBP1;PGK1
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.46317130261398975,-0.7110394502469934,0.819672131147541,1.0,1.0,1/6,0.74%,CCL3
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.3345076875748655,0.711013072313311,0.9069767441860465,0.9816769756599611,1.0,6/22,16.26%,VCPKMT;SMYD5;SETD3;SETD2;SETD5;SETD4
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.41871779386041286,0.7106989641905295,0.7916666666666666,0.9816016507918858,1.0,3/6,36.66%,EPHA4;INPP5F;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),-0.4768813496251375,-0.7103207718836015,0.8245614035087719,1.0,1.0,1/5,11.81%,NCKAP1L
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.45185978212818334,-0.7102111008282779,0.7636363636363637,1.0,1.0,2/7,23.51%,ADAR;DICER1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.42663395798705145,0.7101626567885063,0.825,0.9816590075956251,1.0,1/7,5.63%,CAT
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.33208769630541385,-0.7101530767082488,0.9436619718309859,1.0,1.0,11/44,22.45%,DDRGK1;GLMN;GABARAPL2;RAD23A;PSME2;GPX1;USP19;PSME1;PINK1;UFL1;PSME3
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.3910425367756595,-0.7100652235071907,0.8518518518518519,1.0,1.0,3/10,14.80%,ABCB1;ABCB4;PLTP
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.39891120219090254,0.7098442814248151,0.7631578947368421,0.9815458971055772,1.0,2/7,17.12%,PIK3C2B;PIK3CA
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.3535478451369226,-0.7097700197319159,0.8611111111111112,1.0,1.0,1/31,0.70%,CD36
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.45774604054449297,-0.7096675307304793,0.8113207547169812,1.0,1.0,2/6,23.51%,ADAR;DICER1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.29411192616592735,-0.7092395663165766,0.935064935064935,1.0,1.0,5/83,7.17%,CATIP;BTG2;RAB11A;PLEK;CORO1B
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4694633083657306,-0.7092164976989948,0.8,1.0,1.0,3/6,33.03%,NOS1AP;SUMO1;ANK3
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.3652203156205201,-0.7089899525292593,0.8448275862068966,1.0,1.0,8/34,25.31%,EFHC1;TTC19;CNTROB;STMN1;SNX9;CKAP2;MITD1;MYH10
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.40449037807190213,-0.7089563428532671,0.7868852459016393,1.0,1.0,5/10,32.81%,BRCA1;CTBP1;SPHK2;NOC2L;SET
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.4082921991070013,0.7088988095391986,0.8048780487804879,0.9822656049152912,1.0,2/10,13.47%,BOD1;NIPBL
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.36992962166781973,-0.7082764966444647,0.8695652173913043,1.0,1.0,3/18,11.81%,PLEK;LLGL2;NCKAP1L
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.40515546888217335,0.707851355728934,0.75,0.9831296226600472,1.0,3/11,18.59%,RBSN;RAB6A;SNX1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.43838744895364556,-0.7078055353828734,0.8064516129032258,1.0,1.0,1/7,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.3800328942948607,0.7071144008951801,0.8823529411764706,0.9834192912322127,1.0,3/12,11.30%,ARID1A;HMGA1;SUPT16H
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.34881399001712277,-0.7070262421020013,0.9166666666666666,1.0,1.0,6/23,21.87%,DDRGK1;KANK2;BRCA1;UFSP2;WBP2;UFL1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.2950197653598601,0.7068166668103663,0.9666666666666667,0.9833181332957022,1.0,7/30,19.85%,GRAMD1A;PTCH1;GRAMD1C;GLRA1;ADCY6;BLM;ADCY1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.43928777651343737,-0.7067854989970882,0.8166666666666667,1.0,1.0,1/7,6.84%,MAP3K12
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.4097092498648707,-0.7059246805114199,0.8253968253968254,1.0,1.0,3/12,16.68%,OVOL2;DAB2;PBLD
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.3627329518072321,-0.7057275273771233,0.8428571428571429,1.0,1.0,4/25,7.71%,MGLL;TYMP;MTCH1;SRI
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.42386937472631503,-0.704929276536753,0.8181818181818182,1.0,1.0,3/10,13.96%,NR1H2;CNEP1R1;C3
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.42679919855709525,-0.7048703599514684,0.8769230769230769,1.0,1.0,1/7,13.67%,DHODH
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.4359392177670157,0.7046206031710629,0.8095238095238095,0.9855528665653587,1.0,1/8,1.11%,PIGU
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.43238795218245984,0.7042344518054726,0.8974358974358975,0.9856206627190701,1.0,3/9,17.86%,VCL;TNF;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.2886753513704364,0.7041940825185873,0.8888888888888888,0.9851537651882646,1.0,8/33,19.95%,PARP1;PPP4R2;MMS19;SIRT6;SETD2;CGAS;ARID2;KLHL15
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.3195282106702367,-0.704177738042105,0.9577464788732394,1.0,1.0,4/59,5.45%,COL5A1;RUNX3;GADD45B;IL10RA
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.39721461947657133,-0.7041541346244394,0.8421052631578947,1.0,1.0,4/15,12.54%,DUOX1;ETS1;SPOCK2;VEGFA
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.4145468442017868,-0.7029812053998005,0.9047619047619048,1.0,1.0,2/9,19.65%,GTPBP3;URM1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.3994017612743902,0.7029216496033368,0.8571428571428571,0.986045239593669,1.0,2/11,4.40%,CDK5R1;GNAQ
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),-0.44692575793964673,-0.702709802747903,0.7931034482758621,1.0,1.0,3/6,17.80%,HSPA1B;HSPA1A;SLC15A3
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.42601580388419114,-0.7025685111564796,0.8596491228070176,1.0,1.0,4/7,30.53%,AACS;SLC27A5;HMGCL;BDH1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.4642749965805293,-0.7022386756378564,0.8545454545454545,1.0,1.0,1/6,6.62%,RANBP1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.43519851712557,0.7021943759556105,0.8461538461538461,0.9864457204789414,1.0,1/6,3.18%,B4GALT7
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.4479318059339046,0.7021211824018019,0.7551020408163265,0.9860419106501768,1.0,1/5,1.89%,ABCA2
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.4172624273830724,-0.7020290045123986,0.8035714285714286,1.0,1.0,4/11,25.38%,CFLAR;SVIL;MYL6B;MYL6
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.3259382364694172,-0.7018087617466521,0.9285714285714286,1.0,1.0,8/45,15.55%,HUS1;TIPIN;MUS81;ABRAXAS1;NOP53;CCND1;BRCA1;RAD9A
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.38796983954585806,0.7013016108090094,0.7857142857142857,0.9865298821272712,1.0,3/8,25.44%,CCDC40;DNAAF2;CABYR
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.4127020242533327,-0.7012667559162932,0.847457627118644,1.0,1.0,5/10,26.49%,CAMK1;BRCA1;PIH1D1;SMARCB1;SPHK2
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.4318979733853488,0.7012518504898038,0.7948717948717948,0.9860887823833544,1.0,5/7,22.32%,EDA2R;STX2;SMURF1;AMER2;ZBTB7B
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.43777651072389556,0.7010224973741231,0.8444444444444444,0.9858676075605632,1.0,1/5,2.45%,SIRT1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.3132989715713375,0.7003003180807778,0.8863636363636364,0.9861355620306123,1.0,2/19,7.87%,EPS8;ELMO1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.3153842523166207,0.7000989109042612,0.9655172413793104,0.9858644611937936,1.0,11/39,22.67%,FER;RELN;DYRK1A;PTK2;ERBB4;ABI1;FGFR1;FGFR2;FGFR3;SYK;ABL1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.2967010481184419,0.7000942355591806,0.8787878787878788,0.9853807200450234,1.0,4/46,6.71%,CPSF4;NSUN2;TRUB1;ZBTB8OS
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3871159040762051,0.6997363016373838,0.8372093023255814,0.985266727341087,1.0,2/12,4.40%,CDK5R1;GNAQ
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.3477149108631586,0.6996563376975761,0.7948717948717948,0.9848775906431612,1.0,5/22,14.87%,SIRT1;HMGA1;NUAK1;CDK6;CGAS
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.3701313527121891,-0.6996326310883155,0.8253968253968254,1.0,1.0,3/14,9.89%,CLU;TPT1;CD44
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.33953822654230104,0.6994174021435474,0.875,0.9846514066989126,1.0,3/17,7.45%,NUMBL;RFX3;LIG4
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.41343628038214897,-0.6992139794870221,0.8909090909090909,1.0,1.0,2/9,16.45%,NR1H2;TTC39B
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.32371031562779323,-0.6989718054203824,0.9411764705882353,1.0,1.0,6/61,7.82%,PDGFD;DUSP1;PAQR3;RGS2;GSTP1;SNF8
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.44102593530493783,-0.6988323854898719,0.8636363636363636,1.0,1.0,1/6,7.68%,NPM1
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.4610667196212471,-0.6987044341772205,0.8305084745762712,1.0,1.0,1/5,9.42%,CITED2
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.34724801592449883,0.6983686543222266,0.8787878787878788,0.9854628920615973,1.0,6/21,15.68%,BAG3;ANP32B;TCF7L2;BARD1;RAPGEF3;GSK3B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.37469471892428896,0.697827940316306,0.7631578947368421,0.985605194002414,1.0,3/13,14.80%,SMAD3;LGALS9;ITGAV
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.47424808559459775,-0.6975806536164754,0.8518518518518519,1.0,1.0,2/5,26.62%,SUPT6H;OGT
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.30765329141017267,-0.6973556240320115,0.9295774647887324,1.0,1.0,14/77,16.66%,MT2A;RACK1;ING5;HSPA1B;TP53TG5;ESR2;ING4;FBP1;BTG1;MT3;HSPA1A;NOTCH2;PSRC1;TCHP
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.3497010411384317,-0.6973505593191245,0.8181818181818182,1.0,1.0,2/20,7.73%,FIS1;ACBD5
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.3435973780275911,-0.697236132918318,0.8787878787878788,1.0,1.0,2/22,3.75%,NKD1;BBS2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.4268908381187486,-0.6964623056211202,0.875,1.0,1.0,2/11,11.51%,NR1H2;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.324037567357396,-0.6959158749721042,0.9420289855072463,1.0,1.0,7/44,13.24%,TRIM5;RACK1;TRIM22;DZIP1L;DVL1;STX10;CAMK1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.2738444564598976,-0.6956792611462207,0.9879518072289156,1.0,1.0,34/285,16.51%,FLNA;GOLGA8A;GABARAPL1;RPS23;BBS2;RAB11A;RPS3;MAK;IFT46;CEP164;NPM1;SNF8;DYNC2I1;DZIP1L;ZFYVE1;HPS4;GABARAPL2;VPS28;ATG2A;TMEM138;TMEM67;STING1;IFT81;VPS37B;TUBGCP2;EIF2A;CSNK1D;ABLIM3;IFT52;CENPF;PATL2;MIS12;MVB12A;TRAPPC6A
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.36600220533943556,-0.6955974584720411,0.8,1.0,1.0,2/15,7.73%,FIS1;ACBD5
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.36351852963315745,0.6955860313887401,0.8888888888888888,0.9874955563718705,1.0,2/12,13.00%,FBXO27;STT3B
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.46154967905946453,0.6954765875234996,0.8709677419354839,0.9871562053536664,1.0,2/7,11.69%,NRG1;BMPR1A
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.37525437584415866,0.6951630456916501,0.9069767441860465,0.9870916346068126,1.0,1/12,1.12%,DPYSL5
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.39751617344593365,-0.6949168439224447,0.8571428571428571,1.0,1.0,5/13,20.99%,ODC1;SNF8;ITGB1;CHMP6;CENATAC
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.3301038333944829,-0.6947910448899055,0.8939393939393939,1.0,1.0,5/28,12.17%,PDXDC1;SEMA6A;CENPV;GPC3;ITGA4
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.44108447574093,-0.6943418252081045,0.8928571428571429,1.0,1.0,3/10,14.09%,GLUL;GOT2;QPRT
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.36325175548544847,0.6939854042153197,0.8611111111111112,0.9878313671175151,1.0,3/17,8.94%,SIRT1;HMGA1;HDAC1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.407371781039417,-0.6932035346521396,0.8636363636363636,1.0,1.0,1/8,7.25%,IQSEC1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.36988599035268616,0.6926742446675294,0.8695652173913043,0.9885953027362567,1.0,4/11,14.32%,EME2;MSH4;ERCC4;HFM1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.32763262909679425,-0.6923893214000947,0.9152542372881356,1.0,1.0,1/41,1.94%,TPP1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.38956700090673974,0.6917589887720679,0.918918918918919,0.9890719892971525,1.0,1/8,1.22%,ZNRF3
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.31481629238264547,-0.6912785909117023,0.92,1.0,1.0,11/90,14.57%,CCDC88C;CCL5;NLRC5;ITGA6;NUP50;GLMN;NCKAP1L;NOP53;CDKN1C;HIF1A;MCM7
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.4332386461715033,0.690701675179599,0.8421052631578947,0.9897660961711607,1.0,3/6,23.79%,PUS1;TRMT10C;TRIT1
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.4259339959588354,0.6906938015401052,0.8076923076923077,0.989283518844895,1.0,3/5,36.66%,EPHA4;INPP5F;PTPRS
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.27177051104085076,0.6905571456104357,0.9354838709677419,0.9888947002994406,1.0,8/57,15.32%,PTPN9;PICALM;CIB1;MMP14;PRKCI;ARF6;DPP10;TNF
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.4018156758406482,0.6902982020248444,0.8604651162790697,0.9887051789188079,1.0,2/7,15.32%,NUAK1;TNF
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.3449019959926007,-0.6898879225398844,0.8793103448275862,1.0,1.0,4/23,17.99%,APOD;OAS1;FBP1;PGM1
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.33855452891422,-0.6897536265677159,0.9130434782608695,1.0,1.0,3/28,5.97%,LPCAT1;NFS1;GNPAT
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.28422338655660523,0.6896122524990485,0.9705882352941176,0.9889942564066111,1.0,6/45,11.55%,FGF2;SIRT1;PPP1R10;HGF;SIRT6;UBE2N
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.4258912312581885,-0.6894230883196006,0.8679245283018868,1.0,1.0,5/8,25.72%,EXOSC10;FBL;LARP7;PARN;TENT4B
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.4118773552341524,0.6893967062978302,0.8571428571428571,0.9887489796821879,1.0,4/8,29.23%,PIP4K2A;DAB2IP;PIP4K2B;PIK3IP1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.3408838536821795,-0.6893684984983557,0.9032258064516129,1.0,1.0,2/38,1.90%,CCDC88C;WARS1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.46009468446474566,0.6893509636180666,0.8444444444444444,0.9883301419370678,1.0,2/7,1.72%,PDPN;GSN
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.3294804215852607,-0.6892670817337004,0.9041095890410958,1.0,1.0,2/36,4.67%,USP36;SYNE1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.34623978145482853,-0.6891795495089676,0.819672131147541,1.0,1.0,1/27,1.73%,PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.30659380326294083,0.6886244567961127,0.9714285714285714,0.9885879595885368,1.0,4/26,7.57%,SERPINE1;SERPINE2;TIMP3;RECK
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.45728150004798357,0.6885421681762578,0.8372093023255814,0.9882006126031063,1.0,1/5,2.28%,SPRY2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3257255287024676,-0.6884432772782535,0.8939393939393939,1.0,1.0,7/37,15.75%,CARD16;NAIP;LAMTOR5;CD44;VEGFA;MT3;GPX1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.2840890270745867,0.6883190831862946,0.9615384615384616,0.9879438016560305,1.0,3/47,5.61%,MEPCE;NSUN2;TFB1M
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.3622982793251096,-0.6881974345037495,0.9295774647887324,1.0,1.0,8/31,23.83%,PRLR;ACAA1;STARD3;NPC1;CYP27A1;CYP3A5;CYP19A1;SCP2
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.4355443934578761,0.6874595037242416,0.86,0.9884430393718759,1.0,1/5,12.37%,MAPKAPK2
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.37036945954885847,-0.6871948695974401,0.8714285714285714,1.0,1.0,4/17,10.64%,LILRB4;IGF1;RPS3;BTN2A2
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.38344598255277773,0.6867811101080495,0.9090909090909091,0.9886693415182998,1.0,6/16,15.83%,MYRF;CSPG5;TPPP;CDK6;NF1;SOX4
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.2735338514907953,0.6867575650507727,1.0,0.9882084376537005,1.0,12/86,11.60%,RUVBL2;SIRT1;MIER3;MTA2;HDAC9;RPS6KA4;HDAC1;TRERF1;TBL1XR1;KAT2A;UBE2N;NSD3
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3461359797784162,0.6865922590184499,0.84375,0.9879026323092256,1.0,2/26,6.16%,RRAGD;GPR137C
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.33071414537809585,0.6864668609832822,0.9032258064516129,0.9875538417940571,1.0,9/28,29.86%,EXOC8;CLCN3;HOOK3;PLEKHJ1;WASHC4;CORO1C;HOOK1;CHMP2B;LAPTM4B
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.3989487673387532,-0.6862817017574714,0.864406779661017,1.0,1.0,2/9,9.64%,CSTF2T;NCBP2
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.4609109971095324,-0.685826591715533,0.8208955223880597,1.0,1.0,2/5,9.14%,SLC7A5;LLGL2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3020402048145944,-0.6857901053192831,0.9726027397260274,1.0,1.0,8/69,13.97%,SYAP1;CDC37;SNF8;CALM1;MTCP1;ACTB;CAMK1;CCND1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.4084066960880614,0.6856210807631861,0.8648648648648649,0.9879408181709174,1.0,1/6,6.35%,TSPOAP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.32837199538042194,0.685153254307213,0.9090909090909091,0.9879567948347845,1.0,1/19,2.45%,SIRT1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.3771665713195529,-0.6842254493192068,0.859375,1.0,1.0,3/15,20.06%,SNF8;CHMP6;SMPD3
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.42592825598652884,-0.68394445166966,0.8947368421052632,1.0,1.0,1/14,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.4177874418723721,-0.6838328352389218,0.8035714285714286,1.0,1.0,3/8,25.78%,CTBP1;PIH1D1;SMARCB1
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.36400970928128124,-0.6829595141411585,0.828125,1.0,1.0,4/18,16.10%,TNFSF10;FBP1;CASP5;NOD2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3137191522107469,0.6828973183203076,0.92,0.9898126368121397,1.0,5/30,13.18%,SIRT1;BOK;FHIT;ZNF385B;BAG6
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.40105234022749514,-0.682839639681611,0.8333333333333334,1.0,1.0,4/13,19.30%,CLDN7;OVOL2;CFTR;GPRC5C
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.3327365391180547,-0.6825522794658648,0.90625,1.0,1.0,8/35,17.42%,CARD16;NAIP;LAMTOR5;CD44;VEGFA;MT3;GPX1;CST7
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.4297478115242299,0.6824053122827264,0.8095238095238095,0.9898647195560166,1.0,2/7,18.07%,NF1;ORAI1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.4278569285988442,-0.6821675425946431,0.8484848484848485,1.0,1.0,4/8,18.30%,SELENOS;CD47;RAC1;NOS1AP
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.4610434408211086,-0.6818469301313222,0.8703703703703703,1.0,1.0,1/6,9.42%,CITED2
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.3765275086493628,-0.6812962575174167,0.8983050847457628,1.0,1.0,5/20,12.85%,DDRGK1;CHI3L1;NAMPT;CD44;SULF2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.30902740110653076,-0.6812401133812327,0.9722222222222222,1.0,1.0,16/73,22.76%,FCER1G;HLA-DRB5;DCTN6;DCTN4;HLA-DRA;AP2S1;DYNC1LI2;HLA-DPA1;SEC13;HLA-DMB;CD74;HLA-DPB1;DCTN2;DYNC1I2;HLA-DRB1;CLTA
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.42036906034057575,0.68102838077101,0.8478260869565217,0.9907371130256168,1.0,2/7,8.92%,CAB39;NEDD4L
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.41127906956502724,-0.6799988951086191,0.8620689655172413,1.0,1.0,2/9,19.65%,GTPBP3;URM1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.347077900984202,-0.6794888726930304,0.8955223880597015,1.0,1.0,3/22,13.17%,PRUNE1;PFN1;FCHSD1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.3686220122918137,-0.6790326556314906,0.9402985074626866,1.0,1.0,6/18,19.82%,AIF1;CORO1B;BAIAP2L2;CALD1;EZR;NEDD9
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.40224541816391507,0.6789220154782104,0.8695652173913043,0.9924286283648167,1.0,2/6,24.28%,RIPK1;TGFB1
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.3073215451276372,-0.678720138747154,0.987012987012987,1.0,1.0,4/90,4.89%,TGFBR3;RIMS1;HAMP;RGS16
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.2594903090595567,-0.6784369748682654,1.0,1.0,1.0,29/332,12.61%,PLEKHG5;ARHGAP4;RASGRF2;CHD3;VAV3;RPL5;GMIP;RPL11;IER3;DDIT4;HUS1;ING5;ARHGEF1;RHOU;OBSCN;TMSB4X;ARHGEF3;PRKAR1B;PRKD2;SGK1;SRGAP3;ANKRD54;ITFG2;ENTPD5;NLRP12;VEGFA;BRIP1;A2M;NOP53
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.4136024388424299,-0.6780799337153133,0.8461538461538461,1.0,1.0,1/7,5.78%,HESX1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.3669155276885055,0.6779448538387284,0.9117647058823529,0.9929476975575828,1.0,3/13,11.74%,ASPA;SLC25A21;GCDH
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),0.4289854873124477,0.67762638956822,0.8809523809523809,0.9928257091606666,1.0,2/5,24.54%,DBI;RAB3GAP2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3322317228692815,0.6775826415739212,0.9411764705882353,0.9923837146774387,1.0,4/19,11.80%,PARP1;GNL3L;ERCC4;HNRNPC
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.35694431358156864,0.6775033764798534,0.925,0.9919790659677861,1.0,6/16,18.44%,CIB1;SLC9A1;TNF;GSK3B;CAMTA1;CHP1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.43618723139598414,0.6772313048642922,0.8571428571428571,0.9917285646011248,1.0,1/6,2.28%,SPRY2
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.3201502274139602,0.6771353286311035,0.9230769230769231,0.9913676526209984,1.0,5/24,19.15%,PBX1;BMPR1B;PBX3;SMOC1;CHD7
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.38518321593066307,-0.676370838877916,0.8225806451612904,1.0,1.0,5/15,22.46%,HIF1A;PIK3CB;IL1B;NOS1AP;PARK7
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.38020164614338897,-0.6762164002332991,0.8235294117647058,1.0,1.0,1/11,7.08%,XRCC3
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.3162680408774595,-0.6760091421520363,0.9452054794520548,1.0,1.0,2/39,3.00%,SNX6;B2M
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.37702399111418083,0.6758155115392476,0.8043478260869565,0.9922912616116972,1.0,3/12,14.98%,SIRT1;HDAC1;SETD5
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.3958401736521333,0.6756524421500155,0.8055555555555556,0.9914962764138309,1.0,3/7,24.28%,PELI1;RIPK1;SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.3958401736521333,0.6756524421500155,0.8055555555555556,0.9914962764138309,1.0,3/7,24.28%,PELI1;RIPK1;SLC25A4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.42064619002719505,-0.6755277854323708,0.8979591836734694,1.0,1.0,2/8,14.23%,TNFAIP3;CYBA
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.36099720214396624,0.6755154213862625,0.8292682926829268,0.9911300346637698,1.0,2/10,12.32%,FBN2;NF1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.4293888745246345,-0.6751775026148705,0.9047619047619048,1.0,1.0,2/10,8.01%,RGS2;TRPM4
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.33492187993759737,-0.675062309772266,0.9705882352941176,1.0,1.0,4/31,10.67%,NR1H2;RBPJ;PCTP;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.3946244573902571,-0.6745640607661032,0.8833333333333333,1.0,1.0,5/10,21.38%,TRUB2;C1QBP;RPUSD4;RPUSD3;UQCC2
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.30091689844555475,0.6744685421511241,0.8484848484848485,0.9901278623625971,1.0,2/11,12.34%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.30091689844555475,0.6744685421511241,0.8484848484848485,0.9901278623625971,1.0,2/11,12.34%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.30091689844555475,0.6744685421511241,0.8484848484848485,0.9901278623625971,1.0,2/11,12.34%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.30091689844555475,0.6744685421511241,0.8484848484848485,0.9901278623625971,1.0,2/11,12.34%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.3995039364453056,-0.6739617279793435,0.8225806451612904,1.0,1.0,2/10,19.39%,NOS1AP;AKAP9
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.4410130924741249,-0.6735886073265932,0.9473684210526315,1.0,1.0,2/6,19.40%,NOTCH2;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.402956168953135,0.6733918355695342,0.8695652173913043,0.9901880017559687,1.0,4/8,18.36%,CIB1;SLC9A1;TNF;CAMTA1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.402956168953135,0.6733918355695342,0.8695652173913043,0.9901880017559687,1.0,4/8,18.36%,CIB1;SLC9A1;TNF;CAMTA1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.32492795673932817,-0.6730520192832316,0.9444444444444444,1.0,1.0,10/43,22.24%,FIS1;ATP5IF1;NUP50;HIF1A;COX7A2;SEC13;NUP88;PINK1;UQCC2;NUP155
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.33288633286299946,0.6730480189781711,0.9487179487179487,0.9900315228829271,1.0,3/17,6.80%,PDGFA;NEK10;PDGFC
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.4110502617563331,-0.6729521630929468,0.8035714285714286,1.0,1.0,3/6,24.44%,MT3;CYP27A1;SCARF1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.4110502617563331,-0.6729521630929468,0.8035714285714286,1.0,1.0,3/6,24.44%,MT3;CYP27A1;SCARF1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.4110502617563331,-0.6729521630929468,0.8035714285714286,1.0,1.0,3/6,24.44%,MT3;CYP27A1;SCARF1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.3317549008418887,-0.6728657023110189,0.9285714285714286,1.0,1.0,8/21,25.56%,NYNRIN;NHP2;NUDT16;TRIR;ERN1;PARN;DICER1;RNASE6
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.4213418444105249,-0.672720583021765,0.8703703703703703,1.0,1.0,1/7,12.54%,VEGFA
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.3012937364016151,0.6723503081303713,0.8928571428571429,0.9902113539352583,1.0,9/30,19.15%,GRM5;NF1;LINS1;NIPBL;RP9;SETD5;TNF;MAGT1;CHD7
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.30935991399102225,0.6719282010100555,0.9047619047619048,0.9901344316701615,1.0,4/32,7.66%,MAML2;PBX1;JAG1;MAML3
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.423078944335875,0.6716002233097733,0.8679245283018868,0.9899476722798218,1.0,3/5,12.38%,MYADM;FERMT2;TJP1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.4344574330373726,-0.6713856900934836,0.8656716417910447,1.0,1.0,2/6,23.41%,RBX1;CAND2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.36437087143463576,-0.6711199502947183,0.8813559322033898,1.0,1.0,6/18,19.16%,LIPG;NR1H2;ABCB4;ABCA8;TTC39B;ABCA5
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.3899064071538956,-0.6704588389744839,0.8709677419354839,1.0,1.0,3/14,19.30%,ADGRG6;PKP2;GPRC5C
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.3686258830906286,0.6694901022234626,0.85,0.9914822028722392,1.0,4/9,26.11%,NIN;HOOK3;PCM1;BICD2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.328873958409864,-0.6691833909368585,0.9130434782608695,1.0,1.0,7/34,17.26%,CHRM2;TACR1;C5AR1;P2RY8;LPAR6;C5AR2;AGT
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.4002012766372679,-0.6683859296329463,0.8833333333333333,1.0,1.0,5/9,18.77%,PID1;SELENOS;PEA15;IL1B;INPP5K
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.4337052975073262,-0.6683789308594685,0.8571428571428571,1.0,1.0,1/5,6.24%,SLC25A5
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.41464315081937114,-0.6682907053948715,0.8823529411764706,1.0,1.0,1/8,11.74%,KDM7A
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.2872466155733228,0.6682033325735557,1.0,0.9921429214694799,1.0,14/51,18.09%,CPSF4;WDR33;SSU72;PCF11;CDK7;SCAF8;CPSF7;TAF1A;NUDT21;POLR2H;PAPOLA;SNRPB;GTF2H3;ERCC2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.2981565927100271,-0.6677416756314559,0.9863013698630136,1.0,1.0,8/65,13.34%,EPHB1;NLRC5;TTN;MUSK;ANKRD54;SOD1;ZNF16;CDKN1C
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.35262144811985174,-0.6675603670846769,0.9482758620689655,1.0,1.0,7/21,25.72%,EXOSC10;ZCCHC8;DEDD2;NUDT16;TRIR;PARN;TENT4B
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.4112012427141637,-0.667347290176664,0.9074074074074074,1.0,1.0,1/7,6.78%,EXOSC10
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.3614619108670417,-0.666963307759257,0.9253731343283582,1.0,1.0,6/19,19.82%,AIF1;CORO1B;BAIAP2L2;CALD1;EZR;NEDD9
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.39676201867965566,0.6666556279237007,0.82,0.9930590994937671,1.0,4/7,34.71%,SIRT2;ECT2;CDC42;APC
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.2780593133111252,-0.6663299937927135,1.0,1.0,1.0,2/84,1.64%,CCDC88C;GRAP2
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.38939152034478874,-0.6662491984941642,0.9310344827586207,1.0,1.0,2/14,12.00%,NEFL;SOD1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.3233597692792776,-0.666143568609432,0.9375,1.0,1.0,7/30,16.86%,AURKAIP1;ATP5IF1;TNFRSF1B;CYFIP2;WDR48;SNX9;IL1B
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.3503511279555165,0.6657749488107646,0.8378378378378378,0.9933344812424784,1.0,4/14,14.39%,GCLC;KCNMB4;SCPEP1;ADCY6
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.3670808468287692,-0.6655354467831167,0.8833333333333333,1.0,1.0,6/15,21.45%,DNAJB9;PHB2;PTPRC;HLA-E;SUPT6H;EPHB2
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.3514716219505127,0.6655206675822819,0.8333333333333334,0.9921385753227923,1.0,3/10,19.63%,CDC23;NSMCE2;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.3514716219505127,0.6655206675822819,0.8333333333333334,0.9921385753227923,1.0,3/10,19.63%,CDC23;NSMCE2;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.3514716219505127,0.6655206675822819,0.8333333333333334,0.9921385753227923,1.0,3/10,19.63%,CDC23;NSMCE2;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.35291023115336384,0.6652753908347583,0.972972972972973,0.9920124014935515,1.0,1/16,2.17%,HIP1R
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.36683338965249573,-0.6650259747421267,0.92,1.0,1.0,2/11,8.74%,RAB3A;RAB3D
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.3703785701361232,-0.664963920170974,0.8888888888888888,1.0,1.0,3/13,12.54%,ZNF335;PTN;VEGFA
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.3571813939944443,-0.6636966647911267,0.875,1.0,1.0,7/15,31.36%,CTDP1;TAF11;NUCKS1;SMARCB1;TFAP4;CHD1;SNW1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.39919130058006347,-0.6635251612096402,0.8461538461538461,1.0,1.0,1/7,13.67%,DHODH
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.4313672027920845,-0.6629607378364175,0.8461538461538461,1.0,1.0,2/7,15.17%,KANK2;BRCA1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3378022501813908,-0.6628172001975278,0.9333333333333333,1.0,1.0,1/22,4.60%,TCEA2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.33065939931427524,-0.6627342021003702,0.971830985915493,1.0,1.0,9/38,16.86%,CD14;PHB2;RPS3;EIF2AK2;IFI35;NLRP12;TERF2IP;NOD2;IL1B
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.33754526800894863,0.6622996337122965,0.9722222222222222,0.9942575362877241,1.0,6/17,19.80%,TPPP;SLAIN2;TUBGCP6;CLASP1;CLASP2;NDE1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3395798843908161,-0.6622551017726767,0.9384615384615385,1.0,1.0,2/26,6.70%,DUSP1;GSTP1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.37264345947211536,0.6622374352656097,0.8723404255319149,0.9938266198433017,1.0,1/8,9.26%,RUNX1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3045570078420626,0.6619608016178588,1.0,0.9935904874422761,1.0,8/35,11.03%,PPARG;ABHD8;SLC4A4;NEDD4L;ACOX3;VGF;FBXW7;WNK1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.424316833918627,-0.66190771049463,0.8571428571428571,1.0,1.0,4/5,21.78%,COA6;COX18;CYBA;SURF1
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.4210039458998621,-0.6614427764912646,0.864406779661017,1.0,1.0,3/6,23.95%,NPM1;NUP88;NMD3
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.3233227577679145,-0.6612009036304999,0.926829268292683,1.0,1.0,5/35,15.09%,PARP9;RPL10;EIF2A;RBM4B;PUM3
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.43814606251533034,0.6611027934010558,0.868421052631579,0.9939252812432121,1.0,2/6,28.69%,USP7;BAP1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.29130409752941444,-0.6607230355425824,0.972972972972973,1.0,1.0,17/89,18.64%,RPS4X;RPL5;NLRC5;IGF1;NPM1;PRKD2;NAMPT;EIF4A3;NLRP12;NOD2;CIITA;ZCCHC4;IL1B;VIM;PASK;ATAD5;EEF2
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.44138098823327465,0.6604532800749111,0.8372093023255814,0.9936112996010781,1.0,1/5,4.24%,SIRPA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.44138098823327465,0.6604532800749111,0.8372093023255814,0.9936112996010781,1.0,1/5,4.24%,SIRPA
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.40845850115787075,-0.6603437522316083,0.8813559322033898,1.0,1.0,2/11,20.80%,TERF2IP;CTC1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.43228988729293105,-0.6603222645529521,0.86,1.0,1.0,1/5,11.13%,FYN
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.38946253855682883,0.6602637456026422,0.9090909090909091,0.9933454049967219,1.0,2/7,21.78%,GAB2;SYK
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.3170015786380427,-0.6601012239796074,0.9545454545454546,1.0,1.0,9/36,18.89%,B2M;CLU;VPS28;GPC3;NCKAP1L;C3;DAB2;CALY;FLOT1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.41215579147064035,-0.660071517689366,0.8571428571428571,1.0,1.0,1/8,4.83%,DDIT4
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.3555850463901281,-0.6599535287856381,0.967741935483871,1.0,1.0,1/19,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.29476375056215315,0.6591490544436137,1.0,0.9937826952297364,1.0,4/24,11.50%,ZDHHC3;HHAT;GOLGA7;ZDHHC11B
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3934424476129584,-0.6591402777860849,0.8166666666666667,1.0,1.0,2/9,6.24%,CHCHD10;SLC25A5
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.3914618668867581,-0.6583165003051634,0.8392857142857143,1.0,1.0,4/8,26.49%,AKAP8;CTBP1;AKAP8L;SPHK2
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.3804288185360064,-0.6582938799112703,0.9047619047619048,1.0,1.0,7/17,19.52%,RIPOR2;NCKAP1L;C1QBP;C5AR2;RAC1;CD74;RAC2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.40919419393814394,-0.6581602870683203,0.8870967741935484,1.0,1.0,3/11,19.49%,NLRP12;IL1B;OPRM1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.34008755212028513,0.6570115577890427,0.9487179487179487,0.9953037528689366,1.0,6/14,18.59%,MAP2K1;LGALS9;MAPK1;CTSH;ITGAV;MAP2K2
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.3599524331417826,-0.6569385576640798,0.8888888888888888,1.0,1.0,5/15,21.38%,TRUB2;C1QBP;RPUSD4;RPUSD3;UQCC2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.2929266486802535,0.6568150617319456,0.9166666666666666,0.9950616498494149,1.0,7/30,18.22%,ARID1A;PLPP1;TRERF1;NCOA4;NEDD4;NR3C1;RBFOX2
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.3286209178133991,-0.6567464109747453,0.8732394366197183,1.0,1.0,4/25,18.93%,XRCC3;THAP9;RECQL5;WRN
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.41781512332382215,-0.6557752499187708,0.8666666666666667,1.0,1.0,1/6,19.54%,SHMT1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.2983740838299181,-0.6557580916637653,0.9605263157894737,1.0,1.0,5/63,8.68%,SRGN;TSPAN32;ISCA1;PITRM1;NNAT
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.4037638252273026,0.6554137272129151,0.9024390243902439,0.9957213965141953,1.0,2/8,12.24%,DCUN1D4;DCUN1D1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.32686859095086807,-0.6551205613056993,0.9117647058823529,1.0,1.0,4/31,13.28%,ING5;GLUL;ING4;ZDHHC16
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.4353569957263611,-0.6550497694769604,0.9019607843137255,1.0,1.0,1/6,14.74%,PTPRB
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.3482798209380036,-0.6548906231694865,0.9076923076923077,1.0,1.0,5/17,19.93%,BUD23;ZCCHC4;NHP2;NOP10;FBL
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.3127934203844649,-0.6543731964558465,0.9726027397260274,1.0,1.0,7/34,22.24%,SSB;NUP50;XPOT;SEC13;NUP88;YBX1;NUP155
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.34958407540141223,-0.65419616616919,0.9420289855072463,1.0,1.0,2/20,14.32%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.2851041316060532,0.6539741134029372,1.0,0.996362373005495,1.0,5/26,18.03%,AP3B2;AP3S1;FBXW11;DYNC1H1;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.43602309838759323,0.6536040525437012,0.8666666666666667,0.9962652023737696,1.0,2/5,18.92%,NFATC3;NFATC2
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.3590004138361308,0.653566337440577,0.9,0.9958236986263661,1.0,2/12,6.22%,MYRF;TPPP
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.40129896084871586,-0.653391062812157,0.8421052631578947,1.0,1.0,1/9,6.70%,GSTP1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.42593327156383565,-0.652772998891132,0.9245283018867925,1.0,1.0,1/6,8.08%,GLA
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.37717337573140935,0.6521881387804513,0.8085106382978723,0.9966086691309787,1.0,4/8,22.40%,NLGN1;NRXN2;PCLO;NRXN1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.3770138797760431,-0.6521804953862335,0.8955223880597015,1.0,1.0,3/12,21.46%,ACTG1;RAC1;WAS
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.3186684340205074,0.6518833568204482,0.8275862068965517,0.9963847464683963,1.0,3/23,7.93%,MAPK11;HDAC9;CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.35711529105381534,0.6517942863771737,0.925,0.9959739823214678,1.0,4/11,15.32%,SMAD7;IRAK3;CUEDC2;TNF
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.2651786737467019,0.6515580411079445,1.0,0.9956420110274334,1.0,10/64,13.18%,UBE2J1;SEL1L;DNAJB2;AUP1;FAM8A1;DNAJC18;RNF185;FBXO27;STT3B;BAG6
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.3303285713209953,-0.6515513362027258,0.9692307692307692,1.0,1.0,1/23,0.89%,TGFBR3
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),0.4165088685504792,0.6515319491661064,0.8431372549019608,0.9951897878633743,1.0,1/5,9.02%,ALOX5AP
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.38260236079915216,-0.6515266391145443,0.9137931034482759,1.0,1.0,1/12,4.39%,EPHB1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.3550787361190083,-0.6513427021409701,0.9104477611940298,1.0,1.0,6/19,25.75%,LGALS1;VPS37B;CD74;HLA-DRB1;KPNA2;CD4
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.35078814385634705,0.6511597754480037,0.8857142857142857,0.9949669580109514,1.0,5/10,19.76%,FBN2;NIPBL;MEGF8;RYR2;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.3670476999813297,-0.651068865084996,0.8688524590163934,1.0,1.0,1/12,4.74%,APOD
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.36730925995362107,0.6508759155368776,0.9333333333333333,0.9947322933046172,1.0,2/12,6.63%,LDLR;PFDN4
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.27847040331149614,-0.6504457063330837,0.9873417721518988,1.0,1.0,9/91,12.99%,RASGRF2;PPP1R15A;DDRGK1;DNAJB9;ERO1A;SELENOS;ATF3;TMCO1;ATG10
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.39994510100433917,0.6499878203518774,0.8846153846153846,0.9949553505345314,1.0,2/5,22.32%,CD274;ZBTB7B
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.41680167111801736,0.6492216467065588,0.8787878787878788,0.9950277747829525,1.0,5/9,23.13%,DCP1B;LSM1;DCP2;EDC3;DCP1A
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.38065736505632336,-0.648971466475746,0.9365079365079365,1.0,1.0,2/13,18.17%,GSTP1;CD74
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.3568999604586795,0.6488358362621136,0.9142857142857143,0.994847539810591,1.0,9/9,64.34%,SLC27A1;LCLAT1;PGS1;PLA2G6;HADHA;PNPLA8;TAMM41;PLA2G4A;HADHB
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.3123408530395499,-0.6482885531468854,0.9230769230769231,1.0,1.0,7/42,14.46%,CCL5;PRKD2;CITED2;NCKAP1L;VEGFA;CD47;C1QBP
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.3809593862171493,0.648195338292555,0.9318181818181818,0.9948778679493683,1.0,2/10,11.36%,LDLR;KAT2A
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.31049576031557935,-0.6475896980652994,0.9384615384615385,1.0,1.0,5/50,9.63%,RAB11A;KLHL13;ENTR1;CALM1;CENPV
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.27349415517416675,0.6464798819590706,0.9375,0.9958154370660267,1.0,10/37,22.56%,ARID1A;MTA2;HDAC1;HNRNPC;ARID1B;VPS72;MBD3;ACTL6A;SMARCA2;SMARCC1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.35640044409928767,0.646009835685368,0.9130434782608695,0.9957371807390063,1.0,5/14,14.95%,NLGN1;CDH20;CDH11;CDH8;CDH19
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.2733709090434969,0.6459289952949938,0.9259259259259259,0.9953768685355951,1.0,12/57,18.71%,CBFA2T3;NUP153;NUP188;NUP42;SLC4A4;GIT1;P2RX7;PRKAA1;NUP133;NDC1;NUP205;ZBTB20
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.39275317659288567,-0.6456473823340929,0.8615384615384616,1.0,1.0,3/8,20.49%,RAB11A;EZR;LIMK2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.3694036586606162,-0.6453867494645144,0.9344262295081968,1.0,1.0,1/12,6.20%,SEMA6A
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.362710655913113,0.6449260338020074,0.8378378378378378,0.9956768877648462,1.0,1/12,2.45%,SIRT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.29333920124246327,-0.6439767242395968,0.9861111111111112,1.0,1.0,16/75,22.76%,FCER1G;HLA-DRB5;DCTN6;DCTN4;HLA-DRA;AP2S1;DYNC1LI2;HLA-DPA1;SEC13;HLA-DMB;CD74;HLA-DPB1;DCTN2;DYNC1I2;HLA-DRB1;CLTA
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.4183987113513414,-0.6437302463141888,0.9583333333333334,1.0,1.0,1/6,6.78%,EXOSC10
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.40701635594457247,-0.6436362998358434,0.9016393442622951,1.0,1.0,3/8,23.32%,PCSK5;SPCS2;SEC11A
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.37908491530320976,-0.6435014862302767,0.8870967741935484,1.0,1.0,6/13,19.52%,RIPOR2;NCKAP1L;C1QBP;RAC1;CD74;RAC2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.37908491530320976,-0.6435014862302767,0.8870967741935484,1.0,1.0,6/13,19.52%,RIPOR2;NCKAP1L;C1QBP;RAC1;CD74;RAC2
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.32008483511203606,0.6434218353790553,0.972972972972973,0.9964024200810889,1.0,4/18,14.37%,MMP14;CTSH;GRIN2A;NLRC4
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.270990971362596,0.6432337568629901,1.0,0.9960662803189904,1.0,16/46,19.66%,WNT5A;RAB7A;NEDD4L;FZR1;SORL1;BARD1;SMURF1;TNF;GSK3B;IDE;TIPARP;NEDD4;HACE1;FOXO1;CSNK2A1;PLK2
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.2756249985872405,-0.6431648180486006,0.9866666666666667,1.0,1.0,8/127,6.31%,CCL3;SLC7A5;PARP14;PARP15;DDRGK1;RACK1;IGF1;PARP9
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.3732663305985975,-0.6427602893175306,0.9032258064516129,1.0,1.0,3/18,9.27%,CDH23;SCN9A;C5AR1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.32826802372301533,0.6417496387901408,0.9024390243902439,0.996880820807245,1.0,5/17,15.59%,COL11A1;MMP14;SETD2;ITGAV;COL6A1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.36991046604333555,-0.6415074222311885,0.9516129032258065,1.0,1.0,6/14,19.52%,RIPOR2;NCKAP1L;C1QBP;RAC1;CD74;RAC2
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.33845942363626236,-0.6409287353115091,0.9365079365079365,1.0,1.0,4/18,21.06%,DTX3L;UHRF1;LEO1;ATXN7L3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.3770449291215782,-0.6402118005693841,0.9285714285714286,1.0,1.0,2/10,9.64%,CSTF2T;NCBP2
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.41529130182750046,-0.6401571018946909,0.9,1.0,1.0,1/7,8.60%,NAMPT
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.415177770191674,-0.6399789659087717,0.8775510204081632,1.0,1.0,1/5,18.05%,HAT1
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.415177770191674,-0.6399789659087717,0.8775510204081632,1.0,1.0,1/5,18.05%,HAT1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.40376802148633195,-0.6396119142900004,0.8771929824561403,1.0,1.0,2/5,24.61%,HOOK2;AKTIP
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.37135643453834155,-0.6394204510381354,0.9818181818181818,1.0,1.0,2/17,6.30%,CLU;IGF1
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.439550350896016,0.6394076430417623,0.9090909090909091,0.9981856678369764,1.0,2/5,15.32%,PRKCI;TNF
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.2912728698732472,-0.6393701291242992,0.9701492537313433,1.0,1.0,15/52,25.00%,NPM1;HK2;CDC7;SEPHS1;CENPF;FANCI;ZGRF1;ATAD5;MSH6;NCL;LIG3;FANCD2;PHF6;MCM3;WDHD1
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.3061871003704779,-0.6391327514092654,0.9466666666666667,1.0,1.0,4/32,15.79%,SSB;NUP50;XPOT;SEC13
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3061871003704779,-0.6391327514092654,0.9466666666666667,1.0,1.0,4/32,15.79%,SSB;NUP50;XPOT;SEC13
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.46186030470956685,-0.6378449763177525,0.9245283018867925,1.0,1.0,1/5,10.07%,HPS4
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.31126000746965815,0.6375685466745451,0.918918918918919,0.9993097149505707,1.0,1/13,2.18%,NOL9
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.3670145477545856,0.63715885178507,0.9130434782608695,0.9991284019868959,1.0,6/6,63.32%,SLC27A1;CDS2;PGS1;PLA2G6;GPAM;TAMM41
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.26883444566624903,-0.6370216477760636,0.987012987012987,1.0,1.0,6/71,11.77%,GZMB;CEMIP;FIS1;FYN;ITGB2;PDCD5
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.2906067301089106,0.6364690274423598,0.975609756097561,0.9992223505387863,1.0,7/21,17.46%,TMEFF2;WASF2;SHANK3;TJP1;CLASP1;PHLDB2;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.43652656570320497,-0.636350606899626,0.8909090909090909,1.0,1.0,1/5,18.77%,INPP5K
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.3928456114933784,0.6356281672951635,0.8536585365853658,0.99939989539461,1.0,2/5,15.32%,TRAF6;TNF
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.27147099645237655,-0.6351076589028797,1.0,1.0,1.0,19/132,17.88%,TFRC;HUS1;TIPIN;ING3;RANBP1;ILF3;BRCA2;PNN;NAA38;DNMT1;RPA3;MCM7;STMN1;SRSF2;BRCA1;PRDX4;SMC1A;RFC1;MCM6
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.38975977457032857,-0.6347801961011738,0.9615384615384616,1.0,1.0,2/6,19.88%,IRF1;TNFRSF14
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.28561382582593337,0.6344104594038013,0.9411764705882353,0.999935753155199,1.0,2/25,11.40%,AEBP2;SMYD5
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.30916377480767654,-0.6343104318460528,0.971830985915493,1.0,1.0,11/31,25.81%,HUS1;ABRAXAS1;NOP53;NABP1;BRCA1;CHFR;NAE1;CDKN1A;RINT1;BRCC3;DONSON
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.4054297072103617,-0.6342447428230169,0.8823529411764706,1.0,1.0,1/7,14.30%,SEC62
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.35187053795469425,-0.6330344842268043,0.9104477611940298,1.0,1.0,3/12,14.06%,TTN;VEGFA;KDM6B
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.29156663769495667,0.6328261555089958,0.918918918918919,1.0,1.0,7/22,29.41%,GPM6A;SETD2;FGFR2;ZNF281;BATF;FBXL17;PUM1
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.415955091714105,-0.6324631173954575,0.8771929824561403,1.0,1.0,6/6,58.43%,CROT;ACOT7;ABHD2;ABHD3;ACAD9;ACADM
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.4124343601342144,-0.6319733988752219,0.8823529411764706,1.0,1.0,1/5,21.87%,UFL1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.36891565809494586,-0.6317166749732116,0.9298245614035088,1.0,1.0,4/10,28.69%,DNMT1;RESF1;SETDB1;MORC2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.293802976985767,-0.6312531343995877,0.9726027397260274,1.0,1.0,8/33,19.52%,PLEK;LLGL2;EPB41L3;TRPV4;NCKAP1L;RAC1;EZR;RAC2
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.2974691287131759,-0.6311183869886128,0.9868421052631579,1.0,1.0,13/56,21.87%,HUS1;XRCC3;BRCA2;NABP1;RPA3;SLX4;BRCA1;POLQ;RECQL5;WRN;ZSWIM7;LIG3;NUCKS1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.35539215686274517,0.6305996629496738,0.8918918918918919,1.0,1.0,6/6,64.48%,SIRT2;DPY30;DOT1L;EZH2;RIF1;EZH1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.4040233375888722,0.6304185077948833,0.8863636363636364,1.0,1.0,2/6,18.92%,NFATC3;NFATC2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.42096898201351307,-0.6295625968005182,0.9206349206349206,1.0,1.0,1/5,12.54%,VEGFA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.37106584266482384,-0.62879624233251,0.9152542372881356,1.0,1.0,1/12,8.13%,CALM1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3085904111778335,-0.6283775479839334,0.9411764705882353,1.0,1.0,6/26,16.17%,TNFSF10;CFLAR;TNFAIP3;BRCA1;GPX1;PEA15
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.3911290322580646,0.628332872767479,0.8809523809523809,1.0,1.0,6/6,60.91%,INSR;PRNP;APP;DCTN1;MAP1A;PSEN1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.3605800827763719,0.6279399434716795,0.85,1.0,1.0,2/11,10.49%,CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3919274816724504,0.6273304119912432,0.8780487804878049,1.0,1.0,1/6,13.88%,ENPP1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.3678856960769408,-0.6270277807026303,0.90625,1.0,1.0,2/10,20.25%,CCND1;RPS27L
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.3488860722553996,-0.6261648111133826,0.921875,1.0,1.0,4/11,13.88%,HK2;MTCH2;COX18;MAIP1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.38141871728994226,-0.6254339407625267,0.9454545454545454,1.0,1.0,1/10,3.75%,BBS2
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.35320333402949317,0.6254063264437502,0.918918918918919,1.0,1.0,5/7,28.09%,PCSK6;SNCA;LIPC;LPL;RHOA
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.34591776706449145,0.6253381120632798,0.8571428571428571,1.0,1.0,3/10,29.67%,ENPP1;BPNT2;PAPSS1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.4087804345393901,-0.6248991759897617,0.9148936170212766,1.0,1.0,1/5,3.29%,RORA
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.35440969193930166,0.6246791493825966,0.9512195121951219,1.0,1.0,3/13,12.54%,RAB10;REEP3;RTN4
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.3641563618802423,0.624663891618315,0.9166666666666666,1.0,1.0,3/9,23.97%,WNK1;GLRX;WNK3
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.3570368015692457,0.6246476987299155,0.8974358974358975,1.0,1.0,1/7,10.51%,DYRK1A
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.3940744584479021,0.6246221058102505,0.8653846153846154,1.0,1.0,1/5,5.56%,PPARG
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.3940744584479021,0.6246221058102505,0.8653846153846154,1.0,1.0,1/5,5.56%,PPARG
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.39403815570450584,-0.6246052426217026,0.8524590163934426,1.0,1.0,1/8,4.13%,GTF2H5
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.35831835312118343,0.6245275456300564,0.918918918918919,1.0,1.0,2/10,11.81%,CTNNBIP1;CDK6
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.3366006448652913,-0.6240089286400207,0.9166666666666666,1.0,1.0,6/15,28.92%,COX18;MAIP1;BMF;TIMM29;TIMM9;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.35235965709882816,0.6240073218469548,0.9,1.0,1.0,3/7,13.05%,ROBO1;RTN4;ZNF703
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.28382305922513645,0.6237822220382593,1.0,0.9999852383804564,1.0,4/26,18.60%,BORA;CHMP1A;DYNC1H1;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.4134965243323858,-0.6237015764533024,0.8596491228070176,1.0,1.0,1/6,1.30%,PID1
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.4087068267435623,-0.6235105017270807,0.8615384615384616,1.0,1.0,2/6,16.24%,AGBL3;AGBL5
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.3147772619077515,0.6229453327339892,0.9555555555555556,1.0,1.0,1/20,3.78%,OTUD7A
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.36829263990504124,-0.6221816965512237,0.8970588235294118,1.0,1.0,5/11,26.73%,NOD2;VIM;TRIM41;PTPN22;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.3072782447339414,-0.6216035095373592,0.9565217391304348,1.0,1.0,7/38,17.65%,IGF1;ARHGEF3;P2RY8;NOTCH2;LPAR6;PIK3CB;RAC1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3179640358066349,-0.6215454581562693,0.921875,1.0,1.0,3/22,12.64%,PLB1;GPC3;SDC3
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.33704622598622513,-0.6208868831527714,0.9552238805970149,1.0,1.0,4/15,17.09%,TRPV4;STMN1;FGF13;MAP7D3
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.37398536657872417,-0.6208753171614003,0.8125,1.0,1.0,1/8,7.08%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.34374166112133975,0.6205988332744503,0.7906976744186046,1.0,1.0,2/7,14.64%,DDX3X;XIAP
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.37196895419788945,-0.6205469123034962,0.9473684210526315,1.0,1.0,2/9,11.14%,ABCB1;BEST1
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.3341735134240647,-0.6203405257626127,0.9444444444444444,1.0,1.0,1/13,3.29%,RORA
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.28367027894310176,0.6198388242845687,1.0,1.0,1.0,17/28,31.52%,ATP6V1B2;RAB7A;RAB14;ATP6V0B;ATP6V0E2;TCIRG1;RAB38;ATP6V0D1;SLAMF8;RAB20;ATP6V1G1;PIKFYVE;ATP6V0E1;RAB32;ATP6V1H;RAB39A;ATP6V1A
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.3331713212404345,-0.6197704239105263,0.9552238805970149,1.0,1.0,3/23,15.55%,HUS1;BRIP1;RAD9A
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.3045954200388343,0.6194563494270284,0.9361702127659575,1.0,1.0,1/24,1.89%,ABCA2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.35791515657160095,-0.6192202192537132,0.9152542372881356,1.0,1.0,4/9,25.41%,TRPV4;TRPM2;TRPV2;ATP2B4
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.35791515657160095,-0.6192202192537132,0.9152542372881356,1.0,1.0,4/9,25.41%,TRPV4;TRPM2;TRPV2;ATP2B4
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.3814641593416679,-0.6191392160321045,0.9137931034482759,1.0,1.0,4/9,15.22%,DNAH17;EFHC1;DNAH1;CCDC39
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.3278254407727226,0.6189603032431291,0.9736842105263158,1.0,1.0,7/16,30.07%,VCPKMT;SNRPB;PRMT3;FAM98A;CAMKMT;EEF1AKMT1;ETF1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.27228890446711623,-0.6187138249923402,0.9736842105263158,1.0,1.0,14/65,23.52%,TRIM5;TRIM22;PHB2;TRIM13;STING1;KAT5;PIK3CB;TP53INP1;TPCN1;PINK1;UFL1;PARK7;BNIP3;PAFAH1B2
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.33632434710358217,0.6186857258036083,0.9210526315789473,1.0,1.0,4/7,29.94%,RUNX1;TGFB1;SERPINF2;SUCO
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.3724821443725575,-0.6183388334548533,0.9137931034482759,1.0,1.0,4/9,16.32%,SMDT1;MICU2;MAIP1;MCUR1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.2854093025080181,0.6179198951708011,0.9523809523809523,1.0,1.0,4/17,18.78%,PRKCSH;ST8SIA5;ST8SIA4;MGAT4B
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.31765795359438515,0.6178721717347014,0.9555555555555556,1.0,1.0,2/15,4.81%,GDAP1;USP30
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.3868636243816586,0.6174601216902831,0.9302325581395349,0.9997870611347686,1.0,2/5,13.69%,RCN3;CTSH
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.3868636243816586,0.6174601216902831,0.9302325581395349,0.9997870611347686,1.0,2/5,13.69%,RCN3;CTSH
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.28106891665234907,0.6174124402301355,0.926829268292683,0.999360239167267,1.0,1/17,3.52%,PICALM
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.30411285829958473,0.6173741201048473,0.9696969696969697,0.9989279143283994,1.0,2/16,5.60%,RELN;RPS6KA4
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.3719025507541296,0.6171437302244746,0.9318181818181818,0.9986079866920888,1.0,2/10,6.63%,LDLR;PFDN4
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.3949277923055616,-0.6169899757289393,0.8928571428571429,1.0,1.0,1/5,6.08%,NLGN2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.3480987143384627,0.6163713328864024,0.8260869565217391,0.9987007875346692,1.0,1/7,5.78%,LDLR
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.33170604119492075,-0.6163089337576089,0.9285714285714286,1.0,1.0,3/12,20.43%,TYMP;MGME1;MEF2A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.37954585527348905,0.615692017260355,0.9302325581395349,0.9986580515402264,1.0,1/7,8.48%,IRAK3
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.31681736242657166,0.6147782164577092,0.9428571428571428,0.9987507436805312,1.0,3/11,14.11%,EMC8;BAG6;MMGT1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.3813811625324928,-0.6146021197544672,0.8615384615384616,1.0,1.0,2/7,11.66%,MTHFD1;EIF4A3
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.3723384347963509,-0.6145922649706346,0.9482758620689655,1.0,1.0,4/9,28.03%,NOD2;AGT;PARK7;POR
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.3898343838033255,-0.6145301769602973,0.9508196721311475,1.0,1.0,2/7,19.84%,NLRP12;MVP
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.33929569321473,0.6144479715577913,1.0,0.9984844414934307,1.0,4/11,16.18%,DIP2B;DDX3X;RAPGEF3;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.36632843344616944,0.614409138586652,0.9024390243902439,0.9980478345758236,1.0,4/9,15.32%,NFAT5;IRAK1;TRAF6;TNF
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.31587826927252693,0.6143550605467658,0.9795918367346939,0.997623386538446,1.0,2/17,4.81%,GDAP1;USP30
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.301896424506851,-0.6142387577236784,0.9714285714285714,1.0,1.0,9/53,17.26%,CCL3;ETS1;OSMR;KARS1;IFI35;NLRP12;CD47;IL1B;AGT
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.3009481019744591,0.6136682229458316,0.9772727272727273,0.9976400012146677,1.0,2/19,8.55%,PTPN23;RAB7A
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.2943877043290275,-0.6130159636590774,1.0,1.0,1.0,6/41,13.89%,JUP;TMSB4X;ETS1;PRKD2;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.3387227807191661,-0.6129603822266756,0.9666666666666667,1.0,1.0,3/22,9.70%,MDFIC;CTDP1;POLR2G
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.3743180200838142,0.6126012985830442,0.9642857142857143,0.9978034236267085,1.0,7/7,62.59%,NPRL3;LARP1;MTOR;CLEC16A;SMG1;CARD11;RPTOR
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.3232158228437148,0.6117496521891567,0.9782608695652174,0.9979549552567957,1.0,6/12,21.92%,NPTXR;NPTX1;DLGAP1;DLGAP4;TMEM108;DLGAP2
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.3248208975247749,-0.6114486020057281,0.9206349206349206,1.0,1.0,8/13,29.91%,POLE3;MCM7;LIG3;MCM3;LIG1;RFC4;MCMDC2;POLE
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.3672471345608997,-0.6108775617346361,0.9259259259259259,1.0,1.0,2/10,18.05%,HIRA;HAT1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.2915338980480989,0.6107611318748715,0.9354838709677419,0.9981239501096205,1.0,6/18,27.06%,SLC19A2;SLC35F3;SLC25A26;SLC25A14;LRRC8D;SLC27A1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.3801894036270092,-0.6104325224835435,0.8923076923076924,1.0,1.0,1/5,18.95%,APH1B
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.3944528867019894,-0.6101883040061092,0.9047619047619048,1.0,1.0,3/5,24.62%,HAVCR2;HLA-DMB;LILRB1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.34758813090937213,0.6101483873863881,0.8837209302325582,0.9981344393815004,1.0,3/10,24.24%,BOK;PIK3R1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.39391105082614314,-0.6095350793326249,0.9347826086956522,1.0,1.0,2/5,27.26%,PDGFB;AP2A1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.30645008051142286,-0.6092394575148405,0.9848484848484849,1.0,1.0,4/27,9.70%,GTF2H5;RNMT;NCBP2;POLR2G
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.30645008051142286,-0.6092394575148405,0.9848484848484849,1.0,1.0,4/27,9.70%,GTF2H5;RNMT;NCBP2;POLR2G
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.2521067871564325,0.6084055047538433,1.0,0.9986783728704051,1.0,6/46,13.92%,EPB41;PGM5;TMOD2;TMOD3;TJP1;FRMD5
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3595504393486755,-0.6079528427293974,0.9375,1.0,1.0,3/12,18.30%,HIF1A;PIK3CB;NOS1AP
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.3590299808347732,0.6078745551791962,0.8775510204081632,0.9985421119859067,1.0,2/7,17.53%,NAPEPLD;OCIAD1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.2565743596841491,0.6074790764163476,0.9666666666666667,0.9983649789209438,1.0,3/34,10.57%,TLR7;TNFRSF10A;SLC9A1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.40600594275044827,-0.6066811271131167,0.9433962264150944,1.0,1.0,1/5,12.10%,TRMT10B
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.28216003768820686,-0.6064362374245692,1.0,1.0,1.0,8/61,11.76%,NKD1;VPS35;SNF8;PTTG1IP;TNFRSF1B;VPS28;GPC3;TNFAIP3
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.33025838292522336,0.6064068015143097,0.8974358974358975,0.9985041277711147,1.0,2/11,22.52%,TMCC2;ADAM10
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.4022654118913772,-0.6059566485777315,0.9090909090909091,1.0,1.0,3/6,16.10%,IRF7;SELENOS;NOD2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.33217215130257444,0.6053901514498758,0.8974358974358975,0.998695811431209,1.0,4/8,29.94%,RUNX1;TGFB1;SERPINF2;SUCO
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.3170792310992874,-0.6052292740939412,0.9411764705882353,1.0,1.0,5/15,23.55%,BUD23;ZCCHC4;EMG1;FBL;NSUN5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.33257523613017315,-0.6052174224187508,0.9464285714285714,1.0,1.0,6/17,21.76%,RBPJ;VEGFA;HIF1A;MT3;CARF;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3525814612649528,-0.6050713023841827,0.9180327868852459,1.0,1.0,1/11,2.73%,CD55
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.3778171532131124,-0.6040170100900953,0.8666666666666667,1.0,1.0,2/5,14.85%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.38479804024958475,0.603845056993382,0.9183673469387755,0.9992323925383237,1.0,1/5,15.33%,GAD1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.3174129241219103,0.6030267467323558,1.0,0.9992774165230288,1.0,3/17,18.60%,TENT5A;THRAP3;HNRNPU
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.22293322430481852,0.6029732449229134,1.0,0.9988432452839093,1.0,27/98,23.78%,BORA;CDK7;TAF2;CEP41;BRSK1;YWHAG;BTRC;FBXW11;CSNK1E;FBXL12;FBXL7;CEP131;DYNC1H1;CLASP1;TPD52L1;ALMS1;CEP135;NDE1;NEDD1;BRSK2;CEP152;YWHAE;CCNH;PAFAH1B1;ODF2;PPP1R12B;CEP290
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.3650670964627031,-0.6028442198201931,0.8813559322033898,1.0,1.0,2/8,12.54%,TTN;VEGFA
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.40658448852020374,-0.6018927302611474,0.8936170212765957,1.0,1.0,1/5,24.59%,BCAT1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.26373913322852127,0.6018729752567967,1.0,0.998987697496532,1.0,13/58,21.19%,RRAGD;EIF2S1;ATP6V1B2;MAPK1;MAP3K5;LAMTOR3;ATP6V0B;SESN2;ATP6V0E2;SH3GLB1;TCIRG1;MIOS;ATP6V0D1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.36106321787670737,-0.6014450856189532,0.9122807017543859,1.0,1.0,2/8,18.77%,IL1B;INPP5K
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.345880275224031,-0.600797613395527,0.9193548387096774,1.0,1.0,1/12,7.82%,SNF8
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3386436042254377,0.6003022845717535,0.926829268292683,0.999429755304636,1.0,2/8,11.69%,JAG1;BMPR1A
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.32315129046470875,-0.600143491172983,0.9577464788732394,1.0,1.0,3/20,15.39%,ANXA2;ADPRH;ENO4
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.32982036245262447,0.5998623910227451,0.9444444444444444,0.9992178523611966,1.0,1/9,3.94%,CBFA2T3
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.3229695535826173,-0.599592632808623,0.9423076923076923,1.0,1.0,4/21,12.12%,LPCAT1;PCYT1A;PCTP;LPCAT3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.36736193470391937,-0.5991605291090107,0.9433962264150944,1.0,1.0,2/8,7.00%,SEMA6A;CD63
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.3639219633060128,-0.5986491988688063,0.9253731343283582,1.0,1.0,3/8,21.05%,GBP2;SLC11A1;CLEC7A
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.29862647920179897,0.598174884977249,1.0,0.9998518786470789,1.0,3/18,13.74%,TGFA;CDC23;NSMCE2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.36527265251985214,0.598071196229704,0.9302325581395349,0.9994650766426069,1.0,4/8,26.91%,DYRK1A;MAP2K2;RIPK1;PIKFYVE
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.3329397112987847,0.5979566503004696,0.96,0.9990611458853014,1.0,3/14,19.47%,SORT1;RAB14;GBF1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.3556063239428144,0.5974859717516701,0.96,0.9988730967307619,1.0,3/8,23.32%,GSK3B;ABL1;CTTN
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.3674091113827556,-0.5972555040125223,0.95,1.0,1.0,3/11,24.51%,IDH3B;ACO2;IDH3G
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.26291464260174324,0.5969010495041522,1.0,0.9988133034908583,1.0,13/59,21.19%,RRAGD;EIF2S1;ATP6V1B2;MAPK1;MAP3K5;LAMTOR3;ATP6V0B;SESN2;ATP6V0E2;SH3GLB1;TCIRG1;MIOS;ATP6V0D1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.3431049027098415,0.5962382258235627,0.9591836734693877,0.9986837324559806,1.0,2/6,29.93%,MAPT;HSPA8
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.3583606664306531,-0.5954600487928348,0.9090909090909091,1.0,1.0,4/12,17.93%,CEMIP;CD44;IL1B;GUSB
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.3055459782836933,-0.5950941900131557,0.95,1.0,1.0,1/22,4.74%,APOD
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.37916040793738637,0.5942850981109878,0.8974358974358975,0.9993279017123882,1.0,5/5,62.10%,PRKD1;SP1;PRKCD;DAPK1;XRCC1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.29778038710996785,0.5941190845835019,1.0,0.9989889082042869,1.0,3/19,13.28%,SPRY2;LZTR1;SYNGAP1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.3719512251182222,-0.5936987256672017,0.94,1.0,1.0,1/7,10.34%,ATG2A
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.3719512251182222,-0.5936987256672017,0.94,1.0,1.0,1/7,10.34%,ATG2A
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.3502328300606815,-0.5933929015237278,0.9354838709677419,1.0,1.0,3/11,17.12%,ZWILCH;NABP1;CHFR
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.3618846282696807,-0.5933883234616321,0.9827586206896551,1.0,1.0,2/10,12.54%,TTN;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.3729148549292434,-0.5931428334326143,0.9245283018867925,1.0,1.0,5/5,62.73%,PPIA;PARP10;PLAA;TRIM44;GPS2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.3806911076456291,-0.5925480607946051,0.9591836734693877,1.0,1.0,1/7,12.12%,LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.4141532600632941,-0.5918059476240002,0.9615384615384616,1.0,1.0,1/5,21.24%,TMEM33
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.30991033532912854,0.5915356063227224,1.0,0.9999054881126068,1.0,5/16,16.54%,TLR7;SETD2;DDX3X;IRF5;HSPD1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.39567185839021934,-0.5913618542912157,0.9183673469387755,1.0,1.0,4/8,25.75%,LGALS1;CD74;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.39567185839021934,-0.5913618542912157,0.9183673469387755,1.0,1.0,4/8,25.75%,LGALS1;CD74;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.2812007582548937,-0.5913570525867959,0.9722222222222222,1.0,1.0,6/49,19.89%,MED25;VENTX;CCND1;MED12;MED30;MED1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.34936239223141313,-0.5908578791282729,0.9545454545454546,1.0,1.0,2/10,16.37%,ATP1A1;PKP2
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.3319228177995277,0.5902444744943852,0.9130434782608695,1.0,1.0,4/7,21.31%,RAPGEF2;OPN3;ZEB2;MFSD12
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.27377890271919414,0.5899768535000265,0.9333333333333333,0.9999188295037095,1.0,3/21,12.34%,NSL1;SMC4;ZNF207
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.3236756188664577,0.5899717170423299,0.9761904761904762,0.9994699177383926,1.0,3/10,11.26%,DNAJB2;DNAJA4;BAG5
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.3522127786995323,-0.5899222836361979,0.896551724137931,1.0,1.0,5/7,39.20%,PTPN2;C1QC;ID2;HSF1;CASP8
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.3322783466489473,0.5894326654425486,0.9555555555555556,0.9992708503817597,1.0,2/6,29.20%,KIF5B;VCP
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.29443492074131994,0.5890895585622838,0.9318181818181818,0.9989502015284033,1.0,7/12,26.73%,NRG1;MMP14;PIEZO1;TGFB1;PROX1;MAPK14;ATP11A
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.34048182281358597,0.5880596682536284,0.9555555555555556,0.9990703076583083,1.0,2/9,11.35%,MAP2K1;MAPK1
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.33924219268250744,-0.5879426490353643,0.9166666666666666,1.0,1.0,1/7,19.54%,SHMT1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.2894314857080672,-0.5871550066020338,0.9692307692307692,1.0,1.0,6/32,20.12%,SLC35B1;SLC25A19;SLC2A8;CFTR;SLC17A9;SLCO3A1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.36423671723540096,-0.5869079165559584,0.9607843137254902,1.0,1.0,1/9,6.43%,NR1H2
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.31021415869941005,0.5862985359193676,0.9354838709677419,0.9994741590486506,1.0,2/15,8.59%,LIG4;YLPM1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.333102370590986,0.5852416132861542,0.9795918367346939,0.9995881281425519,1.0,3/11,22.49%,DROSHA;MRPL44;AGO1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.2760937919684137,-0.585171484882203,1.0,1.0,1.0,4/40,12.26%,GABARAPL1;GABARAPL2;ATG2A;STING1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2810341749599847,-0.5851656867979645,0.96875,1.0,1.0,6/28,22.46%,DDRGK1;DDX5;PRMT2;UFSP2;UFL1;PARK7
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2604201037771982,0.5845373903051596,1.0,0.9995515139099015,1.0,6/25,18.60%,CDK13;SUPT16H;WDR43;CDK12;EAPP;HNRNPU
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.3284309000859774,0.5842804908066352,0.9761904761904762,0.9992835301965642,1.0,2/8,23.34%,EEF1A2;PIK3R1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.35550617846521054,-0.5842156112430607,0.9285714285714286,1.0,1.0,2/10,9.89%,CEMIP;CD44
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.3675914945413763,0.5840202727432543,0.9183673469387755,0.9989463999841645,1.0,2/5,12.57%,NLGN1;NRXN2
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.3908652145423773,-0.5835841522064503,0.9615384615384616,1.0,1.0,3/5,31.56%,EDEM1;MAN1B1;EDEM2
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.3908652145423773,-0.5835841522064503,0.9615384615384616,1.0,1.0,3/5,31.56%,EDEM1;MAN1B1;EDEM2
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.3908652145423773,-0.5835841522064503,0.9615384615384616,1.0,1.0,3/5,31.56%,EDEM1;MAN1B1;EDEM2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3339581966773299,-0.5835668201615812,0.9333333333333333,1.0,1.0,2/11,12.53%,FANCB;WDR48
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.33749349001705087,-0.5830528251401799,0.9622641509433962,1.0,1.0,3/11,19.20%,EXOSC10;DEDD2;TRIR
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.32896485757906857,-0.582517809164778,0.927536231884058,1.0,1.0,3/15,18.41%,HINT1;ENTPD4;NUDT16
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.35720867506603815,0.5823442481851347,0.975609756097561,0.9994303105487474,1.0,3/7,24.96%,NIN;HOOK3;PCM1
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.2850697131728816,0.5821785971740692,1.0,0.9990472014406936,1.0,4/16,15.58%,DDIT3;LAPTM5;LGALS9;CR1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.34251095729769,-0.5819436914598715,0.9354838709677419,1.0,1.0,4/11,21.70%,PARP2;PARP11;PARP12;PARP8
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.3649544455489272,0.5815836541503612,0.92,0.9988780990966045,1.0,2/5,13.30%,TJP1;AFDN
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.28058000808075634,-0.5814976049475775,0.9861111111111112,1.0,1.0,9/49,22.91%,SSB;GTPBP3;TRMT44;OSGEP;METTL2A;URM1;WDR6;TYW5;THUMPD3
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.37786235951134794,0.5811175114211606,0.9148936170212766,0.9987149217015248,1.0,1/5,12.18%,SORL1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.3728024366776804,-0.5808707291896315,0.9649122807017544,1.0,1.0,4/5,38.20%,PARN;TENT4B;TUT4;DIS3L2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.34615901743258287,0.5806529948820219,0.925,0.9985230449696152,1.0,2/10,14.37%,GRIN2A;NLRC4
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),-0.3992410467230611,-0.5801083595963734,0.9272727272727272,1.0,1.0,5/5,60.10%,TLR3;IFIH1;SERINC3;SERINC5;ZCCHC3
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.2953381598509299,-0.580095682226382,0.9722222222222222,1.0,1.0,7/25,19.39%,TRPV4;TUBGCP2;CSNK1D;FGF13;MAP7D3;TUBGCP5;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.3050027283781745,-0.5793725973507632,0.9242424242424242,1.0,1.0,2/22,11.51%,NR1H2;CNEP1R1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.3631446469330717,-0.5789258827372625,0.9038461538461539,1.0,1.0,2/8,17.91%,EGLN3;P4HA3
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.3277495431751778,0.5785571380744937,0.9714285714285714,0.999236724221524,1.0,2/12,7.32%,LARGE1;DISP1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.38736119423839194,0.5779935079442389,0.9791666666666666,0.9990678417900796,1.0,1/5,13.56%,PTPRN
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.3072511724089714,-0.5775978317169765,1.0,1.0,1.0,3/24,12.48%,LPCAT1;GNPAT;ABCA8
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.2945376988144083,0.5775450874238075,1.0,0.9988991118484153,1.0,3/19,12.32%,PPARG;PTPRM;NF1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.2770195791226942,0.5758935017618817,0.9615384615384616,0.9991682152259376,1.0,1/27,2.19%,AP3B2
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.35368089056515184,0.5758834441238896,0.9565217391304348,0.9987232867831525,1.0,4/9,25.29%,UBR3;FGFR1;USP22;CELF1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.3229136825256477,0.5756413051759772,0.8918918918918919,0.9983880811315056,1.0,2/8,17.60%,ATG13;TRAPPC8
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.29141980388994015,0.5745595693559055,1.0,0.998409750459911,1.0,2/18,6.17%,DGUOK;PPAT
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.3358429574869304,0.5745465806568466,0.9318181818181818,0.9979657649225738,1.0,2/6,21.57%,TWSG1;CD274
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.3818956468419119,-0.5736364491065278,0.9361702127659575,1.0,1.0,1/7,12.54%,VEGFA
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.3037028104043615,-0.572928627980844,1.0,1.0,1.0,5/21,19.73%,THEM4;ACOT9;MCEE;ACSM5;DLST
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3228454749583688,-0.5727947401523795,0.9333333333333333,1.0,1.0,4/14,16.41%,FCER1G;C5AR1;SPG21;C5AR2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.3398952336554965,-0.5722089306064138,0.9491525423728814,1.0,1.0,2/9,12.85%,DYNC2I1;SULF2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.27636335709443693,-0.572128301206149,1.0,1.0,1.0,2/29,12.38%,SNRPD2;PRPF3
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.3458049453803698,0.5707651665824726,0.9772727272727273,0.9994068659473835,1.0,2/6,16.08%,JAM2;ADGRB3
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.37210138532955694,-0.5707254559725367,0.9607843137254902,1.0,1.0,1/6,17.47%,KDM1B
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.32938814139643896,0.570700289946385,0.9761904761904762,0.9989972917516378,1.0,3/8,18.81%,KLF7;KCNB1;SIRT4
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.2633602993772905,-0.5703858395790015,1.0,1.0,1.0,7/52,17.72%,CYREN;POLM;ABRAXAS1;KAT5;ERCC8;BRCA1;POLQ
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.2441452935094049,0.5702929533070157,1.0,0.9986569759631119,1.0,4/31,9.78%,BOD1;CENPE;CHMP7;CDC23
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.26456243796887435,-0.5702661020382951,0.987012987012987,1.0,1.0,4/42,12.26%,GABARAPL1;GABARAPL2;ATG2A;STING1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.28598170649859006,0.5691792227992886,1.0,0.9986669991779308,1.0,10/21,26.09%,ATP6V1B2;RAB7A;ATP6V0B;ATP6V0E2;TCIRG1;RAB38;ATP6V0D1;SLAMF8;RAB20;ATP6V1G1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.3196520363780149,0.5687010065695138,0.9523809523809523,0.9984705293954446,1.0,9/9,68.06%,ICE2;ELL;CHD8;ZNF143;CEBPA;ICE1;MTOR;RPTOR;ZC3H8
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3016103428322803,0.5679631762457913,0.9230769230769231,0.998348766301186,1.0,2/15,7.93%,WASF2;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.2919149959228351,-0.5656717101554964,0.9661016949152542,1.0,1.0,2/18,8.68%,NLGN2;NNAT
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.32541735490865986,0.5651122216490225,0.868421052631579,0.9992356832512799,1.0,2/8,13.19%,ANO6;PRKCI
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.3060900626656618,-0.5644696975343211,0.9803921568627451,1.0,1.0,5/16,20.72%,GPR137B;KARS1;CD200;CD74;TNIP2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.32292293044449083,-0.5642031068850594,1.0,1.0,1.0,3/15,16.51%,HPS4;BLOC1S2;TRAPPC6A
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.29078278720784345,0.5639939148194107,0.9487179487179487,0.9993313478769715,1.0,2/10,22.52%,DYRK1A;ADAM10
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.368780589085677,-0.5627100839743114,0.9344262295081968,1.0,1.0,1/5,11.13%,FYN
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.378111892022586,-0.5621317305642398,0.9615384615384616,1.0,1.0,2/6,15.65%,ODC1;SMS
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.28509708587112736,0.5616220968952068,0.975,0.9999708371505063,1.0,4/20,18.78%,PBX1;BMPR1B;PBX3;SMOC1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.27760529155097924,0.5588737543536052,1.0,1.0,1.0,5/20,17.83%,RELN;SHOC2;VAV1;ITGAV;ERBIN
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.3567870977942919,0.5585956010820439,0.9302325581395349,1.0,1.0,5/5,64.34%,LCLAT1;PLA2G6;HADHA;PLA2G4A;HADHB
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.3317603089352645,-0.5579512908508983,0.9666666666666667,1.0,1.0,5/11,33.40%,GTF3A;NIFK;SIRT7;GTF3C1;POLR1G
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.25749551243575575,-0.5578765869938416,0.9864864864864865,1.0,1.0,18/47,30.15%,AIF1;TYROBP;CYBA;NOD2;IL1B;CD74;CLEC7A;TLR2;PTPN11;SPHK2;ARHGEF2;CARD9;XBP1;IL1A;STAT3;BCL10;LILRB2;MYD88
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.34207585180914457,-0.5576807973986476,0.9838709677419355,1.0,1.0,3/10,23.22%,CRYM;DLST;PHYKPL
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.34207585180914457,-0.5576807973986476,0.9838709677419355,1.0,1.0,3/10,23.22%,CRYM;DLST;PHYKPL
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.33569703321352495,0.5554634942009572,0.8913043478260869,1.0,1.0,1/6,16.60%,NUP133
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.2440110867904061,0.555073761329338,0.9736842105263158,1.0,1.0,11/28,26.09%,ATP6V1B2;RAB7A;ATP6V0B;CLCN3;ATP6V0E2;TCIRG1;RAB38;ATP6V0D1;SLAMF8;RAB20;ATP6V1G1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.2939664960990866,0.5549212108789863,1.0,1.0,1.0,1/9,3.98%,BAIAP3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.33333838702017493,-0.5544232689771995,0.9444444444444444,1.0,1.0,1/8,8.27%,STK39
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.33730320075805803,-0.5524710230002284,0.9464285714285714,1.0,1.0,2/6,34.68%,KIFAP3;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.26448523941682334,0.5524460118292562,0.9736842105263158,1.0,1.0,2/16,10.03%,STK25;KLHDC10
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.2985481378051732,-0.5505628142770074,0.9166666666666666,1.0,1.0,6/13,33.50%,ATG2A;WIPI1;ATG12;WIPI2;WDR45B;ATG5
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.28219217608453323,-0.5499022434567967,0.96875,1.0,1.0,1/22,6.57%,ITGA6
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.3662551317230901,0.5494178711251618,0.9649122807017544,1.0,1.0,1/5,11.36%,KAT2A
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.3356826862991521,0.5490202162496967,0.9302325581395349,1.0,1.0,3/9,25.96%,ALOX5AP;MGST3;MGST2
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.30952630968576983,-0.548900553469931,0.9795918367346939,1.0,1.0,4/11,21.26%,PTPRC;CD200;CST7;NR1D1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2483296258169232,0.548668784929313,1.0,1.0,1.0,12/28,26.46%,PI4KB;PIK3C2B;PIP4K2A;PIK3CA;SOCS6;SOCS4;ITPKB;PIK3R1;IP6K2;IP6K1;PIK3CG;PIP4K2B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.34146376286694985,0.5486155696578446,0.9591836734693877,1.0,1.0,2/5,28.16%,CHRM3;DOCK4
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.2962291008974941,0.543961910148906,1.0,1.0,1.0,2/11,18.81%,ACADVL;SIRT4
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.2597004526440323,-0.5438299650268997,1.0,1.0,1.0,1/43,2.55%,EMD
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.2597004526440323,-0.5438299650268997,1.0,1.0,1.0,1/43,2.55%,EMD
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.30713293444382195,0.543428625045845,0.9818181818181818,1.0,1.0,3/10,15.45%,PPARG;NFIB;NFATC3
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.28551221762520274,-0.5428646580778652,0.9848484848484849,1.0,1.0,2/18,15.87%,ATP6V1F;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.3067399359350644,0.5427730570514927,1.0,1.0,1.0,1/10,12.18%,SORL1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.2775708305313046,-0.5425527663847011,0.9420289855072463,1.0,1.0,5/25,21.76%,RBM22;U2AF2;HSPA1A;NCL;ERN1
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.3476346858865978,-0.5415371146117901,0.9821428571428571,1.0,1.0,3/6,30.95%,MAPK3;MAP2K6;CHEK2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.27324512794174194,0.541209245299063,0.975609756097561,1.0,1.0,2/16,13.58%,PPAT;AK3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.27639987454184556,-0.5400815485107913,1.0,1.0,1.0,5/23,16.83%,NLGN2;TRPM4;NNAT;CFTR;MYRIP
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.2874537707506122,0.539220422797033,1.0,1.0,1.0,4/14,19.85%,ADCY9;PRRC1;ADCY6;ADCY1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.32886513144331325,0.5390572242381215,0.9583333333333334,1.0,1.0,1/6,14.00%,SLCO2B1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.32886513144331325,0.5390572242381215,0.9583333333333334,1.0,1.0,1/6,14.00%,SLCO2B1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.297186939368783,0.5386889750150718,0.9166666666666666,1.0,1.0,2/9,18.54%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.346819475650738,-0.5360503857080687,0.953125,1.0,1.0,3/6,26.49%,HLA-E;IL18;SPHK2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.3093742318210259,0.535601350284379,0.9743589743589743,1.0,1.0,1/8,5.36%,PLPP1
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),-0.3614887535556701,-0.5353571025112552,0.9649122807017544,1.0,1.0,2/5,27.48%,C1QB;C1QC
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.2572459811618052,-0.5348445653938467,0.9857142857142858,1.0,1.0,8/51,16.45%,RAB11A;AQP11;NACA;ZDHHC4;VPS37B;COX18;OXA1L;ZDHHC19
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.36295372558285427,-0.5348237685979464,0.9491525423728814,1.0,1.0,3/5,26.49%,HLA-E;IL18;SPHK2
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.2955324996647726,0.5331191820283722,1.0,1.0,1.0,3/8,31.25%,DGKQ;DGKB;PLA2G15
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.3246943067869822,-0.5323760221431574,0.9433962264150944,1.0,1.0,2/10,19.35%,IHO1;CSNK2A2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.32555235319556125,-0.531947592541622,0.9629629629629629,1.0,1.0,1/9,6.30%,IGF1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.27991211060771615,-0.5318201158215938,1.0,1.0,1.0,1/14,6.78%,EXOSC10
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.3333397938485908,-0.5314817197528403,0.9354838709677419,1.0,1.0,3/6,32.28%,CCND1;EGFR;AKT1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),-0.3302197543926866,-0.5314361080192184,0.9508196721311475,1.0,1.0,3/9,17.50%,HSPA1B;HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.2792203988033388,0.5312686456036645,1.0,1.0,1.0,3/11,18.76%,DYRK1A;MAP2;SNCA
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.301753606269653,-0.5309037938076014,0.9523809523809523,1.0,1.0,1/13,5.34%,NLRC5
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.3229150560974675,-0.530537528296161,0.9310344827586207,1.0,1.0,1/8,14.79%,STMN1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.2667206973747247,-0.5303661036294186,1.0,1.0,1.0,5/19,21.46%,CGNL1;PFN1;STMN1;INPP5K;WAS
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.2944041200253503,0.5298415289674557,0.9803921568627451,1.0,1.0,4/8,26.80%,ANKS1A;ADGRB3;CX3CL1;FARP2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.3077713653253222,0.5282349400395844,0.9148936170212766,1.0,1.0,5/5,69.24%,BDP1;CRCP;BRF1;GTF3C1;POLR3H
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.30624493687955157,0.5279674553390646,0.9791666666666666,1.0,1.0,2/7,24.24%,NEDD4;DAB2IP
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.36301541434695594,-0.5277532382715805,0.9259259259259259,1.0,1.0,1/5,25.72%,TENT4B
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.3468119609768978,0.5274891307341493,0.975609756097561,1.0,1.0,2/5,22.76%,LGALS9;SLAMF8
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.3479928307855237,-0.5274149415747721,1.0,1.0,1.0,2/7,24.10%,MID1;CHAMP1
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.285086083155481,0.5260418865429771,0.9565217391304348,1.0,1.0,3/7,25.64%,SETD4;SETD1B;KMT2C
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.3321488175812082,0.5255254818370003,0.9555555555555556,1.0,1.0,1/7,8.38%,NEK9
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.34681966126423547,-0.525343026105225,0.9807692307692307,1.0,1.0,3/6,29.06%,DNMT1;PDGFB;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.3308479726424769,-0.5248767055981852,0.9833333333333333,1.0,1.0,2/7,22.31%,NRDE2;SLIRP
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.315069576217584,0.5246260226353798,0.9285714285714286,1.0,1.0,6/6,68.51%,SENP6;USPL1;SENP2;SENP5;SENP7;SENP1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.30697787601768783,0.523663964595006,0.9512195121951219,1.0,1.0,1/9,7.21%,IL13RA1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.34048831946514746,-0.5235488875896097,0.9807692307692307,1.0,1.0,1/7,8.62%,BEX4
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.3335699260609836,-0.5235228085164455,0.9655172413793104,1.0,1.0,2/7,19.71%,TCF3;MSH6
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.25960090928444995,0.523019287985061,1.0,1.0,1.0,3/15,23.37%,DROSHA;XPO5;SND1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.32736797535145895,0.5227911310302141,1.0,1.0,1.0,1/6,11.03%,WNK1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.33203935535192336,-0.5219992788996451,0.9833333333333333,1.0,1.0,2/8,16.07%,EMC2;EMC1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.3242564430364016,-0.5217092886498049,0.9423076923076923,1.0,1.0,1/8,8.27%,STK39
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.29862131043506573,-0.521311341839769,0.984375,1.0,1.0,7/11,29.48%,MCM7;RECQL5;MCM6;WRN;RECQL;SSBP1;MCMDC2
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.313442236451706,-0.5196771101964957,0.9482758620689655,1.0,1.0,2/10,18.17%,PTGES2;CD74
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.2854489875571725,0.5195973698639916,1.0,1.0,1.0,3/9,25.61%,FERMT2;SLIT2;PDE2A
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.26820903298665394,0.5194880783863813,0.9761904761904762,1.0,1.0,1/13,6.17%,PPAT
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.3240959936457123,0.5189685424150736,0.9512195121951219,1.0,1.0,4/6,27.12%,MTPN;MEGF10;TGFB1;SIRT2
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.2825656552113447,-0.5189230236458318,0.9846153846153847,1.0,1.0,6/17,21.53%,TRPM4;PIM3;CFTR;STXBP4;NR1D1;HLA-DRB1
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.2619987858344591,0.5188435060210049,1.0,0.9997596381357752,1.0,1/12,6.35%,TSPOAP1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.3205998577405663,0.5185713804256704,0.9743589743589743,0.9994083931393107,1.0,1/7,11.03%,WNK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.3576012713870931,-0.5184587677916371,0.9830508474576272,1.0,1.0,1/5,14.28%,EFNB2
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.3372583664412374,-0.516553626417951,0.9811320754716981,1.0,1.0,1/6,23.77%,CYP19A1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.3285788753701139,0.5157457306009855,0.8918918918918919,0.9997558122332522,1.0,2/6,12.04%,MCU;MICU1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.24845885295966724,-0.515642924321126,1.0,1.0,1.0,1/46,2.55%,EMD
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.3022582924332642,-0.5153068865390216,0.9538461538461539,1.0,1.0,5/9,33.26%,TCF3;LIG3;LIG1;HMGB2;XRCC4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.29530274501669435,-0.515161865944811,0.9491525423728814,1.0,1.0,3/10,18.89%,VEGFA;DENND6A;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.32243838720824397,0.5147796869208584,0.9574468085106383,0.9995568726934821,1.0,2/6,29.29%,PRKCB;NFAM1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.2968410767717386,-0.5135661195638885,1.0,1.0,1.0,3/14,17.22%,DDX5;SLU7;SCNM1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.2866339833771927,-0.5127569495807283,0.9814814814814815,1.0,1.0,3/12,27.17%,ATF3;GSTO1;DHX36
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.321443391544295,-0.5118810167556174,0.9827586206896551,1.0,1.0,2/6,15.95%,CENPF;MIS12
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.3104584010602043,0.5114611222970099,0.9090909090909091,1.0,1.0,4/5,35.81%,MAPK14;CAP1;MAPK8;CAP2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.26359901656599055,-0.5114148053460534,1.0,1.0,1.0,3/26,12.64%,PLB1;GPC3;SDC3
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.23247537241825578,0.5113530337720126,1.0,0.9996938416115321,1.0,2/24,7.81%,ZC4H2;BRINP3
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.3114500039262392,-0.510597069580284,1.0,1.0,1.0,2/9,20.63%,ANKRD13D;LRPAP1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.2918966832078955,0.5102641474947556,1.0,0.9995008142509746,1.0,5/12,24.59%,VCL;TNF;TNFRSF1A;ADD1;PPP1R12A
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.30874446552814677,0.5102025987942284,0.9803921568627451,0.9990606994054215,1.0,6/6,69.14%,SLC30A10;ROCK1;ROCK2;NFKB1;PRKCD;RELA
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.3143893634773936,-0.508036795142591,1.0,1.0,1.0,2/9,19.52%,RAC1;RAC2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.2689049374444474,0.5078356963244269,0.9767441860465116,0.9992444606250657,1.0,3/8,26.16%,PTK2;TGFB1;PRKCE
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.3198678651868816,-0.507752513650773,0.9841269841269841,1.0,1.0,3/9,22.46%,FYN;PINK1;PARK7
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.21674879792218057,-0.5076838805972868,1.0,1.0,1.0,19/99,24.17%,ABCB1;SSNA1;CEP164;PPP1CB;CEP72;AKAP8;CSNK1D;PRKAR2B;TUBB4B;AKAP9;DCTN2;NINL;DYNC1I2;SFI1;AKAP8L;HAUS5;TUBB4A;CEP250;CDKN1A
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.337058885615784,-0.506673575746891,1.0,1.0,1.0,2/7,22.46%,HIF1A;PARK7
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.35144793636546706,-0.5062457373310768,0.9821428571428571,1.0,1.0,1/5,29.07%,PGP
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.2966427036583498,-0.5056169041603246,1.0,1.0,1.0,2/12,19.54%,INPP5K;PPP1R16B
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.3211711984081948,0.5052593366325232,0.9743589743589743,0.9995684237438951,1.0,3/5,31.52%,ATP6V0D1;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.33106159460337853,-0.5050801945301967,0.9821428571428571,1.0,1.0,1/6,9.68%,PTGES2
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.3404464024643087,-0.5043843766512263,0.9661016949152542,1.0,1.0,1/5,20.56%,LEO1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.34417824087914795,-0.5013500583360979,0.96,1.0,1.0,1/5,8.62%,BEX4
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.3041627122910487,-0.49996689576431896,0.9402985074626866,1.0,1.0,2/9,23.35%,DGKD;DGKH
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.26826964903830525,-0.49947166836553597,1.0,1.0,1.0,3/21,17.35%,SULF2;PTPRC;RPL13
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.253628115007014,0.4994517700925856,1.0,1.0,1.0,4/17,22.36%,PRDX6;TRA2B;THRAP3;NUP98
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.2818226225437561,-0.4983960735109355,1.0,1.0,1.0,2/10,27.55%,CD4;STAT3
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.2818226225437561,-0.4983960735109355,1.0,1.0,1.0,2/10,27.55%,CD4;STAT3
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.2967227996595785,-0.4980432756441277,0.9852941176470589,1.0,1.0,4/12,23.79%,PRR5L;CNOT8;PNPT1;GTPBP1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.2816614494342726,0.49743468243897987,0.9782608695652174,1.0,1.0,1/12,4.52%,PGM5
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.2643646646884438,0.4966953750596818,1.0,1.0,1.0,3/10,15.88%,BARD1;AHCYL1;PAPOLA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.27742530365634555,-0.49647927611566794,0.9848484848484849,1.0,1.0,1/15,8.13%,CALM1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.3200115889377587,0.49596414755055646,0.9782608695652174,1.0,1.0,3/6,19.42%,JAG1;MYO1E;PTPRO
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.33733892007273303,-0.49594533763474746,0.9827586206896551,1.0,1.0,5/5,66.29%,BECN1;AMBRA1;ATG14;GPS2;SQSTM1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.2883812404289574,0.49500479995598157,0.9777777777777777,0.9999738933639382,1.0,2/9,15.24%,RPS6KA4;CDK9
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.2933149278354271,0.4929318079067185,0.9791666666666666,1.0,1.0,1/5,15.68%,GSK3B
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.30491855132057566,-0.4928591928802596,0.9830508474576272,1.0,1.0,8/8,69.54%,SOCS3;BCL3;NF2;VHL;PTPRT;HGS;SH2B3;ADIPOR1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.32987533794139157,-0.4922561141301591,0.9411764705882353,1.0,1.0,2/5,28.68%,CARMIL1;ABCG2
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.2929141820811442,0.49145726402816886,1.0,0.9999643057046641,1.0,1/6,16.60%,AKT2
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.28365867891589236,-0.4909689293107472,1.0,1.0,1.0,3/17,15.17%,SLX4;KAT5;BRCA1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.24862059531251982,0.48917867604924375,1.0,0.9996191908308182,1.0,7/13,34.65%,PHACTR1;SORBS1;RHOA;KCTD13;ARRB1;FAM171A1;TNFAIP1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.24862059531251982,0.48917867604924375,1.0,0.9996191908308182,1.0,7/13,34.65%,PHACTR1;SORBS1;RHOA;KCTD13;ARRB1;FAM171A1;TNFAIP1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.3207797344635859,0.4882337208125174,0.9444444444444444,0.9994440651694209,1.0,1/5,10.52%,MFHAS1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.2613911922205506,0.48467753330958263,1.0,0.9994070369442071,1.0,3/17,24.22%,DBT;AUH;ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.2613911922205506,0.48467753330958263,1.0,0.9994070369442071,1.0,3/17,24.22%,DBT;AUH;ACAT1
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.32304370205852323,0.4838488522011414,0.9714285714285714,0.998733933664227,1.0,2/5,21.65%,SLC12A2;DLG2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.32304370205852323,0.4838488522011414,0.9714285714285714,0.998733933664227,1.0,2/5,21.65%,SLC12A2;DLG2
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.29700068665733464,-0.48167567920460025,1.0,1.0,1.0,1/10,14.30%,SEC62
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.2594338100302758,-0.48033003916691114,1.0,1.0,1.0,11/24,31.54%,GTPBP3;TRMT44;METTL2A;WDR6;THUMPD3;FTSJ1;DALRD3;THUMPD2;ALKBH8;THADA;TARBP1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.24849672852750293,0.479539293799546,0.972972972972973,0.9992065948751059,1.0,4/16,18.47%,PPARG;ITGAV;TNF;OSBPL8
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.2801150203462156,-0.47947968795632395,1.0,1.0,1.0,2/13,17.07%,PRKAR1B;PRKAR2B
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.28296153639278926,0.47944948154149136,0.9782608695652174,0.9987812200914745,1.0,2/7,19.06%,AKT2;GLRX
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.24125734363347517,0.47700898838149647,1.0,0.9988744931260604,1.0,2/13,15.09%,CHMP7;CHMP1A
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.28392123758340954,-0.4760529665141227,1.0,1.0,1.0,2/9,22.53%,CNEP1R1;AKAP8L
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.27661527129168684,-0.4757029631099835,1.0,1.0,1.0,2/15,17.07%,PRKAR1B;PRKAR2B
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.30966874851766935,0.4752822898040425,0.975609756097561,0.9989175508554463,1.0,5/5,69.05%,PRKCB;DCAF1;PRKCA;PKN1;VRK1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.25178073124272,-0.4748927624687682,1.0,1.0,1.0,4/16,31.67%,DGKD;DGKH;PNPLA2;DGKG
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.2788100264206891,-0.47480558218951335,0.9516129032258065,1.0,1.0,3/6,30.06%,NFE2L2;BCAP31;HERPUD1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.2789594370206372,0.4731640035064549,0.96875,0.9988547789996152,1.0,7/7,72.12%,MAN2C1;MAN2B2;NEU1;NEU3;MAN2B1;GBA3;MANBA
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.2956112683309598,-0.47231394304652236,0.9824561403508771,1.0,1.0,3/8,22.53%,AKAP8;CTBP1;AKAP8L
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.2587105385825844,0.47184482141613615,1.0,0.9986696193012803,1.0,2/12,18.25%,SRSF12;CD2BP2
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.28925993631584485,-0.4716635553029866,1.0,1.0,1.0,2/7,15.95%,CENPF;MIS12
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.29065201733267254,-0.47136419028399124,0.9814814814814815,1.0,1.0,3/8,24.03%,TNFAIP3;NR1D1;LYN
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.30109907487941817,0.4702381438916224,0.975,0.998479057886217,1.0,7/7,69.91%,SYK;DEF8;ATP6AP1;PRKCA;SPP1;PLEKHM1;TNFRSF11A
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.2516884337311277,0.46912332882471325,1.0,0.9982497374819728,1.0,2/11,20.20%,GSK3B;PLS1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.2794967704559178,-0.4683306373133898,0.9672131147540983,1.0,1.0,2/8,19.08%,PTN;PURB
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.21649051692159943,-0.4635002738257255,1.0,1.0,1.0,5/49,16.56%,MED25;VENTX;CCND1;MED12;MED30
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.2517667290849052,-0.4624547380491676,1.0,1.0,1.0,2/16,17.07%,PRKAR1B;PRKAR2B
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.2698877115293375,0.4617399189359751,1.0,0.9992934676111269,1.0,8/8,73.03%,TOP2B;TOP3A;TOP1;ERCC3;HMGB1;TOP3B;HMGB2;TOP2A
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.27825979954051944,-0.46157746088316637,1.0,1.0,1.0,2/5,31.86%,PSMC3;CCNK
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.27625690917638224,0.45962211866570324,1.0,0.9992584481411823,1.0,2/8,14.38%,SLC31A1;STEAP3
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.26846092779219777,0.4595009140245847,1.0,0.9988458236773637,1.0,2/10,15.64%,BRPF3;FAF1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.24875443448410817,0.45776346462684053,0.9285714285714286,0.9987000084403218,1.0,3/8,23.26%,USP14;UBQLN1;SGTA
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.28913662239089183,-0.4567510320325056,0.9818181818181818,1.0,1.0,6/6,71.11%,ATP2B4;SLC8B1;SLC8A2;LETM1;ATP2B1;SLC35G1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.3066895686559999,0.4540040736735717,0.9795918367346939,0.9989038839239228,1.0,1/5,14.11%,SCPEP1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.28003894761042636,-0.4536646671528548,0.9838709677419355,1.0,1.0,2/7,31.33%,APH1B;GALNT11
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.24218215338237772,-0.4493775909889577,1.0,1.0,1.0,5/11,28.23%,BRCA1;LRIF1;SMCHD1;YTHDC1;METTL3
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.2699156253945685,0.4468096387699092,1.0,0.9991946834306981,1.0,2/7,19.85%,ADCY6;ADCY1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.2699156253945685,0.4468096387699092,1.0,0.9991946834306981,1.0,2/7,19.85%,ADCY6;ADCY1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.24573233129706515,-0.4460020362553375,1.0,1.0,1.0,2/12,19.31%,PATL2;LSM4
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.2816771977737435,-0.4451663507816334,0.9642857142857143,1.0,1.0,4/7,29.80%,LYN;FGR;LILRB1;LILRB2
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.27385901644608396,0.4451461791425585,0.9767441860465116,0.9989990973222065,1.0,3/6,30.67%,TNF;LPL;TIRAP
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.24865984119125772,0.442311537297458,0.9722222222222222,0.9990861700281088,1.0,5/10,27.78%,RHOBTB1;XKR6;MEGF10;RHOH;XKR4
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.2848446517511266,0.44104640666373296,0.9523809523809523,0.9988741909100317,1.0,5/5,71.53%,GBF1;PLK3;GOLGA2;VRK1;STX5
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.2903396318489061,-0.4403102458566753,0.9607843137254902,1.0,1.0,1/5,17.47%,KDM1B
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.26626116765265184,-0.43724172288556873,1.0,1.0,1.0,4/9,27.20%,PDHA1;ACSS1;PDHB;MLYCD
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.23743048564073022,-0.4361973546460362,1.0,1.0,1.0,6/16,32.76%,CDKN1C;CDKN1A;TFAP4;CDKN1B;HEXIM1;CDKN2A
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.25732060934212914,0.43312079616682625,0.9787234042553191,0.9995755380961758,1.0,3/7,27.68%,FNBP1L;PACSIN2;BIN3
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.2640389176017168,-0.43268586774368617,0.9824561403508771,1.0,1.0,2/8,17.15%,CIITA;VIM
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.2662871600253006,0.42901832388118744,1.0,0.9996733113032708,1.0,6/6,73.38%,NSUN3;MTG1;MTG2;ALKBH1;METTL4;MTRES1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.22796058555694923,0.427292606492314,1.0,0.9994447651242596,1.0,2/12,13.12%,SIRT6;SETDB2
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.2268807847480421,-0.42697778164531536,0.9852941176470589,1.0,1.0,13/13,77.34%,HAT1;TOP2A;HMGB2;TOP3B;HMGB1;ERCC3;MTERF1;HHEX;KAT6A;TOP1;TOP3A;TOP2B;ABL1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.27566675787929784,-0.4267793036830981,1.0,1.0,1.0,2/8,22.52%,ZNF16;PITHD1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.28779253636938645,-0.4261764913281016,0.9814814814814815,1.0,1.0,6/6,71.24%,GRK2;GTF2H2;ADRB2;GRK3;ARRB1;ARRB2
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.2749543779918445,0.4255905163304543,1.0,0.9992164169064257,1.0,1/5,22.20%,LOXL2
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.269556134583931,-0.42309602674524505,0.984375,1.0,1.0,1/7,18.17%,CD74
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.2596546135774692,-0.4203986637451577,0.9838709677419355,1.0,1.0,2/8,31.66%,PINK1;HEBP2
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.2707584964859427,-0.4202388785043168,0.9830508474576272,1.0,1.0,1/6,20.07%,PINK1
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.25516951597178417,0.4146554453627923,1.0,1.0,1.0,3/7,25.93%,ERCC4;ERCC1;WAPL
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.24096515820226816,-0.41334809331703104,1.0,1.0,1.0,3/7,36.25%,THBS4;AAMP;PLAT
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.2712260094164949,-0.40757555133095424,1.0,1.0,1.0,1/6,14.46%,C1QBP
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.2463132354468363,0.4063942889608362,1.0,1.0,1.0,2/6,23.52%,SETD4;SETD1B
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.24180568319424545,0.40560068524610166,1.0,1.0,1.0,3/7,22.51%,PIK3CA;ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.21589520864100697,-0.4041617741769502,1.0,1.0,1.0,10/23,32.72%,SLU7;LUC7L3;SF3A3;SF3A1;SNRPC;YTHDC1;SRSF5;PSIP1;SRSF9;SRSF10
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.23469264586218924,0.40127158642782906,1.0,0.9999602329567532,1.0,3/11,20.18%,TOGARAM1;CCDC40;DNAAF2
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.22327684097471096,0.3981723954975315,1.0,0.9997873060219667,1.0,1/11,11.55%,UBE2N
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.23679215438152482,-0.39764005642143435,1.0,1.0,1.0,10/10,76.35%,SLC17A9;LRRC8A;SLC25A42;SLC19A1;SLC25A17;SLC25A24;ABCC4;ABCC5;SLC25A4;LRRC8D
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.23036919217027307,-0.3951915370924815,0.9824561403508771,1.0,1.0,1/9,16.86%,IL1B
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.18562207822901705,-0.3875987172882401,1.0,1.0,1.0,7/49,22.60%,EFHC1;TTC19;STMN1;SNX9;CKAP2;MITD1;SEPTIN9
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.24238356840236364,-0.3853104998261622,1.0,1.0,1.0,3/8,24.59%,PICK1;ATP6V0A2;NDUFS2
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.25849507779723785,-0.3827048420350879,1.0,1.0,1.0,3/6,35.47%,SHMT1;PAICS;UMPS
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.19461018504519872,0.37753320122672734,1.0,1.0,1.0,2/17,17.57%,NSD3;PRMT7
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.21643207338288795,0.3744996577507198,1.0,1.0,1.0,8/8,78.37%,AKT2;IRS2;MFSD2A;MTLN;PPARA;TYSND1;AKT1;LONP2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.20044291752189064,-0.36423818925330237,1.0,1.0,1.0,5/14,32.76%,CDKN1C;TFAP4;CDKN1B;HEXIM1;CDKN2A
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.218405319297238,-0.3506724640098752,1.0,1.0,1.0,1/11,14.57%,MCM7
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.2142461854692069,0.3470442541747311,1.0,0.9998403391416852,1.0,5/5,78.58%,USP7;STPG4;USP9X;OTUD4;TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.2142461854692069,0.3470442541747311,1.0,0.9998403391416852,1.0,5/5,78.58%,USP7;STPG4;USP9X;OTUD4;TOX
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.23177563711502083,-0.342938523923229,1.0,1.0,1.0,1/5,18.90%,STOML2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.21512315843363528,-0.32661251182460105,1.0,0.9999345474776234,1.0,2/6,28.73%,PINK1;REST
